isoniazid has been researched along with Pulmonary Consumption in 4830 studies
Hydra: A genus of freshwater polyps in the family Hydridae, order Hydroida, class HYDROZOA. They are of special interest because of their complex organization and because their adult organization corresponds roughly to the gastrula of higher animals.
hydrazide : Compounds derived from oxoacids RkE(=O)l(OH)m (l =/= 0) by replacing -OH by -NRNR2 (R groups are commonly H). (IUPAC).
| Excerpt | Relevance | Reference |
|---|---|---|
| "In people with HIV-associated DS-PTB with CD4+ counts ≥100 cells/μL on efavirenz-based ART, the 4-month daily rifapentine-moxifloxacin regimen was noninferior to the 6-month control regimen and was safe." | 9.69 | Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349). ( Bryant, K; Chaisson, RE; Dawson, R; Dooley, KE; Dorman, SE; Johnson, JL; Kurbatova, E; Lalloo, UG; Mohapi, L; Muzanyi, G; Nahid, P; Pettit, AC; Phillips, PPJ; Podany, AT; Samaneka, W; Sanne, I; Savic, RM; Scott, N; Sizemore, E; Swindells, S; Vernon, A; Waja, Z, 2023) |
| "The aim was to evaluate the efficacy, safety and completion rate of 3-month, once-weekly rifapentine and isoniazid for tuberculosis (TB) prevention among Chinese silicosis patients." | 9.41 | Efficacy and safety of weekly rifapentine and isoniazid for tuberculosis prevention in Chinese silicosis patients: a randomized controlled trial. ( Cai, LM; Hong, JJ; Huang, XT; Jiang, T; Lin, MY; Ling, Q; Liu, XF; Ma, CL; Mao, JC; Pan, KC; Peng, GQ; Ruan, QL; Shao, LY; Shen, YJ; Wang, XD; Wang, XZ; Wu, J; Wu, TZ; Yang, QL; Zhang, WH, 2021) |
| " The aim of the study was to document the pharmacokinetics of the first-line anti-TB agents in children <2 years of age comparing previous and revised WHO dosages of isoniazid (INH; 5 versus 10 mg/kg/day), rifampin (RMP; 10 versus 15 mg/kg/day), and pyrazinamide (PZA; 25 versus 35 mg/kg/day) and to investigate the effects of clinical covariates, including HIV coinfection, nutritional status, age, gender, and type of tuberculosis (TB), and the effect of NAT2 acetylator status." | 9.15 | Pharmacokinetics of isoniazid, rifampin, and pyrazinamide in children younger than two years of age with tuberculosis: evidence for implementation of revised World Health Organization recommendations. ( Donald, PR; Hesseling, AC; Magdorf, K; Roll, S; Rosenkranz, B; Schaaf, HS; Seddon, JA; Seifart, HI; Thee, S; Werely, CJ, 2011) |
| "To investigate the efficacy and safety of Isoniazid prophylaxis (INHP) for tuberculosis in Chinese patients with rheumatoid arthritis (RA) who receive long-term Methotrexate (MTX) therapy." | 9.14 | [Isoniazid prophylaxis for pulmonary tuberculosis in Chinese patients with rheumatoid arthritis receiving long-term methotrexate therapy]. ( Wen, FQ; Xie, QB; Yin, G, 2009) |
| "To study intralesional concentrations of isoniazid (INH), rifampicin (RMP) and pyrazinamide (PZA) in tuberculous pleural effusions and psoas abscesses, and to compare these to reference serum values and minimal inhibitory concentration (MIC)." | 9.11 | Penetration of isoniazid, rifampicin and pyrazinamide in tuberculous pleural effusion and psoas abscess. ( Jutte, PC; Rutgers, SR; Uges, DR; Van Altena, R; Van Horn, JR, 2004) |
| "Isoniazid is recommended for prevention of tuberculosis (TB) in HIV-infected adults, but its efficacy in children living with HIV (CLHIV) is not known." | 8.98 | Isoniazid for the Prevention of Tuberculosis in HIV-Infected Children: A Systematic Review and Meta-Analysis. ( Charan, J; Emmanuel, P; Goyal, JP; Kumar, A; Patel, A; Reljic, T, 2018) |
| "We have experienced a case of isoniazid induced pancreatitis." | 8.88 | Isoniazid-induced recurrent pancreatitis. ( Aflalo, V; Biour, M; Bouchaud, O; Chabrol, A; Mattioni, S; Mechai, F; Raynaud, JJ; Zamy, M, 2012) |
| "A case of isoniazid induced gynecomastia is being reported in an 18-year old male, who received a re-treatment regimen for the relapse of pulmonary tuberculosis (TB)." | 8.87 | Unilateral and painless development of isoniazid induced gynecomastia during re-treatment of pulmonary tuberculosis. ( Behera, D; Gupta, R; Jaiswal, A; Kumar, L; Murar, A; Puri, MM, 2011) |
| "We experienced 4 cases of agranulocytosis due to anti-tuberculosis drugs (rifampicin [RFP], isoniazid [INH], ethambutol [EB], streptomycin [SM] or pyrazinamide [PZA]) among some 6,400 tuberculosis patients who underwent chemotherapy over the past 20 years from 1981 to 2002 in our hospital, and the incidence rate of agranulocytosis was estimated at 0." | 8.82 | [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature]. ( Akagawa, S; Baba, M; Kawabe, Y; Komatsu, H; Kurashima, A; Machida, K; Masuda, K; Nagai, H; Nagayama, N; Shishido, Y; Tamura, A; Yotsumoto, H, 2003) |
| "Two patients with liver failure secondary to isoniazid hepatotoxicity were successfully treated with orthotopic liver transplantation." | 8.79 | Treatment of hepatic failure secondary to isoniazid hepatitis with liver transplantation. ( Esquivel, CO; Farrell, FJ; Imperial, JC; Keeffe, EB; Man, KM, 1994) |
| "Isoniazid resistant Mycobacterium tuberculosis (Hr-TB) is the most frequently encountered TB resistance phenotype in North America but limited data exist on the effectiveness of current therapeutic regimens." | 7.96 | Incidence, treatment, and outcomes of isoniazid mono-resistant Mycobacterium tuberculosis infections in Alberta, Canada from 2007-2017. ( Cooper, R; Edwards, BD; Edwards, J; Fisher, D; Kunimoto, D; Somayaji, R, 2020) |
| "Lopinavir-ritonavir forms the backbone of current first-line antiretroviral regimens in young HIV-infected children." | 7.88 | Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis. ( de Kock, M; Denti, P; Garcia-Prats, AJ; Hesseling, AC; McIlleron, H; Norman, J; Schaaf, HS; Tikiso, T; van der Laan, LE; Wiesner, L; Winckler, J, 2018) |
| "Rifampin (RIF) mono-resistant tuberculosis (RMR-TB) is a rare disease." | 7.85 | Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis. ( Jo, KW; Kim, WS; Lee, SD; Park, S; Shim, TS, 2017) |
| "A large isoniazid-resistant tuberculosis outbreak centred on London, United Kingdom, has been ongoing since 1995." | 7.83 | Whole Genome Sequence Analysis of a Large Isoniazid-Resistant Tuberculosis Outbreak in London: A Retrospective Observational Study. ( Broda, A; Brown, T; Casali, N; Drobniewski, F; Harris, SR; Parkhill, J, 2016) |
| " We report 2 possible cases of isoniazid-induced tenosynovitis." | 7.80 | [Tenosynovitis confirmed by MRI during anti-tuberculous treatment suspected due to isoniazid--2 case reports and literature review]. ( Kobayashi, N; Morino, E; Sugiyama, H; Takasaki, J; Yamamoto, K, 2014) |
| "Pellagra is characterized by dermatitis, diarrhea, dementia and eventually death occurring as a result of niacin or its precursor tryptophan deficiency." | 7.77 | Isoniazid-induced pellagra. ( Altun, F; Bilgili, SG; Calka, O; Karadag, AS, 2011) |
| "Anaphylaxis from isoniazid is a possible side effect to this commonly prescribed antibiotic." | 7.72 | Isoniazid-induced anaphylaxis. ( Crook, MJ, 2003) |
| "We report a case of pleuro-pericarditis related to administration of isoniazid." | 7.72 | [Isoniazid-induced pleuro-pericarditis]. ( Belleguic, C; Brinchault, G; Delaval, P; Jouneau, S; Morel, V; Volatron, AC, 2003) |
| "Treatment of latent Mycobacterium tuberculosis infection with isoniazid can cause hepatotoxicity, but the risk of isoniazid-associated hepatotoxicity among persons coinfected with hepatitis C virus (HCV) is unknown." | 7.71 | Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis. ( Astemborski, J; Bonds, M; Graham, NM; Madison, A; Sadaphal, P; Sheely, L; Sterling, TR; Thomas, DL; Vlahov, D, 2001) |
| "A 63-year-old woman in whom polymyositis had been diagnosed since 1994 was treated with ten mg of prednisolone." | 7.71 | [A case of polymyositis complicated with pulmonary tuberculosis concerned with steroid resistance due to rifampin administration]. ( Hayashi, R; Kawasaki, A; Kobayashi, M; Maruyama, M; Shinoda, C, 2001) |
| "In this study we investigated whether leptin and TNFalpha levels change with improvement in body weight with antituberculotic therapy in active tuberculosis patients." | 7.70 | Relation of leptin and tumor necrosis factor alpha to body weight changes in patients with pulmonary tuberculosis. ( Aral, Y; Cakir, B; Demirbaş, B; Güler, S; Gürsoy, G; Odabaşi, E; Yönem, A, 1999) |
| "We report three patients who experienced hepatotoxic reactions in association with acetaminophen ingestion while undergoing treatment for active tuberculosis with isoniazid, rifampin, and other agents." | 7.69 | Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis. ( Nelson, SD; Nolan, CM; Sandblom, RE; Slattery, JT; Thummel, KE, 1994) |
| "This case study reveals an unusual finding of rapidly proliferative crescentic glomerulonephritis in a patient treated with rifampin who had no other identifiable causes for developing this disease." | 7.69 | Crescentic fibrillary glomerulonephritis associated with intermittent rifampin therapy for pulmonary tuberculosis. ( Gohara, AF; Hamilton, RW; Kohler, LJ; Reeves, RS, 1994) |
| "Noncaseating granulomatous hepatitis may be caused by a variety of drugs, but we have not found, by computer search of the literature, a previous describe of granulomatous hepatitis associated with pyrazinamide." | 7.69 | Pyrazinamide-induced granulomatous hepatitis. ( Buyanowsky, G; Dan, M; Knobel, B; Zaidel, L, 1997) |
| "To report a case of reversible seizures and mental status changes in a dialysis patient given preventive isoniazid therapy." | 7.68 | Reversible seizures and mental status changes in a dialysis patient on isoniazid preventive therapy. ( Asnis, DS; Bhat, JG; Melchert, AF, 1993) |
| "Pharmacokinetic parameters of isoniazid, hydrazine (a metabolite of isoniazid), rifampicin and pyrazinamide in a 74-year-old man with pulmonary tuberculosis who died of submassive hepatic necrosis eight days after starting antituberculosis therapy were compared with those of other elderly patients who did not develop hepatotoxicity." | 7.68 | Hydrazine--a possible cause of isoniazid--induced hepatic necrosis. ( Chan, CH; Chan, KK; Walubo, A; Woo, J, 1992) |
| "A 33-year-old man with AIDS and pleuro-pulmonary tuberculosis was treated with a combination of antituberculous medications for 12 months and with continuation of isoniazid." | 7.68 | Relapse of tuberculosis in a patient with the acquired immunodeficiency syndrome despite 12 months of antituberculous therapy and continuation of isoniazid. ( Jones, WD; Shafer, RW, 1991) |
| "Results are presented of the incidence of hepatitis, nearly always with jaundice, among 1686 patients in clinical trials of the treatment of spinal tuberculosis, of tuberculosis meningitis and of pulmonary tuberculosis with short-course regimens containing rifampicin, isoniazid, streptomycin and pyrazinamide." | 7.67 | Hepatic toxicity in South Indian patients during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin and pyrazinamide. ( Janardhanam, B; Parthasarathy, R; Ramachandran, P; Santha, T; Sarma, GR; Sivasubramanian, S; Somasundaram, PR; Tripathy, SP, 1986) |
| "Since isoniazid is metabolized in man to several derivatives with little or no specific activity against the tubercle bacillus, its rate of inactivation in the body may have an important bearing on its efficacy as an antituberculosis drug." | 7.64 | Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis. ( BHATIA, AL; GANGADHARAM, PR; RADHAKRISHNA, S; SELKON, JB, 1961) |
| "A series of studies on the rate of inactivation of isoniazid in Indian patients with pulmonary tuberculosis in a 1-year comparison of four domiciliary chemotherapeutic regimens-three of isoniazid alone, either in moderate (HI-1 and HI-2 regimens) or in low (H regimen) dosage, and one of isoniazid in low dosage plus p-aminosalicylic acid (PAS) (PH regimen) -has recently been undertaken by the Tuberculosis Chemotherapy Centre, Madras." | 7.64 | Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis. 3. Serum concentrations of isoniazid produced by three regimens of isoniazid alone and one of isoniazid plus PAS. ( DEVADATTA, S; FOX, W; GANGADHARAM, PR; NAIR, CN; SELKON, JB, 1961) |
| "This study from the Tuberculosis Chemotherapy Centre, Madras, summarizes the progress during the second year of the patients in a concurrent comparison of four domiciliary chemotherapeutic regimens (isoniazid plus PAS and three regimens of isoniazid alone) who had bacteriologically active or bacteriologically relapsed pulmonary tuberculosis, with isoniazid-resistant organisms, at the end of the first year of treatment." | 7.64 | The course of pulmonary tuberculosis in patients excreting organisms which have acquired resistance. Response to continued treatment for a second year with isoniazid alone or with isoniazid plus PAS. ( BHATIA, AL; DEVADATTA, S; FOX, W; NARAYANA, AS; RAMAKRISHNAN, CV; SELKON, JB; VELU, S, 1962) |
| "In people with HIV-associated DS-PTB with CD4+ counts ≥100 cells/μL on efavirenz-based ART, the 4-month daily rifapentine-moxifloxacin regimen was noninferior to the 6-month control regimen and was safe." | 5.69 | Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349). ( Bryant, K; Chaisson, RE; Dawson, R; Dooley, KE; Dorman, SE; Johnson, JL; Kurbatova, E; Lalloo, UG; Mohapi, L; Muzanyi, G; Nahid, P; Pettit, AC; Phillips, PPJ; Podany, AT; Samaneka, W; Sanne, I; Savic, RM; Scott, N; Sizemore, E; Swindells, S; Vernon, A; Waja, Z, 2023) |
| " Eighty children with TBI received a 12-dose once-weekly isoniazid/rifapentine regimen; 79 (99%) completed therapy, 94% reported no adverse events, 1 child had mildly elevated transaminases but 1 adolescent later developed pulmonary TB." | 5.43 | Safety and Adherence for 12 Weekly Doses of Isoniazid and Rifapentine for Pediatric Tuberculosis Infection. ( Cruz, AT; Starke, JR, 2016) |
| " One hundred patients with pulmonary tuberculosis (65% coinfected with HIV-1) were intensively sampled to determine rifampin, isoniazid, and pyrazinamide plasma concentrations after 7 to 8 weeks of a daily quadruple-therapy regimen dosed according to World Health Organization (WHO) weight bands." | 5.43 | HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients. ( Chirehwa, M; Denti, P; McIlleron, H; Meintjes, G; Rockwood, N; Wiesner, L; Wilkinson, RJ, 2016) |
| "Rosacea is a common chronic inflammatory cutaneous disease of unknown etiology, characterized by remissions and exacerbations, presenting with centrofacial erythema and telangiectasias." | 5.42 | Pyridoxine induced rosacea-like dermatitis. ( Mokos, ZB; Paštar, Z; Rezaković, S, 2015) |
| "The aim was to evaluate the efficacy, safety and completion rate of 3-month, once-weekly rifapentine and isoniazid for tuberculosis (TB) prevention among Chinese silicosis patients." | 5.41 | Efficacy and safety of weekly rifapentine and isoniazid for tuberculosis prevention in Chinese silicosis patients: a randomized controlled trial. ( Cai, LM; Hong, JJ; Huang, XT; Jiang, T; Lin, MY; Ling, Q; Liu, XF; Ma, CL; Mao, JC; Pan, KC; Peng, GQ; Ruan, QL; Shao, LY; Shen, YJ; Wang, XD; Wang, XZ; Wu, J; Wu, TZ; Yang, QL; Zhang, WH, 2021) |
| "Isoniazid monotherapy was restarted after 2 weeks." | 5.38 | A case of isoniazid-induced thrombocytopenia: recovery with immunoglobulin therapy. ( Cho, YJ; Hwang, YS; Jeong, YY; Kim, HC; Kim, YE; Lee, EJ; Lee, JD; Lee, SH; Lee, SJ, 2012) |
| "Isoniazid (INH) is an integral component of treatment of tuberculosis." | 5.38 | Seizures with single therapeutic dose of isoniazid. ( Behera, D; Kumar, L; Puri, MM; Vishwakarma, PD, 2012) |
| "Resectional lung surgery combined with isoniazid- and rifampin-based anti-tuberculous chemotherapy can be an effective treatment strategy for patients with well-localized, cavitary pulmonary MDR-TB and XDR-TB." | 5.35 | Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. ( Cho, JS; Kang, H; Kim, JH; Park, SK; Smego, RA, 2009) |
| "The isoniazid was discontinued, and the gynecomastia was partially resolved by the end of treatment." | 5.35 | Gynecomastia: a rare adverse effect of isoniazid. ( Braz, AG; Maia, JA; Morrone Junior, N; Morrone, N, 2008) |
| "There was no further recurrence during successful treatment with full doses of rifampicin and pyrazinamide for 1 year." | 5.29 | Recurrent acute pancreatitis induced by isoniazid. ( Chan, HS; Chan, KL; Lai, KN; Lui, SF, 1994) |
| "Isoniazid did not cause greater hepatotoxicity in hepatitis B carriers than in noncarriers." | 5.27 | Isoniazid prophylaxis in hepatitis B carriers. ( London, WT; Lustbader, ED; McGlynn, KA; Murphy, EC; Sharrar, RG, 1986) |
| " The aim of the study was to document the pharmacokinetics of the first-line anti-TB agents in children <2 years of age comparing previous and revised WHO dosages of isoniazid (INH; 5 versus 10 mg/kg/day), rifampin (RMP; 10 versus 15 mg/kg/day), and pyrazinamide (PZA; 25 versus 35 mg/kg/day) and to investigate the effects of clinical covariates, including HIV coinfection, nutritional status, age, gender, and type of tuberculosis (TB), and the effect of NAT2 acetylator status." | 5.15 | Pharmacokinetics of isoniazid, rifampin, and pyrazinamide in children younger than two years of age with tuberculosis: evidence for implementation of revised World Health Organization recommendations. ( Donald, PR; Hesseling, AC; Magdorf, K; Roll, S; Rosenkranz, B; Schaaf, HS; Seddon, JA; Seifart, HI; Thee, S; Werely, CJ, 2011) |
| "To investigate the efficacy and safety of Isoniazid prophylaxis (INHP) for tuberculosis in Chinese patients with rheumatoid arthritis (RA) who receive long-term Methotrexate (MTX) therapy." | 5.14 | [Isoniazid prophylaxis for pulmonary tuberculosis in Chinese patients with rheumatoid arthritis receiving long-term methotrexate therapy]. ( Wen, FQ; Xie, QB; Yin, G, 2009) |
| "South African guidelines recommend protease-inhibitor-based antiretroviral therapy (ART) with lopinavir-ritonavir for human immunodeficiency virus (HIV)-infected children <36 months of age." | 5.14 | Initial response to protease-inhibitor-based antiretroviral therapy among children less than 2 years of age in South Africa: effect of cotreatment for tuberculosis. ( Abrams, EJ; Coovadia, A; Ko, S; Kuhn, L; Meyers, T; Reitz, C; Sherman, G; Strehlau, R, 2010) |
| "To study intralesional concentrations of isoniazid (INH), rifampicin (RMP) and pyrazinamide (PZA) in tuberculous pleural effusions and psoas abscesses, and to compare these to reference serum values and minimal inhibitory concentration (MIC)." | 5.11 | Penetration of isoniazid, rifampicin and pyrazinamide in tuberculous pleural effusion and psoas abscess. ( Jutte, PC; Rutgers, SR; Uges, DR; Van Altena, R; Van Horn, JR, 2004) |
| "A history of alcoholism is often regarded as a relative contraindication to the use of isoniazid and rifampin in patients with tuberculosis." | 5.05 | Rifampin-isoniazid therapy of alcoholic and nonalcoholic tuberculous patients in a U.S. Public Health Service Cooperative Therapy Trial. ( Banner, AS; Cross, FS; Long, MW; Snider, DE, 1980) |
| "Isoniazid is recommended for prevention of tuberculosis (TB) in HIV-infected adults, but its efficacy in children living with HIV (CLHIV) is not known." | 4.98 | Isoniazid for the Prevention of Tuberculosis in HIV-Infected Children: A Systematic Review and Meta-Analysis. ( Charan, J; Emmanuel, P; Goyal, JP; Kumar, A; Patel, A; Reljic, T, 2018) |
| "We have experienced a case of isoniazid induced pancreatitis." | 4.88 | Isoniazid-induced recurrent pancreatitis. ( Aflalo, V; Biour, M; Bouchaud, O; Chabrol, A; Mattioni, S; Mechai, F; Raynaud, JJ; Zamy, M, 2012) |
| "In this systematic review, we present information relating to the effectiveness and safety of the following interventions: adding pyrazinamide in chemotherapy regimens lasting up to 6 months, adding rifampicin to isoniazid regimens, benefits of different regimens, chemotherapy for <6 months, daily chemotherapy, direct observation treatment, intermittent chemotherapy for 6 months or longer, isoniazid, low-level laser therapy for pulmonary tuberculosis, regimens containing quinolones, rifampicin plus isoniazid, substituting rifampicin with ethambutol in the continuous phase, and support mechanisms for directly observed treatment." | 4.87 | Tuberculosis (HIV-negative people). ( Eisenhut, M; Ziganshina, LE, 2011) |
| "A case of isoniazid induced gynecomastia is being reported in an 18-year old male, who received a re-treatment regimen for the relapse of pulmonary tuberculosis (TB)." | 4.87 | Unilateral and painless development of isoniazid induced gynecomastia during re-treatment of pulmonary tuberculosis. ( Behera, D; Gupta, R; Jaiswal, A; Kumar, L; Murar, A; Puri, MM, 2011) |
| "In this systematic review we present information relating to the effectiveness and safety of the following interventions: adding pyrazinamide in chemotherapy regimens lasting up to 6 months; adding rifampicin to isoniazid regimens; benefits of different regimens; chemotherapy for less than 6 months; daily chemotherapy; direct observation treatment; intermittent chemotherapy for 6 months or longer; isoniazid; low-level laser therapy for pulmonary tuberculosis; regimens containing quinolones; rifampicin plus isoniazid; substituting rifampicin with ethambutol in the continuous phase; and support mechanisms for directly observed treatment." | 4.85 | Tuberculosis (HIV-negative people). ( Garner, P; Ziganshina, LE, 2009) |
| "We experienced 4 cases of agranulocytosis due to anti-tuberculosis drugs (rifampicin [RFP], isoniazid [INH], ethambutol [EB], streptomycin [SM] or pyrazinamide [PZA]) among some 6,400 tuberculosis patients who underwent chemotherapy over the past 20 years from 1981 to 2002 in our hospital, and the incidence rate of agranulocytosis was estimated at 0." | 4.82 | [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature]. ( Akagawa, S; Baba, M; Kawabe, Y; Komatsu, H; Kurashima, A; Machida, K; Masuda, K; Nagai, H; Nagayama, N; Shishido, Y; Tamura, A; Yotsumoto, H, 2003) |
| "Two patients with liver failure secondary to isoniazid hepatotoxicity were successfully treated with orthotopic liver transplantation." | 4.79 | Treatment of hepatic failure secondary to isoniazid hepatitis with liver transplantation. ( Esquivel, CO; Farrell, FJ; Imperial, JC; Keeffe, EB; Man, KM, 1994) |
| "Isoniazid resistant Mycobacterium tuberculosis (Hr-TB) is the most frequently encountered TB resistance phenotype in North America but limited data exist on the effectiveness of current therapeutic regimens." | 3.96 | Incidence, treatment, and outcomes of isoniazid mono-resistant Mycobacterium tuberculosis infections in Alberta, Canada from 2007-2017. ( Cooper, R; Edwards, BD; Edwards, J; Fisher, D; Kunimoto, D; Somayaji, R, 2020) |
| " Since 25% of the drug resistance was attributable to sanctuary EPTB sites notorious for poor rifampin penetration, we hypothesize that poor anti-tuberculosis drug dosing might have a role in the development of resistance." | 3.96 | Machine learning reveals that Mycobacterium tuberculosis genotypes and anatomic disease site impacts drug resistance and disease transmission among patients with proven extra-pulmonary tuberculosis. ( Magazi, BT; Malinga, LA; Maningi, NE; Mbelle, NN; Pasipanodya, JG; Shey, BA; Sibandze, DB, 2020) |
| "Lopinavir-ritonavir forms the backbone of current first-line antiretroviral regimens in young HIV-infected children." | 3.88 | Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis. ( de Kock, M; Denti, P; Garcia-Prats, AJ; Hesseling, AC; McIlleron, H; Norman, J; Schaaf, HS; Tikiso, T; van der Laan, LE; Wiesner, L; Winckler, J, 2018) |
| "Rifampin (RIF) mono-resistant tuberculosis (RMR-TB) is a rare disease." | 3.85 | Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis. ( Jo, KW; Kim, WS; Lee, SD; Park, S; Shim, TS, 2017) |
| "A child's risk of developing tuberculosis (TB) can be reduced by nearly 60% with administration of 6 months course of isoniazid preventive therapy (IPT)." | 3.83 | Uptake of Isoniazid Preventive Therapy among Under-Five Children: TB Contact Investigation as an Entry Point. ( Daba, S; G Suarez, P; Gashu, Z; Gebre, N; Habte, D; Hiruy, N; Jerene, D; K Haile, Y; Kassie, Y; Melese, M; Melkieneh, K; Negash, S; Tadesse, Y, 2016) |
| "A large isoniazid-resistant tuberculosis outbreak centred on London, United Kingdom, has been ongoing since 1995." | 3.83 | Whole Genome Sequence Analysis of a Large Isoniazid-Resistant Tuberculosis Outbreak in London: A Retrospective Observational Study. ( Broda, A; Brown, T; Casali, N; Drobniewski, F; Harris, SR; Parkhill, J, 2016) |
| " We report 2 possible cases of isoniazid-induced tenosynovitis." | 3.80 | [Tenosynovitis confirmed by MRI during anti-tuberculous treatment suspected due to isoniazid--2 case reports and literature review]. ( Kobayashi, N; Morino, E; Sugiyama, H; Takasaki, J; Yamamoto, K, 2014) |
| " tuberculosis by MTBDRplus, this assay's sensitivity and specificity for rifampin resistance were 85." | 3.78 | Genotype MTBDRplus for direct detection of Mycobacterium tuberculosis and drug resistance in strains from gold miners in South Africa. ( Beylis, N; Chihota, VN; Churchyard, GJ; Dorman, SE; Fielding, KL; Grant, AD; Lewis, JJ; Mathema, B; van der Meulen, M, 2012) |
| " The objectives of this investigation were to evaluate the impact of body weight on the overall systemic exposure to pyrazinamide (PZA) and to assess whether the use of one fixed dose, without adjustment according to weight, would ensure target exposure and safety requirements across the overall patient population." | 3.78 | Feasibility of a fixed-dose regimen of pyrazinamide and its impact on systemic drug exposure and liver safety in patients with tuberculosis. ( Della Pasqua, O; Sahota, T, 2012) |
| " She had pulmonary tuberculosis and developed a fever, systemic exudative erythema, exanthema, and epidermolysis covering 30% of her body surface area while being treated with four agents, including isoniazid (INH) and rifampicin (RFP)." | 3.78 | [A case of Stevens-Johnson syndrome (SJS) progressive toxic epidermal necrolysis (TEN) onset during hyposensitization therapy for pulmonary tuberculosis complicated with dermatomyositis]. ( Mimori, A; Takahashi, Y; Ueda, Y; Yamashita, H, 2012) |
| "Pellagra is characterized by dermatitis, diarrhea, dementia and eventually death occurring as a result of niacin or its precursor tryptophan deficiency." | 3.77 | Isoniazid-induced pellagra. ( Altun, F; Bilgili, SG; Calka, O; Karadag, AS, 2011) |
| "A 12-year-old girl with latent Mycobacterium tuberculosis infection and currently receiving prophylaxis with isoniazid presented with nausea, vomiting and increasing frontal headache." | 3.75 | Your diagnosis? A 12-year-old girl with latent tuberculosis presenting with nausea, vomiting and increasing frontal headache. ( Catania, P; Chiappini, E; De Gaudio, M; de Martino, M; Galli, L; Mussa, F, 2009) |
| "We report the case of a 13-year-old girl with tuberculosis who developed persistent symptomatic thrombocytopenia whilst being treated with rifampicin and isoniazid." | 3.75 | Carry on doctor. ( Carroll, WD; Nair, S, 2009) |
| "A 25-year-old, 54-kg Hispanic man who had recently started multidrug therapy for pulmonary tuberculosis presented in status epilepticus after ingesting 9 g of isoniazid in a suicide attempt." | 3.73 | Acute isoniazid toxicity and the need for adequate pyridoxine supplies. ( Malesker, M; Morrow, LE; Schuller, D; Wear, RE, 2006) |
| "Anaphylaxis from isoniazid is a possible side effect to this commonly prescribed antibiotic." | 3.72 | Isoniazid-induced anaphylaxis. ( Crook, MJ, 2003) |
| "The capacity to generate a chronic and persistent infection in the experimental murine model of tuberculosis induced aerogenically by a low-dose inoculum was determined in eight isoniazid-resistant clinical strains of Mycobacterium tuberculosis showing different catalase-peroxidase (C-P) activities." | 3.72 | Catalase-peroxidase activity has no influence on virulence in a murine model of tuberculosis. ( Amat, I; Ariza, A; Ausina, V; Cardona, PJ; Díaz, J; Gordillo, S; Llatjós, R; Lonca, J; Pallarés, A; Vilaplana, C, 2003) |
| "We report a case of pleuro-pericarditis related to administration of isoniazid." | 3.72 | [Isoniazid-induced pleuro-pericarditis]. ( Belleguic, C; Brinchault, G; Delaval, P; Jouneau, S; Morel, V; Volatron, AC, 2003) |
| "Treatment of latent Mycobacterium tuberculosis infection with isoniazid can cause hepatotoxicity, but the risk of isoniazid-associated hepatotoxicity among persons coinfected with hepatitis C virus (HCV) is unknown." | 3.71 | Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis. ( Astemborski, J; Bonds, M; Graham, NM; Madison, A; Sadaphal, P; Sheely, L; Sterling, TR; Thomas, DL; Vlahov, D, 2001) |
| "A 63-year-old woman in whom polymyositis had been diagnosed since 1994 was treated with ten mg of prednisolone." | 3.71 | [A case of polymyositis complicated with pulmonary tuberculosis concerned with steroid resistance due to rifampin administration]. ( Hayashi, R; Kawasaki, A; Kobayashi, M; Maruyama, M; Shinoda, C, 2001) |
| "In this study we investigated whether leptin and TNFalpha levels change with improvement in body weight with antituberculotic therapy in active tuberculosis patients." | 3.70 | Relation of leptin and tumor necrosis factor alpha to body weight changes in patients with pulmonary tuberculosis. ( Aral, Y; Cakir, B; Demirbaş, B; Güler, S; Gürsoy, G; Odabaşi, E; Yönem, A, 1999) |
| "Using a Markov decision-analysis model, the following three strategies were evaluated for treatment of latent tuberculosis infection in pregnancy, defined as positive tuberculin skin reaction of 10 mm or greater and negative chest radiograph: no treatment, antepartum isoniazid administration, in which women were given 300 mg of isoniazid with pyridoxine beginning at 20 weeks' gestation for 6 months; and postpartum isoniazid, in which women were given isoniazid and pyridoxine for 6 months after delivery." | 3.70 | Antepartum or postpartum isoniazid treatment of latent tuberculosis infection. ( Boggess, KA; Hamilton, CD; Myers, ER, 2000) |
| "We report three patients who experienced hepatotoxic reactions in association with acetaminophen ingestion while undergoing treatment for active tuberculosis with isoniazid, rifampin, and other agents." | 3.69 | Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis. ( Nelson, SD; Nolan, CM; Sandblom, RE; Slattery, JT; Thummel, KE, 1994) |
| "To test the efficacy of a short-course regimen of 6 months rifampicin and isoniazid supplemented by 2 months initial pyrazinamide (2HRZ-4HR), in the treatment of smear and culture-negative pulmonary tuberculosis and tuberculous pleural effusion in routine clinical practice." | 3.69 | Short-course chemotherapy for tuberculous pleural effusion and culture-negative pulmonary tuberculosis. ( Horsfield, N; McCarthy, OR; Ormerod, LP; Rudd, RM, 1995) |
| "This case study reveals an unusual finding of rapidly proliferative crescentic glomerulonephritis in a patient treated with rifampin who had no other identifiable causes for developing this disease." | 3.69 | Crescentic fibrillary glomerulonephritis associated with intermittent rifampin therapy for pulmonary tuberculosis. ( Gohara, AF; Hamilton, RW; Kohler, LJ; Reeves, RS, 1994) |
| "Noncaseating granulomatous hepatitis may be caused by a variety of drugs, but we have not found, by computer search of the literature, a previous describe of granulomatous hepatitis associated with pyrazinamide." | 3.69 | Pyrazinamide-induced granulomatous hepatitis. ( Buyanowsky, G; Dan, M; Knobel, B; Zaidel, L, 1997) |
| " Overall, 33 percent of these patients had isolates resistant to one or more antituberculosis drugs, 26 percent had isolates resistant to at least isoniazid, and 19 percent had isolates resistant to both isoniazid and rifampin." | 3.68 | The emergence of drug-resistant tuberculosis in New York City. ( Cauthen, GM; Dooley, SW; Frieden, TR; Kilburn, JO; Pablos-Mendez, A; Sterling, T, 1993) |
| "To report a case of reversible seizures and mental status changes in a dialysis patient given preventive isoniazid therapy." | 3.68 | Reversible seizures and mental status changes in a dialysis patient on isoniazid preventive therapy. ( Asnis, DS; Bhat, JG; Melchert, AF, 1993) |
| "Pharmacokinetic parameters of isoniazid, hydrazine (a metabolite of isoniazid), rifampicin and pyrazinamide in a 74-year-old man with pulmonary tuberculosis who died of submassive hepatic necrosis eight days after starting antituberculosis therapy were compared with those of other elderly patients who did not develop hepatotoxicity." | 3.68 | Hydrazine--a possible cause of isoniazid--induced hepatic necrosis. ( Chan, CH; Chan, KK; Walubo, A; Woo, J, 1992) |
| "A 33-year-old man with AIDS and pleuro-pulmonary tuberculosis was treated with a combination of antituberculous medications for 12 months and with continuation of isoniazid." | 3.68 | Relapse of tuberculosis in a patient with the acquired immunodeficiency syndrome despite 12 months of antituberculous therapy and continuation of isoniazid. ( Jones, WD; Shafer, RW, 1991) |
| "Concentrations of isoniazid and rifampicin were determined in time-matched samples of saliva and serum from 30 tuberculous patients (18 with pulmonary tuberculosis and 12 with intestinal tuberculosis), comprising 18 slow and 12 rapid acetylators of isoniazid, following administration of isoniazid 300 mg and rifampicin 12 mg/kg." | 3.68 | Salivary levels of isoniazid and rifampicin in tuberculous patients. ( Gurumurthy, P; Narayana, AS; Rahman, F; Sarma, GR, 1990) |
| "Results are presented of the incidence of hepatitis, nearly always with jaundice, among 1686 patients in clinical trials of the treatment of spinal tuberculosis, of tuberculosis meningitis and of pulmonary tuberculosis with short-course regimens containing rifampicin, isoniazid, streptomycin and pyrazinamide." | 3.67 | Hepatic toxicity in South Indian patients during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin and pyrazinamide. ( Janardhanam, B; Parthasarathy, R; Ramachandran, P; Santha, T; Sarma, GR; Sivasubramanian, S; Somasundaram, PR; Tripathy, SP, 1986) |
| "An analysis carried out on the dosage schemes adopted in several controlled clinical trials in tuberculosis has indicated that preestablishing the daily doses of isoniazid, rifampicin, and pyrazinamide in the initial intensive phase results in large deviations of the doses administered from those considered appropriate in mg/kg body weight." | 3.67 | Short-course chemotherapy of pulmonary tuberculosis: a new approach to drug dosage in the initial intensive phase. ( Acocella, G; Angel, JH, 1986) |
| "A controlled comparison by the Tuberculosis Chemotherapy Centre, Madras, of the merits of home as compared with sanatorium treatment for pulmonary tuberculosis showed that, at the end of a year of chemotherapy with isoniazid plus p-aminosalicylic acid (PAS), the response of the home patients closely approached that of the sanatorium patients." | 3.64 | Progress in the second and third years of patients with quiescent pulmonary tuberculosis after a year of chemotherapy at home or in sanatorium, and influence of further chemotherapy on the relapse rate. ( ANDREWS, RH; ANGEL, JH; BHATIA, AL; DEVADATTA, S; FOX, W; JANARDHANAM, B; RADHAKRISHNA, S; RAMAKRISHNAN, CV; SUBBAIAH, TV; VELU, S, 1961) |
| "A recent report by the Tuberculosis Chemotherapy Centre, Madras, showed that the response of patients to a year's domiciliary treatment for pulmonary tuberculosis with isoniazid plus p-aminosalicylic acid closely approached that of patients to a year's sanatorium treatment with the same combination of drugs." | 3.64 | Progress in the second year of patients with quiescent pulmonary tuberculosis after a year of chemotherapy at home or in sanatorium, and influence of further chemotherapy on the relapse rate. ( ANDREWS, RH; DEVADATTA, S; FOX, W; RADHAKRISHNA, S; RAMAKRISHNAN, CV; SELKON, JB; SOMASUNDARAM, PR; SUBBAIAH, TV; VELU, S, 1960) |
| "This study from the Tuberculosis Chemotherapy Centre, Madras, compares patients infected with isoniazid-resistant tubercle bacilli ("R" patients) with those infected with isoniazid-sensitive tubercle bacilli ("S" patients) as regards, first, their pretreatment status and, secondly, their response to a year's chemotherapy, either with isoniazid plus p-aminosalicylic acid (PAS) or with isoniazid alone." | 3.64 | Response of patients infected with isoniazid-resistant tubercle bacilli to treatment with isoniazid plus PAS or isoniazid alone. ( ANDREWS, RH; BHATIA, AL; DEVADATTA, S; FOX, W; MITCHISON, DA; RADHAKRISHNA, S; RAMAKRISHNAN, CV; SELKON, JB; VELU, S, 1961) |
| "Since isoniazid is metabolized in man to several derivatives with little or no specific activity against the tubercle bacillus, its rate of inactivation in the body may have an important bearing on its efficacy as an antituberculosis drug." | 3.64 | Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis. ( BHATIA, AL; GANGADHARAM, PR; RADHAKRISHNA, S; SELKON, JB, 1961) |
| "A series of studies on the rate of inactivation of isoniazid in Indian patients with pulmonary tuberculosis in a 1-year comparison of four domiciliary chemotherapeutic regimens-three of isoniazid alone, either in moderate (HI-1 and HI-2 regimens) or in low (H regimen) dosage, and one of isoniazid in low dosage plus p-aminosalicylic acid (PAS) (PH regimen) -has recently been undertaken by the Tuberculosis Chemotherapy Centre, Madras." | 3.64 | Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis. 3. Serum concentrations of isoniazid produced by three regimens of isoniazid alone and one of isoniazid plus PAS. ( DEVADATTA, S; FOX, W; GANGADHARAM, PR; NAIR, CN; SELKON, JB, 1961) |
| "This study from the Tuberculosis Chemotherapy Centre, Madras, summarizes the progress during the second year of those patients in a 1-year comparison of four domiciliary chemotherapeutic regimens (isoniazid plus PAS and three regimens of isoniazid alone) whose pulmonary tuberculosis had attained bacteriological quiescence at the end of the year of chemotherapy." | 3.64 | Progress in the second year of patients with quiescent pulmonary tuberculosis after a year of domiciliary chemotherapy, and influence of further chemotherapy on the relapse rate. ( ANDREWS, RH; ANGEL, JH; DEVADATTA, S; FOX, W; GANGADHARAM, PR; NARAYANA, AS; RAMAKRISHNAN, CV; SELKON, JB; SOMASUNDARAM, PR; VELU, S, 1961) |
| "Recent work carried out at the Tuberculosis Chemotherapy Centre, Madras, and at the Postgraduate Medical School of London has shown that isoniazid-sensitive cultures of tubercle bacilli obtained before the start of chemotherapy from South Indian patients with pulmonary tuberculosis are of lower average virulence than corresponding cultures from British patients." | 3.64 | A COMPARISON OF THE VIRULENCE IN THE GUINEA-PIG OF TUBERCLE BACILLI FROM THAI AND BRITISH PATIENTS. ( BHATIA, AL; HITZE, KL; JACOB, CV; RAMACHANDRAN, K; SELKON, JB, 1963) |
| "This study from the Tuberculosis Chemotherapy Centre, Madras, summarizes the progress during the second year of the patients in a concurrent comparison of four domiciliary chemotherapeutic regimens (isoniazid plus PAS and three regimens of isoniazid alone) who had bacteriologically active or bacteriologically relapsed pulmonary tuberculosis, with isoniazid-resistant organisms, at the end of the first year of treatment." | 3.64 | The course of pulmonary tuberculosis in patients excreting organisms which have acquired resistance. Response to continued treatment for a second year with isoniazid alone or with isoniazid plus PAS. ( BHATIA, AL; DEVADATTA, S; FOX, W; NARAYANA, AS; RAMAKRISHNAN, CV; SELKON, JB; VELU, S, 1962) |
| "People with radiographic evidence for pulmonary tuberculosis (TB), but negative sputum cultures, have increased risk of developing culture-positive TB." | 3.01 | Treatment for radiographically active, sputum culture-negative pulmonary tuberculosis: A systematic review and meta-analysis. ( Carlin, F; Esmail, H; Gray, AT; Houben, RMGJ; Kik, SV; Macpherson, L; MacPherson, P; Quartagno, M; Richards, AS; Rogozińska, E; Sossen, B, 2023) |
| " Secondary outcomes were clinical signs and symptoms of pulmonary TB and adverse drug reactions (ADRs) related to anti-TB agents." | 3.01 | Efficacy and safety of combined isoniazid-rifampicin-pyrazinamide-levofloxacin dry powder inhaler in treatment of pulmonary tuberculosis: A randomized controlled trial. ( Kawkitinarong, K; Laohapojanart, N; Ratanajamit, C; Srichana, T, 2021) |
| "Linezolid is increasingly used for the treatment of tuberculosis resistant to first-line agents, but the most effective dosing strategy is yet unknown." | 2.94 | Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis. ( Burger, DA; Dawson, R; De Jager, VR; Diacon, AH; Everitt, D; Mendel, CM; Narunsky, K; Nedelman, J; Pappas, F; Vanker, N, 2020) |
| " We investigated the incidence of adverse events and cure rates according to HIV status for patients receiving standard TB therapy in the trial." | 2.90 | Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status. ( Crook, AM; Dawson, R; Diacon, AH; Gillespie, SH; McHugh, TD; Mendel, CM; Meredith, SK; Mohapi, L; Murphy, ME; Nunn, AJ; Phillips, PPJ; Singh, KP; Spigelman, M; Tweed, CD, 2019) |
| "Linezolid improves the treatment outcomes of multidrug-resistant tuberculosis substantially." | 2.90 | Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: a prospective, multicentre, randomised, open-label, phase 2 trial. ( Ahn, H; Cho, YJ; Choi, HS; Choi, SM; Hahn, S; Han, J; Heo, EY; Hwang, YR; Jeong, I; Jo, YS; Joh, JS; Ki, J; Kim, DK; Kim, H; Kim, HS; Kim, J; Kim, SJ; Kwak, N; Lee, CH; Lee, J; Lee, JH; Lee, JK; Lee, JY; Lee, M; Lee, SH; Lee, SM; Lee, YJ; Lim, JN; Park, JH; Park, JS; Park, SS; Park, YS; Song, T; Yim, JJ; Yoon, HI, 2019) |
| " 501 (98·0%) of 511 patients had at least one treatment-emergent adverse event." | 2.90 | Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial. ( Balanag, V; Bielskiene, V; Cadena, E; Caoili, J; Cirule, A; Danilovits, M; Davidaviciene, E; Domente, L; Geiter, LJ; Gupta, R; Hafkin, J; Hittel, N; Lizarbe, V; Patientia, R; Petersen, C; Sanchez, E; Segura, P; Staples, S; Ticona, E; Variava, E; von Groote-Bidlingmaier, F; Wells, C; Yu, C, 2019) |
| " Incidence rate of adverse effects was 19." | 2.90 | Efficacy and safety of cholecalciferol-augmented anti-tuberculosis therapy for treatment of naïve patients with pulmonary tuberculosis: A randomized, controlled, clinical study. ( Abd-Ellatief, RB; Hasanain, AFA; Nafee, AMA; Zayed, AAH, 2019) |
| " In conclusion, regimen including PZA seems to be safe for late elderly patients with pulmonary TB." | 2.90 | Safety of pyrazinamide-including regimen in late elderly patients with pulmonary tuberculosis: A prospective randomized open-label study. ( Asaoka, M; Baba, T; Hagiwara, E; Katano, T; Kitamura, H; Komatsu, S; Ogura, T; Okuda, R; Sekine, A; Suido, Y, 2019) |
| "We enrolled HIV-infected Ugandans with pulmonary tuberculosis." | 2.87 | Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations. ( Buzibye, A; Byakika-Kibwika, P; Castelnuovo, B; Corti, N; de Kock, M; Denti, P; Eberhard, N; Fehr, JS; Gutteck, U; Henning, L; Jetter, A; Joloba, M; Kambugu, A; Kamya, MR; Lamorde, M; Ledergerber, B; Manabe, YC; Matovu, J; Muller, D; Musaazi, J; Sekaggya-Wiltshire, C; von Braun, A, 2018) |
| " Intensive pharmacokinetic sampling occurred in 63 patients after 6 weeks of treatment, and safety/tolerability was assessed." | 2.84 | Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis. ( Aarnoutse, RE; Boeree, MJ; Colbers, A; Gillespie, SH; Haraka, F; Hoelscher, M; Kibiki, GS; Logger, JGM; Magis-Escurra, C; Mpagama, SG; Mtabho, CM; Phillips, PPJ; Plemper van Balen, G; Reither, K; Semvua, HH; Sumari-de Boer, IM; Te Brake, LHM; van den Boogaard, J; Wattenberg, M, 2017) |
| "Piperine has been found to increase bioavailability of several drugs including Amoxicillin, Cefotaxime, Theophylline and Propranolol." | 2.84 | A Randomized, Controlled, Phase III Clinical Trial to Evaluate the Efficacy and Tolerability of Risorine with Conventional Rifampicin in the Treatment of Newly Diagnosed Pulmonary Tuberculosis Patients. ( Jagannath, K; Patel, A; Patel, M; Patel, N; Vora, A, 2017) |
| "Reference standards were culture (pulmonary tuberculosis detection); phenotypic DST (pDST), genotypic DST (gDST),composite (pDST and gDST) (drug resistance detection)." | 2.82 | Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin. ( Chaplin, M; Davies, GR; De Vos, M; Pillay, S; Schumacher, SG; Steingart, KR; Theron, G; Warren, R, 2022) |
| " Nonlinear mixed-effects modeling found that influential covariates for the pharmacokinetics were weight, sex, and a 30% increased bioavailability among heterozygous carriers of SLCO1B1 rs1104581 (previously associated with low rifampin concentrations)." | 2.82 | Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis. ( Egan, D; Hennig, S; Kellerman, T; McIlleron, H; Naiker, S; Owen, A; Pym, A; Reddy, T; Wiesner, L, 2016) |
| "There are limited pharmacokinetic data for use of the first-line antituberculosis drugs during infancy (<12 months of age), when drug disposition may differ." | 2.82 | Pharmacokinetics of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol in Infants Dosed According to Revised WHO-Recommended Treatment Guidelines. ( Bekker, A; Donald, PR; Draper, HR; Hesseling, AC; McIlleron, HM; Murray, S; Schaaf, HS; van der Laan, L; Wiesner, L, 2016) |
| "To assess whether increasing the dose of rifampicin (RMP) from 10 mg/kg to 15 or 20 mg/kg results in an increase in grade 3 or 4 hepatic adverse events and/or serious adverse events (SAE)." | 2.82 | A randomised Phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis. ( Atwine, D; Bonnet, M; Borgulya, G; Burgos, M; Checkley, AM; de Fernandes, RA; de Patiño, IW; Dubash, F; Gonzales, T; Harrison, TS; Jindani, A; Mitchison, D; Patel, N; Shrestha, B, 2016) |
| " Median rifapentine area under the concentration-time curve (AUC0-24) was 313 mcg*h/mL, similar to recent studies of rifapentine dosed at 450-600 mg daily." | 2.82 | A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis. ( Armstrong, DT; Barnes, GL; Cavalcante, SC; Chaisson, RE; Cohn, S; Conde, MB; Dalcolmo, M; Dooley, KE; Dorman, SE; Duarte, RS; Durovni, B; Efron, A; Loredo, C; Marzinke, MA; Mello, FC; Moulton, LH; Rolla, V; Savic, RM, 2016) |
| " There was a nonlinear increase in exposure to rifampin without an apparent ceiling effect and a greater estimated fall in bacterial load in the higher dosing groups." | 2.80 | A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis. ( Aarnoutse, RE; Boeree, MJ; Burger, D; Dawson, R; Diacon, AH; du Bois, J; Gillespie, SH; Heinrich, N; Hoelscher, M; Magis-Escurra, C; McHugh, TD; Narunsky, K; Phillips, PP; Plemper van Balen, G; Rehal, S; van Ingen, J; van Soolingen, D; Venter, A, 2015) |
| " We also assessed safety and tolerability by monitoring adverse events." | 2.80 | Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pul ( Burger, DA; Conradie, A; Dawson, R; Diacon, AH; Donald, PR; Eisenach, K; Everitt, D; Ive, P; Mendel, CM; Ntinginya, NE; Page-Shipp, L; Pym, A; Reither, K; Schall, R; Spigelman, M; van Niekerk, C; Variava, E; Venter, A; von Groote-Bidlingmaier, F, 2015) |
| "3%] in the RPT 450 mg, RPT 600 mg and RMP groups), as were ⩾grade 3 adverse events (0/54 [0%], 1/51 [2." | 2.80 | Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis. ( Barnes, GL; Carman, D; Chaisson, RE; Dawson, R; Dorman, SE; Efron, A; Gupte, N; Hoffman, J; McIlleron, H; Narunsky, K; Whitelaw, A, 2015) |
| "To observe the clinical effect on type 2 diabetes mellitus (T2DM) complicated with pulmonary tuberculosis (TB) of insulin, isoniazid, rifampicin, pyrazinamide and ethambutol (conventional medication) administered together with Qi-boosting and Yin-nourishing decoction derived from Traditional Chinese Medicine (TCM)." | 2.80 | Effects on type 2 diabetes complicated with pulmonary tuberculosis: regiment of insulin, isoniazid, rifampicin, pyrazinamide and ethambutol versus the regiment plus Qi-boosting and Yin-nourishing decoction of Traditional Chinese Medicine. ( Shi, G; Zhang, L, 2015) |
| " Data was analysed using population pharmacokinetic modelling." | 2.80 | Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania. ( Andersen, AB; Castel, S; Changalucha, J; Chigutsa, E; Christiansen, M; Denti, P; Faurholt-Jepsen, D; Friis, H; Hagen, CM; Jeremiah, K; McIlleron, H; PrayGod, G; Range, N; Wiesner, L, 2015) |
| " Adverse events were mostly mild and no serious adverse events or drug discontinuations were reported." | 2.78 | Efavirenz, tenofovir and emtricitabine combined with first-line tuberculosis treatment in tuberculosis-HIV-coinfected Tanzanian patients: a pharmacokinetic and safety study. ( Aarnoutse, RE; Boeree, MJ; Burger, DM; Fillekes, Q; Kibiki, GS; Kisanga, ER; Kisonga, RM; Mleoh, L; Mtabho, CM; Ndaro, A; Semvua, HH; van den Boogaard, J; van der Ven, A, 2013) |
| " Noninferiority was dependent on consistent results from a per-protocol and modified intention-to-treat analysis, using 2 different models for the latter, classifying all changes of treatment or refusal to continue treatment (eg, bacteriological failure/relapse, adverse event, default, drug resistance) as unfavorable (model 1) and classifying changes of treatment for reasons other than therapeutic outcomes according to their 18-month bacteriological outcome if available (post hoc model 2)." | 2.76 | Efficacy and safety of a 4-drug fixed-dose combination regimen compared with separate drugs for treatment of pulmonary tuberculosis: the Study C randomized controlled trial. ( Anyo, G; Burgos, M; Cook, SV; Enarson, DA; Jindani, A; Kim, SJ; Lienhardt, C; Nunn, AJ; Rigouts, L; Yorke-Edwards, V, 2011) |
| "Vitamin D deficiency is associated with susceptibility to active tuberculosis (TB) in many settings." | 2.75 | Serum 25-hydroxy-vitamin D3 concentrations increase during tuberculosis treatment in Tanzania. ( Boeree, MJ; Kibiki, GS; Tostmann, A; van der Ven, AJ; Verhoef, H; Wielders, JP, 2010) |
| "Moxifloxacin has potent activity against Mycobacterium tuberculosis in vitro and in a mouse model of antituberculosis (TB) chemotherapy, but data regarding its activity in humans are limited." | 2.74 | Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis. ( Bernardo, J; Bozeman, L; Chaisson, RE; Choudhri, S; Dorman, SE; Goldberg, S; Grosset, JH; Guy, E; Guyadeen, P; Heilig, CM; Johnson, JL; Leus, MC; Maltas, G; Menzies, D; Muzanye, G; Nuermberger, EL; Padayatchi, N; Vernon, A; Villarino, M, 2009) |
| " Pharmacokinetic sampling was performed on day 7 of TMC207 administration up to 24 h postdose." | 2.73 | Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis. ( Allen, J; De Beule, K; De Marez, T; Diacon, AH; Donald, PR; Kerstens, R; Koul, A; McNeeley, DF; Mthiyane, TC; Patientia, RF; Reddy, C; Rustomjee, R; van Heeswijk, R; Venter, A, 2008) |
| "The patients with drug susceptible pulmonary tuberculosis treated with 2HRZE/4H2R2 under the supervision by the pharmacists or the patients treated with 2HRZE/4HR by self-administration were followed-up for two years after completion of chemotherapy." | 2.73 | [Relapse rate of pulmonary tuberculosis within two years following completion of twice weekly intermittent chemotherapy]. ( Hoshino, H; Mitarai, S; Ogata, H; Ohmori, M; Okumura, M; Uchimura, K; Wada, M; Yoshiyama, T, 2008) |
| " With a dosage of 30 mg/kg PZA, efficient serum levels were reached." | 2.73 | Pyrazinamide serum levels in childhood tuberculosis. ( Detjen, A; Magdorf, K; Thee, S; Wahn, U, 2008) |
| "Linezolid has modest early bactericidal activity against rapidly dividing tubercle bacilli in patients with cavitary pulmonary tuberculosis during the first 2 days of administration, but little extended early bactericidal activity." | 2.73 | Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis. ( Boom, WH; Debanne, SM; Dietze, R; Eisenach, K; Hadad, DJ; Johnson, DF; Johnson, JL; Maciel, EL; McGee, B; Molino, LP; Palaci, M; Peloquin, CA, 2008) |
| "Rifampin is a key drug for tuberculosis (TB) treatment." | 2.73 | Pharmacokinetics and tolerability of a higher rifampin dose versus the standard dose in pulmonary tuberculosis patients. ( Aarnoutse, RE; Alisjahbana, B; Nijland, HM; Parwati, I; Ruslami, R; van Crevel, R, 2007) |
| "Patients were treated in a controlled clinical trial with 2HRZE3/6HE with thrice-weekly direct dosing in the intensive phase and once-weekly with six doses self-administered in the continuation phase." | 2.73 | Evaluation of a non-rifampicin continuation phase (6HE) following thrice-weekly intensive phase for the treatment of new sputum positive pulmonary tuberculosis. ( , 2007) |
| " The occurrence of adverse effects was also monitored." | 2.73 | Clinical evaluation and monitoring of adverse effects for fixed multidose combination against single drug therapy in pulmonary tuberculosis patients. ( Chaudhry, A; Jamshaid, M; Zaka-Ur-Rehman, Z, 2008) |
| "The concentration and half-life of theophylline was decreased and its clearance was increased significantly at days 5-7 after administration of antituberculosis agents compared to before the therapy was started." | 2.71 | The clearance of theophylline is increased during the initial period of tuberculosis treatment. ( Ahn, HC; Lee, YC, 2003) |
| "Moxifloxacin has an activity similar to rifampin in human subjects with pulmonary tuberculosis, suggesting that it should undergo further assessment as part of a short course regimen for the treatment of drug-susceptible tuberculosis." | 2.71 | The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis. ( Bongard, E; Gillespie, SH; Gosling, RD; Kanduma, EG; Morris, RW; Nyindo, M; Sam, NE; Uiso, LO, 2003) |
| "Thirty-one patients with documented pulmonary tuberculosis were treated with rifampin/isoniazid for six months, plus pyrazinamide for the first two months." | 2.71 | Use of Rhu-GM-CSF in pulmonary tuberculosis patients: results of a randomized clinical trial. ( Badaró, R; Bandeira, AC; Barberin, MG; Brites, C; Guerra, C; Netto, EM; Pedral-Sampaio, DB, 2003) |
| " There was no significant difference in the pharmacokinetic parameters of rifampicin as a component of Mairin-P and in combination with antitubercuous agents as free dosage forms." | 2.71 | [Assessment of the use of a multicomponent drug in the treatment of new cases of pulmonary tuberculosis]. ( Semenova, OV, 2003) |
| " The present pharmacokinetic study supports further trials to determine the optimal rifapentine dose for treatment of tuberculosis." | 2.71 | Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy. ( Bock, N; Burman, WJ; Goldberg, S; Hayden, K; Khan, A; Peloquin, CA; Sterling, TR; Vernon, A; Weiner, M; Weis, S; Zhao, Z, 2004) |
| "After the completion of the treatment course, the negative sputum conversion rate in V+D+M treatment protocol group was 84%, significantly higher than that in the control group (42%); the former group showed a focal absorption rate and pulmonary cavity closure rate of 83% and 66%, which were 33% and 26% respectively in the latter." | 2.71 | [Short-term effect of treatment protocol utilizing levofloxacin, pasiniazide and M. Vaccae on multi- drug resistant pulmonary tuberculosis]. ( Li, SM; Xing, BC; Zheng, XM, 2004) |
| "Paromomycin was estimated to be 1." | 2.70 | The early bactericidal activity of streptomycin. ( Donald, PR; Doré, CJ; Mitchison, DA; Parkin, DP; Sirgel, FA; Smit, E; Van de Wal, BW; Venter, A, 2002) |
| "Rifapentine has a long half-life in serum, which suggests a possible treatment once a week for tuberculosis." | 2.70 | Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. ( Benator, D; Bhattacharya, M; Bozeman, L; Burman, W; Cantazaro, A; Chaisson, R; Gordin, F; Horsburgh, CR; Horton, J; Khan, A; Lahart, C; Metchock, B; Pachucki, C; Stanton, L; Vernon, A; Villarino, ME; Wang, YC; Weiner, M; Weis, S, 2002) |
| "Fifty patients with drug-resistant pulmonary tuberculosis were managed by withdrawing all anti-tuberculosis drugs until the results of a drug sensitivity test were obtained (approximately 3 months), and then a 12-month self-administered regimen with four to six anti-tuberculosis drugs at full daily doses was initiated, based primarily on the sensitivity test and secondarily on the history of previous treatment." | 2.70 | Results of a 12-month regimen for drug-resistant pulmonary tuberculosis. ( Martínez-Rossier, LA; Pérez-Guzmán, C; Torres-Cruz, A; Vargas, MH; Villarreal-Velarde, H, 2002) |
| " Group II also registered; the maximum cost and highest incidence of adverse effects." | 2.70 | Comparative evaluation of efficacy and safety profile of three anti-tuberculous regimens in Mangalore. ( Beena, S; Pai, MR; Rao, KN, 2002) |
| "115 cases of the senile pulmonary tuberculosis with bacteriological positive were divided into therapy group(group A) and control group(group B1 and B2) randomly." | 2.70 | [Clinical research of pasinizid on retreated sputum positive pulmonary tuberculosis in senilities]. ( Hu, X; Wang, J; Yu, D, 2001) |
| " Further studies with increased rifapentine dosage are necessary." | 2.70 | Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures. ( Chan, SL; Goodall, RL; Kam, KM; Mitchison, DA; Tam, CM, 2002) |
| " Because of poor bioavailability of the rifapentine used (produced in China), its dose size was increased from 600 mg initially to about 750 mg in the last third of patients to obtain serum concentrations similar to those with rifapentine of Western origin; all doses were given after a meal promoting absorption." | 2.69 | Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis. Initial report. ( Chan, SL; Kam, KM; Lam, CW; Leung, CC; Mitchison, DA; Morris, JS; Tam, CM, 1998) |
| "Rifapentine is a cyclopentyl-substituted rifamycin whose serum half-life is five times that of rifampin." | 2.69 | Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium. ( Benator, D; Bozeman, L; Burman, W; Khan, A; Vernon, A, 1999) |
| "Ethambutol (E) was sometimes substituted for streptomycin." | 2.69 | Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report. ( Bakare, NA; Ige, OM; Onadeko, BO, 2000) |
| "Three hundred eight new smear positive pulmonary tuberculosis patients were randomly allocated with a ratio of 2 to 1 into treatment group (227 cases, receiving 2RIFATER/4RIFINAH regimen) and controls (81 cases, 2HRZ/4HR) for observation." | 2.69 | [Controlled clinical study on efficacy of fixed-dose compounds rifater/rifinah in antituberculous chemotherapy]. ( Ma, W; Yan, B; Zhu, L, 1998) |
| "The triple combination studied could replace the separate drugs in the initial treatment phase in countries where the bioavailability of the drugs used has been proven." | 2.68 | [Clinical trial of a combination of three drugs in fixed proportions in the treatment of tuberculosis. Groupe de Travail sur la Chimiothérapie de la Tuberculose]. ( Boulahbal, F; Chaulet, P, 1995) |
| "Pefloxacin may have a role in the retreatment of pulmonary tuberculosis along with other drugs, as a companion drug in selected cases." | 2.68 | An uncontrolled trial of pefloxacin in the retreatment of patients with pulmonary tuberculosis. ( Rao, S, 1995) |
| " Food may however decrease the oral bioavailability of rifampicin and isoniazid." | 2.68 | Study of the effect of concomitant food on the bioavailability of rifampicin, isoniazid and pyrazinamide. ( Smith, P; Zent, C, 1995) |
| "(1) Most patients with drug-resistant pulmonary tuberculosis were middle-aged or past middle-aged." | 2.68 | [The present situation, treatment and prognosis of drug-resistant pulmonary tuberculosis. Cooperative Study Unit of Chemotherapy of Tuberculosis of the National Sanitoria in Japan]. ( Katayama, T; Kurashima, A; Mori, M; Nagai, H; Sato, K, 1995) |
| "To compare the pharmacokinetic parameters and the clinical efficacy of isoniazid, administered in 10 mg/kg or 5 mg/kg to children suffering from pulmonary tuberculosis." | 2.68 | Pharmacokinetics of isoniazid in pulmonary tuberculosis--a comparative study at two dose levels. ( Chopra, K; Roy, V; Tekur, U, 1996) |
| "Isoniazid (INH) was used as a model drug." | 2.68 | Early bactericidal activity of isoniazid in pulmonary tuberculosis. Optimization of methodology. The DATRI 008 Study Group. ( Cohn, JA; Dunlap, NE; Egorin, MJ; Enama, ME; Hafner, R; Heifets, LB; Mor, N; Muth, K; Peloquin, CA; Wright, DJ, 1997) |
| "Altogether 267 patients of initial pulmonary tuberculosis with positive smears were randomly divided into 3 groups; Group I with DL473 twice-weekly (2HE+L2/7H2L2), Group IIARFp twice-weekly (2HE+R2/7H2R2) and Group IIBRFP daily (2HRE/7HR) for controls." | 2.67 | [A comparative study of rifapentine treatment and three years follow-up on initial pulmonary tuberculous]. ( He, GJ, 1993) |
| "310 patients with pulmonary tuberculosis disseminating bacteria received isoniazid, rifampicin, streptomycin (ethambutol) and pirazinamid in different regimens and dosage forms." | 2.67 | [Combined chemotherapy of patients with tuberculosis - new regimens and dosage forms]. ( Elistratova, NA; Khalbaeva, IV; Koriakin, VA; Sokolova, GB; Ziia, AV, 1993) |
| " The formulation employed contained 125 mg of isoniazid (H), 100 mg of rifampicin (R) and 375 mg of pyrazinamide (Z) per tablet; six tablets were administered to every subject, giving a total dosage of 750 mg of isoniazid, 600 mg of rifampicin and 2,250 mg of pyrazinamide." | 2.67 | Bioavailability of isoniazid, rifampicin and pyrazinamide (in free combination or fixed-triple formulation) in intermittent antituberculous chemotherapy. ( Acocella, G; Grassi, C; Grassi, GG; Luisetti, M; Peona, V; Pozzi, E, 1993) |
| "For patients with pulmonary tuberculosis that is resistant to rifampin and isoniazid, even the best available treatment is often unsuccessful." | 2.67 | Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. ( Ackerson, L; Goble, M; Horsburgh, CR; Iseman, MD; Madsen, LA; Waite, D, 1993) |
| "Active pulmonary tuberculosis developed more frequently during the 5 yr in the placebo series than in the three chemoprophylaxis series (p less than 0." | 2.67 | A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council. ( , 1992) |
| "250 patients suffering from pulmonary tuberculosis who were smear positive received a chemotherapy regime for 6 months combining Rifampicin and Isoniazid every day with a daily supplement of Pyrazinamide for the first 8 weeks." | 2.67 | [A therapeutic trial of a combination of 3 essential drugs in a short course of chemotherapy in tuberculosis. Results 6 months after the end of treatment]. ( Agounitestane, D; Ait Khaled, N; Boulahbal, F; Chaulet, P; Chiheb, M; Khaled, S, 1990) |
| "7%]); had similar rates of adverse drug reactions (7." | 2.67 | USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results. ( Combs, DL; Geiter, LJ; O'Brien, RJ, 1990) |
| " New data on optimal drug selection and dosing are emerging with the inclusion of children in clinical trials and ongoing research on age-related pharmacokinetics and pharmacodynamics." | 2.66 | Tuberculosis treatment in children: The changing landscape. ( Huynh, J; Marais, BJ; Schaaf, HS; Thwaites, G, 2020) |
| "Intracranial tuberculomas are rare yet lethal forms of tuberculosis." | 2.66 | Multiple tuberculomas in an immunocompetent patient and their diagnostic challenge in a high prevalence country: Case report and literature review. ( Alva-Diaz, C; Esteban-Arias, D; López-Saavedra, A; Metcalf, T; Orellana-Tovar, I; Pacheco-Barrios, K; Rodriguez-López, E; Velásquez-Rimachi, V, 2020) |
| "667 patients with newly diagnosed pulmonary tuberculosis were randomly allocated to continue daily treatment with isoniazid (400 mg) and rifampicin (600 mg) or to twice-weekly treatment with isoniazid (900 mg) and rifampicin (600 mg)." | 2.66 | Comparison of daily and twice-weekly regimens to treat pulmonary tuberculosis. ( Castelo, A; da Silva, EA; Dalboni, MA; Goihman, S; Haynes, RB; Jardim, JR; Kalckman, AS, 1989) |
| " The dosage of each drug was very similar whether it was given combined or separately." | 2.66 | Acceptability, compliance, and adverse reactions when isoniazid, rifampin, and pyrazinamide are given as a combined formulation or separately during three-times-weekly antituberculosis chemotherapy. ( , 1989) |
| "Patients with pulmonary tuberculosis who were failures of primary chemotherapy with strains resistant to isoniazid or to isoniazid and streptomycin were allocated at random to receive a regimen of rifampicin and ethambutol for 6 (4RE) or 9 months (7RE), supplemented in both treatment series by streptomycin plus pyrazinamide for the first 2 months." | 2.66 | Controlled clinical trial of a regimen of two durations for the treatment of isoniazid resistant pulmonary tuberculosis. ( Aluoch, JA; Babu Swai, O; Darbyshire, JH; Edwards, EA; Githui, WA; Nunn, AJ; Thiong'o, R, 1988) |
| "To measure the effectiveness of treatment for pulmonary tuberculosis in Peru we evaluated the fate of 2,669 patients who had tuberculosis diagnosed in 1981." | 2.66 | Operational evaluation of treatment for tuberculosis. Results of 8- and 12-month regimens in Peru. ( Baron, RB; Ganter, B; Hopewell, PC; Sanchez-Hernandez, M, 1985) |
| " tuberculosis were treated in the initial phase as inpatients for 2-3 months at random with either pyrazinamide (Z) or ethambutol (E) in combination with isoniazid (H) and rifampicin (R)." | 2.66 | [Which is the best drug combination for the short-term therapy of tuberculosis? A prospective randomized study with 190 patients]. ( Bezel, R; Brändli, O; Häcki, M; Karrer, W; Röthlisberger, K; Rubin, S, 1985) |
| " The bioavailability of the active, orally administered rifampicin decreased from 93% after the first single oral dose to 68% after 3 weeks of oral and intravenous rifampicin therapy." | 2.66 | Pharmacokinetics of oral and intravenous rifampicin during chronic administration. ( Eichelbaum, M; Jensen, JC; Loos, U; Mikus, G; Musch, E; Schwabe, HK, 1985) |
| "When pyrazinamide was omitted in the first 2 months the relapse rates were 18% for the 6-month and 6% for the 8-month series." | 2.65 | Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis. Second report. Third East African/British Medical Research Council Study. ( , 1980) |
| "Of those treated for pulmonary tuberculosis during childhood, the striking absence of adolescent reactivation points to the likelihood of a permanent cure." | 2.65 | Thirty years after isoniazid. Its impact on tuberculosis in children and adolescents. ( Hsu, KH, 1984) |
| "A cooperative french trial in the treatment of pulmonary tuberculosis has compared the efficacy and the tolerance of daily antituberculous regimes, one of short duration of 18 weeks (HRSZ/HRZ), the other of standard duration of 9 months (HRE)." | 2.65 | [Short-term chemotherapy of tuberculosis. Cooperative French trial]. ( Pretet, S, 1983) |
| "Relapses have occurred in two of 119 SHRZ6 patients, four of 127 EHRZ6 patients and two of 127 EHR9 patients." | 2.65 | A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society. ( , 1984) |
| " In a controlled study of culture-positive advanced pulmonary tuberculosis we have compared treatment regimens with PZA in a dosage of less than 2 g and with ethambutol (EMB)." | 2.65 | [Pyrazinamide versus ethambutol in short-term therapy of lung tuberculosis. A randomized study]. ( Brändli, O; Fiala, W; Häcki, MA, 1983) |
| "Relapse has occurred in 1 of 125 SHRZ6 patients, 3 of 132 EHRZ6, and 2 of 136 EHR9 patients." | 2.65 | A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. British Thoracic Association. ( , 1982) |
| "Patients with culture-positive pulmonary tuberculosis were allocated at random into two groups for a three-phase regimen in original course chemotherapy." | 2.65 | A controlled trial of individually-adapted short-course chemotherapy versus two-year scheme in original treatment of pulmonary tuberculosis. Report after a five-year follow-up. ( Favez, G; Leuenberger, P, 1982) |
| "Patients in whom pulmonary tuberculosis had been newly diagnosed and confirmed bacteriologically were given standard triple chemotherapy with streptomycin, PAS and isoniazid for 6 weeks or 3 months." | 2.64 | A study of two twice-weekly and once-weekly continuation regimen of tuberculosis chemotherapy, including a comparison of two durations of treatment. 1. First report: the results at 18 months. ( , 1976) |
| "In this study, pulmonary tuberculosis was treated on an ambulatory basis, with the patients engaging in their usual activities and with a shortened period of chemotherapy." | 2.64 | Short-duration treatment of pulmonary tuberculosis. ( Pilheu, JA, 1977) |
| "All 33 relapses were with strains sensitive to isoniazid and streptomycin, and 76 per cent of them occurred in the first 3 months after the end of chemotherapy." | 2.64 | Controlled trial of 6- and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong. ( , 1975) |
| " Complaints of vomiting or diarrhoea that did not require a reduction of the PAS dosage were made on one or two occasions by 23(21%) out of 109 twice-weekly and 25 (23%) out of 108 daily patients, and on at least three occasions by 4 (4%) and 12 (11%) respectively." | 2.64 | Controlled comparison of oral twice-weekly and oral daily isoniazid plus PAS in newly diagnosed pulmonary tuberculosis. ( , 1973) |
| " They were then allocated at random either to standard daily continuation chemotherapy with isoniazid plus PAS or to fully supervised treatment with streptomycin and high dosage isoniazid, given twice weekly." | 2.64 | A comparative study of daily and twice-weekly continuation regimens of tuberculosis chemotherapy, including a comparison of two durations of sanatorium treatment. 1. First report: the results at 12 months. ( , 1971) |
| " It might be possible to overcome these disadvantages, by substituting for the PAS a drug which is equally effective but less expensive and more acceptable, or by reducing the daily dosage of PAS and the period for which it is prescribed." | 2.63 | Isoniazid plus thioacetazone compared with two regimens of isoniazid plus PAS in the domiciliary treatment of pulmonary tuberculosis in South Indian patients. ( , 1966) |
| " The results confirm that the twice-weekly regimen is highly effective and demonstrate that its efficacy is not influenced by the rate of inactivation of isoniazid or by a reduction (by one-fourth) in the dosage of streptomycin." | 2.63 | A controlled comparison of a twice-weekly and three once-weekly regimens in the initial treatment of pulmonary tuberculosis. ( , 1970) |
| "We present a case of isoniazid-induced encephalopathy in a haemodialysis patient." | 2.61 | Isoniazid-induced encephalopathy in an end-stage renal disease patient - A case report and literature review. ( Low, JM; Wong, KW, 2019) |
| "Isoniazid is a pro-drug in which first pass metabolism happens via N-acetyltransferase and is fast, intermediate or slow, depending on the genetics of the host." | 2.55 | Isoniazid Resistance and Dosage as Treatment for Patients with Tuberculosis. ( Klopper, M; Nagel, S; Streicher, EM; Van Helden, PD; Warren, RM, 2017) |
| "Treatment of isoniazid-resistant tuberculosis with the WHO standard regimen for new patients resulted in treatment failure, relapse, and acquired multidrug resistance in 11% (6-17), 10% (5-15) and 8% (3-13), respectively; treatment with the standard WHO regimen for previously treated patients resulted in treatment failure in 6% (2-10), relapse in 5% (2-8), and acquisition of multidrug resistance in 3% (0-6)." | 2.55 | Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis. ( Benedetti, A; Gegia, M; Menzies, D; van Soolingen, D; Winters, N, 2017) |
| "The management of latent tuberculosis (LTBI) in children represents an important issue for paediatricians because of the disease burden, the lack of a gold standard for the diagnosis and the high annual risk of progression to active disease." | 2.55 | Optimizing the management of children with latent tuberculosis infection. ( Chiappini, E; de Martino, M; Galli, L; Tersigni, C; Venturini, E, 2017) |
| "To supplement previous state-of-art reviews on anti-tuberculosis treatment and to pave the way forward with reference to the current status, we systematically reviewed published literature on clinical research on tuberculosis (TB) over the past decade in the treatment of drug-susceptible and multidrug-resistant TB (MDR-TB), with a focus on drugs, dosing factors and regimens." | 2.52 | Clinical research in the treatment of tuberculosis: current status and future prospects. ( Chang, KC; Sotgiu, G; Yew, WW, 2015) |
| "This review will introduce pharmacokinetic parameters for key anti-TB drugs, as well as the indications and limitations of measuring these parameters in clinical practice." | 2.50 | Understanding pharmacokinetics to improve tuberculosis treatment outcome. ( Heysell, SK; Reynolds, J, 2014) |
| "Treatment of latent tuberculosis infection reduces the risk of active TB in HIV positive individuals especially in those with a positive tuberculin skin test." | 2.46 | Treatment of latent tuberculosis infection in HIV infected persons. ( Adetifa, I; Akolo, C; Shepperd, S; Volmink, J, 2010) |
| "In the cases of Crohn's disease and rheumatoid arthritis administered anti-TNF-alpha, chemoprophylaxis is necessary for those who show healing of TB despite those who are suspected of having TB infection by a tuberculin test." | 2.42 | [Measures for tuberculosis in compromised hosts--mainly on chemoprophylaxis]. ( Yamagishi, F, 2003) |
| "In the past, five cases of INH-induced pneumonitis were reported, but desensitization of INH did not occur in any." | 2.42 | [A case of successful desensitization therapy for isoniazid-induced pneumonitis]. ( Fujimura, M; Nakao, S; Nishizawa, Y; Tagami, A; Yamamori, C; Yasui, M, 2004) |
| "About 97% of patients with pulmonary tuberculosis became bacteriologically quiescent by the 12 months of streptomycin, para-aminosalicylate and isoniazid." | 2.41 | [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients]. ( Wada, M, 2001) |
| "Treatment of tuberculosis has three major goals: healing the patient, preventing selection of resistant strains and control transmission of tuberculosis." | 2.40 | [Antitubercular chemotherapy]. ( Dautzenberg, B; Jouveshomme, S, 1997) |
| " The investigations--in most cases estimations of the nonbiotransformated part of antituberculotic drugs and theophylline had following purposes: security of the necessary dose especially in the case of INH (hereditary INH-polymorphismus), proof of a sufficient permeation of INH and RMP in the tuberculous kidney, control of the usefulness or uselessness of the INH-depot-preparations, relations between the concentration in the serum and dose respectively of the appearance of side effects, estimation of bioavailability and pharmacokinetic parameters during the development of an useful retard-preparation of theophylline." | 2.38 | [Clinical pharmacology in optimization of therapy of lung diseases]. ( Iwainsky, H; Wiesner, B; Winsel, K, 1991) |
| "The here described investigations show correspondingly that the administration of isoniazid, rifampicin and pyrazinamide in a fixed combination of the administration of the individual substances is bioequivalent under pharmacokinetic aspects." | 2.38 | [Pharmacokinetic aspects of tuberculosis therapy with a fixed combination of rifampicin, isoniazide and pyrazinamide]. ( Lode, H; Schaberg, T, 1991) |
| "Pneumocystis pneumonia is decreased in frequency by any one of several prophylactic agents, the best established being pentamidine administered as an inhaled aerosol." | 2.38 | Prevention of lung infections associated with human immunodeficiency virus infection. ( Hopewell, PC, 1989) |
| "Rifampin is a potent antituberculous drug." | 2.35 | Rifampin. ( Dorken, E; Grzybowski, S; Schonell, M, 1972) |
| "For patients with drug-susceptible pulmonary tuberculosis who do not tolerate rifampicin owing to its toxicity, a shorter regimen may be a useful alternative." | 1.91 | Real-world experience of adverse reactions-necessitated rifampicin-sparing treatment for drug-susceptible pulmonary tuberculosis. ( Cho, YJ; Kim, HJ; Kim, YW; Kwon, BS; Lee, CT; Lee, JH; Lee, YJ; Lim, SY; Park, JS; Song, MJ, 2023) |
| "Four patients (2." | 1.91 | Evaluation of treatment regimens and long-term clinical outcomes in patients with isoniazid-resistant pulmonary tuberculosis: a 5-year follow-up. ( Aslan, AF; Bağcı, BA; Ortaköylü, MG; Toprak, S, 2023) |
| "Directly observed treatment (DOT) for tuberculosis (TB) is recommended by the World Health Organization." | 1.91 | Community-supported self-administered tuberculosis treatment combined with active tuberculosis screening: a pilot experience in Conakry, Guinea. ( Camara, LM; Cherif, GF; de Jong, BC; Decroo, T; Delamou, A; Gils, T; Hassane-Harouna, S; Ortuño-Gutiérrez, N; Rigouts, L, 2023) |
| "Isoniazid is a key component of tuberculosis treatment." | 1.91 | Influence of sex on the exposure to isoniazid in patients with pulmonary tuberculosis. ( Albério, CAA; Rivera, JGB; Vieira, JLF, 2023) |
| "Multidrug-resistant pulmonary tuberculosis (MDR-TB) is a major health problem worldwide." | 1.72 | Discovery and preclinical evaluations of JBD0131, a novel nitrodihydro-imidazooxazole anti-tuberculosis agent. ( Bin, W; Chen, S; Ding, CZ; Franzblau, SG; Hu, Y; Huang, Z; Jiang, N; Luo, W; Shen, L; Tao, X; Wei, X; Wei, Y; Xu, D; Yang, M; Zhu, Y, 2022) |
| "Isoniazid resistance was detected in 13% of the patients and rifampicin resistance was detected in 8%." | 1.72 | Evaluation of diagnostic components and management of childhood pulmonary tuberculosis: a prospective study from Istanbul, Turkey. ( Cakin, ZE; Cakir, E; Cakir, FB; Collak, A; Dogan Demir, A; Erenberk, U; Kut, A; Nursoy, M; Ozaydin, E; Ustabas Kahraman, F; Uzuner, S, 2022) |
| " Population pharmacokinetic models used plasma and intrapulmonary drug levels at 8 and 16 weeks." | 1.72 | High Intrapulmonary Rifampicin and Isoniazid Concentrations Are Associated With Rapid Sputum Bacillary Clearance in Patients With Pulmonary Tuberculosis. ( Chasweka, M; Chirambo, AP; Chitani, A; Corbett, EL; Davies, GR; Ghany, JF; Gordon, SB; Khoo, SH; Malamba, R; Mallewa, JE; McCallum, AD; Meghji, JZ; Mwandumba, HC; Pertinez, HE; Shani, D; Sheha, I; Sloan, DJ, 2022) |
| "Isoniazid displays saturable kinetics at doses >10 mg/kg." | 1.72 | Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis. ( Chirehwa, M; Court, R; de Jager, V; de Vries, N; Denti, P; Diacon, A; Dooley, KE; Gausi, K; Gumbo, T; Hafner, R; Harding, J; Ignatius, EH; McIlleron, H; Moran, L; Rosenkranz, SL; Sun, X; Swindells, S; Wiesner, L, 2022) |
| "A model-based therapeutic drug monitoring strategy for personalized dosing of isoniazid using sampling at 2 and 4 h after dosing was successfully developed." | 1.62 | A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis. ( Aarnoutse, RE; Alffenaar, JC; Magis-Escurra, C; Svensson, EM; Ter Heine, R; van Beek, SW, 2021) |
| "The prevalence of pulmonary tuberculosis at enrollment was 1." | 1.62 | Pulmonary tuberculosis screening in anti-retroviral treated adults living with HIV in Kenya. ( Barnabas, RV; Feldman, Z; Gersh, JK; Horne, DJ; Kamene, M; Kinuthia, J; Lacourse, SM; Matemo, D; Mecha, J; Warr, AJ, 2021) |
| "Empiric treatment for latent tuberculosis infection (LTBI) was individually considered for immunocompromised patients." | 1.62 | Low uptake of isoniazid window prophylaxis in patients exposed to a health-care worker with pulmonary tuberculosis in a paediatric ward. ( Ang, S; Bagdasarian, N; Chan, HC; Chan, SM; Sinnathamby, A, 2021) |
| "Contacts of pulmonary tuberculosis (TB) cases are at high risk of TB infection and progression to disease." | 1.56 | Contact evaluation and isoniazid preventive therapy among close and household contacts of tuberculosis patients in Lima, Peru: an analysis of routine data. ( Battaglioli, T; De la Torre, Z; Ordoñez, C; Otero, L; Ríos, J; Seas, C; Trocones, N; Van der Stuyft, P, 2020) |
| "Isoniazid is an essential drug in the management of tuberculosis but there is a high degree of variation in the Indian population's capacity to acetylate or inactivate isoniazid to the inactive metabolite acetyl isoniazid, and they can be distinctly characterized phenotypically as being either slow or rapid inactivators (the concentration of the enzyme being higher in rapid inactivators)." | 1.56 | A case series of three patients presenting with isoniazid induced toxicity and N-acetyl transferase 2 gene mutation: A management conundrum for programmatic therapy of tuberculosis in India. ( Darole, P; Munshi, R; Panchal, F; Shetty, P; Sundar, U, 2020) |
| " Blood sampling was also performed 120 minutes after dosing for the detection of Cmax purpose." | 1.56 | Effect of interval between food intake and drug administration at fasting condition on the plasma concentrations of first-line anti-tuberculosis drugs in Chinese population. ( Chu, N; Du, Y; Guo, R; Han, X; Pang, Y; Wang, J; Wang, Q, 2020) |
| "There is a need for individualized dosing of isoniazid and rifampicin based on plasma concentration measurements (therapeutic drug monitoring) and for clinical trials on higher doses of these TB drugs in patients with TB and DM." | 1.51 | Effect of diabetes mellitus on TB drug concentrations in Tanzanian patients. ( Aarnoutse, RE; Boeree, MJ; Burger, DM; Colbers, A; Irongo, CF; Kibiki, GS; Mtabho, CM; Semvua, HH; Tostmann, A; van Crevel, R; van den Boogaard, J; van der Ven, AJAM, 2019) |
| " Pharmacokinetic parameters can be affected by comorbidities or the interaction of drugs with food." | 1.51 | Intra-individual effects of food upon the pharmacokinetics of rifampicin and isoniazid. ( Ardrey, A; Davies, G; Jave, O; López-Romero, SL; Moore, DAJ; Requena-Méndez, A; Ward, SA; Waterhouse, D, 2019) |
| " Patients with severe illness received high-dose rifampicin immediately, the others had a higher dosage guided by therapeutic drug monitoring." | 1.51 | High-dose rifampicin in tuberculosis: Experiences from a Dutch tuberculosis centre. ( Aarnoutse, R; Bergsma-de Guchteneire, I; Boeree, M; Hoefsloot, W; Kuipers, S; Magis-Escurra, C; Seijger, C; Te Brake, L; van Crevel, R; van Ingen, J, 2019) |
| "Patients were mainly in advanced acquired immunodeficiency syndrome (AIDS) stage." | 1.51 | Drug resistance and pathogenic spectrum of patients coinfected with nontuberculous mycobacteria and human-immunodeficiency virus in Chengdu, China. ( Li, QF; Li, YJ; Liao, Y; Luo, J; Wang, DM; Wu, GH; Xu, YH; Zhong, J; Zhu, M, 2019) |
| " Stochastic PK/pharmacodynamic (PD) simulations were carried out to evaluate current regimen combinations and dosing guidelines in distinct patient strata." | 1.51 | Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization. ( Bang, H; Barry, CE; Dartois, V; Eum, S; Fox, WS; Gupta, SV; Lee, M; Savic, RM; Shim, T; Strydom, N; Via, LE; Zimmerman, M, 2019) |
| "Pulmonary tuberculosis was bacteriologically confirmed in 4 057 subjects." | 1.51 | Tuberculosis in Poland in 2017 ( Korzeniewska- Koseła, M, 2019) |
| "Retinal vasculitis was occlusive in six patients (50%)." | 1.48 | Review of people with retinal vasculitis and positive QuantiFERON ( Barthelmes, D; Böni, C; Brunner, DR; Meier, F; Zweifel, SA, 2018) |
| "Treatment of isoniazid, rifampicin, pyrazinamide with the diagnosis of epituberculosis was started by taking a sample of gastric aspirate culture sample." | 1.48 | [Management and treatment difficulties of multi-drug resistant pulmonary tuberculosis in a pediatric case]. ( Acar, EM; Bayramoğlu, Z; Çalışkan, E; Erköse, G; Hançerli Törün, S; Kılıçaslan, Z; Şatana, D; Somer, A, 2018) |
| " However, their neurotoxicity could cause adverse effect and the patients with end-stage renal disease are especially vulnerable due to the reduction in renal drug clearance." | 1.48 | Ethambutol and isoniazid induced severe neurotoxicity in a patient undergoing continuous ambulatory peritoneal dialysis. ( Chen, Y; Li, H; Peng, H; Si, M, 2018) |
| "Ulcerative skin tuberculosis (TB) is a rare form of extrapulmonary TB." | 1.48 | Perianal ulcerative skin tuberculosis: A case report. ( Chen, H; Song, X; Wang, W; Wu, S; Xiong, W; Yu, X, 2018) |
| "All grade 3 & 4 adverse events (AEs) and their relationship to treatment for patients who had taken at least one dose of therapy in the REMoxTB clinical trial were recorded." | 1.48 | Toxicity associated with tuberculosis chemotherapy in the REMoxTB study. ( Amukoye, EI; Crook, AM; Dawson, R; Diacon, AH; Gillespie, SH; Hanekom, M; McHugh, TD; Mendel, CM; Meredith, SK; Murphy, ME; Murthy, SE; Nunn, AJ; Phillips, PPJ; Singh, KP; Spigelman, M; Tweed, CD; Wills, GH, 2018) |
| "In new pulmonary tuberculosis patients, rapid spread of MDR-TB and XDR-TB challenging the effectiveness of national TB control programs especially in many low-income countries." | 1.48 | Drug resistance pattern in Mycobacterium tuberculosis to the first line drugs of pulmonary tuberculosis patients at Hazara Region, Pakistan. ( Ahmad, M; Ahmad, W; Akbar, HS; Akbar, MT; Jan, F; Khalid, A; Sadia, S; Wali, S, 2018) |
| "Ethionamide is an important contributor to MDR-TB treatment regimens, at Sensititre MIC <2." | 1.48 | Ethionamide Pharmacokinetics/Pharmacodynamics-derived Dose, the Role of MICs in Clinical Outcome, and the Resistance Arrow of Time in Multidrug-resistant Tuberculosis. ( Bendet, P; Deshpande, D; Gumbo, T; Heysell, SK; Koeuth, T; Lee, PS; Mpagama, SG; Pasipanodya, JG; Srivastava, S, 2018) |
| " Pyrazinamide pharmacokinetic (PK) data from 61 HIV/TB-coinfected patients in South Africa were used in the analysis." | 1.46 | Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis. ( Chirehwa, MT; Denti, P; McIlleron, H; Mthiyane, T; Onyebujoh, P; Rustomjee, R; Smith, P, 2017) |
| "Upon diagnosis, Pulmonary Tuberculosis patients are treated for TB for a period of 6-9 months." | 1.46 | Serum levels of soluble urokinase plasminogen activator receptor (suPAR) as a marker of tuberculosis treatment efficacy. ( Indumati, V; Krishnaswamy, D; Rajeshwari, V; Ramesh, A; Shantala, D; Shilpa, A; Vijay, V, 2017) |
| "Isoniazid was stopped, and the patient has completed 18 months of a fluoroquinolone-based regimen without relapse." | 1.46 | Rapid identification of a Mycobacterium tuberculosis full genetic drug resistance profile through whole genome sequencing directly from sputum. ( Booth, H; Breuer, J; Brown, M; Burgess, C; Doyle, R; Gorton, R; McHugh, TD; Morris-Jones, S; Nimmo, C; Williams, R, 2017) |
| "Treatment with standardized antituberculosis regimens dosed daily throughout, high uptake of antiretroviral therapy, and low prevalence of isoniazid monoresistance were associated with a low frequency of ADR." | 1.46 | Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence. ( Meintjes, G; Rockwood, N; Sirgel, F; Streicher, E; Warren, R; Wilkinson, RJ, 2017) |
| "Among 236 patients with pulmonary tuberculosis, 59 (25%) had isoniazid resistance." | 1.46 | Time to Sputum Culture Conversion and Treatment Outcomes Among Patients with Isoniazid-Resistant Tuberculosis in Atlanta, Georgia. ( Bizune, D; Holland, DP; Kagei, M; Kempker, RR; Machaidze, M; Oladele, A; Ray, SM; Rebolledo, PA; Schechter, MC; Wang, YF, 2017) |
| " As irrational use and inadequate dosing of anti-TB drugs may contribute to the epidemic of drug-resistant TB, we assessed the drug types and dosages prescribed in the treatment of TB cases in a representative sample of health care facilities in Yunnan." | 1.46 | Prescription practice of anti-tuberculosis drugs in Yunnan, China: A clinical audit. ( Chen, J; Chiang, CY; Innes, AL; Li, L; Xu, L, 2017) |
| "This is known as latent tuberculosis infection (LTBI) although, rather than a distinct entity, this probably represents part of a dynamic spectrum." | 1.46 | National position statement for the management of latent tuberculosis infection. ( Stock, D, 2017) |
| "The currently preferred regimen for treatment of pulmonary tuberculosis (PTB) is isoniazid, rifampin, pyrazinamide, and ethambutol, which has been used either as separate tablets (ST) or as fixed-dose combination (FDC)." | 1.46 | Treatment outcomes of fixed-dose combination versus separate tablet regimens in pulmonary tuberculosis patients with or without diabetes in Qatar. ( Al-Shaer, MH; Elewa, H; Iqbal, F; Mansour, H; Salameh, P, 2017) |
| "Data regarding coexisting pulmonary thromboembolism (PTE) in patients with tuberculosis are limited." | 1.46 | Clinical Characteristics of Coexisting Pulmonary Thromboembolism in Patients With Respiratory Tuberculosis. ( Cha, SI; Kim, CH; Lee, J; Lee, SY; Lim, JK; Nyeo Jeon, K; Park, H; Park, JY; Yoo, SS, 2017) |
| "If isoniazid Cmax was <4." | 1.46 | Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis. ( Denti, P; Gumbo, T; Lesosky, M; McIlleron, H; Meintjes, G; Pasipanodya, JG; Rockwood, N; Sirgel, F; Wilkinson, RJ, 2017) |
| "Seventeen (4." | 1.43 | Serum Levels of Antituberculosis Drugs and Their Effect on Tuberculosis Treatment Outcome. ( Cho, YJ; Kim, SJ; Lee, CT; Lee, JH; Lee, JY; Lee, YJ; Park, JS; Song, J; Yoon, HI, 2016) |
| "Rifampin is a key sterilizing drug in the treatment of tuberculosis (TB)." | 1.43 | Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction. ( Chirehwa, MT; Denti, P; McIlleron, H; Mthiyane, T; Onyebujoh, P; Rustomjee, R; Smith, P, 2016) |
| "Contact tracing of a case of pulmonary tuberculosis was performed in a Bolivian patient." | 1.43 | Outbreak of isoniazid-resistant tuberculosis in an immigrant community in Spain. ( Andrés García, I; Eiros Bouza, JM; Fernández Arribas, S; Fernández Espinilla, V; Hernán García, C; Moreno Cea, L; Rubio, V; Ruiz Lopez Del Prado, G; Vesenbeckh, S, 2016) |
| "Pyrazinamide (PZA) is a key sterilizing drug in first-line tuberculosis (TB) regimens and exerts its activity entirely during the first 2 months in human infections." | 1.43 | Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of Tuberculosis. ( Betoudji, F; Lanoix, JP; Nuermberger, E, 2016) |
| "The association of latent tuberculosis infection (LTBI) with subsequent cancer remains unclear." | 1.43 | Latent Tuberculosis Infection and the Risk of Subsequent Cancer. ( Chen, TJ; Chen, YM; Chou, KT; Chuang, PH; Feng, JY; Pan, SW; Su, VY; Su, WJ; Yen, YF, 2016) |
| "The strains were isolated from a pulmonary tuberculosis patient before and after drug treatment." | 1.43 | Comparing isogenic strains of Beijing genotype Mycobacterium tuberculosis after acquisition of Isoniazid resistance: A proteomics approach. ( Dobos, KM; Mehaffy, C; Nieto R, LM, 2016) |
| " Eighty children with TBI received a 12-dose once-weekly isoniazid/rifapentine regimen; 79 (99%) completed therapy, 94% reported no adverse events, 1 child had mildly elevated transaminases but 1 adolescent later developed pulmonary TB." | 1.43 | Safety and Adherence for 12 Weekly Doses of Isoniazid and Rifapentine for Pediatric Tuberculosis Infection. ( Cruz, AT; Starke, JR, 2016) |
| " One hundred patients with pulmonary tuberculosis (65% coinfected with HIV-1) were intensively sampled to determine rifampin, isoniazid, and pyrazinamide plasma concentrations after 7 to 8 weeks of a daily quadruple-therapy regimen dosed according to World Health Organization (WHO) weight bands." | 1.43 | HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients. ( Chirehwa, M; Denti, P; McIlleron, H; Meintjes, G; Rockwood, N; Wiesner, L; Wilkinson, RJ, 2016) |
| " To mechanistically assess the trade-off between toxicity and efficacy, we developed a physiologically based pharmacokinetic (PBPK) model describing the NAT2-dependent pharmacokinetics of INH and its metabolites." | 1.43 | A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy. ( Aschmann, HE; Baier, V; Blank, LM; Cordes, H; Kuepfer, L; Thiel, C, 2016) |
| "Cellulitis is a common disease seen by dermatologists; however, sometimes other diseases may masquerade as this banal illness." | 1.43 | Tuberculous cellulitis: diseases behind cellulitislike erythema. ( Chishiki, M; Horinosono, H; Kawakubo, Y; Maeshima, H; Sakiyama, M, 2016) |
| "Treatment of latent tuberculosis infection (LTBI) is essential for eradicating tuberculosis (TB)." | 1.43 | Impacts of 12-dose regimen for latent tuberculosis infection: Treatment completion rate and cost-effectiveness in Taiwan. ( Huang, YW; Tsao, SM; Tsao, TC; Yang, SF; Yeh, YP, 2016) |
| "Pirfenidone is a recently approved antifibrotic drug for the treatment of idiopathic pulmonary fibrosis (IPF)." | 1.43 | The antifibrotic drug pirfenidone promotes pulmonary cavitation and drug resistance in a mouse model of chronic tuberculosis. ( Ahidjo, BA; Andrade, BB; Beck, S; Bishai, WR; Cheung, LS; Ihms, EA; Jain, S; Maiga, M; Maiga, MC; Ordonez, AA, 2016) |
| "Anti-tuberculosis drug-induced hepatotoxicity (ATDH) is a serious adverse reaction to anti-tuberculosis (TB) treatment." | 1.43 | Association between TXNRD1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a prospective study. ( He, JQ; Ji, GY; Liu, QQ; Sandford, AJ; Wang, Y; Wu, JC; Wu, SQ; Zhang, MM, 2016) |
| "33 patients with pulmonary tuberculosis were treated with one Risorine kit, daily consisting of one capsule of Risorine, one tablet of ethambutol (800 mg) and two tablets of Pyrazinamide 750 mg each, for first two months of therapy." | 1.43 | Role of Risorine in the Treatment of Drug - Susceptible Pulmonary Tuberculosis: A Pilot Study. ( Patel, K; Patel, S; Vora, A, 2016) |
| " Adequacy of SDC was based on the maximum concentration (Cmax) achieved in serum, with rifampicin (RMP) values <8 μg/ml and isoniazid (INH) values <3 μg/ml for daily dosing and <9 μg/ml for intermittent dosing considered inadequate." | 1.42 | Serum drug concentrations of INH and RMP predict 2-month sputum culture results in tuberculosis patients. ( Ahmed, R; Cooper, R; Der, E; Gao, Z; Hansen, E; Kharrat, H; Kunimoto, D; Long, R; Mah, A, 2015) |
| "We report a case of isoniazid induced convulsions in 35 years old male alcoholic and smoker patient receiving intensive phase therapy for pulmonary tuberculosis." | 1.42 | Isoniazid induced convulsions at therapeutic dose in an alcoholic and smoker patient. ( Aiwale, AS; Barvaliya, MJ; Jha, PR; Patel, UA; Tripathi, C, 2015) |
| "The available pharmacokinetic data on anti-tubercular drugs in children raises the concern of suboptimal plasma concentrations attained when doses extrapolated from adult studies are used." | 1.42 | Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children. ( Kabra, SK; Kanhiya, K; Lodha, R; Mukherjee, A; Singla, M; Velpandian, T, 2015) |
| "Despite efforts to detect and treat active tuberculosis (TB) at the border, 75% of all active TB cases diagnosed in our hospital were illegal migrants." | 1.42 | Preventing tuberculosis transmission at a maternity hospital by targeted screening radiography of migrants. ( Abu-Hanna, J; Aviram, G; Braun, T; Carmeli, Y; Grisaru-Soen, G; Lessing, JB; Schechner, V, 2015) |
| "Rosacea is a common chronic inflammatory cutaneous disease of unknown etiology, characterized by remissions and exacerbations, presenting with centrofacial erythema and telangiectasias." | 1.42 | Pyridoxine induced rosacea-like dermatitis. ( Mokos, ZB; Paštar, Z; Rezaković, S, 2015) |
| "Next, in human subjects, previously treated for pulmonary tuberculosis, the MTB-containing CD271(+) BM-MSCs exhibited high expression of hypoxia-inducible factor 1α and low expression of CD146, a hypoxia down-regulated cell surface marker of human BM-MSCs." | 1.42 | Preclinical and Clinical Evidence of Mycobacterium tuberculosis Persistence in the Hypoxic Niche of Bone Marrow Mesenchymal Stem Cells after Therapy. ( Bhatnagar, R; Bhuyan, S; Das, B; Garhyan, J; Kalita, D; Pulu, I, 2015) |
| "Isoniazid prophylaxis was started in neonates." | 1.42 | Nosocomial exposure to active pulmonary tuberculosis in a neonatal intensive care unit. ( Ahn, JG; Kim, DS; Kim, KH, 2015) |
| "Ethionamide (ETH) is an antibiotic used for the treatment of multidrug-resistant (MDR) tuberculosis (TB) (MDR-TB), and its use may be limited with the emergence of resistance in the Mycobacterium tuberculosis population." | 1.42 | Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates. ( Ferro, BE; Mejia, GI; Realpe, T; Robledo, J; Rozo, JC; Rueda, J; Zapata, E, 2015) |
| " Lead optimization resulted in the identification of potent compounds with improved oral bioavailability and reduced cardiac ion channel liability." | 1.40 | Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis. ( Achar, V; Arora, U; Awasthy, D; Bharath, S; Bheemarao, U; Chinnapattu, M; Coulson, M; de Sousa, SM; Ganguly, S; Gaonkar, S; Ghosh, A; Hameed P, S; Hoffner, S; Humnabadkar, V; Kaur, P; Kumar K N, M; Kumar, CN; Madhavapeddi, P; Manjrekar, P; Menasinakai, S; Mukherjee, K; Nandishaiah, R; Narayan, C; Panduga, V; Patil, V; Puttur, J; Raichurkar, A; Ramya, VK; Reddy, J; Rudrapatana, S; Sambandamurthy, VK; Shanbhag, G; Sharma, S; Sharma, U; Shinde, V; Solapure, S; Waterson, D; Werngren, J, 2014) |
| "To determine the characteristics of pulmonary tuberculosis (TB) patients harbored organisms with isoniazid mono-resistant drug susceptibility pattern." | 1.40 | Clinical features and outcomes of isoniazid mono-resistant pulmonary tuberculosis. ( Chierakul, N; Foongladda, S; Saengthongpinij, V, 2014) |
| " In this study, we sought to investigate the sterilizing activity of human-equivalent doses of thioridazine when given in combination with the "Denver regimen" against acute murine tuberculosis." | 1.40 | Sterilizing activity of thioridazine in combination with the first-line regimen against acute murine tuberculosis. ( Dutta, NK; Karakousis, PC; Pinn, ML, 2014) |
| "Seventy-five male patients with pulmonary tuberculosis (mean age, 40." | 1.40 | Association of serum levels of iron, copper, and zinc, and inflammatory markers with bacteriological sputum conversion during tuberculosis treatment. ( de Melo Guedes de Oliveira, HM; de Oliveira, MM; Delogo, KN; Dos Anjos, MJ; Kritski, AL; Mesquita, ED; Miranda, PF; Moraes, ML; Netto, AR; Ramalho, DM, 2014) |
| "Isoniazid levels were analyzed at 2 and 6 h after drug intake using liquid chromatography mass spectrometric methods." | 1.40 | Effects of dosage, comorbidities, and food on isoniazid pharmacokinetics in Peruvian tuberculosis patients. ( Ardrey, A; Davies, G; Jave, O; López-Romero, SL; Moore, DA; Requena-Méndez, A; Ward, SA; Waterhouse, D, 2014) |
| "Worldwide highest number of new pulmonary tuberculosis (PTB) cases, was reported from India in 2012." | 1.40 | Correlates of treatment outcomes and drug resistance among pulmonary tuberculosis patients attending tertiary care hospitals of Kolkata, India. ( Bhattacharya, B; Chakraborty, U; Das, A; Das, S; Dey, SK; Goswami, A; Mahapatra, S; Mahapatra, T; Mukherjee, T; Pal, NK; Ray, S, 2014) |
| "Nitazoxanide (NTZ) has bactericidal activity against the H37Rv laboratory strain of Mycobacterium tuberculosis with a MIC of 16 μg/ml." | 1.39 | Efficacy of nitazoxanide against clinical isolates of Mycobacterium tuberculosis. ( Fitzgerald, DW; Johnson, WD; Merveille, YM; Nathan, CF; Ocheretina, O; Pape, JW; Shigyo, K, 2013) |
| " We therefore determined the pharmacokinetic characteristics of first-line TB drugs in Tanzanian patients using intensive pharmacokinetic sampling." | 1.39 | Pharmacokinetics of first-line tuberculosis drugs in Tanzanian patients. ( Aarnoutse, RE; Boeree, MJ; Kibiki, GS; Mtabho, CM; Semvua, HH; Tostmann, A; van den Boogaard, J, 2013) |
| "The isoniazid C2 h was noticeably lower in fast versus slow acetylators (0." | 1.39 | Isoniazid, rifampin, and pyrazinamide plasma concentrations in relation to treatment response in Indonesian pulmonary tuberculosis patients. ( Aarnoutse, R; Ascobat, P; Burhan, E; Donders, R; Ginanjar, A; Mangunnegoro, H; Ruesen, C; Ruslami, R; van Crevel, R, 2013) |
| "tuberculosis strain in a patient with mixed infection." | 1.39 | Undetected multidrug-resistant tuberculosis amplified by first-line therapy in mixed infection. ( Bremang, S; Casey, R; Connell, D; Evans, JT; Hawkey, PM; Hingley-Wilson, SM; Jepson, A; Kon, OM; Lalvani, A; Philip, S; Smith, GE, 2013) |
| " Serum concentration-time profiles, maximum serum concentrations, time to achieve maximum serum concentrations, the half-life and the areas under the serum concentration-time curve for each of the four drugs were determined." | 1.39 | Pharmacokinetics and serum concentrations of antimycobacterial drugs in adult Turkish patients. ( Arpag, H; Babalık, A; Bakirci, N; Çarpaner, E; Dagyildiz, L; Kuyucu, T; Ulus, IH, 2013) |
| "The study was performed among 60 pulmonary tuberculosis (TB) in-patients at a tertiary care university-affiliated hospital in Tehran, Iran." | 1.39 | Isoniazid, rifampicin and pyrazinamide plasma concentrations 2 and 6 h post dose in patients with pulmonary tuberculosis. ( Bozorg, BD; Dastan, F; Emami, S; Fahimi, F; Goodarzi, A; Habibi, M; Kobarfard, F; Salamzadeh, J; Shahsavari, N; Tabarsi, P, 2013) |
| "He experienced a sense of drunkenness when he received isoniazid, apparently not in association with any of the other antituberculosis drugs given." | 1.39 | [Drunkenness caused by isoniazid in a tuberculosis patient with extrapulmonary lesions on hemodialysis: a case report]. ( Fukasawa, K; Honda, T; Miyashita, Y; Saiki, M; Sano, K; Sogami, Y, 2013) |
| "Tuberculosis is still a global health problem all over the world despite its mortality has been decreased with effective treatment regimens." | 1.39 | Unfinished battle with childhood tuberculosis: is it curable with less drugs and shorter duration? ( Cinel, G; Çobanoğlu, N; Doğru, D; Göçmen, A; Kiper, N; Köse, M; Koyun, M; Özçelik, U; Pekcan, S; Tana Aslan, A; Yalçın, E, 2013) |
| "Ex vivo blood samples from 27 pulmonary tuberculosis patients were assayed at diagnosis and during treatment." | 1.39 | Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response. ( Cho, JE; Clark, TG; Cliff, JM; Constantinou, N; Dockrell, HM; Duncan, K; King, EC; Lee, JS; Lukey, PT; Ronacher, K; Van Helden, PD; Walzl, G, 2013) |
| " This is despite the availability of antibiotics that have good activity against Mycobacterium tuberculosis in vitro and favorable pharmacokinetic profiles in plasma." | 1.38 | Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions. ( Barry, CE; Dartois, V; Goh, A; Kern, S; Kjellsson, MC; Low, KM; Pillai, G; Via, LE; Weiner, D, 2012) |
| "Tuberculosis (TB) treatment can cause serious sequelae including adverse effects such as anti-TB drug-induced hepatotoxicity (ATDH)." | 1.38 | Genetic variants in antioxidant pathway: risk factors for hepatotoxicity in tuberculosis patients. ( Fukushima, K; Higuchi, N; Inamine, T; Kohno, S; Kondo, S; Mawatari, T; Nakaura, A; Nanashima, K; Suyama, N; Tahara, N; Tsukamoto, K; Yanagihara, K, 2012) |
| "Isoniazid monotherapy was restarted after 2 weeks." | 1.38 | A case of isoniazid-induced thrombocytopenia: recovery with immunoglobulin therapy. ( Cho, YJ; Hwang, YS; Jeong, YY; Kim, HC; Kim, YE; Lee, EJ; Lee, JD; Lee, SH; Lee, SJ, 2012) |
| "A smear positive pulmonary tuberculosis mother with productive cough was diagnosed on the fifth day of admission." | 1.38 | Outcome of neonates exposed to active pulmonary tuberculosis. ( Jirapradittha, J; Kiatchoosakun, P; Saengnipanthkul, S, 2012) |
| "Pyrazinamide was omitted in 15 cases while rifampicin only in one patient." | 1.38 | Management of and risk factors related to hepatotoxicity during tuberculosis treatment. ( Ağca, S; Arda, H; Babalık, A; Bakırcı, N; Calışır, HC; Cetintaş, G; Kızıltaş, S; Oruç, K, 2012) |
| "Metronidazole (MTZ), which has activity only against anaerobic, nonreplicating bacteria, was as effective as either of these treatments in preventing reactivation of latent infection." | 1.38 | Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques. ( Barry, CE; Dartois, V; Flynn, JL; Goodwin, MB; Janssen, C; Johnston, PJ; Klein, E; Lin, PL; Via, L, 2012) |
| "Isoniazid (INH) is an integral component of treatment of tuberculosis." | 1.38 | Seizures with single therapeutic dose of isoniazid. ( Behera, D; Kumar, L; Puri, MM; Vishwakarma, PD, 2012) |
| "A population pharmacokinetic model was developed to characterize the highly variable pharmacokinetics of isoniazid in a South African pulmonary tuberculosis patient population." | 1.37 | Variability in the population pharmacokinetics of isoniazid in South African tuberculosis patients. ( Langdon, G; McIlleron, H; Pillai, G; Simonsson, US; Smith, PJ; Wilkins, JJ, 2011) |
| "Rifampin-treated BALB/c mice remained culture positive at 3 months." | 1.37 | Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient mice. ( Ahmad, Z; Almeida, DV; Converse, PJ; Grosset, JH; Li, SY; Nuermberger, EL; Peloquin, CA; Rosenthal, IM; Zhang, M, 2011) |
| "Paragonimiasis is a food-borne zoonosis caused by a trematode of the genus Paragonimus(1,2)." | 1.37 | [Pulmonary paragonimiasis]. ( Fortes-Alen, J; Gómez-Escolar, PF; Gómez-Seco, J; Presa-Abos, T; Rodríguez-Guzmán, MJ; Rodríguez-Nieto, MJ, 2011) |
| "Thirteen patients with pulmonary tuberculosis detected." | 1.37 | Pulmonary tuberculosis in infants less than one year old: implications for early diagnosis. ( Bayhan, GI; Ekşioğlu, AS; Kitiş Çelik, B; Tanır, G, 2011) |
| "Fifty antiretroviral drug naïve new AIDS patients with clinical evidence of pulmonary tuberculosis and no previous history of tuberculosis were recruited." | 1.37 | Drug susceptibility of Mycobacterium tuberculosis in patients with AIDS at a tertiary care hospital in northern India. ( Baveja, CP; Bhalla, P; Gautam, H; Jha, H; Saini, S; Vidyanidhi, G, 2011) |
| "The frequency of late recurrences following treatment completion has not been well-studied." | 1.37 | When tuberculosis comes back: who develops recurrent tuberculosis in california? ( Deriemer, K; Flood, JM; Pascopella, L; Watt, JP, 2011) |
| "Isoniazid (INH) is an effective first-line antituberculosis drug." | 1.36 | Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis. ( Ando, H; Kato, S; Kirikae, T; Kondo, Y; Mori, T; Suetake, T; Toyota, E, 2010) |
| "Pyrazinamide (PZA) is an important first-line antituberculous drug, which is applied together with INH, RMP, EMB and SM." | 1.36 | [Phenotypic characterization of pyrazinamide-resistant Mycobacterium tuberculosis isolated in Poland]. ( Augustynowicz-Kopeć, E; Napiórkowska, A; Zwolska, Z, 2010) |
| " Dosage adjustment of rifampin was more likely to elevate serum concentration to the target range than adjustment of isoniazid given in daily doses (p = 0." | 1.36 | Therapeutic drug monitoring for slow response to tuberculosis treatment in a state control program, Virginia, USA. ( Heysell, SK; Houpt, ER; Keller, SJ; Moore, JL, 2010) |
| "Metronidazole treatment (for 6 weeks at 100 mg/kg of body weight) resulted in no reduction in the bacillary burden and significantly worsened lesion inflammation." | 1.35 | Metronidazole lacks antibacterial activity in guinea pigs infected with Mycobacterium tuberculosis. ( Basaraba, RJ; Brooks, EJ; Caraway, ML; Driver, ER; Hoff, DR; Lenaerts, AJ; Orme, IM; Peloquin, CA; Ryan, GJ, 2008) |
| "Pyrazinamide was the most sensitive drug i." | 1.35 | Primary drug resistance against Mycobacterium tuberculosis in Karachi. ( Hussain, SJ; Irfan, M; Rao, NA, 2008) |
| "Treatment with rifampin and pyrazinamide was more effective than treatment with rifampin, isoniazid, and pyrazinamide at reducing the lung CFU count, consistent with past evidence of isoniazid's antagonism in this model." | 1.35 | Enhanced bactericidal activity of rifampin and/or pyrazinamide when combined with PA-824 in a murine model of tuberculosis. ( Grosset, J; Nuermberger, E; Tasneen, R; Tyagi, S; Williams, K, 2008) |
| "Resectional lung surgery combined with isoniazid- and rifampin-based anti-tuberculous chemotherapy can be an effective treatment strategy for patients with well-localized, cavitary pulmonary MDR-TB and XDR-TB." | 1.35 | Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. ( Cho, JS; Kang, H; Kim, JH; Park, SK; Smego, RA, 2009) |
| "Temozolomide (TMZ) is a cytotoxic agent of the imidazotetrazine class, chemically related to dacarbazine." | 1.35 | Tuberculosis in a patient on temozolomide: a case report. ( de Barros e Silva, MJ; de Paiva, TF; Fanelli, MF; Gimenes, DL; Rinck, JA, 2009) |
| "Patients with active pulmonary tuberculosis (TB) infect 10-15 other persons per year, making diagnosing active TB essential to both curing the patient and preventing new infections." | 1.35 | The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis. ( Brady, MF; Coronel, J; Gilman, RH; Moore, DA, 2008) |
| "The isoniazid was discontinued, and the gynecomastia was partially resolved by the end of treatment." | 1.35 | Gynecomastia: a rare adverse effect of isoniazid. ( Braz, AG; Maia, JA; Morrone Junior, N; Morrone, N, 2008) |
| " Therapy was performed according to regimens 3 and 1, by using individual dosage regimens depending on the extent and severity of a specific process, the presence of complications, and age-related features." | 1.35 | [Optimization of chemotherapy regimens in children with primary pulmonary tuberculosis]. ( Dovgaliuk, IF; Ovchinnikova, IuE; Starshinova, AA, 2009) |
| "Diabetes mellitus was documented in 57/135 (42." | 1.35 | Radiographic manifestations of culture-positive pulmonary tuberculosis: cavitary or non-cavitary? ( Al-Tawfiq, JA; Saadeh, BM, 2009) |
| "Coexistence of pulmonary tuberculosis (TB) and lung cancer in clinic poses significant challenges for the diagnostic and treatment of both diseases." | 1.35 | Lung carcinogenesis induced by chronic tuberculosis infection: the experimental model and genetic control. ( Bronson, RT; Kramnik, I; Nalbandian, A; Pichugin, A; Yan, BS, 2009) |
| "Isoniazid was stopped and patient was continued on R & E till completion of the treatment up to nine months." | 1.35 | Isoniazid induced gynaecomastia: a case report. ( Garg, R; Mehra, S; Prasad, R, 2009) |
| "In drug-resistant pulmonary tuberculosis, the imbalance of spontaneous, protein- and drug-induced mononuclear secretion of cytokines was established to be more pronounced than in drug-sensitive tuberculosis." | 1.35 | [Modulatory effect of isoniazid and rifampicin in vitro on cytokine secretion in pulmonary tuberculosis]. ( Budkina, TE; Churina, EG; Khasanova, RR; Kolosova, AE; Naslednikova, IO; Novitskiĭ, VV; Serebriakova, VA; Strelis, AK; Urazova, OI; Vasil'eva, OA; Voronkova, OV, 2009) |
| " Serum isoniazid level was in the toxic range, the result of a dispensing error as well as a possible pharmacogenetic factor." | 1.35 | Neuroimaging findings in isoniazid central nervous system toxicity, presumed intramyelinic edema. ( Bitnun, A; Blaser, S; Cohen, E; Fluss, J; Hawkes, M; Kitai, I; Tran, D, 2008) |
| "In previous studies, the diarylquinoline R207910 (also known as TMC207) was demonstrated to have high bactericidal activity when combined with first- or second-line antituberculous drugs." | 1.34 | Synergistic activity of R207910 combined with pyrazinamide against murine tuberculosis. ( Andries, K; Chauffour, A; Ibrahim, M; Jarlier, V; Lounis, N; Truffot-Pernot, C; Veziris, N, 2007) |
| "Isoniazid preventive treatment (IPT) is particularly beneficial in the case of children who are infected with the human immunodeficiency virus (HIV)." | 1.34 | Chapter 4: childhood contact screening and management. ( , 2007) |
| "He was diagnosed as pulmonary tuberculosis, and started treatment with INH, RFP, EB, and PZA." | 1.34 | [A case of tuberculosis showing immune reconstitution syndrome after the initiation of antiretroviral therapy for HIV infection]. ( Izumi, S; Taniguchi, H, 2007) |
| "A 65-year-old woman developed a confusional syndrome one week after starting treatment for pulmonary military tuberculosis." | 1.34 | [Aseptic cerebral venous thrombosis and multiple cerebral tuberculomas associated with pulmonary miliary tuberculosis]. ( Amara, B; Belahsen, MF; Benjelloun, FZ; Benjelloun, MC; Messouak, O; Tizniti, S, 2007) |
| " The dosage form of the drug is a lyophilized powder (containing dioxidine, 100 mg, and isoniazid, 250 mg) in flasks." | 1.34 | [The new combined antituberculous drug: the original combined antituberculous drug dioxazid]. ( Glushkov, RG; Krylova, LIu; Sharova, SA; Sokolova, GB; Stebaeva, LF, 2007) |
| "This study evaluated the pharmacokinetics of isoniazid (INH) associated with optimal early bactericidal activity (EBA), defined as 90% of the maximum EBA (EBA(90)) and the influence of N-acetyltransferase-2 (NAT2) subtype on the ability of pulmonary tuberculosis (PTB) patients to reach the identified pharmacokinetic values after INH doses ranging from 0." | 1.34 | The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid. ( Donald, PR; Maritz, JS; Parkin, DP; Schaaf, HS; Seifart, HI; Sirgel, FA; van Helden, PD; Venter, A; Werely, CJ, 2007) |
| "Patients with liver cirrhosis are likely to be susceptible to tuberculosis (TB) because of immune system dysfunction." | 1.34 | Clinical characteristics of tuberculosis in patients with liver cirrhosis. ( Cho, YJ; Han, SK; Kim, YW; Lee, SM; Shim, YS; Yim, JJ; Yoo, CG, 2007) |
| " The low frequency of resistance to kanamycin could be related to the low dosage of this drug used at that time." | 1.34 | Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences. ( Barrera, L; de Kantor, IN, 2007) |
| "A 50-year-old ESRD who received LUR renal graft abroad." | 1.34 | Fatal hemorrhagic intracranial TB in a renal transplant recipient despite INH prophylaxis. ( Abutaleb, N; Adem, M; Afifi, H; Fallata, S; Hamza, A; Obaideen, A; Younis, S; Zakaria, M, 2007) |
| "Isoniazid (INH) is a drug widely used in the treatment of tuberculosis." | 1.34 | [Detection of mutation in NAT II gene as a method of determination of izoniazyd (INH) acetylation type in human population]. ( Augustynowicz-Kopeć, E; Brzezińska, S; Kozińska, M; Zabost, A; Zwolska, Z, 2007) |
| " The primary design consideration was to improve the solubility and consequently the bioavailability of the series by the addition of hydrophilic rings to the benzyl and phenyl B ring core." | 1.33 | Synthesis and evaluation of cyclic secondary amine substituted phenyl and benzyl nitrofuranyl amides as novel antituberculosis agents. ( Lee, RE; Lenaerts, AJ; Tangallapally, RP; Yendapally, R, 2005) |
| "We present a 23 year-old male with ankylosing spondylitis, who developed endobronchial and widespread pulmonary tuberculosis, 2 years after initiation of treatment with infliximab." | 1.33 | Delayed response to anti-tuberculosis treatment in a patient on infliximab. ( Iliopoulos, A; Psathakis, K; Tsintiris, K; Vlachaki, E, 2005) |
| "The first order elimination rate constant (k) and area under the concentration curve (AUC) were calculated in 64 children <13 years of age (median 3." | 1.33 | Isoniazid pharmacokinetics in children treated for respiratory tuberculosis. ( Donald, PR; Hesseling, PB; Maritz, JS; Parkin, DP; Schaaf, HS; Seifart, HI; van Helden, PD; Werely, CJ, 2005) |
| " The pharmacokinetic feature of isoniazid during its lymphotropic administration is its shorter elimination half-life, decreased total clearance, and a larger area under the pharmacokinetic curve." | 1.33 | [The clinical and pharmacokinetic features of lymphotropic therapy in patients with new-onset pulmonary tuberculosis]. ( Kolpakov, AR; Kolpakov, MA; Mokhina, OG; Priakhina, VN; Zyrianova, TV, 2005) |
| "Isoniazid is a first line antituberculosis drug metabolized mainly in the liver by the Nacetyltransferase." | 1.33 | [Isoniazid acetylation in a group of Tunisian patients. Report of 620 patients]. ( Béji, M; Chelbi, B; Chérif, J; Daghfous, J; Daghfous, R; Louzir, B; Mehiri, BR; Oueslati, MH; Ourari, B; Zouaoui, A, 2005) |
| "Out of 222 adolescents with pulmonary tuberculosis, 115 received a short-term intensive DOTS chemotherapy and 107 had a conventional triple antibacterial treatment (TAT) regimen." | 1.33 | [Reserves for enhancing the efficiency of treatment for pulmonary tuberculosis in adolescents]. ( Balashova, NA; Guseĭnov, GK; Pakhieva, KhIu, 2006) |
| " Pyridoxine is preventative in low dosage and curative in high dosage." | 1.33 | [Isoniazid induced neuropathy: consider prevention]. ( De Broucker, T; Martinez-Almoyna, L; Steichen, O, 2006) |
| "All cases had evidence of pulmonary tuberculosis." | 1.33 | Ocular tuberculosis in acquired immunodeficiency syndrome. ( Babu, RB; Biswas, J; Kumarasamy, N; Sudharshan, S; Therese, L, 2006) |
| " The objective of this research was to study intestinal absorptive function and bioavailability of rifampin and isoniazid in TB patients." | 1.33 | Intestinal permeability and malabsorption of rifampin and isoniazid in active pulmonary tuberculosis. ( Barroso, EC; Bushen, OY; Façanha, MC; Guerrant, RL; Lima, AA; Monteiro, HS; Peloquin, CA; Pinheiro, VG; Ramos, LM, 2006) |
| "Major adverse reactions to antituberculosis drugs can cause significant morbidity, and compromise treatment regimens for tuberculosis (TB)." | 1.32 | Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. ( Menzies, D; Parisien, I; Pelletier, M; Rocher, I; Valiquette, C; Yee, D, 2003) |
| "A healthy 57 year-old woman with past untreated pulmonary tuberculosis, disclosed a bilateral uveitic syndrome characte rized by iritis, vitreitis, multiple peripheral retinal punched-out lesions, and cystoid macular edema." | 1.32 | [Tuberculous peripheral multifocal choroiditis]. ( González Guijarro, J; Pérez Alvarez, MJ; Santos Gil, I, 2003) |
| "Isoniazid is an efficacious treatment for latent tuberculosis." | 1.32 | Use of isoniazid for latent tuberculosis infection in a public health clinic. ( LoBue, PA; Moser, KS, 2003) |
| "In total, 45 children with pulmonary tuberculosis participated." | 1.32 | Follow-up of compliance with tuberculosis treatment in children: monitoring by urine tests. ( Gultekin, D; Kayaalp, N; Palanduz, A, 2003) |
| "A diagnosis of pulmonary tuberculosis was made by sputum smears positive for acid-fast bacilli." | 1.32 | [Remission of pulmonary alveolar proteinosis during antituberculosis chemotherapy]. ( Kuraoka, T; Murai, H; Nakao, R; Onari, Y; Taniwaki, M; Terada, M; Yamaoka, N, 2003) |
| " Relative bioavailability of encapsulated drugs was greater than that of free drugs." | 1.32 | Chemotherapeutic potential of orally administered poly(lactide-co-glycolide) microparticles containing isoniazid, rifampin, and pyrazinamide against experimental tuberculosis. ( Khuller, GK; Sharma, S; Ul-Ain, Q, 2003) |
| " Acetylation greatly reduces the therapeutic activity of the drug, resulting in underdosing, decreased bioavailability and acquired INH resistance." | 1.32 | Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base. ( Cynamon, MH; Hearn, MJ, 2004) |
| " Approximately 70% of participants experienced at least one side effect during the trial." | 1.32 | Somatic complaints and isoniazid (INH) side effects in Latino adolescents with latent tuberculosis infection (LTBI). ( Berg, J; Blumberg, EJ; Friedman, LS; Hofstetter, CR; Hovell, MF; Kelley, NJ; Sipan, CL; Vera, AY, 2004) |
| "All 44 non-private hospitals in Malawi treating pulmonary tuberculosis (PTB) patients with an oral regimen (0." | 1.32 | Prescriptions and dosages of anti-tuberculosis drugs in the National Tuberculosis Control Programme of Malawi. ( Gausi, F; Harries, AD; Salaniponi, FM, 2004) |
| "A hundred new cases of active pulmonary tuberculosis whose age was 60 to 87 years were treated by the intensive chemotherapy regimen recommended by the WHO." | 1.32 | [Efficiency of an intensive stage of chemotherapy for tuberculosis in elderly and senile patients]. ( Karachunskiĭ, MA; Uvarova, TE, 2004) |
| "Staging revealed metastases in her left adrenal gland, kidney and spine." | 1.32 | Mucoepidermoid carcinoma of the lung presenting as a cavitary lesion. ( Leopairat, J; Ratanatharathorn, V; Tanvetyanon, T, 2004) |
| " Severe adverse reactions included rash (two), toxic hepatitis (six), Immune Reconstitution Syndrome (seven), and four deaths." | 1.32 | Efficacy and safety of Efavirenz in HIV patients on Rifampin for tuberculosis. ( Alves, CR; Badaro, R; Brites, C; Netto, EM; Oliveira, AS; Pedral-Sampaio, DB, 2004) |
| "Tuberculosis is a major cause of childhood morbidity and mortality in high-burden settings, particularly in the third-world settings." | 1.32 | Childhood turberculosis: reflections from the front line. ( Marais, BJ, 2004) |
| "Pulmonary tuberculosis was diagnosed in his 22-year-old son, in his 20-year-old daughter and in his 3-year-old granddaughter." | 1.32 | [The importance of a careful examination of all persons in close contact with newly diagnosed infectious tuberculosis]. ( Brunner, H; Fleisch, F; Kuhn, M; Reinhart, WH; Zodtke, F, 2004) |
| "A case of Pulmonary Alveolar Proteinosis (PAP), in association with tuberculosis, is described in a 35-year-old diabetic patient." | 1.31 | Pulmonary alveolar proteinosis and tuberculosis in a diabetic patient: a rare or a seldom diagnosed association? ( Coelho JC, JC; Marinho, MM; Pereira-Silva, JL; Veloso, TV, 2002) |
| "01) in INH concentrations, acetylation rate and bioavailability between 163 fast and 74 slow acetylators have been observed." | 1.31 | [Type of isoniazid (INH) acetylation determined in tuberculosis patients treated at the Institute of Tuberculosis and Lung Diseases in Warsaw during the years 1990-1997]. ( Augustynowicz-Kopeć, E; Zwolska, Z, 2002) |
| "A 66-year-old man, with a history of pulmonary tuberculosis 40 years before admission, complained of headache and dysarthria that lasted for 2 weeks and was followed by diplopia." | 1.31 | Solitary pontine tuberculoma. ( Fujishima, M; Ibayashi, S; Iida, M; Ogasawara, T; Saku, Y; Sugimori, H, 2002) |
| "Lupus vulgaris is the most common cutaneous manifestation of tuberculosis in industrialised countries, but nevertheless it remains rare and it is a very unusual presenting feature of underlying pulmonary tuberculosis." | 1.31 | [Pulmonary tuberculosis presenting as tubercular lupus]. ( Barbaud, A; Fays, S; Martin, S; Schmutz, JL, 2002) |
| "A total of 1472 pulmonary tuberculosis patients who had taken anti-tuberculosis treatment were evaluated retrospectively with respect to their drug resistance pattern by sputum culture for acid-fast bacilli (AFB) and sensitivity testing with isoniazid, rifampicin, streptomycin and ethambutol (E)." | 1.31 | Study of drug resistance in previously treated tuberculosis patients in Gujarat, India. ( Agarwal, SK; Shah, AR; Shah, KV, 2002) |
| "2% developed adverse hepatic reaction within the first month of INH + RMP treatment." | 1.31 | Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity. ( Azuma, J; Fukuda, T; Igarashi, T; Ito, M; Komuta, K; Maeda, K; Maekura, R; Ogura, T; Ohno, M; Yamaguchi, I; Yamamoto, I; Yamamoto, Y; Yokota, S, 2000) |
| "A patient with fulminant pulmonary tuberculosis died after 41 days of intensive care despite pansensitive organisms and no known underlying immunosuppression." | 1.31 | Delayed death from pulmonary tuberculosis: unsuspected subtherapeutic drug levels. ( Morehead, RS, 2000) |
| "Rifalazil (formerly known as KRM-1648) in combination with isoniazid has been found to be more active than rifampin/isoniazid." | 1.31 | Durable cure for tuberculosis: rifalazil in combination with isoniazid in a murine model of Mycobacterium tuberculosis infection. ( Cynamon, MH; DeStefano, MS; Shoen, CM, 2000) |
| "Intracranial tuberculomas are a rare manifestation of neurotuberculosis and are due to hematogenous dissemination of distant focuses of Mycobacterium tuberculosis infection." | 1.31 | [Intracranial tuberculomas developing during treatment of pulmonary tuberculosis: case report]. ( Alves, SM; Belo Neto, E; Brandão, RZ; Novis, SA; Pimentel, ML, 2000) |
| "Isoniazid was prescribed to infected and anergic patients not previously treated when added to the waiting list." | 1.31 | Isoniazid prophylaxis in lung transplantation. ( Bravo, C; Levy, G; Maestre, J; Monforte, V; Morell, F; Roman, A; Solé, J; Vidal, R, 2000) |
| "Pyrazinamide was not used in the intensive phase in the control group (n = 73)." | 1.31 | [Effectiveness of chemotherapy of intrathoracic tuberculosis in children: late follow-up data]. ( Iukhimenko, NV, 2001) |
| "Isoniazid inactivation was studied in 60 patients with concomitant diseases (pulmonary tuberculosis and diabetes mellitus)." | 1.31 | [Features of isoniazid activation in patients with tuberculosis and diabetes mellitus]. ( Chernykh, NA; Kaminskaia, GO; Karachunskiĭ, MA; Kossiĭ, IuE, 2001) |
| "The prevalence of smear-positive pulmonary tuberculosis was 568 per 100,000 inmates, which was eight times higher than that in the general population." | 1.31 | Tuberculosis in Thai prisons: magnitude, transmission and drug susceptibility. ( Palittapongarnpim, P; Phongdara, A; Silapapojakul, K; Sretrirutchai, S; Vuddhakul, V, 2002) |
| "Pericardial effusion was shown by echocardiography and subsequently removed by pericardiocentesis." | 1.31 | Tuberculous pericarditis in an infant evolving during triple chemotherapy. ( Bettendorf, M; Meyburg, J; Nützenadel, W; Schmidt, KG, 2002) |
| "The re-treatment pulmonary tuberculosis with positive spits represent 13." | 1.30 | [The results of retreatment of pulmonary tuberculosis using a short 6-month protocol 1985-1991 in the pneumo-phthisiology department of the Point G hospital in Bamako]. ( Kayantao, D; Keïta, B; Sangaré, S, 1997) |
| "Two patients with multidrug-resistant pulmonary tuberculosis were surgically treated after 3 and 7 years of unsuccessful chemotherapy." | 1.30 | [Surgical treatment of patients with multi-resistant pulmonary tuberculosis--case reports]. ( Kuś, J; Michałowska-Mitczuk, D, 1997) |
| "Although relapse was more frequent in patients with positive smears than those with negative smears (9." | 1.30 | Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis? ( Bechan, S; Connolly, C; Short, GM; Standing, E; Wilkinson, D, 1998) |
| "Pulmonary tuberculosis is more intense and the source of adult contact is more frequently found in children < 3 years old." | 1.30 | [Pulmonary tuberculosis in children: its age-dependent aspects]. ( Borque, C; del Castillo Martín, F; García-Hortelano, J; García-Miguel, MJ; Sánchez-Albisua, I; Vidal López, ML, 1998) |
| "Pneumonitis did not recur and the pulmonary tuberculosis improved." | 1.30 | [A case of isoniazid-induced pneumonitis]. ( Endo, T; Hasegawa, S; Nakayama, M; Ohse, H; Saito, T; Tamai, S; Watanabe, S, 1998) |
| " INH penetrates into bronchoalveolar fluid, and concentrations of INH in the BAL fluid suggest that assessment of the INH serum concentration is adequate to evaluate bioavailability of the drug in patients with pulmonary tuberculosis." | 1.30 | Isoniazid levels in the bronchoalveolar lavage fluid of patients with pulmonary tuberculosis. ( Doerfler, ME; Harkin, TJ; O'Brien, JK; Rom, WN, 1998) |
| "Pyrazinamide, which was readministered last (at the full dose in one case and at progressive doses in the two others), induced a recurrence in two of them." | 1.30 | [Eruption after the 1st dose of standard antitubercular chemotherapy. Thoughts on pyrazinamide]. ( Autret, E; Carré, P; Jonville-Bera, AP; Lemarié, E; Radal, M; Van-Egroo, C, 1998) |
| "In this study, multidrug-resistant pulmonary tuberculosis responded relatively well to carefully selected regimens." | 1.30 | Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. ( Kim, CT; Park, SK; Song, SD, 1998) |
| "The management of pulmonary tuberculosis (TB) in Scotland in 1993 was studied by asking the physicians responsible for all 321 adult cases of the disease notified that year to complete a standardized questionnaire relating to drug treatment and bacteriology." | 1.30 | The management of pulmonary tuberculosis in adults notified in Scotland in 1993. ( Heald, SH; Leitch, AG; Simpson, AJ; Sudlow, MF; Watt, B, 1998) |
| "Pyrazinamide, which was re-administered last, induced a recurrence." | 1.30 | -Skin eruption after the first dose of antitubercular quadri-therapy: consideration of pyrazinamide-. ( Autret, E; Jonville-Béra, AP; Martel, C; Mazaud, S; Olivier, C; Radal, M, 1998) |
| "Out of 1128 new pulmonary tuberculosis patients, six-hundred twenty started treatment with six-month (2HRZS or E/4HRE) in Fukujuji Hospital, JATA, in Tokyo from January 1991 to December 1996." | 1.30 | [Six-months chemotherapy (2HRZS or E/4HRE) of new cases of pulmonary tuberculosis--six year experiences on its effectiveness, toxicity, and acceptability]. ( Ito, K; Mizutani, S; Ogata, H; Sugita, H; Wada, M; Yoshiyama, T, 1999) |
| "Seventy-seven patients had pulmonary tuberculosis, 23 extrapulmonary and three had both." | 1.30 | The spectrum of mycobacterial disease in a Dublin teaching hospital. ( McDonnell, T; O'Reilly, P, 1999) |
| "Neurological examination revealed myoclonic jerking in the upper limbs." | 1.30 | [A case of transient isoniazid-induced myoclonic seizures]. ( Ichikawa, Y; Ikeda, K; Iwasaki, Y; Kinoshita, M, 1999) |
| "Treatment with isoniazide and rifampin was discontinued after 6 months, without reappearance of either pulmonary or renal symptoms." | 1.30 | Immunoglobulin A nephropathy complicating pulmonary tuberculosis. ( Barnaba, V; Bruno, G; De Siati, L; Ferri, C; Muda, AO; Paroli, M, 1999) |
| "We report a case of pulmonary tuberculosis with acute renal failure caused by readministration of Rifampicin (RFP)." | 1.30 | [A case of pulmonary tuberculosis with acute renal failure caused by readministration of rifampicin]. ( Kuroda, F; Mizutani, F; Sasaki, Y; Wada, A; Yagi, T; Yamagishi, F, 1999) |
| " The median proportion of dosing days attended in 6 months was 96%." | 1.30 | Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk community. ( Edlin, BR; Kral, AH; Lifson, AR; Lorvick, J; Thompson, S; Watters, JK, 1999) |
| "Isoniazid resistance was more likely in HIV seronegative patients with M." | 1.30 | Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda. ( Borgdorff, MW; Bretzel, G; Bwire, R; Kawuma, HJ; Rieder, HL; Rüsch-Gerdes, S; Sticht-Groh, V, 1999) |
| "There was no further recurrence during successful treatment with full doses of rifampicin and pyrazinamide for 1 year." | 1.29 | Recurrent acute pancreatitis induced by isoniazid. ( Chan, HS; Chan, KL; Lai, KN; Lui, SF, 1994) |
| "One patient presented twice with seizures." | 1.29 | Acute isoniazid neurotoxicity in an urban hospital. ( Santucci, K; Shah, BR; Sinert, R; Steiner, P, 1995) |
| "785 patients with pulmonary tuberculosis (both old = 525/785 and new = 260/785 cases) referred to our center were evaluated with respect to their drug resistance patterns." | 1.29 | High initial and acquired drug resistance in pulmonary tuberculosis in Turkey. ( Karagöz, T; Kizkin, O; Partal, M; Sadoğlu, T; Tahaoğlu, K; Tor, M, 1994) |
| "The frequency of chromosomal aberrations and sister-chromatid exchanges (SCEs) did not show any statistically significant differences in the patients before treatment and after exposure to combined HRZ therapy as compared to controls (p > 0." | 1.29 | Cytogenetic study of tuberculosis patients before and after tuberculostatic drug treatment. ( Ekmekçi, A; Sayli, A, 1995) |
| "Fourteen (30%) infants had extrapulmonary tuberculosis (11 central nervous system disease, 2 disseminated disease, and 1 cervical adenitis)." | 1.29 | Clinical features, diagnosis, and treatment of tuberculosis in infants. ( Ong, LT; Starke, JR; Vallejo, JG, 1994) |
| "Culture positive pulmonary tuberculosis occurred in 292 patients." | 1.29 | Characteristics of patients with drug resistant and drug sensitive tuberculosis in East London between 1984 and 1992. ( al Jarad, N; Empey, DW; Gaya, H; Parastatides, S; Paul, EA; Rudd, RM; Sheldon, CD, 1994) |
| "One hundred fifty nine retreatment pulmonary tuberculosis cases admitted to Fukujuji Hospital were retrospectively analyzed." | 1.29 | [Retreatment of pulmonary tuberculosis--duration of chemotherapy]. ( Mori, T; Ogata, H; Seita, A; Sugie, T; Sugita, H; Wada, M, 1993) |
| " Clinically it is important to know to which genetic group the patient belongs because we may have to increase the dosage for the rapid acetylators to achieve the desired therapeutic effect, while we may have to reduce the dosage for slow acetylators in whom the incidence of side effect is high." | 1.29 | [Testing for heterogeneity in genetic polymorphism of N-acetylation using isoniazid by metameters--probit, logit, and arcsine transformation]. ( Katayama, T; Kohno, H; Mori, M, 1993) |
| "Sputum samples from pulmonary tuberculosis patients attending a hospital for chest diseases and tuberculosis at Jaipur, India were directly subjected to sensitivity tests to detect drug resistance to streptomycin (S), isoniazid (I), rifampicin (R) and ethambutol (Emb) by slide culture technique." | 1.29 | Prevalence of initial drug resistance in tuberculosis patients attending a chest hospital. ( Gupta, PR; Gupta, RB; Sharma, TN; Singhal, B, 1993) |
| "The authors made an attempt to treat experimental tuberculosis with sodium glutamate and isoniazide under chronic exposure to PAH dust." | 1.29 | [Morphological features of tissue reactions in combined treatment of experimental tuberculosis induced by xenobiotics]. ( Kazak, TI; Kleĭn, AV; Nosova, NA; Pavlov, VA, 1995) |
| " Plasma levodopa and levodopa metabolite pharmacokinetic profiles were determined using standard techniques." | 1.29 | A clinical and pharmacokinetic case study of an interaction of levodopa and antituberculous therapy in Parkinson's disease. ( O'Connell, MT; Patsalos, PN; Quinn, NP; Wenning, GK, 1995) |
| "133 homeless subjects with pulmonary tuberculosis were examined microbiologically in Moscow Tuberculosis Hospital N 7 in 1993-1994." | 1.29 | [Biological characteristics of mycobacterial agent in homeless patients with pulmonary tuberculosis]. ( Batyrov, FA; Dorozhkova, IR; Kornilova, ZKh, 1996) |
| "There are few reports of children with AIDS and TB." | 1.29 | Clinical manifestation and outcome of tuberculosis in children with acquired immunodeficiency syndrome. ( Birnbaum, J; Chan, SP; Rao, M; Steiner, P, 1996) |
| "Nosocomial transmission among 7 AIDS patients admitted into the same ward between June and December/94 was supported by temporal clustering of cases, matching drug susceptibility, and identical IS6110 fingerprints." | 1.29 | Hospital transmission of multidrug-resistant Mycobacterium tuberculosis in Rosario, Argentina. ( Aita, J; Barrera, L; Biglione, J; Largacha, C; Lopez, B; Rajmil, JC; Reniero, A; Ritacco, V; Weisburd, G, 1996) |
| "Tuberculosis is increasing in Siberia." | 1.29 | Tuberculosis in Siberia: 2. Diagnosis, chemoprophylaxis and treatment. ( Besse, C; Connolly, M; Drobniewski, F; Ignatenko, N; Lyagoshina, T; Nye, P; Paul, J; Tayler, E, 1996) |
| "Patients with cavitating pulmonary tuberculosis continue to excrete viable tubercle bacilli for approximately 6 weeks despite supervised treatment." | 1.29 | The duration of excretion of viable bacilli in elderly patients on treatment for cavitating pulmonary tuberculosis. ( Morris, CD, 1996) |
| "They are enlarged in acute pulmonary tuberculosis." | 1.29 | Changes in the size of adrenal glands in acute pulmonary tuberculosis with therapy. ( Durak, AC; Gülmez, I; Keleştimur, F; Ozesmi, M, 1996) |
| "Isoniazide treatment of 87 children whose parents worked with cattle that might be infected prevented tuberculosis in them, diminished tuberculin sensitivity." | 1.29 | [Detection of tuberculosis in children of new risk groups and efficacy of chemoprophylaxis]. ( Altynova, MP; Demeshko, ND; Elufimova, VF; Iukhimenko, NV; Kufakova, GA; Mitinskaia, LA, 1996) |
| "1,350 smear positive pulmonary tuberculosis cases in the ten research pilot counties of Liaoning province from 1992 to 1993 were selected to receive short-course intermittent chemotherapies under full-course supervision." | 1.29 | [Analysis of short-term effects of short-course intermittent chemotherapies of the World Bank Loaned Project]. ( Su, Y; Wen, S; Zhang, F, 1996) |
| "We retrospectively studied 71 cases of lymph node tuberculosis confirmed by culture or pathology from 1983 to 1989." | 1.28 | Lymph node tuberculosis: 7-year experience in Veterans General Hospital, Taipei, Taiwan. ( Chen, YM; Lee, PY; Perng, RP; Su, WJ, 1992) |
| "Twenty-nine patients with extensive pulmonary tuberculosis and drug-induced hepatitis were treated with ofloxacin along with other relatively non-hepatotoxic drugs, either during the interim phase to await recovery of liver function in some, or as definitive therapy as required by the compromised hepatic status of others." | 1.28 | Tolerance of ofloxacin in the treatment of pulmonary tuberculosis in presence of hepatic dysfunction. ( Kwan, SY; Lee, J; Wong, PC; Yew, WW, 1992) |
| "Patients with direct smear positive pulmonary tuberculosis were admitted to hospital during the initial phase of treatment for two months." | 1.28 | Fixed dose combination short course chemotherapy in the treatment of pulmonary tuberculosis. ( Abdi, A; Lema, E; Roscigno, G; Wolde, K, 1992) |
| "Isoniazid, 900 mg, was administered twice weekly to men at the shelter and at the downtown Public Health Clinic." | 1.28 | Results of a directly observed intermittent isoniazid preventive therapy program in a shelter for homeless men. ( Nazar-Stewart, V; Nolan, CM, 1992) |
| "Pyrazinamide (PZN) was administered to 10 patients of pulmonary tuberculosis (for 7 consecutive days) each day after an overnight fast." | 1.28 | Effect of simultaneous isoniazid administration on pharmacokinetic parameters of pyrazinamide. ( Singhal, KC; Varshney, MK, 1991) |
| "Forty-one of our patients had pulmonary tuberculosis, 38 had extra pulmonary and in 61 it was disseminated." | 1.28 | AIDS and tuberculosis in Spain. A report of 140 cases. ( Adrados, M; Díaz, F; García Aguado, C; González Lahoz, JM; Laguna, F; Martínez, R; Puente, S, 1991) |
| "Dimephosphon was found to be responsible for both the in vivo and in vitro decrease of the degree of MBT resistance to rifampicin." | 1.28 | [Use of dimephosphon in pathogenetic therapy of experimental tuberculosis]. ( Aleksandrova, AE; Shchegoleva, RA; Shcherbakova, NM; Zabolotnykh, NV, 1991) |
| "Seven patients received no treatment because tuberculosis was first diagnosed after death." | 1.28 | Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. ( Chaisson, RE; Goodman, PC; Hopewell, PC; Sande, MA; Schecter, GF; Small, PM, 1991) |
| "Isoniazid was discontinued after the patient was admitted to the hospital." | 1.28 | Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenström's macroglobulinemia. ( Huang, ST; Krumdieck, R; Poon, MC; Rustagi, PK; Shaw, DR, 1991) |
| "Pyrazinamide was prescribed to 80%, which represents a substantial increase on the 19% recorded in a similar survey of patients notified in 1983." | 1.28 | The management of pulmonary tuberculosis in adults notified in England and Wales in 1988. The British Thoracic Society Research Committee and the Medical Research Council Cardiothoracic Epidemiology Group. ( , 1991) |
| "0, 12 experimental groups, each containing 10 mice, were treated for 8 weeks with pyrazinamide (PZA) given in mean daily dosages of 100, 200 or 400 mg/kg/day, with the interval between the doses within each dosage group being 1, 2, 4 or 8 days." | 1.28 | Efficacy of intermittent pyrazinamide in experimental murine tuberculosis. ( Dickinson, JM; Mitchison, DA, 1991) |
| " Elderly patients are more sensitive to antituberculous (anti-TB) drugs; therefore, a modification in the dosage for this patient group should be considered." | 1.28 | The disposition of antituberculous drugs in plasma of elderly patients. II. Isoniazid, rifampicin and pyrazinamide. ( Chan, HS; Chan, K; Walubo, A; Wong, CL; Woo, J, 1991) |
| "We report a case of secondary skin tuberculosis due to endogenous secondary infection in a 27-year-old subject affected by ulcerative colitis." | 1.28 | Cutaneous tuberculosis: atypical skin lesions in immunodepressed patients. ( Actis, G; Alberico, G; Genovesio, L; Goitre, M; Mele, M; Molinaro, GC; Puiatti, P; Salvai, M, 1990) |
| "Findings of immunologic observation of 35 subjects included into Group III of dispensary observation before and after antirecurring treatment with isoniazid and isoniazid in combination with ethymisole are presented." | 1.28 | [The effect of anti-recurrence treatment with isoniazid in combination with etimizol on the immune reactivity of Group III ambulatory care patients]. ( Lokhov, MG; Makarova, VM; Maslauskene, TP; Savvateeva, VG, 1990) |
| "Pyridoxine may cause peripheral neuropathy and this case illustrates the need for caution in the use of this vitamin in the prevention and treatment of isoniazid induced peripheral neuropathy." | 1.28 | Exacerbation of isoniazid induced peripheral neuropathy by pyridoxine. ( Agnew, RA; Bucknall, RC; Nisar, M; Watkin, SW, 1990) |
| "In Zimbabwe patients with pulmonary tuberculosis who are acid-fast bacilli (AFB) negative in the sputum are treated in the two month intensive phase with isoniazid, thiacetazone pyrazinamide and streptomycin (regimen A)." | 1.28 | Effects of two pulmonary tuberculosis drug treatments and acetylator status on liver function in a Zimbabwean population. ( Kusema, T; Mhonda, M; Neill, P; Nhachi, CF; Pringle, D, 1990) |
| "One hundred and seventeen children with pulmonary tuberculosis underwent treatment with a 6-month daily regimen of rifampin (15 mg/kg/day) and isoniazid (10 mg/kg/day)." | 1.28 | Six-month isoniazid-rifampin treatment for pulmonary tuberculosis in children. ( Assis, I; Bedran, MB; Moura, JA; Reis, FJ; Rodrigues, ME, 1990) |
| "No relapse was noted among patients with extrapulmonary tuberculosis." | 1.28 | [Treatment of tuberculosis. Drug combinations, therapeutic problems and results in a 10-year case load]. ( Morland, L, 1990) |
| "We investigated the pharmacokinetic interaction of RMP (administered from the first day of treatment onwards), PZA (given from the second day onwards), and INH (day 17 onwards) in ten, previously untreated patients with pulmonary tuberculosis (five slow acetylators and five fast acetylators)." | 1.28 | [Clinico-pharmacokinetic interactions of rifampicin, pyrazinamide and isoniazide]. ( Loos, U; Musch, E; Schwabe, HK, 1990) |
| "In a pilot study involving 62 patients with open pulmonary tuberculosis, we established that slow acetyators and patients receiving intravenous rifampicin treatment showed a tendency towards a more rapid negativisation of the sputum culture than did fast acetyators (lower levels of isoniazid) or patients receiving oral rifampicin therapy (decreasing bioavailability of the rifampicin during treatment)." | 1.28 | [Significance of the acetylator phenotype and initial oral/intravenous rifampicin administration in the treatment of tuberculosis]. ( Loos, U; Musch, E; Schwabe, HK, 1990) |
| " The main factors increasing the risk of hepatic toxicity was a high dosage of INH and overall malnutrition." | 1.28 | [Hepatotoxicity of the combination of isoniazid-rifampicin in African children. Role of malnutrition and HB virus]. ( Boguikouma, JB; Gahouma, D; Gendrel, D; Mouba, JF; Moussavou, A; Nardou, M, 1989) |
| " electric field in combination with specific antibacterial therapy on the character of morphological shifts, isoniazid accumulation, collagen fractional composition and tubercle bacilli population in the foci of infiltrative tuberculosis of the lungs was studied experimentally." | 1.28 | [Experimental validation of the expediency of the use of ultra-high frequency therapy in combination with antibacterial drugs in infiltrative tuberculosis of the lungs]. ( Bazhenov, SM; Lomachenkov, VD; Pavliunin, AM; Pavliunina, LD; Zhamoĭdo, SV, 1989) |
| "Treatment of pulmonary tuberculosis was realized with rifadin, isoniazid and streptomycin." | 1.28 | [Treatment efficacy in destructive forms of pulmonary tuberculosis in relation to the methods of administering rifadin and isoniazid]. ( Akhtyrskiĭ, AI; German, AK; Shevchenko, RN; Smirnova, VV, 1989) |
| "The frequency of chromosome aberrations was significantly increased in patients treated with both the triple drug combinations, i." | 1.27 | Cytogenetic effects of chemotherapy with three combinations of anti-tubercular drugs involving isoniazid, thiacetazone, para-aminosalicylic acid and streptomycin on human lymphocytes: chromosome aberrations, sister chromatid exchanges and mitotic index. ( Ahuja, YR; Jaju, M, 1983) |
| "Possible toxic side-effects of antituberculous chemotherapy are studied in 718 children affected with pulmonary tuberculosis." | 1.27 | [Toxicity in the current treatment of pulmonary tuberculosis in children]. ( Alcáide Megías, J; Altet Gómez, MN; Boque Genovard, MA, 1984) |
| " By an iteration process, based on non-linear regression analysis, the following pharmacokinetic parameters were calculated: Vd, Ka, Ke, T0." | 1.27 | Pharmacokinetics of antituberculosis drugs after oral isolated and simultaneous administration in triple combination. ( Janků, I; Papezová, E; Stastná, J; Tousek, J; Zítková, L, 1983) |
| "The good results gotten employing short-term (6 months) medication regimes with rifampin, isoniazid and an initial supplement (2 months) of streptomycin and pyrazinamide, gave an impulse to pharmacodynamic research." | 1.27 | [Pharmacokinetics of antitubercular agents in man]. ( Acocella, G, 1984) |
| "Tuberculosis is a significant public health problem in developing countries, despite the fact that the means for effective control have been available for more than 35 yr." | 1.27 | Tuberculosis in Cuba. ( Pedraza, RO; Pérez-Stable, EJ, 1984) |
| "Pemphigus foliaceus was seen in a patient with pulmonary tuberculosis during rifampicin therapy." | 1.27 | Pemphigus foliaceus induced by rifampicin. ( Kang, HJ; Lee, CW; Lim, JH, 1984) |
| " As a consequence there are no grounds for reducing the dosage of isoniazid given to patients with impaired renal function." | 1.27 | [The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis]. ( Ellard, GA, 1984) |
| " Major toxic effects occurred in 22 patients; in 14 during the daily phase and in 8 during the twice-weekly phase." | 1.27 | Undesirable side effects of isoniazid and rifampin in largely twice-weekly short-course chemotherapy for tuberculosis. ( Dutt, AK; Moers, D; Stead, WW, 1983) |
| "In ethambutol-treated cases a statistically significant increase in mean serum uric acid levels was observed in the second, third and fourth week of treatment." | 1.27 | Hyperuricaemia induced by ethambutol. ( Agarwal, MC; Bihari, K; Narang, RK; Raina, AK; Sharma, SN; Singh, SN, 1983) |
| " The dosage used according to this protocol varied greatly, going from 1." | 1.27 | [Value of determining plasma INH during antitubercular treatment. Retrospective analysis of 204 cases]. ( Cheminat, JC; Ducarrouge, C; Lavarenne, J; Molina, C; Paire, M, 1983) |
| "After years of declining incidence, pulmonary tuberculosis is increasing, owing in part to the influx of Asian refugees." | 1.27 | Chemotherapy for pulmonary tuberculosis. A short-course regimen and its rationale. ( Dall, L, 1983) |
| "The outcome of treatment for pulmonary tuberculosis using isoniazid and rifampin for 9 months supplemented by ethambutol for the initial 2 months was evaluated in a cohort of 233 patients." | 1.27 | The results of 9-month isoniazid-rifampin therapy for pulmonary tuberculosis under program conditions in San Francisco. ( Hopewell, PC; Schecter, GF; Slutkin, G, 1988) |
| "Streptomycin was well absorbed in all nutritional groups and therapeutic levels were obtained with 20 mg/kg i." | 1.27 | INH and streptomycin in Ethiopian children with tuberculosis and different nutritional status. ( Bolme, P; Eriksson, M; Habte, D; Paalzow, L, 1988) |
| "Rifampin is known to lower plasma warfarin concentrations by increasing the rate of warfarin clearance." | 1.27 | Complex interaction of rifampin and warfarin. ( Almog, S; Bank, HZ; Farfel, Z; Halkin, H; Martinowitz, U, 1988) |
| " Self-induction of rifampin clearance by chronic dosing with the drug may lead to subtherapeutic levels of rifampin." | 1.27 | Pharmacokinetics of antituberculosis drugs in patients. ( el-Attar, H; Israili, ZH; Rogers, CM, 1987) |
| "Four relapses were seen during the fixed follow-up period." | 1.27 | [Antitubercular therapeutic regimens routinely prescribed in Bas-Rhin and results of treatment]. ( Burghard, G; Chenuet, J; Liard, R; Perdrizet, S; Petitjean, R; Pierau, F; Rempp, M, 1986) |
| "Two patients with non-miliary pulmonary tuberculosis developed a syndrome resembling adult respiratory distress following initiation of drug treatment." | 1.27 | Acute respiratory distress related to chemotherapy of advanced pulmonary tuberculosis: a study of two cases and review of the literature. ( Onwubalili, JK; Scott, GM; Smith, H, 1986) |
| "Isoniazid did not cause greater hepatotoxicity in hepatitis B carriers than in noncarriers." | 1.27 | Isoniazid prophylaxis in hepatitis B carriers. ( London, WT; Lustbader, ED; McGlynn, KA; Murphy, EC; Sharrar, RG, 1986) |
| "Due to these findings systemic lupus erythematosus (SLE) was suspected." | 1.27 | [Tuberculostatics-induced systemic lupus erythematosus]. ( Engelhard, M; Layer, P, 1986) |
| " Minor adverse reactions occurred with similar frequencies during daily (5%) and intermittent (5%) treatment but in no case was modification of rifampicin dosage required." | 1.27 | Safety of thrice-weekly rifampicin for tuberculosis in South-East Asian refugees. ( McKenzie, DK; Mukerjee, CM, 1985) |
| "Of the 191 patients with extra-pulmonary tuberculosis, 39% had lymph node involvement, 26% bone or joint disease and 19% a pleural effusion." | 1.27 | Tuberculosis in Tanzania--a national survey of newly notified cases. Tanzanian/British Medical Research Council Collaborative Study. ( , 1985) |
| "There was pre-existing pulmonary disease in 22 patients and another 4 were taking immuno-suppressive drugs." | 1.27 | Pulmonary infection with Mycobacterium malmoense--a review of treatment and response. ( Banks, J; Jenkins, PA; Smith, AP, 1985) |
| "Phenytoin kinetics were unchanged after further 3 months of combined treatment." | 1.27 | Influence of rifampicin and isoniazid on the kinetics of phenytoin. ( Hansen, JE; Kampmann, JP; Kay, L; Kristensen, M; Skovsted, L; Svendsen, TL; Vergman, B, 1985) |
| "3 cases of aplastic anaemia occurring in association with anti-tuberculosis chemotherapy are reported." | 1.26 | Aplastic anaemia associated with anti-tuberculosis chemotherapy. ( Adenle, AD; Aderoju, EA; Esan, GJ; Sekoni, G; Williams, CK, 1982) |
| "In 1979 two patients with cavitary pulmonary tuberculosis were treated by a combination of three tuberculostatic drugs." | 1.26 | [The problem of infectiousness of tuberculosis patients during chemotherapy]. ( Schulthess, HK; Zollikofer, H, 1981) |
| "Deaths from pulmonary tuberculosis continue at the same rate as 10 years ago." | 1.26 | Survey of pulmonary tuberculosis in south and west Wales (1976-8). ( Campbell, IA; Hunter, AM; Kilpatrick, GS; Monie, RD; Rocchiccioli, K; White, J, 1982) |
| "Amikacin was found to be a potent inhibitor of clinical isolates of Mycobacterium tuberculosis in vitro." | 1.26 | Activity of amikacin against Mycobacteria in vitro and in murine tuberculosis. ( Cacciatore, R; Hartwig, C; Sanders, WE; Schneider, N; Valdez, H, 1982) |
| "The adverse effects of drugs which caused changes in therapeutic regimens have been studied in 511 patients with pulmonary tuberculosis, at the Pavilion Koch of Buenos Aires University." | 1.26 | Adverse effects of antituberculosis drugs causing changes in treatment. ( Dambrosi, A; Dambrosi, VM; Gonzalez Montaner, LJ; Manassero, M, 1982) |
| "To determine whether or not low dosage prothionamide (PTH), with or without diamino diphenyl sulphone (DDS), can replace PAS or thiacetazone as the companion drug to isoniazid (INH) in the treatment of tuberculosis, two experiments have been performed in mice." | 1.26 | The role of low dosage prothionamide with and without 4,4'-diamino diphenyl sulphone for use with isoniazid in the treatment of experimental mouse tuberculosis. ( Boval, C; Grosset, J; Truffot, C, 1982) |
| " If the determination of the acetylator phenotype could not be used systematically in our country, in view of the individual adaptation to the dosage--the dosage might, on the other hand be worked out in a prompt way before toxic signs appear at a dose of 10 mg/kg or under, of INH--thanks to the calculation of the index of inactivation estimated from a single sample." | 1.26 | [Acetylation phenotype of isoniazid in Morocco. Preliminary study of 100 cases]. ( Bartal, M; Bouayad, Z; Chevalier, B; Maurin, R, 1982) |
| "Patients aged over 50 with pulmonary tuberculosis were treated with streptomycin and isoniazid administered by the routine routes and in the form of ultrasound aerosols." | 1.26 | [Concentration of streptomycin and isoniazid in the blood of patients over 50 with pulmonary tuberculosis after administration of the drugs in ultrasonic aerosols]. ( Korablev, VN, 1982) |
| "Isoniazid, which is an invariable constituent of any antituberculous drug regimen, is a potent histamine inhibitor." | 1.26 | Histamine poisoning in tuberculous patients after ingestion of tuna fish. ( Uragoda, CG, 1980) |
| "(4) Isoniazid prophylaxis has been shown to be effective in reducing later reactivation of primary tuberculosis." | 1.26 | Tuberculosis surveillance of hospital personnel. ( Gaeuman, JV, 1981) |
| "Increased deaths from liver cirrhosis (5 vs 0." | 1.26 | Late effects following isoniazid therapy. ( Boice, JD; Fraumeni, JF, 1980) |
| "Of 1490 patients, 88." | 1.26 | Tuberculosis in Kenya: a second national sampling survey of drug resistance and other factors, and a comparison with the prevalence data from the first national sampling survey. An East African and British Medical Research Council Co-operative Investigati ( , 1978) |
| "Isoniazid was given orally, 10 mg/kg/24 hours." | 1.26 | Control of streptomycin and isoniazid in malnourished children treated for tuberculosis. ( Akbani, Y; Bolme, P; Lindblad, BS; Rahimtoola, RJ, 1977) |
| " Usefully results are obtained after application per os of an uniform dosage and a sampling period for urine of 4 hours." | 1.26 | [The different inactivation of isoniazid in intermittent chemotherapy (author's transl)]. ( Eule, H; Fischer, P; Franke, H; Iwainsky, H; Werner, E; Winsel, K, 1977) |
| " The 350 children were treated with 2 drugs, during the early years isoniazid and PAS and in the past 3 years isoniazid and rifampicin in standard dosage for either 12 or 18 months." | 1.26 | Occult tuberculous infection in children. ( Fox, TG, 1977) |
| " Uniform practice was found with regard to the dosage of isoniazid administered, duration of treatment, and most other indications for preventive therapy recommended by the American Thoracic Society and the U." | 1.26 | Tuberculosis chemoprophylaxis practices in metropolitan clinics. ( Brewin, A; Gibert, J; Herskowitz, D; Leff, A, 1979) |
| "The mothers of children who developed cancer reported about 25% more illnesses during pregnancy than mothers of healthy control children." | 1.26 | Childhood cancer and drugs in pregnancy. ( Draper, GJ; Sanders, BM, 1979) |
| "Both ethambutol and isoniazid were totally ineffective against any of the anaerobes tested, even at 64 microgram/ml." | 1.26 | Antimicrobial activity of antituberculosis agents against anaerobic bacteria. ( Bach, VT; Thadepalli, H; Webb, DW, 1979) |
| "The others had scrofula or abxcess." | 1.26 | Group III atypical mycobacterial infections. ( Robinson, PA, 1979) |
| " Both drugs given together have unchanged cinetics and with adapted dosing of isoniazide the hepatic accidents seem to disappear." | 1.26 | [New information on the metabolism of isoniazide and rifampicin. Their therapeutical consequences (author's transl)]. ( Canavate, A; Sainte-Laudy, J; Sauvaget, J, 1979) |
| "During treatment of active pulmonary tuberculosis with isoniazid, rifampicin and ethambutol in 15 patients transaminase activity increased in seven to levels of 60-340 U/l (group I)." | 1.26 | [Plasma levels of rifampicin and isoniazid and serum levels of aminotransferases in combined tuberculostatic treatment (author's transl)]. ( Austerhoff, A; Kindler, U; Knop, P, 1977) |
| "One hundred and forty-two cases of bladder cancer and 48 cases of renal cancer were found in the follow-up of a 1963 census population." | 1.26 | Urinary tract cancer and isoniazid. ( Comstock, GW; Glassroth, JL; Snider, DE, 1977) |
| " The relative risks of death from all malignant neoplasms for patients receiving a total dosage of less than 50, 50-99, 100-199 and 200 g or more were 1." | 1.26 | An assessment of the carcinogenicity of isoniazid in patients with pulmonary tuberculosis. ( Fox, W; Peto, J; Stephens, R; Stott, H, 1976) |
| "tuberculosis were isolated from patients with pulmonary disease, no catalase-negative strains were isolated from patients with extrapulmonary disease, suggesting limited pathogenic potentialities of catalase-negative strains for man." | 1.26 | Some bacteriologic aspects of the epidemiology of pulmonary and extrapulmonary tuberculosis. ( Ali, MA; Middlebrook, G; Siddiqi, SH; Stauffer, JC, 1976) |
| "Three of them had evidence of pulmonary tuberculosis." | 1.26 | Tuberculosis infection in a paediatric department. ( Stewart, CJ, 1976) |
| "Of 1694 patients with pulmonary tuberculosis with or without extra-pulmonary tuberculosis, 96." | 1.25 | Tuberculosis in Tanzania: a national sampling survey of drug resistance and other factors. ( , 1975) |
| "Initial chemotherapy of active pulmonary tuberculosis in contacts of known drug-resistant patients should be based on drug susceptibility studies in the index case." | 1.25 | Failure of isoniazid prophylaxis after exposure to isoniazid-resistant tuberculosis. ( Fairshter, RD; Garlin, J; Randazzo, GP; Wilson, AF, 1975) |
| "This report reviews the history of scrofula and deals with specific diagnostic tests which are helpful in separating tuberculous adenitis from other masses found commonly in the neck." | 1.25 | Diagnosis and management of tuberculous cervical adenitis. ( Cantrell, RW; Jensen, JH; Reid, D, 1975) |
| "Isoniazid therapy has been proved an effective means of preventing overt clinical tuberculosis in persons with positive tuberculin skin tests, persons who are close contacts of active cases, and persons with inactive tuberculosis that were never treated." | 1.25 | The Jewish Hospital of St. Louis therapeutic grand rounds number 10. Chemoprophylaxis of tuberculosis. ( Avioli, LV; Byrd, R; Lefrak, SS; Senior, RM, 1975) |
| "About 10% of the patients had active pulmonary tuberculosis immediately before or during gestation." | 1.25 | Pregnancy and pulmonary tuberculosis. ( David, S; Fuchs, FF; Schaefer, G; Zervoudakis, IA, 1975) |
| "A patient with Addison's disease required increased corticosteroid dosage whilst receiving rifampicin." | 1.25 | Changes in cortisol metabolism following rifampicin therapy. ( Courtenay-Evans, RJ; Edwards, OM; Galley, JM; Hunter, J; Tait, AD, 1974) |
| "Four had developed serious pulmonary tuberculosis and one tuberculous meningitis, all within the three months which followed a post-contact negative tuberculin test." | 1.25 | Preventive treatment of tuberculin-negative contacts. ( Beaudry, PH; Brickman, HF, 1973) |
| "Rifampin is a newer semi-synthetic derivative of rifamycin." | 1.25 | Rifampin in the treatment of pulmonary tuberculosis. ( Hyde, L, 1972) |
| " This association of toxic reactions with antibodies is highly significant (P<0." | 1.25 | Potentially serious side effects of high-dose twice-weekly rifampicin. ( Poole, G; Stradling, P; Worlledge, S, 1971) |
| "plus isoniazid 600 mg." | 1.25 | Intermittent chemotherapy for tuberculosis in an urban community. ( Poole, G; Stradling, P, 1969) |
| "A series of studies on the rate of inactivation of isoniazid in Indian patients with pulmonary tuberculosis undergoing domiciliary chemotherapy with isoniazid, alone or in combination with p-aminosalicylic acid, has recently been undertaken by the Tuberculosis Chemotherapy Centre, Madras." | 1.24 | Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis. 2. Clinical implications in the treatment of pulmonary tuberculosis with isoniazid either alone or in combination with PAS. ( FOX, W; GANGADHARAM, PR; RAMACHANDRAN, K; RAMAKRISHNAN, CV; SELKON, JB; VELU, S, 1961) |
| " The present report gives results which show that the B-complex preparation is fully effective in preventing peripheral neuropathy in patients receiving the same high dosage of isoniazid, and that this is due to the small pyridoxine content of only 6 mg daily, and not to any of its other constituents." | 1.24 | THE PREVENTION AND TREATMENT OF ISONIAZID TOXICITY IN THE THERAPY OF PULMONARY TUBERCULOSIS. 2. AN ASSESSMENT OF THE PROPHYLACTIC EFFECT OF PYRIDOXINE IN LOW DOSAGE. ( BAJDAKOVA, ZL; BARABADZE, EM; BUNINA, TL; GARDASJAN, AN; KONOVALOV, NV; ZILBER, LA, 1963) |
| " All patients with an unsatisfactory response to treatment yielded resistant cultures, showing that the isoniazid dosage was never too low to inhibit sensitive organisms." | 1.24 | THE EMERGENCE OF ISONIAZID-RESISTANT CULTURES IN PATIENTS WITH PULMONARY TUBERCULOSIS DURING TREATMENT WITH ISONIAZID ALONE OR ISONIAZID PLUS PAS. ( DEVADATTA, S; KULKARNI, KG; MITCHISON, DA; NAIR, CN; NARAYANA, AS; RAMACHANDRAN, K; SELKON, JB, 1964) |
| " Before mass domiciliary chemotherapy can be introduced, however, a question that has to be decided is what drug or drugs and what dosage and rhythm of administration will be most effective." | 1.24 | A concurrent comparison of isoniazid plus PAS with three regimens of isoniazid alone in the domiciliary treatment of pulmonary tuberculosis in South India. ( , 1960) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3349 (69.34) | 18.7374 |
| 1990's | 436 (9.03) | 18.2507 |
| 2000's | 472 (9.77) | 29.6817 |
| 2010's | 484 (10.02) | 24.3611 |
| 2020's | 89 (1.84) | 2.80 |
| Authors | Studies |
|---|---|
| Tangallapally, RP | 2 |
| Yendapally, R | 2 |
| Lee, RE | 5 |
| Hevener, K | 1 |
| Jones, VC | 1 |
| Lenaerts, AJ | 10 |
| McNeil, MR | 1 |
| Wang, Y | 9 |
| Franzblau, S | 2 |
| Bogatcheva, E | 1 |
| Hanrahan, C | 1 |
| Nikonenko, B | 1 |
| Samala, R | 1 |
| Chen, P | 2 |
| Gearhart, J | 1 |
| Barbosa, F | 1 |
| Einck, L | 1 |
| Nacy, CA | 1 |
| Protopopova, M | 1 |
| Ibrahim, M | 2 |
| Andries, K | 4 |
| Lounis, N | 2 |
| Chauffour, A | 1 |
| Truffot-Pernot, C | 3 |
| Jarlier, V | 2 |
| Veziris, N | 2 |
| Bitting, C | 1 |
| Woolhiser, L | 1 |
| Gruppo, V | 2 |
| Marietta, KS | 1 |
| Johnson, CM | 1 |
| Orme, IM | 4 |
| Rustomjee, R | 6 |
| Diacon, AH | 11 |
| Allen, J | 1 |
| Venter, A | 12 |
| Reddy, C | 1 |
| Patientia, RF | 1 |
| Mthiyane, TC | 1 |
| De Marez, T | 1 |
| van Heeswijk, R | 1 |
| Kerstens, R | 1 |
| Koul, A | 1 |
| De Beule, K | 1 |
| Donald, PR | 22 |
| McNeeley, DF | 2 |
| Vicente, E | 1 |
| Villar, R | 1 |
| Burguete, A | 1 |
| Solano, B | 1 |
| Pérez-Silanes, S | 1 |
| Aldana, I | 1 |
| Maddry, JA | 1 |
| Franzblau, SG | 2 |
| Cho, SH | 1 |
| Monge, A | 1 |
| Goldman, RC | 1 |
| Hoff, DR | 1 |
| Caraway, ML | 2 |
| Brooks, EJ | 1 |
| Driver, ER | 1 |
| Ryan, GJ | 1 |
| Peloquin, CA | 13 |
| Basaraba, RJ | 2 |
| Rullas, J | 1 |
| García, JI | 1 |
| Beltrán, M | 1 |
| Cardona, PJ | 4 |
| Cáceres, N | 2 |
| García-Bustos, JF | 1 |
| Angulo-Barturen, I | 1 |
| Hameed P, S | 1 |
| Patil, V | 1 |
| Solapure, S | 1 |
| Sharma, U | 1 |
| Madhavapeddi, P | 1 |
| Raichurkar, A | 1 |
| Chinnapattu, M | 1 |
| Manjrekar, P | 1 |
| Shanbhag, G | 1 |
| Puttur, J | 1 |
| Shinde, V | 1 |
| Menasinakai, S | 1 |
| Rudrapatana, S | 1 |
| Achar, V | 1 |
| Awasthy, D | 1 |
| Nandishaiah, R | 1 |
| Humnabadkar, V | 1 |
| Ghosh, A | 1 |
| Narayan, C | 1 |
| Ramya, VK | 1 |
| Kaur, P | 1 |
| Sharma, S | 4 |
| Werngren, J | 1 |
| Hoffner, S | 1 |
| Panduga, V | 1 |
| Kumar, CN | 1 |
| Reddy, J | 1 |
| Kumar K N, M | 1 |
| Ganguly, S | 1 |
| Bharath, S | 1 |
| Bheemarao, U | 1 |
| Mukherjee, K | 1 |
| Arora, U | 1 |
| Gaonkar, S | 1 |
| Coulson, M | 1 |
| Waterson, D | 1 |
| Sambandamurthy, VK | 1 |
| de Sousa, SM | 1 |
| Kumar, D | 2 |
| Khare, G | 1 |
| Kidwai, S | 1 |
| Tyagi, AK | 1 |
| Singh, R | 1 |
| Rawat, DS | 1 |
| Luo, W | 1 |
| Huang, Z | 2 |
| Xu, D | 1 |
| Yang, M | 1 |
| Zhu, Y | 1 |
| Shen, L | 2 |
| Chen, S | 2 |
| Tao, X | 1 |
| Bin, W | 1 |
| Hu, Y | 3 |
| Jiang, N | 1 |
| Wei, Y | 1 |
| Wei, X | 1 |
| Ding, CZ | 1 |
| Shaikh, A | 1 |
| Sriraman, K | 1 |
| Vaswani, S | 1 |
| Oswal, V | 1 |
| Rao, S | 3 |
| Mistry, N | 1 |
| Li, H | 2 |
| Wu, Q | 2 |
| Hu, J | 1 |
| Feng, L | 1 |
| Yu, H | 2 |
| Li, L | 5 |
| Li, X | 3 |
| Ozturk, M | 1 |
| Chia, JE | 1 |
| Hazra, R | 1 |
| Saqib, M | 1 |
| Maine, RA | 1 |
| Guler, R | 1 |
| Suzuki, H | 1 |
| Mishra, BB | 1 |
| Brombacher, F | 1 |
| Parihar, SP | 1 |
| Fernández-Paz, C | 1 |
| Fernández-Paz, E | 1 |
| Salcedo-Abraira, P | 1 |
| Rojas, S | 1 |
| Barrios-Esteban, S | 1 |
| Csaba, N | 1 |
| Horcajada, P | 1 |
| Remuñán-López, C | 1 |
| Kim, JS | 2 |
| Kim, YH | 3 |
| Lee, SH | 4 |
| Kim, JW | 2 |
| Kang, JY | 1 |
| Kim, SK | 1 |
| Kim, SJ | 6 |
| Kang, YS | 1 |
| Kim, TH | 1 |
| Mok, J | 2 |
| Byun, MK | 1 |
| Park, HJ | 1 |
| Joh, JS | 2 |
| Park, YB | 1 |
| Lim, HS | 1 |
| Choi, H | 1 |
| Kim, H | 4 |
| Yang, J | 1 |
| Shen, X | 1 |
| Alsultan, A | 1 |
| Cho, I | 1 |
| Geiter, L | 2 |
| Shim, TS | 2 |
| Dogan Demir, A | 1 |
| Kut, A | 1 |
| Ozaydin, E | 1 |
| Nursoy, M | 1 |
| Cakir, FB | 1 |
| Ustabas Kahraman, F | 1 |
| Erenberk, U | 1 |
| Uzuner, S | 1 |
| Collak, A | 1 |
| Cakin, ZE | 1 |
| Cakir, E | 2 |
| Carr, W | 1 |
| Kurbatova, E | 2 |
| Starks, A | 1 |
| Goswami, N | 1 |
| Allen, L | 1 |
| Winston, C | 1 |
| Soltobekova, N | 1 |
| Kozukeev, T | 1 |
| Yiehdego, G | 1 |
| Labib, F | 1 |
| Hovhannesyan, A | 1 |
| Rossi, R | 2 |
| McCallum, AD | 1 |
| Pertinez, HE | 1 |
| Chirambo, AP | 1 |
| Sheha, I | 1 |
| Chasweka, M | 1 |
| Malamba, R | 1 |
| Shani, D | 1 |
| Chitani, A | 1 |
| Mallewa, JE | 1 |
| Meghji, JZ | 1 |
| Ghany, JF | 1 |
| Corbett, EL | 4 |
| Gordon, SB | 1 |
| Davies, GR | 5 |
| Khoo, SH | 2 |
| Sloan, DJ | 1 |
| Mwandumba, HC | 1 |
| Benoit Vásquez, GI | 1 |
| Morrobel, AL | 1 |
| Benjumea-Bedoya, D | 2 |
| Del Corral-Londoño, H | 1 |
| Lopez-Varela, E | 2 |
| Abulfathi, AA | 1 |
| Strydom, N | 2 |
| Goussard, P | 1 |
| van Wyk, AC | 1 |
| Demers, AM | 1 |
| Deventer, AV | 1 |
| Garcia-Prats, AJ | 3 |
| van der Merwe, J | 1 |
| Zimmerman, M | 2 |
| Carter, CL | 1 |
| Janson, J | 1 |
| Morrison, J | 1 |
| Reuter, H | 1 |
| Decloedt, EH | 1 |
| Seddon, JA | 3 |
| Svensson, EM | 2 |
| Warren, R | 4 |
| Savic, RM | 4 |
| Dartois, V | 8 |
| Hesseling, AC | 12 |
| Pillay, S | 1 |
| Steingart, KR | 2 |
| Chaplin, M | 1 |
| De Vos, M | 2 |
| Schumacher, SG | 2 |
| Theron, G | 1 |
| Jiang, Y | 2 |
| Zhao, X | 2 |
| Fan, Z | 1 |
| Shin, AY | 1 |
| Jekarl, DW | 1 |
| Kim, HW | 1 |
| Ha, JH | 1 |
| Ahn, JH | 1 |
| Gausi, K | 1 |
| Chirehwa, M | 2 |
| Ignatius, EH | 5 |
| Court, R | 1 |
| Sun, X | 1 |
| Moran, L | 1 |
| Hafner, R | 5 |
| Wiesner, L | 6 |
| Rosenkranz, SL | 1 |
| de Jager, V | 2 |
| de Vries, N | 1 |
| Harding, J | 1 |
| Gumbo, T | 4 |
| Swindells, S | 3 |
| Diacon, A | 1 |
| Dooley, KE | 7 |
| McIlleron, H | 14 |
| Denti, P | 10 |
| Kwak, N | 2 |
| Jeon, D | 1 |
| Park, Y | 1 |
| Kang, YA | 1 |
| Kim, KJ | 1 |
| Kim, YR | 1 |
| Kwon, BS | 2 |
| Kwon, YS | 1 |
| Kim, HJ | 5 |
| Lee, JH | 5 |
| Lee, JY | 3 |
| Lee, JK | 3 |
| Cheon, M | 1 |
| Park, J | 1 |
| Hahn, S | 2 |
| Yim, JJ | 3 |
| Pettit, AC | 1 |
| Phillips, PPJ | 5 |
| Vernon, A | 10 |
| Nahid, P | 2 |
| Dawson, R | 13 |
| Sanne, I | 3 |
| Waja, Z | 2 |
| Mohapi, L | 3 |
| Podany, AT | 1 |
| Samaneka, W | 1 |
| Johnson, JL | 10 |
| Muzanyi, G | 1 |
| Lalloo, UG | 1 |
| Bryant, K | 1 |
| Sizemore, E | 1 |
| Scott, N | 1 |
| Dorman, SE | 9 |
| Chaisson, RE | 14 |
| Marais, BJ | 7 |
| Bernays, S | 1 |
| Schaaf, HS | 15 |
| Fox, GJ | 2 |
| Manyazewal, T | 2 |
| Woldeamanuel, Y | 3 |
| Holland, DP | 3 |
| Fekadu, A | 2 |
| Marconi, VC | 2 |
| Hasan, MS | 1 |
| Hossain, MA | 2 |
| Paul, SK | 1 |
| Nasreen, SA | 1 |
| Ahmed, S | 1 |
| Haque, N | 1 |
| Hasan, M | 1 |
| Khan, MK | 1 |
| Das, BR | 1 |
| Biswas, JP | 1 |
| Islam, A | 1 |
| David, A | 2 |
| Scott, L | 2 |
| da Silva, P | 1 |
| Trollip, A | 1 |
| Ruhwald, M | 1 |
| Schumacher, S | 1 |
| Stevens, W | 2 |
| Hendricks, B | 3 |
| Gupte, N | 7 |
| Barnes, G | 3 |
| Narunsky, K | 8 |
| Whitelaw, C | 3 |
| Smit, T | 3 |
| Friedman, A | 3 |
| Wang, X | 6 |
| Wu, Z | 3 |
| Zeng, J | 4 |
| Zhao, Y | 3 |
| Zhang, C | 3 |
| Yu, M | 3 |
| Wang, W | 5 |
| Chen, X | 3 |
| Chen, L | 4 |
| Wang, J | 10 |
| Xu, L | 4 |
| Zhou, J | 4 |
| Tan, Q | 3 |
| Wei, W | 3 |
| Li, Y | 8 |
| Villegas Arbeláez, E | 1 |
| Martínez-Peñaloza, D | 1 |
| Beltrán-Arroyave, CP | 1 |
| Restrepo Gouzy, AV | 1 |
| Marín, D | 1 |
| Cadavid Álvarez, LM | 1 |
| Molinares, B | 1 |
| Montes Zuluaga, FN | 1 |
| Pulido Duarte, H | 1 |
| Suárez Parra, PM | 1 |
| Alzate Ángel, JC | 1 |
| Vélez-Parra, G | 1 |
| Realpe, T | 2 |
| Vásquez Villa, M | 1 |
| Ríos Buitrago, SY | 1 |
| Puerta Zapata, J | 1 |
| Arango García, LM | 1 |
| Perea Torres, Y | 1 |
| Pérez Doncel, N | 1 |
| Arbeláez Montoya, MP | 1 |
| Robledo, J | 2 |
| Blumenfeld, A | 1 |
| Rubinstein, F | 1 |
| Mancini, P | 2 |
| Knopoff, EG | 1 |
| Montoya I de Manuel-Rimbau, A | 1 |
| Nguenha, D | 2 |
| Mambuque, E | 1 |
| Ehrlich, J | 1 |
| Munguambe, S | 1 |
| Saavedra, B | 1 |
| Matsena, T | 1 |
| Chiconela, H | 1 |
| Casellas, A | 1 |
| Acacio, S | 1 |
| Garcia-Basteiro, AL | 2 |
| Paton, NI | 2 |
| Cousins, C | 1 |
| Suresh, C | 2 |
| Burhan, E | 3 |
| Chew, KL | 1 |
| Dalay, VB | 1 |
| Lu, Q | 1 |
| Kusmiati, T | 1 |
| Balanag, VM | 1 |
| Lee, SL | 1 |
| Ruslami, R | 6 |
| Pokharkar, Y | 1 |
| Djaharuddin, I | 1 |
| Sugiri, JJR | 1 |
| Veto, RS | 1 |
| Sekaggya-Wiltshire, C | 4 |
| Avihingsanon, A | 1 |
| Sarin, R | 1 |
| Papineni, P | 1 |
| Nunn, AJ | 17 |
| Crook, AM | 4 |
| Lee, YJ | 4 |
| Song, MJ | 1 |
| Kim, YW | 2 |
| Lim, SY | 3 |
| Park, JS | 4 |
| Cho, YJ | 7 |
| Lee, CT | 3 |
| Aslan, AF | 1 |
| Ortaköylü, MG | 1 |
| Bağcı, BA | 1 |
| Toprak, S | 1 |
| Srikar, A | 1 |
| Venkataramana, B | 1 |
| Mohan, A | 2 |
| Sarma, P | 1 |
| Rekha Devi, K | 1 |
| Narain, K | 1 |
| Chaudhury, A | 1 |
| Xu, Q | 1 |
| Xu, B | 2 |
| Lin, Y | 2 |
| Yang, X | 2 |
| Tong, J | 1 |
| Huang, C | 1 |
| Hassane-Harouna, S | 1 |
| Gils, T | 1 |
| Decroo, T | 1 |
| Ortuño-Gutiérrez, N | 1 |
| Delamou, A | 1 |
| Cherif, GF | 1 |
| Camara, LM | 1 |
| Rigouts, L | 6 |
| de Jong, BC | 3 |
| Rivera, JGB | 1 |
| Albério, CAA | 1 |
| Vieira, JLF | 1 |
| Gray, AT | 1 |
| Macpherson, L | 1 |
| Carlin, F | 1 |
| Sossen, B | 1 |
| Richards, AS | 1 |
| Kik, SV | 1 |
| Houben, RMGJ | 1 |
| MacPherson, P | 2 |
| Quartagno, M | 1 |
| Rogozińska, E | 1 |
| Esmail, H | 2 |
| Tweed, CD | 2 |
| McHugh, TD | 10 |
| Mendel, CM | 5 |
| Meredith, SK | 4 |
| Murphy, ME | 2 |
| Singh, KP | 2 |
| Spigelman, M | 3 |
| Gillespie, SH | 17 |
| Flores-Treviño, S | 1 |
| Rodríguez-Noriega, E | 1 |
| Garza-González, E | 2 |
| González-Díaz, E | 1 |
| Esparza-Ahumada, S | 1 |
| Escobedo-Sánchez, R | 1 |
| Pérez-Gómez, HR | 1 |
| León-Garnica, G | 1 |
| Morfín-Otero, R | 1 |
| Li, G | 2 |
| Zhang, J | 1 |
| Zhao, LL | 1 |
| Liu, H | 1 |
| Li, M | 1 |
| Wan, K | 1 |
| Lipman, MC | 2 |
| Nunn, A | 2 |
| Walker, TM | 1 |
| Kloprogge, F | 1 |
| Hammond, R | 1 |
| Copas, A | 1 |
| Della Pasqua, O | 2 |
| Becerra, MC | 2 |
| Huang, CC | 2 |
| Lecca, L | 2 |
| Bayona, J | 1 |
| Contreras, C | 2 |
| Calderon, R | 2 |
| Yataco, R | 2 |
| Galea, J | 2 |
| Zhang, Z | 4 |
| Atwood, S | 1 |
| Cohen, T | 4 |
| Mitnick, CD | 1 |
| Farmer, P | 1 |
| Murray, M | 1 |
| Mtabho, CM | 4 |
| Semvua, HH | 5 |
| van den Boogaard, J | 4 |
| Irongo, CF | 1 |
| Boeree, MJ | 7 |
| Colbers, A | 3 |
| Burger, DM | 3 |
| van Crevel, R | 7 |
| van der Ven, AJAM | 1 |
| Kibiki, GS | 8 |
| Tostmann, A | 3 |
| Aarnoutse, RE | 9 |
| Ambreen, A | 1 |
| Jamil, M | 1 |
| Rahman, MAU | 1 |
| Mustafa, T | 1 |
| Peetluk, LS | 2 |
| Rebeiro, PF | 2 |
| Cordeiro-Santos, M | 2 |
| Kritski, A | 3 |
| Andrade, BB | 4 |
| Durovni, B | 3 |
| Calvacante, S | 2 |
| Arriaga, MB | 1 |
| Turner, MM | 1 |
| Figueiredo, MC | 2 |
| Rolla, VC | 2 |
| Sterling, TR | 5 |
| Otero, L | 2 |
| Battaglioli, T | 1 |
| Ríos, J | 1 |
| De la Torre, Z | 1 |
| Trocones, N | 1 |
| Ordoñez, C | 1 |
| Seas, C | 2 |
| Van der Stuyft, P | 3 |
| Kim, LB | 3 |
| Putyatina, AN | 3 |
| Russkikh, GS | 4 |
| Shkurupy, VA | 5 |
| Jhanjhria, S | 1 |
| Kashyap, B | 1 |
| Gomber, S | 1 |
| Gupta, N | 1 |
| Hyanki, P | 1 |
| Singh, NP | 1 |
| Khanna, A | 3 |
| Sharma, AK | 2 |
| Low, JM | 1 |
| Wong, KW | 1 |
| De Jager, VR | 2 |
| Vanker, N | 2 |
| Burger, DA | 2 |
| Everitt, D | 2 |
| Pappas, F | 2 |
| Nedelman, J | 1 |
| Genestet, C | 1 |
| Hodille, E | 1 |
| Berland, JL | 1 |
| Ginevra, C | 1 |
| Bryant, JE | 1 |
| Ader, F | 1 |
| Lina, G | 1 |
| Dumitrescu, O | 1 |
| Ciesielczuk, H | 1 |
| Kouvas, N | 1 |
| North, N | 1 |
| Buchanan, R | 1 |
| Tiberi, S | 2 |
| Kamboj, D | 1 |
| Gupta, P | 1 |
| Basil, MV | 1 |
| Guleria, R | 2 |
| Bhatnagar, A | 1 |
| Mehta, G | 1 |
| Kumar, P | 1 |
| Saurabh, A | 1 |
| Deepak, R | 1 |
| Thakral, D | 1 |
| Misra, P | 1 |
| Tandon, R | 1 |
| Gupta, UD | 1 |
| Mitra, DK | 1 |
| Edwards, BD | 1 |
| Edwards, J | 1 |
| Cooper, R | 2 |
| Kunimoto, D | 3 |
| Somayaji, R | 1 |
| Fisher, D | 1 |
| Rahimi, BA | 1 |
| Rahimy, N | 1 |
| Ahmadi, Q | 1 |
| Hayat, MS | 1 |
| Wasiq, AW | 1 |
| van Niekerk, C | 3 |
| Hutchings, J | 1 |
| Kim, J | 3 |
| van der Merwe, L | 2 |
| Choi, J | 1 |
| Nam, K | 1 |
| Huynh, J | 1 |
| Thwaites, G | 1 |
| Lobie, TA | 1 |
| Asrat, D | 1 |
| Beyene, D | 1 |
| Bjørås, M | 1 |
| Aseffa, A | 5 |
| Cherdantseva, LA | 1 |
| Kovner, AV | 1 |
| Troitskiy, AV | 2 |
| Bystrova, AV | 1 |
| Starostenko, AA | 1 |
| Bisognin, F | 1 |
| Lombardi, G | 1 |
| Finelli, C | 1 |
| Re, MC | 1 |
| Dal Monte, P | 1 |
| Blumberg, HM | 1 |
| Sinyavskaya, AM | 1 |
| Kovner, AM | 1 |
| Jain, N | 1 |
| Kalam, H | 1 |
| Singh, L | 1 |
| Sharma, V | 1 |
| Kedia, S | 1 |
| Das, P | 1 |
| Ahuja, V | 1 |
| Sharma, N | 1 |
| Basu, S | 1 |
| Chopra, KK | 2 |
| Sharma, P | 1 |
| Ruan, QL | 1 |
| Huang, XT | 1 |
| Yang, QL | 1 |
| Liu, XF | 1 |
| Wu, J | 2 |
| Pan, KC | 1 |
| Shen, YJ | 1 |
| Cai, LM | 1 |
| Ling, Q | 1 |
| Jiang, T | 1 |
| Hong, JJ | 1 |
| Wang, XD | 1 |
| Ma, CL | 1 |
| Peng, GQ | 1 |
| Wang, XZ | 1 |
| Mao, JC | 1 |
| Wu, TZ | 1 |
| Lin, MY | 1 |
| Shao, LY | 1 |
| Zhang, WH | 2 |
| Rivière, E | 1 |
| Whitfield, MG | 1 |
| Nelen, J | 1 |
| Heupink, TH | 1 |
| Van Rie, A | 3 |
| Dean, P | 1 |
| Berger, T | 1 |
| Matt, M | 1 |
| Schlaudecker, E | 1 |
| Riney, L | 1 |
| Sibandze, DB | 1 |
| Magazi, BT | 1 |
| Malinga, LA | 1 |
| Maningi, NE | 1 |
| Shey, BA | 1 |
| Pasipanodya, JG | 4 |
| Mbelle, NN | 1 |
| Govender, L | 1 |
| Furrer, J | 1 |
| Rakgokong, M | 1 |
| Martinson, N | 3 |
| Eisenberg, G | 1 |
| Marlowe, E | 1 |
| Welekidan, LN | 1 |
| Skjerve, E | 1 |
| Dejene, TA | 1 |
| Gebremichael, MW | 1 |
| Brynildsrud, O | 1 |
| Agdestein, A | 1 |
| Tessema, GT | 1 |
| Tønjum, T | 1 |
| Yimer, SA | 1 |
| Velásquez-Rimachi, V | 1 |
| Orellana-Tovar, I | 1 |
| Rodriguez-López, E | 1 |
| López-Saavedra, A | 1 |
| Esteban-Arias, D | 1 |
| Pacheco-Barrios, K | 1 |
| Metcalf, T | 1 |
| Alva-Diaz, C | 1 |
| Shetty, P | 1 |
| Panchal, F | 1 |
| Munshi, R | 1 |
| Sundar, U | 1 |
| Darole, P | 1 |
| Adkinson, BC | 1 |
| De La Fuente, J | 1 |
| Ninneman, M | 1 |
| Chuadry, ZA | 1 |
| Adkinson, BD | 1 |
| Khalid, L | 1 |
| Du, Y | 1 |
| Guo, R | 1 |
| Han, X | 1 |
| Wang, Q | 4 |
| Pang, Y | 2 |
| Chu, N | 1 |
| Xu, Y | 2 |
| Stockdale, JE | 1 |
| Naidu, V | 1 |
| Hatherell, H | 1 |
| Stimson, J | 1 |
| Stagg, HR | 1 |
| Abubakar, I | 3 |
| Colijn, C | 1 |
| Hsieh, YL | 1 |
| Jahn, A | 1 |
| Menzies, NA | 1 |
| Yaesoubi, R | 1 |
| Salomon, JA | 1 |
| Girma, B | 1 |
| Gunde, L | 1 |
| Eaton, JW | 1 |
| Auld, A | 1 |
| Odo, M | 1 |
| Kiyiika, CN | 1 |
| Kalua, T | 1 |
| Chiwandira, B | 1 |
| Mpunga, JU | 1 |
| Mbendra, K | 1 |
| Corbett, L | 1 |
| Hosseinipour, MC | 2 |
| Kunkel, A | 1 |
| Kabir, S | 1 |
| Junaid, K | 1 |
| Rehman, A | 1 |
| Ejo, M | 1 |
| Torrea, G | 2 |
| Uwizeye, C | 1 |
| Kassa, M | 1 |
| Girma, Y | 1 |
| Bekele, T | 1 |
| Ademe, Y | 1 |
| Diro, E | 1 |
| Gehre, F | 1 |
| Kuaban, C | 3 |
| Toukam, LDI | 1 |
| Sander, M | 1 |
| Gil, H | 1 |
| Margaryan, H | 1 |
| Azamat, I | 1 |
| Ziba, B | 1 |
| Bayram, H | 1 |
| Nazirov, P | 1 |
| Gomez, D | 1 |
| Singh, J | 1 |
| Zayniddin, S | 1 |
| Parpieva, N | 1 |
| Achar, J | 1 |
| van Beek, SW | 1 |
| Ter Heine, R | 1 |
| Alffenaar, JC | 1 |
| Magis-Escurra, C | 4 |
| Amisi, JA | 1 |
| Carter, EJ | 2 |
| Masini, E | 1 |
| Szkwarko, D | 1 |
| Gersh, JK | 1 |
| Barnabas, RV | 1 |
| Matemo, D | 1 |
| Kinuthia, J | 1 |
| Feldman, Z | 1 |
| Lacourse, SM | 1 |
| Mecha, J | 1 |
| Warr, AJ | 1 |
| Kamene, M | 1 |
| Horne, DJ | 1 |
| Orazulike, N | 1 |
| Sharma, JB | 1 |
| Umeora, OUJ | 1 |
| Chakraborty, P | 1 |
| Bajeli, S | 1 |
| Kaushal, D | 1 |
| Radotra, BD | 1 |
| Kumar, A | 2 |
| Rodrigues, S | 2 |
| Cunha, L | 2 |
| Kollan, J | 1 |
| Neumann, PR | 1 |
| Rosa da Costa, AM | 2 |
| Dailey, LA | 1 |
| Grenha, A | 2 |
| Sinnathamby, A | 1 |
| Ang, S | 1 |
| Bagdasarian, N | 1 |
| Chan, HC | 1 |
| Chan, SM | 1 |
| Lin, D | 1 |
| Yu, X | 2 |
| Lin, B | 2 |
| Chen, Y | 2 |
| Lei, C | 1 |
| Zhang, X | 4 |
| Huang, J | 1 |
| Yang, W | 1 |
| Liu, X | 2 |
| Fernandez Do Porto, DA | 1 |
| Monteserin, J | 1 |
| Campos, J | 1 |
| Sosa, EJ | 1 |
| Matteo, M | 1 |
| Serral, F | 1 |
| Yokobori, N | 1 |
| Benevento, AF | 1 |
| Poklepovich, T | 1 |
| Pardo, A | 1 |
| Wainmayer, I | 1 |
| Simboli, N | 1 |
| Castello, F | 1 |
| Paul, R | 1 |
| Martí, M | 1 |
| López, B | 2 |
| Turjanski, A | 1 |
| Ritacco, V | 3 |
| Krishnan, S | 1 |
| Queiroz, ATL | 1 |
| Gupta, A | 4 |
| Bisson, GP | 1 |
| Kumwenda, J | 1 |
| Naidoo, K | 1 |
| Mave, V | 2 |
| Mngqibisa, R | 1 |
| Lama, JR | 1 |
| Karakousis, PC | 7 |
| Liu, M | 1 |
| Xu, P | 1 |
| Liao, X | 1 |
| Li, Q | 4 |
| Chen, W | 2 |
| Gao, Q | 1 |
| Li, N | 1 |
| Luo, T | 1 |
| Fang, G | 1 |
| Cheng, NC | 1 |
| Huang, LL | 1 |
| Xie, WP | 1 |
| Hu, CM | 1 |
| Ridolfi, FM | 1 |
| Haas, DW | 1 |
| Liu, D | 1 |
| Brandenburg, J | 1 |
| Marwitz, S | 1 |
| Tazoll, SC | 1 |
| Waldow, F | 1 |
| Kalsdorf, B | 1 |
| Vierbuchen, T | 1 |
| Scholzen, T | 1 |
| Gross, A | 1 |
| Goldenbaum, S | 1 |
| Hölscher, A | 1 |
| Hein, M | 1 |
| Linnemann, L | 1 |
| Reimann, M | 1 |
| Kispert, A | 1 |
| Leitges, M | 1 |
| Rupp, J | 1 |
| Lange, C | 2 |
| Niemann, S | 3 |
| Behrends, J | 1 |
| Goldmann, T | 1 |
| Heine, H | 1 |
| Schaible, UE | 1 |
| Hölscher, C | 1 |
| Schwudke, D | 1 |
| Reiling, N | 1 |
| Laohapojanart, N | 1 |
| Ratanajamit, C | 1 |
| Kawkitinarong, K | 1 |
| Srichana, T | 1 |
| Iqbal, A | 1 |
| Ashraf, M | 1 |
| Rathore, AW | 1 |
| Omer, MO | 1 |
| Anjum, AA | 1 |
| Ishtiaq, S | 1 |
| Ali, RA | 1 |
| Arshad, U | 1 |
| Zaman, M | 1 |
| Churchyard, G | 3 |
| Cárdenas, V | 1 |
| Chihota, V | 1 |
| Mngadi, K | 1 |
| Sebe, M | 1 |
| Brumskine, W | 1 |
| Yimer, G | 2 |
| Wang, SH | 1 |
| Masilela, L | 1 |
| Waggie, Z | 1 |
| van den Hof, S | 1 |
| Charalambous, S | 5 |
| Cobelens, F | 2 |
| Grant, AD | 6 |
| Fielding, KL | 5 |
| Anthwal, D | 1 |
| Gupta, RK | 1 |
| Bhalla, M | 1 |
| Bhatnagar, S | 1 |
| Tyagi, JS | 1 |
| Haldar, S | 1 |
| Xiang, X | 1 |
| Wu, SQ | 4 |
| Chen, G | 2 |
| Zhang, MM | 4 |
| Wang, MG | 2 |
| Wang, FJ | 1 |
| Sandford, AJ | 3 |
| He, JQ | 4 |
| Bahi, GA | 1 |
| Boyvin, L | 1 |
| Méité, S | 1 |
| M'Boh, GM | 1 |
| Yeo, K | 1 |
| N'Guessan, KR | 1 |
| Bidié, AD | 1 |
| Djaman, AJ | 1 |
| Tashiro, K | 2 |
| Horita, N | 1 |
| Nagai, K | 1 |
| Ikeda, M | 1 |
| Shinkai, M | 1 |
| Yamamoto, M | 2 |
| Sato, T | 1 |
| Hara, Y | 2 |
| Nagakura, H | 1 |
| Shibata, Y | 1 |
| Watanabe, H | 2 |
| Nakashima, K | 1 |
| Ushio, R | 1 |
| Nagashima, A | 2 |
| Narita, A | 1 |
| Kobayashi, N | 2 |
| Kudo, M | 1 |
| Kaneko, T | 2 |
| Dutta, NK | 4 |
| Pinn, ML | 4 |
| Abanda, NN | 1 |
| Djieugoué, JY | 1 |
| Lim, E | 1 |
| Pefura-Yone, EW | 1 |
| Mbacham, WF | 1 |
| Vernet, G | 1 |
| Penlap, VM | 1 |
| Eyangoh, SI | 1 |
| Taylor, DW | 1 |
| Leke, RGF | 1 |
| Omonge, E | 1 |
| Otieno, F | 1 |
| Kubo, M | 2 |
| Shiruli, B | 1 |
| Chirehwa, MT | 2 |
| Mthiyane, T | 4 |
| Onyebujoh, P | 2 |
| Smith, P | 6 |
| de Knegt, GJ | 2 |
| Dickinson, L | 1 |
| Pertinez, H | 3 |
| Evangelopoulos, D | 2 |
| Bakker-Woudenberg, IAJM | 1 |
| de Steenwinkel, JEM | 2 |
| Gao, M | 1 |
| Gao, J | 2 |
| Du, J | 3 |
| Liu, Y | 5 |
| Zhang, Y | 8 |
| Ma, L | 3 |
| Mi, F | 1 |
| Tang, S | 1 |
| Namasivayam, S | 1 |
| Maiga, M | 3 |
| Yuan, W | 1 |
| Thovarai, V | 1 |
| Costa, DL | 1 |
| Mittereder, LR | 1 |
| Wipperman, MF | 1 |
| Glickman, MS | 1 |
| Dzutsev, A | 1 |
| Trinchieri, G | 1 |
| Sher, A | 1 |
| Goel, N | 1 |
| Kumar, V | 1 |
| Arora, S | 1 |
| Ghosh, B | 1 |
| Indumati, V | 1 |
| Vijay, V | 1 |
| Krishnaswamy, D | 1 |
| Rajeshwari, V | 1 |
| Ramesh, A | 1 |
| Shantala, D | 1 |
| Shilpa, A | 1 |
| Vashistha, H | 1 |
| Hanif, M | 3 |
| Shrivastava, D | 1 |
| Santos, G | 1 |
| Oliveira, O | 1 |
| Gaio, R | 1 |
| Duarte, R | 1 |
| Nimmo, C | 1 |
| Doyle, R | 1 |
| Burgess, C | 1 |
| Williams, R | 2 |
| Gorton, R | 1 |
| Brown, M | 1 |
| Morris-Jones, S | 1 |
| Booth, H | 1 |
| Breuer, J | 1 |
| Mourik, BC | 1 |
| Verbon, A | 1 |
| Mouton, JW | 1 |
| Bax, HI | 1 |
| Bonnet, M | 4 |
| Kyakwera, C | 1 |
| Kyomugasho, N | 1 |
| Atwine, D | 2 |
| Mugabe, F | 1 |
| Nansumba, M | 2 |
| Ii, YB | 1 |
| Mwanga-Amumpaire, J | 1 |
| Kiwanuka, J | 1 |
| Gengenbacher, M | 1 |
| Duque-Correa, MA | 1 |
| Kaiser, P | 1 |
| Schuerer, S | 1 |
| Lazar, D | 1 |
| Zedler, U | 1 |
| Reece, ST | 1 |
| Nayyar, A | 1 |
| Cole, ST | 1 |
| Makarov, V | 1 |
| Barry Iii, CE | 1 |
| Kaufmann, SHE | 1 |
| Nasiri, MJ | 1 |
| Zamani, S | 1 |
| Pormohammad, A | 1 |
| Feizabadi, MM | 1 |
| Aslani, HR | 1 |
| Amin, M | 1 |
| Halabian, R | 1 |
| Imani Fooladi, AA | 1 |
| Datiko, DG | 1 |
| Yassin, MA | 2 |
| Theobald, SJ | 1 |
| Cuevas, LE | 2 |
| Reither, K | 3 |
| Haraka, F | 1 |
| Mpagama, SG | 3 |
| Sumari-de Boer, IM | 1 |
| Wattenberg, M | 1 |
| Logger, JGM | 1 |
| Te Brake, LHM | 1 |
| Hoelscher, M | 3 |
| Plemper van Balen, G | 2 |
| Zunza, M | 1 |
| Gray, DM | 3 |
| Young, T | 1 |
| Cotton, M | 3 |
| Zar, HJ | 7 |
| Díaz, A | 1 |
| Bongiovanni, B | 1 |
| D'Attilio, L | 1 |
| Santucci, N | 1 |
| Dídoli, G | 1 |
| Fernández, RDV | 1 |
| Kovalevski, L | 1 |
| Lioi, S | 1 |
| Gardeñez, W | 1 |
| Brandan, N | 1 |
| Nannini, LJ | 1 |
| Besedovsky, H | 1 |
| Del Rey, A | 1 |
| Bottasso, O | 2 |
| Bay, ML | 1 |
| Mueller, Y | 1 |
| Mpala, Q | 1 |
| Kerschberger, B | 1 |
| Rusch, B | 1 |
| Mchunu, G | 1 |
| Mazibuko, S | 1 |
| Castelnuovo, B | 3 |
| von Braun, A | 3 |
| Musaazi, J | 2 |
| Muller, D | 3 |
| Buzibye, A | 3 |
| Gutteck, U | 3 |
| Henning, L | 2 |
| Ledergerber, B | 3 |
| Corti, N | 3 |
| Lamorde, M | 3 |
| Fehr, J | 2 |
| Kambugu, A | 4 |
| Rockwood, N | 3 |
| Sirgel, F | 2 |
| Streicher, E | 1 |
| Meintjes, G | 3 |
| Wilkinson, RJ | 5 |
| Feng, M | 1 |
| Wu, JC | 4 |
| Ji, GY | 2 |
| Liu, QQ | 2 |
| Park, S | 1 |
| Jo, KW | 1 |
| Lee, SD | 2 |
| Kim, WS | 1 |
| Shepherd, JG | 1 |
| Chapman, ALN | 1 |
| Chavalertsakul, K | 1 |
| Boonsarngsuk, V | 1 |
| Saengsri, S | 1 |
| Santanirand, P | 1 |
| Schechter, MC | 1 |
| Bizune, D | 1 |
| Kagei, M | 1 |
| Machaidze, M | 1 |
| Oladele, A | 1 |
| Wang, YF | 1 |
| Rebolledo, PA | 1 |
| Ray, SM | 1 |
| Kempker, RR | 1 |
| Chesov, D | 1 |
| Ciobanu, N | 1 |
| Heyckendorf, J | 1 |
| Crudu, V | 2 |
| Brunner, DR | 1 |
| Zweifel, SA | 1 |
| Barthelmes, D | 1 |
| Meier, F | 1 |
| Böni, C | 1 |
| Khosravi, AD | 1 |
| Shahraki, AH | 1 |
| Dezfuli, SK | 1 |
| Hashemzadeh, M | 1 |
| Goodarzi, H | 1 |
| Mohajeri, P | 1 |
| Nagel, S | 1 |
| Streicher, EM | 1 |
| Klopper, M | 1 |
| Warren, RM | 2 |
| Van Helden, PD | 8 |
| Chen, J | 2 |
| Innes, AL | 1 |
| Chiang, CY | 5 |
| Sigal, GB | 1 |
| Segal, MR | 1 |
| Mathew, A | 1 |
| Jarlsberg, L | 1 |
| Wang, M | 2 |
| Barbero, S | 1 |
| Small, N | 1 |
| Haynesworth, K | 1 |
| Davis, JL | 1 |
| Weiner, M | 4 |
| Whitworth, WC | 1 |
| Jacobs, J | 1 |
| Schorey, J | 1 |
| Lewinsohn, DM | 1 |
| van der Laan, LE | 1 |
| Tikiso, T | 1 |
| de Kock, M | 2 |
| Winckler, J | 1 |
| Norman, J | 2 |
| Kim, S | 1 |
| Lee, H | 2 |
| Park, HY | 2 |
| Jeon, K | 2 |
| Huh, HJ | 2 |
| Lee, NY | 2 |
| Jeong, BH | 2 |
| Wondale, B | 1 |
| Medihn, G | 1 |
| Teklu, T | 1 |
| Mersha, W | 1 |
| Tamirat, M | 1 |
| Ameni, G | 3 |
| Hsia, YC | 1 |
| Naseri, A | 1 |
| Schallhorn, JM | 1 |
| Kumbakumba, E | 1 |
| Orikiriza, P | 1 |
| Bastard, M | 1 |
| Mwanga, JA | 1 |
| Boum, Y | 1 |
| de Beaudrap, P | 1 |
| Charan, J | 1 |
| Goyal, JP | 1 |
| Reljic, T | 1 |
| Emmanuel, P | 1 |
| Patel, A | 2 |
| Patel, N | 2 |
| Jagannath, K | 1 |
| Vora, A | 2 |
| Patel, M | 1 |
| Cerezo Lajas, A | 1 |
| Caminero Luna, JA | 1 |
| Rodríguez Guzmán, MDC | 1 |
| de Miguel Díez, J | 1 |
| Tilahun, M | 1 |
| Desta, K | 1 |
| Zewude, A | 1 |
| Yamuah, L | 1 |
| Abebe, M | 3 |
| Martinez, L | 1 |
| le Roux, DM | 1 |
| Barnett, W | 1 |
| Stadler, A | 1 |
| Nicol, MP | 2 |
| Adane, K | 2 |
| Spigt, M | 1 |
| Dinant, GJ | 1 |
| Gopalan, N | 1 |
| Santhanakrishnan, RK | 1 |
| Palaniappan, AN | 1 |
| Menon, PA | 1 |
| Lakshman, S | 1 |
| Chandrasekaran, P | 1 |
| Sivaramakrishnan, GN | 1 |
| Reddy, D | 1 |
| Kannabiran, BP | 1 |
| Agiboth, HKK | 1 |
| Krishnamoorthy, V | 1 |
| Rathinam, S | 1 |
| Chockalingam, C | 1 |
| Manoharan, T | 1 |
| Ayyamperumal, M | 1 |
| Jayanthi, N | 1 |
| Satagopan, K | 1 |
| Narayanan, R | 1 |
| Krishnaraja, R | 1 |
| Sathiyavelu, S | 1 |
| Kesavamurthy, B | 1 |
| Selvachitiram, M | 1 |
| Arasan, G | 1 |
| Susaimuthu, S | 1 |
| Rathinam, P | 1 |
| Angamuthu, P | 1 |
| Jayabal, L | 1 |
| Murali, L | 1 |
| Ramachandran, R | 2 |
| Tripathy, SP | 21 |
| Swaminathan, S | 7 |
| Thai, PVK | 1 |
| Ha, DTM | 1 |
| Hanh, NT | 1 |
| Day, J | 1 |
| Dunstan, S | 1 |
| Nhu, NTQ | 1 |
| Kiet, VS | 1 |
| Lan, NH | 1 |
| Dung, NH | 1 |
| Lan, NTN | 1 |
| Thuong, NT | 1 |
| Lan, NN | 1 |
| Liễu, PTT | 1 |
| Hồng, NT | 1 |
| Điệp, ĐC | 1 |
| Thanh, NTK | 1 |
| Hội, NV | 1 |
| Nghĩa, NV | 1 |
| Đại, TN | 1 |
| Minh, HQ | 1 |
| Thơm, NV | 1 |
| Farrar, J | 3 |
| Caws, M | 2 |
| Jetter, A | 1 |
| Byakika-Kibwika, P | 2 |
| Eberhard, N | 1 |
| Matovu, J | 1 |
| Joloba, M | 1 |
| Manabe, YC | 2 |
| Kamya, MR | 2 |
| Fehr, JS | 1 |
| Choudhary, CR | 1 |
| Kumari, J | 1 |
| Advani, M | 1 |
| Migliori, GB | 3 |
| Sotgiu, G | 2 |
| Alagappan, C | 1 |
| Sunil Shivekar, S | 1 |
| Brammacharry, U | 1 |
| Cuppusamy Kapalamurthy, VR | 1 |
| Sakkaravarthy, A | 1 |
| Subashkumar, R | 1 |
| Muthaiah, M | 1 |
| Hançerli Törün, S | 1 |
| Acar, EM | 1 |
| Somer, A | 1 |
| Erköse, G | 1 |
| Şatana, D | 1 |
| Bayramoğlu, Z | 1 |
| Çalışkan, E | 1 |
| Kılıçaslan, Z | 1 |
| Coates, AR | 1 |
| Broda, A | 3 |
| Nikolayevskyy, V | 2 |
| Casali, N | 4 |
| Khan, H | 1 |
| Bowker, R | 1 |
| Blackwell, G | 1 |
| Patel, B | 1 |
| Hume, J | 1 |
| Hussain, W | 1 |
| Drobniewski, F | 7 |
| Stock, D | 1 |
| Zhao, G | 1 |
| Wu, L | 2 |
| Lu, M | 1 |
| Liu, W | 2 |
| Wu, Y | 1 |
| Wang, L | 3 |
| Wang, K | 2 |
| Qian, HZ | 1 |
| Xie, L | 1 |
| Si, M | 1 |
| Peng, H | 2 |
| Lin, S | 2 |
| Guan, W | 1 |
| LaZhou, C | 1 |
| Shi, Y | 1 |
| Iacobino, A | 1 |
| Giannoni, F | 1 |
| Fattorini, L | 1 |
| Brucoli, F | 1 |
| Wu, S | 1 |
| Chen, H | 1 |
| Xiong, W | 1 |
| Song, X | 1 |
| Benmerzoug, S | 1 |
| Marinho, FV | 1 |
| Rose, S | 1 |
| Mackowiak, C | 1 |
| Gosset, D | 1 |
| Sedda, D | 1 |
| Poisson, E | 1 |
| Uyttenhove, C | 1 |
| Van Snick, J | 1 |
| Jacobs, M | 1 |
| Garcia, I | 1 |
| Ryffel, B | 2 |
| Quesniaux, VFJ | 1 |
| Gobena, D | 1 |
| Ameya, G | 1 |
| Haile, K | 1 |
| Abreha, G | 1 |
| Worku, Y | 1 |
| Debela, T | 1 |
| Chen, YQ | 1 |
| Liu, YH | 1 |
| Sun, ZG | 1 |
| Ma, Y | 3 |
| Shu, W | 1 |
| Lyu, XY | 1 |
| Tian, XZ | 1 |
| Gao, WW | 1 |
| Amukoye, EI | 1 |
| Hanekom, M | 2 |
| Murthy, SE | 1 |
| Wills, GH | 1 |
| Chiang, TY | 1 |
| Fan, SY | 1 |
| Jou, R | 1 |
| Jan, F | 1 |
| Wali, S | 3 |
| Sadia, S | 1 |
| Akbar, MT | 1 |
| Akbar, HS | 1 |
| Ahmad, W | 1 |
| Ahmad, M | 1 |
| Khalid, A | 1 |
| du Preez, K | 2 |
| du Plessis, L | 2 |
| O'Connell, N | 1 |
| Alfarisi, O | 1 |
| Gaikwad, S | 2 |
| Sahasrabudhe, T | 1 |
| Ramachandran, G | 2 |
| Kumar, H | 2 |
| Kulkarni, V | 1 |
| Deshmukh, S | 1 |
| Atre, S | 1 |
| Raskar, S | 1 |
| Lokhande, R | 2 |
| Barthwal, M | 1 |
| Kakrani, A | 1 |
| Chon, S | 1 |
| Golub, JE | 5 |
| Birungi, FM | 2 |
| van Wyk, B | 2 |
| Uwimana, J | 2 |
| Ntaganira, J | 1 |
| Graham, SM | 4 |
| Rana, P | 1 |
| Roy, V | 3 |
| Ahmad, J | 1 |
| Yates, WB | 1 |
| Nothling, S | 1 |
| Lawlor, M | 1 |
| Leflot, M | 1 |
| Bonnet, S | 1 |
| Belgaumkar, V | 1 |
| Chandanwale, A | 1 |
| Valvi, C | 1 |
| Pardeshi, G | 1 |
| Kadam, D | 1 |
| Joshi, S | 1 |
| Jain, D | 1 |
| Dhumal, G | 1 |
| Deluca, A | 1 |
| Golub, J | 1 |
| Kinikar, A | 1 |
| Bollinger, RC | 1 |
| Holla, SK | 1 |
| Achappa, B | 1 |
| Manibettu Raguram, P | 1 |
| Yerramsetti, S | 1 |
| Sawry, S | 1 |
| Moultrie, H | 1 |
| Requena-Méndez, A | 3 |
| Davies, G | 5 |
| Waterhouse, D | 2 |
| Ardrey, A | 2 |
| Jave, O | 3 |
| López-Romero, SL | 2 |
| Ward, SA | 2 |
| Moore, DAJ | 1 |
| McAulay, K | 1 |
| Saito, K | 3 |
| Warrier, T | 1 |
| Walsh, KF | 1 |
| Mathurin, LD | 1 |
| Royal-Mardi, G | 2 |
| Lee, MH | 1 |
| Ocheretina, O | 3 |
| Pape, JW | 5 |
| Fitzgerald, DW | 4 |
| Nathan, CF | 2 |
| Kim, DK | 1 |
| Yoon, HI | 3 |
| Jeong, I | 2 |
| Heo, EY | 1 |
| Park, YS | 1 |
| Jo, YS | 1 |
| Park, SS | 1 |
| Lee, SM | 2 |
| Lee, CH | 1 |
| Lee, J | 3 |
| Choi, SM | 1 |
| Park, JH | 1 |
| Hwang, YR | 1 |
| Ki, J | 1 |
| Lim, JN | 1 |
| Choi, HS | 1 |
| Lee, M | 2 |
| Song, T | 1 |
| Kim, HS | 1 |
| Han, J | 1 |
| Ahn, H | 1 |
| Deshpande, D | 1 |
| Srivastava, S | 1 |
| Bendet, P | 1 |
| Koeuth, T | 1 |
| Lee, PS | 1 |
| Heysell, SK | 4 |
| Khan, S | 1 |
| Mandal, RK | 1 |
| Elasbali, AM | 1 |
| Dar, SA | 1 |
| Jawed, A | 1 |
| Wahid, M | 1 |
| Mahto, H | 1 |
| Lohani, M | 1 |
| Mishra, BN | 1 |
| Akhter, N | 1 |
| Rabaan, AA | 1 |
| Haque, S | 1 |
| Hamada, Y | 1 |
| Ford, N | 1 |
| Schenkel, K | 1 |
| Getahun, H | 1 |
| Kim, HY | 1 |
| Hanrahan, CF | 3 |
| Dowdy, DW | 1 |
| von Groote-Bidlingmaier, F | 2 |
| Patientia, R | 1 |
| Sanchez, E | 1 |
| Balanag, V | 1 |
| Ticona, E | 1 |
| Segura, P | 1 |
| Cadena, E | 1 |
| Yu, C | 1 |
| Cirule, A | 1 |
| Lizarbe, V | 1 |
| Davidaviciene, E | 1 |
| Domente, L | 1 |
| Variava, E | 2 |
| Caoili, J | 1 |
| Danilovits, M | 1 |
| Bielskiene, V | 1 |
| Staples, S | 1 |
| Hittel, N | 1 |
| Petersen, C | 1 |
| Wells, C | 2 |
| Hafkin, J | 1 |
| Geiter, LJ | 6 |
| Gupta, R | 3 |
| Musabimana, A | 1 |
| Robertson, GT | 1 |
| Ektnitphong, VA | 1 |
| Scherman, MS | 1 |
| McNeil, MB | 1 |
| Dennison, D | 1 |
| Korkegian, A | 1 |
| Smith, AJ | 1 |
| Halladay, J | 1 |
| Carter, DS | 1 |
| Xia, Y | 3 |
| Zhou, Y | 2 |
| Choi, W | 1 |
| Berry, PW | 1 |
| Mao, W | 1 |
| Hernandez, V | 1 |
| Alley, MRK | 1 |
| Parish, T | 1 |
| Khan, N | 1 |
| Mendonca, L | 1 |
| Dhariwal, A | 1 |
| Fontes, G | 1 |
| Menzies, D | 10 |
| Xia, J | 1 |
| Divangahi, M | 1 |
| King, IL | 1 |
| Lung, T | 1 |
| Marks, GB | 1 |
| Nhung, NV | 1 |
| Anh, NT | 1 |
| Hoa, NLP | 1 |
| Anh, LTN | 1 |
| Hoa, NB | 1 |
| Britton, WJ | 1 |
| Bestrashniy, J | 1 |
| Jan, S | 1 |
| Hasanain, AFA | 1 |
| Zayed, AAH | 1 |
| Abd-Ellatief, RB | 1 |
| Nafee, AMA | 1 |
| Padmapriyadarsini, C | 2 |
| Bhavani, PK | 1 |
| Natrajan, M | 1 |
| Ponnuraja, C | 1 |
| Gomathy, SN | 1 |
| Jawahar, SM | 1 |
| Singh, M | 5 |
| Balganesh, T | 1 |
| Seijger, C | 1 |
| Hoefsloot, W | 1 |
| Bergsma-de Guchteneire, I | 1 |
| Te Brake, L | 1 |
| van Ingen, J | 2 |
| Kuipers, S | 1 |
| Aarnoutse, R | 4 |
| Boeree, M | 1 |
| Xue, M | 1 |
| Liu, Q | 2 |
| Ogari, CO | 1 |
| Nyamache, AK | 1 |
| Nonoh, J | 1 |
| Amukoye, E | 3 |
| Tamura, K | 1 |
| Kawasuji, H | 1 |
| Tachi, S | 1 |
| Kawasaki, Y | 1 |
| Nagaoka, M | 1 |
| Makimoto, M | 1 |
| Sakamaki, I | 1 |
| Yamamoto, Y | 2 |
| Kanatani, J | 1 |
| Isobe, J | 1 |
| Mitarai, S | 5 |
| Yoneda, N | 1 |
| Yoneda, S | 1 |
| Saito, S | 1 |
| Yoshida, T | 3 |
| Abakur, EHA | 1 |
| Alnour, TMS | 1 |
| Abuduhier, F | 1 |
| Albalawi, FMA | 1 |
| Alfifi, KAS | 1 |
| Wang, DM | 1 |
| Liao, Y | 1 |
| Li, QF | 1 |
| Zhu, M | 1 |
| Wu, GH | 1 |
| Xu, YH | 1 |
| Zhong, J | 2 |
| Luo, J | 1 |
| Li, YJ | 1 |
| Gupta, SV | 1 |
| Fox, WS | 1 |
| Via, LE | 4 |
| Bang, H | 1 |
| Eum, S | 1 |
| Shim, T | 1 |
| Barry, CE | 7 |
| Faleiro, L | 1 |
| Buttini, F | 1 |
| Saldanha, N | 1 |
| Runwal, K | 1 |
| Ghanekar, C | 1 |
| Sane, S | 1 |
| Pujari, S | 1 |
| Suárez, I | 1 |
| Maria Fünger, S | 1 |
| Jung, N | 1 |
| Lehmann, C | 1 |
| Reimer, RP | 1 |
| Mehrkens, D | 1 |
| Bunte, A | 1 |
| Plum, G | 1 |
| Jaspers, N | 1 |
| Schmidt, M | 3 |
| Fätkenheuer, G | 1 |
| Rybniker, J | 1 |
| Hagiwara, E | 1 |
| Suido, Y | 1 |
| Asaoka, M | 1 |
| Katano, T | 1 |
| Okuda, R | 1 |
| Sekine, A | 1 |
| Kitamura, H | 1 |
| Baba, T | 1 |
| Komatsu, S | 1 |
| Ogura, T | 3 |
| Mendis, C | 1 |
| Thevanesam, V | 1 |
| Kumara, A | 1 |
| Wickramasinghe, S | 1 |
| Madegedara, D | 1 |
| Gamage, C | 1 |
| Gordon, SV | 1 |
| Suzuki, Y | 1 |
| Ratnatunga, C | 1 |
| Nakajima, C | 1 |
| Muntean, PE | 1 |
| Svensson, RJ | 1 |
| Sabiiti, W | 1 |
| Ntinginya, NE | 3 |
| Bhatt, N | 1 |
| Simonsson, USH | 1 |
| Korzeniewska- Koseła, M | 1 |
| Zumla, A | 3 |
| Raviglione, M | 5 |
| von Reyn, CF | 1 |
| Escalante, P | 2 |
| McKean-Cowdin, R | 1 |
| Ramaswamy, SV | 1 |
| Williams-Bouyer, N | 1 |
| Teeter, LD | 1 |
| Jones, BE | 4 |
| Graviss, EA | 2 |
| Al-Hajoj, S | 1 |
| Varghese, B | 1 |
| Shoukri, MM | 1 |
| Al-Omari, R | 1 |
| Al-Herbwai, M | 1 |
| Alrabiah, F | 1 |
| Alrajhi, AA | 1 |
| Abuljadayel, N | 1 |
| Al-Thawadi, S | 1 |
| Zignol, M | 3 |
| Raviglione, MC | 2 |
| Memish, Z | 2 |
| den Hertog, AL | 1 |
| de Vos, AF | 1 |
| Klatser, PR | 1 |
| Anthony, RM | 1 |
| Chehab, JC | 1 |
| Vilakazi-Nhlapo, AK | 1 |
| Vranken, P | 1 |
| Peters, A | 1 |
| Klausner, JD | 1 |
| Ishiwada, N | 1 |
| Tokunaga, O | 1 |
| Nagasawa, K | 1 |
| Ichimoto, K | 1 |
| Kinoshita, K | 2 |
| Hishiki, H | 1 |
| Kohno, Y | 1 |
| Shigyo, K | 1 |
| Merveille, YM | 1 |
| Johnson, WD | 3 |
| Claassens, M | 2 |
| van Schalkwyk, C | 1 |
| den Haan, L | 1 |
| Floyd, S | 2 |
| Dunbar, R | 1 |
| van Helden, P | 2 |
| Godfrey-Faussett, P | 4 |
| Ayles, H | 1 |
| Borgdorff, M | 1 |
| Enarson, D | 3 |
| Beyers, N | 4 |
| Belardinelli, JM | 1 |
| Morbidoni, HR | 1 |
| Sumenkova, DV | 1 |
| Poteryaeva, ON | 1 |
| Polyakov, LM | 1 |
| Panin, LE | 1 |
| Kateruttanakul, P | 1 |
| Unsematham, S | 1 |
| Ruesen, C | 2 |
| Ginanjar, A | 1 |
| Mangunnegoro, H | 1 |
| Ascobat, P | 1 |
| Donders, R | 1 |
| Kibrik, BS | 4 |
| Chelnokova, OG | 3 |
| Terekhina, LM | 1 |
| Sosnina, OIu | 1 |
| Dierberg, KL | 1 |
| Hingley-Wilson, SM | 1 |
| Casey, R | 1 |
| Connell, D | 1 |
| Bremang, S | 1 |
| Evans, JT | 1 |
| Hawkey, PM | 1 |
| Smith, GE | 1 |
| Jepson, A | 1 |
| Philip, S | 1 |
| Kon, OM | 1 |
| Lalvani, A | 1 |
| Smythe, W | 1 |
| Merle, CS | 2 |
| Gninafon, M | 3 |
| Lo, MB | 2 |
| Bah-Sow, O | 1 |
| Olliaro, PL | 2 |
| Lienhardt, C | 7 |
| Horton, J | 3 |
| Simonsson, US | 2 |
| Wang, F | 2 |
| Sambandan, D | 1 |
| Halder, R | 1 |
| Batt, SM | 1 |
| Weinrick, B | 1 |
| Ahmad, I | 2 |
| Yang, P | 1 |
| Hassani, M | 1 |
| Huszar, S | 1 |
| Trefzer, C | 1 |
| Ma, Z | 1 |
| Mdluli, KE | 2 |
| Chatterjee, AK | 1 |
| Johnsson, K | 1 |
| Johnson, K | 1 |
| Mikusova, K | 1 |
| Besra, GS | 2 |
| Fütterer, K | 1 |
| Robbins, SH | 1 |
| Barnes, SW | 1 |
| Walker, JR | 1 |
| Jacobs, WR | 2 |
| Schultz, PG | 1 |
| Wejse, C | 2 |
| Furtado, A | 1 |
| Camara, C | 1 |
| Lüneborg-Nielsen, M | 1 |
| Sodemann, M | 1 |
| Gerstoft, J | 1 |
| Katzenstein, TL | 1 |
| Sharma, SK | 1 |
| Sharma, A | 1 |
| Kadhiravan, T | 1 |
| Tharyan, P | 1 |
| Coussens, AK | 1 |
| Elkington, PT | 2 |
| Hanifa, Y | 2 |
| Islam, K | 1 |
| Timms, PM | 1 |
| Bothamley, GH | 2 |
| Claxton, AP | 1 |
| Packe, GE | 1 |
| Darmalingam, M | 1 |
| Davidson, RN | 1 |
| Milburn, HJ | 1 |
| Baker, LV | 1 |
| Barker, RD | 1 |
| Drobniewski, FA | 3 |
| Mein, CA | 1 |
| Bhaw-Rosun, L | 1 |
| Nuamah, RA | 1 |
| Griffiths, CJ | 1 |
| Martineau, AR | 1 |
| Farooqi, JQ | 1 |
| Khan, E | 1 |
| Alam, SM | 1 |
| Ali, A | 2 |
| Hasan, Z | 2 |
| Hasan, R | 2 |
| Burger, A | 2 |
| Wash, PA | 1 |
| Alonso, M | 1 |
| Martínez-Lirola, M | 1 |
| Palacios, JJ | 1 |
| Menéndez, Á | 1 |
| Herranz, M | 1 |
| Martínez, S | 1 |
| Bouza, E | 1 |
| García-de-Viedma, D | 1 |
| Babalik, A | 3 |
| Ulus, IH | 2 |
| Bakirci, N | 3 |
| Kuyucu, T | 2 |
| Arpag, H | 2 |
| Dagyildizi, L | 1 |
| Capaner, E | 1 |
| Colasanti, P | 1 |
| Cardone, M | 1 |
| Zanchini, R | 1 |
| Cordedda, M | 1 |
| Grande, A | 1 |
| Mozzillo, R | 1 |
| Workalemahu, B | 1 |
| Berg, S | 1 |
| Tsegaye, W | 1 |
| Abdissa, A | 2 |
| Girma, T | 1 |
| Tsou, CC | 1 |
| Chien, JY | 2 |
| Coronel, J | 2 |
| Roper, MH | 1 |
| Herrera, C | 1 |
| Bonilla, C | 1 |
| Gianella, C | 1 |
| Sabogal, I | 1 |
| Huancaré, V | 1 |
| Leo, E | 1 |
| Tyas, A | 1 |
| Mendoza-Ticona, A | 1 |
| Caviedes, L | 1 |
| Moore, DA | 4 |
| Dagyildiz, L | 1 |
| Çarpaner, E | 1 |
| Bark, CM | 1 |
| Gitta, P | 2 |
| Ogwang, S | 1 |
| Nsereko, M | 1 |
| Thiel, BA | 1 |
| Boom, WH | 4 |
| Eisenach, KD | 4 |
| Joloba, ML | 3 |
| Deepa, D | 1 |
| Achanta, S | 1 |
| Jaju, J | 1 |
| Rao, K | 1 |
| Samyukta, R | 1 |
| Kumar, AM | 1 |
| Ph, V | 1 |
| Anuwatnonthakate, A | 1 |
| Whitehead, SJ | 1 |
| Varma, JK | 1 |
| Silachamroon, U | 1 |
| Kasetjaroen, Y | 1 |
| Moolphate, S | 2 |
| Limsomboon, P | 1 |
| Inyaphong, J | 1 |
| Suriyon, N | 1 |
| Kavinum, S | 1 |
| Chiengson, N | 1 |
| Tunteerapat, P | 1 |
| Kaewkungwal, J | 1 |
| Hung, NV | 1 |
| Ando, H | 2 |
| Thuy, TT | 1 |
| Kuwahara, T | 1 |
| Hang, NT | 1 |
| Sakurada, S | 1 |
| Thuong, PH | 1 |
| Lien, LT | 1 |
| Keicho, N | 1 |
| Fahimi, F | 3 |
| Tabarsi, P | 4 |
| Kobarfard, F | 2 |
| Bozorg, BD | 1 |
| Goodarzi, A | 1 |
| Dastan, F | 1 |
| Shahsavari, N | 1 |
| Emami, S | 1 |
| Habibi, M | 1 |
| Salamzadeh, J | 2 |
| Neino Mourtala Mohamed, A | 1 |
| Tummino, C | 1 |
| Gouitaa, M | 1 |
| Chanez, P | 1 |
| Slivkin, AI | 1 |
| Lapenko, VL | 1 |
| Bychuk, AI | 1 |
| Suslina, SN | 1 |
| Slivkin, DA | 1 |
| Kornienko, SV | 1 |
| Belenova, AS | 1 |
| Nomi, F | 1 |
| Hosaka, K | 1 |
| Kurosawa, T | 2 |
| Yu, XL | 1 |
| Wen, ZL | 1 |
| Chen, GZ | 1 |
| Li, R | 1 |
| Ding, BB | 1 |
| Yao, YF | 1 |
| Wu, H | 2 |
| Guo, XK | 1 |
| Wang, HH | 1 |
| Zhang, SL | 1 |
| Huai, P | 1 |
| Jiang, S | 1 |
| Li, J | 2 |
| Peng, Y | 1 |
| Yao, H | 1 |
| Ma, W | 2 |
| van Soelen, N | 1 |
| van Wyk, SS | 1 |
| Mandalakas, AM | 3 |
| Enarson, DA | 6 |
| Reid, AJ | 1 |
| Saiki, M | 1 |
| Honda, T | 2 |
| Sogami, Y | 1 |
| Fukasawa, K | 1 |
| Miyashita, Y | 1 |
| Sano, K | 1 |
| Rutherford, ME | 1 |
| Anselmo, M | 1 |
| Alisjahbana, B | 3 |
| Yulianti, N | 1 |
| Sampurno, H | 1 |
| Hill, PC | 1 |
| Akkerman, OW | 2 |
| van Altena, R | 2 |
| Bolhuis, MS | 2 |
| van der Werf, TS | 2 |
| Alffenaar, JW | 2 |
| Salina, TIu | 1 |
| Morozova, TI | 1 |
| Zabost, A | 3 |
| Brzezińska, S | 2 |
| Kozińska, M | 3 |
| Błachnio, M | 1 |
| Jagodziński, J | 1 |
| Zwolska, Z | 6 |
| Augustynowicz-Kopeć, E | 6 |
| Gutiérrez-Aroca, JB | 1 |
| Ruiz, P | 1 |
| Casal, M | 1 |
| Xiang, Y | 1 |
| Wu, W | 1 |
| Zhu, X | 1 |
| Ma, J | 1 |
| Cao, M | 1 |
| Yao, X | 1 |
| Yang, L | 1 |
| Wubuli, A | 1 |
| Merle, C | 1 |
| Milligan, P | 1 |
| Mao, Y | 1 |
| Gu, J | 1 |
| Xin, X | 1 |
| Cinel, G | 1 |
| Kiper, N | 2 |
| Pekcan, S | 1 |
| Koyun, M | 1 |
| Köse, M | 1 |
| Çobanoğlu, N | 1 |
| Tana Aslan, A | 1 |
| Yalçın, E | 1 |
| Doğru, D | 1 |
| Özçelik, U | 2 |
| Göçmen, A | 2 |
| Kurup, R | 1 |
| George, C | 1 |
| Zelner, JL | 1 |
| Murray, MB | 1 |
| Grenfell, BT | 1 |
| Reynolds, J | 1 |
| Oualil, H | 1 |
| Nejjari, S | 1 |
| Bourkadi, JE | 1 |
| Iraqi, G | 1 |
| Workman, LJ | 1 |
| Lombard, CJ | 2 |
| Jennings, T | 1 |
| Innes, S | 1 |
| Grobbelaar, CJ | 1 |
| Cotton, MF | 4 |
| Tella, E | 1 |
| Daubercies, G | 1 |
| Sin, C | 1 |
| Marchal, A | 1 |
| Sigal, ML | 1 |
| Mahé, E | 1 |
| Nishiyama, H | 1 |
| Aono, A | 1 |
| Sugamoto, T | 1 |
| Mizuno, K | 1 |
| Chikamatsu, K | 1 |
| Yamada, H | 1 |
| Chierakul, N | 2 |
| Saengthongpinij, V | 1 |
| Foongladda, S | 1 |
| Rangaka, MX | 1 |
| Boulle, A | 1 |
| Glynn, JR | 3 |
| Fielding, K | 2 |
| van Cutsem, G | 2 |
| Wilkinson, KA | 1 |
| Goliath, R | 1 |
| Mathee, S | 1 |
| Goemaere, E | 2 |
| Maartens, G | 3 |
| Goel, S | 1 |
| Harries, AD | 10 |
| Gao, T | 1 |
| Cheng, S | 2 |
| Du, X | 1 |
| Singh, S | 1 |
| Kubler, A | 1 |
| Singh, UK | 1 |
| Singh, A | 1 |
| Gardiner, H | 1 |
| Prasad, R | 2 |
| Friedland, JS | 2 |
| Deery, CB | 1 |
| Selibas, K | 1 |
| Bassett, J | 1 |
| Moraes, ML | 1 |
| Ramalho, DM | 1 |
| Delogo, KN | 1 |
| Miranda, PF | 1 |
| Mesquita, ED | 1 |
| de Melo Guedes de Oliveira, HM | 1 |
| Netto, AR | 1 |
| Dos Anjos, MJ | 1 |
| Kritski, AL | 4 |
| de Oliveira, MM | 1 |
| Fu, EQ | 1 |
| Jin, FG | 1 |
| Pouplin, T | 1 |
| Phuong, PN | 1 |
| Toi, PV | 1 |
| Nguyen Pouplin, J | 1 |
| Thakur, BK | 1 |
| Verma, S | 2 |
| Mishra, J | 1 |
| Alvarez, GG | 1 |
| VanDyk, DD | 1 |
| Aaron, SD | 1 |
| Cameron, DW | 2 |
| Davies, N | 1 |
| Stephen, N | 1 |
| Mallick, R | 1 |
| Momoli, F | 1 |
| Moreau, K | 1 |
| Obed, N | 1 |
| Baikie, M | 1 |
| Osborne, G | 1 |
| Saitou, Y | 1 |
| Hatazi, O | 1 |
| Aonuma, H | 1 |
| Ogura, S | 1 |
| Yamamoto, N | 1 |
| Kobayashi, T | 4 |
| Papadopoulou, MV | 1 |
| Bloomer, WD | 1 |
| Rosenzweig, HS | 1 |
| Arena, A | 1 |
| Arrieta, F | 1 |
| Rebolledo, JC | 1 |
| Smith, DK | 1 |
| Chen, C | 2 |
| Kong, W | 1 |
| Zhu, L | 3 |
| Shao, Y | 1 |
| Song, H | 1 |
| Shi, J | 2 |
| Zhong, C | 1 |
| Ding, X | 2 |
| Yang, H | 1 |
| Lu, W | 2 |
| Grisaru-Soen, G | 2 |
| Savyon, M | 1 |
| Sadot, E | 1 |
| Schechner, V | 2 |
| Sivan, Y | 1 |
| Schwartz, D | 1 |
| Tarabeia, J | 1 |
| Amitai, Z | 1 |
| Yoabov, I | 1 |
| Carmeli, Y | 2 |
| Yamamoto, K | 5 |
| Takasaki, J | 1 |
| Morino, E | 1 |
| Sugiyama, H | 1 |
| Murray, SR | 1 |
| Phillips, PP | 4 |
| Rusen, ID | 1 |
| Van Deun, A | 3 |
| Squire, SB | 1 |
| Madan, J | 1 |
| Cook, SV | 3 |
| Burgos, M | 3 |
| Yorke-Edwards, V | 2 |
| Anyo, G | 2 |
| Jindani, A | 9 |
| Mathys, V | 1 |
| van de Vyvere, M | 1 |
| de Droogh, E | 1 |
| Soetaert, K | 1 |
| Groenen, G | 1 |
| Sacks, HS | 1 |
| Porvaznik, I | 1 |
| Mokry, J | 1 |
| Solovic, I | 1 |
| Traoré, FA | 1 |
| Sako, FB | 1 |
| Sylla, D | 1 |
| Bangoura, M | 1 |
| Kpamy, DO | 1 |
| Traoré, M | 1 |
| Doumbouya, M | 1 |
| Sangare, I | 1 |
| Goswami, A | 1 |
| Chakraborty, U | 1 |
| Mahapatra, T | 1 |
| Mahapatra, S | 2 |
| Mukherjee, T | 1 |
| Das, S | 1 |
| Das, A | 2 |
| Dey, SK | 1 |
| Ray, S | 1 |
| Bhattacharya, B | 1 |
| Pal, NK | 1 |
| Supervía, A | 1 |
| Pallàs, O | 1 |
| Piccari, L | 1 |
| Herrera Fernández, S | 1 |
| Domínguez Álvarez, M | 1 |
| Cirera, I | 1 |
| del Baño, F | 1 |
| Sow, OB | 1 |
| Odhiambo, J | 2 |
| Bah, B | 1 |
| Kassa, F | 1 |
| N'Diaye, A | 1 |
| Perronne, C | 1 |
| Sismanidis, C | 2 |
| Lapujade, O | 1 |
| Harrison, TS | 2 |
| Churchyard, GJ | 6 |
| Hatherill, M | 1 |
| Geldenhuys, H | 1 |
| McIlleron, HM | 2 |
| Zvada, SP | 1 |
| Mungofa, S | 1 |
| Shah, NA | 1 |
| Zizhou, S | 1 |
| Magweta, L | 1 |
| Shepherd, J | 1 |
| Nyirenda, S | 1 |
| van Dijk, JH | 1 |
| Clouting, HE | 1 |
| Coleman, D | 1 |
| Bateson, AL | 1 |
| Butcher, PD | 1 |
| Mitchison, DA | 52 |
| Oshi, SN | 2 |
| Alobu, I | 2 |
| Ukwaja, KN | 2 |
| Oshi, DC | 2 |
| Yamana, H | 1 |
| Matsui, H | 1 |
| Fushimi, K | 1 |
| Yasunaga, H | 1 |
| Mah, A | 1 |
| Kharrat, H | 1 |
| Ahmed, R | 1 |
| Gao, Z | 2 |
| Der, E | 1 |
| Hansen, E | 1 |
| Long, R | 3 |
| Yang, G | 2 |
| Cheng, Q | 1 |
| Liu, S | 1 |
| Tan, S | 3 |
| Tan, Y | 1 |
| Cai, X | 1 |
| Bakayoko, AS | 2 |
| Kaloga, M | 1 |
| Kamagate, M | 1 |
| Kone, Z | 2 |
| Daix, AT | 2 |
| Ohui, E | 1 |
| Gbery, I | 1 |
| Domoua, K | 2 |
| Chen, YT | 1 |
| Wu, SG | 1 |
| Lee, JJ | 3 |
| Wang, JY | 2 |
| Yu, CJ | 2 |
| Song, J | 2 |
| du Bois, J | 2 |
| Heinrich, N | 2 |
| Rehal, S | 2 |
| van Soolingen, D | 2 |
| Burger, D | 1 |
| Kargiotis, O | 1 |
| Marangos, M | 1 |
| Polychronopoulos, P | 1 |
| Garg, T | 1 |
| Rath, G | 2 |
| Goyal, AK | 2 |
| Hall, C | 1 |
| Sukijthamapan, P | 1 |
| dos Santos, R | 1 |
| Nourse, C | 1 |
| Murphy, D | 1 |
| Gibbons, M | 1 |
| Francis, JR | 1 |
| Verma, G | 1 |
| Singh, DV | 1 |
| Mokta, J | 1 |
| Negi, RS | 1 |
| Jhobta, A | 1 |
| Kanga, A | 1 |
| Gómez-Gómez, A | 1 |
| Magaña-Aquino, M | 1 |
| López-Meza, S | 1 |
| Aranda-Álvarez, M | 1 |
| Díaz-Ornelas, DE | 1 |
| Hernández-Segura, MG | 1 |
| Salazar-Lezama, MÁ | 1 |
| Castellanos-Joya, M | 1 |
| Noyola, DE | 1 |
| Brigden, G | 1 |
| Furin, J | 1 |
| Van Gulik, C | 1 |
| Marais, B | 1 |
| Honeyborne, I | 1 |
| Eckold, C | 1 |
| Pym, A | 4 |
| Sturkenboom, MG | 1 |
| de Lange, WC | 1 |
| Schall, R | 2 |
| Conradie, A | 1 |
| Eisenach, K | 3 |
| Ive, P | 1 |
| Page-Shipp, L | 2 |
| Mata-Espinosa, D | 1 |
| Molina-Salinas, GM | 1 |
| Barrios-Payán, J | 1 |
| Navarrete-Vázquez, G | 1 |
| Marquina, B | 1 |
| Ramos-Espinosa, O | 1 |
| Bini, EI | 1 |
| Baeza, I | 1 |
| Hernández-Pando, R | 1 |
| Nwofor, AC | 1 |
| Nyamngee, A | 1 |
| Nwabuisi, C | 1 |
| Iwakun, M | 1 |
| Gidado, M | 1 |
| Mensah, C | 1 |
| Dakum, P | 1 |
| Agbede, OO | 1 |
| Ndembi, N | 1 |
| Blattner, WA | 1 |
| Abimiku, AG | 1 |
| Nagu, TJ | 1 |
| Aboud, S | 1 |
| Mwiru, R | 1 |
| Matee, M | 1 |
| Fawzi, W | 1 |
| Mugusi, F | 1 |
| Aiwale, AS | 1 |
| Patel, UA | 1 |
| Barvaliya, MJ | 1 |
| Jha, PR | 1 |
| Tripathi, C | 1 |
| Braga, JU | 1 |
| Trajman, A | 1 |
| Mukherjee, A | 1 |
| Velpandian, T | 1 |
| Singla, M | 1 |
| Kanhiya, K | 1 |
| Kabra, SK | 1 |
| Lodha, R | 1 |
| Saleem, AF | 1 |
| Arbab, S | 1 |
| Naz, FQ | 1 |
| Cooke, M | 1 |
| Jordan, J | 1 |
| Mugwagwa, T | 1 |
| Townsend, C | 1 |
| Sivaramakrishnan, A | 1 |
| Green, N | 1 |
| Jit, M | 1 |
| Lipman, M | 1 |
| Lord, J | 1 |
| White, PJ | 1 |
| Lessing, JB | 1 |
| Braun, T | 1 |
| Abu-Hanna, J | 1 |
| Aviram, G | 1 |
| Cheng, JM | 1 |
| Hiscoe, L | 1 |
| Pollock, SL | 1 |
| Hasselback, P | 1 |
| Gardy, JL | 1 |
| Parker, R | 1 |
| Manaenkova, EV | 1 |
| Savin, AA | 1 |
| Escuyer, VE | 1 |
| Mabou, MM | 1 |
| Collins, SE | 1 |
| Igari, H | 1 |
| Imasawa, T | 1 |
| Noguchi, N | 1 |
| Nagayoshi, M | 1 |
| Mizuno, S | 1 |
| Ishikawa, S | 1 |
| Kadomura, M | 1 |
| Nishimura, M | 1 |
| Yamagishi, F | 5 |
| Carman, D | 1 |
| Whitelaw, A | 1 |
| Efron, A | 5 |
| Barnes, GL | 3 |
| Hoffman, J | 1 |
| Rezaković, S | 1 |
| Mokos, ZB | 1 |
| Paštar, Z | 1 |
| Garhyan, J | 1 |
| Bhuyan, S | 1 |
| Pulu, I | 1 |
| Kalita, D | 1 |
| Das, B | 1 |
| Bhatnagar, R | 1 |
| Gao, C | 1 |
| Chi, X | 1 |
| Hu, YW | 1 |
| Zheng, L | 1 |
| Zeng, T | 1 |
| Oshima, K | 1 |
| Yokouchi, H | 2 |
| Minemura, H | 1 |
| Saito, J | 1 |
| Tanino, Y | 1 |
| Munakata, M | 1 |
| Bekele, S | 1 |
| Rangari, GM | 1 |
| Sethi, GR | 1 |
| Mishra, TK | 1 |
| Mulu, W | 1 |
| Mekonnen, D | 1 |
| Yimer, M | 1 |
| Admassu, A | 1 |
| Abera, B | 1 |
| Asante-Poku, A | 1 |
| Otchere, ID | 1 |
| Danso, E | 1 |
| Mensah, DD | 1 |
| Bonsu, F | 1 |
| Gagneux, S | 1 |
| Yeboah-Manu, D | 1 |
| Wilson, D | 2 |
| Goggin, K | 1 |
| Williams, K | 4 |
| Gerkovich, MM | 1 |
| Gqaleni, N | 1 |
| Syce, J | 1 |
| Bartman, P | 1 |
| Johnson, Q | 1 |
| Folk, WR | 1 |
| Shi, G | 1 |
| Zhang, L | 2 |
| Karoli, R | 1 |
| Fatima, J | 1 |
| Jain, V | 1 |
| Umar, MS | 1 |
| Ayele, HT | 1 |
| van Mourik, MS | 1 |
| Bonten, MJ | 1 |
| Lisdawati, V | 1 |
| Puspandari, N | 1 |
| Rif'ati, L | 1 |
| Soekarno, T | 1 |
| M, M | 1 |
| K, S | 1 |
| Ratnasari, L | 1 |
| Izzatun, N | 1 |
| Parwati, I | 2 |
| Ahn, JG | 1 |
| Kim, DS | 1 |
| Kim, KH | 1 |
| Arenas-Pinto, A | 1 |
| Thompson, J | 1 |
| Musoro, G | 1 |
| Musana, H | 1 |
| Lugemwa, A | 1 |
| Mweemba, A | 1 |
| Atwongyeire, D | 1 |
| Thomason, MJ | 1 |
| Walker, AS | 1 |
| Rueda, J | 1 |
| Mejia, GI | 1 |
| Zapata, E | 1 |
| Rozo, JC | 1 |
| Ferro, BE | 1 |
| Chen, M | 1 |
| Deng, J | 1 |
| Li, W | 2 |
| Su, C | 1 |
| Abuaku, BK | 1 |
| Tan, H | 1 |
| Wen, SW | 1 |
| Maiga, MC | 2 |
| Ahidjo, BA | 2 |
| Bishai, WR | 6 |
| Fan, L | 1 |
| Bai, D | 1 |
| Yao, J | 1 |
| Yi, L | 1 |
| Manika, K | 1 |
| Chatzika, K | 1 |
| Papaioannou, M | 1 |
| Kontou, P | 1 |
| Boutou, A | 1 |
| Zarogoulidis, K | 1 |
| Kioumis, I | 1 |
| Hennig, S | 1 |
| Naiker, S | 1 |
| Reddy, T | 1 |
| Egan, D | 1 |
| Kellerman, T | 1 |
| Owen, A | 1 |
| Désire, I | 1 |
| Cyrille, B | 1 |
| Florencia, D | 1 |
| Souba, D | 1 |
| Albert, Y | 1 |
| Valerie, BJ | 1 |
| Rebecca, C | 1 |
| Charlemagne, G | 1 |
| Tamboura, D | 1 |
| Rémy, M | 1 |
| Virginio, P | 1 |
| Simplice, KD | 1 |
| Martial, O | 1 |
| Jacques, S | 1 |
| Jeremiah, K | 1 |
| Chigutsa, E | 2 |
| Faurholt-Jepsen, D | 1 |
| PrayGod, G | 1 |
| Range, N | 1 |
| Castel, S | 1 |
| Hagen, CM | 1 |
| Christiansen, M | 1 |
| Changalucha, J | 1 |
| Friis, H | 1 |
| Andersen, AB | 1 |
| Mekonnen, F | 1 |
| Tessema, B | 1 |
| Moges, F | 1 |
| Gelaw, A | 1 |
| Eshetie, S | 1 |
| Kumera, G | 1 |
| Homorodean, D | 1 |
| Pop, CM | 1 |
| Jodal, AM | 1 |
| Man, MA | 1 |
| Lawn, SD | 2 |
| Suthar, AB | 1 |
| Granich, R | 1 |
| Koh, WJ | 3 |
| David, S | 2 |
| Mateus, AR | 1 |
| Duarte, EL | 1 |
| Albuquerque, J | 1 |
| Portugal, C | 1 |
| Sancho, L | 1 |
| Lavinha, J | 1 |
| Gonçalves, G | 1 |
| Hernán García, C | 1 |
| Moreno Cea, L | 1 |
| Fernández Espinilla, V | 1 |
| Ruiz Lopez Del Prado, G | 1 |
| Fernández Arribas, S | 1 |
| Andrés García, I | 1 |
| Rubio, V | 1 |
| Vesenbeckh, S | 1 |
| Eiros Bouza, JM | 1 |
| Garrido-Colmenero, C | 1 |
| Ruiz-Villaverde, R | 1 |
| Martínez-López, A | 1 |
| Aneiros-Fernández, J | 1 |
| Principi, N | 1 |
| Galli, L | 3 |
| Lancella, L | 1 |
| Tadolini, M | 1 |
| Villani, A | 1 |
| Esposito, S | 1 |
| Chang, KC | 2 |
| Yew, WW | 9 |
| Xie, M | 1 |
| Lanoix, JP | 1 |
| Betoudji, F | 1 |
| Nuermberger, E | 5 |
| Chan, HH | 1 |
| Mpe, J | 1 |
| Kapoor, S | 1 |
| Shah, M | 1 |
| Carroll, J | 1 |
| Bhardwaj, A | 2 |
| Grobler, A | 1 |
| Jain, AK | 1 |
| Mehta, A | 1 |
| Singer-Leshinsky, S | 1 |
| Bekker, A | 1 |
| Draper, HR | 2 |
| van der Laan, L | 1 |
| Murray, S | 1 |
| Dobler, CC | 1 |
| Chidiac, R | 1 |
| Williamson, JP | 1 |
| Jelfs, PJ | 1 |
| Su, VY | 1 |
| Yen, YF | 1 |
| Pan, SW | 1 |
| Chuang, PH | 1 |
| Feng, JY | 2 |
| Chou, KT | 1 |
| Chen, YM | 3 |
| Chen, TJ | 1 |
| Su, WJ | 4 |
| Das, MK | 1 |
| Arya, R | 1 |
| Debnath, S | 1 |
| Debnath, R | 1 |
| Lodh, A | 1 |
| Bishwal, SC | 1 |
| Nanda, RK | 1 |
| Zhu, G | 1 |
| Fu, Y | 2 |
| Liu, F | 1 |
| Hu, D | 1 |
| Turapov, O | 1 |
| O'Connor, BD | 1 |
| Sarybaeva, AA | 1 |
| Williams, C | 1 |
| Patel, H | 1 |
| Kadyrov, AS | 1 |
| Sarybaev, AS | 1 |
| Woltmann, G | 1 |
| Barer, MR | 1 |
| Mukamolova, GV | 1 |
| Guehi, C | 1 |
| Badjé, A | 1 |
| Gabillard, D | 1 |
| Ouattara, E | 1 |
| Koulé, SO | 1 |
| Moh, R | 1 |
| Ekouevi, D | 1 |
| Ahibo, H | 1 |
| N'Takpé, JB | 1 |
| Menan, GK | 1 |
| Deschamps, N | 1 |
| Lecarrou, J | 1 |
| Eholié, S | 1 |
| Anglaret, X | 1 |
| Danel, C | 1 |
| Nieto R, LM | 1 |
| Mehaffy, C | 1 |
| Dobos, KM | 1 |
| Subbian, S | 2 |
| Tsenova, L | 2 |
| Holloway, J | 1 |
| Peixoto, B | 2 |
| O'Brien, P | 2 |
| Khetani, V | 1 |
| Zeldis, JB | 2 |
| Kaplan, G | 2 |
| Villegas, L | 1 |
| Huaman, MA | 1 |
| Gotuzzo, E | 1 |
| Park, SH | 1 |
| Lee, SJ | 2 |
| Jeong, YY | 2 |
| Kim, HC | 3 |
| Lee, JD | 2 |
| Alemu, YM | 1 |
| Andargie, G | 1 |
| Gebeye, E | 1 |
| Cruz, AT | 1 |
| Starke, JR | 3 |
| Chaitanya, V | 1 |
| Sangeetha, B | 1 |
| Reddy, MH | 1 |
| Venkata Kumar, AC | 1 |
| Ram, R | 1 |
| Sivakumar, V | 1 |
| Huang, L | 1 |
| Abramovitch, RB | 1 |
| Rohde, KH | 1 |
| Zimmerman, MD | 1 |
| VanderVen, BC | 1 |
| Russell, DG | 1 |
| Borgulya, G | 1 |
| de Patiño, IW | 1 |
| Gonzales, T | 1 |
| de Fernandes, RA | 1 |
| Shrestha, B | 1 |
| Dubash, F | 1 |
| Checkley, AM | 1 |
| Mitchison, D | 1 |
| Conde, MB | 4 |
| Mello, FC | 2 |
| Duarte, RS | 1 |
| Cavalcante, SC | 1 |
| Rolla, V | 1 |
| Dalcolmo, M | 1 |
| Loredo, C | 3 |
| Armstrong, DT | 1 |
| Marzinke, MA | 1 |
| Cohn, S | 1 |
| Moulton, LH | 2 |
| Arruti, N | 1 |
| Villarreal, O | 1 |
| Bernedo, N | 1 |
| Audicana, MT | 1 |
| Velasco, M | 1 |
| Uriel, O | 1 |
| Martinez, A | 1 |
| Bellón, T | 1 |
| Jezmir, J | 1 |
| Nyakan, E | 1 |
| Hedt-Gauthier, BL | 1 |
| Gardner, A | 1 |
| Kamle, L | 1 |
| Injera, W | 1 |
| Velen, K | 1 |
| Lewis, JJ | 3 |
| Popane, F | 1 |
| Hoffmann, CJ | 1 |
| Tadesse, Y | 1 |
| Gebre, N | 1 |
| Daba, S | 1 |
| Gashu, Z | 1 |
| Habte, D | 2 |
| Hiruy, N | 1 |
| Negash, S | 1 |
| Melkieneh, K | 1 |
| Jerene, D | 1 |
| K Haile, Y | 1 |
| Kassie, Y | 1 |
| Melese, M | 1 |
| G Suarez, P | 1 |
| Ortega-Muro, F | 1 |
| Alameda-Martin, L | 1 |
| Schipani, A | 1 |
| Coates, A | 1 |
| Bao, XD | 1 |
| Ou, XC | 1 |
| Zhao, YL | 1 |
| Tadesse, M | 1 |
| Aragaw, D | 1 |
| Dimah, B | 1 |
| Efa, F | 1 |
| Abdella, K | 1 |
| Kebede, W | 1 |
| Abdissa, K | 2 |
| Abebe, G | 2 |
| Obregón-Henao, A | 1 |
| Wallach, JB | 1 |
| North, EJ | 1 |
| Gonzalez-Juarrero, M | 2 |
| Schnappinger, D | 1 |
| Jackson, M | 1 |
| Chukwu, JN | 1 |
| Vahedi, M | 2 |
| Aguwa, EN | 1 |
| Bedru, A | 1 |
| Mebrahtu, T | 1 |
| Ezechi, OC | 1 |
| Yamuah, LK | 1 |
| Medhin, G | 1 |
| Connolly, C | 3 |
| Rida, W | 2 |
| Aderaye, G | 1 |
| Zumla, AI | 1 |
| Onyebujoh, PC | 2 |
| Bélard, S | 1 |
| Remppis, J | 1 |
| Bootsma, S | 1 |
| Janssen, S | 1 |
| Kombila, DU | 1 |
| Beyeme, JO | 1 |
| Rossatanga, EG | 1 |
| Kokou, C | 1 |
| Osbak, KK | 1 |
| Obiang Mba, RM | 1 |
| Kaba, HM | 1 |
| Traoré, AN | 1 |
| Ehrhardt, J | 1 |
| Bache, EB | 1 |
| Flamen, A | 1 |
| Rüsch-Gerdes, S | 2 |
| Frank, M | 1 |
| Adegnika, AA | 1 |
| Lell, B | 1 |
| Kremsner, PG | 1 |
| Loembé, MM | 1 |
| Alabi, AS | 1 |
| Grobusch, MP | 1 |
| Ribeiro, MG | 1 |
| Lima, MCF | 1 |
| Franco, MMJ | 1 |
| Megid, J | 1 |
| Soares, LM | 1 |
| Machado, LHA | 1 |
| Miyata, M | 1 |
| Pavan, FR | 1 |
| Heinemann, MB | 1 |
| Souza Filho, AF | 1 |
| Lara, GHB | 1 |
| Sanches, OC | 1 |
| Sanches, CDC | 1 |
| Listoni, FJP | 1 |
| Paes, AC | 1 |
| Adjobimey, M | 1 |
| Masserey, E | 1 |
| Adjonou, C | 1 |
| Gbénagnon, G | 1 |
| Schwoebel, V | 1 |
| Anagonou, S | 1 |
| Zellweger, JP | 1 |
| Maritz, ER | 1 |
| Montepiedra, G | 1 |
| Liu, L | 1 |
| Mitchell, CD | 1 |
| Madhi, SA | 1 |
| Bobat, R | 1 |
| Violari, A | 1 |
| Ogwu, A | 1 |
| Triasih, R | 1 |
| Padmawati, RS | 1 |
| Duke, T | 1 |
| Robertson, C | 1 |
| Sawyer, SM | 1 |
| Jensen, TO | 1 |
| Darley, DR | 1 |
| Goeman, EE | 1 |
| Shaw, K | 1 |
| Marriott, DJ | 1 |
| Glanville, AR | 1 |
| Cordes, H | 1 |
| Thiel, C | 1 |
| Aschmann, HE | 1 |
| Baier, V | 1 |
| Blank, LM | 1 |
| Kuepfer, L | 1 |
| Shenai, S | 1 |
| Ronacher, K | 2 |
| Malherbe, S | 1 |
| Stanley, K | 1 |
| Kriel, M | 1 |
| Winter, J | 1 |
| Peppard, T | 1 |
| Dodd, LE | 1 |
| Walzl, G | 3 |
| Alland, D | 1 |
| Sakiyama, M | 1 |
| Maeshima, H | 1 |
| Chishiki, M | 1 |
| Horinosono, H | 1 |
| Kawakubo, Y | 1 |
| Namburete, EI | 1 |
| Tivane, I | 1 |
| Lisboa, M | 1 |
| Passeri, M | 1 |
| Pocente, R | 1 |
| Ferro, JJ | 1 |
| Harrison, LH | 1 |
| Bollela, VR | 1 |
| Huang, YW | 1 |
| Yang, SF | 1 |
| Yeh, YP | 1 |
| Tsao, TC | 1 |
| Tsao, SM | 1 |
| McNaughton, A | 1 |
| Blackmore, T | 1 |
| McNaughton, H | 1 |
| Ihms, EA | 1 |
| Ordonez, AA | 1 |
| Cheung, LS | 1 |
| Beck, S | 1 |
| Jain, S | 2 |
| Harris, SR | 1 |
| Parkhill, J | 1 |
| Brown, T | 3 |
| Walusimbi, S | 1 |
| Kwesiga, B | 1 |
| Rodrigues, R | 1 |
| Haile, M | 1 |
| de Costa, A | 1 |
| Bogg, L | 1 |
| Katamba, A | 1 |
| Hofmann-Thiel, S | 1 |
| Molodtsov, N | 1 |
| Antonenka, U | 1 |
| Hoffmann, H | 1 |
| Kerubo, G | 1 |
| Kariuki, S | 2 |
| Zimri, K | 1 |
| Coulibaly, G | 2 |
| Samaké, K | 1 |
| Kouassi, DP | 1 |
| Domoua, KM | 1 |
| Ammerman, NC | 1 |
| Swanson, RV | 1 |
| Tapley, A | 1 |
| Moodley, C | 1 |
| Ngcobo, B | 1 |
| Adamson, J | 1 |
| Dorasamy, A | 1 |
| Moodley, S | 1 |
| Mgaga, Z | 1 |
| Bester, LA | 1 |
| Singh, SD | 1 |
| Almeida, DV | 2 |
| Grosset, JH | 7 |
| Usui, T | 1 |
| Meng, X | 1 |
| Saide, K | 1 |
| Farrell, J | 1 |
| Thomson, P | 1 |
| Whitaker, P | 1 |
| Watson, J | 1 |
| French, NS | 1 |
| Kevin Park, B | 1 |
| Naisbitt, DJ | 1 |
| Patel, S | 1 |
| Patel, K | 2 |
| Tun, T | 1 |
| Nyunt, WW | 1 |
| Latt, KZ | 1 |
| Samaranayaka, A | 1 |
| Crump, JA | 1 |
| Thinn, KK | 1 |
| Cook, GM | 1 |
| Aung, HL | 1 |
| Baghban, A | 1 |
| Azar, MM | 1 |
| Bernardo, RM | 1 |
| Malinis, M | 1 |
| Kostera, J | 1 |
| Leckie, G | 1 |
| Tang, N | 1 |
| Lampinen, J | 1 |
| Szostak, M | 1 |
| Abravaya, K | 1 |
| Wang, H | 2 |
| Gegia, M | 1 |
| Winters, N | 1 |
| Benedetti, A | 3 |
| Venkataramani, V | 1 |
| Seif Amir Hosseini, A | 1 |
| Schulze, MH | 1 |
| Trümper, L | 1 |
| Wulf, G | 1 |
| Bacher, U | 1 |
| Jung, W | 1 |
| Yousef, SA | 1 |
| AbdelRahim, KA | 1 |
| Ahmed, AO | 1 |
| Almaary, KS | 1 |
| Mohamed, AM | 2 |
| Báez-Saldaña, R | 1 |
| Delgado-Sánchez, G | 1 |
| García-García, L | 1 |
| Cruz-Hervert, LP | 1 |
| Montesinos-Castillo, M | 1 |
| Ferreyra-Reyes, L | 1 |
| Bobadilla-Del-Valle, M | 1 |
| Canizales-Quintero, S | 1 |
| Ferreira-Guerrero, E | 1 |
| Téllez-Vázquez, N | 1 |
| Montero-Campos, R | 1 |
| Yanes-Lane, M | 1 |
| Mongua-Rodriguez, N | 1 |
| Martínez-Gamboa, RA | 1 |
| Sifuentes-Osornio, J | 1 |
| Ponce-de-León, A | 1 |
| Venturini, E | 1 |
| Tersigni, C | 1 |
| Chiappini, E | 2 |
| de Martino, M | 2 |
| Minja, LT | 1 |
| Hunt, RD | 1 |
| Manyama, C | 1 |
| Mtafya, B | 1 |
| Wallis, RS | 2 |
| Mekota, A | 1 |
| Henne, S | 1 |
| van Balen, GP | 1 |
| Nathavitharana, RR | 1 |
| Cudahy, PG | 1 |
| Pai, M | 2 |
| Denkinger, CM | 1 |
| Scherrer, AU | 1 |
| Al-Shaer, MH | 1 |
| Mansour, H | 1 |
| Elewa, H | 1 |
| Salameh, P | 1 |
| Iqbal, F | 1 |
| Park, H | 2 |
| Cha, SI | 1 |
| Lim, JK | 1 |
| Nyeo Jeon, K | 1 |
| Yoo, SS | 1 |
| Lee, SY | 2 |
| Kim, CH | 1 |
| Park, JY | 1 |
| Lesosky, M | 1 |
| Agibothu Kupparam, HK | 1 |
| Vedhachalam, C | 1 |
| Thiruvengadam, K | 1 |
| Rajagandhi, V | 1 |
| Dusthackeer, A | 1 |
| Karunaianantham, R | 1 |
| Jayapal, L | 1 |
| Chawla, PK | 1 |
| Lokhande, RV | 1 |
| Naik, PR | 1 |
| Dherai, AJ | 1 |
| Amale, RA | 1 |
| Udwadia, ZF | 1 |
| Mahashur, AA | 1 |
| Soman, R | 1 |
| Ashavaid, TF | 1 |
| Agrawal, RL | 1 |
| Dwivedi, NC | 1 |
| Agrawal, M | 1 |
| Agrawal, A | 1 |
| Wada, M | 9 |
| Okumura, M | 1 |
| Hoshino, H | 2 |
| Ohmori, M | 3 |
| Uchimura, K | 2 |
| Yoshiyama, T | 3 |
| Ogata, H | 6 |
| Rao, NA | 2 |
| Irfan, M | 1 |
| Hussain, SJ | 1 |
| Guirado, E | 1 |
| Gil, O | 1 |
| Vilaplana, C | 2 |
| Samad, A | 1 |
| Sultana, Y | 1 |
| Khar, RK | 1 |
| Aqil, M | 1 |
| Kalam, MA | 1 |
| Chuttani, K | 1 |
| Mishra, AK | 1 |
| Okan, G | 1 |
| Yaylaci, S | 1 |
| Alzafer, S | 1 |
| Gevers, T | 1 |
| Van Den Berg, J | 1 |
| Aslan, G | 1 |
| Tezcan, S | 1 |
| Serin, MS | 1 |
| Emekdas, G | 1 |
| Asiimwe, BB | 1 |
| Ghebremichael, S | 3 |
| Kallenius, G | 3 |
| Koivula, T | 3 |
| Pamuk, ON | 1 |
| Yesil, Y | 1 |
| Donmez, S | 1 |
| Unlü, E | 1 |
| Köker, IH | 1 |
| Cakir, N | 1 |
| Tasneen, R | 3 |
| Tyagi, S | 4 |
| Grosset, J | 16 |
| Manicheva, OA | 3 |
| Skvortsova, LA | 3 |
| Pavlova, MV | 6 |
| Sapozhnikova, NV | 2 |
| Archakova, LI | 4 |
| Vishnevskiĭ, BI | 4 |
| Thee, S | 2 |
| Detjen, A | 1 |
| Wahn, U | 2 |
| Magdorf, K | 3 |
| Park, SK | 2 |
| Kim, JH | 1 |
| Kang, H | 1 |
| Cho, JS | 1 |
| Smego, RA | 1 |
| Dietze, R | 3 |
| Hadad, DJ | 2 |
| McGee, B | 1 |
| Molino, LP | 1 |
| Maciel, EL | 2 |
| Johnson, DF | 1 |
| Debanne, SM | 2 |
| Palaci, M | 3 |
| Ani, AE | 1 |
| Idoko, J | 1 |
| Dalyop, YB | 1 |
| Pitmang, SL | 1 |
| De Gaudio, M | 1 |
| Catania, P | 1 |
| Mussa, F | 1 |
| Acharya, PR | 1 |
| Sahoo, R | 1 |
| Baliga, P | 1 |
| de Paiva, TF | 1 |
| de Barros e Silva, MJ | 1 |
| Rinck, JA | 1 |
| Fanelli, MF | 1 |
| Gimenes, DL | 1 |
| Tost, JR | 1 |
| Vidal, R | 4 |
| Maldonado, J | 1 |
| Caylà, JA | 3 |
| Nunes, EA | 1 |
| De Capitani, EM | 1 |
| Coelho, E | 1 |
| Panunto, AC | 1 |
| Joaquim, OA | 1 |
| Ramos, Mde C | 1 |
| Moatter, T | 1 |
| Tanveer, M | 1 |
| Varela, G | 1 |
| González, S | 1 |
| Gadea, P | 1 |
| Coitinho, C | 1 |
| Mota, I | 1 |
| González, G | 2 |
| Goñi, F | 1 |
| Rivas, C | 1 |
| Schelotto, F | 1 |
| Brady, MF | 1 |
| Gilman, RH | 1 |
| Glushkov, RG | 2 |
| Sokolova, GB | 15 |
| Barboza, CE | 1 |
| Winter, DH | 1 |
| Seiscento, M | 1 |
| Santos, Ude P | 1 |
| Terra Filho, M | 1 |
| Morrone, N | 1 |
| Morrone Junior, N | 1 |
| Braz, AG | 1 |
| Maia, JA | 1 |
| Chacón, L | 1 |
| Lainez, M | 1 |
| Rosales, E | 1 |
| Mercado, M | 1 |
| Caminero, JA | 4 |
| Cailleaux-Cezar, M | 1 |
| de A Melo, D | 1 |
| Xavier, GM | 1 |
| de Salles, CL | 1 |
| de Mello, FC | 1 |
| Ruffino-Netto, A | 1 |
| Zar, H | 2 |
| Isakova, ZhT | 3 |
| Kamal, A | 1 |
| Azeeza, S | 1 |
| Malik, MS | 1 |
| Shaik, AA | 1 |
| Rao, MV | 1 |
| Kononets, AS | 1 |
| Kondakova, MN | 2 |
| Vinogradova, TI | 3 |
| Kovaleva, RG | 1 |
| Wikman, PE | 1 |
| Jover, F | 1 |
| Peris, J | 1 |
| Cuadrado, JM | 1 |
| Lobato, MN | 2 |
| Jereb, JA | 1 |
| Castro, KG | 1 |
| Ovchinnikova, IuE | 1 |
| Starshinova, AA | 1 |
| Dovgaliuk, IF | 1 |
| Hirano, Y | 1 |
| Kojima, T | 1 |
| Kanayama, Y | 1 |
| Ishikawa, H | 1 |
| Ishiguro, N | 1 |
| Al-Tawfiq, JA | 1 |
| Saadeh, BM | 1 |
| Shamaei, M | 1 |
| Marjani, M | 1 |
| Chitsaz, E | 1 |
| Kazempour, M | 1 |
| Esmaeili, M | 1 |
| Farnia, P | 2 |
| Amiri, MV | 1 |
| Mirsaeidi, M | 1 |
| Mansouri, D | 1 |
| Masjedi, MR | 2 |
| Velayati, AA | 3 |
| Xie, QB | 1 |
| Wen, FQ | 1 |
| Yin, G | 1 |
| Sar, B | 1 |
| Keo, C | 1 |
| Leng, C | 1 |
| Saman, M | 1 |
| Min, DC | 1 |
| Chan, S | 1 |
| Monchy, D | 1 |
| Sarthou, JL | 1 |
| Nalbandian, A | 1 |
| Yan, BS | 1 |
| Pichugin, A | 1 |
| Bronson, RT | 1 |
| Kramnik, I | 1 |
| Naidu, VG | 1 |
| Tammineni, AK | 1 |
| Biscopink, RJ | 1 |
| Davis, TL | 1 |
| Veerabagu, MP | 1 |
| De Souza, GR | 1 |
| Graça, NP | 1 |
| Cezar, MC | 1 |
| Ram, M | 1 |
| Chaudhary, MA | 1 |
| Singh, N | 1 |
| Dubey, S | 1 |
| Chinnaraj, S | 1 |
| Golani, A | 1 |
| Maitra, A | 1 |
| Garg, R | 1 |
| Mehra, S | 1 |
| Goldberg, S | 2 |
| Muzanye, G | 1 |
| Padayatchi, N | 1 |
| Bozeman, L | 4 |
| Heilig, CM | 1 |
| Bernardo, J | 2 |
| Choudhri, S | 1 |
| Guy, E | 1 |
| Guyadeen, P | 1 |
| Leus, MC | 1 |
| Maltas, G | 1 |
| Nuermberger, EL | 4 |
| Villarino, M | 1 |
| Ramos, A | 1 |
| Daza, R | 2 |
| Alvarez-Espejo, T | 1 |
| Guzmán, MF | 1 |
| Chideya, S | 1 |
| Winston, CA | 1 |
| Bradford, WZ | 2 |
| Hopewell, PC | 12 |
| Wells, CD | 1 |
| Reingold, AL | 3 |
| Kenyon, TA | 4 |
| Moeti, TL | 3 |
| Tappero, JW | 2 |
| Ziganshina, LE | 2 |
| Garner, P | 3 |
| Machado, A | 1 |
| Finkmoore, B | 1 |
| Emodi, K | 1 |
| Takenami, I | 1 |
| Barbosa, T | 1 |
| Tavares, M | 1 |
| Reis, MG | 1 |
| Arruda, S | 1 |
| Riley, LW | 4 |
| Bartacek, A | 1 |
| Schütt, D | 1 |
| Panosch, B | 1 |
| Borek, M | 1 |
| Asghar, RJ | 1 |
| Patlan, DE | 1 |
| Miner, MC | 1 |
| Rhodes, HD | 1 |
| Solages, A | 1 |
| Katz, DJ | 1 |
| Beall, DS | 1 |
| Ijaz, K | 1 |
| Oeltmann, JE | 1 |
| Sewali, B | 1 |
| Okwera, A | 5 |
| Mugerwa, RD | 4 |
| Alcaneses, MR | 1 |
| Quelapio, MI | 1 |
| Tupasi, TE | 1 |
| Horter, L | 1 |
| Singh-Minott, I | 1 |
| Pierre, RB | 1 |
| Olugbuyi, O | 1 |
| Dunkley-Thompson, J | 1 |
| Haughton, D | 1 |
| Christie, CD | 1 |
| Lancioni, C | 1 |
| LaBeaud, AD | 1 |
| Esper, F | 1 |
| Abughali, N | 1 |
| Auletta, J | 1 |
| Almeida, D | 3 |
| Rosenthal, I | 2 |
| Peloquin, C | 1 |
| Mokrousov, I | 3 |
| Valcheva, V | 1 |
| Sovhozova, N | 1 |
| Aldashev, A | 1 |
| Rastogi, N | 3 |
| Isakova, J | 1 |
| Lee, LN | 1 |
| Chien, YJ | 1 |
| Yang, PC | 1 |
| Mazumdar, K | 1 |
| DasGupta, A | 1 |
| Dastidar, SG | 1 |
| Serebriakova, VA | 1 |
| Vasil'eva, OA | 1 |
| Urazova, OI | 2 |
| Novitskiĭ, VV | 1 |
| Voronkova, OV | 1 |
| Strelis, AK | 4 |
| Budkina, TE | 1 |
| Khasanova, RR | 1 |
| Naslednikova, IO | 2 |
| Churina, EG | 1 |
| Kolosova, AE | 1 |
| Nair, S | 1 |
| Carroll, WD | 1 |
| Gray, D | 1 |
| Nuttall, J | 1 |
| Lombard, C | 2 |
| Davies, MA | 1 |
| Workman, L | 1 |
| Apolles, P | 1 |
| Eley, B | 2 |
| Albini, TA | 1 |
| Kumaradas, M | 1 |
| Fraig, MM | 1 |
| Paydar, A | 2 |
| Martin, I | 1 |
| Royce, S | 2 |
| Burman, W | 6 |
| Mohapatra, PR | 1 |
| Mathuria, JP | 1 |
| Nath, G | 1 |
| Samaria, JK | 1 |
| Anupurba, S | 1 |
| Freidlin, PJ | 1 |
| Goldblatt, D | 1 |
| Kaidar-Shwartz, H | 1 |
| Rorman, E | 1 |
| Banu Rekha, VV | 1 |
| Jagarajamma, K | 1 |
| Wares, F | 3 |
| Chandrasekaran, V | 3 |
| Gupta, AK | 1 |
| Katoch, VM | 1 |
| Chauhan, DS | 1 |
| Sharma, R | 3 |
| Venkatesan, K | 1 |
| Sharma, VD | 1 |
| Bame, R | 1 |
| Mouangue, L | 1 |
| Djella, S | 1 |
| Yomgni, C | 1 |
| Akolo, C | 1 |
| Adetifa, I | 1 |
| Shepperd, S | 1 |
| Volmink, J | 2 |
| Bray, MG | 1 |
| Poulain, C | 1 |
| Dougados, M | 1 |
| Gossec, L | 1 |
| Madhukar, P | 1 |
| Ordway, DJ | 1 |
| Shanley, CA | 1 |
| Orme, EA | 1 |
| Bucy, DS | 1 |
| Hascall-Dove, L | 1 |
| Henao-Tamayo, M | 1 |
| Harton, MR | 1 |
| Shang, S | 1 |
| Ackart, D | 1 |
| Kraft, SL | 1 |
| Façanha, MC | 2 |
| Gondim, AM | 1 |
| Pinheiro, VG | 2 |
| Barroso, EC | 2 |
| Guerrant, RL | 2 |
| Lima, AA | 2 |
| Guerra, RL | 1 |
| Bastos, G | 1 |
| Kondo, Y | 1 |
| Suetake, T | 1 |
| Toyota, E | 2 |
| Kato, S | 1 |
| Mori, T | 3 |
| Kirikae, T | 1 |
| Reitz, C | 1 |
| Coovadia, A | 1 |
| Ko, S | 1 |
| Meyers, T | 1 |
| Strehlau, R | 1 |
| Sherman, G | 1 |
| Kuhn, L | 1 |
| Abrams, EJ | 1 |
| del Rosal, T | 1 |
| Baquero-Artigao, F | 1 |
| García-Miguel, MJ | 2 |
| Méndez-Echevarría, A | 1 |
| López, G | 1 |
| Aracil, FJ | 1 |
| de José, MI | 1 |
| del Castillo, F | 1 |
| Anderson, C | 1 |
| Story, A | 2 |
| Wibaux, C | 1 |
| Andrei, I | 1 |
| Paccou, J | 1 |
| Philippe, P | 1 |
| Biver, E | 1 |
| Duquesnoy, B | 1 |
| Flipo, RM | 1 |
| Baniasadi, S | 2 |
| Eftekhari, P | 1 |
| Raoufy, MR | 1 |
| Jesinger, RA | 1 |
| Ballard, EA | 1 |
| Allton, DR | 1 |
| Lane, JW | 1 |
| Folio, L | 1 |
| Zachariah, R | 2 |
| Santos-Filho, ET | 1 |
| Chimzizi, R | 2 |
| Harrington, M | 1 |
| Maher, D | 1 |
| Williams, BG | 2 |
| De Cock, KM | 2 |
| Sada-Ovalle, I | 1 |
| Sköld, M | 1 |
| Tian, T | 1 |
| Behar, SM | 1 |
| Chiu, YC | 1 |
| Huang, SF | 1 |
| Lee, YC | 2 |
| Chimote, G | 1 |
| Banerjee, R | 1 |
| Lu, J | 1 |
| Yue, J | 1 |
| Luo, R | 1 |
| Hu, Z | 1 |
| Bai, Y | 1 |
| Tang, Z | 1 |
| Xian, Q | 1 |
| Tutor-Ureta, P | 1 |
| Martín-Jiménez, ML | 1 |
| Vargas, JA | 1 |
| Guo, N | 1 |
| Marra, F | 1 |
| Fitzgerald, JM | 7 |
| Elwood, RK | 4 |
| Marra, CA | 1 |
| Cheigh, CI | 1 |
| Senaratne, R | 1 |
| Uchida, Y | 1 |
| Kendall, LV | 1 |
| Napiórkowska, A | 1 |
| Morais, P | 1 |
| Ferreira, O | 1 |
| Nogueira, A | 1 |
| Bettencourt, H | 1 |
| Azevedo, F | 1 |
| Wielders, JP | 1 |
| Verhoef, H | 1 |
| van der Ven, AJ | 1 |
| Maritz, JS | 5 |
| Moore, JL | 1 |
| Keller, SJ | 1 |
| Houpt, ER | 2 |
| Chevalier, B | 2 |
| Margery, J | 1 |
| Sane, M | 2 |
| Camara, P | 1 |
| Lefebvre, N | 1 |
| Gueye, M | 1 |
| Thiam, M | 1 |
| Perrier-Gros-Claude, JD | 1 |
| Simon, F | 1 |
| Fabre, M | 2 |
| Soler, C | 1 |
| Herve, V | 1 |
| Mbaye, PS | 2 |
| Debonne, JM | 1 |
| Kubo, S | 1 |
| Yamaoka, K | 1 |
| Tanaka, Y | 2 |
| Singh, V | 1 |
| Patra, S | 1 |
| Chihota, VN | 2 |
| Cox, HS | 1 |
| McDermid, C | 1 |
| Azevedo, V | 1 |
| Muller, O | 1 |
| Coetzee, D | 1 |
| Simpson, J | 1 |
| Barnard, M | 1 |
| Coetzee, G | 2 |
| Hemmati, S | 1 |
| Samandari, T | 1 |
| Bishai, D | 1 |
| Luteijn, M | 1 |
| Mosimaneotsile, B | 2 |
| Motsamai, O | 1 |
| Postma, M | 1 |
| Hubben, G | 1 |
| Yadav, AB | 1 |
| Muttil, P | 1 |
| Kajal, H | 1 |
| Misra, A | 2 |
| Hayes, RJ | 2 |
| Wateba, MI | 1 |
| Diop, SA | 1 |
| Salou, M | 1 |
| Womitso, K | 1 |
| Nichols, S | 1 |
| Tidjani, O | 1 |
| Wilkins, JJ | 1 |
| Langdon, G | 1 |
| Pillai, G | 2 |
| Smith, PJ | 4 |
| Zhang, M | 2 |
| Li, SY | 1 |
| Rosenthal, IM | 3 |
| Ahmad, Z | 1 |
| Converse, PJ | 1 |
| Perri, BR | 1 |
| Proops, D | 1 |
| Moonan, PK | 1 |
| Munsiff, SS | 3 |
| Kreiswirth, BN | 2 |
| Kurepina, N | 1 |
| Goranson, C | 1 |
| Ahuja, SD | 2 |
| Eisenhut, M | 1 |
| Khajotia, R | 1 |
| Manthari, K | 1 |
| Seersholm, N | 1 |
| Wilcke, T | 1 |
| Gómez-Seco, J | 1 |
| Rodríguez-Guzmán, MJ | 1 |
| Rodríguez-Nieto, MJ | 1 |
| Gómez-Escolar, PF | 1 |
| Presa-Abos, T | 1 |
| Fortes-Alen, J | 1 |
| Ivanyi, J | 1 |
| Crampin, A | 1 |
| Kasimba, S | 1 |
| Mwaungulu, NJ | 1 |
| Dacombe, R | 1 |
| Fine, PE | 1 |
| Mulliez, P | 1 |
| Mbassi Fouda, FL | 1 |
| Roy Saint-Georges, F | 1 |
| Bilgili, SG | 1 |
| Karadag, AS | 1 |
| Calka, O | 1 |
| Altun, F | 1 |
| Bayhan, GI | 1 |
| Ekşioğlu, AS | 1 |
| Kitiş Çelik, B | 1 |
| Tanır, G | 1 |
| Vasilyeva, OA | 1 |
| Serebryakova, VA | 1 |
| Novitsky, VV | 1 |
| Kononova, TE | 1 |
| Tripathy, S | 1 |
| Anand, A | 1 |
| Inamdar, V | 1 |
| Manoj, MM | 1 |
| Khillare, KM | 1 |
| Datye, AS | 1 |
| Iyer, R | 1 |
| Kanoj, DM | 1 |
| Thakar, M | 1 |
| Kale, V | 1 |
| Pereira, M | 1 |
| Risbud, AR | 1 |
| Baek, SH | 1 |
| Li, AH | 1 |
| Sassetti, CM | 1 |
| Bounouar, M | 1 |
| Baybay, H | 1 |
| Gallouj, S | 1 |
| Meziane, M | 1 |
| Mikou, O | 1 |
| Mernissi, F | 1 |
| Chraibi, M | 1 |
| Harmouch, T | 1 |
| Amarti, A | 1 |
| Koo, MS | 1 |
| Fallows, D | 1 |
| Muller, G | 1 |
| Gautam, H | 1 |
| Bhalla, P | 2 |
| Vidyanidhi, G | 1 |
| Saini, S | 1 |
| Jha, H | 1 |
| Baveja, CP | 1 |
| Leung, EC | 2 |
| Leung, CC | 3 |
| Leung, WM | 2 |
| Tam, CM | 8 |
| Fortún, J | 2 |
| Martín-Dávila, P | 2 |
| Navas, E | 2 |
| López-Vélez, R | 1 |
| Pintado, V | 1 |
| Cobo, J | 2 |
| González, A | 1 |
| Bonilla, M | 1 |
| Aneiros, V | 1 |
| Gómez-Mampaso, E | 2 |
| Moreno, S | 3 |
| Pothukuchi, M | 1 |
| Nagaraja, SB | 1 |
| Kelamane, S | 1 |
| Satyanarayana, S | 1 |
| Babu, S | 1 |
| Dewan, P | 1 |
| Consunji-Araneta, R | 1 |
| Higgins, R | 1 |
| Qing, G | 1 |
| Bouhasan, L | 1 |
| Oxlade, O | 2 |
| Falzon, D | 2 |
| Seifart, HI | 7 |
| Werely, CJ | 3 |
| Rosenkranz, B | 1 |
| Roll, S | 1 |
| Mtabho, C | 1 |
| Mpagama, S | 1 |
| Mwaigwisya, S | 1 |
| Pholwat, S | 1 |
| Ndusilo, N | 1 |
| Gratz, J | 1 |
| Kjellsson, MC | 1 |
| Goh, A | 1 |
| Weiner, D | 1 |
| Low, KM | 1 |
| Kern, S | 1 |
| Magro-Checa, C | 1 |
| Navas-Parejo Casado, A | 1 |
| Borrego-García, E | 1 |
| Raya-Álvarez, E | 1 |
| Rosales-Alexander, JL | 1 |
| Salvatierra, J | 1 |
| Caballero-Morales, T | 1 |
| Gómez-Morales, M | 1 |
| Teixeira, RL | 1 |
| Morato, RG | 1 |
| Cabello, PH | 1 |
| Muniz, LM | 1 |
| Moreira, Ada S | 1 |
| Suffys, PN | 2 |
| Miranda, AB | 1 |
| Santos, AR | 1 |
| Peck, MT | 1 |
| Stephen, LX | 1 |
| Marnewick, J | 1 |
| Majeed, A | 1 |
| Woolhiser, LK | 3 |
| Belisle, JT | 1 |
| Garie, KT | 1 |
| Pascopella, L | 1 |
| Deriemer, K | 1 |
| Watt, JP | 1 |
| Flood, JM | 2 |
| Losada, I | 1 |
| Cifuentes, C | 1 |
| Martín, C | 1 |
| García, M | 1 |
| Gomes, VF | 1 |
| Oliveira, I | 1 |
| Andersen, A | 1 |
| Vieira, FJ | 1 |
| Carlos, LJ | 1 |
| Vieira, CS | 1 |
| Aaby, P | 1 |
| Gustafson, P | 1 |
| De Groote, MA | 1 |
| Gilliland, JC | 1 |
| Khawcharoenporn, T | 1 |
| Apisarnthanarak, A | 1 |
| Manosuthi, W | 1 |
| Sungkanuparph, S | 1 |
| Mundy, LM | 1 |
| van der Meulen, M | 1 |
| Mathema, B | 1 |
| Beylis, N | 1 |
| Ndung'u, PW | 1 |
| Ng'ang'a, Z | 1 |
| Revathi, G | 1 |
| Jain, P | 1 |
| Hartman, TE | 1 |
| Eisenberg, N | 1 |
| O'Donnell, MR | 1 |
| Kriakov, J | 1 |
| Govender, K | 1 |
| Makume, M | 1 |
| Thaler, DS | 1 |
| Hatfull, GF | 1 |
| Sturm, AW | 1 |
| Larsen, MH | 1 |
| Moodley, P | 1 |
| Stratan, E | 1 |
| Romancenco, E | 1 |
| Allerheiligen, V | 1 |
| Hillemann, A | 1 |
| Moraru, N | 1 |
| de Faria, TJ | 1 |
| Roman, M | 1 |
| de Souza, NM | 1 |
| De Vecchi, R | 1 |
| de Assis, JV | 1 |
| dos Santos, AL | 1 |
| Bechtold, IH | 1 |
| Winter, N | 1 |
| Soares, MJ | 1 |
| Silva, LP | 1 |
| De Almeida, MV | 1 |
| Báfica, A | 1 |
| Nanashima, K | 1 |
| Mawatari, T | 1 |
| Tahara, N | 1 |
| Higuchi, N | 1 |
| Nakaura, A | 1 |
| Inamine, T | 1 |
| Kondo, S | 2 |
| Yanagihara, K | 2 |
| Fukushima, K | 2 |
| Suyama, N | 1 |
| Kohno, S | 2 |
| Tsukamoto, K | 1 |
| Perry, A | 1 |
| Angoulvant, F | 1 |
| Chadelat, K | 1 |
| De Lauzanne, A | 1 |
| Houdouin, V | 1 |
| Kheniche, A | 1 |
| Lorrot, M | 1 |
| Mesples, B | 1 |
| Nouyrigat, V | 1 |
| Aujard, Y | 2 |
| Gaudelus, J | 1 |
| Grimprel, E | 1 |
| Faye, A | 1 |
| Erondu, N | 1 |
| Ginsberg, AM | 1 |
| Becker, P | 1 |
| Spigelman, MK | 1 |
| Lee, EJ | 2 |
| Kim, YE | 1 |
| Hwang, YS | 1 |
| Evans, D | 1 |
| Takuva, S | 1 |
| Rassool, M | 1 |
| Firnhaber, C | 1 |
| Maskew, M | 1 |
| Greco, E | 1 |
| Quintiliani, G | 1 |
| Santucci, MB | 1 |
| Serafino, A | 1 |
| Ciccaglione, AR | 1 |
| Marcantonio, C | 1 |
| Papi, M | 1 |
| Maulucci, G | 1 |
| Delogu, G | 1 |
| Martino, A | 1 |
| Goletti, D | 1 |
| Sarmati, L | 1 |
| Andreoni, M | 1 |
| Altieri, A | 1 |
| Alma, M | 1 |
| Caccamo, N | 1 |
| Di Liberto, D | 1 |
| De Spirito, M | 1 |
| Savage, ND | 1 |
| Nisini, R | 1 |
| Dieli, F | 1 |
| Ottenhoff, TH | 1 |
| Fraziano, M | 1 |
| Brooks, E | 1 |
| DeGroote, MA | 1 |
| Bhat, S | 1 |
| Radhakrishna, M | 1 |
| Kotian, M | 1 |
| Mattioni, S | 1 |
| Zamy, M | 1 |
| Mechai, F | 1 |
| Raynaud, JJ | 1 |
| Chabrol, A | 1 |
| Aflalo, V | 1 |
| Biour, M | 1 |
| Bouchaud, O | 1 |
| Zaoui, A | 1 |
| Abdelghani, A | 1 |
| Ben Salem, H | 1 |
| Ouanes, W | 1 |
| Hayouni, A | 1 |
| Khachnaoui, F | 1 |
| Rejeb, N | 1 |
| Benzarti, M | 1 |
| Apers, L | 1 |
| Agonafir, M | 1 |
| de-Jong, BC | 1 |
| Colebunders, R | 1 |
| Kumar, L | 4 |
| Puri, MM | 2 |
| Jaiswal, A | 1 |
| Murar, A | 1 |
| Behera, D | 3 |
| Gönlügür, U | 1 |
| Koşar, S | 1 |
| Mirici, A | 1 |
| Fábrega, E | 1 |
| Sampedro, B | 1 |
| Cabezas, J | 1 |
| Casafont, F | 1 |
| Mieses, MÁ | 1 |
| Moraleja, I | 1 |
| Crespo, J | 1 |
| Pons-Romero, F | 1 |
| Figaji, A | 1 |
| Hawkridge, A | 1 |
| Schimel, D | 1 |
| Weiner, DM | 1 |
| Dayao, E | 1 |
| Cai, Y | 1 |
| Yoon, YS | 1 |
| Dreher, MR | 1 |
| Kastenmayer, RJ | 1 |
| Laymon, CM | 1 |
| Carny, JE | 1 |
| Flynn, JL | 2 |
| Herscovitch, P | 1 |
| Xu, J | 1 |
| Lu, Y | 1 |
| Fu, L | 1 |
| Zhu, H | 1 |
| Wang, B | 1 |
| Mdluli, K | 1 |
| Upton, AM | 1 |
| Jin, H | 1 |
| Zheng, M | 1 |
| Zhao, W | 1 |
| Li, P | 1 |
| Kirchner, HL | 1 |
| Grewal, HM | 2 |
| Gie, RP | 5 |
| Sinanovic, E | 1 |
| McLaughlin, AM | 1 |
| Gibbons, N | 1 |
| Fitzgibbon, M | 1 |
| Power, JT | 1 |
| Foley, SC | 1 |
| Hayes, JP | 1 |
| Rogers, T | 1 |
| Keane, J | 1 |
| Saengnipanthkul, S | 1 |
| Jirapradittha, J | 1 |
| Kiatchoosakun, P | 1 |
| Sahota, T | 1 |
| Arda, H | 1 |
| Ağca, S | 1 |
| Oruç, K | 1 |
| Kızıltaş, S | 1 |
| Cetintaş, G | 1 |
| Calışır, HC | 1 |
| Chia, BS | 1 |
| Lanzas, F | 1 |
| Rifat, D | 1 |
| Herrera, A | 1 |
| Kim, EY | 1 |
| Sailer, C | 1 |
| Torres-Chavolla, E | 1 |
| Narayanaswamy, P | 1 |
| Einarsson, V | 1 |
| Bravo, J | 1 |
| Pascale, JM | 1 |
| Ioerger, TR | 1 |
| Sacchettini, JC | 1 |
| Khadka, JB | 1 |
| Rai, SK | 1 |
| Shrestha, S | 1 |
| Maharjan, B | 1 |
| Bhatta, DR | 1 |
| Ghimire, P | 1 |
| Tsai, TF | 1 |
| Chiu, HY | 1 |
| Song, M | 1 |
| Chan, D | 1 |
| Lin, PL | 1 |
| Johnston, PJ | 1 |
| Janssen, C | 1 |
| Via, L | 1 |
| Goodwin, MB | 1 |
| Klein, E | 1 |
| Vishwakarma, PD | 1 |
| Cliff, JM | 1 |
| Lee, JS | 1 |
| Constantinou, N | 1 |
| Cho, JE | 1 |
| Clark, TG | 1 |
| King, EC | 1 |
| Lukey, PT | 1 |
| Duncan, K | 2 |
| Dockrell, HM | 1 |
| Narang, RK | 4 |
| Murthy, RS | 1 |
| Coler, RN | 1 |
| Bertholet, S | 1 |
| Pine, SO | 1 |
| Orr, MT | 1 |
| Reese, V | 1 |
| Windish, HP | 1 |
| Davis, C | 1 |
| Kahn, M | 2 |
| Baldwin, SL | 1 |
| Reed, SG | 1 |
| Yamashita, H | 1 |
| Ueda, Y | 2 |
| Takahashi, Y | 1 |
| Mimori, A | 1 |
| Fillekes, Q | 1 |
| Kisonga, RM | 1 |
| Mleoh, L | 1 |
| Ndaro, A | 1 |
| Kisanga, ER | 1 |
| van der Ven, A | 1 |
| Gulec, SG | 1 |
| Telhan, L | 1 |
| Koçkaya, T | 1 |
| Erdem, E | 2 |
| Bayraktar, B | 1 |
| Palanduz, A | 3 |
| Cegielski, JP | 2 |
| Griffith, DE | 2 |
| McGaha, PK | 1 |
| Wolfgang, M | 1 |
| Robinson, CB | 1 |
| Clark, PA | 1 |
| Hassell, WL | 1 |
| Robison, VA | 1 |
| Walker, KP | 1 |
| Wallace, C | 1 |
| González, C | 1 |
| Sáenz, C | 1 |
| Herrmann, E | 1 |
| Jajati, M | 1 |
| Kaplan, P | 1 |
| Monzón, D | 1 |
| Lee, PH | 1 |
| Chang, FY | 1 |
| Visser, M | 1 |
| Kirkpatrick, CM | 1 |
| Karlsson, MO | 1 |
| Trindade, MÂ | 1 |
| Miyamoto, D | 1 |
| Benard, G | 1 |
| Sakai-Valente, NY | 1 |
| Vasconcelos, Dde M | 1 |
| Naafs, B | 1 |
| Glaziou, P | 2 |
| Dara, M | 1 |
| Floyd, K | 1 |
| Erasmus, L | 1 |
| Koornhof, H | 1 |
| Hsu, AH | 2 |
| Li, YH | 1 |
| Chen, LK | 1 |
| Lin, CB | 1 |
| Shaweno, D | 1 |
| Worku, A | 1 |
| van Kampen, S | 1 |
| Ochodo, E | 1 |
| Atun, R | 1 |
| Pinheiro, RO | 1 |
| de Oliveira, EB | 1 |
| Dos Santos, G | 1 |
| Sperandio da Silva, GM | 1 |
| de Andrade Silva, BJ | 1 |
| Teles, RM | 1 |
| Milagres, A | 1 |
| Sarno, EN | 1 |
| Dalcolmo, MP | 1 |
| Sampaio, EP | 1 |
| Albanna, AS | 1 |
| Smith, BM | 1 |
| Cowan, D | 1 |
| Gochi, M | 1 |
| Kaneko, Y | 1 |
| Seki, A | 1 |
| Saitou, Z | 1 |
| Samejima, T | 1 |
| Seki, Y | 1 |
| Takeda, H | 1 |
| Kinoshita, A | 1 |
| Kuwano, K | 1 |
| Porwal, C | 1 |
| Kaushik, A | 1 |
| Makkar, N | 1 |
| Banavaliker, JN | 1 |
| Singla, R | 2 |
| Bhatnagar, AK | 1 |
| Pande, JN | 1 |
| Singh, UB | 1 |
| Dye, C | 2 |
| Espinal, MA | 2 |
| Burton, MJ | 1 |
| Burton, KJ | 1 |
| Chuka-Okosa, CM | 1 |
| Bailey, RL | 1 |
| Sirgel, FA | 10 |
| Smit, E | 2 |
| Parkin, DP | 11 |
| Van de Wal, BW | 7 |
| Doré, CJ | 2 |
| Pereira-Silva, JL | 1 |
| Marinho, MM | 1 |
| Veloso, TV | 1 |
| Coelho JC, JC | 1 |
| Kawakami, K | 2 |
| Benator, D | 3 |
| Bhattacharya, M | 1 |
| Cantazaro, A | 1 |
| Chaisson, R | 1 |
| Gordin, F | 1 |
| Horsburgh, CR | 3 |
| Khan, A | 5 |
| Lahart, C | 1 |
| Metchock, B | 2 |
| Pachucki, C | 1 |
| Stanton, L | 1 |
| Villarino, ME | 2 |
| Wang, YC | 1 |
| Weis, S | 3 |
| Jaworski, A | 1 |
| Kostrzewa, E | 1 |
| Klatt, M | 1 |
| Swiderska, A | 1 |
| Drozd, I | 1 |
| Sugimori, H | 1 |
| Saku, Y | 1 |
| Ibayashi, S | 1 |
| Ogasawara, T | 1 |
| Fujishima, M | 2 |
| Iida, M | 1 |
| Chakaya, JM | 1 |
| Kibuga, D | 2 |
| Ng'ang'a, L | 1 |
| Githui, WA | 2 |
| Mansoer, JR | 1 |
| Gakiria, G | 1 |
| Kwamanga, D | 1 |
| Maende, J | 1 |
| Karchmer, TB | 1 |
| Phipps, JD | 1 |
| Giannetta, ET | 1 |
| Farr, BM | 1 |
| Fays, S | 1 |
| Martin, S | 1 |
| Barbaud, A | 1 |
| Schmutz, JL | 1 |
| Semenova, OV | 3 |
| Bogadel'nikova, IV | 1 |
| Kunichan, AD | 6 |
| Zeliger, LR | 3 |
| Elistratova, NA | 4 |
| Nishii, K | 1 |
| Nakazono, T | 2 |
| Masuyama, H | 1 |
| Inaba, K | 1 |
| Itoh, K | 1 |
| Saegusa, M | 1 |
| Kimura, M | 1 |
| Shimouchi, A | 1 |
| Miltgen, J | 1 |
| Morillon, M | 1 |
| Koeck, JL | 1 |
| Varnerot, A | 1 |
| Briant, JF | 1 |
| Nguyen, G | 1 |
| Verrot, D | 1 |
| Bonnet, D | 1 |
| Vincent, V | 1 |
| Nolan, CM | 7 |
| Goldberg, SV | 4 |
| Perng, RP | 2 |
| Harth, G | 1 |
| Horwitz, MA | 1 |
| Giller, DB | 1 |
| Kostenko, AD | 1 |
| Giller, BM | 1 |
| Giller, GV | 1 |
| Peleneva, IM | 1 |
| Gariaeva, NA | 1 |
| Burukhina, LV | 1 |
| Zavgorodniĭ, IG | 1 |
| Shurygin, AA | 1 |
| Gorovits, GA | 1 |
| Miroshnikova, IP | 1 |
| Barlamov, OP | 1 |
| Pavlov, VA | 2 |
| Sabadash, EV | 1 |
| Fadina, OV | 1 |
| Mironova, AL | 1 |
| Aït Moussa, L | 1 |
| Khassouani, CE | 1 |
| Hüe, B | 1 |
| Jana, M | 1 |
| Bégaud, B | 1 |
| Soulaymani, R | 1 |
| Mokaddas, E | 2 |
| Ahmad, S | 2 |
| Abal, AT | 1 |
| Gierek, T | 1 |
| Markowski, J | 1 |
| Kieda-Szurkowska, J | 1 |
| Paluch, J | 1 |
| Bielecki, I | 1 |
| Chelnokova, GA | 1 |
| McNeill, L | 1 |
| Allen, M | 1 |
| Estrada, C | 1 |
| Cook, P | 1 |
| King, B | 1 |
| Shah, N | 1 |
| Hodge, T | 1 |
| Shah, AR | 1 |
| Agarwal, SK | 1 |
| Shah, KV | 1 |
| Pérez-Guzmán, C | 1 |
| Vargas, MH | 1 |
| Martínez-Rossier, LA | 1 |
| Torres-Cruz, A | 1 |
| Villarreal-Velarde, H | 1 |
| Baptista, IM | 1 |
| Oelemann, MC | 1 |
| Opromolla, DV | 1 |
| Bonnaud, F | 1 |
| Zigani, A | 1 |
| Yee, D | 1 |
| Valiquette, C | 1 |
| Pelletier, M | 1 |
| Parisien, I | 1 |
| Rocher, I | 2 |
| N'guessan, K | 1 |
| Dosso, M | 1 |
| Marchal, G | 1 |
| Chavarot, P | 1 |
| Romain, F | 1 |
| Pescher, P | 1 |
| Phyu, S | 1 |
| Ti, T | 2 |
| Jureen, R | 1 |
| Hmun, T | 1 |
| Myint, H | 1 |
| Htun, A | 2 |
| Bjorvatn, B | 1 |
| Wang, HY | 1 |
| Chien, CC | 1 |
| Lu, PL | 1 |
| Lee, YW | 1 |
| Peng, CF | 1 |
| Tsai, JJ | 1 |
| Chen, YH | 1 |
| Hwang, KP | 1 |
| Chen, TP | 1 |
| Ratsirahonana, O | 1 |
| Rasolofo Razanamparany, V | 1 |
| Rasolonavalona, T | 1 |
| Rakotonirina, V | 1 |
| Rakotoarisaonina, A | 1 |
| Rakotoherisoa, A | 1 |
| Ralamboson, M | 1 |
| Cauchoix, B | 1 |
| Rakotondramarina, D | 1 |
| Ramarokoto, H | 1 |
| Beena, S | 1 |
| Rao, KN | 1 |
| Pai, MR | 1 |
| Gültekin, D | 2 |
| Kayaalp, N | 2 |
| Guseĭnov, GK | 3 |
| Mamaev, IA | 1 |
| Abdulaeva, ZK | 1 |
| Samman, Y | 2 |
| Krayem, A | 1 |
| Haidar, M | 1 |
| Mimesh, S | 1 |
| Osoba, A | 1 |
| Al-Mowaallad, A | 1 |
| Abdelaziz, M | 1 |
| Pérez Alvarez, MJ | 1 |
| González Guijarro, J | 1 |
| Santos Gil, I | 1 |
| Valerio, G | 1 |
| Bracciale, P | 1 |
| Manisco, V | 1 |
| Quitadamo, M | 1 |
| Legari, G | 1 |
| Bellanova, S | 1 |
| Kishi, K | 1 |
| Homma, S | 2 |
| Kurosaki, A | 1 |
| Kawabata, M | 1 |
| Tsuboi, E | 1 |
| Narui, K | 1 |
| Nakatani, T | 1 |
| Kono, T | 1 |
| Motoi, N | 1 |
| Tanimoto, H | 1 |
| Nakata, K | 1 |
| Steponaviciene, D | 1 |
| Kudzyte, I | 1 |
| Roberts, CM | 1 |
| Musiska, M | 1 |
| LoBue, PA | 2 |
| Moser, KS | 2 |
| Crook, MJ | 1 |
| Han, JP | 1 |
| Sun, SL | 1 |
| Li, RZ | 1 |
| Zhang, FS | 1 |
| Wang, SC | 1 |
| Cheng, J | 1 |
| Deng, YF | 1 |
| Yu, CB | 1 |
| Xu, WG | 2 |
| Fan, BD | 1 |
| Ahn, HC | 1 |
| Matsushima, H | 1 |
| Sugita, Y | 1 |
| Yanagisawa, T | 1 |
| Ubukata, M | 1 |
| Yoshida, F | 2 |
| Kanazawa, M | 2 |
| Onari, Y | 1 |
| Yamaoka, N | 1 |
| Taniwaki, M | 1 |
| Nakao, R | 1 |
| Murai, H | 1 |
| Terada, M | 1 |
| Kuraoka, T | 1 |
| Parra Ruiz, J | 1 |
| Ortego Centeno, N | 1 |
| Raya Alvarez, E | 1 |
| Charalambous, BM | 2 |
| Ivanova, LA | 1 |
| Gosling, RD | 3 |
| Uiso, LO | 3 |
| Sam, NE | 2 |
| Bongard, E | 1 |
| Kanduma, EG | 2 |
| Nyindo, M | 1 |
| Morris, RW | 1 |
| Ul-Ain, Q | 1 |
| Khuller, GK | 2 |
| Borisova, MI | 2 |
| Stakhanov, VA | 2 |
| Sharkova, TI | 1 |
| Ivashchenko, NA | 1 |
| Botha, T | 1 |
| MacIntyre, CR | 3 |
| Goebel, K | 1 |
| Brown, GV | 1 |
| Skull, S | 1 |
| Starr, M | 1 |
| Fullinfaw, RO | 1 |
| SAMITIER AZPARREN, J | 1 |
| GOMEZ, FD | 2 |
| CANCELA FREIJO, J | 1 |
| BREA, RJ | 1 |
| TRENCHI, A | 1 |
| BURGOS, R | 1 |
| MALLUCHE, H | 1 |
| GEMMI, A | 1 |
| MARONCELLI, P | 3 |
| SALVATORI, GC | 1 |
| WIESMANN, E | 2 |
| WANNER, J | 1 |
| TANNER, E | 1 |
| FETTERHOFF, KI | 1 |
| HOLMES, CX | 2 |
| MARTIN, GE | 3 |
| MOUNT, FW | 9 |
| FEREBEE, SH | 10 |
| JOINER, CL | 2 |
| MACLEAN, KS | 2 |
| PRITCHARD, EK | 1 |
| ANDERSON, K | 1 |
| KING, MB | 1 |
| COLLARD, P | 2 |
| KNOX, R | 2 |
| ALARCON, DG | 2 |
| RIVAS, A | 2 |
| CONTI, A | 1 |
| BRAMBILLA, G | 1 |
| GUERRA SANZ, FJ | 3 |
| TOVAR MARTIN, E | 3 |
| OMODEI ZORINI, A | 9 |
| KONIECZNY, S | 1 |
| PROUST, AJ | 3 |
| BEACHAM, EG | 3 |
| SIVRIERE, E | 2 |
| KRIESER, AE | 1 |
| SANDERSON, AG | 1 |
| VIK, M | 1 |
| MYERS, JA | 2 |
| MORELLI, E | 2 |
| DADDI, G | 4 |
| OMODEI-ZORINI, A | 4 |
| D'AMBROSIO, R | 1 |
| CUTILLO, E | 1 |
| MONACO, A | 2 |
| PURSELL MENGUEZ, A | 2 |
| GUERRA, RB | 1 |
| SCARPA, A | 1 |
| MELIS, A | 1 |
| GIURA, F | 1 |
| IZAR, G | 2 |
| MCDERMOTT, W | 9 |
| MUSCHENHEIM, C | 6 |
| CLARK, C | 1 |
| ELMENDORF, DF | 1 |
| CAWTHON, WU | 1 |
| BOWEN, DA | 2 |
| COLLINS, DM | 2 |
| SITA LUMSDEN, EG | 1 |
| SWOBODA, JA | 1 |
| RADENBACH, KL | 9 |
| PITTS, FW | 2 |
| MILLER, FL | 2 |
| DYE, WE | 1 |
| TEMPEL, CW | 4 |
| FITZPATRICK, MJ | 2 |
| AMSCHLER, H | 1 |
| STAHLMANN, W | 2 |
| BETHGE, W | 3 |
| INGRAO, F | 1 |
| FERRETTI, R | 2 |
| LAPP, AD | 2 |
| BLACK, GA | 2 |
| O'RAFFERTY, JN | 2 |
| LOPEZ SENDON, M | 2 |
| BETETTO, D | 1 |
| DIAS, O | 1 |
| FARRELL, FP | 1 |
| CARDOSO, M | 1 |
| HEINRICH, K | 1 |
| NAGORNY, S | 2 |
| POGGIO, G | 2 |
| BEEUWKES, H | 1 |
| ESSEVELD, H | 1 |
| NANNINGA, HS | 1 |
| DI BENEDETTO, V | 1 |
| AZZARELLO, L | 1 |
| BESTA, B | 6 |
| DE SIMONI, G | 4 |
| TADDEI, M | 1 |
| ROMANO, S | 3 |
| CARUSELLI, M | 1 |
| THOREN, M | 1 |
| HINSHAW, HC | 2 |
| PURRIEL, P | 5 |
| MURAS, O | 5 |
| MARTISCHNIG, KM | 3 |
| WARD, PM | 1 |
| PATSCH, J | 1 |
| BLASI, A | 2 |
| BRUSTOLON, A | 3 |
| GANGEMI, G | 4 |
| BEVILOTTI, V | 1 |
| GYSELEN, A | 10 |
| REGINSTER, A | 5 |
| THYS, F | 2 |
| WINS, J | 2 |
| BRAY, G | 2 |
| MORIN, J | 3 |
| TORLONE, M | 1 |
| LOFFLER, W | 1 |
| ENGEL, M | 1 |
| GSELL, O | 1 |
| COUNIHAN, HE | 1 |
| ABRAHAMSON, ML | 1 |
| O'CONNOR, MH | 1 |
| DICKENSON, J | 1 |
| BAROUKY, E | 1 |
| KHOURY, MB | 1 |
| HATEM, JM | 1 |
| SEBETY, AM | 1 |
| GRECO, RA | 1 |
| FORD, RA | 1 |
| HAWKINS, GK | 1 |
| HAIZMANN, R | 1 |
| BRANDSCHWEDE, S | 1 |
| BOCCONI, VL | 1 |
| D'ARCANGELO, D | 1 |
| BERTACCINI, S | 1 |
| RUSSO, V | 1 |
| BARBAGIANNI, A | 1 |
| MORGAGNI, W | 1 |
| BOLONDI, O | 3 |
| TOSI, B | 1 |
| MARANGONI, P | 2 |
| VALENTI, S | 2 |
| LENTI, R | 1 |
| CONFORTO, S | 1 |
| LUCENTINI, L | 1 |
| PEREZ HERVADA, E | 1 |
| WACKER, T | 1 |
| BONARD, EC | 1 |
| GASTESI, A | 1 |
| LINTON, WS | 1 |
| RABINOVITZ, E | 1 |
| OLIE, M | 1 |
| TEMPLE, AD | 1 |
| GALZERANO, G | 2 |
| GRUNDLAND, I | 1 |
| PRINKE, H | 1 |
| RANDOLPH, H | 1 |
| JOSEPH, S | 2 |
| COHEN, SS | 1 |
| ALLEN, HS | 1 |
| MORETTI, E | 3 |
| NYIREDY, G | 1 |
| KOVACS, M | 1 |
| HUNYADI, G | 1 |
| ROKA, J | 1 |
| RENYI, L | 1 |
| SZUCS, S | 1 |
| MCLEAN, RL | 2 |
| HEIN, J | 3 |
| STEFANI, H | 1 |
| MORERE, P | 4 |
| ALBERTINI, G | 4 |
| PIETRI, A | 4 |
| LEVI-VALENSI, A | 4 |
| MOLINA, C | 7 |
| RAVINA, A | 3 |
| PESTEL, M | 3 |
| LE JOUBIOUX, E | 2 |
| GROB, W | 1 |
| JONES, WA | 1 |
| JONES, GP | 1 |
| MARTONI, L | 1 |
| NICOLAJ, P | 1 |
| MALASPINA, M | 1 |
| ORIOL ANGUERA, J | 1 |
| GUALLAR SEGARRA, J | 1 |
| POMARES RIQUELME, A | 1 |
| ALTAVA, V | 1 |
| BARRERA, M | 1 |
| PENA, J | 1 |
| PERIS CEBOLLA, M | 1 |
| BULGARELLI, R | 2 |
| BUFFONI, L | 3 |
| DUFOURT, A | 2 |
| OLLAGNIER, C | 1 |
| LAMBERT, R | 1 |
| Gebala, A | 1 |
| Małeski, K | 1 |
| Michałowicz, Z | 1 |
| Sekułowa, J | 1 |
| Studnicka, K | 1 |
| CANTORE, B | 1 |
| ZUCCONI, C | 1 |
| MELILLO, G | 1 |
| KAKAVIAS, S | 1 |
| PINERO, MR | 1 |
| ZAPATERO, J | 2 |
| CALDERON, J | 2 |
| GARCIA-MORENO PEREGRIN, A | 1 |
| AGURTO, MA | 1 |
| RODRIGUEZ JOHNSON, ME | 1 |
| DE QUEIROZ, R | 2 |
| REGO, G | 1 |
| PELEGATTI, W | 1 |
| DE PASSOS, JA | 1 |
| BITTENCOURT, C | 1 |
| DE SOUSA, HV | 1 |
| CATTINI, S | 2 |
| ANAN'EV, PN | 1 |
| CHU, J | 1 |
| GEISSBERGER, M | 1 |
| POINTILLART, J | 1 |
| CONARD, V | 1 |
| KLARNET, JA | 1 |
| GUGELOT, A | 1 |
| BAUD, P | 1 |
| CHEVALIER, R | 1 |
| SANDS, JH | 1 |
| WEISER, O | 1 |
| DESMEULES, R | 2 |
| DORVAL, CH | 1 |
| LESSARD, C | 1 |
| MONTMINY, L | 1 |
| DION, R | 2 |
| GAREAU, PE | 1 |
| SEGA, A | 1 |
| VRSCAJ, B | 1 |
| LARMOLA, E | 1 |
| TCHERTKOFF, IG | 1 |
| ASISIAN, M | 1 |
| NENASHEV, P | 1 |
| DAVIDSON, LR | 1 |
| BEAULIEU, M | 1 |
| ALTMAN, V | 1 |
| TENDLAU, A | 1 |
| SHIN, E | 1 |
| CASATI, G | 1 |
| COGO, L | 1 |
| GEMELLI, D | 1 |
| ALMANSA DE CARA, S | 2 |
| BLANCO RODRIGUEZ, F | 2 |
| BARIETY, M | 4 |
| CHOUBRAC, P | 2 |
| GUERIN, C | 1 |
| THIBAUT, P | 1 |
| QUATTROCCHI, G | 1 |
| LA ROSA, G | 1 |
| CHATONNIER, F | 1 |
| CHATONNIER-ROQUELAURE, MT | 1 |
| LABORDE, J | 1 |
| MIGUERES, J | 2 |
| ASSERAF, W | 1 |
| DENST, J | 2 |
| TANZI, PL | 2 |
| D'ALFONSO, G | 1 |
| IZZO, A | 1 |
| NEGRI, B | 1 |
| GUNELLA, G | 2 |
| FILLA, E | 4 |
| SAVASTANO, D | 1 |
| ERTUG, C | 2 |
| EASOM, HF | 2 |
| WILLIS, HS | 1 |
| GORGENYI-GOTTCHE, O | 6 |
| SIRALY, F | 4 |
| SZATMARY, M | 1 |
| KRASNITZ, A | 1 |
| JENKINS, BE | 1 |
| MARK, HJ | 2 |
| HARROWER, JR | 1 |
| BROWN, WB | 1 |
| BIEHL, JP | 3 |
| SKLAVEM, JH | 1 |
| DUGGELI, O | 4 |
| TRENDELENBURG, F | 3 |
| SCHETTINO, S | 1 |
| HARING, W | 1 |
| HENNIG, K | 1 |
| TIEDEMANN, IL | 1 |
| KLEE, P | 2 |
| DOBRZYNSKI, Z | 2 |
| GRABOWSKI, L | 1 |
| SAJEWICZ, A | 1 |
| DA SILVEIRA, AG | 1 |
| MENEZES, J | 1 |
| CASTRO, LM | 1 |
| MANTA, MC | 1 |
| DE LIMA, JQ | 1 |
| FELIX, S | 1 |
| VIEIRA, TG | 1 |
| TAVARES, W | 2 |
| AGUIAR, A | 1 |
| MAGARAO, MF | 1 |
| SOARES, DP | 1 |
| DE CORTES, VC | 1 |
| O'BRIEN, B | 1 |
| STEWART, JF | 1 |
| GAUTHIER, H | 1 |
| WOLF, HJ | 1 |
| DZIUBA, K | 2 |
| ASTALDI, G | 2 |
| GORINI, P | 2 |
| GALDI, G | 2 |
| RICCI, G | 1 |
| RAVAZZONI, L | 1 |
| CAVEZZALI, A | 1 |
| LEVI, R | 1 |
| BARONI, V | 2 |
| GRAMAZIO, V | 1 |
| MAGISTRETTI, M | 1 |
| CASPANI, R | 1 |
| SADA, E | 2 |
| DE MARTINI, A | 1 |
| LOSANO, G | 1 |
| PALENZONA, C | 2 |
| RONA, G | 1 |
| PAUTASSI, G | 1 |
| BIANCO, T | 1 |
| VOARINO, EL | 1 |
| ROLLA, G | 1 |
| ROSSINI, G | 2 |
| SPADA, E | 1 |
| CAPELLO, M | 1 |
| CERESA, C | 1 |
| DE BLASIIS, M | 1 |
| NOBILE, F | 1 |
| RAZZABONI, G | 1 |
| SETTI, L | 1 |
| ZEICHNER, J | 1 |
| CHILDRESS, WG | 1 |
| PANCOTTO, L | 1 |
| ZEBROWSKI, T | 3 |
| PIENIAZEK, J | 3 |
| PLEWIK, W | 3 |
| BRUEL, R | 1 |
| AMOUROUX, P | 1 |
| BRIONES, E | 1 |
| ROMERO SAN LUCAS, E | 1 |
| LUNA RUILOVA, M | 1 |
| CATTA, J | 1 |
| ALBERTI, H | 1 |
| LEYS, A | 1 |
| AGIUS, J | 1 |
| BERNARD, E | 11 |
| KREIS, B | 10 |
| LOTTE, A | 7 |
| DANIELS, M | 1 |
| FOX, W | 37 |
| DA SILVA, OD | 1 |
| DE ALDA CALLEJA, M | 1 |
| RODRIGUEZ ADRADOS, J | 1 |
| BAYO CABANA, E | 1 |
| AGUILERA MAS, J | 1 |
| VENDRELL VILA, D | 1 |
| LIANAS COLOMINAS, A | 1 |
| SORIANO, M | 1 |
| GONZALEZ RIBAS, M | 1 |
| CASANOVAS, P | 1 |
| TRUJOLS, A | 1 |
| VINTRO, P | 1 |
| POUSSIER, J | 1 |
| COLETSOS, PJ | 1 |
| DAVY, PE | 1 |
| VERAN, P | 7 |
| BERNOU, A | 1 |
| TRICOIRE, J | 1 |
| COANT, F | 1 |
| LANOE, JF | 1 |
| JULLIEN, W | 1 |
| GERAUD, J | 1 |
| FABRE, P | 1 |
| GERNEZ-RIEUX, C | 3 |
| BEERENS, H | 2 |
| FOURNIER, P | 2 |
| TACQUET, A | 6 |
| BUTTARO, CA | 1 |
| ROY, A | 1 |
| MAGRO, G | 1 |
| EHRNER, L | 1 |
| REYMANN, F | 1 |
| SPATH, F | 1 |
| KOLE, W | 1 |
| TEICHMANN, W | 1 |
| FORSTER, E | 1 |
| MACCONE, V | 1 |
| ROMUALDI, A | 1 |
| TORRIANI, S | 1 |
| KUSKE, FA | 1 |
| LUBING, HN | 1 |
| FOUQUET, J | 3 |
| CORNU, P | 1 |
| FREESE, H | 1 |
| VERNA, JF | 2 |
| SCHECHTMANN, MR | 1 |
| HANNA, M | 1 |
| SHEHATA, AH | 1 |
| HANNA, AZ | 1 |
| GRAF, R | 1 |
| DESPIERRES, G | 3 |
| CHARLEUX, P | 1 |
| REVOL, L | 1 |
| RUBIN, EH | 1 |
| CHEIFETZ, I | 1 |
| KATZEV, H | 1 |
| EIDINGER, SL | 1 |
| BRIEF, C | 1 |
| CENSI, G | 1 |
| BAROZZI, R | 1 |
| SCHWENKENBECKER, D | 1 |
| SCHLEPCKOW, D | 1 |
| SCARINCI, C | 1 |
| DA RIVA, M | 1 |
| PEREDA, A | 1 |
| BRUN, O | 1 |
| MASSON, H | 1 |
| SPINOIT, C | 1 |
| FUST, B | 2 |
| NIGOGHOSSIAN, GA | 1 |
| BARTH, F | 1 |
| NIXDORF, H | 1 |
| DE LUCA, V | 1 |
| KAPL, R | 1 |
| OBRECHT, V | 2 |
| RENOVANZ, HD | 3 |
| SCHETTLER, U | 1 |
| GAASE, A | 1 |
| GISELEN, A | 1 |
| SEHM, G | 2 |
| NAWROCKI, G | 1 |
| FERNANDEZ BUA, H | 2 |
| MELLO AGUERRE, M | 1 |
| PINTOS FUENTES, RJ | 1 |
| BERLIN, II | 1 |
| SUMBATOV, GA | 2 |
| FORD, RM | 1 |
| MICHEL, W | 2 |
| BURGOS DE PABLO, A | 1 |
| FERNANDEZ CAMARA, J | 1 |
| JACOB, P | 1 |
| CHAUVEAU, J | 1 |
| CARTIER, R | 1 |
| VIVERET, J | 1 |
| GAGLIO, M | 1 |
| CONSOLO, F | 1 |
| VERRIENTI, G | 1 |
| BELSANTI, R | 1 |
| NUGEL, A | 1 |
| BELLINGI, J | 1 |
| FOSSATI, C | 1 |
| GUILLONES, NO | 1 |
| SCHWEID, C | 1 |
| BUTZENGEIGER, KH | 1 |
| KRUMBHOLZ, J | 1 |
| WESSING, L | 1 |
| LORENZ, TH | 1 |
| CALDEN, G | 1 |
| OUSLEY, JL | 1 |
| BLOCH, H | 2 |
| WIDELOCK, D | 6 |
| PEIZER, LR | 6 |
| SUAREZ PALACIOS, F | 1 |
| OECONOMOPOULOS, N | 1 |
| STEPHANOPOULOS, C | 1 |
| LIACACOS, D | 1 |
| COSTELETOS, E | 1 |
| POLYCHRONIDIS, A | 1 |
| TSIMONOS, T | 1 |
| NASAINAS, A | 1 |
| AILIANOS, T | 1 |
| SHARMA, OD | 1 |
| BLUNDI, E | 1 |
| BREATHNACH, CS | 1 |
| CHILDRESS, ME | 1 |
| THOREN, ME | 1 |
| DANIELS, AC | 1 |
| CARINENA, J | 1 |
| ADAN, A | 1 |
| IZZO, G | 1 |
| HUNT, B | 1 |
| WASSERSUG, JD | 1 |
| ATTILI, L | 1 |
| GUARNERIO, GC | 1 |
| BRUN, J | 1 |
| VIALLIER, J | 2 |
| SERRE, H | 1 |
| DANZER, R | 1 |
| LANDOLT, R | 1 |
| BERNARDINI, M | 1 |
| TRABUCCO, G | 1 |
| RENEDO FORNOS, JA | 1 |
| ROMEO, JL | 1 |
| DE PARTEARROYO, FR | 2 |
| AYERBE VALLES, SA | 2 |
| CIAMILLO, E | 1 |
| CHRETIEN, J | 1 |
| POLI, M | 1 |
| ENGLER, M | 1 |
| CAPON, AW | 1 |
| KOSTKA, Z | 1 |
| BROZ, O | 1 |
| ORICCHIO, D | 1 |
| D'AGOSTINO, N | 1 |
| GARCIA-MORENO, F | 1 |
| COSTANTINI, E | 1 |
| SANSOTTA, V | 1 |
| MANAI, G | 1 |
| ROVESCALLI, A | 1 |
| CANESI, MT | 1 |
| VIDAL, J | 5 |
| VIDAL, F | 1 |
| HUSSON, M | 1 |
| GAILLARD, C | 1 |
| BENDA, R | 3 |
| URQUIA, DA | 1 |
| LA TORRE, C | 1 |
| PENA, A | 1 |
| AGOS DE PASTORE, C | 1 |
| HARTUNG, A | 1 |
| HELWEG-LARSEN, P | 3 |
| RASMUSSEN, KN | 6 |
| DALET, R | 1 |
| MOATTI, G | 1 |
| VALDES RUIZ, M | 1 |
| JUANES GONZALEZ, A | 1 |
| GRANADO, MA | 1 |
| JUANES GONZALEZ, M | 2 |
| MIGLIOLI, S | 1 |
| DI LUZIO, G | 1 |
| PAULY, W | 1 |
| GLAUBITZ, E | 1 |
| MARTIN-LALANDE, J | 1 |
| LAFORGE, S | 1 |
| NOUVION, H | 2 |
| PELLIER, G | 2 |
| GUILBAUD, P | 2 |
| CHOVELON, R | 2 |
| PLACE-VERGHNES, A | 2 |
| DUROUX, A | 1 |
| MASSON, P | 1 |
| MARTY, J | 1 |
| JARNIOU, A | 1 |
| AZORIN, D | 1 |
| PARAF, J | 1 |
| ZIVY, P | 1 |
| PARAF, M | 1 |
| RAPAUD, G | 1 |
| ROSENBERG, E | 1 |
| LABRE, J | 1 |
| BOULLET, M | 1 |
| KUMAGAI, T | 2 |
| KUMAGAI, H | 1 |
| ASHINO, Y | 1 |
| AIZAWA, S | 1 |
| KANAYA, A | 2 |
| SUGAWARA, T | 2 |
| KAWAMORITA, K | 1 |
| OIKAWA, Y | 1 |
| HEUNER, W | 1 |
| ABEE, H | 1 |
| BLOCH, RG | 2 |
| DOONEIEF, AS | 2 |
| BUCHBERG, AS | 2 |
| SPELLMAN, S | 2 |
| LICHTENSTEIN, MR | 2 |
| MIZENBERG, E | 2 |
| TEPE, J | 1 |
| FIRZLAFF, HU | 1 |
| WIESE, O | 1 |
| EWERBECK, H | 1 |
| WECHSELBERG, K | 1 |
| HORLEIN, H | 1 |
| JAHNKE, K | 1 |
| STECHER, W | 1 |
| COATES, EO | 2 |
| BRICKMAN, GL | 1 |
| MEADE, GM | 5 |
| CAMPAGNA, M | 3 |
| CALIX, A | 1 |
| HAUSER, G | 1 |
| PANA, C | 1 |
| KLEINSCHMIDT, H | 1 |
| WEICKSEL, P | 2 |
| NIEMSCH, H | 1 |
| SITT, W | 1 |
| MULLER, E | 1 |
| POPPENDIECK, K | 1 |
| BADE, G | 1 |
| WINFIELD, DL | 1 |
| SPARER, PJ | 1 |
| PHILLIPS, S | 8 |
| GARBINSKI, T | 3 |
| DERUBSKA, B | 2 |
| SZLENKIER, E | 2 |
| NIEWIADOMSKA, S | 3 |
| CZANIK, P | 1 |
| KERTES, I | 1 |
| BEKIERKUNST, A | 1 |
| KRATOCHWIL, L | 1 |
| SZULGA, T | 1 |
| WOJCIECHOWSKI, Z | 1 |
| BUDISAVLJEVIC, M | 1 |
| VUCKOVIC, Lj | 1 |
| GRUJIC, M | 1 |
| ILIC, Lj | 1 |
| LABAN, M | 1 |
| MILETIC, V | 1 |
| POPOVIC, J | 1 |
| PUTNIK, Dj | 1 |
| SLAVIN, P | 2 |
| POROT, M | 1 |
| BLOEDORN, H | 2 |
| SWEANY, HC | 1 |
| PEREZ, JA | 4 |
| VICENTE-MASTELLARI, A | 1 |
| YOUNG, RV | 1 |
| DE LIMA, SO | 1 |
| LOUBRY, MP | 1 |
| LUNTZ, G | 1 |
| ROSENOW, H | 2 |
| EISENBLATTER, J | 2 |
| TODOROFF, T | 3 |
| BOMBARDELLI, E | 1 |
| MARCHESI, C | 1 |
| REALE, M | 4 |
| PAOLI, G | 3 |
| MERLO, P | 1 |
| NELLO, RP | 1 |
| VALERI, FM | 1 |
| MULARGIA, A | 1 |
| TAPIA SANZ, J | 1 |
| BELENGUER RIPOLLES, P | 1 |
| PEDRAZA PALOMO, M | 1 |
| VALLEDOR, T | 1 |
| HERNANDEZ MIYARES, C | 1 |
| COSTALES, F | 1 |
| BORBOLLA, L | 1 |
| SATANOSWSKY, C | 1 |
| GARCIA PALACIOS, A | 1 |
| JOHNSEN, L | 1 |
| HEWITT, WC | 1 |
| DICKIE, HA | 1 |
| LARSON, FC | 2 |
| OLSON, DE | 1 |
| BOHLKE, E | 2 |
| MUDIE, IS | 1 |
| HORNE, NW | 3 |
| CROFTON, JW | 6 |
| PAYNE, HM | 1 |
| HACKNEY, RL | 1 |
| CLARK, EA | 1 |
| JOHNSON, PC | 1 |
| COHEN, S | 1 |
| ANG, E | 1 |
| ROTHSTEIN, E | 1 |
| BRUCE, TH | 1 |
| LUISETTI, GL | 1 |
| EDER, J | 1 |
| WARM, I | 1 |
| JUAREZ PEINADO, R | 1 |
| SALMAREGGI, A | 1 |
| INGRASSIA, L | 1 |
| MIDGLEY, RL | 1 |
| MOORE, B | 1 |
| VON GERZANITS, P | 1 |
| WALTHER, G | 1 |
| WINTER, KA | 1 |
| FRANK, F | 2 |
| CARON, M | 3 |
| MITFESSEL, M | 1 |
| ALIOTTA, N | 1 |
| CANITANO, PF | 1 |
| PATUREL, G | 1 |
| SUSINI, R | 1 |
| DALLET, R | 1 |
| WEISS, M | 1 |
| SALZMAN, L | 1 |
| PERI, T | 1 |
| CLEMENTI, E | 1 |
| PEREZ, O | 1 |
| IBANEZ, S | 1 |
| LEGARRETA, J | 1 |
| GERVOIS, M | 1 |
| ZORINI, AO | 2 |
| PIOVANO, S | 1 |
| CASAMAYOU, E | 1 |
| WALLACE, AT | 1 |
| STEWART, SM | 7 |
| TURNBULL, FA | 1 |
| KITTEL, H | 3 |
| BUNDY, M | 1 |
| ALEXANDER, IH | 1 |
| KUEHN, CC | 1 |
| HUGHES, HB | 1 |
| JONES, AP | 1 |
| SCHMIDT, LH | 5 |
| DEUSCHLE, K | 6 |
| ORMOND, L | 2 |
| ELMENDORF, D | 1 |
| SAIFER, A | 1 |
| ORESKES, I | 1 |
| VOLK, BW | 1 |
| DANGLER, G | 3 |
| CANTARELLA, R | 1 |
| DE MARCO, F | 1 |
| CARTER, FS | 1 |
| PREGOWSKI, W | 3 |
| BRODA, Z | 3 |
| FRYCZ, L | 1 |
| MALINOWSKI, J | 1 |
| MADAR, E | 1 |
| SANTESSON, G | 1 |
| SCHWARTZ, WS | 4 |
| MOYER, RE | 2 |
| NIMITZ, HJ | 1 |
| OESTREICHER, R | 1 |
| DRESSLER, SH | 4 |
| MIDDLEBROOK, G | 7 |
| BEHR, W | 1 |
| SALKIN, D | 2 |
| SCHWARTZ, JA | 2 |
| MELI, G | 2 |
| LONGARATO, FJ | 1 |
| GAMMARROTA, V | 1 |
| McCUNE, R | 1 |
| TOMPSETT, R | 2 |
| OGILVIE, CM | 2 |
| CAZZANIGA, G | 1 |
| CARROLL, JD | 1 |
| MARSH, K | 1 |
| ZORINI, O | 1 |
| DE ALMEIDA, EB | 1 |
| DE BRITO, AA | 1 |
| FERRARI, B | 1 |
| D'ANGELO, G | 1 |
| BONOMI, F | 1 |
| TUCZEK, H | 1 |
| SAUPE, M | 1 |
| CROCCO, G | 1 |
| BATTIGELLI, G | 1 |
| BABICH, S | 1 |
| BENNARI, B | 1 |
| LEGNANI, F | 1 |
| MARCHIO', B | 1 |
| SEGOVINI, A | 1 |
| SPANGHERO, L | 1 |
| ZMAJEVICICH, G | 1 |
| LOUBRY, P | 1 |
| COBY, J | 1 |
| KASTARLAK, N | 1 |
| ONEN, K | 1 |
| GORPE, A | 1 |
| KALBIAN, VV | 1 |
| FRAWLEY, TF | 1 |
| ROSCH, PJ | 1 |
| KATZ, S | 6 |
| STOREY, PB | 3 |
| McCORMICK, GF | 1 |
| LAHESMAA, R | 1 |
| GIANANDREA, G | 1 |
| BERG, G | 2 |
| SCHLICHT, K | 1 |
| ORLOWSKI, EH | 5 |
| CLAUS, H | 1 |
| TURNBULL, FW | 1 |
| LUKAVSKY, J | 1 |
| PETROVICKY, O | 2 |
| SATO, N | 2 |
| HOFFMANN, I | 2 |
| TELEGDI, I | 2 |
| ORBAN, S | 2 |
| ROMEO, F | 2 |
| WIER, JA | 2 |
| GREGORY, LJ | 1 |
| STEAD, W | 1 |
| MAYOCK, RL | 2 |
| WEISER, OL | 2 |
| BERGSMANN, O | 2 |
| KESZTELE, V | 4 |
| TRAUTWEIN, H | 1 |
| KLINGE, A | 1 |
| DONNO, L | 1 |
| TROJANOWSKI, S | 1 |
| ZEBROWSKI, L | 1 |
| PACZKOWSKI, A | 1 |
| BOROWIECKA, A | 1 |
| RODRIGUEZ-PINERO Y JIMENEZ, M | 1 |
| PEREL'MAN, EI | 1 |
| MALM, E | 1 |
| MEISSNER, G | 6 |
| ANGELI, G | 1 |
| BUSANI, L | 1 |
| TEDESCHI, G | 1 |
| OVERBY, HT | 1 |
| WOLIUNG, RW | 1 |
| ORNSTEIN, GG | 1 |
| STEINLIN, H | 1 |
| CHAVES, AD | 5 |
| ROBINS, AB | 2 |
| ABELES, H | 4 |
| BOHNI, F | 1 |
| CORACH, L | 1 |
| DE PIFFARETTI, MM | 1 |
| MOLINA, MA | 1 |
| BARRIE, J | 2 |
| ROULET, A | 1 |
| CELLERINO, RJ | 1 |
| CAMPOS, RM | 1 |
| WEISBERG, MM | 1 |
| BURGHARD, G | 3 |
| RYDE, C | 2 |
| BLENNERHASSETT, GH | 1 |
| MURDOCH, JM | 2 |
| GRANT, IW | 2 |
| MENDES, F | 1 |
| SEGAGNI, E | 2 |
| MITCHELL, RS | 3 |
| ANDERSON, L | 1 |
| OHR, I | 1 |
| CLEGG, JW | 1 |
| GELLIS, SN | 1 |
| MURPHY, RV | 1 |
| ALLEN, AR | 1 |
| MARCY, GE | 1 |
| YU, JK | 2 |
| ABRIC, J | 1 |
| GIROULLE, H | 1 |
| CARDINALI, G | 1 |
| MAJ, A | 1 |
| MACCAGNANI, G | 1 |
| ORGANICK, A | 1 |
| MCCUNE, RM | 3 |
| BATTEN, J | 1 |
| WILLNER, I | 1 |
| PETRONELLI, A | 1 |
| DA COL, A | 1 |
| ZAIDI, SH | 2 |
| HARRISON, CV | 2 |
| KING, EJ | 2 |
| GAUTHIER, M | 1 |
| KOPEC, H | 3 |
| DUBEY, VD | 1 |
| PILHEU, JA | 7 |
| MASANTI, J | 1 |
| CARBAJO MARTIN, JJ | 1 |
| TIBURTIUS, HF | 2 |
| VERGANI, F | 2 |
| PAGANI, E | 1 |
| LUPACCHINI, A | 1 |
| MEESE, T | 2 |
| BLITTERSDORF, F | 1 |
| BROZ, J | 1 |
| RACINE, R | 1 |
| MELLO-AGUERRE, M | 2 |
| FON-IUNG, Ie | 1 |
| CANETTI, G | 9 |
| GEORGOPOULOS, G | 1 |
| DE PALMA, M | 1 |
| CENTNER, J | 1 |
| MODAVE, J | 1 |
| BOUDOURESQUES, J | 1 |
| MASSAD, L | 1 |
| PHELIP, H | 1 |
| CAJGFINGER, H | 1 |
| WEILLER, P | 2 |
| PEREGO, MA | 1 |
| CARBAJO, JJ | 1 |
| SZANTO, S | 1 |
| HANKOVSZKY, M | 1 |
| PETIT, A | 1 |
| RUSSELL, WF | 5 |
| HORTON, GE | 1 |
| LINCOLN, EM | 2 |
| LYTHCOTT, GI | 1 |
| GRABOWSKI, W | 1 |
| SOROKO, J | 1 |
| ZITRIN, A | 1 |
| THOMPSON, DS | 1 |
| WOLOSKER, N | 4 |
| CIVIL INGLES, J | 2 |
| MELNOTTE, P | 1 |
| SENAULT, R | 1 |
| SADOUL, P | 1 |
| HUTTIN, R | 1 |
| SCHOEPS, U | 1 |
| SILORATA, AB | 1 |
| CALDERATO, V | 1 |
| BOUR, H | 2 |
| DUCOMET, JC | 1 |
| OKA, S | 10 |
| SUZUKI, C | 1 |
| KUROBANE, T | 1 |
| KANNO, I | 2 |
| SATO, S | 1 |
| NIITU, Y | 1 |
| AWATAGUCHI, S | 1 |
| UEDA, H | 1 |
| YAMADA, S | 3 |
| YAKUWA, E | 1 |
| SHOJI, M | 1 |
| KOMATSUDA, K | 1 |
| BIRK, G | 1 |
| HEINE, F | 1 |
| STROBEL, W | 1 |
| TOUSSAINT-FRANCX, Y | 1 |
| FILOGRANA, V | 1 |
| KLEMM, E | 1 |
| KOSTER, K | 1 |
| CORCOS, A | 2 |
| CORCOS, S | 2 |
| BRETON, A | 2 |
| GAUDIER, B | 2 |
| PIERRET, R | 2 |
| CONCEICAO, J | 2 |
| DE ALEMQUER, M | 3 |
| DE MORO, ER | 2 |
| MARTINEZ MARCHETTI, A | 2 |
| HIGASHI, K | 2 |
| IMAI, S | 2 |
| KAWASAKI, H | 2 |
| KITAGAWA, R | 2 |
| KUBO, T | 2 |
| MASUI, I | 2 |
| NAITO, M | 5 |
| NAKAMURA, A | 2 |
| NAKAYAMA, K | 2 |
| SAKAGAMI, K | 2 |
| TAI, Y | 2 |
| TANI, T | 2 |
| TOKUSHIMA, K | 2 |
| ALEXANIAN, DA | 2 |
| FUSCO, G | 2 |
| TOZZI, M | 2 |
| GAIDA, A | 2 |
| QUISUMBING, M | 2 |
| MAZZEI, G | 2 |
| TUMMINELLO, B | 2 |
| KLOSE, G | 2 |
| MERTENS, J | 2 |
| DOBROWOLSKI, B | 3 |
| GRUMBACH, R | 3 |
| KAPLAN, M | 3 |
| ABELLO, J | 2 |
| PHILBERT, M | 2 |
| SCHWOB, RA | 2 |
| FAVEZ, G | 15 |
| LAUENER, H | 2 |
| HANDLEY, AE | 2 |
| HUSEN, JH | 2 |
| BERKTIN, K | 2 |
| YENER, MS | 2 |
| BALOGH, A | 2 |
| KOLBOW, H | 2 |
| DASGUPTA, HN | 2 |
| MAZUMDAR, NK | 2 |
| PAL, BK | 2 |
| RAY, KS | 2 |
| SEN, NN | 4 |
| BETHLEM, N | 6 |
| BITTENCOURT, R | 2 |
| DIAS, L | 5 |
| GOMES, O | 5 |
| IBIAPINA, A | 2 |
| VERBEKE, R | 2 |
| BEKAERT, J | 2 |
| DE BRABANDERE, R | 2 |
| STEYAERT, J | 2 |
| NICK, J | 1 |
| STEINHAEUSER, F | 1 |
| EPSTEIN, IG | 2 |
| NAIR, KG | 2 |
| BOYD, LJ | 2 |
| MORALES, SM | 1 |
| HAY, D | 3 |
| MORAR', SS | 1 |
| WAREMBOURG, H | 2 |
| VOISIN, C | 1 |
| PAUCHANT, M | 1 |
| LUCCHESI, M | 6 |
| MALAGUZZIVALERI, F | 1 |
| SPINA, G | 3 |
| STORNIELLO, G | 1 |
| VON ARNIM, HH | 1 |
| KOANG, NK | 1 |
| HU, TC | 1 |
| TCH'EN, CL | 1 |
| CHU, TH | 1 |
| MUTTI, E | 1 |
| PETRONE, R | 1 |
| LUTTEN, W | 1 |
| GUIN, JJ | 3 |
| DUBOIS-VERLIERE, T | 1 |
| SAVEL, J | 1 |
| BECK, J | 1 |
| DE SOUSA, MA | 1 |
| CAEIRO, A | 1 |
| DONNERBERG, RL | 1 |
| ATWELL, RJ | 1 |
| BROWNING, RH | 1 |
| WILDE, W | 1 |
| AGUET, F | 2 |
| SOURDAT, P | 1 |
| MAGNENAT, P | 1 |
| BRINSMADE, A | 1 |
| CHORTIS, P | 1 |
| SOLINARAIOS, E | 1 |
| VOURVOULIS, K | 1 |
| CUTHBERT, J | 4 |
| BRUCE, LG | 3 |
| PROSEK, A | 2 |
| VALCHAR, J | 2 |
| GARAVENTA, A | 3 |
| COSTA, G | 2 |
| GUNELLA, S | 1 |
| MORELL CASTILLO, DF | 1 |
| LANGER, R | 1 |
| MARSHALL, G | 1 |
| WALKER, WC | 1 |
| GRIESBACH, R | 1 |
| REISS, J | 1 |
| TOWNSEND, SM | 1 |
| MEYERHOFF, WK | 1 |
| LEONCINI, G | 2 |
| MAZZINI, C | 1 |
| DOS NEVES, JS | 1 |
| ESPINDOLA, N | 1 |
| MESCOLINI, G | 2 |
| ZUBIANI, M | 3 |
| ROGNATO, C | 1 |
| KIRSHNER, JJ | 3 |
| STOTT, H | 13 |
| PRICE, JM | 1 |
| BROWN, RR | 1 |
| POPPE DE FIGUEIREDO, F | 3 |
| DE PAOLA, D | 1 |
| WRUBL, A | 1 |
| SEREMBE, M | 1 |
| GOTI, F | 1 |
| VERCELLINO, A | 1 |
| RABINO, A | 1 |
| TORREGROSSA, O | 1 |
| BELL, JC | 1 |
| CHRISTENSEN, O | 2 |
| HOLM, S | 1 |
| RASMUSSEN, KH | 1 |
| ABDURASHITOVA, MV | 2 |
| FEREBEE, S | 2 |
| ANASTASIADES, A | 1 |
| SUDA, J | 1 |
| WYSS, A | 1 |
| JOOS, H | 1 |
| DESSAUER, P | 1 |
| MOREAU, F | 1 |
| MOTIWALE, AG | 1 |
| WOLINSKY, E | 3 |
| SACCO, F | 1 |
| GUALA, B | 1 |
| GUERRA, P | 1 |
| ZUCCHETTI, B | 1 |
| BORSELLA, C | 1 |
| MERELLI, B | 1 |
| SOSNOWSKI, K | 3 |
| ALTMANN, V | 1 |
| DIAZ, RM | 1 |
| JORDAHL, C | 3 |
| DES PREZ, R | 3 |
| PARRELLA, M | 1 |
| ROYE, WE | 1 |
| EWART, GE | 1 |
| AUSPITZ, P | 1 |
| SISTI, MA | 1 |
| SCODITTI, G | 1 |
| KOURILSKY, R | 1 |
| KOURILSKY, S | 1 |
| THUILLIER, Y | 1 |
| SELKON, JB | 19 |
| ESCH, D | 1 |
| GIERHAKE, FW | 2 |
| HERRMANN, W | 1 |
| MARTINI, P | 1 |
| GOFRON, W | 1 |
| CROZAFON, C | 1 |
| BARBEITO, AM | 1 |
| BUCHWALD, G | 1 |
| PICKROTH, G | 3 |
| CROFTON, J | 2 |
| VAN VLIERBERGHE, RG | 1 |
| PATTYN, S | 1 |
| VANBREUSEGHEM, R | 1 |
| WU, SC | 1 |
| KU, CY | 1 |
| CHENG, TY | 2 |
| TS'UI, HP | 1 |
| MA, KC | 1 |
| CH'EN, JP | 1 |
| MACHON, Z | 1 |
| KROBER, KH | 1 |
| ROBEL, G | 1 |
| DEL PRINCIPE, A | 2 |
| EDWARD, DW | 1 |
| GIOVA, C | 1 |
| DI RUGGIERO, A | 1 |
| MARINELLI, N | 1 |
| CANIGLIA, M | 1 |
| MIYOSHI, H | 1 |
| OKANO, G | 1 |
| POZZI, G | 1 |
| SCOCCIA, S | 1 |
| LEONARDI, G | 1 |
| RUBBO, SD | 1 |
| ROUCH, LC | 1 |
| EGAN, JB | 1 |
| WADDINGTON, AL | 1 |
| TELLESSON, WG | 1 |
| RENKIN, A | 1 |
| SMART, J | 1 |
| GOUGH, J | 1 |
| KUO, TL | 1 |
| CHANG, JC | 1 |
| CHU, TY | 1 |
| KAMEYAMA, Y | 2 |
| WALSH, JJ | 1 |
| LINN, RH | 1 |
| JACOBS, S | 2 |
| IANNELLO, JA | 1 |
| EVANDER, LC | 2 |
| ROSE, NR | 1 |
| BEUTNER, EH | 2 |
| DOYLE, W | 1 |
| BRIDGE, EV | 1 |
| CARR, DT | 2 |
| BERTE, SJ | 5 |
| DEWLETT, HJ | 3 |
| SCHMIDT, HW | 2 |
| KRACHT, J | 1 |
| RIST, N | 6 |
| MASSOLA, U | 1 |
| UTKIN, VV | 14 |
| HAHN, J | 1 |
| BIERSCHENK, H | 1 |
| PFAFFENBERG, R | 1 |
| JAHLER, H | 1 |
| BACHMAN, H | 1 |
| FREUND, J | 1 |
| ALLISON, ST | 1 |
| MASSA, B | 1 |
| MANZONE, P | 1 |
| SARTORIO, E | 1 |
| OSEGLIA, G | 1 |
| GENAZZANI, E | 2 |
| PAOLETTI, A | 1 |
| PERELLI, A | 1 |
| NEVES, S | 1 |
| ESPINDULA, N | 1 |
| ELOY, LM | 1 |
| MANNION, RA | 1 |
| COTTRELL, TL | 1 |
| LLOYD, FA | 1 |
| MACLEOD, HM | 1 |
| NOWAK, K | 1 |
| LYON, RH | 1 |
| HALL, WH | 1 |
| ORGANICK, AB | 1 |
| BOTTINO, D | 1 |
| MAGGIORA, L | 1 |
| SANTOPADRE, I | 1 |
| RAVAZZONI, C | 1 |
| SCARPONI, F | 1 |
| BARBERA, L | 1 |
| MAGGIONI, L | 1 |
| GIUROVA, P | 1 |
| BANKOV, P | 1 |
| LEITES, V | 1 |
| MANDEL, W | 2 |
| HEATON, AD | 1 |
| ACETO, JN | 1 |
| COVERT, DF | 1 |
| ADACHI, I | 3 |
| TAKAHASHI, C | 1 |
| SHIMADA, H | 3 |
| OKAI, T | 3 |
| TAKAHASI, T | 2 |
| BALDAMUS, U | 1 |
| BARBOLINI, G | 1 |
| LOSCHI, GC | 1 |
| BURNETT, PC | 1 |
| BRODIE, D | 1 |
| CHICOU, J | 3 |
| HETRICK, G | 4 |
| LAHLOU, M | 2 |
| LE HIR, M | 2 |
| MERCIER, A | 3 |
| NEEL, R | 3 |
| COVACEV, L | 1 |
| GREBENNIK, LI | 3 |
| MAKEEVA, OO | 1 |
| PASHCHENKO, NI | 1 |
| HAAPANEN, J | 1 |
| GILL, R | 1 |
| KASS, I | 5 |
| HAWARD, LR | 1 |
| HERTWIG, B | 1 |
| VIRCHOW, C | 3 |
| HERZOG, H | 1 |
| STAUB, H | 1 |
| REBER, H | 1 |
| PFALTZ, R | 1 |
| BURRI, HP | 1 |
| CREUX, G | 1 |
| SCHMID, R | 1 |
| VOUTE, C | 1 |
| DEVADATTA, S | 17 |
| ANDREWS, RH | 6 |
| ANGEL, JH | 6 |
| BHATIA, AL | 7 |
| JANARDHANAM, B | 5 |
| RADHAKRISHNA, S | 21 |
| RAMAKRISHNAN, CV | 21 |
| SUBBAIAH, TV | 5 |
| VELU, S | 16 |
| DORMER, BA | 4 |
| WOOD, MM | 1 |
| ECKLEY, GM | 1 |
| WILSON, JL | 2 |
| OHSATO, T | 1 |
| PECORA, DV | 1 |
| SALIBA, A | 3 |
| BEATTY, OA | 3 |
| PACINI, L | 1 |
| DOWDEN, CW | 1 |
| SALVETTI, F | 1 |
| BILLIA, P | 1 |
| SCHIFFRIN, D | 1 |
| REPETTI, L | 1 |
| UCERO, G | 1 |
| KARLSON, AG | 2 |
| KRASOWSKA, M | 1 |
| MAZUR, G | 1 |
| TORBUS, W | 1 |
| KOCHNOVA, Ie | 1 |
| MIKHAILOVA, GN | 1 |
| LEMENAGER, J | 2 |
| MOREL, C | 1 |
| MAREK, L | 1 |
| THODE, P | 1 |
| EPIFANIO, C | 1 |
| ANASTASIADES, AA | 1 |
| SCHNACK, GA | 1 |
| TITCHE, LL | 1 |
| STEIN, HF | 1 |
| MEETZ, SP | 1 |
| TSUKAMURA, M | 8 |
| TUENNERHOFF, FK | 3 |
| SCHWABE, HK | 10 |
| SOMASUNDARAM, PR | 13 |
| WEISS, W | 2 |
| CHUN, HH | 1 |
| FLIPPIN, HF | 1 |
| YAHNI, E | 1 |
| CETRANGOLO, CA | 1 |
| DEODATO, FP | 1 |
| YASHIRO, A | 1 |
| JIMENEZ, M | 1 |
| MUSCHENHELM, C | 1 |
| ARMSTRONG, AR | 1 |
| PEART, HE | 1 |
| ASEEV, DD | 2 |
| GUR'EVA, IG | 1 |
| BELL, WJ | 3 |
| BROWN, PP | 2 |
| JARNIOU, AP | 2 |
| ISRAEL, L | 3 |
| ENJALBERT, M | 1 |
| FABRE, C | 1 |
| BOWEN, CD | 1 |
| BORINA, MIa | 1 |
| DARRAS, T | 3 |
| DAVID, JD | 1 |
| LEAHY, DJ | 1 |
| MOISAN, F | 1 |
| TURMEL, C | 1 |
| DONOHOE, RF | 3 |
| DUKE, CJ | 1 |
| ROMANSKY, MJ | 1 |
| GREUEL, H | 1 |
| SCHAEFER, EL | 1 |
| GROBLI, CW | 1 |
| LERNER, S | 2 |
| SMALL, MJ | 2 |
| THOMAS, HE | 3 |
| KAPUR, VN | 1 |
| BLAKE, DH | 1 |
| BONSIGNORE, G | 1 |
| DAIROV, D | 1 |
| DEBERTSHAUSER, E | 1 |
| GANGADHARAM, PR | 5 |
| NAIR, CN | 2 |
| GOOSSENS, M | 1 |
| GROUNDS, JG | 3 |
| GUGLIELMETTI, P | 1 |
| RASPI, E | 1 |
| HAGIHARA, K | 1 |
| ITO, N | 1 |
| TAKEUCHI, K | 1 |
| KAJIMA, H | 1 |
| DEGUCHI, T | 1 |
| FETERHOFF, KI | 1 |
| KAISER, JC | 1 |
| HUETTL, C | 1 |
| RAMACHANDRAN, K | 5 |
| SHENOY, MA | 1 |
| SHIMOIDE, H | 3 |
| TOYOHARA, M | 4 |
| GERAGHTY, E | 1 |
| SUGIMOTO, H | 3 |
| MIYAJIMA, T | 1 |
| VIGONI, A | 1 |
| GIACOMUZZI, F | 1 |
| NARAYANA, AS | 6 |
| MOIGNETEAU, C | 3 |
| COTTIN, S | 3 |
| CLOUARD, P | 1 |
| LEPEUPLE, A | 3 |
| THIBIER, R | 3 |
| VIVIEN, JN | 2 |
| AUGUSTI, G | 1 |
| LEVI-VALENSI, P | 1 |
| KESPI, JM | 1 |
| MARCUS, H | 1 |
| YOO, OH | 1 |
| AKYOL, T | 1 |
| WILLIAMS, MH | 2 |
| NAGASAWA, S | 2 |
| OMORI, Y | 1 |
| OSATO, T | 4 |
| KINO, C | 3 |
| PASTOR, MF | 1 |
| HERRERO, JJ | 2 |
| LOPEZ MEDRANO, CM | 1 |
| PATIALA, J | 3 |
| FARIAS, CE | 4 |
| PETTY, TL | 1 |
| MASTROLORENZO, HC | 1 |
| PINES, A | 5 |
| DI CARLO, FC | 1 |
| CAFIRE, N | 1 |
| FERNANDEZ, H | 1 |
| GELLER, BS | 1 |
| SZOCSKA, M | 1 |
| SUKHANOVSKII, VP | 1 |
| SULITSKII, VA | 1 |
| HELGAKER, J | 1 |
| HEYMER, A | 2 |
| HORNUNG, S | 1 |
| POLONCZYK, M | 2 |
| DRAJKA-KROPACZEK, L | 1 |
| RAPF, T | 1 |
| HOTTER, GJ | 1 |
| IIZUKA, Y | 1 |
| ARIGA, H | 1 |
| TEYSSIER, L | 2 |
| KAMEDA, K | 8 |
| PARIENTE, D | 1 |
| PIERON, R | 3 |
| PRETET, S | 6 |
| ROBINSON, E | 1 |
| TERAMATSU, T | 3 |
| REY, JC | 2 |
| DUBRA, FA | 4 |
| RIEBE, J | 1 |
| RUCHELMAN, HH | 1 |
| CHOFNAS, I | 2 |
| FRANZOSI, P | 1 |
| TOKIWA, T | 2 |
| SMIRNOV, GA | 6 |
| TURNER, PP | 1 |
| TUXEN, A | 1 |
| UEMURA, T | 1 |
| VARGA, J | 1 |
| WERNER, E | 9 |
| DROBNY, H | 1 |
| ZIECHE, K | 1 |
| YAD, MI | 1 |
| BOSZORMENYI, M | 7 |
| FAUSZT, I | 3 |
| BARABAS, M | 1 |
| BARAT, I | 2 |
| JAKAB, Z | 1 |
| MAJZIK, G | 1 |
| SCHWEIGER, O | 5 |
| SAGODI, R | 1 |
| BYUN, HW | 1 |
| D'ESOPO, ND | 1 |
| CATTANEO, C | 1 |
| EL-DEWI, T | 1 |
| BONSTEIN, H | 1 |
| LEES, AW | 16 |
| DIMOND, AH | 3 |
| MURRAY, FJ | 4 |
| LIVESAY, VT | 2 |
| KITAMOTO, O | 2 |
| SHIGEMATSU, T | 1 |
| KONDO, K | 2 |
| ITO, M | 6 |
| MUELLER, F | 1 |
| KRULIK, R | 1 |
| KOHOUT, M | 1 |
| PONGOR, F | 1 |
| BERENCSI, G | 2 |
| CHENEBAULT, J | 1 |
| BENNIS, M | 1 |
| BASTAROLI, JC | 1 |
| BUTT, H | 1 |
| SABLJICA, B | 1 |
| RAJCEVIC, V | 1 |
| BOESZOERMENYI, M | 2 |
| KANITZ, E | 1 |
| MAJUMDAR, AC | 2 |
| SEN, R | 2 |
| MATHUR, PD | 2 |
| DELOFF, L | 2 |
| GRZESKOWSKI, J | 2 |
| MICHALIK, M | 2 |
| OKLEK, K | 3 |
| KOCHNOWSKI, G | 1 |
| SAITO, T | 2 |
| SOSNOWSKI, W | 8 |
| LLOYD, J | 2 |
| VERMA, BN | 1 |
| SCHRADI, A | 2 |
| OSVATH, S | 2 |
| GERGELY, I | 2 |
| TANI, P | 3 |
| POPPIUS, H | 1 |
| BASU, SK | 2 |
| MAHASAYA, DR | 1 |
| VISHNEVSKY-VYSNIAUSKAS, C | 1 |
| DOYLE, WM | 1 |
| STUPENENGO, RH | 1 |
| WENDY, CD | 1 |
| LEVENDEL, L | 1 |
| VARADY, T | 1 |
| BEDE, L | 1 |
| KAROLYI, A | 1 |
| SERI, I | 5 |
| ASTERIADOU-SAMARTZE, E | 1 |
| MIKHAILOV, FA | 1 |
| PARFENOVA, IP | 2 |
| TRIGUB, NI | 3 |
| BROIDE, L | 1 |
| ORSI, A | 1 |
| ACCARD, R | 1 |
| TOURAINE, J | 1 |
| SOMI KOVACS, T | 1 |
| NEMETH, T | 1 |
| HORVATH, B | 1 |
| MAROTI, A | 1 |
| WABROSCH, G | 1 |
| KRACT, J | 1 |
| RUHE, AF | 1 |
| OKAWA, H | 1 |
| ITO, T | 1 |
| KAMESAKI, H | 1 |
| SUGIYAMA, I | 1 |
| ICHIOKA, M | 1 |
| GEISLER, F | 1 |
| PFUETZE, KH | 1 |
| PYLE, MM | 3 |
| DISSMANN, E | 3 |
| IGLAUER, E | 1 |
| ZECHNER, E | 1 |
| AOKI, K | 1 |
| YAMAMOTO, T | 1 |
| SZACSURY, J | 1 |
| LOUGHEED, JC | 1 |
| SAPORTA, J | 1 |
| HOLMES, J | 1 |
| ZILBER, LA | 1 |
| BAJDAKOVA, ZL | 1 |
| GARDASJAN, AN | 1 |
| KONOVALOV, NV | 1 |
| BUNINA, TL | 1 |
| BARABADZE, EM | 1 |
| JACOB, CV | 1 |
| HITZE, KL | 1 |
| PASZKOWSKA, A | 2 |
| WAGNER, J | 1 |
| COTTE, J | 1 |
| ROULLET, A | 1 |
| MATSUDA, M | 1 |
| SASA, M | 1 |
| SUGIYAMA, K | 1 |
| MEYER, A | 4 |
| JANCIK, E | 6 |
| TOUSEK, J | 10 |
| MAKOVA, M | 2 |
| ZELENKA, M | 4 |
| DICKINSON, JM | 3 |
| LEFFORD, MJ | 1 |
| MORRIS, D | 1 |
| LETACON, J | 1 |
| MICHETTI, F | 1 |
| LACHINIAN, SR | 1 |
| EVDOKIMOVA, AD | 1 |
| ROZANOVA, MD | 1 |
| KUZMINA, VS | 1 |
| EREMICHEVA, TI | 1 |
| LOPATNIKOVA, IV | 1 |
| TERENTEVA, GM | 1 |
| DUMON, G | 6 |
| TARANGER, JH | 1 |
| DUMON LEGRE, M | 1 |
| URBANCIK, R | 1 |
| TRNKA, L | 5 |
| KRUML, J | 1 |
| POLENSKA, H | 1 |
| NORRIS, FH | 1 |
| GARVEY, PH | 1 |
| SWALBACH, GW | 1 |
| MATERNOWSKA, W | 2 |
| KANTARBAEVA, ZK | 1 |
| BLONSKAIA, LI | 1 |
| KRIVTSOVA, AI | 1 |
| BINSTOCK, A | 1 |
| CETRANGOLO, R | 1 |
| GARCIAVELLOSO, MA | 1 |
| MARCHESE, MJ | 1 |
| BERTORELLO, MC | 1 |
| CARDOZO, E | 1 |
| MASSARO, D | 2 |
| MACHADOFILHO, J | 3 |
| BARUFFI, W | 1 |
| FADEL, JC | 1 |
| KOGA, K | 1 |
| MONTENEGRO, W | 1 |
| CAPALDO, G | 1 |
| ETTORRE, D | 1 |
| GAGLIARDI, L | 1 |
| SILVEIRA, J | 1 |
| MEDEIROS, S | 1 |
| PUECH, P | 1 |
| ABELOOS, D | 1 |
| BARRAT, L | 1 |
| VITOLO, A | 1 |
| LUSZCZEWSKA-TOMASZEWSKA, D | 1 |
| KOLOSOWSKA, J | 1 |
| MERGEL-MADEY, B | 1 |
| MONDESHKI, M | 1 |
| PASHMAKOV, I | 1 |
| DUNCAN, JT | 1 |
| CONN, HO | 1 |
| SINGH, B | 2 |
| SACHS, M | 1 |
| MITCHELL, JH | 1 |
| RUIZ, RC | 1 |
| PROCHAZKA, J | 1 |
| PASSOSJDE, A | 1 |
| RIOSSDA, C | 1 |
| SPROVIERI, JW | 1 |
| PADOVAN, JA | 1 |
| DARZINS, E | 1 |
| PUKITE, A | 1 |
| LOWE, CR | 1 |
| SCHOENE, W | 1 |
| MAYO, P | 1 |
| HAGER-MALECKA, B | 1 |
| GREGER, J | 1 |
| WITKOWSKI, W | 1 |
| SNAJDR, V | 1 |
| KRAKORA, P | 1 |
| FISER, F | 1 |
| CHODOUNSKA, V | 1 |
| STERNLIEB, I | 1 |
| BANCALE, A | 2 |
| ROSSI, P | 1 |
| COHEN, I | 1 |
| RUBIOPALACIOS, H | 1 |
| RODRIGUEZ, J | 1 |
| FREIJEIRO, R | 1 |
| OSORIO, HS | 1 |
| FERNANDEZLIRA, D | 1 |
| RODRIGUEZ, HM | 1 |
| GONZALEZCRUZ, E | 1 |
| SABAR, IR | 1 |
| BAYGIN, R | 1 |
| RAO, KR | 1 |
| RAJAGOPALAN, CR | 1 |
| REDDY, DJ | 1 |
| TODD, RM | 2 |
| ZDUNCZYNK PAWELEK, H | 1 |
| BLITEK GOLC, D | 1 |
| KOSTRZEWSKA, K | 3 |
| RICCHETTI, C | 2 |
| CRISCI, J | 1 |
| LARKIN, JC | 2 |
| HALL, ZM | 1 |
| ZORAB, PA | 1 |
| JEFFERSON, KE | 1 |
| HOBBY, GL | 4 |
| JOHNSON, PM | 4 |
| LENERT, TF | 1 |
| CRAWFORD GALIARDI, L | 1 |
| GREETHAM, L | 1 |
| IVASKA, T | 1 |
| LAPIN, A | 1 |
| MAIER, J | 1 |
| O'MALLEY, P | 1 |
| TREMBLEY, C | 1 |
| TARANGER, J | 5 |
| LAUGIER, J | 2 |
| ACCARD, JL | 1 |
| BERMAN-ROBERT, D | 1 |
| NESTADT, A | 1 |
| HARRISON, I | 1 |
| ZHUKOVA, MP | 1 |
| LAUGERI, S | 1 |
| LAMI, L | 1 |
| MAEDA, M | 1 |
| NAGAISHI, C | 1 |
| NAGASAWA, J | 1 |
| DEENSTRA, H | 1 |
| CORPE, RF | 6 |
| TUSZYNSKA, B | 1 |
| ZAJACZKOWSKA, J | 5 |
| KRAKOWKA, P | 6 |
| JANCZY, S | 3 |
| BURACZEWSKA, M | 6 |
| KORLAKOWSKI, J | 2 |
| ZYCH, D | 4 |
| KRYCHNIAK, W | 4 |
| ZIERSKI, M | 19 |
| BEK, E | 11 |
| SIWINSKA, I | 1 |
| WOZNIAK, S | 1 |
| PALLIES, J | 1 |
| LAUROC, DE | 1 |
| DUBRA, F | 2 |
| EDUARDOGARAY, C | 1 |
| CETRANGOLO, A | 3 |
| CUCCHIANIACEVEDO, RA | 1 |
| FIORINO, A | 1 |
| NIKOLAJUKDEIRURZUN, R | 1 |
| MANDE, R | 2 |
| HERRAULT, A | 1 |
| GOMAA, TM | 1 |
| REICHEL, G | 1 |
| ZIESCHE, K | 1 |
| WALCZAK, H | 1 |
| IARKHO, MI | 1 |
| DONADIO, V | 1 |
| CIRILLO, R | 1 |
| LAUSTELA, EV | 1 |
| KYLLOENEN, KE | 1 |
| SZUNGYI, Z | 1 |
| PENKOVSKAJA, A | 1 |
| DEBENEST, P | 1 |
| MIRZOIAN, EZ | 1 |
| LAMPE, WT | 1 |
| CANDAU, MG | 1 |
| CHARCOSSET, F | 1 |
| GABRIEL, MT | 1 |
| WAARDENBURG, HA | 1 |
| JOHNSTON, RN | 1 |
| SMITH, DH | 1 |
| RITCHIE, RT | 1 |
| LOCKHART, W | 1 |
| VILDERMAN, AM | 2 |
| EVGRAFOVA, ZA | 1 |
| REZNIK, SE | 2 |
| FINN, ER | 1 |
| AKOPIAN, IM | 1 |
| SIMEONOV, MN | 1 |
| ZVANTSEVA, VA | 1 |
| IZVEKOV, AT | 1 |
| LAMY, R | 1 |
| MENEGAZZO, C | 1 |
| MAGNITSKII, VA | 1 |
| LAVRENTEVA, LL | 1 |
| OTTO, H | 1 |
| HUETTL, T | 1 |
| LANYI, M | 2 |
| KADAR, A | 1 |
| NINNI, A | 3 |
| MARCATILI, S | 1 |
| YAMAMURA, Y | 1 |
| HUTCHIN, P | 1 |
| LINDSKOG, GE | 1 |
| NAKAMURA, RM | 1 |
| KANAI, K | 2 |
| MUROHASHI, T | 1 |
| ACEVEDO, RC | 1 |
| PILHEU, J | 2 |
| RODRIGUEZ, E | 1 |
| CASTELLARIERA, J | 1 |
| GRANENAFUGUET, P | 1 |
| COLLCOLOME, F | 1 |
| MONTEROJARAMILLO, SC | 1 |
| KILLEN, DA | 1 |
| FOSTER, JH | 1 |
| RHEA, WG | 1 |
| MCCRACKEN, RC | 1 |
| DIVELEY, WL | 1 |
| HUBBARD, WW | 1 |
| GUILFOIL, PH | 1 |
| LORIAN, V | 2 |
| ZANON, U | 1 |
| NAGRATH, SP | 1 |
| SANTOS, JC | 1 |
| GRUMBACH, F | 5 |
| DAWSON, JJ | 3 |
| KULKARNI, KG | 2 |
| MOHAN, K | 1 |
| VILARDO, S | 1 |
| JENSEN, KA | 1 |
| KLAER, I | 1 |
| ZORZOLI, P | 1 |
| COZAN, R | 2 |
| REY, J | 1 |
| JIMENEZHERRERO, J | 1 |
| LESTON, JM | 3 |
| GONZALEZMONTANER, LJ | 1 |
| SARTORIS, L | 1 |
| CUNARRODEGIMENO, G | 1 |
| TSUI, HP | 1 |
| TUNG, C | 1 |
| CHEN, TM | 1 |
| CHANG, KS | 1 |
| LI, TS | 1 |
| MORIYAMA, E | 1 |
| NOZAKI, T | 1 |
| GAVRILENKO, VS | 5 |
| REPNITSKAIA, ZD | 4 |
| MELKUMOV, GA | 1 |
| KHAIKIN, AIa | 1 |
| OKREMA, VIa | 1 |
| SORKIN, Ie | 1 |
| CIMINO, A | 1 |
| MATHUR, JB | 2 |
| KHANNA, BK | 2 |
| THOMAS, CP | 1 |
| LAPERUTA, AM | 1 |
| EQUIOIZ, LP | 1 |
| SILVA, GA | 1 |
| GARBULSKY, R | 1 |
| BERTOGLIO, O | 1 |
| DIFRANCO, G | 1 |
| GRIGORIAN, VG | 2 |
| ZEMSKOVA, ZS | 3 |
| LECNAIA, AA | 1 |
| FRANCIS, RS | 2 |
| CURWEN, MP | 1 |
| ANKIEWICZ, J | 1 |
| ZAJAC, J | 1 |
| KRAAN, JK | 3 |
| AMADIO, G | 2 |
| CAFURE, N | 1 |
| KATONA, L | 1 |
| LAKITS, E | 1 |
| PALOS, F | 1 |
| MUNROE, WD | 1 |
| LAWSON, WJ | 1 |
| HOLCOMB, TH | 1 |
| BARASZ, Z | 1 |
| UNGAR, I | 1 |
| VINCZE, E | 1 |
| PAPP, A | 1 |
| ILLES, I | 1 |
| VIZER, K | 1 |
| VAMOS, G | 1 |
| ASPINALL, DL | 1 |
| COMENALE, D | 1 |
| ROSSI, F | 1 |
| COMENALEPINTO, D | 1 |
| MATTEI, AF | 1 |
| KOSMALA, U | 1 |
| DUDEK, Z | 1 |
| KNAPIKOWA, D | 1 |
| KAZAK, TI | 2 |
| KRZHIVITSKAIA, VP | 1 |
| NAZAROVA, IB | 2 |
| KULIK, NM | 4 |
| STRUTINSKII, MI | 1 |
| KERTSELLI, IuS | 2 |
| LISITSINA, LP | 1 |
| LEHIR, M | 1 |
| SAEED, AH | 1 |
| IAROSLAVSKII, VE | 1 |
| BLALOCK, FA | 4 |
| CAFIERO, F | 1 |
| KAWAGUCHI, M | 1 |
| AOJI, I | 1 |
| KINUGASA, S | 1 |
| SANO, Y | 1 |
| ROSA, E | 1 |
| GREENBERG, HB | 6 |
| SIMPSON, DG | 2 |
| MCCLEMENT, JH | 1 |
| SUN, TN | 1 |
| TENG, WW | 1 |
| YUE, CJ | 1 |
| LARSON, CL | 1 |
| WICHT, WC | 1 |
| SERGEEV, IS | 1 |
| LAPTEVA, NV | 1 |
| SELLERS, RD | 1 |
| SCOTT, WR | 1 |
| ROOT, HD | 1 |
| PERRY, JF | 1 |
| LEDWITH, JW | 1 |
| STARR, S | 1 |
| BERKOVICH, S | 1 |
| VULLIEMOZ, P | 4 |
| MOODIE, AS | 3 |
| FOORD, RD | 1 |
| GIUNIO, N | 1 |
| DEVI, PK | 1 |
| MUJUMDAR, SS | 1 |
| MOKADAM, NG | 1 |
| MENON, CR | 2 |
| GAWAI, TB | 1 |
| ANGAWA, JO | 1 |
| GROSS, JH | 1 |
| GOLDHAMMER, EJ | 1 |
| RAUNIO, O | 1 |
| ELO, O | 1 |
| SMITH, AE | 1 |
| ASPEVIK, E | 1 |
| EVENSTAD, E | 1 |
| HAUKENES, G | 1 |
| LOCKS, MO | 2 |
| GOODMAN, SB | 1 |
| BLOCK, MH | 1 |
| SUNDBERG, T | 1 |
| LARGE, SE | 2 |
| PUCHKOV, VV | 1 |
| CHERNITSKII, GI | 1 |
| KORNIENKO, VT | 1 |
| VERWILGHEN, R | 1 |
| REYBROUCK, G | 1 |
| CALLENS, L | 1 |
| COSEMANS, J | 3 |
| CURCI, G | 1 |
| MAURO, G | 1 |
| HATTON, F | 1 |
| PERDRIZET, S | 4 |
| ROUILLON, A | 1 |
| MATHUR, KS | 1 |
| MATHUR, JS | 1 |
| SAPRU, RP | 1 |
| BONDAREV, IM | 23 |
| MEDINA, G | 1 |
| CHAPMAN, PT | 2 |
| BOLAR, SS | 1 |
| NESET, G | 1 |
| VERGARAOLIVAS, A | 1 |
| ALIMOV, CA | 1 |
| LAUCKNER, JR | 1 |
| BALL, JD | 1 |
| JARRY, JJ | 1 |
| BALGAIRIES, E | 1 |
| SCHMELEV, NA | 1 |
| BARTMANN, K | 3 |
| CHIBA, Y | 1 |
| TAKAHARA, T | 1 |
| CLAICIU, I | 2 |
| DEVOE, AG | 1 |
| LOCATCHER-KHORAZO, D | 1 |
| PURTSKHVENIDZE, ChG | 1 |
| AMSON, KM | 1 |
| DVOIRIN, MS | 1 |
| SCHLESS, JM | 1 |
| ALLISON, RF | 1 |
| INGLIS, RM | 1 |
| WHITE, EF | 1 |
| TOPPERMAN, S | 1 |
| DECOR, Y | 1 |
| ROE, FJ | 1 |
| BOYLAND, E | 1 |
| HADDOW, A | 1 |
| BROUILLET-GABRIEL, MT | 3 |
| MESDJIAN, E | 1 |
| MENON, NK | 12 |
| HANN, ES | 1 |
| CORNEA, P | 3 |
| HAMNER, JE | 1 |
| BELOGUROVA, VP | 5 |
| SUSLOVA, AL | 1 |
| OLEJNICEK, M | 1 |
| WEBEROVA, M | 1 |
| NOVAK, M | 3 |
| MAJUMDAR, SS | 1 |
| KARKARE, GS | 1 |
| CHEUNG, OT | 2 |
| BEYER, A | 1 |
| WEIDMANN, R | 1 |
| SUTTON, PH | 1 |
| BEATTIE, PH | 1 |
| SANCHEZ PEREZ, F | 1 |
| MEYER, L | 1 |
| DURAND, M | 1 |
| LEFEVRE, JP | 1 |
| MORELEC, R | 1 |
| LEJOUBIOUX, E | 1 |
| JULLIEN, JL | 1 |
| CHANAS, P | 1 |
| GRACE, EJ | 1 |
| CALOV, WL | 1 |
| JOHNSTON, GA | 1 |
| RITCHIE, FL | 1 |
| WHYTE, HM | 1 |
| SIFONTES, JE | 1 |
| DIAZ DE GARAU, P | 1 |
| VICENS, CN | 1 |
| ACOSTA, R | 1 |
| LINDGREN, G | 1 |
| UNGER, H | 1 |
| BUNGER, P | 1 |
| LASS, A | 2 |
| SCHWADERER, A | 1 |
| SZATHMARY, M | 1 |
| REHBERG, W | 1 |
| REISNER, D | 2 |
| JANSSEN, G | 1 |
| VASILEV, VN | 1 |
| TRICHEREAU, R | 1 |
| GEFFRIAUD, M | 1 |
| ROBIN, C | 1 |
| NURIT, Y | 1 |
| BOURGEOIS, J | 1 |
| SHER, BC | 1 |
| LOPEZ-BELIO, M | 1 |
| TAKIMURA, Y | 1 |
| AMORATI, A | 1 |
| GALLETTI, F | 1 |
| GELLI, G | 1 |
| LOLI-PICCOLOMINI, M | 1 |
| ROVERSI, L | 1 |
| TEPE, HJ | 1 |
| WUNDERLICH, K | 1 |
| FERABOLI, M | 1 |
| SUTHERLAND, I | 1 |
| MIYAMOTO, T | 2 |
| WITTENSTEIN, GJ | 2 |
| IWAINSKY, H | 8 |
| KAUFFMANN, GW | 1 |
| SIEGEL, D | 1 |
| GERISCHER, C | 1 |
| KENDIG, EL | 6 |
| HUDGENS, RO | 1 |
| KIRCHHOFF, HW | 1 |
| KIRCHNER, JJ | 1 |
| LEE, HK | 3 |
| NATHAN, A | 1 |
| PECYNA, J | 1 |
| CISZEK, J | 1 |
| KULEJEWSKA, M | 1 |
| LACHOWICZ, D | 1 |
| ROWINSKA, E | 1 |
| PEPYS, J | 1 |
| KINSLEY, BJ | 1 |
| PRUS, F | 2 |
| ROMEO, G | 1 |
| SCHLOSS, J | 1 |
| ISMAIL, Z | 1 |
| SCHWARTZ, I | 1 |
| SEGARRA, FO | 2 |
| SHERMAN, DS | 2 |
| SHEEHY, TF | 1 |
| FERGUS, EM | 1 |
| LEE, JR | 1 |
| SILANOS, G | 1 |
| SIMPSON, JM | 1 |
| ASHIZAWA, H | 1 |
| HYDE, L | 3 |
| JUVARA, I | 1 |
| SIMIONESCU, N | 1 |
| REDULESCU, D | 1 |
| KASZA, L | 1 |
| KOBAYASHI, H | 2 |
| KAWADA, Y | 1 |
| TERAMURA, F | 1 |
| KOHN, R | 1 |
| HEILMEYER, L | 1 |
| CLOTTEN, R | 1 |
| LORBER, J | 1 |
| MAEKAWA, N | 2 |
| HAMADA, K | 1 |
| KAWAI, M | 1 |
| NAKAI, J | 1 |
| KUSUNODA, F | 1 |
| MORI, K | 1 |
| MATHEY, J | 1 |
| LORO MARCHESE, JH | 1 |
| NIKITOVA, AN | 1 |
| OATWAY, WH | 1 |
| OFUJI, M | 1 |
| NAKAYA, T | 1 |
| AIDANI, K | 1 |
| WALLACE, JG | 1 |
| RAJENDRAN, K | 1 |
| JACOB, PG | 1 |
| ROBSON, JM | 1 |
| SMITH, JT | 1 |
| RODRIGUES, F | 2 |
| ROMEO, V | 1 |
| STAFFIERI, P | 1 |
| SAHEKI, T | 1 |
| ARAI, K | 1 |
| ASAKURA, H | 1 |
| NOZOE, N | 1 |
| Yotsumoto, H | 3 |
| Yonemaru, M | 1 |
| Suzuki, K | 3 |
| Kawabe, Y | 3 |
| Sasaki, Y | 3 |
| Toyoda, E | 1 |
| Kudoh, K | 1 |
| Kurasawa, T | 1 |
| Kawashiro, T | 2 |
| Sakatani, M | 3 |
| Mori, M | 4 |
| van Doorn, HR | 1 |
| Claas, EC | 1 |
| Templeton, KE | 1 |
| van der Zanden, AG | 1 |
| te Koppele Vije, A | 1 |
| de Jong, MD | 1 |
| Dankert, J | 1 |
| Kuijper, EJ | 1 |
| Pedral-Sampaio, DB | 2 |
| Netto, EM | 2 |
| Brites, C | 2 |
| Bandeira, AC | 1 |
| Guerra, C | 1 |
| Barberin, MG | 1 |
| Badaró, R | 2 |
| Spielmann, MP | 1 |
| Gomani, P | 1 |
| Bakali, E | 1 |
| Humblet, P | 1 |
| Nyirenda, TE | 1 |
| Kemp, JR | 1 |
| Squire, BS | 1 |
| Salaniponi, FM | 5 |
| White, MC | 4 |
| Duong, TM | 1 |
| Cruz, ES | 1 |
| Rodas, A | 1 |
| McCall, C | 1 |
| Menéndez, E | 2 |
| Carmody, ER | 1 |
| Tulsky, JP | 3 |
| Chintu, C | 2 |
| Mwaba, P | 2 |
| Talbot, EA | 2 |
| Hone, NM | 1 |
| Moalosi, G | 1 |
| Moffat, HJ | 2 |
| Saito, W | 1 |
| Nagayama, N | 2 |
| Miyamoto, M | 1 |
| Hara, H | 1 |
| Suzuki, J | 1 |
| Masuda, K | 2 |
| Baba, M | 2 |
| Tamura, A | 2 |
| Nagai, H | 3 |
| Akagawa, S | 2 |
| Machida, K | 2 |
| Kurashima, A | 3 |
| Gordillo, S | 1 |
| Amat, I | 1 |
| Díaz, J | 1 |
| Lonca, J | 1 |
| Pallarés, A | 1 |
| Llatjós, R | 1 |
| Ariza, A | 1 |
| Ausina, V | 2 |
| Bochar, K | 1 |
| Chomyc, S | 1 |
| Talbot, J | 1 |
| Tilley, P | 1 |
| Sheff, B | 1 |
| Uzum, K | 1 |
| Karahan, OI | 1 |
| Dogan, S | 1 |
| Coşkun, A | 1 |
| Topcu, F | 1 |
| Shishido, Y | 1 |
| Komatsu, H | 2 |
| Hearn, MJ | 1 |
| Cynamon, MH | 4 |
| Berg, J | 1 |
| Blumberg, EJ | 1 |
| Sipan, CL | 1 |
| Friedman, LS | 1 |
| Kelley, NJ | 1 |
| Vera, AY | 1 |
| Hofstetter, CR | 1 |
| Hovell, MF | 1 |
| Jouneau, S | 1 |
| Volatron, AC | 1 |
| Brinchault, G | 1 |
| Morel, V | 1 |
| Belleguic, C | 1 |
| Delaval, P | 1 |
| Naudziūnas, A | 1 |
| Jacunskiene, L | 1 |
| Tarūta, A | 1 |
| ROBITZEK, EH | 1 |
| SELIKOFF, IJ | 1 |
| PAYNE, RF | 2 |
| SPROVIERI, L | 1 |
| GEMMI, M | 1 |
| SARTI, A | 1 |
| CINAGLIA, S | 1 |
| GUIDERI, R | 1 |
| BONELLI, M | 1 |
| GUNELLA, P | 1 |
| MAZZETTA, A | 1 |
| VIALE, L | 1 |
| GIOBBI, A | 2 |
| GHIONE, M | 1 |
| LUPI, C | 1 |
| ROSSI, B | 1 |
| FEGIZ, G | 1 |
| TØRNING, K | 1 |
| HAARHØJ, J | 1 |
| Bock, N | 1 |
| Burman, WJ | 2 |
| Zhao, Z | 1 |
| Hayden, K | 1 |
| Woldehanna, S | 1 |
| Pletz, MW | 1 |
| De Roux, A | 1 |
| Roth, A | 1 |
| Neumann, KH | 1 |
| Mauch, H | 1 |
| Lode, H | 3 |
| Choudhary, J | 1 |
| Mubarik, M | 1 |
| Parvez, A | 1 |
| Naikoo, MA | 1 |
| Norkina, OV | 1 |
| Filipenko, ML | 1 |
| Nikonova, AA | 1 |
| Kinsht, VN | 1 |
| Kurunov, IuN | 3 |
| Krasnov, VA | 4 |
| Tat'kov, SI | 1 |
| Teo, DT | 1 |
| Lim, TW | 1 |
| Ruiz, M | 1 |
| Torres, MJ | 2 |
| Llanos, AC | 1 |
| Arroyo, A | 1 |
| Palomares, JC | 2 |
| Aznar, J | 2 |
| Pandey, R | 1 |
| Santha, T | 7 |
| Rehman, F | 1 |
| Sarma, GR | 4 |
| Reetha, AM | 1 |
| Prabhaker, R | 1 |
| Zhao, JR | 2 |
| Luo, M | 2 |
| Zhang, ZX | 1 |
| Bai, YJ | 2 |
| Yan, XJ | 2 |
| Victor, T | 1 |
| Wiid, I | 1 |
| Tariq, SM | 1 |
| Tariq, S | 1 |
| Makarov, OV | 1 |
| Kaiukova, SI | 1 |
| Chernousova, LN | 2 |
| Slastnikova, EB | 1 |
| Chee, CB | 1 |
| Teleman, MD | 1 |
| Boudville, IC | 1 |
| Do, SE | 1 |
| Wang, YT | 2 |
| Visser, ME | 1 |
| Texeira-Swiegelaar, C | 1 |
| Gausi, F | 2 |
| Zheng, XM | 1 |
| Li, SM | 1 |
| Xing, BC | 1 |
| Stout, JE | 1 |
| Gordin, FM | 2 |
| Sbarbaro, JA | 14 |
| Coly, A | 1 |
| Morisky, D | 1 |
| Levesque, JF | 1 |
| Dongier, P | 1 |
| Brassard, P | 3 |
| Allard, R | 1 |
| Moulding, TS | 3 |
| Le, HQ | 1 |
| Rikleen, D | 1 |
| Davidson, P | 1 |
| Story, RE | 1 |
| Ditto, AM | 1 |
| Simcock, DE | 1 |
| Mukherjee, D | 1 |
| Gendi, NS | 1 |
| Yang, BF | 1 |
| Jiang, WL | 1 |
| Zhou, PY | 1 |
| Jiang, QW | 1 |
| Arai, S | 1 |
| Goldenson, J | 1 |
| Kawamura, LM | 1 |
| Panteleev, AM | 1 |
| Ivanov, AK | 1 |
| Vinogradova, EN | 1 |
| Karachunskiĭ, MA | 6 |
| Uvarova, TE | 1 |
| Ursov, IG | 8 |
| Khodashova, ML | 1 |
| Iuditskiĭ, MV | 1 |
| Yepes, JF | 1 |
| Sullivan, J | 1 |
| Pinto, A | 1 |
| Nishizawa, Y | 1 |
| Yasui, M | 1 |
| Yamamori, C | 1 |
| Tagami, A | 1 |
| Fujimura, M | 1 |
| Nakao, S | 1 |
| Belianin, II | 3 |
| Shmelev, EI | 3 |
| Tanvetyanon, T | 1 |
| Ratanatharathorn, V | 1 |
| Leopairat, J | 1 |
| Nikolayevsky, V | 1 |
| Balabanova, Y | 1 |
| Ruddy, M | 1 |
| Fedorin, I | 1 |
| Alves, CR | 1 |
| Oliveira, AS | 1 |
| Jasmer, RM | 2 |
| Schwartzman, K | 2 |
| Cave, MD | 3 |
| Saukkonen, JJ | 1 |
| Wojtyczka, RD | 1 |
| Dworniczak, S | 1 |
| Pacha, J | 1 |
| Idzik, D | 1 |
| Kepa, M | 1 |
| Wydmuch, Z | 1 |
| Głab, S | 1 |
| Bajorek, M | 1 |
| Kozielski, J | 1 |
| Seung, KJ | 1 |
| Gelmanova, IE | 1 |
| Peremitin, GG | 1 |
| Golubchikova, VT | 1 |
| Pavlova, VE | 1 |
| Sirotkina, OB | 1 |
| Yanova, GV | 1 |
| Werely, C | 1 |
| Zodtke, F | 1 |
| Fleisch, F | 1 |
| Brunner, H | 1 |
| Reinhart, WH | 1 |
| Kuhn, M | 1 |
| Negi, SS | 1 |
| Gupta, S | 1 |
| Lal, S | 3 |
| Dhingra, VK | 1 |
| Rajpal, S | 1 |
| Yadav, A | 1 |
| Jain, SK | 2 |
| Lambert, ML | 1 |
| Delgado, R | 1 |
| Michaux, G | 1 |
| Volz, A | 1 |
| Jutte, PC | 1 |
| Rutgers, SR | 1 |
| Uges, DR | 1 |
| Van Horn, JR | 1 |
| Vanacore, P | 2 |
| Koehler, B | 1 |
| Carbonara, S | 1 |
| Zacchini, F | 1 |
| Bassetti, D | 1 |
| Antonucci, G | 2 |
| Ippolito, G | 2 |
| Girardi, E | 2 |
| Herrera-León, L | 1 |
| Molina, T | 1 |
| Saíz, P | 1 |
| Sáez-Nieto, JA | 1 |
| Jiménez, MS | 1 |
| Perel'man, MI | 1 |
| Cokolova, GB | 1 |
| Mozhokina, GN | 1 |
| Lazareva, IaV | 2 |
| Strekchev, AIu | 1 |
| Nakanishi, N | 1 |
| Moritaka, T | 1 |
| Ueda, N | 1 |
| Inoue, T | 1 |
| Tanaka, E | 2 |
| Sakuramoto, M | 1 |
| Maeda, Y | 1 |
| Maniwa, K | 1 |
| Taguchi, Y | 1 |
| Conaty, SJ | 1 |
| Hayward, AC | 2 |
| Watson, JM | 2 |
| Holmes, A | 2 |
| Ziganshina, L | 2 |
| Martínez Sanchís, A | 1 |
| Calpe Calpe, JL | 1 |
| Llavador Ros, G | 1 |
| Ena Muñoz, J | 1 |
| Calpe Armero, A | 1 |
| Farah, MG | 1 |
| Tverdal, A | 1 |
| Steen, TW | 1 |
| Heldal, E | 1 |
| Brantsaeter, AB | 1 |
| Bjune, G | 2 |
| Dam, T | 1 |
| Isa, M | 1 |
| Bose, M | 1 |
| Chernykh, NA | 2 |
| Kaminskaia, GO | 3 |
| Kossiĭ, IuE | 2 |
| Ubaĭdullaev, AM | 2 |
| Belotserkovets, VG | 1 |
| Zhang, QH | 1 |
| Coban, AY | 2 |
| Bilgin, K | 2 |
| Uzun, M | 2 |
| Tasdelen Fisgin, N | 1 |
| Akgunes, A | 2 |
| Cihan, CC | 1 |
| Birinci, A | 1 |
| Durupinar, B | 2 |
| Ige, OM | 2 |
| Sogaolu, OM | 1 |
| Odaibo, GN | 1 |
| Olaleye, OD | 1 |
| Kasahara, K | 1 |
| Fukuoka, A | 1 |
| Murakawa, K | 1 |
| Okamura, H | 1 |
| Mikasa, K | 1 |
| Narita, N | 1 |
| Kimura, H | 1 |
| Vlachaki, E | 1 |
| Psathakis, K | 1 |
| Tsintiris, K | 1 |
| Iliopoulos, A | 1 |
| Kulkarni, S | 1 |
| Sola, C | 1 |
| Filliol, I | 1 |
| Kadival, G | 1 |
| Aguilar, R | 1 |
| Garay, J | 1 |
| Villatoro, M | 1 |
| Ramirez, M | 1 |
| Villatoro, F | 1 |
| Abarca, H | 1 |
| Hesseling, PB | 1 |
| Tasduq, SA | 1 |
| Kaisar, P | 1 |
| Gupta, DK | 1 |
| Kapahi, BK | 1 |
| Maheshwari, HS | 1 |
| Jyotsna, S | 1 |
| Johri, RK | 1 |
| Ormerod, LP | 4 |
| Jenkins, C | 1 |
| Raghavan, A | 1 |
| Duraipandian, M | 1 |
| Kripasankar, AS | 1 |
| Ramachandran, P | 2 |
| Chambers, HF | 1 |
| Turner, J | 1 |
| Schecter, GF | 3 |
| Kawamura, M | 1 |
| Agerton, TB | 1 |
| Hopewell, P | 1 |
| Lockman, S | 1 |
| Oyewo, A | 1 |
| Priakhina, VN | 1 |
| Kolpakov, MA | 2 |
| Kolpakov, AR | 1 |
| Zyrianova, TV | 2 |
| Mokhina, OG | 1 |
| Shiraishi, Y | 1 |
| Chirazi, MS | 1 |
| Kwon, OJ | 3 |
| Park, YK | 2 |
| Lew, WJ | 1 |
| Bai, GH | 2 |
| Chen, B | 1 |
| Li, JH | 1 |
| Xu, YM | 1 |
| Cao, XM | 1 |
| Zheng, DY | 1 |
| Zhou, R | 1 |
| He, HJ | 1 |
| Gu, XR | 1 |
| Skotnikova, OI | 1 |
| Galkina, KIu | 1 |
| Nosova, EIu | 1 |
| Krasnova, MA | 1 |
| Moroz, AM | 2 |
| Mehiri, BR | 1 |
| Zouaoui, A | 1 |
| Chérif, J | 1 |
| Ourari, B | 1 |
| Daghfous, R | 1 |
| Oueslati, MH | 1 |
| Louzir, B | 2 |
| Daghfous, J | 2 |
| Chelbi, B | 1 |
| Béji, M | 2 |
| Uiso, L | 1 |
| Shimizu, Y | 1 |
| Dobashi, K | 1 |
| Mita, Y | 1 |
| Endou, K | 1 |
| Moriya, S | 1 |
| Osano, K | 1 |
| Koike, Y | 1 |
| Higuchi, S | 1 |
| Yabe, S | 1 |
| Utsugi, M | 1 |
| Ishizuka, T | 1 |
| Hisada, T | 1 |
| Nakazawa, T | 1 |
| Ozturk, CE | 1 |
| Sanic, A | 1 |
| Kaya, D | 1 |
| Ceyhan, I | 1 |
| Currie, GP | 1 |
| Emmanuel, FX | 1 |
| Ford, D | 1 |
| Devereux, G | 1 |
| Makanjuola, OO | 1 |
| van Zyl, S | 2 |
| Quy, HT | 2 |
| Cobelens, FG | 1 |
| Lan, NT | 2 |
| Buu, TN | 1 |
| Lambregts, CS | 1 |
| Borgdorff, MW | 2 |
| Thomas, A | 1 |
| Selvakumar, N | 2 |
| Gopi, PG | 1 |
| Subramani, R | 1 |
| Rajeswari, R | 1 |
| Rani, B | 1 |
| Paramasivan, CN | 6 |
| Perumal, M | 1 |
| Narayanan, PR | 2 |
| Schechter, M | 1 |
| Zajdenverg, R | 1 |
| Falco, G | 1 |
| Faulhaber, JC | 1 |
| Coberly, JS | 2 |
| Moore, RD | 1 |
| Khudushina, TA | 1 |
| Voloshina, EP | 1 |
| Adamovich, NV | 1 |
| Maslakova, MG | 1 |
| Terekhova, ND | 1 |
| Pakhieva, KhIu | 1 |
| Balashova, NA | 1 |
| Krüüner, A | 2 |
| Yates, MD | 1 |
| Lavigne, M | 1 |
| Steensma, C | 1 |
| Pitche, P | 1 |
| Mouzou, T | 1 |
| Padonou, C | 1 |
| Tchangai-Walla, K | 1 |
| Vernon, AA | 1 |
| Day, JH | 1 |
| Freier, G | 1 |
| Wright, A | 2 |
| Nelson, G | 1 |
| Brenner, E | 1 |
| Mase, S | 1 |
| Tasker, S | 1 |
| Matthews, KL | 1 |
| Bohnker, BK | 1 |
| Cekic Cihan, C | 1 |
| Cetinkaya, E | 1 |
| van Aardt, M | 1 |
| Stepashina, VN | 1 |
| Ivanov, IIu | 1 |
| Lipin, MIu | 1 |
| Shemiakin, IG | 1 |
| Vuilleumier, N | 1 |
| Rossier, MF | 1 |
| Chiappe, A | 1 |
| Degoumois, F | 1 |
| Dayer, P | 1 |
| Mermillod, B | 1 |
| Nicod, L | 1 |
| Desmeules, J | 1 |
| Hochstrasser, D | 1 |
| Szakacs, TA | 1 |
| Clark, M | 1 |
| Kocheleff, P | 1 |
| Muller, FJ | 1 |
| McCarthy, AE | 1 |
| Shrestha, RK | 1 |
| Mugisha, B | 1 |
| Bunnell, R | 1 |
| Mermin, J | 1 |
| Hitimana-Lukanika, C | 1 |
| Odeke, R | 1 |
| Madra, P | 1 |
| Adatu, F | 1 |
| Blandford, JM | 1 |
| Porco, TC | 1 |
| Lewis, B | 1 |
| Marseille, E | 1 |
| Grinsdale, J | 1 |
| Royce, SE | 1 |
| Steichen, O | 1 |
| Martinez-Almoyna, L | 1 |
| De Broucker, T | 1 |
| Yu, WC | 1 |
| Lai, ST | 1 |
| Chiu, MC | 1 |
| Chau, TN | 1 |
| Ng, TK | 1 |
| Chanwong, S | 1 |
| Maneekarn, N | 1 |
| Makonkawkeyoon, L | 1 |
| Makonkawkeyoon, S | 1 |
| Tang, WW | 1 |
| Lai, JS | 1 |
| Tham, CC | 1 |
| Chan, KK | 2 |
| Chan, KS | 1 |
| Williams, KN | 1 |
| Yagui, M | 1 |
| Perales, MT | 1 |
| Asencios, L | 1 |
| Vergara, L | 1 |
| Suarez, C | 1 |
| Yale, G | 1 |
| Salazar, C | 1 |
| Saavedra, M | 1 |
| Shin, S | 1 |
| Ferrousier, O | 1 |
| Cegielski, P | 1 |
| Moniruzzaman, A | 1 |
| Schulzer, M | 1 |
| Jacquet, V | 1 |
| Morose, W | 1 |
| Barr, G | 1 |
| Grimard, F | 1 |
| Isaacs, D | 1 |
| Jones, CA | 1 |
| Dalton, D | 1 |
| Cripps, T | 1 |
| Vidler, L | 1 |
| Rochefort, M | 1 |
| Bide, E | 1 |
| Banner, P | 1 |
| Crawford, H | 1 |
| Babu, RB | 1 |
| Sudharshan, S | 1 |
| Kumarasamy, N | 1 |
| Therese, L | 1 |
| Biswas, J | 1 |
| Brindle, R | 2 |
| Aarons, LJ | 1 |
| Morrow, LE | 1 |
| Wear, RE | 1 |
| Schuller, D | 1 |
| Malesker, M | 1 |
| Kuz'min, AV | 1 |
| Vasil'eva, IA | 2 |
| Golyshevskaia, VI | 7 |
| Selishcheva, AA | 1 |
| Martynova, LP | 3 |
| Lepekha, LN | 1 |
| Kalashnikova, TM | 1 |
| Kornilova, ZKh | 2 |
| Erokhin, VV | 2 |
| Rozenberg, OA | 1 |
| El-Sayed Zaki, M | 1 |
| Goda, T | 1 |
| Sichletidis, L | 1 |
| Settas, L | 1 |
| Spyratos, D | 1 |
| Chloros, D | 1 |
| Patakas, D | 1 |
| Lwin, T | 1 |
| Mar, TT | 1 |
| Maung, W | 1 |
| Noe, P | 1 |
| Kluge, HH | 1 |
| Aziz, MA | 1 |
| Alavez-Ramírez, J | 1 |
| Castellanos, JR | 1 |
| Esteva, L | 1 |
| Flores, JA | 1 |
| Fuentes-Allen, JL | 1 |
| García-Ramos, G | 1 |
| Gómez, G | 1 |
| López-Estrada, J | 1 |
| Strauss, S | 1 |
| Karpakis, J | 1 |
| Hussey, G | 1 |
| Rabie, H | 1 |
| Lysov, AV | 1 |
| Mordyk, AV | 1 |
| Zatvornitskiĭ, VA | 1 |
| Kondria, AV | 1 |
| Aung, KJ | 1 |
| Hamid Salim, MA | 1 |
| Ali, MA | 2 |
| Naha, MS | 1 |
| Das, PK | 1 |
| Declercq, E | 1 |
| Panickar, JR | 1 |
| Hoskyns, W | 1 |
| Pospelov, LE | 1 |
| Isaev, AA | 1 |
| Bocharova, IV | 1 |
| Avdienko, VG | 1 |
| Babaian, SS | 1 |
| Pospelov, AL | 1 |
| Guseva, AN | 1 |
| Gergert, VIa | 2 |
| Ashkin, D | 1 |
| Julien, J | 1 |
| Lauzardo, M | 1 |
| Hollender, E | 1 |
| Lardizabal, A | 1 |
| Passannante, M | 1 |
| Kojakali, F | 1 |
| Hayden, C | 1 |
| Reichman, LB | 8 |
| Poojary, A | 1 |
| Nataraj, G | 1 |
| Kanade, S | 1 |
| Mehta, P | 1 |
| Baveja, S | 1 |
| Bandason, T | 1 |
| Cheung, YB | 1 |
| Munyati, S | 1 |
| Hayes, R | 3 |
| Butterworth, A | 1 |
| Mason, P | 1 |
| Frieden, TR | 3 |
| Wong, HY | 1 |
| Chau, CH | 1 |
| Umubyeyi, AN | 1 |
| Vandebriel, G | 1 |
| Gasana, M | 1 |
| Basinga, P | 1 |
| Zawadi, JP | 1 |
| Gatabazi, J | 1 |
| Pauwels, P | 1 |
| Nzabintwali, F | 1 |
| Nyiramasarabwe, L | 1 |
| Fissette, K | 2 |
| Struelens, MJ | 1 |
| Portaels, F | 5 |
| Khan, M | 1 |
| Jaber, AA | 1 |
| Taniguchi, H | 2 |
| Izumi, S | 1 |
| Khalilzadeh, S | 1 |
| Boloorsaz, MR | 1 |
| Safavi, A | 1 |
| Messouak, O | 1 |
| Amara, B | 1 |
| Benjelloun, FZ | 1 |
| Tizniti, S | 1 |
| Benjelloun, MC | 1 |
| Belahsen, MF | 1 |
| Molina, A | 1 |
| Hermida, JM | 1 |
| Ramos, LM | 1 |
| Monteiro, HS | 1 |
| Bushen, OY | 1 |
| Tho, DQ | 1 |
| Duy, PM | 1 |
| Hoa, DV | 1 |
| Torok, ME | 1 |
| Chau, TT | 1 |
| Chau, NV | 1 |
| Chinh, NT | 1 |
| Choi, YW | 1 |
| Bai, JI | 1 |
| Chang, CL | 1 |
| Nijland, HM | 2 |
| Krylova, LIu | 1 |
| Stebaeva, LF | 1 |
| Sharova, SA | 1 |
| Awodu, OA | 1 |
| Ajayi, IO | 1 |
| Famodu, AA | 1 |
| Yoo, CG | 1 |
| Han, SK | 1 |
| Shim, YS | 1 |
| Jagielski, T | 1 |
| Sirmatel, O | 1 |
| Yazgan, P | 1 |
| Gursoy, B | 1 |
| Sirmatel, F | 1 |
| Zeyrek, FY | 1 |
| Ozturk, A | 1 |
| Panova, LV | 1 |
| Ovsiankina, ES | 3 |
| de Kantor, IN | 5 |
| Barrera, L | 4 |
| Byrne, ST | 1 |
| Denkin, SM | 1 |
| Gu, P | 1 |
| Goncharova, ZK | 1 |
| Iusupova, EU | 1 |
| Tumashova, AF | 1 |
| Kozhomkulov, MD | 1 |
| Kozhomkulov, DK | 1 |
| Chubakov, TCh | 1 |
| Alisherov, ASh | 1 |
| Aldashev, AA | 1 |
| Tu, DH | 1 |
| Schumann, A | 1 |
| Nyamathi, A | 1 |
| Stein, JA | 1 |
| Suroto, AJ | 1 |
| Gubkina, MF | 3 |
| Kuz'mina, IK | 1 |
| Stakheeva, LB | 1 |
| Borodina, NN | 1 |
| Zaletina, EIu | 1 |
| Steiner, M | 12 |
| Cosio, A | 1 |
| Abutaleb, N | 1 |
| Obaideen, A | 1 |
| Hamza, A | 1 |
| Zakaria, M | 1 |
| Afifi, H | 1 |
| Fallata, S | 1 |
| Younis, S | 1 |
| Adem, M | 1 |
| Harada, Y | 1 |
| Koyama, K | 1 |
| Yamaryo, T | 1 |
| Kimura, Y | 1 |
| Zaker Bostanabad, S | 1 |
| Titov, LP | 1 |
| Slizen, VV | 1 |
| Taghikhani, M | 1 |
| Bahrmand, A | 1 |
| Kabedi, MJ | 1 |
| Kashongwe, M | 1 |
| Kayembe, JM | 1 |
| Mumba Ngoyi, D | 1 |
| Mampasi, P | 1 |
| Mbaya, P | 1 |
| Verhaegen, J | 1 |
| Muyembe-Tamfum, JJ | 1 |
| Matsuki, A | 1 |
| P V, K | 1 |
| Palaian, S | 1 |
| Ojha, P | 1 |
| P R, S | 1 |
| Kazumi, Y | 1 |
| Itagaki, N | 1 |
| Sugawara, I | 1 |
| Ishikawa, N | 1 |
| Ida, N | 1 |
| Gonda, H | 1 |
| Oishi, T | 1 |
| Suganuma, N | 1 |
| Yamaguchi, I | 2 |
| Suzuki, R | 1 |
| Suh, GY | 2 |
| Chung, MP | 2 |
| Kan, B | 1 |
| Berggren, I | 1 |
| Bennet, R | 1 |
| Bruchfeld, J | 1 |
| Chryssanthou, E | 1 |
| Petersson, R | 1 |
| Petrini, B | 1 |
| Romanus, V | 1 |
| Sylvan, S | 1 |
| Kalin, M | 1 |
| Hawkes, M | 1 |
| Kitai, I | 1 |
| Blaser, S | 1 |
| Cohen, E | 1 |
| Bitnun, A | 1 |
| Fluss, J | 1 |
| Tran, D | 1 |
| Sukumar, B | 1 |
| Iliayas, S | 1 |
| Kumar, SR | 1 |
| Triveni, C | 1 |
| Gomathy, P | 1 |
| Thomas, B | 2 |
| Mathew, M | 1 |
| Pina-Gutiérrez, JM | 1 |
| Ferrer-Traid, A | 1 |
| Arias, C | 1 |
| Sala-Farré, MR | 1 |
| López-Sanmartín, JL | 1 |
| Zaka-Ur-Rehman, Z | 1 |
| Jamshaid, M | 1 |
| Chaudhry, A | 1 |
| Walubo, A | 5 |
| Coetsee, C | 1 |
| Arti, D | 1 |
| Du Plessis, JB | 1 |
| Gocmen, B | 1 |
| Uyan, ZS | 1 |
| Oktem, S | 1 |
| Kiyan, G | 1 |
| Karakoc, F | 1 |
| Ersu, R | 1 |
| Karadag, B | 1 |
| Dagli, T | 1 |
| Dagli, E | 1 |
| Miotto, P | 1 |
| Piana, F | 1 |
| Cirillo, DM | 1 |
| Bong, CN | 1 |
| Chen, SC | 1 |
| Dzimadzi, R | 1 |
| Lu, DY | 1 |
| Makombe, SD | 1 |
| Schouten, EJ | 1 |
| Kamoto, K | 1 |
| Removskiĭ, VM | 1 |
| San, DE | 1 |
| San, BB | 1 |
| Smirnov, AG | 1 |
| Pervova, TN | 1 |
| Polevikt, GK | 1 |
| Shulutko, ML | 1 |
| Zislin, BD | 1 |
| Panfilova, GA | 1 |
| Al'tman, EI | 1 |
| Dvalidze, IuF | 1 |
| Suganova, NM | 1 |
| Turbina, NV | 1 |
| Forshtadt, VM | 1 |
| DiMase, J | 1 |
| Fiegenberg, DS | 1 |
| Levy, SE | 1 |
| Phelps, HW | 1 |
| Thomas, PA | 2 |
| Weiss, H | 1 |
| Malatinszky, I | 1 |
| Lorange, G | 1 |
| Klipstein, FA | 1 |
| Berlinger, FC | 1 |
| Reed, LJ | 1 |
| Arrell, RW | 1 |
| Clark, LA | 1 |
| Marcus, JC | 1 |
| Barrie, JD | 1 |
| Muhs, EO | 1 |
| Bobrowitz, ID | 7 |
| Robins, DE | 1 |
| Kent, DC | 3 |
| Elliott, RC | 2 |
| Curry, FJ | 3 |
| Furman, Z | 1 |
| Evans, C | 6 |
| Kamat, SR | 1 |
| Rajagopalan, S | 1 |
| Haden, HT | 1 |
| Zaworski, C | 1 |
| Randazzo, SD | 1 |
| Chaulet, P | 14 |
| Larbaoui, D | 7 |
| Abderrahim, K | 7 |
| Welsh, KS | 1 |
| Dawson, P | 1 |
| Overfield, TM | 1 |
| Bolten, RS | 1 |
| Przemyska, B | 3 |
| de Graaff, JL | 1 |
| Taniai, S | 1 |
| Ramirez, J | 2 |
| Aksüğür, H | 2 |
| Gülbaran, R | 1 |
| Cakirca, R | 1 |
| Maddock, RK | 1 |
| Markkanen, T | 1 |
| Levanto, A | 1 |
| Sallinen, V | 1 |
| Virtanen, S | 1 |
| Niemirowska, H | 6 |
| Potworowska, M | 1 |
| Hokama, S | 2 |
| Naruto, H | 1 |
| Sugiura, H | 1 |
| Matsumiya, T | 2 |
| Fukuhara, Y | 2 |
| Abrahams, EW | 1 |
| Edwards, FG | 1 |
| Harris, KW | 1 |
| Howells, G | 1 |
| Marshman, RS | 1 |
| Pearson, IR | 1 |
| Young, LF | 1 |
| Jittinandana, A | 4 |
| Kecharanantana, P | 1 |
| Somner, AR | 6 |
| Less, AW | 1 |
| Allan, GW | 7 |
| Smith, J | 7 |
| Tyrrell, WF | 5 |
| Ertli, AA | 1 |
| Khandulaev, MM | 1 |
| Solov'eva, AS | 1 |
| Lukomskaia, VM | 1 |
| Krishnaswami, KV | 6 |
| Vaidyanathan, B | 1 |
| Williams, CK | 1 |
| Aderoju, EA | 1 |
| Adenle, AD | 1 |
| Sekoni, G | 1 |
| Esan, GJ | 1 |
| Carpenter, JL | 3 |
| Covelli, HD | 3 |
| Avant, ME | 1 |
| McAllister, CK | 3 |
| Higbee, JW | 1 |
| Ognibene, AJ | 2 |
| Bahemuka, M | 1 |
| Kioy, PM | 1 |
| Wanjama, M | 1 |
| Wainaina, CM | 1 |
| Jaju, M | 6 |
| Ahuja, YR | 3 |
| Sanchez-Hernandez, M | 2 |
| Baron, RB | 2 |
| Ganter, B | 2 |
| Eandi, M | 1 |
| Buraglio, M | 1 |
| Fischer, P | 3 |
| Schilling, W | 1 |
| George, RH | 1 |
| Shennan, DH | 3 |
| Gupta, VP | 1 |
| Singh, MP | 1 |
| Altet Gómez, MN | 1 |
| Alcáide Megías, J | 1 |
| Boque Genovard, MA | 1 |
| Bollinelli, R | 1 |
| Kasenov, KU | 2 |
| Baĭnasheva, TI | 1 |
| Pickwell, SM | 1 |
| Bailey, WC | 6 |
| Comstock, GW | 10 |
| González Montaner, LJ | 4 |
| Palma Beltrán, O | 1 |
| Abbate, E | 1 |
| Dambrosi, A | 3 |
| Mosca, C | 2 |
| Hsu, KH | 5 |
| Roussel, G | 2 |
| Bernadou, M | 2 |
| Cheminat, JC | 2 |
| Choffel, C | 1 |
| Decroix, G | 1 |
| Fréour, P | 3 |
| Guillet, P | 1 |
| Lemanissier, AF | 1 |
| Milleron, B | 1 |
| Gurumurthy, P | 2 |
| Krishnamurthy, MS | 1 |
| Nazareth, O | 6 |
| Parthasarathy, R | 5 |
| Ellard, GA | 13 |
| Snider, DE | 23 |
| Long, MW | 8 |
| Cross, FS | 3 |
| Farer, LS | 11 |
| Dorken, E | 3 |
| Grzybowski, S | 8 |
| Snider, D | 2 |
| Rotermund, C | 1 |
| Nagami, P | 2 |
| Yoshikawa, TT | 3 |
| Steiner, P | 12 |
| Rao, M | 7 |
| Victoria, MS | 1 |
| Hunt, J | 1 |
| Kühne, W | 1 |
| Willgeroth, C | 1 |
| Obnibene, AJ | 1 |
| Gorby, EW | 1 |
| Neimes, RE | 1 |
| Koch, JR | 1 |
| Perkins, WL | 1 |
| Zítková, L | 2 |
| Janků, I | 1 |
| Papezová, E | 2 |
| Stastná, J | 1 |
| Rudnik, J | 1 |
| Majewska-Zalewska, H | 1 |
| Acocella, G | 3 |
| Dutt, AK | 18 |
| Moers, D | 4 |
| Stead, WW | 26 |
| Suwanogool, S | 1 |
| Smith, SM | 1 |
| Smith, LG | 1 |
| Eng, R | 1 |
| Viaz'mina, LN | 1 |
| Kurmanbaev, KK | 1 |
| Agzamova, RA | 1 |
| Kurmangalieva, KK | 1 |
| Stambekov, AS | 2 |
| Rosin, MA | 1 |
| King, LE | 1 |
| Ylitalo, P | 1 |
| Auterinen, L | 1 |
| Marttinen, A | 1 |
| Frappaz, D | 1 |
| Biron, P | 1 |
| Biron, E | 1 |
| Amrane, A | 1 |
| Philip, T | 1 |
| Brunat-Mentigny, M | 1 |
| Valenzuela, P | 4 |
| Valenzuela, MT | 3 |
| Farga, V | 3 |
| Yañez, A | 2 |
| Scheel, G | 2 |
| Mendoza, F | 2 |
| Torres, E | 2 |
| Icekson, I | 2 |
| Grinspun, M | 2 |
| Fernández, M | 3 |
| Pérez-Stable, EJ | 1 |
| Pedraza, RO | 1 |
| Berg, JD | 1 |
| Pandov, HI | 1 |
| Sammons, HG | 1 |
| Ivanov, VL | 1 |
| Novoselova, VP | 9 |
| Kovaleva, LA | 1 |
| Shtegel'man, LA | 1 |
| Conen, D | 1 |
| Zimmermann, W | 1 |
| Dubach, UC | 1 |
| Maeda, T | 1 |
| Ohkubo, K | 1 |
| Ikeda, K | 2 |
| Shinohara, S | 1 |
| Miyata, Y | 1 |
| Hashimoto, T | 1 |
| Shimao, T | 3 |
| Aoki, M | 2 |
| Misawa, H | 1 |
| Takasawa, N | 1 |
| Shiozawa, S | 1 |
| Miles, SH | 1 |
| Maat, RB | 1 |
| Lee, CW | 1 |
| Lim, JH | 1 |
| Kang, HJ | 1 |
| Sokolova, GV | 2 |
| Ivleva, AIa | 4 |
| Ziia, AV | 4 |
| Suvorova, VI | 1 |
| Graczyk, J | 3 |
| Rogowski, J | 3 |
| Androsov, EE | 1 |
| Vinokurov, VA | 1 |
| Garvalinskiĭ, GF | 1 |
| Karita, VR | 1 |
| Pogrebinskiĭ, MB | 1 |
| Dehaut, P | 1 |
| Beaupré, A | 1 |
| Sjögren, I | 1 |
| Boman, G | 2 |
| Löfdahl, CG | 1 |
| Skoogh, BE | 1 |
| Bednarski, Z | 1 |
| Nikodemowicz, E | 2 |
| Kamińska, M | 2 |
| Caban, M | 1 |
| Struzik, T | 1 |
| Mack, RB | 1 |
| O'Brien, RJ | 6 |
| Lyle, MA | 2 |
| Abernathy, RS | 2 |
| Moers, DJ | 1 |
| Bouveret, JP | 1 |
| Hanoteau, J | 4 |
| Gerbeaux, J | 6 |
| Houin, G | 1 |
| Tillement, JP | 1 |
| Gvasaliia, T | 1 |
| Bartelink, AK | 1 |
| Lenders, JW | 1 |
| van Herwaarden, CL | 1 |
| van Haelst, UJ | 1 |
| van Tongeren, JH | 1 |
| Dahlstrom, G | 1 |
| Kleeberg, HH | 7 |
| Swart, DJ | 1 |
| Carey, SM | 1 |
| Savula, MM | 8 |
| Tytor, IaN | 3 |
| Agarwal, MC | 1 |
| Raina, AK | 1 |
| Singh, SN | 1 |
| Bihari, K | 1 |
| Sharma, SN | 1 |
| Neumann, G | 2 |
| Ahn, CH | 2 |
| Lowell, JR | 1 |
| Ahn, SS | 2 |
| Ahn, SI | 1 |
| Hurst, GA | 1 |
| Boulahbal, F | 7 |
| Ait Khaled, N | 3 |
| El Awadi, Z | 2 |
| Tazir, M | 3 |
| Fiala, W | 1 |
| Häcki, MA | 2 |
| Brändli, O | 4 |
| Paire, M | 1 |
| Lavarenne, J | 1 |
| Ducarrouge, C | 1 |
| Volokitin, FN | 2 |
| Borovinskaia, TA | 2 |
| Glik, MS | 1 |
| Grassi, C | 3 |
| Maskeev, KM | 1 |
| Shefer, LB | 1 |
| Baĭgunov, MA | 1 |
| Mehrotra, ML | 3 |
| Gautam, KD | 3 |
| Chaube, CK | 2 |
| Gerasin, VG | 1 |
| Din, RKh | 1 |
| Semenova, EV | 2 |
| Svistunova, VP | 1 |
| Druzhinina, AIa | 1 |
| Gupta, RC | 1 |
| Nair, CR | 1 |
| Jindal, SK | 1 |
| Malik, SK | 1 |
| Suzuyama, Y | 1 |
| Shigeno, Y | 1 |
| Shigeno, H | 1 |
| Nakazato, H | 1 |
| Nagasawa, M | 1 |
| Koga, H | 2 |
| Tomita, H | 1 |
| Tomonaga, A | 1 |
| Yamaguchi, K | 1 |
| Izumikawa, K | 1 |
| Khaled, S | 3 |
| Catlin, BJ | 2 |
| Iseman, M | 2 |
| Costello, HD | 1 |
| Caras, GJ | 3 |
| Khomenko, AG | 5 |
| Dorozhkova, IR | 3 |
| Chukanov, VI | 4 |
| Balta, IuE | 1 |
| Gerstenhaber, BJ | 1 |
| Aber, VR | 4 |
| Edwards, EA | 2 |
| Sakurai, H | 1 |
| Watanabe, Y | 1 |
| Yamanaka, M | 1 |
| Moriguchi, T | 1 |
| Fujii, K | 1 |
| Uenoyama, T | 1 |
| Schulthess, HK | 1 |
| Zollikofer, H | 1 |
| Giorgis, GE | 1 |
| Moschini, MT | 1 |
| Bardessono, F | 1 |
| Amelio, M | 1 |
| Monie, RD | 1 |
| Hunter, AM | 2 |
| Rocchiccioli, K | 1 |
| White, J | 2 |
| Campbell, IA | 7 |
| Kilpatrick, GS | 2 |
| Fujita, NK | 1 |
| Brown, FS | 1 |
| Anderson, RH | 1 |
| Burnett, JW | 1 |
| Pitchenik, AE | 1 |
| Russell, BW | 1 |
| Cleary, T | 1 |
| Pejovic, I | 1 |
| Cole, C | 1 |
| Kanevskaia, SS | 11 |
| Leuenberger, P | 2 |
| Cinman, AC | 1 |
| Sanders, WE | 2 |
| Hartwig, C | 1 |
| Schneider, N | 1 |
| Cacciatore, R | 2 |
| Valdez, H | 2 |
| Pinto, MR | 2 |
| Arseculeratne, SN | 2 |
| Dasan, P | 1 |
| Uragoda, CG | 5 |
| Augé, C | 1 |
| Lecocguic, Y | 1 |
| Touaty, E | 1 |
| Bussi, S | 1 |
| Pariente, R | 1 |
| Scheel, A | 1 |
| Stiefel, M | 1 |
| Lefrock, JL | 1 |
| Smith, BR | 1 |
| Roman, IC | 1 |
| Vainer, E | 1 |
| Socosan, I | 1 |
| Drăghicescu, T | 1 |
| Kawabata, S | 2 |
| Funakoshi, M | 1 |
| Buechner, HA | 2 |
| Styblo, K | 4 |
| Aloysius, DJ | 1 |
| Cohen, CD | 1 |
| Sayed, AR | 1 |
| Kirsch, RE | 1 |
| Hyland, RN | 1 |
| Gotfried, MH | 1 |
| Bloom, J | 1 |
| Lebowitz, MD | 1 |
| Kobeleva, GV | 1 |
| Ganiev, KG | 3 |
| Esanbaev, DE | 1 |
| Kirina, SB | 1 |
| Reĭkhrud, VM | 2 |
| Armstrong, EM | 1 |
| Loos, U | 4 |
| Musch, E | 6 |
| Mackes, KG | 1 |
| Reetz, KP | 1 |
| Gläser, R | 1 |
| Hengstmann, J | 1 |
| Eichelbaum, M | 3 |
| Johnson, JR | 4 |
| Dall, L | 1 |
| Hopkins, SJ | 1 |
| Manassero, M | 1 |
| Dambrosi, VM | 1 |
| Miller, J | 1 |
| Robinson, A | 1 |
| Percy, AK | 1 |
| Kuzina, LN | 1 |
| Bolganova, MN | 1 |
| Bistritzer, T | 1 |
| Barzilay, Z | 1 |
| Jonas, A | 1 |
| Linna, O | 1 |
| Uhari, M | 1 |
| Averbakh, MM | 1 |
| Keleberda, KIa | 3 |
| Mingazitinova, DM | 1 |
| Layde, PM | 1 |
| Johnson, MW | 2 |
| Shesterina, MV | 4 |
| Tarasova, EF | 6 |
| Tregubov, IuG | 2 |
| Batmanov, NIa | 1 |
| Banner, AS | 1 |
| Chwalibóg, B | 3 |
| Pilipchuk, NS | 4 |
| Frimodt-Moller, J | 2 |
| Acharyulu, GS | 1 |
| Kesava Pillai, K | 1 |
| Spagnolo, SV | 1 |
| Raver, JM | 1 |
| Escreet, BC | 2 |
| Cowie, RL | 6 |
| Engbaek, HC | 4 |
| Heckscher, T | 1 |
| Højgaard, C | 1 |
| Larsen, SO | 3 |
| Vergmann, B | 4 |
| Benatar, SR | 1 |
| Baĭramaliev, G | 1 |
| Krasheninnikova, MA | 1 |
| Kolosovskaia, VP | 2 |
| Anderson, HR | 1 |
| Casimir, MT | 1 |
| Fainstein, V | 1 |
| Papadopolous, N | 1 |
| Sagalovich, VIa | 6 |
| Medunitsyna, ND | 1 |
| Andrzheiuk, NI | 3 |
| Chelnokova, NV | 3 |
| Sagalovich, AV | 1 |
| Hirasing, RA | 1 |
| van Bel, F | 1 |
| Sors, C | 1 |
| Dautzenberg, B | 2 |
| Blaha, H | 4 |
| Zabow, M | 1 |
| Pearson, JO | 3 |
| Truffot, C | 2 |
| Boval, C | 1 |
| Abrarov, BA | 1 |
| Tursunov, FI | 1 |
| Leĭbzon, IuN | 1 |
| Slobodskoĭ, SA | 1 |
| Arifov, SA | 1 |
| Wang, JK | 1 |
| von Sassen, W | 1 |
| Castro-Parra, M | 1 |
| Dengler, HJ | 1 |
| Press, P | 1 |
| Brodie, MJ | 2 |
| Boobis, AR | 2 |
| Hillyard, CJ | 2 |
| Abeyasekera, G | 2 |
| Stevenson, JC | 1 |
| MacIntyre, I | 2 |
| Park, BK | 2 |
| Bogaerts, Y | 1 |
| Elinck, W | 1 |
| van Renterghem, D | 1 |
| Pauwels, R | 1 |
| van der Straeten, M | 1 |
| Griffiths, TM | 1 |
| Thomas, P | 1 |
| Guillaumont, M | 1 |
| Leclercq, M | 1 |
| Frobert, Y | 1 |
| Guise, B | 1 |
| Harf, R | 1 |
| Nemsadze, MN | 3 |
| Zbants, AN | 1 |
| Tsurkan, VP | 2 |
| Mustiatsé, NA | 1 |
| Kurochkin, SIa | 1 |
| Ustiian, AI | 1 |
| Wagatsuma, H | 1 |
| Bouayad, Z | 1 |
| Maurin, R | 1 |
| Bartal, M | 2 |
| Schröder, KH | 1 |
| Müller, U | 1 |
| Korablev, VN | 2 |
| Sighart, H | 4 |
| Opl, G | 5 |
| Weirich, H | 1 |
| Chailleux, E | 2 |
| Ordronneau, J | 2 |
| Le Normand, Y | 2 |
| Kergueris, MF | 2 |
| Larousse, C | 2 |
| Martynenko, AG | 1 |
| Kartasheva, LA | 1 |
| Aberun, DE | 1 |
| Sinha, CP | 2 |
| Sinha, S | 2 |
| Sinha, KP | 2 |
| Choudhary, KD | 1 |
| Oda, T | 1 |
| Degtiarev, VP | 1 |
| Zhigalina, LI | 5 |
| Radzinskiĭ, AG | 2 |
| Lisikhin, VN | 1 |
| Dudchik, GKh | 4 |
| Bilyk, MA | 5 |
| Olson, WA | 1 |
| Pruitt, AW | 1 |
| Dayton, PG | 1 |
| Barrett-Connor, E | 2 |
| Girling, DJ | 5 |
| Chefranov, VS | 1 |
| Berman, AS | 1 |
| Dolzhanskiĭ, VM | 1 |
| Tsuprova, AE | 1 |
| Keiner, F | 1 |
| Krawczyk, Z | 2 |
| Górnicka-Wilczyńska, M | 1 |
| Pilarska-Machowicz, A | 1 |
| Pruszyńska, S | 2 |
| Pawlik, J | 2 |
| Wardowa, A | 2 |
| Woźniak, B | 1 |
| Tomaszkiewicz, L | 2 |
| Szymański, A | 5 |
| Walecki, J | 1 |
| Czaplińska-Jóźwiak, E | 4 |
| Kuczborska, Z | 1 |
| Gaik, A | 1 |
| Bilczak, Z | 1 |
| Swiatnicka, I | 1 |
| Swica, T | 1 |
| Zdawski, T | 1 |
| Beresneva, RE | 1 |
| Ivanova, VB | 1 |
| Ershov, AI | 1 |
| Tikhonov, VA | 1 |
| Grigaliunas, AP | 1 |
| Sushkin, AG | 3 |
| Guzeeva, SA | 3 |
| King, JW | 1 |
| Leonin, TA | 1 |
| McDonagh, DJ | 1 |
| Mochizuki, K | 3 |
| Stepanov, VM | 1 |
| Brant, AL | 1 |
| Semenova, EA | 1 |
| Gaeuman, JV | 1 |
| Iashchenko, BP | 1 |
| Bal'tseva, LB | 2 |
| Gomoliako, IV | 1 |
| Klimenko, MT | 4 |
| Long, M | 2 |
| Wood, ER | 1 |
| Vilenskaia, RN | 6 |
| Galenko, NN | 2 |
| Jenkins, PA | 4 |
| Smith, AP | 2 |
| Advenier, C | 1 |
| Saint-Aubin, A | 1 |
| Scheinmann, P | 1 |
| Paupe, J | 1 |
| Tanaka, I | 1 |
| Iwai, K | 2 |
| Uriz Urzainqui, S | 1 |
| Masvidal Aliberch, RM | 1 |
| Sabriá Pau, J | 1 |
| Bofill Bernaldo, AM | 1 |
| de Salvo, MC | 1 |
| Koch, O | 1 |
| Barcat, JA | 1 |
| Zhang, LX | 2 |
| Powell, DA | 1 |
| Walker, DH | 1 |
| Iseman, MD | 5 |
| Stallworth, JR | 1 |
| Brasfield, DM | 1 |
| Tiller, RE | 1 |
| Bernstein, RE | 1 |
| Shchutskaia, EI | 1 |
| Khlebnikova, LA | 1 |
| Derbikova, TI | 1 |
| Ivanova, GT | 1 |
| Veyrac, MJ | 1 |
| Petrunina, MP | 1 |
| Pashkova, IN | 1 |
| Jenkins, PF | 1 |
| Williams, TD | 1 |
| Palsson, G | 1 |
| Samuelson, G | 1 |
| Kolesnikov, VV | 1 |
| Mikhaĭlov, VI | 1 |
| Matviiakina, TS | 1 |
| Neumann, HH | 1 |
| Schalm, SW | 1 |
| Taal, BG | 1 |
| Kislitsyna, NA | 3 |
| Kotova, NI | 1 |
| Burkhardt, KR | 1 |
| Nel, EE | 2 |
| Boice, JD | 1 |
| Fraumeni, JF | 1 |
| Shirai, S | 1 |
| Piatnochka, IT | 3 |
| Rybak, LD | 1 |
| Kozulitsyna, TI | 1 |
| Uvarova, OA | 3 |
| El'shanskaia, MP | 3 |
| Vladimirskiĭ, MA | 1 |
| Strel'tsov, VP | 1 |
| Stapanov, VM | 1 |
| Braude, VI | 2 |
| Dash, LA | 1 |
| Flynn, JP | 2 |
| Humber, DP | 1 |
| Nsanzumuhire, H | 1 |
| Aluoch, JA | 3 |
| Webster, AD | 1 |
| Staflová, S | 1 |
| Drápela, J | 1 |
| Waterfill, DB | 1 |
| Templeton, WC | 1 |
| Raff, MJ | 1 |
| Melo, JC | 1 |
| Tong, YY | 1 |
| Korzeniewska, M | 1 |
| Buckingham, WB | 2 |
| Kiblawi, SS | 1 |
| Jay, SJ | 1 |
| Stonehill, RB | 2 |
| Norton, J | 1 |
| Brandspigel, K | 1 |
| Mattern, WD | 1 |
| Mital, VN | 1 |
| Misra, M | 1 |
| Gupta, OP | 1 |
| Ozick, LA | 1 |
| Jacob, L | 1 |
| Comer, GM | 1 |
| Lee, TP | 1 |
| Ben-Zvi, J | 1 |
| Donelson, SS | 1 |
| Felton, CP | 1 |
| Sarasin, FP | 1 |
| Perrier, A | 1 |
| Rochat, T | 1 |
| Sandblom, RE | 1 |
| Thummel, KE | 1 |
| Slattery, JT | 1 |
| Nelson, SD | 1 |
| Whalen, C | 1 |
| Byekwaso, F | 1 |
| Vjecha, M | 1 |
| Johnson, J | 1 |
| Huebner, R | 5 |
| Mugerwa, R | 1 |
| Ellner, J | 1 |
| Chan, KL | 1 |
| Chan, HS | 3 |
| Lui, SF | 1 |
| Lai, KN | 1 |
| Folb, PI | 1 |
| Perriëns, JH | 1 |
| Punnotok, J | 2 |
| Pumprueg, U | 1 |
| Chakorn, T | 1 |
| Gol'shevskaia, VI | 1 |
| Grishina, TA | 1 |
| Karpenko, OL | 1 |
| Safonova, SG | 1 |
| Grishina, TD | 1 |
| Sedlaczek, AM | 1 |
| Serwatowski, P | 1 |
| Spiewak, W | 1 |
| van den Brande, P | 1 |
| van Steenbergen, W | 1 |
| Vervoort, G | 1 |
| Demedts, M | 1 |
| de Villiers, CL | 1 |
| Macnab, MF | 1 |
| Le, C | 1 |
| Gómez Marín, JE | 1 |
| Villegas Londoño, LE | 1 |
| Gonzalez-Rothi, RJ | 1 |
| Sorresso, DJ | 1 |
| Mehta, JB | 2 |
| Harvill, LM | 1 |
| Bentley, S | 1 |
| Williams, DL | 2 |
| el-Hajj, H | 1 |
| Hooton, TM | 1 |
| Thompson, RL | 1 |
| Shkurupiĭ, VA | 2 |
| Chernova, TG | 1 |
| Mitinskaia, LA | 8 |
| Elufimova, VF | 5 |
| Iukhimenko, NV | 7 |
| Pogodaeva, NP | 2 |
| Iavorskiĭ, KM | 2 |
| Trautmann, M | 1 |
| Ruhnke, M | 1 |
| Held, T | 1 |
| Weinke, T | 1 |
| Woods, GL | 1 |
| Witebsky, FG | 1 |
| McCarthy, OR | 2 |
| Rudd, RM | 3 |
| Horsfield, N | 3 |
| Ong, EL | 1 |
| Shah, BR | 1 |
| Santucci, K | 1 |
| Sinert, R | 1 |
| Mühlberger, F | 1 |
| Nturanye, F | 1 |
| Nasbimana, J | 1 |
| Mulder, D | 1 |
| Schrappe, M | 1 |
| Wassermann, K | 1 |
| Kroegel, C | 1 |
| Demeshko, ND | 3 |
| Zriachkina, LI | 1 |
| Pesnia, NP | 1 |
| van Zyl, LE | 1 |
| de Villiers, J | 1 |
| Zent, C | 1 |
| Sauret, J | 1 |
| Hernández-Flix, S | 1 |
| Castro, E | 1 |
| Hernández, L | 1 |
| Coll, P | 1 |
| Pennie, RA | 1 |
| al-Majed, SA | 1 |
| Bourke, SJ | 1 |
| Stenton, SC | 1 |
| Hendrick, DJ | 1 |
| Mitchell, I | 1 |
| Wendon, J | 1 |
| Fitt, S | 1 |
| Ferrazoli, L | 1 |
| Telles, MA | 1 |
| Ueki, SY | 1 |
| Marques, LR | 1 |
| Ferreira, OC | 1 |
| Cockerill, FR | 1 |
| Uhl, JR | 1 |
| Temesgen, Z | 1 |
| Stockman, L | 1 |
| Roberts, GD | 1 |
| Kline, BC | 1 |
| Arizzi-Rusche, AF | 1 |
| Kohler, LJ | 1 |
| Gohara, AF | 1 |
| Hamilton, RW | 1 |
| Reeves, RS | 1 |
| Lo, RS | 1 |
| Chan, JC | 1 |
| Cockram, CS | 1 |
| Lai, FM | 1 |
| Yosiyama, T | 1 |
| Yosikawa, M | 1 |
| Sugie, T | 2 |
| Nakasono, T | 1 |
| Sugita, H | 3 |
| Tahaoğlu, K | 2 |
| Kizkin, O | 1 |
| Karagöz, T | 1 |
| Tor, M | 1 |
| Partal, M | 1 |
| Sadoğlu, T | 1 |
| Dubus, JC | 1 |
| Piarroux, R | 1 |
| Panuel, M | 1 |
| Garnier, JM | 1 |
| Faure, F | 1 |
| Devred, P | 1 |
| Unal, D | 1 |
| Kindelán, JM | 1 |
| Serrano, I | 1 |
| Jurado, R | 1 |
| Villanueva, JL | 1 |
| García-Lázaro, M | 1 |
| García-Herola, A | 1 |
| Torre Cisneros, J | 1 |
| Ekmekçi, A | 1 |
| Sayli, A | 1 |
| van der Kooi, K | 1 |
| Mottet, JJ | 1 |
| Regamey, C | 1 |
| Farrell, FJ | 1 |
| Keeffe, EB | 1 |
| Man, KM | 1 |
| Imperial, JC | 1 |
| Esquivel, CO | 1 |
| Bucher, H | 1 |
| Weinbacher, M | 1 |
| Gyr, K | 1 |
| Chan, SL | 6 |
| Wong, PC | 2 |
| Otaya, M | 1 |
| Antoniskis, D | 1 |
| Sian, S | 1 |
| Mercado, A | 1 |
| Davidson, PT | 3 |
| Barnes, PF | 2 |
| Suzuki, T | 3 |
| Tagawa, K | 1 |
| Takahara, M | 1 |
| Arai, T | 1 |
| Kabe, J | 1 |
| Baba, H | 5 |
| Bluestone, H | 1 |
| Frances, R | 1 |
| Eshankhanov, ME | 1 |
| Khodzhaeva, ME | 1 |
| Kozarez, MI | 1 |
| Aliev, ShT | 1 |
| Sirenko, IA | 1 |
| Nastas, PN | 1 |
| Terashima, T | 1 |
| Sakamaki, F | 1 |
| Hasegawa, N | 2 |
| Peona, V | 2 |
| Yamamoto, S | 1 |
| Sugita, N | 1 |
| Kino, T | 1 |
| Hayashi, A | 1 |
| Vallejo, JG | 1 |
| Ong, LT | 2 |
| Horn, DL | 1 |
| Hewlett, D | 1 |
| Haas, WH | 1 |
| Butler, WR | 1 |
| Alfalla, C | 1 |
| Tan, E | 1 |
| Levine, A | 1 |
| Nayak, A | 1 |
| Opal, SM | 1 |
| Luo, C | 1 |
| Bhat, G | 1 |
| Diwan, V | 1 |
| DuPont, HL | 1 |
| Kruglova, EG | 2 |
| Trevett, A | 1 |
| Temu, P | 1 |
| Naraqi, S | 1 |
| Chen, CH | 1 |
| Hsieh, H | 1 |
| Lai, MK | 1 |
| Tantawichien, T | 1 |
| Suwangool, P | 1 |
| Suvanapha, R | 1 |
| Russo, PA | 1 |
| Chaglasian, MA | 1 |
| Levée, G | 1 |
| Gicquel, B | 1 |
| Chanteau, S | 1 |
| al Jarad, N | 1 |
| Parastatides, S | 1 |
| Paul, EA | 1 |
| Sheldon, CD | 1 |
| Gaya, H | 1 |
| Empey, DW | 1 |
| Jean, SS | 1 |
| Ho, JL | 1 |
| Hafner, A | 1 |
| Bevilacqua, N | 1 |
| Marasca, G | 1 |
| Moscati, A | 1 |
| Fantoni, M | 1 |
| Ricci, F | 1 |
| Ortona, L | 1 |
| Seth, V | 5 |
| Beotra, A | 4 |
| Seth, SD | 2 |
| Semwal, OP | 1 |
| Kabra, S | 1 |
| Jain, Y | 1 |
| Mukhopadhya, S | 1 |
| Botha, FJ | 5 |
| Clark, PK | 1 |
| Greth, A | 1 |
| Flamand, JR | 1 |
| Delhomme, A | 1 |
| Binkin, NJ | 2 |
| Ghersi, G | 1 |
| Boeri, V | 1 |
| Lo Monaco, R | 1 |
| Salamina, G | 1 |
| Robson, SC | 1 |
| Pillans, P | 1 |
| Willcox, PA | 1 |
| Miller, B | 1 |
| He, GJ | 1 |
| Yamaguchi, Y | 1 |
| Kishi, M | 1 |
| Kennedy, N | 2 |
| Fox, R | 2 |
| Kisyombe, GM | 2 |
| Saruni, AO | 2 |
| Ramsay, AR | 2 |
| Ngowi, FI | 2 |
| Neville, K | 1 |
| Bromberg, A | 1 |
| Bromberg, R | 1 |
| Bonk, S | 1 |
| Hanna, BA | 1 |
| Rom, WN | 2 |
| Cheshek, VG | 1 |
| Shevchenko, NI | 1 |
| Potashova, VA | 1 |
| Naryshkina, SL | 1 |
| Koriakin, VA | 5 |
| Khalbaeva, IV | 1 |
| Siskind, MS | 1 |
| Thienemann, D | 1 |
| Kirlin, L | 1 |
| Dias, F | 1 |
| Michael, SG | 1 |
| Hoffner, SE | 2 |
| Martins, L | 1 |
| Norberg, R | 1 |
| Kamolratanakul, P | 1 |
| Chunhaswasdikul, B | 1 |
| Tangcharoensathien, V | 1 |
| Udomrati, N | 1 |
| Akksilp, S | 1 |
| Peschke, B | 1 |
| Ernst, W | 1 |
| Gossmann, J | 1 |
| Kachel, HG | 1 |
| Schoeppe, W | 1 |
| Scheuermann, EH | 1 |
| Kochi, A | 1 |
| Vareldzis, B | 1 |
| Jalleh, RD | 1 |
| Kuppusamy, I | 1 |
| Soshila, R | 1 |
| Aziah, AM | 1 |
| Faridza, MY | 1 |
| Anagonou, SY | 1 |
| Josse, R | 1 |
| Kinde-Gazard, D | 1 |
| Tawo, L | 1 |
| Foundohou, J | 1 |
| Seita, A | 1 |
| Datta, M | 1 |
| Radhamani, MP | 1 |
| Selvaraj, R | 1 |
| Gopalan, BN | 1 |
| Sudeendra, CR | 1 |
| Prabhakar, R | 3 |
| Luisetti, M | 1 |
| Grassi, GG | 1 |
| Pozzi, E | 2 |
| Kohno, H | 1 |
| Katayama, T | 2 |
| Sterling, T | 1 |
| Pablos-Mendez, A | 1 |
| Kilburn, JO | 2 |
| Cauthen, GM | 2 |
| Dooley, SW | 1 |
| Gupta, PR | 1 |
| Singhal, B | 1 |
| Sharma, TN | 2 |
| Gupta, RB | 1 |
| Plant, AJ | 1 |
| Goble, M | 2 |
| Madsen, LA | 1 |
| Waite, D | 1 |
| Ackerson, L | 1 |
| Passannante, MR | 1 |
| Restifo, RA | 1 |
| Jaswal, S | 1 |
| Dhand, R | 2 |
| Sethi, AK | 1 |
| Kohli, KK | 1 |
| Ganguly, NK | 1 |
| Asnis, DS | 1 |
| Bhat, JG | 1 |
| Melchert, AF | 1 |
| Trkanjec, Z | 1 |
| Tekavec, J | 1 |
| Sudarsanam, NM | 1 |
| Abbo, AW | 1 |
| Atkin, SL | 1 |
| Masson, EA | 1 |
| Bodmer, CW | 1 |
| Walker, BA | 1 |
| Kassim, S | 1 |
| Sassan-Morokro, M | 1 |
| Ackah, A | 1 |
| Abouya, LY | 1 |
| Digbeu, H | 1 |
| Yesso, G | 1 |
| Coulibaly, IM | 1 |
| Coulibaly, D | 1 |
| Whitaker, PJ | 1 |
| Doorly, R | 1 |
| Sato, K | 2 |
| Kleĭn, AV | 1 |
| Nosova, NA | 1 |
| Wenning, GK | 1 |
| O'Connell, MT | 1 |
| Patsalos, PN | 1 |
| Quinn, NP | 1 |
| Nakamura, Y | 3 |
| Nakamura, H | 2 |
| Matsuse, A | 1 |
| Monden, J | 1 |
| Shimoda, T | 1 |
| Kawano, S | 1 |
| Hara, K | 2 |
| Masumoto, H | 1 |
| Asai, T | 1 |
| Arnheim, K | 1 |
| Turner, MT | 2 |
| Dean, S | 1 |
| McColloster, P | 1 |
| Neff, NE | 1 |
| Asch, S | 1 |
| Knowles, L | 1 |
| Rai, A | 1 |
| Pogoda, J | 1 |
| Aguilar, X | 1 |
| Ruiz, J | 1 |
| Fernández-Muixí, J | 1 |
| Teixidó, A | 1 |
| Gallego, M | 1 |
| Ribas, J | 1 |
| Richart, C | 1 |
| Morera, J | 1 |
| Batyrov, FA | 1 |
| Park, SB | 1 |
| Joo, I | 1 |
| Park, YI | 1 |
| Suk, J | 1 |
| Cho, WH | 1 |
| Park, CH | 1 |
| Wilcox, WD | 1 |
| Hacker, YE | 1 |
| Geller, RJ | 1 |
| Allos, BM | 1 |
| Genshelmer, KF | 1 |
| Bloch, AB | 2 |
| Parrotte, D | 1 |
| Horan, JM | 1 |
| Lewis, V | 1 |
| Schaffner, W | 1 |
| Berger, L | 1 |
| Curram, J | 1 |
| Gutmann, J | 1 |
| Sam, N | 1 |
| Tillotson, G | 1 |
| Yates, M | 1 |
| Chan, SP | 1 |
| Birnbaum, J | 1 |
| Rothe, TB | 1 |
| Karrer, W | 2 |
| Morcillo, N | 1 |
| Alito, A | 1 |
| Romano, MI | 1 |
| Cataldi, A | 1 |
| Dolmann, A | 1 |
| Reniero, A | 2 |
| Aita, J | 1 |
| Biglione, J | 1 |
| Weisburd, G | 1 |
| Rajmil, JC | 1 |
| Largacha, C | 1 |
| Vega, RA | 1 |
| Conde, JG | 1 |
| Díaz, M | 1 |
| Kufakova, GA | 2 |
| Lu, H | 1 |
| Liang, G | 1 |
| Tekur, U | 1 |
| Chopra, K | 1 |
| Wanger, A | 1 |
| Mills, K | 1 |
| Tayler, E | 1 |
| Ignatenko, N | 1 |
| Paul, J | 1 |
| Connolly, M | 1 |
| Nye, P | 1 |
| Lyagoshina, T | 1 |
| Besse, C | 1 |
| Morris, CD | 1 |
| Pérez, G | 2 |
| Camilo, E | 1 |
| Soto, S | 1 |
| Cruz, E | 1 |
| Matos, N | 1 |
| Bahrmand, AR | 1 |
| Madani, H | 1 |
| Samar, G | 1 |
| Khalilzadeh, L | 1 |
| Bakayev, VV | 1 |
| Yaghli, M | 1 |
| babaei, MH | 1 |
| Bustreo, F | 2 |
| Fisher, M | 1 |
| Tomlinson, DR | 1 |
| Coker, RJ | 1 |
| Marttila, HJ | 1 |
| Soini, H | 2 |
| Huovinen, P | 1 |
| Viljanen, MK | 2 |
| Schaberg, T | 2 |
| Rebhan, K | 1 |
| Scriven, JM | 1 |
| Berry, D | 1 |
| Escobar, MA | 1 |
| Saravia, NG | 1 |
| Weigle, KA | 1 |
| Polesky, A | 1 |
| Farber, HW | 1 |
| Gottlieb, DJ | 1 |
| Levinson, S | 1 |
| O'Connell, JJ | 1 |
| McInnis, B | 2 |
| Nieves, RL | 1 |
| Cho, KH | 1 |
| Lee, DY | 1 |
| Kim, CW | 1 |
| Tai, DY | 1 |
| Yeo, JK | 1 |
| Eng, PC | 1 |
| Martinez, FD | 1 |
| Hernandez, HM | 1 |
| Barakat, MT | 1 |
| Scott, J | 1 |
| Hughes, JM | 1 |
| Walport, M | 1 |
| Calam, J | 1 |
| Ind, PW | 1 |
| McKenna, C | 1 |
| Gülmez, I | 1 |
| Keleştimur, F | 1 |
| Durak, AC | 1 |
| Ozesmi, M | 1 |
| Schütte, W | 1 |
| Berghaus, A | 1 |
| Schütte, A | 1 |
| Zuehlke, RK | 1 |
| Kerns, DG | 1 |
| Greenwell, H | 1 |
| Kerns, LL | 1 |
| Franco Serrano, J | 1 |
| Blanquer Olivas, R | 1 |
| Flores Cid, J | 1 |
| Domínguez Martínez, A | 1 |
| Nogueira Coito, JM | 1 |
| Iñigo Zaera, C | 1 |
| Altynova, MP | 1 |
| Firsova, VA | 4 |
| Roll, L | 1 |
| Elarth, AM | 1 |
| Iwanaga, T | 2 |
| Yokota, K | 1 |
| Kishikawa, R | 1 |
| Ikeda, T | 1 |
| Tsurutani, H | 1 |
| Hirose, T | 1 |
| Nishima, S | 1 |
| Fujiwara, PI | 2 |
| Rutherford, CM | 1 |
| Crawford, JT | 2 |
| Glickman, SE | 1 |
| Sachdev, PS | 1 |
| Osahan, SS | 2 |
| Ebrahimzadeh, A | 1 |
| Wilson, SM | 1 |
| al-Suwaidi, Z | 1 |
| McNerney, R | 1 |
| Porter, J | 2 |
| Rodrigues de Jesus, LS | 1 |
| Andrade, MK | 1 |
| Werneck-Barroso, E | 1 |
| Vieira, MA | 1 |
| Haffner, A | 1 |
| Vandenplas, S | 1 |
| Vandenplas, ML | 2 |
| van der Walt, BJ | 1 |
| van Jaarsveld, PP | 1 |
| Ridzon, R | 2 |
| Weismuller, PC | 1 |
| Elcock, M | 1 |
| Maxwell, RM | 1 |
| Meador, J | 1 |
| Carson, ML | 1 |
| Davies, PD | 1 |
| Nettleman, MD | 1 |
| Geerdes, H | 1 |
| Roy, MC | 1 |
| Kuyvenhoven, JV | 1 |
| Lambregts-van Weezenbeek, CS | 1 |
| Année-van Bavel, JA | 1 |
| Miravitlles, M | 1 |
| Torrella, M | 1 |
| de Gracia, J | 1 |
| Morell, F | 2 |
| Fattinger, K | 1 |
| Braunschweig, S | 1 |
| Reichen, J | 1 |
| Meier-Abt, PJ | 1 |
| Krähenbühl, S | 1 |
| Bloom, B | 1 |
| Cole, S | 1 |
| Fine, P | 1 |
| Ginsberg, A | 1 |
| La Montagne, J | 1 |
| Young, D | 1 |
| Matts, JP | 2 |
| Miller, C | 1 |
| Brown, LS | 1 |
| John, SL | 1 |
| Klein, M | 1 |
| Vaughn, A | 1 |
| Besch, CL | 1 |
| Szabo, S | 1 |
| El-Sadr, W | 1 |
| Gavril'ev, SS | 2 |
| Vinokurova, MK | 2 |
| Knobel, B | 1 |
| Buyanowsky, G | 1 |
| Dan, M | 1 |
| Zaidel, L | 1 |
| Kayantao, D | 1 |
| Keïta, B | 1 |
| Sangaré, S | 1 |
| Whalen, CC | 3 |
| Hom, DL | 2 |
| Mugyenyi, P | 1 |
| Ellner, JJ | 4 |
| Cohn, JA | 1 |
| Wright, DJ | 1 |
| Dunlap, NE | 2 |
| Egorin, MJ | 1 |
| Enama, ME | 1 |
| Muth, K | 1 |
| Mor, N | 1 |
| Heifets, LB | 1 |
| Victor, TC | 1 |
| Butt, JL | 1 |
| Jordaan, AM | 1 |
| Felix, JV | 1 |
| Richardson, M | 1 |
| Naqvi, A | 1 |
| Akhtar, F | 1 |
| Naqvi, R | 1 |
| Akhtar, S | 1 |
| Askari, H | 1 |
| Lal, M | 1 |
| Bhatti, S | 1 |
| Shahzad, A | 1 |
| Soomro, S | 1 |
| Rizvi, A | 1 |
| Blanco Ramos, JR | 1 |
| Rosel Rioja, L | 1 |
| Dopereiro Gómez, R | 1 |
| Oteo Revuelta, JA | 1 |
| Sybrecht, GW | 1 |
| Yan, S | 1 |
| Ye, H | 1 |
| Aguado, JM | 1 |
| Pulido, F | 1 |
| Dore, GJ | 1 |
| Law, MG | 1 |
| Kaldor, JM | 1 |
| Erreimi, N | 1 |
| Hida, M | 1 |
| Mouane, N | 1 |
| Bouchta, F | 1 |
| Laszlo, A | 1 |
| Rahman, M | 1 |
| Mqoqi, NP | 1 |
| Churchyard, GA | 1 |
| Kleinschmidt, I | 1 |
| Williams, B | 1 |
| Michałowska-Mitczuk, D | 3 |
| Kuś, J | 2 |
| Billo, N | 1 |
| Jouveshomme, S | 1 |
| Ben Rhomdane, N | 1 |
| Zouari, M | 1 |
| Mtimet, B | 1 |
| Desvarieux, M | 1 |
| Halsey, NA | 1 |
| Desormeaux, J | 1 |
| Losikoff, P | 1 |
| Atkinson, J | 1 |
| Contave, M | 1 |
| Johnson, M | 1 |
| Davis, H | 1 |
| Johnson, E | 1 |
| Boulos, R | 1 |
| Park, IW | 1 |
| Choi, BW | 1 |
| Hue, SH | 1 |
| Trébucq, A | 2 |
| Rieder, HL | 4 |
| Codecasa, LR | 1 |
| Besozzi, G | 1 |
| Tsuyuguchi, K | 1 |
| Amitani, R | 1 |
| Matsumoto, H | 1 |
| Mizuno, H | 1 |
| Hitomi, S | 1 |
| Kuze, F | 2 |
| Tamaki, K | 1 |
| Hirakata, H | 1 |
| Okuda, S | 1 |
| Wilkinson, D | 3 |
| Bechan, S | 1 |
| Standing, E | 1 |
| Short, GM | 1 |
| Jansà, JM | 1 |
| Serrano, J | 1 |
| Ocaña, I | 1 |
| Español, T | 1 |
| Bai, KJ | 1 |
| Yu, MC | 1 |
| Suo, J | 2 |
| Chiang, IH | 1 |
| Lin, TP | 3 |
| Luh, KT | 3 |
| Mbala, L | 1 |
| Matendo, R | 1 |
| Nkailu, R | 1 |
| Kimerling, ME | 1 |
| Phillips, P | 1 |
| Patterson, P | 1 |
| Hall, M | 1 |
| Robinson, CA | 1 |
| Wen, S | 1 |
| Su, Y | 1 |
| Zhang, F | 1 |
| el-Sadr, WM | 1 |
| Perlman, DC | 1 |
| Nelson, ET | 1 |
| Cohn, DL | 2 |
| Salomon, N | 1 |
| Olibrice, M | 1 |
| Medard, F | 1 |
| Chirgwin, KD | 1 |
| Mildvan, D | 1 |
| Telzak, EE | 1 |
| Klein, O | 1 |
| Heifets, L | 1 |
| Sánchez-Albisua, I | 1 |
| Vidal López, ML | 2 |
| del Castillo Martín, F | 1 |
| Borque, C | 1 |
| García-Hortelano, J | 1 |
| Antoun, F | 1 |
| Momas, I | 1 |
| Vieu, V | 1 |
| Poinsard, R | 1 |
| Crespy, M | 1 |
| Endo, T | 1 |
| Nakayama, M | 1 |
| Ohse, H | 1 |
| Watanabe, S | 1 |
| Tamai, S | 1 |
| Hasegawa, S | 1 |
| Lam, CW | 2 |
| Kam, KM | 4 |
| Morris, JS | 1 |
| Liu, Z | 1 |
| Shilkret, KL | 1 |
| Finelli, L | 1 |
| O'Brien, JK | 1 |
| Doerfler, ME | 1 |
| Harkin, TJ | 1 |
| Zeenreich, A | 1 |
| Gochstein, B | 1 |
| Grinshpoon, A | 1 |
| Miron, M | 1 |
| Rosenman, J | 1 |
| Ben-Dov, I | 1 |
| Vyshnevskiy, BI | 1 |
| Otten, TF | 1 |
| Vyshnevskaya, E | 1 |
| Marjamäki, M | 1 |
| Laippala, PJ | 1 |
| Vasilyef, AV | 1 |
| Dilber, E | 1 |
| Radal, M | 2 |
| Jonville-Bera, AP | 2 |
| Van-Egroo, C | 1 |
| Carré, P | 1 |
| Lemarié, E | 1 |
| Autret, E | 2 |
| Latini, O | 1 |
| Riantawan, P | 1 |
| Chaisuksuwan, R | 1 |
| Pransujarit, V | 1 |
| Collazos, J | 2 |
| España, P | 1 |
| Mayo, J | 2 |
| Martínez, E | 2 |
| Izquierdo, F | 1 |
| Morgan, JR | 1 |
| Clarke, KW | 1 |
| Brear, SG | 1 |
| Fujino, T | 2 |
| Satou, R | 1 |
| Kawada, K | 1 |
| Loeffler, AM | 1 |
| Furst, K | 1 |
| Cole, B | 1 |
| Fodor, T | 3 |
| Vadász, I | 1 |
| Lõrinczi, I | 1 |
| Brewer, TF | 1 |
| Heymann, SJ | 1 |
| Tong, FM | 1 |
| Chow, SK | 1 |
| Ilias, I | 1 |
| Papachristou, K | 1 |
| Vassilikos, G | 1 |
| Filippou, N | 1 |
| B1tashova, VA | 1 |
| Kudelia, OA | 1 |
| Volkova, ZhA | 1 |
| Gromyko, NI | 1 |
| Bercion, R | 1 |
| Sethna, KB | 1 |
| Mistry, NF | 1 |
| Dholakia, Y | 1 |
| Antia, NH | 1 |
| Harboe, M | 1 |
| Talarmin, F | 1 |
| Eladari, D | 1 |
| Klotz, F | 1 |
| Nyole, S | 1 |
| Nsubuga, P | 2 |
| Pekovic, V | 1 |
| Mugyenyi, PN | 2 |
| Kim, CT | 1 |
| Song, SD | 1 |
| Goyal, A | 1 |
| Nagarkar, NM | 1 |
| Uppal, KS | 1 |
| Mohan, H | 1 |
| Dass, A | 1 |
| Heal, G | 1 |
| Pang, SC | 2 |
| Harrison, RH | 2 |
| Brearley, J | 1 |
| Jegathesan, V | 1 |
| Clayton, AS | 2 |
| Mwinga, A | 1 |
| Hosp, M | 1 |
| Quigley, M | 1 |
| Mugala, BN | 1 |
| Nyirenda, O | 1 |
| Luo, N | 1 |
| Pobee, J | 1 |
| Elliott, AM | 1 |
| McAdam, KP | 1 |
| Porter, JD | 1 |
| Asai, S | 1 |
| Futsuki, Y | 1 |
| Tomari, S | 1 |
| Araki, J | 1 |
| Simpson, AJ | 1 |
| Watt, B | 3 |
| Heald, SH | 1 |
| Sudlow, MF | 1 |
| Leitch, AG | 1 |
| Smith, KC | 2 |
| Green, HL | 1 |
| Kistler, A | 1 |
| Lappin, DW | 1 |
| Coward, RA | 1 |
| Xing, T | 1 |
| Zhang, G | 1 |
| Fang, Z | 1 |
| Doig, C | 1 |
| Rayner, A | 1 |
| Kenna, DT | 1 |
| Forbes, KJ | 1 |
| Chan, TY | 2 |
| Miki, K | 2 |
| Yokota, S | 3 |
| Hiraga, T | 1 |
| Yamaguchi, T | 4 |
| Nakagawa, M | 1 |
| Maekura, R | 2 |
| Teo, SK | 1 |
| Mwasekaga, MJ | 1 |
| Rumisha, D | 1 |
| Binkin, N | 1 |
| Maganu, E | 1 |
| Filimonov, PN | 1 |
| Pupyshev, AB | 1 |
| Panasenko, SG | 1 |
| Muratake, T | 1 |
| Hayashi, S | 1 |
| Scheid, P | 1 |
| Kanny, G | 1 |
| Tréchot, P | 1 |
| Rosner, V | 1 |
| Ménard, O | 1 |
| Vignaud, JM | 1 |
| Anthoine, D | 1 |
| Martinet, Y | 1 |
| Olivier, C | 1 |
| Mazaud, S | 1 |
| Martel, C | 1 |
| Ito, K | 1 |
| Mizutani, S | 1 |
| Ming, A | 1 |
| Xiao, C | 1 |
| Li, Z | 1 |
| Hawken, M | 1 |
| Ngángá, L | 1 |
| Meme, H | 1 |
| Chakaya, J | 1 |
| Snyder, DC | 2 |
| Paz, EA | 1 |
| Mohle-Boetani, JC | 1 |
| Fallstad, R | 1 |
| Black, RL | 1 |
| Chin, DP | 2 |
| O'Reilly, P | 1 |
| McDonnell, T | 1 |
| Duchin, JS | 1 |
| Shields, T | 1 |
| Kopelman, RI | 1 |
| Wong, JB | 1 |
| Pauker, SG | 1 |
| Coninx, R | 1 |
| Mathieu, C | 1 |
| Debacker, M | 1 |
| Mirzoev, F | 1 |
| Ismaelov, A | 1 |
| de Haller, R | 1 |
| Meddings, DR | 1 |
| Gleissberg, V | 1 |
| Pérez-Perdomo, R | 1 |
| Pérez-Cardona, CM | 1 |
| Iwasaki, Y | 1 |
| Ichikawa, Y | 1 |
| Kinoshita, M | 1 |
| Ito, KL | 1 |
| Dlugovitzky, D | 1 |
| Dominino, JC | 1 |
| Valentini, E | 1 |
| Hartopp, R | 1 |
| Stanford, C | 1 |
| Stanford, J | 1 |
| De Siati, L | 1 |
| Paroli, M | 1 |
| Ferri, C | 1 |
| Muda, AO | 1 |
| Bruno, G | 1 |
| Barnaba, V | 1 |
| Curtis, AB | 1 |
| Vogel, R | 1 |
| McDonough, S | 1 |
| Hargreaves, J | 1 |
| Ferry, J | 1 |
| Valway, S | 1 |
| Onorato, IM | 2 |
| Kuroda, F | 1 |
| Yagi, T | 1 |
| Mizutani, F | 1 |
| Wada, A | 1 |
| Sah, SP | 1 |
| Raj, GA | 1 |
| Bahadur, T | 1 |
| Lorvick, J | 1 |
| Thompson, S | 1 |
| Edlin, BR | 1 |
| Kral, AH | 1 |
| Lifson, AR | 1 |
| Watters, JK | 1 |
| Barker, J | 1 |
| Makatini, Z | 1 |
| Millard, J | 1 |
| Belotserkovskiĭ, VG | 1 |
| Mishin, VIu | 2 |
| Pilote, L | 1 |
| Hahn, JA | 1 |
| Zolopa, AJ | 1 |
| Burke, M | 2 |
| Chesney, M | 1 |
| Moss, AR | 1 |
| Van Vooren, JP | 1 |
| Bwire, R | 1 |
| Sticht-Groh, V | 1 |
| Kawuma, HJ | 1 |
| Bretzel, G | 1 |
| Ohno, M | 1 |
| Yamamoto, I | 1 |
| Fukuda, T | 1 |
| Maeda, K | 1 |
| Komuta, K | 1 |
| Igarashi, T | 1 |
| Azuma, J | 1 |
| Sim, E | 1 |
| Staples, D | 1 |
| Sole, KM | 2 |
| Al-Ghusein, H | 1 |
| Smieja, MJ | 1 |
| Marchetti, CA | 1 |
| Cook, DJ | 1 |
| Smaill, FM | 1 |
| Moulding, T | 4 |
| Te Water Naude, JM | 1 |
| Hussey, GD | 1 |
| Kibel, MA | 1 |
| Louw, A | 1 |
| Perkins, DR | 1 |
| Morehead, RS | 1 |
| Githui, W | 1 |
| Umapathy, KC | 1 |
| Ramasamy, R | 1 |
| Reginald, A | 1 |
| Ganesan, E | 1 |
| Ansari, MZ | 1 |
| Carnie, J | 1 |
| Hart, WG | 1 |
| Milchev, M | 1 |
| Kishi, F | 1 |
| Ouedraogo, M | 1 |
| Ouedraogo, SM | 1 |
| Diagbouga, S | 1 |
| Achi, V | 1 |
| N'Dathz, M | 1 |
| Yapi, A | 1 |
| Shoen, CM | 1 |
| DeStefano, MS | 1 |
| Rao, GP | 1 |
| Slayden, RA | 1 |
| Sousa, AO | 1 |
| Wargnier, A | 1 |
| Poinsignon, Y | 1 |
| Simonney, N | 1 |
| Gerber, F | 1 |
| Lavergne, F | 1 |
| Herrmann, JL | 1 |
| Lagrange, PH | 1 |
| Mishkinis, K | 1 |
| Kaminskaĭte, A | 1 |
| Purvanetskene, B | 1 |
| Grigor'ev, IuG | 1 |
| Budak-Alpdogan, T | 1 |
| Tangün, Y | 1 |
| Kalayoglu-Besisik, S | 1 |
| Ratip, S | 1 |
| Akan, H | 1 |
| Baslar, Z | 1 |
| Soysal, T | 1 |
| Bayik, LA | 1 |
| Koç, H | 1 |
| Pimentel, ML | 1 |
| Alves, SM | 1 |
| Novis, SA | 1 |
| Brandão, RZ | 1 |
| Belo Neto, E | 1 |
| Sebastian, MS | 1 |
| Cakir, B | 1 |
| Yönem, A | 1 |
| Güler, S | 1 |
| Odabaşi, E | 1 |
| Demirbaş, B | 1 |
| Gürsoy, G | 1 |
| Aral, Y | 1 |
| Criado, A | 1 |
| Draper, P | 1 |
| Shaĭkhaev, AIa | 1 |
| Naumov, VN | 1 |
| Remis, RS | 1 |
| Jamieson, F | 1 |
| Chedore, P | 1 |
| Haddad, A | 1 |
| Vernich, L | 1 |
| McNab, BD | 1 |
| Marciniuk, DD | 1 |
| Alvi, RA | 1 |
| Tan, L | 1 |
| Hoeppner, VH | 1 |
| Amaya-Tapia, G | 1 |
| Martín-Del Campo, L | 1 |
| Aguirre-Avalos, G | 1 |
| Portillo-Gómez, L | 1 |
| Covarrubias-Pinedo, A | 1 |
| Aguilar-Benavides, S | 1 |
| Roman, A | 1 |
| Bravo, C | 1 |
| Levy, G | 1 |
| Monforte, V | 1 |
| Solé, J | 1 |
| Maestre, J | 1 |
| Gilroy, SA | 1 |
| Rogers, MA | 1 |
| Blair, DC | 1 |
| Roosihermiatie, B | 1 |
| Nishiyama, M | 1 |
| Nakae, K | 1 |
| Boggess, KA | 1 |
| Myers, ER | 1 |
| Hamilton, CD | 1 |
| Lamarre, V | 1 |
| Cuthbert, SS | 1 |
| Antonio Paz, E | 1 |
| Daley, CL | 1 |
| Matteelli, A | 1 |
| Casalini, C | 1 |
| El-Hamad, I | 1 |
| Scolari, C | 1 |
| Bombana, E | 1 |
| Bugiani, M | 1 |
| Caputo, M | 1 |
| Scarcella, C | 1 |
| Carosi, G | 1 |
| Morse, MM | 1 |
| Herbert, J | 1 |
| Tolani, SL | 1 |
| Rathi, GL | 1 |
| Gupta, HP | 1 |
| Asano, T | 1 |
| Kawamoto, H | 1 |
| Asakuma, J | 1 |
| Tanimoto, T | 1 |
| Hayakawa, M | 1 |
| Valencia, ME | 1 |
| Moreno, V | 1 |
| Laguna, F | 2 |
| González-Lahoz, JM | 1 |
| Sasano, S | 1 |
| Yamamoto, H | 1 |
| Otsuka, T | 1 |
| Fujita, A | 1 |
| Onuki, T | 1 |
| Nitta, S | 1 |
| Arnadottir, T | 1 |
| Goloubeva, V | 1 |
| Lecocq, M | 1 |
| Lassowsky, P | 1 |
| Matthys, F | 1 |
| Bastian, I | 1 |
| Ofoefule, SI | 1 |
| Onyeagba, OE | 1 |
| Orisakwe, OE | 1 |
| Khan, MY | 1 |
| Kinsara, AJ | 1 |
| Osoba, AO | 1 |
| Bakare, NA | 1 |
| Onadeko, BO | 4 |
| Musser, JM | 1 |
| Awe, RJ | 1 |
| Teixeira, L | 1 |
| Rocha, LM | 1 |
| Rose, L | 1 |
| Lademarco, MF | 1 |
| Tung, LB | 1 |
| Cĵ, NV | 1 |
| Esteban, J | 1 |
| Gadea, I | 1 |
| Fernandez-Roblas, R | 1 |
| Granizo, JJ | 1 |
| Soriano, F | 1 |
| Viader-Salvadó, JM | 1 |
| Valdez-Leal, R | 1 |
| del Bosque-Moncayo, MA | 1 |
| Tijerina-Menchaca, R | 1 |
| Guerrero-Olazarán, M | 1 |
| Harada, S | 1 |
| Takamoto, M | 2 |
| Ishibashi, T | 1 |
| Mohri, M | 1 |
| Tanabe, K | 1 |
| Sato, R | 1 |
| Tano, M | 1 |
| Tanizawa, M | 1 |
| Morimoto, T | 1 |
| Kawahara, S | 1 |
| Hotta, N | 1 |
| Shigeto, E | 2 |
| Nishimura, K | 1 |
| Abe, T | 1 |
| Oe, T | 1 |
| Shimazu, K | 1 |
| Ebihara, M | 1 |
| Nakagawa, S | 2 |
| Kuba, M | 1 |
| Törün, T | 1 |
| Sevim, T | 1 |
| Ataç, G | 1 |
| Kir, A | 1 |
| Karasulu, L | 1 |
| Ozmen, I | 1 |
| Kapakli, N | 1 |
| Yan, B | 1 |
| Nikolaev, VP | 1 |
| Petukhova, NIu | 1 |
| Gavril'eva, LP | 1 |
| Malogulova, ISh | 1 |
| Yoshida, N | 1 |
| Kolpakova, TA | 1 |
| Bashkirova, IuV | 1 |
| Rachkovskaia, LN | 1 |
| Burylin, SIu | 1 |
| Liubarskiĭ, MS | 1 |
| Sevast'ianova, EV | 1 |
| Voronina, GA | 1 |
| Braden, CR | 1 |
| Morlock, GP | 1 |
| Woodley, CL | 1 |
| Johnson, KR | 1 |
| Colombel, AC | 1 |
| Yang, Z | 1 |
| Valway, SE | 1 |
| Angarano, G | 1 |
| Chirianni, A | 1 |
| Pagano, G | 1 |
| Suter, F | 1 |
| Lauria, FN | 1 |
| Piyaworawong, S | 1 |
| Yanai, H | 1 |
| Nedsuwan, S | 1 |
| Akarasewi, P | 1 |
| Sawanpanyalert, P | 1 |
| Sadaphal, P | 1 |
| Astemborski, J | 1 |
| Graham, NM | 1 |
| Sheely, L | 1 |
| Bonds, M | 1 |
| Madison, A | 1 |
| Vlahov, D | 1 |
| Thomas, DL | 1 |
| Toyota, M | 2 |
| Morioka, S | 2 |
| Mayanja, H | 1 |
| Mutuluuza Kityo, C | 1 |
| Nakibali, JG | 1 |
| Loughlin, AM | 1 |
| Yun, H | 1 |
| Saxena, D | 1 |
| Dwivedi, AK | 1 |
| Rebollo, S | 1 |
| Sanchez, P | 1 |
| Vega, JM | 1 |
| Sedano, E | 1 |
| Sanchís, ME | 1 |
| Asensio, T | 1 |
| Callejo, A | 1 |
| Ivanova, LI | 1 |
| Kravchenko, NS | 1 |
| Sel'tsovskiĭ, PP | 1 |
| Irtuganova, OA | 1 |
| Slogotskaia, LV | 1 |
| Smirnova, NS | 1 |
| Borzenko, AS | 1 |
| Spasov, AA | 1 |
| Smirnova, LA | 1 |
| Dzhura, PI | 1 |
| Karpov, AV | 1 |
| Ivanovskiĭ, VB | 1 |
| Pauker, MN | 1 |
| Plemiannikova, GI | 1 |
| Hargreaves, NJ | 1 |
| Al-Marri, MR | 1 |
| Grange, JM | 1 |
| Yu, D | 1 |
| Hu, X | 1 |
| Kaplan, JE | 1 |
| Gaitonde, S | 1 |
| Pathan, E | 1 |
| Sule, A | 1 |
| Mittal, G | 1 |
| Joshi, VR | 1 |
| Hashiguchi, M | 1 |
| Ohno, K | 1 |
| Sakuma, A | 1 |
| Hino, F | 1 |
| Tanaka, T | 1 |
| Ohtsuji, M | 1 |
| Matsumoto, N | 1 |
| Yanase, K | 1 |
| Urae, A | 1 |
| Hosogai, Y | 1 |
| Yazaki, A | 1 |
| Matsuda, K | 1 |
| Yamazaki, K | 1 |
| Rikihisa, T | 1 |
| Al-Dossary, FS | 1 |
| Correa, AG | 1 |
| Chaiprasert, A | 1 |
| Tingtoy, N | 1 |
| Arjratanakul, W | 1 |
| Pattanakitsakul, SN | 1 |
| Shinoda, C | 1 |
| Hayashi, R | 1 |
| Kawasaki, A | 1 |
| Maruyama, M | 1 |
| Kobayashi, M | 1 |
| Dixit, R | 1 |
| Joshi, N | 1 |
| Jain, NK | 3 |
| Goodall, RL | 1 |
| Dosumu, EA | 1 |
| Sretrirutchai, S | 1 |
| Silapapojakul, K | 1 |
| Palittapongarnpim, P | 1 |
| Phongdara, A | 1 |
| Vuddhakul, V | 1 |
| Sundaram, V | 1 |
| Driver, CR | 1 |
| Claessens, NJ | 1 |
| Gausi, FF | 1 |
| Meijnen, S | 1 |
| Weismuller, MM | 1 |
| Narvskaya, O | 2 |
| Otten, T | 2 |
| Limeschenko, E | 2 |
| Steklova, L | 2 |
| Vyshnevskiy, B | 2 |
| Lee, KA | 1 |
| Ki, CS | 1 |
| Meyburg, J | 1 |
| Schmidt, KG | 1 |
| Nützenadel, W | 1 |
| Bettendorf, M | 1 |
| Huang, TS | 1 |
| Tu, HZ | 1 |
| Lee, SS | 1 |
| Huang, WK | 1 |
| Liu, YC | 1 |
| Toungoussova, S | 1 |
| Caugant, DA | 1 |
| Sandven, P | 1 |
| Mariandyshev, AO | 1 |
| Melzer, M | 1 |
| Brown, TJ | 1 |
| French, GL | 1 |
| Dickens, A | 1 |
| Bagg, LR | 1 |
| Storring, RA | 1 |
| Lacey, S | 1 |
| Pehme, L | 1 |
| Mikelsaar, M | 1 |
| Filipenko, M | 1 |
| Vyazovaya, A | 1 |
| Chrapov, E | 1 |
| Al-Sharif, N | 1 |
| Al-Sayegh, MO | 1 |
| Osman, MM | 1 |
| Shaikh, MA | 1 |
| Perry, W | 1 |
| Jenkins, MV | 1 |
| Erooga, MA | 1 |
| Stamp, TC | 1 |
| Anah, CO | 2 |
| Ziegler, HK | 1 |
| Sinazadeh, M | 1 |
| Farid, Z | 1 |
| Trabolsi, B | 1 |
| Hassan, A | 1 |
| Miner, WF | 1 |
| Rossouw, JE | 1 |
| Saunders, SJ | 1 |
| Sofowora, EO | 2 |
| Fawcett, IW | 1 |
| Watkins, BJ | 1 |
| Clarke, PD | 1 |
| Warkany, J | 1 |
| Goel, J | 1 |
| Singh, H | 1 |
| Dhatt, PS | 1 |
| Gupta, HL | 1 |
| Nielsen, NJ | 1 |
| González Montaner, LF | 1 |
| Garay, C | 1 |
| Abbate, EH | 1 |
| Albareda, MA | 1 |
| Urbanczik, R | 2 |
| Forschbach, G | 1 |
| Harris, AA | 1 |
| Karakusis, P | 1 |
| Loudon, RG | 3 |
| Hershfield, ES | 2 |
| Eidus, L | 9 |
| Helbecque, DM | 1 |
| Ogiĭ, NV | 2 |
| Janowiec, M | 2 |
| Zwolska-Kwiek, Z | 1 |
| Kundu, AK | 1 |
| Murashko, TI | 1 |
| Marchenko, GR | 1 |
| Riaskova, GD | 1 |
| Grenville-Mathers, R | 1 |
| Akbani, Y | 1 |
| Bolme, P | 2 |
| Lindblad, BS | 1 |
| Rahimtoola, RJ | 1 |
| Schmid, PC | 3 |
| Rothfield, NF | 1 |
| Bierer, WF | 1 |
| Garfield, JW | 2 |
| Rapp, RS | 1 |
| Campbell, RW | 1 |
| Howell, JC | 1 |
| Swalbach, WG | 1 |
| Sivasubramanian, SS | 1 |
| Subbammal, S | 4 |
| Milinder, NM | 1 |
| Falk, A | 2 |
| Fuchs, GF | 1 |
| Spiess, H | 2 |
| Guernsey, BG | 1 |
| Alexander, MR | 1 |
| Shukiurov, ShZ | 2 |
| Shmeleva, LV | 1 |
| Rakhmanova, RA | 1 |
| Agaeva, LN | 1 |
| Dzhamalova, ED | 1 |
| Krebs, A | 9 |
| Sattler, FR | 1 |
| Ruskin, J | 1 |
| Kononenko, VG | 1 |
| Mozes, MF | 1 |
| Jonasson, O | 1 |
| Aquinas, M | 1 |
| Coutts, II | 1 |
| Jegarajah, S | 1 |
| Stark, JE | 1 |
| Clavel, S | 1 |
| Clement, F | 1 |
| Poliakova, AN | 1 |
| Ianovskaia, OM | 1 |
| Samuliak, ID | 1 |
| Vasilik, GV | 1 |
| Matviĭchuk, VM | 1 |
| Indzhiia, LV | 1 |
| Yakovleva, LA | 1 |
| Simovonjan, VG | 1 |
| Dshikidze, EK | 1 |
| Kovaljova, VI | 1 |
| Popova, VN | 1 |
| Simmons, NA | 1 |
| Eule, H | 15 |
| Winsel, K | 5 |
| Franke, H | 1 |
| Fox, TG | 1 |
| Mingers, AM | 1 |
| Gekle, D | 1 |
| Pfüller, H | 1 |
| Burk, JR | 1 |
| Bahar, D | 1 |
| Wolf, FS | 2 |
| Greene, J | 1 |
| Afanas'eva, IuP | 2 |
| Kuznetsova, VI | 1 |
| Khalil, A | 1 |
| Sathianathan, S | 1 |
| Riabenko, TM | 1 |
| Postoiuk, MG | 1 |
| Leff, A | 2 |
| Herskowitz, D | 1 |
| Gibert, J | 1 |
| Brewin, A | 2 |
| Spyridis, P | 1 |
| Sinaniotis, C | 1 |
| Papadea, I | 1 |
| Oreopoulos, L | 1 |
| Hadjiyiannis, S | 1 |
| Papadatos, C | 1 |
| Dasta, JF | 1 |
| Prior, JA | 1 |
| Kurzrok, S | 1 |
| Burke, RM | 1 |
| Schwartz, LP | 1 |
| Inui, TS | 1 |
| Hill, TA | 1 |
| Leiby, GM | 1 |
| Sanders, BM | 1 |
| Draper, GJ | 1 |
| Thadepalli, H | 1 |
| Bach, VT | 1 |
| Webb, DW | 1 |
| Campbell, PB | 1 |
| Lester, W | 6 |
| Jones, L | 1 |
| Graham, WG | 1 |
| Dundas, GR | 1 |
| Robinson, PA | 1 |
| Baum, C | 2 |
| Broll, I | 1 |
| Schumacher, W | 1 |
| Glatthaar, E | 3 |
| Hodgkin, MM | 4 |
| Afonja, AO | 1 |
| Arhavwarien, ED | 1 |
| Okotore, RO | 1 |
| Femi-Pearse, D | 1 |
| Sharapova, VI | 1 |
| Smagulov, AS | 1 |
| Sakhipova, NK | 1 |
| V'iukova, RN | 1 |
| Golenitskiĭ, AI | 2 |
| Koval', NN | 1 |
| Iareshko, AG | 1 |
| Spielmann, E | 1 |
| Promisloff, RA | 1 |
| Johnston, RF | 3 |
| Logan, J | 1 |
| Aizawa, H | 2 |
| Inoue, I | 1 |
| Sasaoka, M | 2 |
| Yamaguchi, W | 2 |
| Shimada, M | 1 |
| Toushek, I | 1 |
| Papezhova, E | 1 |
| Wipf, R | 1 |
| Woolcock, WJ | 1 |
| Dawson, DJ | 1 |
| Sharma, GS | 3 |
| Gupta, PK | 1 |
| Shanker, A | 1 |
| Nanawati, V | 1 |
| Steinbrück, P | 3 |
| Renger, F | 2 |
| Weise, L | 2 |
| Addington, WW | 2 |
| Geppert, EF | 1 |
| Matthiessen, W | 1 |
| Wundschock, M | 1 |
| Göbel, D | 2 |
| Jungbluth, H | 4 |
| Kropp, R | 2 |
| Bürger, B | 1 |
| Rzaĭ, OV | 1 |
| Smyslov, VV | 1 |
| Layton, CR | 1 |
| Mitchell, WH | 1 |
| Clemmesen, J | 1 |
| Hjalgrim-Jensen, S | 1 |
| Sauvaget, J | 1 |
| Sainte-Laudy, J | 1 |
| Canavate, A | 1 |
| Lange, W | 1 |
| Ioffe, RA | 4 |
| Senanayake, N | 1 |
| Vyravanathan, S | 1 |
| Kanagasuriyam, S | 1 |
| Knop, P | 3 |
| Kindler, U | 4 |
| Austerhoff, A | 2 |
| Kita, R | 1 |
| Kim, E | 1 |
| Yukawa, K | 1 |
| Hayashi, M | 1 |
| Yukawa, E | 1 |
| Karabach, SS | 1 |
| Steiner, A | 1 |
| Medici, TC | 1 |
| Yang, SP | 3 |
| Luan, HW | 1 |
| Chang, CE | 2 |
| Lauver, GL | 1 |
| Bauchinger, M | 1 |
| Gebhart, E | 1 |
| Fonatsch, C | 1 |
| Schmid, E | 1 |
| Müller, W | 2 |
| Obe, G | 1 |
| Beek, B | 1 |
| Kuntz, HD | 2 |
| Rausch, V | 2 |
| Bammel, E | 1 |
| Thompson, JE | 2 |
| Hoose, C | 2 |
| Lowenfels, AB | 1 |
| Modai, J | 1 |
| Coulaud, JP | 1 |
| Vivien, JM | 1 |
| Berthelot, G | 1 |
| Bergogne-Berezin, E | 2 |
| Kopanoff, DE | 1 |
| Ehring, F | 1 |
| Shinkai, A | 2 |
| Azuma, Y | 4 |
| Vivés, JF | 1 |
| Rouy, JM | 1 |
| Wagner, A | 1 |
| Vallat, G | 1 |
| Kiselova, ES | 3 |
| Kotchabhakdi, N | 1 |
| Junnanond, C | 1 |
| Ksiaźek, A | 1 |
| Wojtczak, A | 1 |
| Kunitskiĭ, EM | 1 |
| Ertevtsian, LN | 1 |
| Vavilin, GI | 1 |
| Butorin, EP | 1 |
| Wilson, RT | 1 |
| Grönhagen-Riska, C | 1 |
| Hellstrom, PE | 1 |
| Fröseth, B | 1 |
| Elliott, J | 1 |
| Powłowska, I | 1 |
| Rakowska, Z | 1 |
| Virsik, K | 1 |
| Kruty, R | 1 |
| Matula, F | 1 |
| Badalik, L | 2 |
| Gamzaem, MM | 1 |
| Karimdzhanova, KhK | 1 |
| Sodikov, ES | 2 |
| Mengistu, M | 1 |
| Maru, M | 1 |
| Chua, FS | 1 |
| Zvetina, JR | 1 |
| Raghunath, TK | 1 |
| Neville, WE | 1 |
| Pifarre, R | 1 |
| Berim, MG | 1 |
| Gozman, EA | 1 |
| Kalugina, NM | 1 |
| Choulot, JJ | 1 |
| Beaufils, F | 1 |
| Labrune, B | 1 |
| Kossmann, CE | 1 |
| Quinteros, CM | 1 |
| Chehín, E | 1 |
| Wayar, E | 1 |
| Ratner, M | 1 |
| Block, ER | 1 |
| Byrd, RB | 3 |
| Horn, BR | 1 |
| Solomon, DA | 1 |
| Griggs, GA | 1 |
| Benkö, M | 2 |
| Heffernan, JF | 4 |
| Peto, J | 2 |
| Gel'berg, SI | 1 |
| Pozniak, SB | 1 |
| Golli, V | 1 |
| Sfârlează, V | 1 |
| Ionescu, N | 1 |
| Stefănescu, I | 1 |
| Stefanin, E | 1 |
| Fairshter, RD | 1 |
| Randazzo, GP | 1 |
| Garlin, J | 1 |
| Wilson, AF | 1 |
| D'Souza, BJ | 1 |
| Lansky, LL | 1 |
| Cho, CT | 1 |
| Bolton, JM | 1 |
| Snelling, MR | 1 |
| Ashley, MJ | 2 |
| Pinkus, G | 2 |
| Doster, B | 5 |
| MacGregor, RR | 1 |
| Sambamoorthy, S | 2 |
| Litt, IF | 1 |
| Cohen, MI | 1 |
| McNamara, H | 1 |
| Sivasubramanian, S | 4 |
| Hashem, N | 1 |
| Shawki, R | 1 |
| Maksimova, NM | 1 |
| Atuk, NO | 3 |
| Hart, AD | 1 |
| Hunt, EH | 2 |
| Kasik, JE | 1 |
| Schuldt, S | 1 |
| Horton, DJ | 1 |
| Spector, SL | 1 |
| Sellers, CA | 1 |
| Lantz, SO | 1 |
| Hardy, GE | 1 |
| Iatsozhinskiĭ, IuD | 1 |
| Molotkov, VN | 1 |
| Kubícková, T | 1 |
| Martynková, M | 1 |
| Geboes, K | 1 |
| Bossaert, H | 1 |
| Voskresenskiĭ, ON | 1 |
| Iqnatova, AV | 1 |
| Semenova, VN | 1 |
| Starostenko, EV | 2 |
| Gol'dshteĭn, VD | 3 |
| Kriukov, VL | 1 |
| Salako, LA | 1 |
| Aderounmu, AF | 1 |
| Goncharov, AV | 1 |
| Koropetskiĭ, VI | 1 |
| Glassroth, JL | 1 |
| Meier, N | 1 |
| Pierart, O | 1 |
| Kuhn, S | 1 |
| Zabala, M | 1 |
| Woywood, E | 1 |
| Abarca, L | 1 |
| Cortés, S | 1 |
| Inaba, N | 1 |
| Ohi, Y | 1 |
| Yamada, E | 1 |
| Yasubuchi, Y | 1 |
| Khorosheva, MN | 1 |
| Chernousova, TIa | 1 |
| Scheinhorn, DJ | 1 |
| Angelillo, VA | 1 |
| McDonald, RJ | 2 |
| Gärtig, D | 1 |
| Stander, MF | 1 |
| Fisher, JR | 1 |
| McGuire, WW | 1 |
| Stephens, R | 1 |
| Kvapilová, M | 1 |
| Mison, P | 1 |
| Podgore, JK | 1 |
| Freeksen, E | 1 |
| Rosenfeld, M | 1 |
| Chew, CH | 2 |
| Peters, M | 1 |
| Papageogiou, A | 1 |
| Pereira, V | 1 |
| Albert, RK | 1 |
| Hudson, LD | 3 |
| Lattimore, WC | 1 |
| Bentz, RR | 1 |
| Fraser, RI | 1 |
| Ostrow, JH | 1 |
| Sewell, EM | 2 |
| Lee, MW | 1 |
| Adebonojo, FO | 1 |
| Pacheco, CR | 2 |
| Cordero, O | 2 |
| Sierra, D | 2 |
| Pacheco, J | 1 |
| Vázquez, E | 2 |
| Daniel, TM | 1 |
| Mahmoud, AA | 1 |
| Warren, KS | 1 |
| Bomb, BS | 2 |
| Purohit, SD | 3 |
| Bedi, HK | 1 |
| Collier, J | 1 |
| Joekes, AM | 1 |
| Philalithis, PE | 1 |
| Thompson, FD | 1 |
| Prytz, S | 1 |
| Hansen, JL | 1 |
| Tytor, IaM | 2 |
| Galbraith, JD | 2 |
| Kordzakhiia, TP | 1 |
| Shaw, T | 1 |
| Misra, BP | 1 |
| Corradini, A | 1 |
| Isekson, I | 1 |
| Deck, C | 1 |
| Zamorano, T | 1 |
| Lee, SK | 1 |
| Kaernbach, E | 1 |
| Kaluza, P | 2 |
| Saerens, E | 1 |
| Alyabina, MG | 2 |
| Shmelev, NA | 3 |
| Pecak, W | 1 |
| Leowski, J | 1 |
| Nachman-Bijas, J | 1 |
| Mroz-Czajka, D | 1 |
| Trzcinski, K | 1 |
| Wlazlo, Z | 1 |
| Riska, N | 2 |
| Edwards, PQ | 2 |
| Levin, ML | 1 |
| Fuchs, G | 1 |
| Oussedik, N | 2 |
| Amrane, R | 1 |
| Hassen, CS | 1 |
| Mercer, N | 1 |
| Citron, K | 1 |
| Allan, WG | 3 |
| Szemzo, J | 1 |
| Calvete, C | 1 |
| Le Rebeller, MJ | 1 |
| Lagoutte, F | 1 |
| Rahim, MA | 1 |
| Turbiner, S | 1 |
| Giunta, J | 1 |
| Maloney, PL | 1 |
| Vasil'ev, VB | 1 |
| Vasil'eva, VV | 1 |
| Ammen, VK | 1 |
| Karpouzas, J | 1 |
| Papagregoriou, M | 1 |
| Casteels-Van Daele, M | 1 |
| Igodt-Ameye, L | 1 |
| Corbeel, L | 1 |
| Eeckels, R | 1 |
| Clochiatti, G | 1 |
| Lorusso, G | 1 |
| De Luca, G | 1 |
| Gastaldi, A | 1 |
| Alarcon-Segovia, D | 2 |
| Fishbein, E | 2 |
| Austoker, LH | 1 |
| Garrioch, DB | 1 |
| Trachtman, L | 1 |
| Thompson, DH | 1 |
| Tala, E | 1 |
| McKenzie, SA | 1 |
| Macnab, AJ | 1 |
| Katz, G | 1 |
| Kupish, SG | 1 |
| Ivanova, AI | 1 |
| Maslauskene, TP | 2 |
| Novruzov, MA | 1 |
| Kahana, LM | 1 |
| Cole, FM | 1 |
| Richardson, H | 1 |
| DeRouen, TA | 1 |
| Ziskind, MM | 2 |
| Tabrisky, J | 1 |
| Lindstrom, RR | 1 |
| Peters, R | 1 |
| Lachman, RS | 1 |
| Cantrell, RW | 1 |
| Jensen, JH | 1 |
| Reid, D | 1 |
| Oleszkiewicz, Z | 1 |
| Mortazawi, H | 1 |
| Banihaschemi, A | 1 |
| Bigdeli, M | 1 |
| Lewis, JE | 1 |
| Mello, P | 1 |
| Knauer, CM | 1 |
| Lefrak, SS | 1 |
| Byrd, R | 1 |
| Senior, RM | 1 |
| Avioli, LV | 1 |
| Jaillard, J | 1 |
| Carre, A | 1 |
| Perrard, C | 1 |
| Ginestet, A | 1 |
| Beuscart, F | 1 |
| Dudckik, GKh | 1 |
| Ershov, AE | 1 |
| Sushkin, AP | 1 |
| Guseva, TM | 1 |
| Mexenskaia, AIa | 1 |
| Klebanova, AA | 5 |
| Israel, HL | 3 |
| Bunyan, SC | 1 |
| Agapov, IuIa | 1 |
| Volkova, NV | 1 |
| Ratajek, M | 1 |
| Schaefer, G | 1 |
| Zervoudakis, IA | 1 |
| Fuchs, FF | 1 |
| Zhukova, GN | 1 |
| Shmeleva, VI | 1 |
| Gammon, PT | 2 |
| Titinen, H | 1 |
| Csata, S | 1 |
| Szendi, L | 1 |
| Koller, O | 1 |
| Agraval, PD | 1 |
| Siddiqi, SH | 1 |
| Stauffer, JC | 1 |
| Stewart, CJ | 1 |
| Derichs, R | 1 |
| Merholz, S | 1 |
| Merholz, T | 1 |
| Kreek, MJ | 1 |
| Gutjahr, CL | 1 |
| Giusti, LM | 1 |
| Schatz, M | 1 |
| Patterson, R | 1 |
| Kloner, R | 1 |
| Falk, J | 1 |
| Nouhouayi, A | 1 |
| Letonturier, P | 1 |
| Thibault, B | 1 |
| Tourneur, R | 1 |
| Smachilo, DT | 1 |
| Hopewell, PD | 1 |
| Buckingham, W | 1 |
| Rosenblatt, WF | 1 |
| Raghupati Sarma, G | 1 |
| Kannapirin, G | 1 |
| Vanderhoof, JA | 1 |
| Ament, ME | 1 |
| Buchanan, N | 1 |
| Strickwold, B | 1 |
| Shuenyane, E | 1 |
| Dukes, CS | 1 |
| Sugarman, J | 1 |
| Lallinger, GJ | 1 |
| Mwakyusa, DH | 1 |
| Lee, PY | 2 |
| Sun, ZH | 1 |
| Nomura, K | 1 |
| Toraya, S | 1 |
| Ujihara, M | 1 |
| Horiba, N | 1 |
| Suda, T | 1 |
| Tsushima, T | 1 |
| Demura, H | 1 |
| Kono, A | 1 |
| Kwan, SY | 2 |
| Lebeaut, A | 1 |
| Parrot, R | 3 |
| Dinh-Xuan, AT | 1 |
| Ma, WK | 2 |
| Felmingham, D | 1 |
| Allen, BW | 1 |
| Wolde, K | 1 |
| Lema, E | 1 |
| Roscigno, G | 1 |
| Abdi, A | 1 |
| Culliton, BJ | 1 |
| Ross, BC | 1 |
| Dwyer, B | 1 |
| Goh, KS | 1 |
| Clavel-Sérès, S | 1 |
| Jeantils, V | 1 |
| Cruaud, P | 1 |
| Nunn, P | 1 |
| Gicheha, C | 1 |
| Gathua, S | 1 |
| Mutie, T | 1 |
| Kamunyi, R | 1 |
| Omwega, M | 1 |
| Were, J | 1 |
| Kumaresan, JA | 1 |
| Maganu, ET | 1 |
| Butyl'chenko, OV | 1 |
| Dickinson, J | 1 |
| Guy, A | 1 |
| Farmakis, M | 1 |
| Travlou, O | 1 |
| Aroni, S | 1 |
| Fertakis, A | 1 |
| Gent, WL | 1 |
| Lamprecht, JH | 1 |
| Kaku, M | 1 |
| Maesaki, S | 1 |
| Bispen, AV | 1 |
| Aleksandrova, AE | 2 |
| Vakhmistrova, TI | 1 |
| Bloom, BR | 1 |
| Yoshimoto, S | 1 |
| Takeuchi, M | 1 |
| Tada, A | 1 |
| Matsuzawa, Y | 1 |
| Fujimoto, K | 1 |
| Kubo, K | 1 |
| Sekiguchi, M | 1 |
| Woo, J | 3 |
| Chan, CH | 2 |
| Gottlieb, JE | 1 |
| Maddrey, WC | 1 |
| Brennan, PJ | 1 |
| Idigbe, EO | 1 |
| Duque, JP | 1 |
| John, EK | 1 |
| Annam, O | 1 |
| Hasegawa, T | 1 |
| Tada, K | 1 |
| Ishii, M | 1 |
| Vennema, A | 1 |
| Blinov, VIu | 2 |
| Gubina, NA | 1 |
| Nazar-Stewart, V | 1 |
| Jarallah, JS | 1 |
| Elias, AK | 1 |
| al Hajjaj, MS | 1 |
| Bukhari, MS | 1 |
| al Shareef, AH | 1 |
| al-Shammari, SA | 1 |
| Turkebaeva, KA | 1 |
| Shipunova, OV | 1 |
| Krivtsova, AE | 2 |
| Moshkevich, SA | 1 |
| Zhubanov, BA | 1 |
| Jordan, TJ | 1 |
| Lewit, EM | 1 |
| Singhal, KC | 2 |
| Varshney, MK | 1 |
| Adrados, M | 1 |
| Díaz, F | 1 |
| Martínez, R | 1 |
| García Aguado, C | 1 |
| Puente, S | 1 |
| González Lahoz, JM | 1 |
| Litvinov, VI | 1 |
| Tikhtaev, MT | 1 |
| Baenskiĭ, AV | 1 |
| Shcherbakova, NM | 1 |
| Zabolotnykh, NV | 1 |
| Shchegoleva, RA | 1 |
| van der Have, JJ | 1 |
| Gol'tsova, NA | 2 |
| Gnezdilova, TM | 1 |
| Kotova, LI | 1 |
| Ergeshov, AE | 1 |
| Matsulevich, TV | 1 |
| Bobarykin, VS | 1 |
| Wiesner, B | 2 |
| Cramer, G | 2 |
| Hamel, U | 1 |
| Roth, G | 1 |
| Ip, M | 1 |
| Cheng, KP | 1 |
| Cheung, WC | 1 |
| Lau, KS | 1 |
| Ling, MH | 1 |
| Deshpande, DV | 1 |
| Nachne, D | 1 |
| Koyande, D | 1 |
| Rodriques, CJ | 1 |
| Niiazbekova, KZh | 1 |
| Arzamova, RA | 1 |
| Tleubergenov, ET | 1 |
| Litvin, LM | 1 |
| Romanchenko, NN | 1 |
| Koltoniuk, RS | 1 |
| Loboda, MV | 1 |
| Rose, DN | 2 |
| Schechted, CB | 1 |
| Silver, AL | 2 |
| Mel'nik, VP | 1 |
| Lefrak, S | 1 |
| Small, PM | 1 |
| Goodman, PC | 1 |
| Sande, MA | 2 |
| Krumdieck, R | 1 |
| Shaw, DR | 1 |
| Huang, ST | 1 |
| Poon, MC | 1 |
| Rustagi, PK | 1 |
| Shapatava, MN | 2 |
| Kalankhodzhaev, AA | 1 |
| Gamzaeva, NF | 1 |
| Shafer, RW | 1 |
| Jones, WD | 1 |
| Jacobs, RF | 2 |
| Shannon, A | 1 |
| Kelly, P | 2 |
| Lucey, M | 1 |
| Cooney, M | 1 |
| Corcoran, P | 1 |
| Clancy, L | 1 |
| Chan, K | 2 |
| Wong, CL | 2 |
| Puiatti, P | 1 |
| Salvai, M | 1 |
| Alberico, G | 1 |
| Goitre, M | 1 |
| Mele, M | 1 |
| Molinaro, GC | 1 |
| Genovesio, L | 1 |
| Actis, G | 1 |
| Rac, VV | 1 |
| Gupta, EV | 1 |
| Thomas, IM | 1 |
| Dowling, PT | 1 |
| Greenberg, PD | 1 |
| Lax, KG | 1 |
| Schechter, CB | 2 |
| Sato, M | 2 |
| Iwasaki, T | 2 |
| Takase, A | 1 |
| Kinoshita, T | 2 |
| Kinjo, T | 1 |
| Odo, A | 1 |
| Hara, M | 1 |
| Hirata, H | 1 |
| Yébenes Díaz, G | 1 |
| Kloppe Villegas, P | 1 |
| Hidalgo Vera, P | 1 |
| Martín-Rabadán Murox, M | 1 |
| Peterson, KL | 1 |
| Judson, FN | 1 |
| Agounitestane, D | 1 |
| Chiheb, M | 1 |
| Clancy, LJ | 1 |
| O'Reilly, L | 1 |
| Byrne, C | 1 |
| Costello, E | 1 |
| Eberhardt, K | 1 |
| Hartmann, W | 1 |
| Wosniok, W | 1 |
| Nowak, D | 2 |
| Radenbach, D | 2 |
| Magnussen, H | 2 |
| Scalcini, M | 1 |
| Carré, G | 1 |
| Jean-Baptiste, M | 1 |
| Hershfield, E | 1 |
| Parker, S | 1 |
| Wolfe, J | 1 |
| Nelz, K | 1 |
| Khin, MA | 1 |
| Chau, PY | 1 |
| Gafni, A | 1 |
| Wosornu, D | 1 |
| MacIntyre, D | 1 |
| Balasubramanian, R | 1 |
| Vijayan, VK | 1 |
| Jawahar, MS | 1 |
| Savvateeva, VG | 1 |
| Makarova, VM | 1 |
| Lokhov, MG | 1 |
| Murriev, A | 1 |
| Combs, DL | 2 |
| Nisar, M | 1 |
| Watkin, SW | 1 |
| Bucknall, RC | 1 |
| Agnew, RA | 1 |
| Brink, BA | 1 |
| Bhatia, MS | 1 |
| Maslova, LI | 1 |
| Kalmykova, GN | 1 |
| Neill, P | 1 |
| Pringle, D | 1 |
| Mhonda, M | 1 |
| Kusema, T | 1 |
| Nhachi, CF | 1 |
| Sbarbaro, J | 1 |
| Onishchenko, VV | 1 |
| Iurchenko, LN | 2 |
| Reis, FJ | 1 |
| Bedran, MB | 1 |
| Moura, JA | 1 |
| Assis, I | 1 |
| Rodrigues, ME | 1 |
| Colice, GL | 1 |
| Smirnova, NA | 1 |
| Narovlianskaia, SE | 2 |
| Morland, L | 1 |
| Singhi, PD | 1 |
| Rao, KL | 1 |
| Katariya, S | 1 |
| Kazakov, KS | 1 |
| Zakharova, RI | 1 |
| Absadykova, FT | 1 |
| Mel'nik, GV | 1 |
| Man'ko, VP | 1 |
| Yeh, PF | 1 |
| Chan, CY | 1 |
| Wang, YJ | 1 |
| Huang, YS | 1 |
| Tsai, YT | 1 |
| Ting, LP | 1 |
| Lo, KJ | 1 |
| Gerasimov, EA | 1 |
| Lütjohann, D | 1 |
| Peter, MG | 1 |
| Noreĭko, BV | 1 |
| Vorodiukhina, AK | 1 |
| Michaud, PA | 1 |
| Sóle Mir, E | 1 |
| Gussiñé Canadell, M | 1 |
| Castillo Salinas, F | 1 |
| Pérez LaCasta, P | 1 |
| Montané Pasamontes, C | 1 |
| Bosch Castañé, J | 1 |
| Carrascosa Lezcano, A | 1 |
| Rahman, F | 1 |
| Schraufnagel, DE | 1 |
| Stoner, R | 1 |
| Whiting, E | 1 |
| Snukst-Torbeck, G | 1 |
| Werhane, MJ | 1 |
| Roslik, SM | 1 |
| Pashkov, IuN | 1 |
| Gerasimova, TG | 1 |
| Marveeva, SL | 1 |
| Sokirko, TA | 2 |
| Maliuk, VI | 1 |
| Suslov, EI | 1 |
| Gimbatov, MM | 1 |
| Zhandulaev, MM | 1 |
| Basirov, MB | 1 |
| Lehingue, Y | 1 |
| Urtizberea, JA | 1 |
| Kecharanandana, P | 1 |
| Payanandana, W | 1 |
| Daramas, M | 1 |
| Gross, TP | 1 |
| Silverman, PR | 1 |
| Smith, TY | 1 |
| Rogers, GW | 1 |
| Saleem, M | 1 |
| Malik, SA | 1 |
| Ahmed, M | 1 |
| Saleem, N | 1 |
| Avasthi, R | 1 |
| Jain, AP | 1 |
| Ligueros, M | 1 |
| Cruz Coke, R | 1 |
| Neira, S | 1 |
| Saavedra, H | 1 |
| Kramer, V | 1 |
| Prieto, JC | 1 |
| Gelman, M | 1 |
| Saavedra, A | 1 |
| Nuñez, A | 1 |
| Pescio, S | 1 |
| Castelo, A | 1 |
| Jardim, JR | 1 |
| Goihman, S | 1 |
| Kalckman, AS | 1 |
| Dalboni, MA | 1 |
| da Silva, EA | 1 |
| Haynes, RB | 1 |
| Takabayashi, K | 1 |
| Koike, T | 1 |
| Kurasawa, K | 1 |
| Yamazaki, S | 1 |
| Sugiyama, T | 1 |
| Matsumura, R | 1 |
| Yoshida, H | 1 |
| Tomioka, H | 1 |
| Yoshida, S | 1 |
| Ohshima, H | 1 |
| Gendrel, D | 1 |
| Nardou, M | 1 |
| Mouba, JF | 1 |
| Gahouma, D | 1 |
| Moussavou, A | 1 |
| Boguikouma, JB | 1 |
| Madan, A | 1 |
| Sharma, DK | 1 |
| Madan, R | 1 |
| González Rodríguez, P | 1 |
| Alvarez-Coca González, J | 1 |
| Gómez Gascón, T | 1 |
| Ladron de Guevara, R | 1 |
| Bellabas, M | 1 |
| Khaled, NA | 1 |
| Haegi, V | 1 |
| Villiger, B | 1 |
| Bohn, W | 1 |
| Baumann, HR | 1 |
| Zäch, R | 1 |
| Glassroth, J | 1 |
| Priĭmak, AA | 1 |
| Goncharov, AM | 1 |
| Glazkov, PV | 1 |
| Makeenkova, LI | 1 |
| Ladniuk, VM | 1 |
| Hanson, CA | 1 |
| Garciá López, JR | 1 |
| Castán Vidal, ML | 1 |
| Borque Andrés, C | 1 |
| de José Gómez, MI | 1 |
| García Hortelano, J | 1 |
| Gel'berg, IS | 1 |
| Romaniuk, SL | 1 |
| Avlasenko, VS | 1 |
| Zharovina, MM | 1 |
| Lomachenkov, VD | 1 |
| Pavliunina, LD | 1 |
| Bazhenov, SM | 1 |
| Pavliunin, AM | 1 |
| Zhamoĭdo, SV | 1 |
| Shimko, NP | 1 |
| Maĭovetskaia, NS | 1 |
| Severina, MV | 1 |
| Alimova, LV | 1 |
| Porokhnia, VV | 1 |
| Khomenko, VV | 1 |
| Petrovich, DI | 1 |
| Iusukhno, EE | 1 |
| Skvira, VP | 1 |
| Felten, MK | 2 |
| Osiĭnskiĭ, IIu | 1 |
| Berezovskiĭ, BA | 1 |
| Kil'diusheva, EI | 1 |
| Shevchenko, RN | 1 |
| German, AK | 1 |
| Akhtyrskiĭ, AI | 1 |
| Smirnova, VV | 1 |
| Lebedeva, LV | 3 |
| Olianishin, VN | 1 |
| Kadnikova, ON | 1 |
| van der Merwe, CA | 1 |
| Krasucka-Kluźniak, A | 1 |
| Drygalska-Pozorońska, A | 1 |
| Pelczarska, B | 1 |
| Szafarkiewicz, M | 1 |
| Helwig, S | 1 |
| Kucharska, I | 1 |
| Sybilska, H | 1 |
| Ogiwara, S | 1 |
| Alhashimi, MM | 1 |
| Citron, ML | 1 |
| Fossieck, BE | 1 |
| Steinberg, SM | 1 |
| Johnston-Early, A | 1 |
| Krasnow, SH | 1 |
| Cohen, MH | 1 |
| Harman, EM | 1 |
| Toppet, M | 2 |
| Vainsel, M | 2 |
| Vertongen, F | 1 |
| Fuss, M | 1 |
| Cantraine, F | 2 |
| Teruel, JL | 1 |
| Matesanz, R | 1 |
| Mampaso, F | 1 |
| Lamas, S | 1 |
| Herrero, JA | 1 |
| Ortuno, J | 1 |
| Ellis, ME | 1 |
| Tayoub, F | 1 |
| Babu Swai, O | 1 |
| Thiong'o, R | 1 |
| Darbyshire, JH | 2 |
| Etzkorn, ET | 1 |
| Lillis, PK | 1 |
| Ismatullaev, F | 1 |
| Mitchell, M | 2 |
| Ayres, JG | 1 |
| Nardell, E | 1 |
| Weidhaas, S | 1 |
| Berliner, DS | 1 |
| Haupt, A | 1 |
| Sarkisian, MA | 1 |
| Demidchik, NIa | 1 |
| Jimenez-Lucho, VE | 1 |
| del Busto, R | 1 |
| Odel, J | 1 |
| Solov'eva, IP | 1 |
| Ponomareva, MB | 1 |
| Shlapkauskaĭte, DP | 1 |
| Malik, NA | 1 |
| Grossman, M | 1 |
| Smith, MH | 3 |
| Xu, RX | 1 |
| Izuchi, R | 2 |
| Trivedi, SS | 1 |
| Desai, SG | 1 |
| Slutkin, G | 1 |
| Eriksson, M | 1 |
| Paalzow, L | 1 |
| Schwartz, MS | 1 |
| Kahlstrom, EJ | 1 |
| Hawkins, DB | 1 |
| Evdokimov, VN | 1 |
| Lecoeur, H | 1 |
| Almog, S | 1 |
| Martinowitz, U | 1 |
| Halkin, H | 1 |
| Bank, HZ | 1 |
| Farfel, Z | 1 |
| Dal Negro, R | 1 |
| Turco, P | 1 |
| Trevisan, F | 1 |
| De Conti, F | 1 |
| Chaturvedi, SK | 1 |
| Upadhyaya, M | 1 |
| Cheung, R | 1 |
| Dickins, J | 1 |
| Nicholson, PW | 1 |
| Thomas, AS | 1 |
| Smith, HH | 1 |
| Larson, HE | 1 |
| Deshmukh, AA | 1 |
| Dobbs, RJ | 1 |
| Dobbs, SM | 1 |
| Panasiuk, AV | 2 |
| Il'nitskiĭ, IG | 2 |
| Kunichkina, SA | 2 |
| Azarenko, II | 1 |
| Lola, AT | 1 |
| Umeki, S | 2 |
| Okamoto, Y | 1 |
| Arai, R | 1 |
| Kawahara, M | 1 |
| Furuse, K | 1 |
| Kita, N | 1 |
| Kamigawara, N | 1 |
| Ueshiba, Y | 1 |
| Hwang, JJ | 1 |
| Liu, HW | 1 |
| Wang, TH | 1 |
| Lin, MN | 1 |
| Chen, CY | 1 |
| Goldberger, MJ | 1 |
| Lee, CN | 1 |
| Cornell, C | 1 |
| Ichiyama, S | 1 |
| Gontsa, FT | 1 |
| Savina, LA | 1 |
| Kovalenko, IP | 1 |
| Harvill, L | 1 |
| Henry, W | 1 |
| Singh, U | 1 |
| Kireeva, SG | 1 |
| Karkishchenko, NN | 1 |
| Khoron'ko, VV | 1 |
| Vorob'ev, VS | 1 |
| Anisimova, NB | 1 |
| Chubarian, VT | 1 |
| Lumish, RM | 1 |
| Miyai, M | 1 |
| Tsubota, T | 1 |
| Asano, K | 1 |
| Ray, D | 1 |
| Yoshii, S | 1 |
| Yasuda, Y | 1 |
| Saito, H | 1 |
| Martinez-Roíg, A | 1 |
| Camí, J | 1 |
| Llorens-Terol, J | 1 |
| de la Torre, R | 1 |
| Perich, F | 1 |
| Sakharova, EA | 1 |
| Kaĭkhinidi, NP | 1 |
| Valuĭskiĭ, PF | 1 |
| Romanov, AI | 1 |
| Galaev, VS | 1 |
| Kim, ACh | 1 |
| Krasnova, TK | 1 |
| Romanova, VIa | 1 |
| Anderson, RA | 1 |
| Murphy, DT | 1 |
| Mammo, A | 1 |
| Beck, H | 1 |
| Evers, H | 1 |
| Kwiatkowski, H | 1 |
| Merkel, S | 1 |
| Reech, R | 1 |
| Sieler, R | 1 |
| Thomas, E | 1 |
| Weinecke, W | 1 |
| Awotedu, AA | 1 |
| Ogunbanjo, BO | 1 |
| Aderinto, EB | 1 |
| Protsiuk, RG | 3 |
| Albertini, M | 1 |
| Picon, M | 1 |
| Boutte, P | 1 |
| Mariani, R | 1 |
| Corsello, BF | 1 |
| Hashimoto, M | 1 |
| Yokoyama, S | 1 |
| Higai, S | 1 |
| Liu, C | 1 |
| Dutkiewicz, J | 1 |
| Goldin, JG | 1 |
| Linton, DM | 1 |
| Potgieter, PD | 1 |
| Xiao, GF | 1 |
| Murden, RA | 1 |
| Kobayashi, Y | 1 |
| Morinari, H | 1 |
| Terashi, R | 1 |
| Okubo, S | 1 |
| Tanaka, M | 1 |
| Kukchenko, GA | 1 |
| Gavrilova, TA | 1 |
| Baĭborodova, TI | 1 |
| Shatskaia, GI | 1 |
| Israili, ZH | 1 |
| Rogers, CM | 1 |
| el-Attar, H | 1 |
| Kovaleva, SI | 2 |
| Dzhokhadze, VA | 1 |
| Mellem, H | 1 |
| Boye, NP | 1 |
| Arnkvaern, R | 1 |
| Fjeld, NB | 1 |
| Sembratowicz, L | 1 |
| Varshney, DP | 1 |
| Rathi, R | 1 |
| Kishore, K | 1 |
| Varshney, SC | 1 |
| Berkani, M | 1 |
| Liard, R | 1 |
| Petitjean, R | 2 |
| Rempp, M | 1 |
| Pierau, F | 1 |
| Chenuet, J | 1 |
| Summers, RS | 1 |
| Crewe-Brown, HH | 1 |
| McCutcheon, JP | 1 |
| Takeda, M | 1 |
| Nishinuma, K | 1 |
| Yamashita, S | 1 |
| Matsubayashi, T | 1 |
| Tanino, S | 1 |
| Nishimura, T | 1 |
| Tamborero, G | 1 |
| Pérez, A | 1 |
| Almazán, C | 1 |
| Nadyrshina, RSh | 1 |
| Melikova, VM | 1 |
| Davis, CE | 1 |
| Huang, M | 1 |
| Zhang, YD | 1 |
| Nemir, RL | 3 |
| Onwubalili, JK | 1 |
| Scott, GM | 1 |
| Smith, H | 1 |
| Schinkai, A | 1 |
| McGlynn, KA | 1 |
| Lustbader, ED | 1 |
| Sharrar, RG | 1 |
| Murphy, EC | 1 |
| London, WT | 1 |
| Layer, P | 1 |
| Engelhard, M | 1 |
| Cooper, JK | 1 |
| Orozco, LC | 1 |
| Quintana, FO | 1 |
| Beltrán, RM | 1 |
| de Moreno, I | 1 |
| Wasserman, M | 1 |
| Rodriguez, G | 1 |
| Shinoda, A | 1 |
| Kondou, H | 1 |
| Nagano, H | 1 |
| Kutsukake, F | 1 |
| Taga, Y | 1 |
| Yasutake, T | 1 |
| Takano, T | 1 |
| Hiro, Y | 1 |
| Glozman, VN | 1 |
| Miltin'sh, AP | 1 |
| Diao, YF | 1 |
| Schönian, U | 1 |
| Ringelmann, R | 1 |
| Grinchar, NA | 1 |
| Williams, SE | 1 |
| Wardman, AG | 1 |
| Taylor, GA | 1 |
| Peacock, M | 1 |
| Cooke, NJ | 1 |
| Valenti, WM | 1 |
| Mukerjee, CM | 1 |
| McKenzie, DK | 1 |
| Tager, IB | 1 |
| Kalaidjian, R | 1 |
| Baldini, L | 1 |
| Rocklin, RE | 2 |
| Sandron, D | 1 |
| Marin, I | 1 |
| Huchon, G | 1 |
| Gomi, J | 5 |
| Aoyagi, T | 1 |
| Röthlisberger, K | 1 |
| Bezel, R | 1 |
| Häcki, M | 1 |
| Rubin, S | 1 |
| Nemcek, AA | 1 |
| Forrest, JV | 1 |
| Kelly, GD | 1 |
| Thompson, NJ | 1 |
| Mazouni, L | 1 |
| Bialik, IB | 3 |
| Kan, GQ | 1 |
| Ma, ZI | 1 |
| Liu, CW | 1 |
| Sun, FZ | 1 |
| Pellock, JM | 2 |
| Howell, J | 1 |
| Baker, H | 1 |
| Pust, RE | 1 |
| Livengood, JR | 1 |
| Sigler, TG | 1 |
| Foster, LR | 1 |
| Bobst, JG | 1 |
| Lofgren, JP | 1 |
| Warren, E | 1 |
| Thomas, C | 1 |
| Novikova, TM | 1 |
| Franckson, M | 1 |
| Petrenko, VI | 2 |
| Ishii, N | 1 |
| Nishihara, Y | 1 |
| Banks, J | 1 |
| Kecharananta, P | 1 |
| Rattarasarn, S | 1 |
| Sriyabhaya, N | 4 |
| Grebenkina, AI | 2 |
| Gamperis, IuL | 1 |
| Gavrilenko, AF | 1 |
| Kuznetsova, GG | 1 |
| Goncharov, VG | 1 |
| Kovalenko, NN | 2 |
| Langton, ME | 2 |
| Kay, L | 1 |
| Kampmann, JP | 1 |
| Svendsen, TL | 1 |
| Vergman, B | 1 |
| Hansen, JE | 1 |
| Skovsted, L | 1 |
| Kristensen, M | 1 |
| Palomera Frade, J | 1 |
| García del Palacio, JI | 1 |
| Jensen, JC | 1 |
| Mikus, G | 1 |
| Warring, FC | 1 |
| Sutramongkole, U | 1 |
| Zykov, MP | 3 |
| Patel, RI | 1 |
| Bwibo, NO | 1 |
| Sen, PK | 2 |
| Saha, JR | 2 |
| Paul, NB | 1 |
| Prodhan, PK | 1 |
| Kent, PW | 2 |
| Miller, AB | 2 |
| Tall, R | 5 |
| Kuznetsova, EE | 2 |
| Lototskaià, RA | 1 |
| Delepierre, F | 2 |
| Rullière, R | 2 |
| Coury, C | 5 |
| Krivinka, R | 1 |
| Wilson, TM | 2 |
| Lakshminarayan, S | 1 |
| Citron, KM | 5 |
| Bhandari, B | 1 |
| Jain, AM | 1 |
| Kulshrestha, SK | 1 |
| Mehta, S | 1 |
| De ville de Goyet, CA | 1 |
| Gay, P | 1 |
| Le Lirzin, M | 3 |
| Rabier, M | 1 |
| Sarrat, H | 1 |
| Greenberg, JH | 1 |
| Lutcher, CL | 1 |
| Chmelev, NA | 1 |
| Watts, TE | 1 |
| Gupta, SK | 2 |
| Law, SC | 1 |
| Sehgal, VN | 1 |
| Bahadur, P | 2 |
| Ghosh, SK | 1 |
| Vadiraj, SN | 1 |
| Hermann, P | 1 |
| Riska, H | 1 |
| Webb, AH | 1 |
| Pamra, SP | 3 |
| Prasad, G | 1 |
| Mathur, GP | 2 |
| Scheuer, PJ | 1 |
| Summerfield, JA | 1 |
| Sherlock, S | 1 |
| van der Meulen, AJ | 1 |
| Kromberg, M | 1 |
| Pearce, SJ | 1 |
| Baker, JT | 1 |
| Pioli, E | 1 |
| Williams, WJ | 1 |
| Kaplan, PD | 1 |
| Gracey, DR | 1 |
| Edwards, OM | 1 |
| Courtenay-Evans, RJ | 1 |
| Galley, JM | 1 |
| Hunter, J | 1 |
| Tait, AD | 1 |
| do Prado, WT | 1 |
| Gomes, Sde C | 1 |
| Kent, P | 1 |
| Karuga, WK | 1 |
| Bignall, JR | 7 |
| Menon, K | 1 |
| Stark, AJ | 1 |
| Bhatia, JL | 1 |
| Clarke, JH | 1 |
| Donia, TO | 1 |
| Marks, J | 2 |
| Weliange, LV | 1 |
| Chang, CC | 1 |
| Dingley, HB | 2 |
| Wstepna, C | 1 |
| Agüero, JG | 1 |
| Chamoles, N | 1 |
| Marengo, R | 1 |
| Epelbaum, A | 1 |
| Patel, RB | 1 |
| Patel, TL | 1 |
| Mehta, HC | 1 |
| DiLorenzo, PA | 1 |
| Horsfall, PA | 1 |
| Mahdi, ME | 1 |
| Briggs, IL | 1 |
| Rochester, WR | 1 |
| Riddell, RW | 1 |
| Mital, OP | 1 |
| Ramalingam, JT | 1 |
| Agarwala, MC | 1 |
| Krishnamurthy, KA | 1 |
| Subramanian, J | 1 |
| Chicou, FJ | 1 |
| Huet, M | 1 |
| Radenac, H | 1 |
| Brudnaia, KB | 1 |
| Slepova, RI | 1 |
| Borovkova, NM | 1 |
| Scott, EH | 1 |
| Förström, L | 1 |
| Hannuksela, M | 1 |
| Volek, V | 1 |
| Vodrázková, A | 1 |
| Polánský, F | 3 |
| Lukes, J | 1 |
| Morbach, SG | 1 |
| Farnesi, A | 1 |
| Corrêa, B | 1 |
| Haddad, R | 1 |
| Barbosa, ZL | 1 |
| Horvátth, I | 1 |
| Tengelyi, W | 1 |
| Pande, DC | 1 |
| Grover, KL | 1 |
| Pejovic, H | 1 |
| Dunbar, FP | 1 |
| Jenne, JW | 1 |
| Beggs, WH | 1 |
| Braman, SS | 1 |
| Goldman, AL | 1 |
| Schwarz, MI | 1 |
| Jurgens, GH | 1 |
| Padre, R | 1 |
| Goldberg, R | 2 |
| Yamanouchi, T | 1 |
| Sawai, A | 1 |
| Hori, M | 1 |
| Brickman, HF | 2 |
| Beaudry, PH | 2 |
| Raleigh, JW | 3 |
| Wichelhausen, R | 1 |
| Volkon, VM | 1 |
| Shrentsel', OA | 1 |
| Ross, JD | 1 |
| Walton, M | 2 |
| White, AB | 2 |
| Ganguin, HG | 1 |
| Götz, J | 1 |
| Holzhauer, H | 1 |
| Niegsch, G | 1 |
| Sieler, H | 1 |
| Velten, G | 1 |
| Völker, L | 1 |
| Gur'ian, IE | 1 |
| Gerhardt FO, G | 1 |
| Magarăo, S | 1 |
| Lakshiminarayan, S | 1 |
| Sahn, SA | 1 |
| Newman, R | 3 |
| Doster, BE | 1 |
| Woolpert, SF | 5 |
| Rein, MF | 1 |
| Fischetti, JL | 1 |
| Debre, R | 1 |
| Naveau, M | 1 |
| Lert, F | 1 |
| Gunnels, JJ | 1 |
| Bates, JH | 3 |
| Swindoll, H | 1 |
| Swinburn, PD | 1 |
| Wilkesmann, M | 1 |
| Rudoĭ, NM | 5 |
| Bochkov, EN | 1 |
| Chioléro, R | 2 |
| Kaupas, V | 1 |
| Jessamine, AG | 2 |
| Gale, GL | 1 |
| Wildrick, KH | 1 |
| Takayama, K | 1 |
| Armstrong, EL | 1 |
| David, HL | 1 |
| Boytar-Papirnyik, V | 3 |
| Nejjar, A | 1 |
| Laraki, A | 1 |
| Schuh, D | 1 |
| Justus, J | 1 |
| Wichmann, G | 1 |
| Victoria, M | 1 |
| Tikhonov, VS | 1 |
| Hampton, JR | 1 |
| Levy, SA | 2 |
| Brouet, G | 2 |
| Corner, BD | 1 |
| Anderson, JD | 1 |
| Laszczka, C | 1 |
| Fineg, J | 1 |
| Hanly, WC | 1 |
| Prine, JR | 1 |
| Van Riper, DC | 1 |
| Day, PW | 1 |
| L'vova, KD | 1 |
| Fujiki, T | 1 |
| Maekawa, Y | 1 |
| Rykowska, Z | 1 |
| Alimov, ShA | 1 |
| Udrit, OO | 1 |
| Azarnykh, MA | 1 |
| Bruk, AZ | 1 |
| Dumon, JF | 2 |
| Lecourtois-Dumon, T | 1 |
| Rozniecki, J | 6 |
| Podoska, M | 1 |
| Galamon, T | 2 |
| Bleandonu, G | 2 |
| Boye, J | 2 |
| Tyrell, WF | 2 |
| Fallon, RJ | 2 |
| Swash, M | 1 |
| Roberts, AH | 1 |
| Murnaghan, DJ | 1 |
| Rudoy, R | 1 |
| Stuemky, J | 1 |
| Poley, JR | 1 |
| Cohen, LK | 1 |
| George, W | 1 |
| Smith, R | 1 |
| Standal, BR | 1 |
| Kao-Chen, SM | 1 |
| Yang, GY | 1 |
| Char, DF | 1 |
| Blagodarnyĭ, IaA | 1 |
| Israel-Asselain, R | 1 |
| Chebat, J | 1 |
| Baillet, A | 1 |
| Malbos, J | 1 |
| Gibson, FD | 1 |
| Gartmann, JC | 1 |
| Jancikova-Máková, M | 1 |
| Le Lourd, R | 1 |
| Rivière, J | 1 |
| Le Lourd, F | 1 |
| Levy, L | 1 |
| Higgins, LJ | 1 |
| Burbridge, TN | 1 |
| Bayliss, CG | 1 |
| Wakefield, SL | 1 |
| Turk, TL | 3 |
| Reniers, J | 1 |
| Martin, L | 1 |
| Raukas, EA | 1 |
| Debeyre, N | 1 |
| Kahn, MF | 1 |
| de Sèze, S | 1 |
| Piard, A | 1 |
| Leblanc, M | 1 |
| Cabanne, F | 1 |
| Michiels, R | 1 |
| Rifle, G | 1 |
| Steininger, WJ | 2 |
| Repin, IuM | 1 |
| Saburenkova, EP | 1 |
| Niederkofler, J | 3 |
| Kubík, A | 1 |
| Langerová, M | 1 |
| Matusková, E | 1 |
| Morávková, K | 1 |
| Mamolat, AS | 1 |
| Rautlin de la Roy Y, DE | 1 |
| Beauchant, G | 1 |
| Brisou, J | 1 |
| Dussouil, P | 1 |
| Foddai, G | 1 |
| Lukinovich, N | 2 |
| Pontiggia, P | 1 |
| Jesiotr, M | 2 |
| Ochoa, J | 1 |
| Gibson, JP | 1 |
| Rohovsky, MW | 1 |
| Newberne, JW | 1 |
| Ivaniuta, OM | 2 |
| Goldman, S | 1 |
| Brzaković, N | 1 |
| Muzikravić, T | 1 |
| Heise, A | 1 |
| Reimann, B | 1 |
| Zaki, MH | 3 |
| Makovskaia, GM | 1 |
| Gautier, H | 1 |
| Duhurt, J | 1 |
| Kauffmann, JP | 1 |
| Mornet, P | 1 |
| Lafon, J | 1 |
| de Mouilliac, MV | 1 |
| Morin, M | 1 |
| Tomkin, GH | 1 |
| Seto, DS | 1 |
| Heller, RM | 1 |
| Horai, Z | 2 |
| Matsumura, K | 1 |
| Yoneda, H | 1 |
| Shimizu, K | 1 |
| Clark, MA | 1 |
| Houillon, G | 1 |
| Samulak, G | 1 |
| Houillon, P | 1 |
| Voog, R | 1 |
| Couderc, P | 1 |
| Martin, H | 1 |
| Pecher, Y | 1 |
| Perdrix, A | 1 |
| Grubier, M | 1 |
| Nielsen, E | 1 |
| Härö, AS | 1 |
| Hjaltested, OP | 1 |
| Mulligan, WJ | 1 |
| Nelson, DG | 1 |
| Brooks, SM | 2 |
| Schwarz, J | 1 |
| Shipin, GE | 1 |
| Mikhaĭlova, ES | 2 |
| Samillo, GK | 2 |
| Al'tshuler, ML | 2 |
| Wise, MB | 2 |
| MacDougall, D | 1 |
| Riley, RL | 1 |
| Daynes, G | 1 |
| Burzibu, JM | 1 |
| Durante, C | 4 |
| Ceicu, A | 2 |
| el Fassi el Fahri, M | 1 |
| Bahsoun, H | 1 |
| Stevenson, DK | 1 |
| Korobkov, ES | 1 |
| Filonenko, PI | 1 |
| Ianova, LA | 1 |
| Pchelintsev, VP | 1 |
| Samtsov, VS | 1 |
| Kartashov, GV | 1 |
| Anfilof'eva, OIu | 1 |
| fedotova, ZN | 1 |
| Pacheco, Mde J | 1 |
| Víznerová, A | 1 |
| Slavíková, Z | 1 |
| Slonchak, AT | 1 |
| Cherednichenko, LP | 3 |
| Krishnaswamy, K | 1 |
| Chomy, P | 1 |
| Faye, I | 1 |
| Marchand, JP | 1 |
| Warion, B | 1 |
| Renault-Steens, CJ | 1 |
| N'Diaye, B | 1 |
| Mukhin, EP | 1 |
| Klimova, TP | 1 |
| Uzbekova, AA | 1 |
| Dankova, D | 3 |
| Gipp, ZI | 1 |
| Smith, FW | 1 |
| Catto, GR | 1 |
| MacLeod, M | 1 |
| Edwards, TA | 1 |
| Davies, D | 1 |
| Khogali, AM | 1 |
| Chazan, BI | 1 |
| Metcalf, VJ | 1 |
| Ramsay, JH | 1 |
| Lacquet, L | 1 |
| Verbist, L | 5 |
| Herrmann, H | 3 |
| Lau, W | 1 |
| Kuhnert, R | 1 |
| Fanter, D | 1 |
| Kahlau, U | 1 |
| Schönert, E | 1 |
| Dobrynin, PP | 1 |
| Nesterovskiĭ, IaI | 1 |
| Hecht, AB | 1 |
| Mattson, K | 2 |
| Stradling, P | 6 |
| Evans, DA | 2 |
| Bullen, MF | 1 |
| Houston, J | 1 |
| Hopkins, CA | 1 |
| Vetters, JM | 1 |
| Jansén, CT | 1 |
| Havu, VK | 1 |
| Anastasatu, C | 3 |
| Stoia, I | 1 |
| Kaufman, S | 1 |
| Ghenoiu, O | 1 |
| Iancovici, O | 3 |
| Dieu, MJ | 1 |
| Furcolow, ML | 1 |
| Deuschle, KW | 2 |
| Rahaju, N | 1 |
| Rahaju, NN | 1 |
| Widya, M | 1 |
| Morrison, JB | 1 |
| Tournier, G | 1 |
| Grunberg, J | 1 |
| Anttolainen, I | 1 |
| Feigin, RD | 1 |
| Zarkowsky, HF | 1 |
| Shearer, W | 1 |
| Anderson, DC | 1 |
| Light, IJ | 1 |
| Saidleman, M | 1 |
| Sutherland, JM | 1 |
| Tonceanu, S | 1 |
| Carp, G | 1 |
| Bazacliu, E | 1 |
| Sabău, I | 1 |
| Runyon, EH | 1 |
| Ter Haar, G | 1 |
| Hamilton, EJ | 1 |
| Mulder, RJ | 2 |
| Mulder-De Jong, MT | 1 |
| van Dijk, B | 2 |
| Nitti, V | 8 |
| Delli Veneri, F | 3 |
| Meola, G | 1 |
| Corpe, R | 1 |
| Schwartz, E | 1 |
| Rosenblatt, MB | 1 |
| Dworski, M | 2 |
| Vandiviere, HM | 1 |
| Melvin, IG | 1 |
| Watson, KA | 1 |
| Begley, J | 1 |
| Nocke-Finck, L | 1 |
| Breuer, H | 1 |
| Reimers, D | 2 |
| Ludford, J | 1 |
| Kradolfer, F | 4 |
| Schnell, R | 3 |
| Helbaque, DM | 1 |
| Narasimhan, V | 1 |
| Kärnbach, E | 1 |
| Horwitz, O | 4 |
| Magnus, K | 1 |
| Kondo, E | 1 |
| Fraga, H | 1 |
| Paz de Almeida, A | 1 |
| Gerhardt, G | 1 |
| Santiago, AC | 1 |
| Votruba, R | 1 |
| Sehgal, KL | 1 |
| el-Fassi el-Fahri, M | 1 |
| Burzoni, FJ | 3 |
| Brito, AA | 1 |
| Laborne Valle, JH | 1 |
| Tavares, PM | 1 |
| Trannin, PL | 1 |
| Baron, DN | 1 |
| Bell, JL | 1 |
| Schonell, M | 1 |
| Constans, P | 4 |
| Baron, A | 1 |
| Mbete, S | 1 |
| Van Landuyt, H | 1 |
| Willa, C | 5 |
| Ashba, JK | 1 |
| Boyce, JM | 1 |
| Noskova, GP | 1 |
| Oblogina, VV | 1 |
| Fichtner, K | 1 |
| Gross, V | 1 |
| Sellau, J | 1 |
| Riley, E | 1 |
| Cahan, WG | 1 |
| Aach, R | 1 |
| Kissane, J | 1 |
| Gelberg, SI | 1 |
| Kulgovenya, PS | 1 |
| Portugaleza, C | 2 |
| Matsuda, T | 2 |
| Levitt, T | 1 |
| Chesak, OI | 1 |
| Biazov, TA | 1 |
| Chaikina, TN | 1 |
| Borhanmanesh, F | 1 |
| Hekmat, K | 1 |
| Vaezzadeh, K | 1 |
| Rezai, HR | 1 |
| Kok-Jensen, A | 2 |
| Proust, A | 1 |
| Nakhutin, LS | 1 |
| Khatenever, NL | 1 |
| Vulikh, MIa | 1 |
| Konno, K | 2 |
| Oizumi, K | 2 |
| Ogata, K | 1 |
| Sasaki, M | 1 |
| Mlczoch, F | 2 |
| Zierler, W | 1 |
| Gubanova, GF | 2 |
| Frank, GL | 1 |
| Roulet, H | 1 |
| Poti, SJ | 2 |
| Oliferovskaia, RP | 1 |
| Venkataraman, P | 2 |
| Nair, NG | 2 |
| Ross, C | 2 |
| Devi, S | 1 |
| Fondaminskaia, LD | 1 |
| Darney, PD | 1 |
| Greene, JE | 1 |
| Johnson, TM | 1 |
| McCann, W | 1 |
| Davey, WN | 1 |
| Nirmul, G | 1 |
| Kirschner, PA | 1 |
| Wilson, EA | 1 |
| Thelin, TJ | 1 |
| Dilts, PV | 1 |
| McCurdy, PR | 3 |
| Bar-On, H | 1 |
| Sharma, BK | 1 |
| Seshagiri, K | 1 |
| Brown, RC | 1 |
| Simon, K | 2 |
| Fortuine, R | 1 |
| Martyniak, K | 1 |
| Samama, M | 1 |
| Fontaine, JL | 1 |
| Lellouch, A | 1 |
| Haik, M | 1 |
| Baur, O | 1 |
| Lallemant, Y | 1 |
| Gehanno, P | 1 |
| Flieder, J | 1 |
| Baudry, A | 1 |
| Gorak, AG | 1 |
| Ginzburg, EA | 1 |
| Levtonova, EV | 1 |
| Kaliamova, RF | 1 |
| Shilova, MV | 1 |
| Samarin, MS | 1 |
| Whitcomb, ME | 1 |
| Ryzhkova, VV | 1 |
| Kasper, GA | 1 |
| Bekembaev, RM | 1 |
| Stopczyk, J | 2 |
| Pecyna-Sielewicz, J | 3 |
| Banaszkiewicz, H | 2 |
| Czerwiński, Z | 1 |
| Królikowska, H | 2 |
| Krahowska, M | 1 |
| Malecki, S | 1 |
| Pezińska, Z | 1 |
| Pilch, Z | 1 |
| Szustrowa, I | 1 |
| Ropek, M | 1 |
| Chetkowski, A | 1 |
| Dabrowska-Solecka, Z | 1 |
| Ignaczak, J | 1 |
| Kondratowicz, W | 1 |
| Pawlowska, I | 1 |
| Sliwińska, M | 1 |
| Szuster, I | 1 |
| Szymánska, W | 1 |
| Greenberg, H | 1 |
| Cramer, PG | 1 |
| Beauvais, P | 1 |
| Mercier, D | 1 |
| Brissaud, HE | 1 |
| Gurfinik, NE | 1 |
| Lesnichii, AV | 3 |
| Ezerskii, VF | 2 |
| Ezerskaia, EN | 2 |
| Greene, ME | 1 |
| Mehrotra, TN | 1 |
| Desai, M | 1 |
| Jariwala, G | 1 |
| Khokhani, B | 1 |
| Desai, NK | 1 |
| Sheth, UK | 1 |
| Wiant, JR | 1 |
| Kurowski, JL | 1 |
| Farhat, S | 1 |
| Jodanoglou, J | 1 |
| Pallikaris, G | 1 |
| Lyberatos, K | 1 |
| Gardikas, C | 1 |
| Hadjiidannou, J | 1 |
| Badger, TL | 2 |
| Alonso, K | 1 |
| Starke, WR | 1 |
| Boitnott, JK | 1 |
| Galleguillos, F | 1 |
| Carrasco, E | 1 |
| Ham, O | 1 |
| Ihnen, R | 1 |
| Klecková, T | 1 |
| Hofhanzlová, E | 1 |
| Leśkiewicz, H | 3 |
| Bohdanowicz, M | 1 |
| Jankowska, H | 1 |
| Kurowicka, A | 1 |
| Krajewski, K | 1 |
| Maślińska, J | 1 |
| Solik-Natkaniec, K | 1 |
| Smreczyńska, J | 2 |
| Warelis, B | 2 |
| Shenderova, RI | 1 |
| Terterian, EA | 1 |
| Devulder, B | 4 |
| Lelievre, G | 1 |
| Capier, P | 1 |
| Fitsaĭ, AV | 1 |
| O'Connell, J | 1 |
| Campbell, AH | 3 |
| Cowen, K | 1 |
| Verins, A | 1 |
| Weuta, H | 1 |
| Wiechert, E | 1 |
| Gadalov, PV | 1 |
| Krohn, J | 1 |
| Feinmann, L | 2 |
| Kagramanov, AI | 1 |
| Kiroshka, IZ | 1 |
| Kashenov, TK | 1 |
| Simonian, LK | 1 |
| Beĭda, MM | 1 |
| Dummich, IuA | 1 |
| Shimko, EP | 1 |
| Pashchenko, SI | 1 |
| Donchenko, VL | 1 |
| Hristic, Lj | 1 |
| Micic, S | 1 |
| Burns, WA | 1 |
| Vander Weide, G | 1 |
| Goldstein, LI | 1 |
| Becker, SM | 1 |
| Kellett, GN | 1 |
| Swasey, LK | 1 |
| Kalkoff, KW | 1 |
| Stein, SC | 1 |
| Pettersson, T | 1 |
| Stenström, R | 1 |
| Kyrönseppä, H | 1 |
| Rohwedder, JJ | 1 |
| Reisinger, KS | 1 |
| Evans, P | 1 |
| Yost, G | 1 |
| Rogers, KD | 1 |
| Black, M | 1 |
| Schaefer, O | 1 |
| Knieriem, HJ | 1 |
| Bercea, O | 1 |
| Barcan, F | 1 |
| Stinghe, R | 1 |
| Dinulică, E | 1 |
| Marcovici, M | 1 |
| Cristea, M | 1 |
| Cărpinişan, L | 1 |
| Gheorghiu, M | 1 |
| Ghinescu, S | 1 |
| Salyer, IL | 1 |
| Craner, GE | 1 |
| Cooper, EB | 1 |
| Weichert, K | 1 |
| Chrobák, L | 1 |
| Filonenko, IA | 1 |
| Chernysheva, GI | 1 |
| Andrianova, MP | 1 |
| Menghini, P | 1 |
| Wiese, HJ | 1 |
| Litwin, A | 1 |
| Claes, F | 1 |
| Krishnamurthy, DV | 2 |
| Rosenberg, M | 1 |
| Gottlieb, RP | 1 |
| Veening, GJ | 1 |
| Levaditi, JC | 1 |
| Kosloff-Sénéchal, F | 1 |
| Balouet, G | 1 |
| Augier, J | 1 |
| Owsiński, J | 1 |
| Piotrowska, E | 1 |
| Thong, KL | 1 |
| Theodore, A | 2 |
| Wolff, M | 1 |
| Lacquet, LM | 1 |
| Prignot, J | 1 |
| Simon-Pouthier, F | 1 |
| Debrabandere, R | 1 |
| Devriendt, J | 1 |
| Torning, K | 3 |
| Protivinsky, R | 1 |
| Morin, Y | 2 |
| Saint-Paul, M | 1 |
| Bonnaud, G | 1 |
| Weill, G | 1 |
| Lévy, A | 1 |
| Guignon, JP | 1 |
| Lecoq, H | 1 |
| Friess, JM | 1 |
| Maman, P | 1 |
| Donomae, I | 3 |
| Fujita, S | 2 |
| Hibino, S | 2 |
| Spada, S | 1 |
| Freerksen, E | 2 |
| Narain, R | 3 |
| Rao, MS | 1 |
| Naganna, K | 1 |
| Bagga, AS | 1 |
| Devine, CM | 1 |
| Hekking, AM | 1 |
| De Voogd, KK | 1 |
| Schütz, I | 1 |
| El'nik, VI | 1 |
| Rajappa, D | 1 |
| Mayer, E | 2 |
| Salamandra, IA | 2 |
| Vinnik, LA | 1 |
| Sutyrina, GV | 1 |
| Boldyreva, AA | 1 |
| Shevchenko, AM | 1 |
| Pruzanski, W | 1 |
| Adler, H | 1 |
| Brander, L | 2 |
| Selroos, O | 2 |
| Feldmann, FM | 2 |
| Lambert, HP | 1 |
| Giza, T | 1 |
| Hanicka, M | 1 |
| Jelonek, A | 1 |
| Kulig, A | 1 |
| Rembiesowa, H | 1 |
| Garapich, M | 1 |
| Wallace, HM | 1 |
| Yeager, H | 1 |
| Lacy, J | 1 |
| Smith, LR | 1 |
| LeMaistre, CA | 1 |
| Steer, A | 2 |
| Rothlauf, MV | 1 |
| Morse, WC | 1 |
| Smith, L | 1 |
| Brander, E | 2 |
| Aho, K | 2 |
| Wasz-Höckert, O | 1 |
| Langer, C | 1 |
| Huempfner, HR | 1 |
| Fulmer, HS | 1 |
| Hanson, ML | 1 |
| Haley, CE | 1 |
| Murata, A | 2 |
| Dargevich, VK | 1 |
| Raafat, H | 1 |
| Bundi, R | 1 |
| Zimmerman, R | 1 |
| Park, BH | 1 |
| Shirali, SR | 1 |
| Schmidt, H | 2 |
| Woodruff, CE | 1 |
| Howard, WL | 1 |
| Klopfenstein, MD | 1 |
| Ujiiye, A | 1 |
| Nemoto, G | 1 |
| Kinoshita, Y | 1 |
| Reil, I | 1 |
| Krivánek, J | 1 |
| Bonforte, RJ | 2 |
| Karpas, CM | 1 |
| Gribetz, I | 2 |
| Shanzer, S | 1 |
| Blazso, A | 1 |
| Natterer-Balogh, C | 1 |
| Wichelhausen, RH | 1 |
| Robinson, LB | 1 |
| Rajvanshi, VS | 1 |
| Tiagi, GK | 1 |
| Fedorova, IE | 2 |
| Sekura, T | 1 |
| Kihara, K | 1 |
| Gonin, JD | 3 |
| Gubéran, E | 3 |
| de Kalbermatten, JP | 3 |
| Hatori, H | 1 |
| Winkelmann, E | 1 |
| Wagner, WH | 1 |
| Hilmer, H | 1 |
| Kovalev, GK | 1 |
| Motomiya, M | 1 |
| Sato, H | 1 |
| Fujimoto, M | 1 |
| Chandrasekhar, P | 1 |
| Satyanarayanachar, RA | 1 |
| Lal, P | 1 |
| Klein, G | 1 |
| Primer, G | 1 |
| Wildner, F | 1 |
| Centrella, G | 1 |
| Stefanelli, R | 1 |
| Tinne, JE | 1 |
| Somasundaram, PA | 1 |
| Lyons, HA | 2 |
| Tizes, R | 3 |
| Godinez, F | 1 |
| Onstad, GD | 3 |
| Lattimer, JK | 1 |
| Ehrlich, RM | 1 |
| Mel'nikov, EL | 1 |
| Vercellino, E | 1 |
| Sbampato, M | 1 |
| Briney, RR | 1 |
| Cowley, RG | 1 |
| Jaroszewicz, W | 2 |
| Pichulowa, K | 2 |
| Pszonicka, A | 2 |
| Tipp, ZI | 1 |
| Navrotskiĭ, VV | 1 |
| Wijsmuller, G | 1 |
| Selin, M | 1 |
| Vall-Spinosa, A | 1 |
| McClatchy, JK | 1 |
| Sibilla, S | 1 |
| Doust, JY | 1 |
| Hedayati, H | 1 |
| Gil'madinova, RSh | 1 |
| Bakanova, DIa | 1 |
| Schaich, W | 2 |
| Kim, SC | 1 |
| Djurovic, V | 1 |
| Dormont, J | 1 |
| Schwarzenberg, L | 1 |
| Acar, JF | 1 |
| Westwater, ML | 1 |
| Mkrtchian, SV | 2 |
| Ushkin, VV | 1 |
| Smirnov, VD | 1 |
| Hayashi, I | 1 |
| Formosa, GM | 1 |
| Lind, A | 1 |
| Margulis, NIu | 1 |
| Kusikova, LM | 1 |
| Solomonova, DE | 1 |
| Kerpel', RS | 1 |
| Catena, E | 1 |
| De Michele, G | 2 |
| Marra, A | 1 |
| Seidell, MA | 1 |
| de Beco, O | 1 |
| Moldow, RE | 1 |
| Bearman, S | 1 |
| Edelman, MH | 1 |
| Fallon, RS | 1 |
| Singhal, SN | 1 |
| Burley, DM | 1 |
| Crossley, G | 1 |
| Sabula, MM | 1 |
| Kubiak, Z | 3 |
| Voĭtova, DI | 2 |
| Jarumilin, A | 2 |
| Chakraborty, H | 1 |
| Rogers, WF | 1 |
| Chatterjee, R | 1 |
| Houk, AN | 1 |
| Radner, DB | 1 |
| Sanchez, ES | 1 |
| Gow, A | 1 |
| Carevic, N | 1 |
| Fernandez, A | 1 |
| Shah, MD | 1 |
| Buhariwalla, RJ | 1 |
| Russell, DW | 2 |
| Katslan, IaD | 1 |
| Mires, MH | 1 |
| Alexander, CH | 1 |
| Drabkina, RO | 1 |
| Ginzburg, TS | 1 |
| Kulachkovskiĭ, IuV | 1 |
| Fraĭt, VM | 1 |
| Golovkin, VA | 1 |
| Saevich, MM | 1 |
| Kornetova, NV | 1 |
| Alekseevskaia, KP | 1 |
| Duthoit, A | 1 |
| Ludes, H | 1 |
| Poffenbarger, PL | 1 |
| Schachter, EN | 1 |
| Karpick, RJ | 1 |
| Alabina, MG | 1 |
| Afanasieva, IuP | 1 |
| Maliutina, TD | 1 |
| Kharchenko, AK | 1 |
| Salinger, PL | 2 |
| Edwards, LB | 1 |
| Cornudella, R | 1 |
| Garcia-Besada, JA | 1 |
| Castellano, A | 1 |
| Refshauge, WD | 1 |
| Clarke, GB | 2 |
| Cuthbert, RJ | 2 |
| Ward, AS | 1 |
| Fishaut, H | 1 |
| Rowe, J | 1 |
| Brown, A | 3 |
| Brummer, DL | 1 |
| Ng, KC | 1 |
| Marr, JJ | 1 |
| Krzyzaniak, J | 1 |
| Lubieńska, B | 1 |
| Zielniewicz, B | 1 |
| Klimczyk, M | 1 |
| Chodera, B | 1 |
| Rastvortseva, TN | 1 |
| Chan-Yeung, M | 1 |
| Schulson, N | 1 |
| Varis, K | 1 |
| Koskinen, R | 1 |
| Jussila, J | 1 |
| Rytömaa, T | 1 |
| Tarpila, S | 1 |
| Launiala, K | 1 |
| Urbanczik, G | 1 |
| Petersen, KF | 1 |
| Chevrel, B | 1 |
| Khitrina, GV | 1 |
| Zakutaeva, VP | 1 |
| Tret'iakov, AS | 1 |
| Evans, DI | 1 |
| Attock, B | 1 |
| Leat, JL | 1 |
| Toulet, J | 1 |
| Plomteux, G | 1 |
| Viteau, JM | 1 |
| Abiven, M | 1 |
| Bonfante, N | 1 |
| Laroche, C | 1 |
| Caquet, R | 1 |
| Desche-Labarthe, S | 1 |
| Fraisse, B | 1 |
| Lemaigre, G | 1 |
| Marche, J | 1 |
| Hugues, FC | 1 |
| Graisely, B | 1 |
| Marche, C | 1 |
| Oury, M | 1 |
| Tuchais, E | 1 |
| Viallet, S | 1 |
| Chauvet, G | 1 |
| Hoffman, R | 1 |
| Klima, E | 1 |
| Ruszel, B | 1 |
| Tybusz, R | 1 |
| Konovich-Ginzburg, RZ | 1 |
| Kunurkul'zhaev, TB | 1 |
| Nikiforchin, RN | 2 |
| Kreukniet, J | 1 |
| Blom van Assendelft, PM | 1 |
| Mouton, RP | 1 |
| Tasman, A | 1 |
| Bangma, PJ | 1 |
| Olsen, PZ | 2 |
| Ockerman, PA | 1 |
| Krstić, B | 1 |
| Prusac, D | 1 |
| Borozan, J | 1 |
| Thomassen, OK | 1 |
| Tiitinen, H | 4 |
| Alimpić, D | 1 |
| Popović, S | 1 |
| Ganguin, G | 2 |
| Ogasawara, FR | 1 |
| Neef, W | 1 |
| Gregg, DB | 1 |
| Kuemmerer, JM | 1 |
| Bruno, MS | 1 |
| Ober, WB | 1 |
| Bjartveit, K | 1 |
| Aceves Ortega, R | 1 |
| Cortés de la Peña, F | 1 |
| Sanchez Ceceña, S | 1 |
| Arreola Chavez, C | 1 |
| Bumbacescu, N | 1 |
| Nadjar, G | 1 |
| Raboukhine, A | 1 |
| Ozgen, ZS | 1 |
| Rogovaia, VF | 1 |
| Kholina, VM | 1 |
| Vlasova, NA | 1 |
| Tsiv'ian, LS | 1 |
| Lupasco, I | 1 |
| Algeorge, G | 1 |
| Ghiu-Cimpeanu, V | 1 |
| Anderson, UM | 1 |
| Grabau, AA | 1 |
| Baculard, A | 1 |
| Couvreur, J | 1 |
| Prakash, R | 1 |
| Potts, WE | 1 |
| Aminov, NR | 1 |
| Grishchenko, VV | 2 |
| Shubinskaia, LV | 1 |
| Trauger, DA | 1 |
| Blair, AW | 1 |
| Davis, SD | 1 |
| Wedgwood, RJ | 1 |
| Wissler, H | 1 |
| Shimamura, K | 1 |
| Mayol, PM | 1 |
| Alvarez Pagán, M | 1 |
| Lees, WM | 1 |
| Fox, RT | 1 |
| Shields, TW | 1 |
| Auquier, L | 1 |
| Seligmann, M | 1 |
| Cannat, A | 1 |
| Paolaggi, JB | 1 |
| Matsaniotis, N | 1 |
| Kattamis, C | 1 |
| economou-Mavrou, E | 1 |
| Kyriazakou, M | 1 |
| Stanulović, M | 1 |
| Miletić, D | 1 |
| Sttock, A | 1 |
| Guimard, P | 1 |
| Gouyon, C | 1 |
| Sitzmann, FC | 1 |
| Shanholtz, MI | 1 |
| Macfadyen, DM | 1 |
| Buchan, T | 1 |
| Tahernia, AC | 1 |
| Vaillaud, JC | 2 |
| Sarrouy, C | 2 |
| Avery, ME | 1 |
| Wolfsdorf, J | 1 |
| Meijer, J | 1 |
| Vass, E | 1 |
| Frolova, VM | 1 |
| Cohen, SN | 1 |
| Weber, WW | 1 |
| Mishina, RG | 1 |
| Khoury, SA | 1 |
| Platte, VJ | 1 |
| Durfee, ML | 1 |
| Warren, BJ | 1 |
| Daehler, C | 1 |
| Katz, F | 1 |
| Carrada, T | 1 |
| Rajtar-Leontiew, Z | 1 |
| Brincourt, J | 1 |
| Iodice, F | 1 |
| Lappa, B | 1 |
| Wilkinson, MC | 2 |
| Robakiewicz, M | 1 |
| Kauffmann, S | 1 |
| Giammona, ST | 1 |
| Poole, CA | 1 |
| Zelkowitz, P | 1 |
| Skrovan, C | 1 |
| Waisbich, E | 1 |
| de Barros, RF | 1 |
| Timoshenko, AS | 2 |
| Caione, C | 1 |
| Zamparelli, F | 1 |
| Khrůleva, TS | 2 |
| Krushevskaia, GM | 1 |
| Lysova, LP | 1 |
| Guseva, LV | 1 |
| Rao, PS | 1 |
| Alva, J | 1 |
| Lipow, HW | 1 |
| Patwardhan, P | 1 |
| Bhatia, M | 1 |
| Merchant, SM | 1 |
| Mankodi, NA | 1 |
| Amdekar, YK | 1 |
| Desai, AG | 1 |
| Patel, BD | 1 |
| Raichur, GS | 1 |
| Meyer, B | 1 |
| Willard, JJ | 1 |
| Rentien, M | 1 |
| Alves, JP | 1 |
| de Andrade, EM | 1 |
| Franca, JL | 1 |
| Tavares, WC | 1 |
| Collins, TF | 1 |
| Subbotskiĭ, ASh | 1 |
| Audambaeva, AI | 1 |
| Bultacheeva, LA | 1 |
| Gutevich, LV | 1 |
| Dehné, EJ | 1 |
| Katz, J | 1 |
| Kunofsky, S | 1 |
| Poole, G | 3 |
| Worlledge, S | 1 |
| Marcar, JR | 1 |
| van Zeben, W | 1 |
| Botenga, AS | 1 |
| De Sario, PN | 1 |
| Vicini, M | 1 |
| Kuznetsov, AIa | 1 |
| Zorina, ZP | 1 |
| Dimakova, RN | 1 |
| Paporish, SD | 1 |
| Mason, E | 1 |
| Zduńczyk-Pawelek, H | 2 |
| Otrzonsek, N | 2 |
| Egsmose, T | 1 |
| Ang'awa, JO | 1 |
| Pasargiklian, M | 1 |
| Magalhães, M | 1 |
| Leal, R | 1 |
| Menezes, E | 1 |
| Walter, N | 1 |
| De March Ayuela, P | 1 |
| Cardona, J | 1 |
| Vaziri, F | 1 |
| Toledo, R | 1 |
| Payne, PG | 1 |
| Wilbek, E | 1 |
| MacDonald, FM | 3 |
| Lintermans, JP | 1 |
| Seyhnaeve, V | 2 |
| McKinnon, NE | 1 |
| Philipps, R | 1 |
| Dettlaff, Z | 1 |
| Hammes, LM | 1 |
| Pio, A | 1 |
| Adamovich, VN | 1 |
| Agrawal, R | 1 |
| Keers, RY | 1 |
| Assem, ES | 1 |
| Ndoping, N | 1 |
| Nicholson, H | 1 |
| Wade, JR | 1 |
| Shabalova, LN | 1 |
| de Figueiredo, FP | 1 |
| Bibik, NF | 1 |
| Kazeĭ, II | 1 |
| Foster-Carter, AF | 1 |
| Pudoĭ, NM | 1 |
| Iampol'skaia, SA | 1 |
| Fomicheva, NI | 1 |
| Chaban, VM | 1 |
| Badalov, SM | 1 |
| Karpina, LZ | 1 |
| Henneghien, C | 1 |
| Ballez, C | 1 |
| Horvath, K | 1 |
| el-Fassi, M | 1 |
| Livandovskiĭ, IuA | 1 |
| Sigalova, RS | 1 |
| Chatterji, JC | 1 |
| Sen, HK | 1 |
| Mozumdar, SC | 1 |
| Subba Rao, KB | 1 |
| Kapoor, ML | 1 |
| Rao, VS | 1 |
| Abadi, O | 1 |
| Charpin, J | 1 |
| Boutin, C | 1 |
| Girbal, JP | 1 |
| Grossman, LA | 1 |
| Kaplan, HJ | 1 |
| Brittingham, TE | 1 |
| Rotenberg, L | 1 |
| Sfikakis, P | 1 |
| Brickman, H | 1 |
| Beaudry, RH | 1 |
| Turner, JA | 1 |
| Ivaniuota, OM | 1 |
| Ponomareva, ES | 1 |
| Zirout, A | 1 |
| Huggin, PM | 1 |
| Aamodt, T | 1 |
| Lèques, B | 1 |
| Bordas, J | 1 |
| Pellegrin, J | 1 |
| Chenu, V | 1 |
| Groen, AS | 1 |
| Asgher, B | 1 |
| Hashem, MA | 1 |
| Sinha, BN | 1 |
| Lintermans, J | 1 |
| Hayashi, N | 1 |
| Gorvenko, GG | 1 |
| Glasson, AA | 1 |
| Kopel'man, MIu | 1 |
| Sokolik, IuI | 1 |
| Badretdinov, RZ | 1 |
| Schlozman, DL | 1 |
| Reĭnval'd, LA | 1 |
| Vasil'ev, NA | 1 |
| Kisielewicz, J | 1 |
| Fafrowicz, B | 1 |
| Jablonowski, Z | 1 |
| Kociecka, I | 1 |
| Turczynowski, R | 1 |
| Szczukowa, W | 1 |
| Wnuk, A | 1 |
| Truszczyńska, J | 1 |
| Herbert-Zebrowska, H | 1 |
| Kruszewska, W | 1 |
| Reid, LR | 1 |
| Rosenthal, SR | 1 |
| Pozdniakova, EI | 1 |
| Matiashvili, NA | 1 |
| Smith, JP | 1 |
| Scharer, L | 1 |
| Guilfoyle, P | 1 |
| Egorkina, ND | 1 |
| Holmes, AM | 1 |
| Hesling, CM | 1 |
| Milne, RC | 1 |
| Pande, BR | 1 |
| Poole, GW | 1 |
| Wasik, A | 1 |
| Shostak, AI | 1 |
| Hinaut, G | 1 |
| Bosio, AM | 1 |
| Estampes, B | 1 |
| Chauvet, J | 1 |
| Weitzenblum, S | 1 |
| Rempt, E | 1 |
| Abdullina, ZR | 1 |
| Ibragimova, RIu | 1 |
| Danilovskiĭ, IuP | 1 |
| Gerasimova, MM | 1 |
| Stäubli, C | 1 |
| Kayaba, K | 1 |
| Ruce, LG | 1 |
| Bugakova, GN | 1 |
| Gurfink, NE | 1 |
| Nickling, HG | 1 |
| Gallen, CS | 1 |
| Tison, F | 1 |
| Martin, JC | 1 |
| Pochart, E | 1 |
| Urbancik, B | 1 |
| Edson, RC | 1 |
| Lathan, SR | 1 |
| Williams, JD | 1 |
| Tveit, J | 1 |
| De Silva, DJ | 1 |
| Koviazina, AI | 1 |
| Lesobre, R | 1 |
| Frey, N | 1 |
| Kühn, RA | 1 |
| Kob, D | 1 |
| Meisl, B | 1 |
| Makiyama, H | 2 |
| Sochocky, S | 1 |
| Bruncsák, A | 1 |
| Timár, S | 1 |
| Cameron, SJ | 1 |
| Crompton, GK | 1 |
| Agnihotri, CB | 1 |
| Höfer, W | 1 |
| Antonijević, A | 1 |
| Mattila, MJ | 2 |
| Kolotovkin, PS | 1 |
| Concina, E | 2 |
| Spataro, C | 2 |
| Efremova, ZR | 1 |
| Temmere, VA | 1 |
| Penna, R | 1 |
| Grattarola, M | 1 |
| Rzhavskov, IuV | 1 |
| Novikova, NA | 1 |
| Lambert, C | 1 |
| Iannello, J | 1 |
| Renard, J | 1 |
| Bertrand, Y | 1 |
| Puvinel, B | 1 |
| Mezard, F | 1 |
| Sagantaev, MM | 1 |
| Lozhevskiĭ, SF | 1 |
| Tkach, VN | 1 |
| Mustafin, SM | 1 |
| Utkin, IuV | 1 |
| Maĭfat, AL | 1 |
| Luk'ianov, NG | 1 |
| Rink, H | 1 |
| Marcovici, G | 1 |
| Pastor, J | 1 |
| Roul, M | 1 |
| Twining, RH | 1 |
| Howe, JS | 1 |
| Houk, VN | 1 |
| Sorensen, K | 1 |
| Baker, JH | 1 |
| Kerby, GR | 1 |
| Schlueter, DP | 1 |
| Jordahl, CW | 1 |
| Ogg, CS | 1 |
| Toseland, PA | 1 |
| Cameron, JS | 1 |
| Barbaro, JA | 1 |
| Johnson, S | 1 |
| McCreary, CB | 1 |
| Govindaraj, M | 1 |
| Grant, LJ | 1 |
| Pugsley, HE | 1 |
| Mozolewska, H | 1 |
| Baronti, A | 1 |
| Hollinrake, K | 1 |
| Torbin, IM | 1 |
| Chernukhina, EV | 1 |
| Reĭderman, IV | 1 |
| Khaĭmovich, NA | 1 |
| Hayman, CR | 1 |
| Glass, R | 1 |
| Summers, DS | 1 |
| Brennan, RW | 1 |
| Dehejia, H | 1 |
| Kutt, H | 1 |
| McDowell, F | 1 |
| Maillard, JM | 1 |
| Vouilloz, M | 1 |
| DeMeo, AN | 1 |
| Lynch, MJ | 1 |
| Okada, S | 1 |
| Ishii, T | 1 |
| Mitsui, Y | 1 |
| Skokna, D | 1 |
| Kula, O | 1 |
| Lowkis, L | 1 |
| Jancíková, M | 1 |
| Krátký, J | 1 |
| Feitová, S | 1 |
| Calvo, AS | 1 |
| Serrano, T | 1 |
| Rivas, HD | 1 |
| Iturbe, P | 1 |
| Bukalska, Z | 1 |
| Rózewska, M | 1 |
| Gajewska, E | 1 |
| Szebanow, FW | 1 |
| Danzer, W | 1 |
| Cartier, F | 1 |
| Curtes, JP | 1 |
| Nakamura, K | 1 |
| Titov, MB | 1 |
| Kelly, PJ | 1 |
| Marschke, G | 1 |
| Regli Fernández, E | 1 |
| Domingo, LA | 1 |
| López Mejías, J | 1 |
| Neff, TA | 1 |
| Coan, BJ | 1 |
| Sharma, SD | 1 |
| Goyl, RK | 1 |
| Arora, HL | 1 |
| Sharma, ML | 1 |
| Czkwianianc, M | 1 |
| Markiewicz, I | 1 |
| Kataria, YP | 1 |
| Araszkiewicz, W | 1 |
| Golanov, VS | 1 |
| Spens, N | 1 |
| Tattersall, WH | 1 |
| María Palermo, F | 1 |
| Alberto Iannello, J | 1 |
| Klein, A | 1 |
| Mysakowska, H | 1 |
| Grodzki, S | 1 |
| Szarewicz, W | 1 |
| Srednicka, D | 1 |
| Komet, H | 1 |
| Schaefer, RF | 1 |
| Mahoney, PL | 1 |
| Corda, M | 1 |
| Voigt, R | 2 |
| Wolf, C | 2 |
| Poliakova, SG | 1 |
| Le Guillou, F | 1 |
| Volkmann, W | 2 |
| Mydlak, G | 2 |
| Uhde, H | 1 |
| Shapiro, BIa | 1 |
| Stepanian, ES | 1 |
| Kato, Y | 1 |
| Kuczborski, S | 1 |
| Dimitrov, DA | 1 |
| Grunert, M | 1 |
| Reutgen, H | 1 |
| Sönnichsen, N | 1 |
| Zoellner, E | 1 |
| Randow, U | 1 |
| Bene, J | 1 |
| Kedrowa, S | 1 |
| Grymiński, J | 1 |
| Soteres, P | 1 |
| Christensen, E | 1 |
| Foster, DW | 1 |
| Johnson, RL | 1 |
| Pierce, AK | 1 |
| Seldin, DW | 1 |
| Nicholson, D | 1 |
| Reynolds, RC | 1 |
| Magovern, M | 1 |
| Surrety, NE | 1 |
| Love, RW | 1 |
| Swynghedauw, B | 1 |
| Clauvel, M | 1 |
| Nisim, F | 1 |
| Nicoulescu, F | 1 |
| Cohen, SC | 1 |
| Steinfeld, LI | 1 |
| Foley, JT | 1 |
| Blacker, E | 1 |
| Kawachi, T | 1 |
| Vuga, D | 1 |
| Pacilio, G | 1 |
| Eskenasy, A | 1 |
| Schwabe, KH | 1 |
| Dobstadt, HP | 1 |
| Godovannyi, BA | 1 |
| Donets, I | 1 |
| Shah, NS | 1 |
| Fox, LE | 1 |
| Martin, SP | 1 |
| Lukas, W | 1 |
| Kunovskiĭ, BV | 1 |
| Kats, NIa | 1 |
| Szabó, G | 1 |
| Sándor, Z | 1 |
| Sipos, G | 1 |
| Cassetti, B | 1 |
| Pirolli, T | 1 |
| Cardis, F | 1 |
| Friedel, H | 1 |
| Largier, E | 1 |
| Grella, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Open-label Study to Evaluate the Extended Early Bactericidal Activity, Safety, Tolerability and Pharmacokinetics of Multiple Oral Doses of TMC207 in Treatment-na�ve Subjects With Sputum Smear Positive Pulmonary Tuberculosis.[NCT00523926] | Phase 2 | 75 participants (Actual) | Interventional | 2005-05-31 | Completed | ||
| A Prospective, Randomized, Open, Active-controlled, Interventional, Exploratory, Phase II Trial to Evaluate the EBA, Safety and PK of Orally Administered LCB01-0371 in Adult Patients With Smear-positive Pulmonary Tuberculosis[NCT02836483] | Phase 2 | 79 participants (Actual) | Interventional | 2016-12-10 | Completed | ||
| Culture Free Diagnosis and Follow-up of Multidrug Resistant Tuberculosis Patients[NCT03303963] | 3,356 participants (Actual) | Observational | 2017-05-04 | Completed | |||
| Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin to 3 Months After Culture Conversion (Hi-DoRi-3): A Phase 3, Multicenter, Randomized, Open-label, Clinical Trial[NCT04485156] | Phase 3 | 926 participants (Anticipated) | Interventional | 2020-09-30 | Not yet recruiting | ||
| Electronic Pillbox-enabled Self-administered Therapy Versus Standard Directly Observed Therapy for Tuberculosis Medication Adherence and Treatment Outcomes in Ethiopia: a Multicenter Randomized Controlled Trial[NCT04216420] | 114 participants (Actual) | Interventional | 2020-06-01 | Completed | |||
| Epidemiology of Multidrug-Resistant Tuberculosis in Peru[NCT00676754] | 18,544 participants (Actual) | Observational | 2009-09-30 | Active, not recruiting | |||
| A Phase 2 Dose-ranging Trial to Evaluate the Bactericidal Activity, Safety, Tolerability and Pharmacokinetics of Linezolid in Adult Subjects With Newly Diagnosed Drug-Sensitive, Smear-Positive Pulmonary Tuberculosis.[NCT02279875] | Phase 2 | 113 participants (Actual) | Interventional | 2014-11-30 | Completed | ||
| Effectiveness and Tolerability of Weekly Rifapentine/Isoniazid for 3 Months for Tuberculosis Preventive Treatment: A Randomized Controlled Study in China[NCT02430259] | Phase 3 | 566 participants (Anticipated) | Interventional | 2015-03-31 | Completed | ||
| A Randomised, Pragmatic, Open-Label Trial To Evaluate The Effect Of Three Months Of High Dose Rifapentine Plus Isoniazid Administered As A Single Round Or Given Annually In HIV-Positive Individuals[NCT02980016] | Phase 3 | 4,027 participants (Actual) | Interventional | 2016-11-30 | Completed | ||
| Shortened Regimens for First Diagnosed Smear Positive Drug Susceptible Pulmonary Tuberculosis: a Randomised Controlled Non-inferiority Trial[NCT02901288] | Phase 4 | 3,900 participants (Anticipated) | Interventional | 2016-08-31 | Recruiting | ||
| 2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB: a 3-arm Randomized Trial.[NCT03988933] | Phase 2 | 1,368 participants (Actual) | Interventional | 2019-09-20 | Active, not recruiting | ||
| Pharmacokinetics and Pharmacodynamics of High Versus Standard Dose Rifampicin in Patients With Pulmonary Tuberculosis in the Kilimanjaro Region, Tanzania.[NCT00760149] | Phase 2 | 150 participants (Actual) | Interventional | 2010-07-31 | Completed | ||
| Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment Outcomes in HIV-tuberculosis Co-infected Ugandan Adults[NCT01782950] | Phase 4 | 400 participants (Anticipated) | Interventional | 2013-02-28 | Recruiting | ||
| A Randomized Controlled Clinical Trial Comparing Daily Vs. Intermittent 6 - Month Short Course Chemotherapy in Reducing Failures & Emergence of Acquired Rifampicin Resistance (ARR) in Patients With HIV and Pulmonary Tuberculosis[NCT00933790] | Phase 3 | 331 participants (Actual) | Interventional | 2009-09-14 | Completed | ||
| A Phase II Trial to Describe the Pharmacokinetics, Safety and Efficacy of Pharmacogenetics-guided Dosing of Isoniazid in Patients With HIV-associated TB[NCT05124678] | Phase 2 | 40 participants (Anticipated) | Interventional | 2021-12-07 | Recruiting | ||
| A Randomized, Four-arm Open Label Phase Two-b Clinical Trial to Evaluate the Pharmacokinetics, Safety/Tolerability and Efficacy of High Dose Rifampicin in TB-HIV Co-infected Patients on Efavirenz- or Dolutegravir-based Antiretroviral Therapy[NCT03982277] | Phase 2 | 130 participants (Actual) | Interventional | 2019-04-30 | Completed | ||
| Substitution of Ethambutol With Linezolid During the Intensive Phase of Treatment of Pulmonary Tuberculosis: A Prospective, Multicenter, Randomized, Open-label Phase II Trial[NCT01994460] | Phase 2 | 429 participants (Anticipated) | Interventional | 2014-01-31 | Recruiting | ||
| A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of Delamanid (OPC-67683) Administered Orally as 200 mg Total Daily Dose for Six Months in Patients With Pulmonary Sputum Culture[NCT01424670] | Phase 3 | 511 participants (Actual) | Interventional | 2011-09-02 | Completed | ||
| A Prospective, Randomized Open-Label Phase II Study of the Safety and Tolerability of Metformin in Combination With Standard Antimicrobial Treatment of Pulmonary Tuberculosis in People With TB and Co-infected With HIV[NCT04930744] | Phase 2 | 112 participants (Anticipated) | Interventional | 2021-08-03 | Recruiting | ||
| Metformin as Adjunctive Therapy in Overweight and Obese Patients With Dengue: an Open-label Safety and Tolerability Trial[NCT04377451] | Phase 1/Phase 2 | 120 participants (Actual) | Interventional | 2020-07-27 | Completed | ||
| Safety of Rifampicin at High Dose for the Treatment of Adult Subjects With Complex Drug Susceptible Pulmonary and Extrapulmonary Tuberculosis[NCT04768231] | Phase 2 | 130 participants (Anticipated) | Interventional | 2021-04-01 | Not yet recruiting | ||
| Pharmacokinetics of Standard First and Second Line Anti-TB Drugs in the Lung and Lesions of Subjects Elected for Resection Surgery[NCT00816426] | Phase 1 | 19 participants (Actual) | Interventional | 2008-12-29 | Completed | ||
| A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis[NCT02684240] | Phase 2 | 30 participants (Actual) | Interventional | 2016-02-29 | Completed | ||
| A Randomised Open-Label Controlled Trial of a 4-Month Gatifloxacin-Containing Regimen Versus Standard Regimen for the Treatment of Adult Patients With Pulmonary Tuberculosis[NCT00216385] | Phase 3 | 2,070 participants | Interventional | 2005-01-31 | Recruiting | ||
| URBAN ARCH (3/5) Uganda Cohort TB Preventive Therapy for HIV-infected Alcohol Users in Uganda: an Evaluation of Safety Tolerability and Adherence[NCT03302299] | Phase 4 | 302 participants (Actual) | Interventional | 2017-04-07 | Completed | ||
| Primary Prophylaxis for Prevention of TB in Prison's Populations[NCT03028129] | Phase 4 | 467 participants (Actual) | Interventional | 2017-09-04 | Terminated (stopped due to Interim analysis showed efficacy less than 2.5%.) | ||
| Pharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis[NCT03827811] | 625 participants (Anticipated) | Observational | 2020-01-30 | Recruiting | |||
| Long Term Study of 2 Isoniazid (INH) Prophylactic Regimens With Concomitant Cotrimoxazole (CTX) in HIV-infected Children - Impact on Morbidity, Mortality, Bacterial Resistance and Incidence of Tuberculosis[NCT00330304] | Phase 3 | 450 participants (Actual) | Interventional | 2003-01-31 | Completed | ||
| A Randomized-controlled Trial of Isoniazid Plus Highly Active Antiretroviral Therapy Against Placebo to Prevent Tuberculosis in HIV-infected Persons[NCT00463086] | 1,368 participants (Actual) | Interventional | 2007-11-30 | Completed | |||
| TB Screening Improves Preventive Therapy Uptake Trial[NCT04557176] | 1,719 participants (Actual) | Interventional | 2020-11-16 | Active, not recruiting | |||
| A Randomised Placebo - Controlled Double Blind Trial Comparing 1) a Two Month Intensive Phase of Ethambutol, Moxifloxacin, Rifampicin, Pyrazinamide Versus the Standard Regimen (Ethambutol, Isoniazid, Rifampicin, Pyrazinamide) and 2) a Treatment Shortening[NCT00864383] | Phase 3 | 1,931 participants (Actual) | Interventional | 2008-01-31 | Completed | ||
| Using Biomarkers to Predict TB Treatment Duration[NCT02821832] | Phase 2 | 946 participants (Actual) | Interventional | 2017-06-21 | Active, not recruiting | ||
| A Prospective, Randomized Controlled Study for the Efficacy and Safety of the Substitution of Pyrazinamide and Ethambutol With Moxifloxacin During the Intensive Phase of Treatment of Pulmonary Tuberculosis[NCT04187469] | 286 participants (Anticipated) | Interventional | 2020-03-01 | Not yet recruiting | |||
| Beta-Lactam Containing Regimen for the Shortening of Buruli Ulcer Disease Therapy: Comparison of 8 Weeks Standard Therapy (Rifampicin Plus Clarithromycin) vs. 4 Weeks Standard Plus Amoxicillin/Clavulanate Therapy [RC8 vs. RCA4][NCT05169554] | Phase 2 | 140 participants (Anticipated) | Interventional | 2021-12-01 | Recruiting | ||
| A Pragmatic Trial With Optimized Dose of Rifampicin and Moxifloxacin for the Treatment of Drug Susceptible Pulmonary Tuberculosis[NCT05575518] | Phase 3 | 414 participants (Anticipated) | Interventional | 2023-08-11 | Recruiting | ||
| Rifampin to Reduce Elevated Levels of Blood and Urine Calcium in Patients With Idiopathic Infantile Hypercalcemia[NCT03384121] | Phase 1 | 5 participants (Anticipated) | Interventional | 2018-02-22 | Recruiting | ||
| A Phase IIA Dose Ranging Trial to Evaluate the Safety, Tolerability, Extended Early Bactericidal Activity and Pharmacokinetics of Higher Doses of Rifampicin in Adult Subjects With Newly Diagnosed, Uncomplicated, Smear-Positive, Pulmonary Tuberculosis[NCT01392911] | Phase 2 | 128 participants (Anticipated) | Interventional | 2011-06-30 | Completed | ||
| A Phase II Open-Label Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability of the Combination of Moxifloxacin Plus PA-824 Plus Pyrazinamide After 8 Weeks of Treatment in Adult Patients With Newly Diagnosed Drug-Sensitive or Multi D[NCT01498419] | Phase 2 | 207 participants (Actual) | Interventional | 2012-03-31 | Completed | ||
| A Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of Lessertia Frutescens (L.)Goldblatt and J.C. Manning (Syn. Sutherlandia Frutescens (L.)R. Br.)in HIV-infected South African Adults[NCT00549523] | Phase 1/Phase 2 | 133 participants (Actual) | Interventional | 2008-04-30 | Completed | ||
| Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in the Treatment of Tuberculosis Patient With HIV Infection in South Africa: A Phase II Trial[NCT00640887] | Phase 2 | 48 participants (Anticipated) | Interventional | 2009-02-28 | Completed | ||
| Clinical Evaluation of Adjusted Doses of Darunavir/Ritonavir With Rifampicin in HIV-infected Volunteers[NCT03892161] | Phase 1 | 17 participants (Actual) | Interventional | 2018-04-12 | Terminated (stopped due to Risks to participation) | ||
| Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)[NCT01637558] | Phase 4 | 200 participants (Actual) | Interventional | 2012-11-30 | Completed | ||
| A Phase II Randomized, Open-label Trial of a Rifapentine Plus Moxifloxacin-Based Regimen for Intensive Phase Treatment of Smear-Positive Pulmonary Tuberculosis[NCT00728507] | Phase 2 | 121 participants (Actual) | Interventional | 2009-11-30 | Terminated (stopped due to Funding withdrawn) | ||
| A Pilot Study to Evaluate Video Observed Treatment Among Tuberculosis Patients From Lambaréné Using an Instant Messenger Application[NCT05865626] | 30 participants (Actual) | Interventional | 2018-10-10 | Completed | |||
| A Multiple Arm, Multiple Stage, Phase 2, OL, Randomized, Controlled Trial to Evaluate 4 Treatment Regimens of SQ109, Increased Doses of Rifampicin, and Moxifloxacin in Adults With Newly Diagnosed, Smear-positive Pulmonary Tuberculosis[NCT01785186] | Phase 2 | 365 participants (Actual) | Interventional | 2013-04-30 | Completed | ||
| Double-Blind, Randomized, Placebo-Controlled Phase II Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Inf[NCT01136161] | Phase 2 | 95 participants (Actual) | Interventional | 2010-06-30 | Completed | ||
| Double-Blind, Randomized, Placebo-Controlled Phase I Study, to Study the Tolerability and Immunogenicity of 4 RUTI Antituberculous Vaccine Different Doses (5, 25, 100 y 200µg of FCMtb) in Healthy Volunteers[NCT00546273] | Phase 1 | 24 participants (Actual) | Interventional | 2007-04-30 | Completed | ||
| A Pharmacokinetics Study Comparing Lopinavir Plasma Exposure When Given as Lopinavir/Ritonavir (1:1) in the Presence of Rifampicin and Lopinavir/Ritonavir (4:1) Without Rifampicin in HIV and TB Co-infected Children in South Africa.[NCT02348177] | Phase 4 | 96 participants (Actual) | Interventional | 2013-01-31 | Completed | ||
| Randomized, Open Label, Multiple Dose Phase I Study of the Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, and Moxifloxacin in HIV-non-infected Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis[NCT00396084] | Phase 1/Phase 2 | 70 participants (Actual) | Interventional | 2004-02-10 | Completed | ||
| TBTC Study 31 PK/PD: Population Pharmacokinetic and Pharmacodynamic Study of Efficacy and Safety of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis in the Study 31 Treatment Trial: Intensive PK Sampling[NCT02563327] | Phase 3 | 60 participants (Anticipated) | Interventional | 2016-05-30 | Recruiting | ||
| Phase 2 Randomized Trial of a Moxifloxacin-Containing Regimen For Treatment of Smear-Positive Pulmonary Tuberculosis in Adults With and Without HIV Infection[NCT00082173] | Phase 2 | 170 participants (Actual) | Interventional | 2004-10-31 | Completed | ||
| TBTC Study 28: Evaluation of a Moxifloxacin-based, Isoniazid-sparing Regimen for Tuberculosis Treatment[NCT00144417] | Phase 2 | 433 participants (Actual) | Interventional | 2006-02-28 | Completed | ||
| DNA Sequencing of MDR TB in Eastern Siberia[NCT02508610] | 630 participants (Anticipated) | Observational | 2013-11-30 | Recruiting | |||
| A Prospective Study of Shortening the Duration of Standard Short Course Chemotherapy From 6 Months to 4 Months in HIV-non-infected Patients With Fully Drug-Susceptible, Non-cavitary Pulmonary Tuberculosis With Negative Sputum Cultures After 2 Months of An[NCT00130247] | Phase 3 | 394 participants (Actual) | Interventional | 2002-04-08 | Completed | ||
| Prophylactic Use of Entecavir to Reduce Hepatitis Flare in Highly Viremic HBV Patients With Active Tuberculosis Receiving Anti-tuberculous Treatment[NCT01724723] | Phase 4 | 50 participants (Anticipated) | Interventional | 2012-12-31 | Not yet recruiting | ||
| Efficacy Of Doxycycline & Versus Rifampin In Treatment Of Rhinoscleroma[NCT05431673] | Phase 1 | 45 participants (Anticipated) | Interventional | 2022-08-21 | Not yet recruiting | ||
| A Phase IV Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Safety of Immediate (Antepartum-Initiated) Versus Deferred (Postpartum-Initiated) Isoniazid Preventive Therapy Among HIV-Infected Women in High Tuberculosis (TB) Incidence Setting[NCT01494038] | Phase 4 | 956 participants (Actual) | Interventional | 2014-08-19 | Completed | ||
| Behavior Change and Digital Health Interventions for Improved TB Treatment Outcomes: a RCT[NCT04119375] | 16,146 participants (Actual) | Interventional | 2018-04-13 | Completed | |||
| PROvide MIner-friendly SErvices for Integrated TB/HIV Care in Lesotho Study (PROMISE Study)[NCT03537872] | 248 participants (Actual) | Interventional | 2018-03-13 | Completed | |||
| TB Treatment Support Tools: Refinement and Evaluation of an Interactive Mobile App and Direct Adherence Monitoring on TB Treatment Outcomes[NCT04221789] | 555 participants (Actual) | Interventional | 2020-11-17 | Active, not recruiting | |||
| Transcriptional Signature of HIV And TB Co-Infection[NCT01611402] | 96 participants (Actual) | Observational | 2012-05-29 | Completed | |||
| International Multicenter Trial for the Evaluation of a Four-Drug Fixed Dose Combined Tablet Daily in the Initial Intensive Phase of Chemotherapy Followed by a Two-Drug Fixed Dose Combined Tablet Three Times a Week in the Continuation Phase for the Treatm[NCT00216333] | Phase 4 | 1,500 participants | Interventional | 2003-12-31 | Recruiting | ||
| A Randomized Clinical Trial of Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa[NCT04618198] | Phase 3 | 436 participants (Anticipated) | Interventional | 2021-12-10 | Recruiting | ||
| Diagnosis of Active and Latent TB Infection With IFN-y Assays in African Children[NCT00456469] | 500 participants | Observational | 2007-05-31 | Not yet recruiting | |||
| A Phase II Dose Ranging Trial to Evaluate the Extended Early Bactericidal Activity, Safety, Tolerability, and Pharmacokinetics of PA-824 in Adult Participants With Newly Diagnosed, Uncomplicated, Smear-Positive, Pulmonary Tuberculosis[NCT00944021] | Phase 2 | 69 participants (Actual) | Interventional | 2009-08-31 | Completed | ||
| Community Intervention for Tuberculosis Active Contact Tracing and Preventive Therapy - a Cluster Randomized Study (CONTACT)[NCT03832023] | 1,400 participants (Actual) | Interventional | 2019-10-14 | Completed | |||
| TBTC Study 22: Efficacy and Safety of Once-Weekly Rifapentine and Isoniazid Compared to Efficacy and Safety of Once-Weekly Rifapentine and Isoniazid Compared to Twice-Weekly Rifampin and Isoniazid in the Continuation Phase of Therapy for Pulmonary Tubercu[NCT00023335] | Phase 3 | 1,000 participants | Interventional | 1995-04-30 | Completed | ||
| Phase I Clinical Trial of the Pharmacokinetics of High-dose Daily Rifapentine, Given as a Single Dose or in Divided Doses to Healthy Volunteers[NCT01574638] | Phase 1 | 44 participants (Actual) | Interventional | 2012-06-30 | Completed | ||
| NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis[NCT02371681] | Phase 2 | 262 participants (Actual) | Interventional | 2015-02-25 | Completed | ||
| Efficacy of Clarithromycin or Moxifloxacin Containing Regimen in 6 Months Sputum Conversion of Mycobacterium Xenopi[NCT01298336] | Phase 3 | 92 participants (Actual) | Interventional | 2011-03-02 | Completed | ||
| Phase 1b/2a Safety and Immunogenicity of the DNMT Inhibitor Azacitidine During Anti-Tuberculosis Therapy[NCT03941496] | Phase 1/Phase 2 | 0 participants (Actual) | Interventional | 2022-10-31 | Withdrawn (stopped due to The study was halted prematurely due to Bristol-Myers Squibb's (BMS) decision to withdraw support for this study.) | ||
| Intensive Pharmacokinetic Study of Three Doses of Rifapentine (600, 900 and 1200mg) During Continuation Phase Therapy of Tuberculosis in HIV-Negative Adults[NCT00023387] | 36 participants | Interventional | 2000-03-31 | Completed | |||
| A Phase 2 Randomized, Open-label Trial of Daily Rifapentine 450mg or 600mg in Place of Rifampicin 600mg for Intensive Phase Treatment of Smear-positive Pulmonary Tuberculosis[NCT00814671] | Phase 2 | 153 participants (Actual) | Interventional | 2010-04-30 | Completed | ||
| Enhanced TB Screening to Determine the Prevalence and Incidence of TB in a Cohort of HIV Clinic Patients in Lusaka, Zambia[NCT02043067] | 400 participants (Actual) | Observational | 2011-10-31 | Completed | |||
| Multi Center Clinical Research and Evaluation of Melting Technology for Rapid Detection of Drug Resistant Tuberculosis[NCT02776150] | 3,100 participants (Anticipated) | Observational | 2016-05-31 | Not yet recruiting | |||
| Preventing Mycobacterium Tuberculosis Infection in HIV-Exposed Infants[NCT02613169] | Phase 2 | 300 participants (Actual) | Interventional | 2016-08-31 | Completed | ||
| A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection Outcomes[NCT02129244] | 3,600 participants (Anticipated) | Interventional | 2014-10-31 | Active, not recruiting | |||
| Pharmacokinetic Interaction Study of Rifampicin, Isoniazid and Moxifloxacin in Tuberculosis Patients in Bandung, Indonesia[NCT00306319] | Phase 2 | 23 participants | Interventional | 2006-01-31 | Completed | ||
| Early Bactericidal Activity of Standard Drugs Used to Treat Mycobacterium Avium Complex: a Pilot Study[NCT04287049] | Phase 2 | 30 participants (Anticipated) | Interventional | 2020-02-24 | Recruiting | ||
| Randomized Clinical Trial to Assess the Efficacy of Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis[NCT00376012] | Phase 3 | 300 participants (Actual) | Interventional | 2001-02-28 | Active, not recruiting | ||
| Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection[NCT00000959] | 600 participants | Interventional | Completed | ||||
| Evaluation of Two Different Preventive Therapy Regimens for Tuberculosis in HIV Infected Persons[NCT00351702] | Phase 3 | 650 participants (Actual) | Interventional | 2001-02-28 | Completed | ||
| The Treatment of Pulmonary Mycobacterium Tuberculosis in HIV Infection[NCT00001033] | Phase 3 | 650 participants | Interventional | Completed | |||
| Evaluation of Endoscopic Ultrasound in Preventing Rebleeding After Endoscopic Cyanoacrylate Injection for Gastric Varices[NCT05515861] | 150 participants (Anticipated) | Interventional | 2022-09-30 | Not yet recruiting | |||
| Efficacy of Simultaneous Versus Sequential Antiretroviral Therapy and Antituberculosis Treatment in Patients With AIDS and Active Tuberculosis. Open, Randomized and Controlled, Multisite Clinical Trial.[NCT00737724] | 63 participants (Actual) | Interventional | 2008-03-31 | Terminated (stopped due to Other published trials showed definitive expected superiority of Group 1) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"The value for TTD was defined (in days) as the time interval from inoculation until a MGIT machine detects a positive signal for a sputum culture. The AUC of the change from Baseline for TTD in days (from Baseline to Month 6) summarizes the overall participant response for the treatment period. The change from Baseline in original time to detection of MGIT positive signal, in days, up to 6 months was performed using AUC in MGIT. The Baseline was defined as the average of Day -1 and Day 1 values if cultures on both days were positive; if only 1 culture was positive, the value for TTD for the positive culture was used as the Baseline.~The TTD is Time to Detection measured by day, so the unit of AUC of change from baseline in TTD is day*day. Since Mean AUC is reported, which is actually Time Averaged AUC, the AUC was divided by the duration of the observation, and thus the unit of the Mean AUC is day." (NCT01424670)
Timeframe: Baseline, up to Month 6
| Intervention | days (Mean) |
|---|---|
| Delamanid + OBR | 21.9 |
| Placebo + OBR | 23.3 |
Acquired resistance was defined as a post-baseline resistant result at any time point after a Baseline susceptible result. The overall resistance to delamanid during the trial was assessed. (NCT01424670)
Timeframe: Up to Month 30
| Intervention | participants (Number) |
|---|---|
| Delamanid + OBR | 3 |
| Placebo + OBR | 0 |
SCC at 6 months was determined by the observation of a sputum specimen negative for growth of mycobacterium tuberculosis (MTB) using the MGIT culture system, followed by at least 1 confirmatory negative sputum culture at least 25 days after the first negative and not followed by a confirmed positive (defined as at least 2 observed positive results, not taking into account indeterminate, missing, or contaminated results). 2 specimens were collected at each visit and an algorithm in the statistical analysis plan (SAP) was used to define a single representative result. Time to SCC was then defined as the interval between the date of first dose of IMP and the date of first of 2 consecutive negative single representative time points that were at least 25 days apart. The median time in days to SCC up to Month 6 is presented. (NCT01424670)
Timeframe: Month 6
| Intervention | Days (Median) |
|---|---|
| Delamanid + OBR | 51 |
| Placebo + OBR | 57 |
The value for TTD was defined (in days) as the time interval from inoculation until a MGIT machine detects a positive signal for a sputum culture during the routine 42-day incubation period. TTD analysis was based only on the corresponding qualitative sputum results of pure positive and pure negative cultures in days and hours of the initial positive signal for a culture from the MGIT printout. Mean change is reported for Baseline, Week 1, Week 2, Week 3, Week 24, Week 26, and Last visit (Month 18 or last visit for participants treated beyond Month 18). (NCT01424670)
Timeframe: Baseline, Week 1, Week 2, Week 3, Week 24, Week 26, and Last visit (Month 18 or last visit for participants treated beyond Month 18)
| Intervention | days (Mean) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| At Baseline | At Week 1 | Change from Baseline at Week 1 | At Week 2 | Change from Baseline at Week 2 | At Week 3 | Change from Baseline at Week 3 | At Week 24 | Change from Baseline at Week 24 | At Week 26 | Change from Baseline at Week 26 | At Last Visit | Change from Baseline at Last Visit | |
| Delamanid + OBR | 16.7 | 20.8 | 4.3 | 24.6 | 7.7 | 28.4 | 11.6 | 40.4 | 23.4 | 40.6 | 23.8 | 39.4 | 22.7 |
| Placebo + OBR | 15.4 | 19.9 | 4.8 | 23.1 | 7.5 | 25.5 | 10.4 | 41.3 | 25.5 | 40.5 | 24.6 | 40.3 | 24.9 |
Treatment success was defined as achieving SCC by 6 months using MGIT, completing the trial out to 30 months with sustained SCC and alive at the last contact for follow-up. All other participants were treatment failures who failed to achieve SCC by Month 6, achieved SCC but have a confirmed positive, early terminate from the trial prior to the Month 30 visit but are alive at the last contact for follow-up, lost to follow-up and vital status unknown and death. (NCT01424670)
Timeframe: Month 30
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| Success | Failure | |
| Delamanid + OBR | 173 | 53 |
| Placebo + OBR | 78 | 23 |
"SCC was evaluated at 2 and 6 months (6-month Intensive Period) using MGIT. SCC at 2 months was defined to occur at the date of collection of the first sputum specimen with mycobacterial culture negative for growth of MTB using MGIT culture, followed by at least 1 confirmatory negative MGIT culture result at least 25 days after the first negative specimen and not followed by any sputum specimens positive for growth in the MGIT culture at any point up to 3 months (Week 12).~SCC at 6 months was determined by the observation of a sputum specimen negative for growth of MTB using the MGIT culture system, followed by at least 1 confirmatory negative sputum culture at least 25 days after the first negative and not followed by a confirmed positive (defined as at least 2 observed positive results, not taking into account indeterminate, missing, or contaminated results). 2 specimens were collected at each visit and an algorithm in the SAP was used to define a single representative result." (NCT01424670)
Timeframe: Month 2 and Month 6
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| At Month 2 | At Month 6 | |
| Delamanid + OBR | 132 | 198 |
| Placebo + OBR | 54 | 87 |
Sustained SCC was defined as SCC achieved by Month 6 and not followed by a confirmed positive thereafter, where confirmed positive was defined as 2 or more observed positive single representative culture results, not taking into account indeterminate, missing, or contaminated results. Sustained SCC was analyzed at Month 18 to 30 using MGIT. (NCT01424670)
Timeframe: Month 18, Month 24, and Month 30
| Intervention | Participants (Count of Participants) | ||
|---|---|---|---|
| At 18 months | At 24 months | At 30 months | |
| Delamanid + OBR | 180 | 178 | 173 |
| Placebo + OBR | 83 | 82 | 78 |
Safety will be assessed by the occurrence of a Grade 3/4 hepatotoxicity at any time during the assigned treatment period. (NCT03302299)
Timeframe: Hepatotoxicity occurring during the six month course (180 pills) of isoniazid (INH), which may be taken over a maximum of 9 months.
| Intervention | percent (Number) |
|---|---|
| INH and Vitamin B6 | 8.3 |
Lack of tolerability will be defined as any isoniazid (INH) treatment discontinuation prior to completion of the prescribed course (6 months of INH taken over a maximum period of 9 months) due to side effects or alanine transaminase (ALT)/aspartate transaminase (AST) elevations. (NCT03302299)
Timeframe: Six month course (180 pills) of isoniazid (INH), which may be taken over a maximum of 9 months.
| Intervention | Participants (Count of Participants) |
|---|---|
| INH and Vitamin B6 | 32 |
Alanine transaminase (ALT) or aspartate transaminase (AST) elevations (>2x the upper limit of normal) at study screening (NCT03302299)
Timeframe: Study screening visit
| Intervention | Participants (Count of Participants) |
|---|---|
| Study Screening | 80 |
Latent tuberculosis assessed at screening via tuberculin skin testing (TST). A TST induration >=5mm was considered positive for latent tuberculosis. (NCT03302299)
Timeframe: Study screening visit
| Intervention | Participants (Count of Participants) |
|---|---|
| Study Screening | 308 |
INH concentration in hair (pmol/mg) will be measured at 3- and 6- months during INH therapy. (NCT03302299)
Timeframe: Measured at 3- and 6- months after INH initiation
| Intervention | pmol/mg (Median) | |
|---|---|---|
| at 3 months | at 6 months | |
| INH and Vitamin B6 | 36.0 | 37.8 |
Suboptimal INH adherence was defined as <90% of days with at least 1 electronic medication management (EMM) pill cap opening in the previous 90 days, at 3- and 6-months. (NCT03302299)
Timeframe: Adherence will be measured over the 6 months on INH or until INH discontinuation (whichever is shorter)
| Intervention | percentage of participants (Number) | |
|---|---|---|
| at 3 months | at 6 months | |
| INH and Vitamin B6 | 31.3 | 43.9 |
"Participants were asked In the past 30 days, how many days in total have you not taken your pill? and were presented with a visual analog scale (VAS) to indicate the percentage of INH taken in the past 30 days. We converted the VAS percentage into number of days out of 30 to match the first question. Our final self-report measure was the minimum number of the 2 self-reported measurements." (NCT03302299)
Timeframe: Self-reported INH medication adherence via VAS will be measured 3- and 6- months after starting INH
| Intervention | days (Median) | |
|---|---|---|
| at 3 months | at 6 months | |
| INH and Vitamin B6 | 30 | 30 |
The Self Rating Single Item (SRSI) adherence scale asks participants to rate their ability to take their medications as prescribed over the past 30 days. Participants reporting INH use in the prior 30 days at the 3- or 6-month interview are included here, and reported their INH adherence in the prior 30 days as excellent, very good, good, fair, poor, or very poor. (NCT03302299)
Timeframe: Self-reported INH medication adherence via SRSI will be measured 3- and 6- months after starting INH
| Intervention | Participants (Count of Participants) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| At 3 months72558043 | At 6 months72558043 | |||||||||||
| Excellent | Very good | Good | Fair | Poor | Very poor | |||||||
| INH and Vitamin B6 | 160 | |||||||||||
| INH and Vitamin B6 | 79 | |||||||||||
| INH and Vitamin B6 | 38 | |||||||||||
| INH and Vitamin B6 | 2 | |||||||||||
| INH and Vitamin B6 | 124 | |||||||||||
| INH and Vitamin B6 | 90 | |||||||||||
| INH and Vitamin B6 | 41 | |||||||||||
| INH and Vitamin B6 | 4 | |||||||||||
| INH and Vitamin B6 | 0 | |||||||||||
| INH and Vitamin B6 | 1 | |||||||||||
Number of participants who had a Quantiferon TB Gold Plus (QIAGEN®) score greater than or equal to 0.35 international units per milliliter, at the time of the premature exclusion visit, on all participants in the group. (NCT03028129)
Timeframe: up to 6 months
| Intervention | participants (Number) |
|---|---|
| Treatment | 49 |
| Control | 77 |
The secondary analysis of efficacy outcome was the proportion of patients who had bacteriologically or clinically defined failure or relapse within 18 months after randomization (a composite unfavorable outcome) based on MGIT. Culture-negative status was defined as two negative-culture results at different visits without an intervening positive result. The date of culture-negative status was defined as the date of the first negative-culture result. This status continued until there were two positive cultures, without an intervening negative culture, or until there was a single positive culture that was not followed by two negative cultures. Relapse strains were those shown to be identical on 24-locus Mycobacterial interspersed repetitive units (MIRU) analysis. (NCT00864383)
Timeframe: 18 months (within one year of completion of therapy)
| Intervention | participants with failure or relapse (Number) |
|---|---|
| Regimen 1 - 2EHRZ/4HR (Control Regimen) | 65 |
| Regimen 2 - 2MHRZ/2MHR | 98 |
| Regimen 3 - 2EMRZ/2MR | 131 |
The primary efficacy outcome was the proportion of patients who had bacteriologically or clinically defined failure or relapse within 18 months after randomization (a composite unfavorable outcome). Culture-negative status was defined as two negative-culture results at different visits without an intervening positive result. The date of culture-negative status was defined as the date of the first negative-culture result. This status continued until there were two positive cultures, without an intervening negative culture, or until there was a single positive culture that was not followed by two negative cultures. Relapse strains were those shown to be identical on 24-locus Mycobacterial interspersed repetitive units (MIRU) analysis. For the final 18 month study visit when both L-J samples were contaminated or missing, if the subject could not be brought back, liquid medium culture results were used in place of solid medium culture results. (NCT00864383)
Timeframe: 18 months (within one year of completion of therapy)
| Intervention | participants with failure or relapse (Number) |
|---|---|
| Regimen 1 - 2EHRZ/4HR (Control Regimen) | 43 |
| Regimen 2 - 2MHRZ/2MHR | 78 |
| Regimen 3 - 2EMRZ/2MR | 105 |
Number of patients who are TB MGIT culture negative at 8 weeks. (NCT00864383)
Timeframe: 8 weeks
| Intervention | participants who are culture negative (Number) |
|---|---|
| Regimen 1 - 2EHRZ/4HR (Control Regimen) | 235 |
| Regimen 2 - 2MHRZ/2MHR | 274 |
| Regimen 3 - 2EMRZ/2MR | 260 |
Number of patients who are TB LJ culture negative at 8 weeks. (NCT00864383)
Timeframe: 8 weeks
| Intervention | participants who are culture negative (Number) |
|---|---|
| Regimen 1 - 2EHRZ/4HR (Control Regimen) | 352 |
| Regimen 2 - 2MHRZ/2MHR | 394 |
| Regimen 3 - 2EMRZ/2MR | 401 |
The number of participants includes all patients who had at least one grade 3 or 4 adverse event. (NCT00864383)
Timeframe: 18 months (within one year of completion of therapy)
| Intervention | participants with Grade 3 or 4 AEs (Number) |
|---|---|
| Regimen 1 - 2EHRZ/4HR (Control Regimen) | 123 |
| Regimen 2 - 2MHRZ/2MHR | 127 |
| Regimen 3 - 2EMRZ/2MR | 111 |
"Sensitivity Analysis of Primary Efficacy Results of All Randomized Subjects Imputing Favorable for Missing Outcomes. Analysis is the number of subjects with an unfavorable outcome. Favorable outcome is defined as the number of subjects with a negative TB culture status at 18 months (at or after 72 weeks), who had not already been classified as having an unfavorable outcome, and whose last positive TB culture result (isolated positive culture) was followed by at least two negative culture results." (NCT00864383)
Timeframe: 18 months
| Intervention | participants with unfavorable outcome (Number) |
|---|---|
| Regimen 1 - 2EHRZ/4HR (Control Regimen) | 87 |
| Regimen 2 - 2MHRZ/2MHR | 132 |
| Regimen 3 - 2EMRZ/2MR | 132 |
"Sensitivity Analysis of Primary Efficacy Results of All Randomized Subjects Imputing Unfavorable for Missing Outcomes. Analysis is the number of subjects with an unfavorable outcome. Favorable outcome is defined as the number of subjects with a negative TB culture status at 18 months (at or after 72 weeks), who had not already been classified as having an unfavorable outcome, and whose last positive TB culture result (isolated positive culture) was followed by at least two negative culture results." (NCT00864383)
Timeframe: 18 months
| Intervention | participants with unfavorable outcome (Number) |
|---|---|
| Regimen 1 - 2EHRZ/4HR (Control Regimen) | 172 |
| Regimen 2 - 2MHRZ/2MHR | 219 |
| Regimen 3 - 2EMRZ/2MR | 217 |
Culture negative for TB using LJ cultures. (NCT00864383)
Timeframe: 18 months
| Intervention | Time to culture negative status / weeks (Median) |
|---|---|
| Regimen 1 - 2EHRZ/4HR (Control Regimen) | 6.0 |
| Regimen 2 - 2MHRZ/2MHR | 6.0 |
| Regimen 3 - 2EMRZ/2MR | 6.0 |
(NCT00864383)
Timeframe: 18 months
| Intervention | Time to culture negative status / weeks (Median) |
|---|---|
| Regimen 1 - 2EHRZ/4HR (Control Regimen) | 11.9 |
| Regimen 2 - 2MHRZ/2MHR | 8.0 |
| Regimen 3 - 2EMRZ/2MR | 8.0 |
Estimation of the lower bound of a one-sided 95% confidence interval of the difference in success rates between arms B and C. If the lower bound is greater than -7%, this will be evidence that the treatment-shortening arm is not inferior to the standard duration arm. (NCT02821832)
Timeframe: 18 months
| Intervention | Participants (Count of Participants) | ||||
|---|---|---|---|---|---|
| Cured | Confirmed relapses | Late withdrawal, lost to follow-up | Probable relapses | Treatment Failure | |
| Arm A | 217 | 5 | 13 | 1 | 1 |
| Arm B | 121 | 1 | 9 | 1 | 0 |
| Arm C | 117 | 9 | 6 | 3 | 4 |
(NCT01498419)
Timeframe: 8 weeks
| Intervention | percentage of participants (Number) |
|---|---|
| Drug Sensitive: M (400 mg) Pa (100 mg) Z (1500 mg) | 13 |
| Drug Sensitive: M (400 mg) Pa (200 mg) Z (1500 mg) | 19 |
| Drug Sensitive: Rifafour | 12 |
| Multi Drug-Resistant: M (400 mg) Pa (200 mg) Z (1500 mg) | 12 |
Sputum culture conversion is defined as a change from a positive growth of M. tuberculosis in a sputum sample to negative M. tuberculosis growth sputum sample in patients with pulmonary TB. This was measured at visit 24(Day 57). (NCT01498419)
Timeframe: Day 57 after eight weeks of daily treatment
| Intervention | percentage of patients (Number) |
|---|---|
| Drug Sensitive: M (400 mg) Pa (100 mg) Z (1500 mg) | 65.7 |
| Drug Sensitive: M (400 mg) Pa (200 mg) Z (1500 mg) | 71.4 |
| Drug Sensitive: Rifafour | 37.8 |
| Multi Drug-Resistant: M (400 mg) Pa (200 mg) Z (1500 mg) | 50.0 |
Sputum culture conversion is defined as a change from a positive growth of M. tuberculosis in a sputum sample to negative M. tuberculosis growth sputum sample in patients with pulmonary TB. (Day 57) (NCT01498419)
Timeframe: Day 57 after eight weeks of daily treatment
| Intervention | percentage of participants (Number) |
|---|---|
| Drug Sensitive: M (400 mg) Pa (100 mg) Z (1500 mg) | 82.9 |
| Drug Sensitive: M (400 mg) Pa (200 mg) Z (1500 mg) | 94.3 |
| Drug Sensitive: Rifafour | 87.5 |
| Multi Drug-Resistant: M (400 mg) Pa (200 mg) Z (1500 mg) | 62.5 |
The primary efficacy endpoint was bactericidal activity characterized by the daily rate of change in mean log10CFU counts during 8 weeks of treatment (bactericidal activity assessed by CFU on solid media for days 0-56). (NCT01498419)
Timeframe: 8 weeks
| Intervention | log10CFU/ml/day (Mean) |
|---|---|
| Drug Sensitive: M (400 mg) Pa (100 mg) Z (1500 mg) | 0.133 |
| Drug Sensitive: M (400 mg) Pa (200 mg) Z (1500 mg) | 0.155 |
| Drug Sensitive: Rifafour | 0.112 |
| Multi Drug-Resistant: M (400 mg) Pa (200 mg) Z (1500 mg) | 0.117 |
Measurement of TTP in liquid culture media Mycobacteria growth indicator tube (MGIT) using standard procedures (NCT01498419)
Timeframe: 8 weeks
| Intervention | log10hours/day (Mean) |
|---|---|
| Drug Sensitive: M (400 mg) Pa (100 mg) Z (1500 mg) | 0.020 |
| Drug Sensitive: M (400 mg) Pa (200 mg) Z (1500 mg) | 0.020 |
| Drug Sensitive: Rifafour | 0.017 |
| Multi Drug-Resistant: M (400 mg) Pa (200 mg) Z (1500 mg) | 0.015 |
liquid culture = Mycobacteria growth indicator tube (MGIT) Sputum culture conversion is defined as a change from a positive growth of M. tuberculosis in a sputum sample to negative M. tuberculosis growth sputum sample in patients with pulmonary TB (NCT01498419)
Timeframe: 8 weeks
| Intervention | days (Median) |
|---|---|
| Drug Sensitive: M (400 mg) Pa (100 mg) Z (1500 mg) | 42.0 |
| Drug Sensitive: M (400 mg) Pa (200 mg) Z (1500 mg) | 49.0 |
| Drug Sensitive: Rifafour | 56.0 |
| Multi Drug-Resistant: M (400 mg) Pa (200 mg) Z (1500 mg) | 56.0 |
Sputum culture conversion is defined as a change from a positive growth of M. tuberculosis in a sputum sample to negative M. tuberculosis growth sputum sample in patients with pulmonary TB (NCT01498419)
Timeframe: 8 weeks
| Intervention | days (Median) |
|---|---|
| Drug Sensitive: M (400 mg) Pa (100 mg) Z (1500 mg) | 28.0 |
| Drug Sensitive: M (400 mg) Pa (200 mg) Z (1500 mg) | 28.0 |
| Drug Sensitive: Rifafour | 35.0 |
| Multi Drug-Resistant: M (400 mg) Pa (200 mg) Z (1500 mg) | 35.0 |
LJ culture conversion (NCT00728507)
Timeframe: Week 8
| Intervention | percentage of participants (Number) |
|---|---|
| HPZM | 78.3 |
| HRZE | 84.3 |
"Pharmacokinetic parameters will be assessed for rifampicin, moxifloxacin and SQ109:~area under the plasma concentration curve from dosing to the end of the dosing interval (AUC 0-24) (in h*ng/mL)~the observed maximum concentration (Cmax( (in ng/mL)~time to reach Cmax (Tmax)(in hours)~the minimum observed plasma concentration 24 hours following the last dose (Cmin) (in hours),~clearance (Cl) (in mL/minute),~volume of distribution (Vd) (in L),~elimination half-life (T1/2,) (in hours)~free (protein-unbound) fraction (for rifampicin only) (in percent)." (NCT01785186)
Timeframe: 0 - 12 weeks
| Intervention | Rifampicin AUC(mg*h/l) (Geometric Mean) |
|---|---|
| HRZQ | 17.4 |
| Arm 1 (R35) | 170 |
| HR20ZQ | 68.3 |
| HR20ZM | 57.8 |
| HRZE | 24.2 |
From enrollment, the time to stable culture conversion (2 consecutive negative weekly cultures) in liquid media. (NCT01785186)
Timeframe: 0 - 12 weeks
| Intervention | days (Median) |
|---|---|
| Arm 1 (R35) | 48 |
| HRZQ | 63 |
| HR20ZQ | 66 |
| HR20ZM | 55 |
| HRZE | 62 |
All Adverse Events (AE), and AEs considered to be drug-related will coded using standard AE dictionaries. (NCT01785186)
Timeframe: 0 - 12 weeks
| Intervention | participants (Number) | |
|---|---|---|
| Number of Patients with at least 1 AE | Number of patients with at least 1 SAE | |
| Arm 1 (R35) | 53 | 4 |
| HR20ZM | 49 | 4 |
| HR20ZQ | 42 | 5 |
| HRZE | 92 | 6 |
| HRZQ | 49 | 4 |
haematological and biochemical laboratory tests (NCT00546273)
Timeframe: at protocol defined timepoints: days 0, 7, 21, 28, 35, 56, 112 & 156
| Intervention | number of abnormalities (Number) |
|---|---|
| RUTI 5 Micrograms of FCMtb | 0 |
| RUTI 25 Micrograms of FCMtb | 0 |
| RUTI 100 Micrograms of FCMtb | 0 |
| RUTI 200 Micrograms of FCMtb | 0 |
| Placebo | 0 |
Area Under the Curve (AUC) During First 12 or 24 Hours /Minimum Inhibitory Concentration. AUC reflects total drug (bound and unbound). MIC values were determined using protein-containing media. (NCT00396084)
Timeframe: Day 5 (7 time points)
| Intervention | ug/ml (Median) |
|---|---|
| Gatifloxacin 400 mg/Day | 85.6 |
| Levofloxacin 1000 mg/Day | 129.1 |
| Moxifloxacin 400 mg/Day | 110.5 |
| Isoniazid (INH) 300 mg/Day | 215.2 |
Early bactericidal activity (EBA 0-2) was calculated as the rate of fall in sputum colony forming units (cfu) (expressed in log10 units) during the first 2 days of monotherapy. (NCT00396084)
Timeframe: Day 0 to Day 2 Monotherapy
| Intervention | log10 cfu/ml/day (Mean) |
|---|---|
| Gatifloxacin 400 mg/Day | 0.35 |
| Levofloxacin 1000 mg/Day | 0.45 |
| Moxifloxacin 400 mg/Day | 0.33 |
| Isoniazid (INH) 300 mg/Day | 0.67 |
Early bactericidal activity (EBA 0-2) was calculated as the rate of fall in sputum cfu (expressed in log10 units) during the first 2 days of monotherapy. Mean values for the 3 treatment groups were compared. (NCT00396084)
Timeframe: Day 0 to Day 2 Monotherapy
| Intervention | log10 cfu/ml/day (Mean) |
|---|---|
| Isoniazid 300 mg/Day | 0.67 |
| Linezolid 600 mg/Once Daily | 0.18 |
| Linezolid 600 mg/Twice Daily | 0.26 |
The rate of fall in sputum cfu between day 2 and day 7 of monotherapy was estimated by the slope of the linear regression obtained by fitting the 6 sputum cfu values corresponding to Days 2 through 7. (NCT00396084)
Timeframe: Day 2 to Day 7 Monotherapy
| Intervention | log10 cfu/ml (Mean) |
|---|---|
| Isoniazid 300 mg/Day | 0.16 |
| Linezolid 600 mg/Once Daily | 0.09 |
| Linezolid 600 mg/Twice Daily | 0.04 |
The rate of fall in sputum cfu between day 2 and day 7 of monotherapy was estimated by the slope of the linear regression obtained by fitting the 6 sputum cfu values corresponding to Days 2 through 7. (NCT00396084)
Timeframe: Day 2 to Day 7 Monotherapy
| Intervention | log10 cfu/ml/day (Mean) |
|---|---|
| Gatifloxacin 400 mg/Day | 0.17 |
| Levofloxacin 1000 mg/Day | 0.18 |
| Moxifloxacin 400 mg/Day | 0.17 |
| Isoniazid (INH) 300 mg/Day | 0.08 |
Maximum plasma concentration, given sampling scheme (NCT00396084)
Timeframe: Day 5 (7 time points)
| Intervention | ug/ml (Median) |
|---|---|
| Gatifloxacin 400 mg/Day | 4.8 |
| Levofloxacin 1000 mg/Day | 15.6 |
| Moxifloxacin 400 mg/Day | 6.1 |
| Isoniazid (INH) 300 mg/Day | 3.6 |
Maximum Plasma Drug Concentration (Cmax), given sampling scheme (NCT00396084)
Timeframe: Day 5 (7 time points)
| Intervention | ug/ml (Median) |
|---|---|
| Isoniazid 300 mg/Day | 3.3 |
| Linezolid 600 mg/Once Daily | 15.0 |
| Linezolid 600 mg/Twice Daily | 19.4 |
(NCT00396084)
Timeframe: Day 5 (7 time points)
| Intervention | ug/ml (Median) |
|---|---|
| Gatifloxacin 400 mg/Day | 9.5 |
| Levofloxacin 1000 mg/Day | 15.6 |
| Moxifloxacin 400 mg/Day | 12.3 |
| Isoniazid (INH) 300 mg/Day | 70.6 |
(NCT00396084)
Timeframe: Day 5 (7 time points)
| Intervention | ug/ml (Median) |
|---|---|
| Isoniazid 300 mg/Day | 62.7 |
| Linezolid 600 mg/Once Daily | 20.0 |
| Linezolid 600 mg/Twice Daily | 16.2 |
Cmax adjusted for free drug concentrations after 5 days of monotherapy with study drugs (NCT00396084)
Timeframe: Day 5 (7 time points)
| Intervention | ug/ml (Median) |
|---|---|
| Isoniazid 300 mg/Day | 3.1 |
| Linezolid 600 mg/Once Daily | 10.3 |
| Linezolid 600 mg/Twice Daily | 13.4 |
Determined by linear extrapolation of concentration-versus-time curve to intersection with MIC. (NCT00396084)
Timeframe: Day 5 (7 time points)
| Intervention | Percentage (Mean) |
|---|---|
| Isoniazid (INH) 300 mg/Day | 95.5 |
| Linezolid 600 mg/Once Daily | 62.8 |
| Linezolid 600 mg/Twice Daily | 100.0 |
Area under the curve (AUC), from time 0-12 hours for INH or 0-24 hours for gatifloxacin, levofloxacin, and moxifloxacin. (NCT00396084)
Timeframe: Day 5 (7 time points)
| Intervention | ug/h/ml (Median) |
|---|---|
| Gatifloxacin 400 mg/Day | 42.8 |
| Levofloxacin 1000 mg/Day | 129.1 |
| Moxifloxacin 400 mg/Day | 55.3 |
| Isoniazid (INH) 300 mg/Day | 11.9 |
Area Under the Curve 0-12 (AUC 0-12) Adjusted for Free Drug Concentrations/Minimum Inhibitory Concentration (MIC) and AUC 0-24/MIC (NCT00396084)
Timeframe: Day 5 (7 time points)
| Intervention | ug/h/ml (Median) | |
|---|---|---|
| AUC 0-12/MIC | AUC 0-24/MIC | |
| Isoniazid 300 mg/Day | 306.7 | 344.6 |
| Linezolid 600 mg/Once Daily | 107.8 | 116.2 |
| Linezolid 600 mg/Twice Daily | 121.6 | 243.2 |
Median pharmacodynamic parameters (range) adjusted for free drug concentrations. AUC 0-12 and AUC 0-24 = area under the curve during the first 12 and 24 hours after dosing, respectively (NCT00396084)
Timeframe: Day 5 (7 time points)
| Intervention | ug/h/ml (Median) | |
|---|---|---|
| AUC 0-12 | AUC 0-24 | |
| Isoniazid 300 mg/Day | 15.3 | 17.2 |
| Linezolid 600 mg/Once Daily | 60.1 | 66.8 |
| Linezolid 600 mg/Twice Daily | 80.3 | 160.7 |
Median pharmacokinetic parameters (range). AUC 0-12 and AUC 0-24 = area under the curve during the first 12 and 24 hours after dosing, respectively (NCT00396084)
Timeframe: Day 5 (7 time points)
| Intervention | ug/h/ml (Median) | |
|---|---|---|
| AUC 0-12 (ug/h/ml) | AUC 0-24 (ug/h/ml) | |
| Isoniazid 300 mg/Day | 17.0 | 19.2 |
| Linezolid 600 mg/Once Daily | 87.0 | 96.9 |
| Linezolid 600 mg/Twice Daily | 116.4 | 232.9 |
The adjusted area under the curve (aAUC) for sputum colony forming unit (cfu) for each day on treatment was calculated for patients in the INH arm and those in the Linezolid once daily and Linezolid twice daily arms. The aAUC represents the percentage of the expected AUC given no change in log cfu in response to study drug administration. (NCT00396084)
Timeframe: Study drug administration duration - 7 days monotherapy
| Intervention | Percentage (Mean) | ||||||
|---|---|---|---|---|---|---|---|
| Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Day 6 | Day 7 | |
| Isoniazid 300 mg/Day | 0.94 | 0.89 | 0.89 | 0.85 | 0.83 | 0.81 | 0.83 |
| Linezolid 600 mg/Once Daily | 0.98 | 0.97 | 0.96 | 0.96 | 0.95 | 0.95 | 0.95 |
| Linezolid 600 mg/Twice Daily | 0.98 | 0.96 | 0.95 | 0.94 | 0.94 | 0.93 | 0.93 |
The adjusted area under the curve (aAUC) for sputum colony forming units (cfu) for each day on treatment was calculated. The aAUC represents the percentage of the expected AUC given no change in log cfu in response to study drug administration. (NCT00396084)
Timeframe: Study drug administration duration - 7 days monotherapy
| Intervention | Percentage (Mean) | ||||||
|---|---|---|---|---|---|---|---|
| Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Day 6 | Day 7 | |
| Gatifloxacin 400 mg/Day | 0.98 | 0.96 | 0.92 | 0.89 | 0.87 | 0.85 | 0.82 |
| Isoniazid (INH) 300 mg/Day | 0.95 | 0.90 | 0.87 | 0.84 | 0.81 | 0.80 | 0.80 |
| Levofloxacin 1000 mg/Day | 0.98 | 0.95 | 0.91 | 0.88 | 0.85 | 0.83 | 0.81 |
| Moxifloxacin 400 mg/Day | 0.96 | 0.94 | 0.91 | 0.89 | 0.87 | 0.85 | 0.83 |
(NCT00396084)
Timeframe: Day 5 (7 time points)
| Intervention | hours (Median) | |
|---|---|---|
| Tmax in h (apparent time of max plasma conc.) | Half-life | |
| Isoniazid 300 mg/Day | 1.0 | 3.6 |
| Linezolid 600 mg/Once Daily | 1.5 | 3.20 |
| Linezolid 600 mg/Twice Daily | 1.0 | 4.56 |
(NCT00396084)
Timeframe: Day 5 (7 time points)
| Intervention | hours (Median) | |
|---|---|---|
| Tmax | Half-life | |
| Gatifloxacin 400 mg/Day | 1.5 | 6.0 |
| Isoniazid (INH) 300 mg/Day | 1 | 2.5 |
| Levofloxacin 1000 mg/Day | 1.0 | 7.6 |
| Moxifloxacin 400 mg/Day | 1.0 | 8.1 |
Proportion of patients with Grade 3 or 4 adverse reactions attributable to study medications (NCT00082173)
Timeframe: 8 weeks
| Intervention | Participants (Number) |
|---|---|
| Experimental Arm | 0 |
| Control Arm | 0 |
Proportion of patients with sterile sputum cultures (NCT00082173)
Timeframe: 8 weeks
| Intervention | Participants (Number) |
|---|---|
| Experimental Arm | 59 |
| Control Arm | 45 |
(NCT00130247)
Timeframe: 2 years
| Intervention | Participants (Number) |
|---|---|
| 4-Month Arm | 0 |
| 6-Month Arm | 0 |
Patients who presented with TB after completion of study phase treatment but before the end of follow-up were classified as relapses. A bacteriologic relapse was defined as a patient who became consistently culture-positive [defined as at least 1 of the following]: (a) at least 1 sputum mycobacterial culture growing at least 10 colonies of MTB on solid medium; (b) 2 or more respiratory secretion cultures that are positive for MTB in liquid media; or (c) any culture from an extrapulmonary site that is positive for MTB during follow-up after successful completion of initial anti-TB treatment. (NCT00130247)
Timeframe: 30 months
| Intervention | Participants (Number) |
|---|---|
| 4-Month Arm | 13 |
| 6-Month Arm | 3 |
Patients who presented with TB after completion of study phase treatment but before the end of follow-up were classified as relapses. A bacteriologic relapse was defined as a patient who became consistently culture-positive [defined as at least 1 of the following]: (a) at least 1 sputum mycobacterial culture growing at least 10 colonies of MTB on solid medium; (b) 2 or more respiratory secretion cultures that are positive for MTB in liquid media; or (c) any culture from an extrapulmonary site that is positive for MTB during follow-up after successful completion of initial anti-TB treatment. (NCT00130247)
Timeframe: 30 months
| Intervention | Participants (Number) |
|---|---|
| 4-Month Arm | 13 |
| 6-Month Arm | 3 |
(NCT00130247)
Timeframe: 1 and 2 years after successful completion of initial anti-TB treatment
| Intervention | Participants (Number) | |
|---|---|---|
| Relapses at 1 year | Relapses at 2 years | |
| 4-Month Arm | 10 | 13 |
| 6-Month Arm | 3 | 3 |
A culture-positive treatment failure was defined as initial culture conversion but subsequent reversion to culture positivity. A clinical treatment failure was defined as a patient with clinical and/or radiographic evidence of progressive tuberculosis not confirmed by a positive culture after 4 or more months of anti-TB treatment while still receiving treatment. Patients who defaulted before completing study treatment and returned later with culture-positive tuberculosis were termed failures after non-adherence. (NCT00130247)
Timeframe: 2 years
| Intervention | Participants (Number) | |
|---|---|---|
| Treatment Failures | Relapses | |
| 4-Month Arm | 0 | 13 |
| 6-Month Arm | 0 | 3 |
A culture-positive treatment failure was defined as initial culture conversion but subsequent reversion to culture positivity. A clinical treatment failure was defined as a patient with clinical and/or radiographic evidence of progressive tuberculosis not confirmed by a positive culture after 4 or more months of anti-TB treatment while still receiving treatment. Patients who defaulted before completing study treatment and returned later with culture-positive tuberculosis were termed failures after non-adherence. (NCT00130247)
Timeframe: 2 years
| Intervention | Participants (Number) | |
|---|---|---|
| Treatment Failures | Relapses | |
| 4-Month Arm | 0 | 13 |
| 6-Month Arm | 0 | 3 |
Incidence rate calculated by Mantel-Haenszel, weighted by gestational age strata (NCT01494038)
Timeframe: Measured from study entry through end of pregnancy
| Intervention | events per 100 person-years (Number) |
|---|---|
| Arm A (Immediate INH Treatment) | 15.93 |
| Arm B (Deferred INH Treatment) | 13.79 |
Incidence rate calculated by Mantel-Haenszel, weighted by gestational age strata. (NCT01494038)
Timeframe: Measured from study entry through 12 weeks after birth
| Intervention | events per 100 person-years (Number) |
|---|---|
| Arm A (Immediate INH Treatment) | 16.98 |
| Arm B (Deferred INH Treatment) | 10.09 |
Incidence rate, calculated by Mantel-Haenszel (MH), weighted by gestational age strata 1) gestational age at entry less than 24 weeks or 2) gestational age at entry greater than or equal to 24 weeks. AE's include laboratory results, signs/symptoms, or diagnoses; graded as per Division of AIDS (DAIDS) or by protocol-defined hepatotoxicity measures. Related to treatment indicates possibly, probably, or definitely related to INH or Placebo for INH as judged by Independent Endpoint Review Committee. Discontinuation refers to permanent discontinuation of study treatment. (NCT01494038)
Timeframe: Measured from study entry through Week 48 after birth
| Intervention | events per 100 person-years (Number) |
|---|---|
| Arm A (Immediate INH Treatment) | 15.03 |
| Arm B (Deferred INH Treatment) | 14.93 |
Incidence rate calculated by Mantel-Haenszel, weighted by gestational age strata. (NCT01494038)
Timeframe: Measured from study entry through Week 48 after birth
| Intervention | events per 100 person-years (Number) |
|---|---|
| Arm A (Immediate INH Treatment) | 2.99 |
| Arm B (Deferred INH Treatment) | 4.68 |
Incidence rate calculated by Mantel-Haenszel, weighted by gestational age strata. (NCT01494038)
Timeframe: Measured from study entry through Week 48 after birth
| Intervention | events per 100 person-years (Number) |
|---|---|
| Arm A (Immediate INH Treatment) | 1.00 |
| Arm B (Deferred INH Treatment) | 1.38 |
Incidence rate calculated by Mantel-Haenszel, weighted by gestational age strata. (NCT01494038)
Timeframe: Measured from study entry through Week 48 after birth
| Intervention | events per 100 person-years (Number) |
|---|---|
| Arm A (Immediate INH Treatment) | 3.42 |
| Arm B (Deferred INH Treatment) | 4.72 |
Incidence rate was calculated by Mantel-Haenszel, weighted by gestational age strata. (NCT01494038)
Timeframe: Measured from study entry through Week 48 after birth
| Intervention | events per 100 person-years (Number) |
|---|---|
| Arm A (Immediate INH Treatment) | 2.99 |
| Arm B (Deferred INH Treatment) | 4.42 |
Incidence rate calculated by Mantel-Haenszel, weighted by gestational age strata. (NCT01494038)
Timeframe: Measured from study entry through Week 48 postpartum
| Intervention | events per 100 person-years (Number) |
|---|---|
| Arm A (Immediate INH Treatment) | 0.40 |
| Arm B (Deferred INH Treatment) | 0.78 |
Incidence rates calculated by Mantel-Haenszel, weighted by gestational age strata. Probable or confirmed TB infection, as judged by Secondary Endpoint Review Committee (NCT01494038)
Timeframe: Measured from study entry to Week 48 after birth
| Intervention | events per 100 person-years (Number) |
|---|---|
| Arm A (Immediate INH Treatment) | 0.60 |
| Arm B (Deferred INH Treatment) | 0.59 |
Incidence rates calculated by Mantel-Haenszel, weighted by gestational age strata. Probable or confirmed TB, or congenital TB as defined using the Cantwell criteria (see reference), judged by the Secondary Endpoint Review Committee. Includes an infant death due to unknown cause. (NCT01494038)
Timeframe: Measured from study entry through Week 48 after birth
| Intervention | events per 100 person-years (Number) |
|---|---|
| Arm A (Immediate INH Treatment) | 0.54 |
| Arm B (Deferred INH Treatment) | 0.52 |
Incidence rates calculated by Mantel-Haenszel, weighted by gestational age strata. (NCT01494038)
Timeframe: Measured from study entry through end of pregnancy
| Intervention | events per 100 person-years (Number) |
|---|---|
| Arm A (Immediate INH Treatment) | 56.36 |
| Arm B (Deferred INH Treatment) | 50.88 |
Incidence rates calculated by Mantel-Haenszel, weighted by gestational age strata. (NCT01494038)
Timeframe: Measured from study entry through delivery
| Intervention | events per 100 person-years (Number) |
|---|---|
| Arm A (Immediate INH Treatment) | 1.77 |
| Arm B (Deferred INH Treatment) | 2.59 |
Incidence rates calculated by Mantel-Haenszel, weighted by gestational age strata. Hepatotoxicity definition as defined by DAIDS AE grading criteria 1.0. (NCT01494038)
Timeframe: Measured from study entry through delivery
| Intervention | events per 100 person-years (Number) |
|---|---|
| Arm A (Immediate INH Treatment) | 1.77 |
| Arm B (Deferred INH Treatment) | 2.59 |
Incidence rate calculated by Mantel-Haenszel, weighted by gestational age strata. Protocol-specific definition of hepatotoxicity: Any one of the following: 1) Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) greater than 5 times the upper limit of normal (ULN), where ULN is specified by the clinic physician; 2) Total bilirubin > 3 X ULN; 3) ALT greater than 3 X ULN and total bilirubin greater than 2 X ULN; or 4) ALT > 3 X ULN and persistent symptomatic clinical hepatitis (NCT01494038)
Timeframe: Measured from study entry through delivery
| Intervention | events per 100 person-years (Number) |
|---|---|
| Arm A (Immediate INH Treatment) | 1.77 |
| Arm B (Deferred INH Treatment) | 2.59 |
Incidence rate calculated by Mantel-Haenszel, weighted by gestational age strata. (NCT01494038)
Timeframe: Measured from study entry through delivery
| Intervention | events per 100 person-years (Number) |
|---|---|
| Arm A (Immediate INH Treatment) | 1.77 |
| Arm B (Deferred INH Treatment) | 2.59 |
Incidence rates calculated by Mantel-Haenszel, weighted by gestational age strata. (NCT01494038)
Timeframe: Measured from study entry through 12 weeks postpartum
| Intervention | events per 100 person-years (Number) |
|---|---|
| Arm A (Immediate INH Treatment) | 8.37 |
| Arm B (Deferred INH Treatment) | 4.98 |
Incidence rate calculated by Mantel-Haenszel, weighted by gestational age strata (NCT01494038)
Timeframe: Measured from study entry through 12 weeks postpartum
| Intervention | events per 100 person-years (Number) |
|---|---|
| Arm A (Immediate INH Treatment) | 7.91 |
| Arm B (Deferred INH Treatment) | 4.52 |
Incidence rates calculated by Mantel-Haenszel, weighted by gestational age strata. (NCT01494038)
Timeframe: Measured from study entry through 12 weeks postpartum
| Intervention | events per 100 person-years (Number) |
|---|---|
| Arm A (Immediate INH Treatment) | 56.48 |
| Arm B (Deferred INH Treatment) | 40.59 |
Incidence rates calculated by Mantel-Haenszel, weighted by gestational age strata. (NCT01494038)
Timeframe: Measured from study start through 12 weeks postpartum
| Intervention | events per 100 person-years (Number) |
|---|---|
| Arm A (Immediate INH Treatment) | 8.37 |
| Arm B (Deferred INH Treatment) | 4.98 |
Incidence rates calculated by Mantel-Haenszel, weighted by gestational age strata (NCT01494038)
Timeframe: Measured from study start through 12 weeks postpartum
| Intervention | events per 100 person-years (Number) |
|---|---|
| Arm A (Immediate INH Treatment) | 7.91 |
| Arm B (Deferred INH Treatment) | 4.52 |
Hospitalization due to reasons other than birth (NCT01494038)
Timeframe: Measured from study entry through Week 48 after birth
| Intervention | Participants (Count of Participants) |
|---|---|
| Arm A (Immediate INH Treatment) | 73 |
| Arm B (Deferred INH Treatment) | 75 |
Laboratory, sign/symptom, or diagnoses graded as 3 or higher by DAIDS criteria. (NCT01494038)
Timeframe: Measured from study entry through Week 48 after birth
| Intervention | Participants (Count of Participants) |
|---|---|
| Arm A (Immediate INH Treatment) | 193 |
| Arm B (Deferred INH Treatment) | 196 |
As before, but AE is judged to be possibly, probably, or definitely related to INH or Placebo for INH, by clinic medical staff (NCT01494038)
Timeframe: Measured from study entry through Week 48 after birth
| Intervention | Participants (Count of Participants) |
|---|---|
| Arm A (Immediate INH Treatment) | 5 |
| Arm B (Deferred INH Treatment) | 6 |
Fetal deaths include both stillbirths and spontaneous abortions; in case of a multiple birth, mothers who had at least one fetal death (NCT01494038)
Timeframe: Measured from study entry through end of pregnancy
| Intervention | Participants (Count of Participants) |
|---|---|
| Arm A (Immediate INH Treatment) | 17 |
| Arm B (Deferred INH Treatment) | 9 |
Premature birth is defined as gestational age of < 37 weeks at delivery. (NCT01494038)
Timeframe: Measured at delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Arm A (Immediate INH Treatment) | 48 |
| Arm B (Deferred INH Treatment) | 40 |
Resistance to INH from isolates of Mycobacterium tuberculosis, as a percentage of mothers who develop culture-confirmed TB (NCT01494038)
Timeframe: Measured from study entry through Week 48 postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Arm A (Immediate INH Treatment) | 1 |
| Arm B (Deferred INH Treatment) | 0 |
Pharmacokinetic parameter was estimated from population PK modeling fitted to the intensive PK data. AUC0-24h was predicted using population pharmacokinetic model using the NONMEM software program. A 2-compartment model with first-order absorption with transit compartment and first-order elimination with well-stirred liver model to capture hepatic clearance and first-pass extraction with 1 parameter (hepatic intrinsic clearance) was used, (NCT01494038)
Timeframe: Measured at antepartum (third trimester and >= 2 weeks after starting study drug) and week 16 postpartum (+/-) 4 weeks) while on active INH; blood samples were drawn pre-dose and at 1, 2, 4, 6, 8, and 12 hours post-dosing.
| Intervention | hour*mg/L (Mean) | |
|---|---|---|
| Third trimester of pregnancy | Week 16 postpartum | |
| Fast Metabolizers | 38.5 | 46.9 |
| Intermediate Metabolizers | 62.5 | 76.2 |
| Slow Metabolizers | 153.02 | 186 |
Pharmacokinetic parameter was estimated from population PK modeling fitted to the intensive PK data. AUC0-24h was predicted using population pharmacokinetic model using the NONMEM software program. A 2-compartment model with first-order absorption with transit compartment and first-order elimination with well-stirred liver model to capture hepatic clearance and first-pass extraction with 1 parameter (hepatic intrinsic clearance) was used, (NCT01494038)
Timeframe: Measured at antepartum (third trimester and >= 2 weeks after starting study drug) and week 16 postpartum (+/-) 4 weeks) while on active INH; blood samples were drawn pre-dose and at 1, 2, 4, 6, 8, and 12 hours post-dosing.
| Intervention | hour*mg/L (Mean) | |
|---|---|---|
| Third trimester of pregnancy | Week 16 postpartum | |
| Fast Metabolizers | 3.63 | 4.25 |
| Intermediate Metabolizers | 6.55 | 7.67 |
| Slow Metabolizers | 21.6 | 25.3 |
(NCT00944021)
Timeframe: 14 consecutive days of treatment
| Intervention | log10CFU/ml/day (Mean) |
|---|---|
| PA-824 50 mg/qd | 0.063 |
| PA-824 100mg/qd | 0.091 |
| PA-824 150mg/qd | 0.078 |
| PA-824 200mg/qd | 0.112 |
| Rifafour e-275mg | 0.177 |
(NCT00944021)
Timeframe: Two consecutive days of treatment
| Intervention | log10CFU/ml/day (Mean) |
|---|---|
| PA-824 50 mg/qd | 0.093 |
| PA-824 100mg/qd | 0.111 |
| PA-824 150mg/qd | -0.009 |
| PA-824 200mg/qd | 0.160 |
| Rifafour e-275mg | 0.470 |
(NCT00944021)
Timeframe: Days 2-14 of 14 consecutive days of treatment
| Intervention | log10CFU/ml/day (Mean) |
|---|---|
| PA-824 50 mg/qd | 0.059 |
| PA-824 100mg/qd | 0.088 |
| PA-824 150mg/qd | 0.096 |
| PA-824 200mg/qd | 0.104 |
| Rifafour e-275mg | 0.128 |
(NCT00944021)
Timeframe: 0 (pre-dose), 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 12, 16, and 24 hours post-dose on Day 1 of treatment
| Intervention | ng * hour/mL (Mean) |
|---|---|
| PA-824 50 mg/qd | 11923.94 |
| PA-824 100mg/qd | 18408.59 |
| PA-824 150mg/qd | 28654.83 |
| PA-824 200mg/qd | 38485.04 |
(NCT00944021)
Timeframe: 0 (pre-dose), 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 12, 16, and 24 hours post-dose on Day 1 of treatment
| Intervention | ng/mL (Mean) |
|---|---|
| PA-824 50 mg/qd | 465.3 |
| PA-824 100mg/qd | 662.3 |
| PA-824 150mg/qd | 994.7 |
| PA-824 200mg/qd | 1183.0 |
(NCT00944021)
Timeframe: 0 (pre-dose), 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 12, 16, and 24 hours post-dose on Day 1 of treatment
| Intervention | hours (Mean) |
|---|---|
| PA-824 50 mg/qd | 16.142 |
| PA-824 100mg/qd | 18.597 |
| PA-824 150mg/qd | 19.005 |
| PA-824 200mg/qd | 21.092 |
(NCT00944021)
Timeframe: 0 (pre-dose), 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 12, 16, 24 and 30 hours post-dose on Day 14 of 14 consecutive days of treatment
| Intervention | hour (Mean) |
|---|---|
| PA-824 50 mg/qd | 18.645 |
| PA-824 100mg/qd | 19.274 |
| PA-824 150mg/qd | 20.207 |
| PA-824 200mg/qd | 23.811 |
(NCT00944021)
Timeframe: 0 (pre-dose), 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 12,16, 24, and 30 hours post-dose on Day 14 of 14 consecutive days of treatment
| Intervention | ng/mL (Mean) |
|---|---|
| PA-824 50 mg/qd | 777.3 |
| PA-824 100mg/qd | 1116.5 |
| PA-824 150mg/qd | 1543.9 |
| PA-824 200mg/qd | 2223.8 |
(NCT00944021)
Timeframe: Fourteen consecutive days of treatment
| Intervention | hours/day (Mean) |
|---|---|
| PA-824 50 mg/qd | 2.621 |
| PA-824 100mg/qd | 4.969 |
| PA-824 150mg/qd | 4.633 |
| PA-824 200mg/qd | 4.640 |
| Rifafour e-275mg | 13.364 |
(NCT00944021)
Timeframe: Two consecutive days of treatment
| Intervention | hours/day (Mean) |
|---|---|
| PA-824 50 mg/qd | 1.483 |
| PA-824 100mg/qd | -1.345 |
| PA-824 150mg/qd | 4.867 |
| PA-824 200mg/qd | 3.096 |
| Rifafour e-275mg | 37.016 |
(NCT00944021)
Timeframe: Days 2-14 of 14 consecutive days of treatment
| Intervention | hours/day (Mean) |
|---|---|
| PA-824 50 mg/qd | 2.958 |
| PA-824 100mg/qd | 5.744 |
| PA-824 150mg/qd | 4.594 |
| PA-824 200mg/qd | 5.391 |
| Rifafour e-275mg | 9.422 |
(NCT00814671)
Timeframe: 8 weeks
| Intervention | percentage of participants w/LJ cx con (Number) |
|---|---|
| RPT450 | 85 |
| RIF 600 | 94 |
| RPT 600 | 96 |
area under the concentration time curve (AUC[0-24]) for rifapentine administered once daily at doses of 450 mg or 600 mg in the context of multi drug intensive phase TB treatment (NCT00814671)
Timeframe: 8 weeks
| Intervention | ug x h/ml (Median) |
|---|---|
| Rifapentine 450 mg | 330 |
| Rifapentine 600 mg | 435 |
Time (in days) to stable culture conversion on liquid MGIT media (NCT00814671)
Timeframe: 12 weeks
| Intervention | days (Median) |
|---|---|
| RPT450 | 50 |
| RIF 600 | 59 |
| RPT 600 | 57 |
Time to stable culture conversion (in days) on Lowenstein Jensen solid medium (NCT00814671)
Timeframe: 12 weeks
| Intervention | days (Median) |
|---|---|
| RPT450 | 37 |
| RIF 600 | 43 |
| RPT 600 | 36 |
percentage of participants discontinuing assigned treatment (NCT00814671)
Timeframe: 10 weeks
| Intervention | percentage of participants (Number) |
|---|---|
| RPT450 | 2.0 |
| RIF 600 | 8.3 |
| RPT 600 | 2.0 |
"Number of infants with a combined endpoint of MTB infection, TB disease, and death~MTB infection as measured by IGRA or tuberculin skin test at 12 months post-enrollment~TB disease including microbiologically confirmed (culture or Xpert positive), or probable TB (clinical diagnosis).~Death of infant" (NCT02613169)
Timeframe: Over 12 months after randomization
| Intervention | Participants (Count of Participants) |
|---|---|
| Isoniazid | 11 |
| No Isoniazid | 19 |
Among HEU infants enrolled at approximately 6 weeks of age, compare the risk of acquiring MTB infection during 1 year of follow-up in infants randomized to receive INH vs. no INH using an interferon-gamma release (IGRA) QuantiFERON-TB Gold Plus (QFT-Plus) assay or tuberculin skin test as part of a composite endpoint to determine MTB infection status (NCT02613169)
Timeframe: at 12 months post randomization
| Intervention | participants (Number) |
|---|---|
| Isoniazid | 10 |
| No Isoniazid | 18 |
Among HEU infants enrolled at approximately 6 weeks of age, compare the risk of acquiring MTB infection during 1 year of follow-up in infants randomized to receive INH vs. no INH using an interferon-gamma release (IGRA) QuantiFERON-TB Gold Plus (QFT-Plus) assay or tuberculin skin test as part of a composite endpoint to determine MTB infection status (NCT02613169)
Timeframe: at 12 months post randomization
| Intervention | TB infections/100 person years (Number) |
|---|---|
| Isoniazid | 7.0 |
| No Isoniazid | 13.4 |
Number of infants with grade 3 or higher treatment-related adverse events as assessed by DAIDS Table for the Grading Severity of Pediatric Adverse Experiences (NCT02613169)
Timeframe: Over 12 months after randomization
| Intervention | Participants (Count of Participants) |
|---|---|
| Isoniazid | 21 |
| No Isoniazid | 16 |
166 reviews available for isoniazid and Pulmonary Consumption
| Article | Year |
|---|---|
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin.
Topics: Adult; Amikacin; Antibiotics, Antitubercular; Drug Resistance, Bacterial; Ethionamide; Fluoroquinolo | 2022 |
Treatment for radiographically active, sputum culture-negative pulmonary tuberculosis: A systematic review and meta-analysis.
Topics: Adult; Antitubercular Agents; Child; Humans; Isoniazid; Prospective Studies; Sputum; Tuberculosis; T | 2023 |
Isoniazid-induced encephalopathy in an end-stage renal disease patient - A case report and literature review.
Topics: Antitubercular Agents; Brain Diseases; Female; Humans; Isoniazid; Kidney Failure, Chronic; Middle Ag | 2019 |
Tuberculosis treatment in children: The changing landscape.
Topics: Antitubercular Agents; Child; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Humans; Is | 2020 |
Identifying isoniazid resistance markers to guide inclusion of high-dose isoniazid in tuberculosis treatment regimens.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Drug Resistance, Bacterial; Genetic Markers; Hu | 2020 |
Multiple tuberculomas in an immunocompetent patient and their diagnostic challenge in a high prevalence country: Case report and literature review.
Topics: Antitubercular Agents; Blindness; Brain; Brain Diseases; Cerebellar Ataxia; Dexamethasone; Drug Ther | 2020 |
Are We There Yet? Short-Course Regimens in TB and HIV: From Prevention to Treatment of Latent to XDR TB.
Topics: Anti-HIV Agents; Antitubercular Agents; Drug Interactions; Extensively Drug-Resistant Tuberculosis; | 2020 |
Tuberculosis (TB) in pregnancy - A review.
Topics: Antitubercular Agents; Female; Humans; Infant, Newborn; Isoniazid; Pregnancy; Tuberculosis; Tubercul | 2021 |
The first report of co-existence of pulmonary tuberculosis and lung malignancy in a kidney transplant recipient: a case report and literature review.
Topics: Adenocarcinoma; China; Ethambutol; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Isoniazid; K | 2021 |
The reliability of rifampicin resistance as a proxy for multidrug-resistant tuberculosis: a systematic review of studies from Iran.
Topics: Antibiotics, Antitubercular; Drug Resistance, Multiple, Bacterial; Humans; Iran; Isoniazid; Microbia | 2018 |
Isoniazid for preventing tuberculosis in HIV-infected children.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antitubercular Agents; Child; HIV Infections | 2017 |
Isoniazid Resistance and Dosage as Treatment for Patients with Tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Resistance, Bacterial; Humans; Isoniazid; Mycobacterium tubercu | 2017 |
Isoniazid for the Prevention of Tuberculosis in HIV-Infected Children: A Systematic Review and Meta-Analysis.
Topics: Antitubercular Agents; Child; HIV; HIV Infections; Humans; Isoniazid; Randomized Controlled Trials a | 2018 |
Prevalence of mutations in genes associated with isoniazid resistance in Mycobacterium tuberculosis isolates from re-treated smear-positive pulmonary tuberculosis patients: A meta-analysis.
Topics: Age Factors; Bacterial Proteins; Catalase; Female; Genotyping Techniques; Humans; India; Isoniazid; | 2018 |
Pharmacogenetic association between
Topics: Alleles; Antitubercular Agents; Arylamine N-Acetyltransferase; Chemical and Drug Induced Liver Injur | 2019 |
Three-month weekly rifapentine plus isoniazid for tuberculosis preventive treatment: a systematic review.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Child; Directly Observed Therapy; Drug Administratio | 2018 |
Abbott RealTime MTB and MTB RIF/INH assays for the diagnosis of tuberculosis and rifampicin/isoniazid resistance.
Topics: Anti-Bacterial Agents; Diagnostic Techniques and Procedures; Drug Resistance, Multiple, Bacterial; H | 2019 |
Severe disseminated tuberculosis in HIV-negative refugees.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Ethambutol; Fluorine Radioisotopes; HIV Infections; | 2019 |
Tuberculosis.
Topics: Antitubercular Agents; BCG Vaccine; HIV Infections; Humans; Isoniazid; Mycobacterium tuberculosis; T | 2013 |
Recycling and refurbishing old antitubercular drugs: the encouraging case of inhibitors of mycolic acid biosynthesis.
Topics: Antitubercular Agents; Drug Design; Drug Resistance, Multiple, Bacterial; Ethionamide; Humans; Isoni | 2013 |
Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment.
Topics: AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Drug Interacti | 2013 |
Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
Topics: Adult; Antibiotics, Antitubercular; Child; Directly Observed Therapy; Drug Administration Schedule; | 2013 |
Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
Topics: Adult; Antibiotics, Antitubercular; Child; Directly Observed Therapy; Drug Administration Schedule; | 2013 |
Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
Topics: Adult; Antibiotics, Antitubercular; Child; Directly Observed Therapy; Drug Administration Schedule; | 2013 |
Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
Topics: Adult; Antibiotics, Antitubercular; Child; Directly Observed Therapy; Drug Administration Schedule; | 2013 |
Understanding pharmacokinetics to improve tuberculosis treatment outcome.
Topics: Antitubercular Agents; Diabetes Mellitus; Drug Monitoring; Ethambutol; HIV Infections; Humans; Isoni | 2014 |
Getting it right for children: improving tuberculosis treatment access and new treatment options.
Topics: Antitubercular Agents; BCG Vaccine; Child; Global Health; Health Knowledge, Attitudes, Practice; Hum | 2015 |
Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis.
Topics: Antitubercular Agents; Bacteriological Techniques; Cost-Benefit Analysis; Drug Resistance, Microbial | 2015 |
Benefits of combined preventive therapy with co-trimoxazole and isoniazid in adults living with HIV: time to consider a fixed-dose, single tablet coformulation.
Topics: Adult; Africa South of the Sahara; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antituber | 2015 |
Recommendations Concerning the First-Line Treatment of Children with Tuberculosis.
Topics: Antitubercular Agents; Child; Drug Resistance, Microbial; Humans; Isoniazid; Medication Adherence; T | 2016 |
Clinical research in the treatment of tuberculosis: current status and future prospects.
Topics: Antitubercular Agents; Biomedical Research; Clinical Trials as Topic; Drug Therapy, Combination; Flu | 2015 |
Susceptibility of N-acetyltransferase 2 slow acetylators to antituberculosis drug-induced liver injury: a meta-analysis.
Topics: Acetylation; Antitubercular Agents; Arylamine N-Acetyltransferase; Chemical and Drug Induced Liver I | 2015 |
Pulmonary tuberculosis: Improving diagnosis and management.
Topics: Antitubercular Agents; Disease Management; Humans; Isoniazid; Latent Tuberculosis; Symptom Assessmen | 2016 |
Disseminated Mycobacterium tuberculosis following renal transplant with alemtuzumab induction.
Topics: Aged; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antitubercular Agents; Female; Humans; Immunos | 2016 |
Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis.
Topics: Antitubercular Agents; Canada; Humans; Isoniazid; Recurrence; Retreatment; Rifampin; Treatment Failu | 2017 |
Optimizing the management of children with latent tuberculosis infection.
Topics: Antitubercular Agents; Biomarkers; Chemokine CXCL10; Child; Disease Management; Enzyme-Linked Immuno | 2017 |
Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis.
Topics: Antitubercular Agents; DNA Probes; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbia | 2017 |
Time Trends in Sputum Mycobacterial Load and Two-Day Bactericidal Activity of Isoniazid-Containing Antituberculosis Therapies.
Topics: Antitubercular Agents; Colony Count, Microbial; Drug Administration Schedule; Humans; Isoniazid; Myc | 2017 |
Tuberculosis and silicosis: epidemiology, diagnosis and chemoprophylaxis.
Topics: Antibiotics, Antitubercular; Brazil; Humans; Isoniazid; Occupational Exposure; Pyrazinamide; Rifampi | 2008 |
Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antitubercular Agents; Child; HIV Infections | 2009 |
Efforts towards the development of new antitubercular agents: potential for thiolactomycin based compounds.
Topics: Animals; Antitubercular Agents; Drug Design; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mol | 2008 |
Tuberculosis (HIV-negative people).
Topics: Antitubercular Agents; HIV Infections; Humans; Isoniazid; Latent Tuberculosis; Low-Level Light Thera | 2009 |
Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis.
Topics: Antibiotics, Antitubercular; Drug Administration Schedule; Drug Resistance, Bacterial; Humans; Isoni | 2009 |
Treatment of latent tuberculosis infection in HIV infected persons.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; HIV Infections; Humans; Isoniaz | 2010 |
Treatment of latent tuberculosis infection in HIV infected persons.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; HIV Infections; Humans; Isoniaz | 2010 |
Treatment of latent tuberculosis infection in HIV infected persons.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; HIV Infections; Humans; Isoniaz | 2010 |
Treatment of latent tuberculosis infection in HIV infected persons.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; HIV Infections; Humans; Isoniaz | 2010 |
Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysis.
Topics: Antitubercular Agents; Cohort Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans | 2009 |
Impact of immigration on pulmonary tuberculosis in Spanish children: a three-decade review.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Contact Tracing; Drug Resistance, Bacter | 2010 |
Bronchiectatic air bronchograms in pulmonary tuberculosis: a case report and literature review.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Bronchiectasis; Bronchoalveolar Lavage; Bronchos | 2010 |
The HIV-associated tuberculosis epidemic--when will we act?
Topics: Africa South of the Sahara; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Anti-Retro | 2010 |
Tuberculosis (HIV-negative people).
Topics: Antitubercular Agents; HIV Infections; Humans; Isoniazid; Low-Level Light Therapy; Tuberculosis; Tub | 2011 |
The secret trumps, impelling the pathogenicity of tubercle bacilli.
Topics: Aerosols; Antigen Presentation; Antigens, Bacterial; Antitubercular Agents; Bacterial Proteins; Cyto | 2011 |
Isoniazid-induced recurrent pancreatitis.
Topics: Aged; Antitubercular Agents; Female; Humans; Isoniazid; Pancreatitis; Secondary Prevention; Tubercul | 2012 |
Unilateral and painless development of isoniazid induced gynecomastia during re-treatment of pulmonary tuberculosis.
Topics: Adolescent; Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Gyn | 2011 |
Advances in childhood tuberculosis - contributions from the University of Cape Town.
Topics: Antitubercular Agents; Child; Endoscopy; Humans; Isoniazid; Mycobacterium tuberculosis; South Africa | 2012 |
Leprosy and tuberculosis co-infection: clinical and immunological report of two cases and review of the literature.
Topics: Adult; Brazil; Coinfection; Female; Humans; Immunity, Cellular; Interferon-gamma; Interleukin-12; Is | 2013 |
Research on implementation of interventions in tuberculosis control in low- and middle-income countries: a systematic review.
Topics: Algorithms; Antitubercular Agents; Coinfection; Cost-Benefit Analysis; Delivery of Health Care; Deve | 2012 |
Fixed-dose combination antituberculosis therapy: a systematic review and meta-analysis.
Topics: Antitubercular Agents; Drug Combinations; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; | 2013 |
[Tuberculosis].
Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; BCG Vacci | 2002 |
[Tuberculous pneumonia in children].
Topics: Administration, Oral; Age Factors; Antibiotics, Antitubercular; Antitubercular Agents; Child; Child, | 2003 |
Prevention of HIV-associated respiratory illness in children in developing countries: potential benefits.
Topics: Antitubercular Agents; Chemoprevention; Child; Child Welfare; Developing Countries; HIV Infections; | 2003 |
[Measures for tuberculosis in compromised hosts--mainly on chemoprophylaxis].
Topics: Antibiotic Prophylaxis; Antitubercular Agents; Arthritis, Rheumatoid; Collagen Diseases; Crohn Disea | 2003 |
[Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
Topics: Aged; Agranulocytosis; Antitubercular Agents; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin | 2003 |
Treatment of latent tuberculosis infection in HIV infected persons.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; HIV Infections; Humans; Isoniaz | 2004 |
Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination | 2004 |
[A case of successful desensitization therapy for isoniazid-induced pneumonitis].
Topics: Aged; Antibiotics, Antitubercular; Antitubercular Agents; Desensitization, Immunologic; Ethambutol; | 2004 |
Tuberculosis.
Topics: Antitubercular Agents; Humans; Isoniazid; Patient Compliance; Tuberculosis, Multidrug-Resistant; Tub | 2004 |
Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Developed Countries; Developing Countries; Human | 2005 |
[Pulmonary tuberculosis in elderly patients].
Topics: Aged; Aged, 80 and over; Antitubercular Agents; Combined Modality Therapy; Drug Resistance, Multiple | 2005 |
Tuberculosis.
Topics: Antitubercular Agents; Humans; Isoniazid; Patient Compliance; Patient Education as Topic; Tuberculos | 2005 |
Treatment of multidrug-resistant tuberculosis: evidence and controversies.
Topics: Antibiotics, Antitubercular; Case Management; Clinical Trials as Topic; Drug Administration Routes; | 2006 |
Advances in the treatment of tuberculosis.
Topics: Adamantane; AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Antitubercular Ag | 2007 |
Pregnancy and tuberculosis.
Topics: Drug Therapy, Combination; Ethambutol; Female; Humans; Infant, Newborn; Isoniazid; Mass Screening; P | 1984 |
[Isoniazid--essential facts and recent advances].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Isoniazid | 1984 |
The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis.
Topics: Acetylation; Chemical and Drug Induced Liver Injury; Homozygote; Humans; Isoniazid; Jaundice; Phenot | 1984 |
Aging and tuberculosis.
Topics: Aged; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Female; Humans; | 1984 |
[Concept of the relapse of tuberculosis].
Topics: Animals; Humans; Isoniazid; Mice; Recurrence; Rifampin; Tuberculosis, Pulmonary | 1982 |
Treatment of tuberculosis. The Mitchell lecture 1979.
Topics: Animals; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Thera | 1980 |
Should isoniazid be used in retreatment of tuberculosis despite acquired isoniazid resistance?
Topics: Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Therapy, Combination; Ethionamide | 1981 |
Bacteriologic basis of short-course chemotherapy for tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Guinea Pigs; | 1980 |
Chemotherapy of tuberculosis for the 1980's.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combi | 1980 |
Antituberculous drugs.
Topics: Antitubercular Agents; Chemical Phenomena; Chemistry; Ethambutol; Humans; Isoniazid; Kinetics; Mycob | 1982 |
Tuberculosis.
Topics: Alcohol Drinking; Carrier State; Chemical and Drug Induced Liver Injury; Ethambutol; Humans; Isoniaz | 1980 |
Treatment of tuberculosis during pregnancy.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Antitubercular Agents; Ethambutol; Female; Hearing D | 1980 |
[Review of the current state of knowledge on prophylactic use of INH].
Topics: Adolescent; Adult; Age Factors; Chemical and Drug Induced Liver Injury; Child; Clinical Trials as To | 1980 |
What's new in tuberculosis?
Topics: Aged; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isonia | 1981 |
Chemoprophylaxis against tuberculosis.
Topics: Adult; Age Factors; Animals; Chemical and Drug Induced Liver Injury; Guinea Pigs; Humans; Isoniazid; | 1980 |
Whither short-course chemotherapy?
Topics: Animals; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Humans | 1981 |
Tuberculosis in the 1980s, with particular reference to South Africa.
Topics: BCG Vaccine; Black or African American; Black People; Female; Humans; India; Isoniazid; Pregnancy; S | 1982 |
Preventive therapy for tuberculosis in HIV infection: the promise and the reality.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Chemical and Drug Induced Liver | 1995 |
Complicated tuberculosis and residual disease.
Topics: HIV Seropositivity; Humans; Isoniazid; Recurrence; Risk Factors; Tuberculosis; Tuberculosis, Pulmona | 1994 |
Mantoux tests. Performing, interpreting, and acting upon them.
Topics: Clinical Protocols; Family Practice; Humans; Isoniazid; Tuberculin Test; Tuberculosis, Pulmonary | 1995 |
Treatment of hepatic failure secondary to isoniazid hepatitis with liver transplantation.
Topics: Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Female; Hepatic Encephalopathy; H | 1994 |
Pulmonary infection due to Mycobacterium xenopi.
Topics: Bacterial Typing Techniques; Clarithromycin; Cycloserine; DNA Probes; Drug Resistance, Microbial; Ga | 1994 |
Preventive therapy for tuberculosis.
Topics: AIDS-Related Opportunistic Infections; HIV Infections; HIV-1; Humans; Isoniazid; Risk Factors; Treat | 1993 |
Isoniazid-induced neurotoxicity in chronic dialysis patients: report of three cases and a review of the literature.
Topics: Aged; Aged, 80 and over; Female; Humans; Isoniazid; Kidney Failure, Chronic; Male; Middle Aged; Nerv | 1993 |
Multidrug-resistant tuberculosis and its control.
Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Drug Resistance, Microbial; Drug | 1993 |
Outpatient management of tuberculosis.
Topics: Algorithms; Ambulatory Care; Antitubercular Agents; Drug Administration Schedule; Drug Interactions; | 1996 |
[Four cases of similar Hexheimer's reaction during the initial chemotherapy for tuberculosis bacillus].
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Child, Preschool; Female; Humans; Isoniaz | 1995 |
Epidemiology, control and treatment of multidrug-resistant tuberculosis.
Topics: Antitubercular Agents; Developing Countries; Humans; Isoniazid; Rifampin; Tuberculosis, Multidrug-Re | 1996 |
Intentional overdosage with isoniazid: case report and review of literature.
Topics: Adult; Antitubercular Agents; Drug Overdose; Humans; Isoniazid; Male; Suicide, Attempted; Tuberculos | 1996 |
Short-course chemoprophylaxis for tuberculosis.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antitubercular Agents; Chronic Disease; Clin | 1997 |
[The epidemiology of tuberculosis and of the resistance to antitubercular agents].
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Developed Countries; Developing Countr | 1997 |
[Antitubercular chemotherapy].
Topics: Aged; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Clinical Protocols; Drug | 1997 |
[Short-course chemotherapy of tuberculosis with pyrazinamide].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Humans | 1998 |
How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?
Topics: Adult; Antitubercular Agents; Clinical Trials as Topic; Humans; Immunocompetence; Isoniazid; Time Fa | 1999 |
Drugs for preventing tuberculosis in HIV infected persons.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; HIV Infections; Humans; Isoniaz | 2000 |
Isoniazid for preventing tuberculosis in non-HIV infected persons.
Topics: Antitubercular Agents; HIV Infections; Humans; Isoniazid; Tuberculosis, Pulmonary | 2000 |
[Tuberculosis prevention].
Topics: Adult; Antitubercular Agents; Humans; Isoniazid; Tuberculosis, Pulmonary | 2000 |
The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Drug Resistance, Microbial; Humans; Isoniazid; Mutation; | 2000 |
Drugs for preventing tuberculosis in HIV infected persons.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; HIV Infections; Humans; Isoniaz | 2000 |
[Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
Topics: Animals; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; E | 2001 |
A case series: initial outcome of persons with multidrug-resistant tuberculosis after treatment with the WHO standard retreatment regimen in Ho Chi Minh City, Vietnam.
Topics: Adolescent; Adult; Antitubercular Agents; Clinical Protocols; Female; Humans; Isoniazid; Male; Middl | 2001 |
Design of regimens for treating tuberculosis in patients with HIV infection, with particular reference to sub-Saharan Africa.
Topics: Africa South of the Sahara; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Admin | 2001 |
Preventing opportunistic infections among human immunodeficiency virus-infected adults in African countries.
Topics: Adult; Africa; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; | 2001 |
Advances in the treatment of tuberculosis.
Topics: Aminosalicylic Acids; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide | 1976 |
The chemotherapy of pulmonary tuberculosis: a review.
Topics: Aminosalicylic Acid; Antitubercular Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Et | 1979 |
[Drug therapy of pulmonary tuberculosis].
Topics: Antitubercular Agents; Cycloserine; Drug Interactions; Drug Therapy, Combination; Ethambutol; Humans | 1978 |
Diagnosis and management of tuberculosis.
Topics: Adrenal Cortex Hormones; Ambulatory Care; Aminosalicylic Acid; Antitubercular Agents; BCG Vaccine; D | 1979 |
[Tuberculosis in infancy nowadays (author's transl)].
Topics: BCG Vaccine; Child; Child, Preschool; Ethambutol; Germany, West; Humans; Infant; Infant, Newborn; Is | 1978 |
The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide.
Topics: Acetylation; Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Clinical Trials as Top | 1978 |
Tuberculosis: review of treatment failure, relapse and drug resistance.
Topics: Aminosalicylic Acid; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Ison | 1978 |
[Clinical pharmacology of isoniazid (a review of the literature)].
Topics: Acetylation; Clinical Trials as Topic; Drug Evaluation; Ethnicity; Female; Humans; Individuality; Is | 1979 |
Variations between individuals and populations in the acetylation of isoniazid and its significance for the treatment of pulmonary tuberculosis.
Topics: Acetylation; Homozygote; Humans; Isoniazid; Kinetics; Tuberculosis, Pulmonary | 1976 |
Diagnosis, prevention and early therapy of tuberculosis.
Topics: Aminosalicylic Acids; Ethambutol; Female; Humans; Hypersensitivity, Delayed; Isoniazid; Male; Mycoba | 1976 |
[Clinical pharmacology in optimization of therapy of lung diseases].
Topics: Antitubercular Agents; Asthma; Biotransformation; Ethionamide; Humans; Isoniazid; Metabolic Clearanc | 1991 |
[Pharmacokinetic aspects of tuberculosis therapy with a fixed combination of rifampicin, isoniazide and pyrazinamide].
Topics: Biological Availability; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuber | 1991 |
Return of tuberculosis: screening and preventive therapy.
Topics: Humans; Isoniazid; Tuberculin Test; Tuberculosis, Pulmonary; United States | 1991 |
Isoniazid--the pivot of chemotherapy in tuberculosis.
Topics: Humans; Isoniazid; Tuberculosis, Pulmonary | 1990 |
Prevention of lung infections associated with human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; CD4-Positive T-Lymphocytes; HIV Infections; Humans; Isoniazid; L | 1989 |
The physician's role in tuberculosis prevention.
Topics: Antitubercular Agents; BCG Vaccine; Humans; Isoniazid; Physician's Role; Role; Tuberculosis, Pulmona | 1989 |
Tuberculosis skin testing and preventive therapy.
Topics: Humans; Isoniazid; Risk Factors; Tuberculin Test; Tuberculosis, Pulmonary | 1989 |
[Short term treatment of infantile pulmonary tuberculosis].
Topics: Antitubercular Agents; BCG Vaccine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Huma | 1989 |
Antituberculosis agents.
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol | 1988 |
Tuberculosis--a bridge to chronic disease epidemiology.
Topics: Adolescent; Adult; Age Factors; Aged; BCG Vaccine; Blood Pressure; Child; Child, Preschool; Epidemio | 1986 |
[Treatment of pleuropulmonary tuberculosis in 1985].
Topics: Aminoglycosides; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Thioa | 1985 |
[Results of chemotherapy in tuberculosis].
Topics: Ambulatory Care; Anti-Bacterial Agents; Antitubercular Agents; Drug Synergism; Ethambutol; Ethionami | 1971 |
Tuberculosis--chemotherapy.
Topics: Aminosalicylic Acids; Costs and Cost Analysis; Drug Resistance, Microbial; Ethambutol; Humans; Isoni | 1972 |
General considerations in intermittent drug therapy of pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Clinical Trials as Topic; Ethambutol; Ethionamide; Huma | 1971 |
Tuberculosis.
Topics: Aminosalicylic Acids; Bronchitis; Cough; Diagnosis, Differential; Ethambutol; Humans; Isoniazid; Mas | 1973 |
[Ocular toxicity of ethambutol].
Topics: Aged; Aminosalicylic Acids; Capreomycin; Chemical Phenomena; Chemistry; Color Perception; Drug Thera | 1971 |
The John Barnwell Lecture. Changing concepts in the chemotherapy of pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Humans; Isoniazid; Streptom | 1968 |
The impact of chemotherapy on the care of patients with tuberculosis.
Topics: Antitubercular Agents; Aspirin; Bacteriological Techniques; BCG Vaccine; Drug Therapy, Combination; | 1974 |
[Chemotherapeutic studies on advanced tuberculosis in mice].
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Drug Resistance, Microbial; Drug Synergism; Et | 1965 |
Ethambutol and viomycin.
Topics: Adolescent; Aged; Body Weight; Child, Preschool; Cycloserine; Deafness; Ethambutol; Female; Humans; | 1970 |
Acute respiratory infections.
Topics: Adolescent; Adult; Aminosalicylic Acids; Bronchitis; Child; Child, Preschool; Erythromycin; Female; | 1974 |
Pulmonary tuberculosis: evolution of modern therapy.
Topics: Aminosalicylic Acids; Collapse Therapy; Europe; History, 18th Century; History, 19th Century; Histor | 1973 |
[Current status of the antitubercular chemotherapy].
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Humans; Isoniazid; Isonicotinic Acids; Microbi | 1973 |
Tuberculosis in Hong Kong ten years later.
Topics: Aminosalicylic Acids; BCG Vaccine; Child, Preschool; China; Cycloserine; Drug Resistance, Microbial; | 1973 |
[Treatment of tuberculosis with streptomycin and isoniazide combined with either aminosalyl or rifampicin].
Topics: Alcoholism; Aminosalicylic Acids; Bilirubin; Drug Therapy, Combination; Humans; Isoniazid; Patient D | 1973 |
[Chemoprevention and preventive chemotherapy of tuberculosis in adulthood (Review)].
Topics: Adult; Amides; Antitubercular Agents; Ethambutol; Evaluation Studies as Topic; False Negative Reacti | 1974 |
Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects.
Topics: Adolescent; Adult; Age Factors; Aged; Drug Administration Schedule; Drug Therapy, Combination; Femal | 1974 |
Rifampin.
Topics: Adult; Aged; Animals; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Jaundice; Male; Mice | 1972 |
Antituberculosis activity of rifampin. Report of studies performed and in progress (1966-1971).
Topics: Aminosalicylic Acids; Animals; Culture Media; Ethambutol; Follow-Up Studies; Guinea Pigs; Half-Life; | 1972 |
Current approach to tuberculosis in childhood.
Topics: Adolescent; BCG Vaccine; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Isonia | 1968 |
Avian tuberculosis.
Topics: Adult; Aminosalicylic Acids; Animals; Australia; Bacteriological Techniques; Bird Diseases; Child; E | 1968 |
Controlled chemoprophylaxis trials in tuberculosis. A general review.
Topics: Adolescent; Adult; Age Factors; Alaska; Anemia; Child; Child, Preschool; Clinical Trials as Topic; D | 1970 |
[Thiocarlide. Attempt of an evaluation].
Topics: Aminosalicylic Acids; Animals; Bacteria; Drug Resistance, Microbial; Ethionamide; Guinea Pigs; Human | 1969 |
[Combined antitubercular treatment of pulmonary tuberculosis in adults].
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Chronic Disease; Cycloserine; Drug Synergism; | 1970 |
[New drugs in antitubercular therapy].
Topics: Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Humans; Isoniazid; R | 1969 |
Genetic factors in drug therapy.
Topics: Adolescent; Aged; Alcohol Oxidoreductases; Animals; Anticoagulants; Child; Female; Glaucoma; Humans; | 1969 |
Ethambutol: a review with special reference to ocular toxicity.
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Ethambutol; Eye; Humans; Isoniazid; Optic Neuritis | 1969 |
[Prevention of tuberculosis: vaccination and chemoprophylaxis].
Topics: BCG Vaccine; Child; Humans; Isoniazid; Italy; Tuberculosis; Tuberculosis, Pulmonary | 1968 |
[Drug therapy of tuberculosis in the child].
Topics: Adolescent; Child; Child, Preschool; Drug Resistance, Microbial; Drug Synergism; Drug Tolerance; Eth | 1969 |
[Current status of chemotherapy of pulmonary tuberculosis and its further prospectives].
Topics: Aminosalicylic Acids; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Cycloserine; Dr | 1971 |
[New anti-tubercular agents--rifampicin and ethambutol].
Topics: Adolescent; Adult; Aged; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tubercu | 1971 |
Intermittent chemotherapy or improvement of initial treatment in tuberculosis.
Topics: Administration, Oral; Aminosalicylic Acids; Animals; Antitubercular Agents; Ethambutol; Guinea Pigs; | 1971 |
[Chemoprophylaxis and prevention chemotherapy in infection and disease].
Topics: Adult; Anti-Bacterial Agents; Communicable Disease Control; Female; Glomerulonephritis; Gonorrhea; H | 1967 |
Chemotherapy of pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Hospitalization | 1969 |
Present aspects of genitourinary tuberculosis.
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Carrier State; Child; Equipment and Supplies; Fe | 1968 |
[BCG vaccination and chemoprophylaxis of tuberculosis. Current status. Indications].
Topics: BCG Vaccine; Humans; Isoniazid; Tuberculosis, Pulmonary | 1965 |
468 trials available for isoniazid and Pulmonary Consumption
| Article | Year |
|---|---|
Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis.
Topics: Administration, Oral; Adolescent; Adult; Antitubercular Agents; Area Under Curve; Diarylquinolines; | 2008 |
Early Bactericidal Activity of Delpazolid (LCB01-0371) in Patients with Pulmonary Tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Middle Aged; Mycob | 2022 |
Treatment shortening of drug-sensitive pulmonary tuberculosis using high-dose rifampicin for 3 months after culture conversion (Hi-DoRi-3): a study protocol for an open-label randomized clinical trial.
Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Multicenter Studies as Topic; P | 2022 |
Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349).
Topics: Antitubercular Agents; Drug Therapy, Combination; HIV; HIV Infections; Humans; Isoniazid; Moxifloxac | 2023 |
Effectiveness of a digital medication event reminder and monitor device for patients with tuberculosis (SELFTB): a multicenter randomized controlled trial.
Topics: Adult; Antitubercular Agents; Ethiopia; Female; Humans; Isoniazid; Male; Medication Adherence; Tuber | 2022 |
Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-Containing Regimens for Drug-Sensitive Tuberculosis: 12-Week Results.
Topics: Animals; Antitubercular Agents; Drug Therapy, Combination; Isoniazid; Mice; Nitroimidazoles; Pyrazin | 2023 |
Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-Containing Regimens for Drug-Sensitive Tuberculosis: 12-Week Results.
Topics: Animals; Antitubercular Agents; Drug Therapy, Combination; Isoniazid; Mice; Nitroimidazoles; Pyrazin | 2023 |
Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-Containing Regimens for Drug-Sensitive Tuberculosis: 12-Week Results.
Topics: Animals; Antitubercular Agents; Drug Therapy, Combination; Isoniazid; Mice; Nitroimidazoles; Pyrazin | 2023 |
Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-Containing Regimens for Drug-Sensitive Tuberculosis: 12-Week Results.
Topics: Animals; Antitubercular Agents; Drug Therapy, Combination; Isoniazid; Mice; Nitroimidazoles; Pyrazin | 2023 |
Treatment Strategy for Rifampin-Susceptible Tuberculosis.
Topics: Antitubercular Agents; Diarylquinolines; Drug Administration Schedule; Drug Therapy, Combination; Et | 2023 |
Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; HIV Seropositivity; Humans; Incidence; Isoniazid; | 2019 |
Clinical predictors of drug-resistant tuberculosis in Mexico.
Topics: Adult; Antitubercular Agents; Female; Humans; Isoniazid; Male; Mexico; Middle Aged; Mycobacterium tu | 2019 |
Transmissibility and potential for disease progression of drug resistant
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Contact Tracing; Disease Pr | 2019 |
Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Line | 2020 |
Telacebec (Q203), a New Antituberculosis Agent.
Topics: Administration, Oral; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Therapy, Combina | 2020 |
Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Cost-Benefit Analysis; Directly Observed Therapy; El | 2020 |
Efficacy and safety of weekly rifapentine and isoniazid for tuberculosis prevention in Chinese silicosis patients: a randomized controlled trial.
Topics: Antitubercular Agents; Area Under Curve; China; Drug Administration Schedule; Half-Life; Humans; Iso | 2021 |
Integrative Multi-Omics Reveals Serum Markers of Tuberculosis in Advanced HIV.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Biomark | 2021 |
Efficacy and safety of combined isoniazid-rifampicin-pyrazinamide-levofloxacin dry powder inhaler in treatment of pulmonary tuberculosis: A randomized controlled trial.
Topics: Dry Powder Inhalers; Humans; Isoniazid; Levofloxacin; Powders; Pyrazinamide; Rifampin; Tuberculosis, | 2021 |
Annual Tuberculosis Preventive Therapy for Persons With HIV Infection : A Randomized Trial.
Topics: Adolescent; Adult; Anti-HIV Agents; Antitubercular Agents; Drug Administration Schedule; Drug Therap | 2021 |
HbA1c level cannot predict the treatment outcome of smear-positive non-multi-drug-resistant HIV-negative pulmonary tuberculosis inpatients.
Topics: Adult; Aged; Aged, 80 and over; Female; Glycated Hemoglobin; HIV; Humans; Isoniazid; Male; Middle Ag | 2017 |
Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis.
Topics: Adult; Antibiotics, Antitubercular; Dose-Response Relationship, Drug; Double-Blind Method; Drug Ther | 2017 |
Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis.
Topics: Adult; Antibiotics, Antitubercular; Dose-Response Relationship, Drug; Double-Blind Method; Drug Ther | 2017 |
Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis.
Topics: Adult; Antibiotics, Antitubercular; Dose-Response Relationship, Drug; Double-Blind Method; Drug Ther | 2017 |
Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis.
Topics: Adult; Antibiotics, Antitubercular; Dose-Response Relationship, Drug; Double-Blind Method; Drug Ther | 2017 |
Adherence, tolerability, and outcome after 36 months of isoniazid-preventive therapy in 2 rural clinics of Swaziland: A prospective observational feasibility study.
Topics: Adult; Antitubercular Agents; Cohort Studies; Drug Administration Schedule; Eswatini; Feasibility St | 2017 |
Association of UGT2B7 polymorphisms with risk of induced liver injury by anti-tuberculosis drugs in Chinese Han.
Topics: Adult; Antitubercular Agents; Asian People; Chemical and Drug Induced Liver Injury; Drug Therapy, Co | 2017 |
Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial.
Topics: Adult; Aged; Antitubercular Agents; Biomarkers; Drug Combinations; Ethambutol; Female; Humans; Isoni | 2017 |
A Randomized, Controlled, Phase III Clinical Trial to Evaluate the Efficacy and Tolerability of Risorine with Conventional Rifampicin in the Treatment of Newly Diagnosed Pulmonary Tuberculosis Patients.
Topics: Adult; Alkaloids; Antibiotics, Antitubercular; Benzodioxoles; Drug Combinations; Female; Humans; Iso | 2017 |
Daily vs Intermittent Antituberculosis Therapy for Pulmonary Tuberculosis in Patients With HIV: A Randomized Clinical Trial.
Topics: Adult; Anti-HIV Agents; Antitubercular Agents; CD4 Lymphocyte Count; Directly Observed Therapy; Drug | 2018 |
Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations.
Topics: Adult; Antitubercular Agents; Coinfection; Drug Therapy, Combination; Female; HIV Infections; Humans | 2018 |
Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations.
Topics: Adult; Antitubercular Agents; Coinfection; Drug Therapy, Combination; Female; HIV Infections; Humans | 2018 |
Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations.
Topics: Adult; Antitubercular Agents; Coinfection; Drug Therapy, Combination; Female; HIV Infections; Humans | 2018 |
Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations.
Topics: Adult; Antitubercular Agents; Coinfection; Drug Therapy, Combination; Female; HIV Infections; Humans | 2018 |
Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations.
Topics: Adult; Antitubercular Agents; Coinfection; Drug Therapy, Combination; Female; HIV Infections; Humans | 2018 |
Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations.
Topics: Adult; Antitubercular Agents; Coinfection; Drug Therapy, Combination; Female; HIV Infections; Humans | 2018 |
Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations.
Topics: Adult; Antitubercular Agents; Coinfection; Drug Therapy, Combination; Female; HIV Infections; Humans | 2018 |
Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations.
Topics: Adult; Antitubercular Agents; Coinfection; Drug Therapy, Combination; Female; HIV Infections; Humans | 2018 |
Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations.
Topics: Adult; Antitubercular Agents; Coinfection; Drug Therapy, Combination; Female; HIV Infections; Humans | 2018 |
Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: a prospective, multicentre, randomised, open-label, phase 2 trial.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Substitution; Drug Therapy, Combination; | 2019 |
Cost-effectiveness of universal isoniazid preventive therapy among HIV-infected pregnant women in South Africa.
Topics: Adolescent; Adult; Antitubercular Agents; Cost-Benefit Analysis; Female; HIV Infections; Humans; Int | 2018 |
Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial.
Topics: Antitubercular Agents; Double-Blind Method; Drug Administration Schedule; Drug Monitoring; Drug Ther | 2019 |
Adherence to isoniazid preventive therapy among child contacts in Rwanda: A mixed-methods study.
Topics: Adult; Antitubercular Agents; Child; Child, Preschool; Cohort Studies; Cross-Sectional Studies; Fema | 2019 |
Household contact investigation for the detection of tuberculosis in Vietnam: economic evaluation of a cluster-randomised trial.
Topics: Adult; Antibiotics, Antitubercular; Contact Tracing; Cost-Benefit Analysis; Ethambutol; Family Chara | 2019 |
Efficacy and safety of cholecalciferol-augmented anti-tuberculosis therapy for treatment of naïve patients with pulmonary tuberculosis: A randomized, controlled, clinical study.
Topics: Adult; Antitubercular Agents; Cholecalciferol; Drug Therapy, Combination; Egypt; Ethambutol; Female; | 2019 |
Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial.
Topics: Adult; Antibiotics, Antitubercular; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans | 2019 |
Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial.
Topics: Adult; Antibiotics, Antitubercular; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans | 2019 |
Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial.
Topics: Adult; Antibiotics, Antitubercular; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans | 2019 |
Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial.
Topics: Adult; Antibiotics, Antitubercular; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans | 2019 |
Safety of pyrazinamide-including regimen in late elderly patients with pulmonary tuberculosis: A prospective randomized open-label study.
Topics: Age Factors; Aged, 80 and over; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug | 2019 |
[Antituberculosis properties of methyldioxotetrahydropyrimidine sulfonisonicotinoyl hydrazide].
Topics: Antitubercular Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Dose-Response Relatio | 2012 |
Evaluation of initial and steady-state gatifloxacin pharmacokinetics and dose in pulmonary tuberculosis patients by using monte carlo simulations.
Topics: Adult; Antitubercular Agents; Area Under Curve; Coinfection; Drug Administration Schedule; Drug Dosa | 2013 |
Impact of tuberculosis treatment on CD4 cell count, HIV RNA, and p24 antigen in patients with HIV and tuberculosis.
Topics: Adult; Antitubercular Agents; Biomarkers; CD4 Lymphocyte Count; Coinfection; Dietary Supplements; Dr | 2013 |
Isoniazid preventive therapy in HIV-infected children on antiretroviral therapy: a pilot study.
Topics: Age Factors; Anti-HIV Agents; Antitubercular Agents; Child Mortality; Child, Preschool; Coinfection; | 2014 |
Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Double- | 2014 |
Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Double- | 2014 |
Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Double- | 2014 |
Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Double- | 2014 |
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis.
Topics: Adult; Antitubercular Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combi | 2014 |
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis.
Topics: Adult; Antitubercular Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combi | 2014 |
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis.
Topics: Adult; Antitubercular Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combi | 2014 |
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis.
Topics: Adult; Antitubercular Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combi | 2014 |
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis.
Topics: Adult; Antitubercular Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combi | 2014 |
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis.
Topics: Adult; Antitubercular Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combi | 2014 |
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis.
Topics: Adult; Antitubercular Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combi | 2014 |
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis.
Topics: Adult; Antitubercular Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combi | 2014 |
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis.
Topics: Adult; Antitubercular Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combi | 2014 |
Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial.
Topics: Antitubercular Agents; Bangladesh; Clinical Protocols; Clofazimine; Drug Administration Schedule; Dr | 2014 |
Results at 30 months of a randomised trial of FDCs and separate drugs for the treatment of tuberculosis.
Topics: Africa; Antitubercular Agents; Asia; Dose-Response Relationship, Drug; Drug Combinations; Ethambutol | 2014 |
A four-month gatifloxacin-containing regimen for treating tuberculosis.
Topics: Adult; Antitubercular Agents; Blood Glucose; Drug Administration Schedule; Drug Therapy, Combination | 2014 |
A four-month gatifloxacin-containing regimen for treating tuberculosis.
Topics: Adult; Antitubercular Agents; Blood Glucose; Drug Administration Schedule; Drug Therapy, Combination | 2014 |
A four-month gatifloxacin-containing regimen for treating tuberculosis.
Topics: Adult; Antitubercular Agents; Blood Glucose; Drug Administration Schedule; Drug Therapy, Combination | 2014 |
A four-month gatifloxacin-containing regimen for treating tuberculosis.
Topics: Adult; Antitubercular Agents; Blood Glucose; Drug Administration Schedule; Drug Therapy, Combination | 2014 |
High-dose rifapentine with moxifloxacin for pulmonary tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Drug Administration Schedule; Drug Therapy, C | 2014 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Thera | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Thera | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Thera | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Thera | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Thera | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Thera | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Thera | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Thera | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Thera | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Thera | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Thera | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Thera | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Thera | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Thera | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Thera | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Thera | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Thera | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Thera | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Thera | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Thera | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Thera | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Thera | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Thera | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Thera | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Thera | 2015 |
Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pul
Topics: Adolescent; Adult; Antitubercular Agents; Colony Count, Microbial; Drug Therapy, Combination; Ethamb | 2015 |
Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; F | 2015 |
Consumption of Sutherlandia frutescens by HIV-Seropositive South African Adults: An Adaptive Double-Blind Randomized Placebo Controlled Trial.
Topics: Administration, Oral; Adult; Antitubercular Agents; CD4 Lymphocyte Count; Drug Administration Schedu | 2015 |
Effects on type 2 diabetes complicated with pulmonary tuberculosis: regiment of insulin, isoniazid, rifampicin, pyrazinamide and ethambutol versus the regiment plus Qi-boosting and Yin-nourishing decoction of Traditional Chinese Medicine.
Topics: Adult; Aged; Antitubercular Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Drugs, Chi | 2015 |
Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trial.
Topics: Adult; Africa South of the Sahara; Alcohol Abstinence; Anti-HIV Agents; Antiretroviral Therapy, High | 2016 |
Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis.
Topics: Adult; Antitubercular Agents; Area Under Curve; CD4 Lymphocyte Count; Coinfection; Ethambutol; Femal | 2016 |
Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Tanzania; T | 2015 |
Pharmacokinetics of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol in Infants Dosed According to Revised WHO-Recommended Treatment Guidelines.
Topics: Anti-Bacterial Agents; Area Under Curve; Coinfection; Drug Dosage Calculations; Ethambutol; Female; | 2016 |
High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial.
Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Body Mass Index; Cote d'Ivoire; Female; HIV Infection | 2016 |
A prospective cohort study of latent tuberculosis in adult close contacts of active pulmonary tuberculosis patients in Korea.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Contact Tracing; Drug Administration Schedule; Femal | 2016 |
A randomised Phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Ethambutol; Female | 2016 |
A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis.
Topics: Adult; Antitubercular Agents; Case-Control Studies; Drug Therapy, Combination; Female; Fluoroquinolo | 2016 |
Household HIV Testing Uptake among Contacts of TB Patients in South Africa.
Topics: Adolescent; Adult; CD4-Positive T-Lymphocytes; Cluster Analysis; Contact Tracing; Family Characteris | 2016 |
Efficacy and Safety of 'Fixed Dose' versus 'Loose' Drug Regimens for Treatment of Pulmonary Tuberculosis in Two High TB-Burden African Countries: A Randomized Controlled Trial.
Topics: Adult; Africa; Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Administration Sc | 2016 |
Source case identification in HIV-exposed infants and tuberculosis diagnosis in an isoniazid prevention study.
Topics: Age Factors; Antitubercular Agents; Coinfection; Early Diagnosis; Female; HIV Infections; Humans; In | 2016 |
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
Topics: Adamantane; Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; E | 2017 |
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
Topics: Adamantane; Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; E | 2017 |
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
Topics: Adamantane; Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; E | 2017 |
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
Topics: Adamantane; Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; E | 2017 |
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
Topics: Adamantane; Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; E | 2017 |
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
Topics: Adamantane; Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; E | 2017 |
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
Topics: Adamantane; Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; E | 2017 |
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
Topics: Adamantane; Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; E | 2017 |
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
Topics: Adamantane; Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; E | 2017 |
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
Topics: Adamantane; Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; E | 2017 |
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
Topics: Adamantane; Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; E | 2017 |
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
Topics: Adamantane; Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; E | 2017 |
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
Topics: Adamantane; Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; E | 2017 |
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
Topics: Adamantane; Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; E | 2017 |
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
Topics: Adamantane; Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; E | 2017 |
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
Topics: Adamantane; Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; E | 2017 |
[Relapse rate of pulmonary tuberculosis within two years following completion of twice weekly intermittent chemotherapy].
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Directly Observed Therapy; Drug Administratio | 2008 |
Pyrazinamide serum levels in childhood tuberculosis.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Humans; Infan | 2008 |
Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis.
Topics: Acetamides; Adult; Antibiotics, Antitubercular; Colony Count, Microbial; Drug Administration Schedul | 2008 |
[Isoniazid prophylaxis for pulmonary tuberculosis in Chinese patients with rheumatoid arthritis receiving long-term methotrexate therapy].
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Chemoprevention; Humans; Immun | 2009 |
Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial.
Topics: Adult; Antitubercular Agents; Aza Compounds; Brazil; Double-Blind Method; Drug Administration Schedu | 2009 |
Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial.
Topics: Adult; Antitubercular Agents; Aza Compounds; Brazil; Double-Blind Method; Drug Administration Schedu | 2009 |
Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial.
Topics: Adult; Antitubercular Agents; Aza Compounds; Brazil; Double-Blind Method; Drug Administration Schedu | 2009 |
Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial.
Topics: Adult; Antitubercular Agents; Aza Compounds; Brazil; Double-Blind Method; Drug Administration Schedu | 2009 |
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Aza Compounds; Dose-Response Relationship, Drug; Drug Administration S | 2009 |
Comparison of a four-drug fixed-dose combination regimen with a single tablet regimen in smear-positive pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Huma | 2009 |
Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion.
Topics: Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; F | 2009 |
Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion.
Topics: Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; F | 2009 |
Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion.
Topics: Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; F | 2009 |
Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion.
Topics: Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; F | 2009 |
Initial response to protease-inhibitor-based antiretroviral therapy among children less than 2 years of age in South Africa: effect of cotreatment for tuberculosis.
Topics: Antiretroviral Therapy, Highly Active; Antitubercular Agents; Child, Preschool; Drug Therapy, Combin | 2010 |
Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Antitubercular Agents; Chemical and Drug Induced Liver Inju | 2010 |
Serum 25-hydroxy-vitamin D3 concentrations increase during tuberculosis treatment in Tanzania.
Topics: Adult; Antitubercular Agents; Calcifediol; Female; Hospitalization; Humans; Isoniazid; Male; Parathy | 2010 |
Time to detection of the growth of Mycobacterium tuberculosis in MGIT 960 for determining the early bactericidal activity of antituberculosis agents.
Topics: Adolescent; Adult; Antitubercular Agents; Colony Count, Microbial; Culture Media; Diarylquinolines; | 2010 |
Thibela TB: design and methods of a cluster randomised trial of the effect of community-wide isoniazid preventive therapy on tuberculosis amongst gold miners in South Africa.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Female; Gold; HIV Infections; Humans; | 2011 |
Efficacy and safety of a 4-drug fixed-dose combination regimen compared with separate drugs for treatment of pulmonary tuberculosis: the Study C randomized controlled trial.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male | 2011 |
Results at 30 months of a randomised trial of two 8-month regimens for the treatment of tuberculosis.
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Drug Combinations; Drug | 2011 |
Pharmacokinetics of isoniazid, rifampin, and pyrazinamide in children younger than two years of age with tuberculosis: evidence for implementation of revised World Health Organization recommendations.
Topics: Antitubercular Agents; Area Under Curve; Child, Preschool; Coinfection; Female; HIV Infections; Huma | 2011 |
Isoniazid preventive therapy and 4-year incidence of pulmonary tuberculosis among HIV-infected Thai patients.
Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Female; Follow-Up Studies; HIV Infections; Humans; In | 2012 |
Phase II dose-ranging trial of the early bactericidal activity of PA-824.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Female; Humans; | 2012 |
Efavirenz, tenofovir and emtricitabine combined with first-line tuberculosis treatment in tuberculosis-HIV-coinfected Tanzanian patients: a pharmacokinetic and safety study.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Cyclopropanes; Deoxyc | 2013 |
A time-to-event pharmacodynamic model describing treatment response in patients with pulmonary tuberculosis using days to positivity in automated liquid mycobacterial culture.
Topics: Antimalarials; Bacterial Load; Bacteriological Techniques; Diagnostic Techniques, Respiratory System | 2013 |
The early bactericidal activity of streptomycin.
Topics: Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Female; Humans; Is | 2002 |
Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial.
Topics: Antibiotics, Antitubercular; Drug Administration Schedule; Drug Therapy, Combination; Ethnicity; Fem | 2002 |
Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial.
Topics: Antibiotics, Antitubercular; Drug Administration Schedule; Drug Therapy, Combination; Ethnicity; Fem | 2002 |
Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial.
Topics: Antibiotics, Antitubercular; Drug Administration Schedule; Drug Therapy, Combination; Ethnicity; Fem | 2002 |
Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial.
Topics: Antibiotics, Antitubercular; Drug Administration Schedule; Drug Therapy, Combination; Ethnicity; Fem | 2002 |
[Preventive therapy in middle-aged and elderly persons selected from the population-based screening by mass miniature radiography--methodological aspect and adverse reactions].
Topics: Aged; Female; Follow-Up Studies; Humans; Informed Consent; Isoniazid; Japan; Male; Mass Chest X-Ray; | 2002 |
Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up.
Topics: Adult; Antitubercular Agents; Drug Combinations; Female; Humans; Isoniazid; Male; Mycobacterium tube | 2002 |
Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine.
Topics: Adult; Analysis of Variance; Antibiotics, Antitubercular; Antitubercular Agents; Biological Availabi | 2003 |
Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Administration Schedule; | 2002 |
Comparative evaluation of efficacy and safety profile of three anti-tuberculous regimens in Mangalore.
Topics: Adult; Antitubercular Agents; Dizziness; Drug Therapy, Combination; Ethambutol; Female; Follow-Up St | 2002 |
The clearance of theophylline is increased during the initial period of tuberculosis treatment.
Topics: Adult; Aged; Antitubercular Agents; Bronchodilator Agents; Drug Interactions; Drug Therapy, Combinat | 2003 |
A novel method for evaluating the antimicrobial activity of tuberculosis treatment regimens.
Topics: Antitubercular Agents; Cell Survival; Ciprofloxacin; Drug Administration Schedule; Humans; Isoniazid | 2003 |
The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Aza Compounds; Female; Fluoroquinolones; Human | 2003 |
[The use of fenazid in patients with pulmonary tuberculosis with poor isoniazid tolerance].
Topics: Adult; Aged; Antitubercular Agents; Female; Humans; Iron Chelating Agents; Isoniazid; Male; Middle A | 2003 |
A randomised controlled clinical trial of the efficacy of family-based direct observation of anti-tuberculosis treatment in an urban, developed-country setting.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Family Health; Female; Humans; Is | 2003 |
Use of Rhu-GM-CSF in pulmonary tuberculosis patients: results of a randomized clinical trial.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Antitubercular Agents; Double-Blind Method; Female; Granu | 2003 |
[Assessment of the use of a multicomponent drug in the treatment of new cases of pulmonary tuberculosis].
Topics: Adolescent; Adult; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Myco | 2003 |
Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy.
Topics: Adult; Antibiotics, Antitubercular; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind | 2004 |
Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy.
Topics: Adult; Antibiotics, Antitubercular; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind | 2004 |
Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy.
Topics: Adult; Antibiotics, Antitubercular; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind | 2004 |
Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy.
Topics: Adult; Antibiotics, Antitubercular; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind | 2004 |
Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study.
Topics: Anti-Infective Agents; Antitubercular Agents; Aza Compounds; Colony Count, Microbial; Female; Fluoro | 2004 |
Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
Topics: Adult; Antitubercular Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Fem | 2004 |
The short-term effects of anti-tuberculosis therapy on plasma pyridoxine levels in patients with pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; HIV Infections; Humans; Isoniaz | 2004 |
[Short-term effect of treatment protocol utilizing levofloxacin, pasiniazide and M. Vaccae on multi- drug resistant pulmonary tuberculosis].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aminosalicylic Acid; Aminosalicylic Acids; Clinical | 2004 |
Predicting completion of treatment among foreign-born adolescents treated for latent tuberculosis infection in Los Angeles.
Topics: Adolescent; Adolescent Behavior; Adult; Antitubercular Agents; Child; Counseling; Emigration and Imm | 2004 |
Recurrent tuberculosis in the United States and Canada: relapse or reinfection?
Topics: Adult; Antitubercular Agents; Canada; Female; Genotype; Humans; Isoniazid; Male; Mycobacterium tuber | 2004 |
Penetration of isoniazid, rifampicin and pyrazinamide in tuberculous pleural effusion and psoas abscess.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Female; Humans; Isoniazid; Male; Microbial Sensitivi | 2004 |
[Optimization of tuberculosis complex chemotherapy with the use of moxifloxacin].
Topics: Adolescent; Adult; Animals; Antitubercular Agents; Aza Compounds; Drug Therapy, Combination; Female; | 2004 |
[Use of lymphotropic therapy in the multimodality treatment of patients with pulmonary tuberculosis and comorbidity].
Topics: Administration, Oral; Antitubercular Agents; Diabetes Complications; Ethambutol; Humans; Hypoglycemi | 2004 |
Evaluation of modified short course chemotherapy in active pulmonary tuberculosis patients with human immunodeficiency virus infection in University College Hospital, Ibadan, Nigeria--a preliminary report.
Topics: Acne Vulgaris; Adolescent; Adult; Age Distribution; Aged; Antitubercular Agents; Drug Therapy, Combi | 2004 |
Short-course chemotherapy for paediatric respiratory tuberculosis: 5-year report.
Topics: Antitubercular Agents; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combinat | 2005 |
[Randomized control study on domestic fixed-dose combinations in the initial treatment of smears positive tuberculosis].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Protocols; Drug Therapy, Combination; Femal | 2004 |
Clinical trial of rifampicin in the treatment of pulmonary tuberculosis in Lagos.
Topics: Adult; Antibiotics, Antitubercular; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Nig | 1973 |
Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts.
Topics: Adult; Antitubercular Agents; Disease Progression; Drug Administration Schedule; Drug Therapy, Combi | 2006 |
[Efficiency of chemotherapy of destructive pulmonary tuberculosis, based on the results of rapid detection of drug sensitivity to isoniazid and rifampicin with the "TB-Biochip" test system].
Topics: Adult; DNA Mutational Analysis; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle | 2006 |
Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial.
Topics: Africa South of the Sahara; Anti-Retroviral Agents; Antitubercular Agents; Child; Child, Preschool; | 2007 |
Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial.
Topics: Africa South of the Sahara; Anti-Retroviral Agents; Antitubercular Agents; Child; Child, Preschool; | 2007 |
Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial.
Topics: Africa South of the Sahara; Anti-Retroviral Agents; Antitubercular Agents; Child; Child, Preschool; | 2007 |
Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial.
Topics: Africa South of the Sahara; Anti-Retroviral Agents; Antitubercular Agents; Child; Child, Preschool; | 2007 |
Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial.
Topics: Africa South of the Sahara; Anti-Retroviral Agents; Antitubercular Agents; Child; Child, Preschool; | 2007 |
Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial.
Topics: Africa South of the Sahara; Anti-Retroviral Agents; Antitubercular Agents; Child; Child, Preschool; | 2007 |
Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial.
Topics: Africa South of the Sahara; Anti-Retroviral Agents; Antitubercular Agents; Child; Child, Preschool; | 2007 |
Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial.
Topics: Africa South of the Sahara; Anti-Retroviral Agents; Antitubercular Agents; Child; Child, Preschool; | 2007 |
Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial.
Topics: Africa South of the Sahara; Anti-Retroviral Agents; Antitubercular Agents; Child; Child, Preschool; | 2007 |
Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial.
Topics: Africa South of the Sahara; Anti-Retroviral Agents; Antitubercular Agents; Child; Child, Preschool; | 2007 |
Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial.
Topics: Africa South of the Sahara; Anti-Retroviral Agents; Antitubercular Agents; Child; Child, Preschool; | 2007 |
Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial.
Topics: Africa South of the Sahara; Anti-Retroviral Agents; Antitubercular Agents; Child; Child, Preschool; | 2007 |
Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial.
Topics: Africa South of the Sahara; Anti-Retroviral Agents; Antitubercular Agents; Child; Child, Preschool; | 2007 |
Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial.
Topics: Africa South of the Sahara; Anti-Retroviral Agents; Antitubercular Agents; Child; Child, Preschool; | 2007 |
Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial.
Topics: Africa South of the Sahara; Anti-Retroviral Agents; Antitubercular Agents; Child; Child, Preschool; | 2007 |
Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial.
Topics: Africa South of the Sahara; Anti-Retroviral Agents; Antitubercular Agents; Child; Child, Preschool; | 2007 |
Pharmacokinetics and tolerability of a higher rifampin dose versus the standard dose in pulmonary tuberculosis patients.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Area Under Curve; Biological | 2007 |
Pharmacokinetics and tolerability of a higher rifampin dose versus the standard dose in pulmonary tuberculosis patients.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Area Under Curve; Biological | 2007 |
Pharmacokinetics and tolerability of a higher rifampin dose versus the standard dose in pulmonary tuberculosis patients.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Area Under Curve; Biological | 2007 |
Pharmacokinetics and tolerability of a higher rifampin dose versus the standard dose in pulmonary tuberculosis patients.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Area Under Curve; Biological | 2007 |
Evaluation of a non-rifampicin continuation phase (6HE) following thrice-weekly intensive phase for the treatment of new sputum positive pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Bacte | 2007 |
HIV risk reduction in a nurse case-managed TB and HIV intervention among homeless adults.
Topics: Adult; Antitubercular Agents; Case Management; Directly Observed Therapy; Female; Health Knowledge, | 2007 |
Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Aza Compounds; Drug Interactions; Female; Fluoroquin | 2007 |
Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Aza Compounds; Drug Interactions; Female; Fluoroquin | 2007 |
Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Aza Compounds; Drug Interactions; Female; Fluoroquin | 2007 |
Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Aza Compounds; Drug Interactions; Female; Fluoroquin | 2007 |
Nutritional status of persons with HIV infection, persons with HIV infection and tuberculosis, and HIV-negative individuals from southern India.
Topics: Adult; AIDS-Related Opportunistic Infections; Anemia; Antitubercular Agents; Body Composition; Drug | 2008 |
Clinical evaluation and monitoring of adverse effects for fixed multidose combination against single drug therapy in pulmonary tuberculosis patients.
Topics: Adolescent; Adult; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Monitoring; Drug Th | 2008 |
Ethambutol-isoniazid versus PAS-isoniazid in original treatment of pulmonary tuberculosis.
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Drug Synergism; Female; Humans; Isoniazid; Male; | 1967 |
A comparative study on short course chemotherapy in sputum negative pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Fo | 1984 |
Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic Association (third report).
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazi | 1980 |
Isoniazid prevention of tuberculosis.
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Double-Blind Method; | 1983 |
Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis. Second report. Third East African/British Medical Research Council Study.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Clinical Trials as Topic; Drug Administration Schedu | 1980 |
A randomised study of two policies for managing default in out-patients collecting supplies of drugs for pulmonary tuberculosis in a large city in South India.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Child; Community Health Nursing; Humans; India; Isoniazid; | 1981 |
Operational evaluation of treatment for tuberculosis. Results of a "standard" 12-month regimen in Peru.
Topics: Adolescent; Adult; Child; Child, Preschool; Clinical Trials as Topic; Communicable Disease Control; | 1984 |
Comparison of a conventional and an initial 2-month intensive drug regimen for treating pulmonary tuberculosis in Swaziland.
Topics: Adult; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, | 1984 |
Short-term chemotherapy of tuberculosis.
Topics: Clinical Trials as Topic; Drug Administration Schedule; Humans; Isoniazid; Rifampin; Tuberculosis, P | 1983 |
New data on preventive treatment with isoniazid.
Topics: Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Administration Schedule; Huma | 1983 |
Study of chemotherapy regimens of 5 and 7 months' duration and the role of corticosteroids in the treatment of sputum-positive patients with pulmonary tuberculosis in South India.
Topics: Adult; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistanc | 1983 |
Controlled clinical trial of 4 short-couse regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedu | 1983 |
[Results of planned treatment of tuberculosis, under field conditions, with a therapeutic regimen consisting of isoniazid, rifampicin and streptomycin].
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; | 1983 |
Thirty years after isoniazid. Its impact on tuberculosis in children and adolescents.
Topics: Adolescent; Aminosalicylic Acid; Child; Child, Preschool; Clinical Trials as Topic; Drug Therapy, Co | 1984 |
[Short-term chemotherapy of tuberculosis. Cooperative French trial].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; | 1983 |
[Long-term results of a trial of short-term chemotherapy. French study 6.9.12].
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Follow-Up St | 1983 |
Lack of relationship between hepatic toxicity and acetylator phenotype in three thousand South Indian patients during treatment with isoniazid for tuberculosis.
Topics: Acetylation; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Humans; India; Isonia | 1984 |
Six-months isoniazid-rifampin therapy for pulmonary tuberculosis. Report of a United States Public Health Service Cooperative Trial.
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Double-Blind Method; | 1984 |
Controlled clinical trial comparing a 6-month and a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Algerian working group/British Medical Research Council cooperative study.
Topics: Adolescent; Adult; Algeria; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Sch | 1984 |
[A controlled trial of 6-month and 12-month regimens after negative conversion of sputum in the original treatment of pulmonary tuberculosis. Report of the 21st series of controlled trials of chemotherapy. Cooperative Study Unit of Chemotherapy of Tubercu
Topics: Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Female; | 1984 |
Ten year evaluation of a trial of chemoprophylaxis against tuberculosis in Frobisher Bay, Canada.
Topics: Adolescent; Adult; Aged; Canada; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Fe | 1984 |
A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society.
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combina | 1984 |
Supervised six-months treatment of newly diagnosed pulmonary tuberculosis using isoniazid, rifampin, and pyrazinamide with and without streptomycin.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Evaluation Studies as Top | 1984 |
[Pyrazinamide versus ethambutol in short-term therapy of lung tuberculosis. A randomized study].
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Humans; | 1983 |
A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. British Thoracic Association.
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combina | 1982 |
Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis.
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Europe, Eastern; Fema | 1982 |
[Short-term chemotherapy of pulmonary tuberculosis. Bacteriologic results].
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Isoniazi | 1980 |
A controlled trial of individually-adapted short-course chemotherapy versus two-year scheme in original treatment of pulmonary tuberculosis. Report after a five-year follow-up.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; | 1982 |
[Intravenous rifampicin therapy in open tuberculosis].
Topics: Administration, Oral; Adult; Biological Availability; Drug Therapy, Combination; Ethambutol; Female; | 1983 |
[Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
Topics: Adult; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, | 1980 |
Side-effects of drug regimens used in short-course chemotherapy for pulmonary tuberculosis. A controlled clinical study.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Clinical Tri | 1980 |
[Is the combination of INH and RFP always bactericidal? An observation in programme condition--report of the B series of 20th Controlled Trial of Chemotherapy (author's transl)].
Topics: Adult; Aged; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Fema | 1980 |
Isoniazid--an attempt at retrospective prediction. A report of an ad hoc expert groups of the International Commission for Protection Against Environmental Mutagens and Carcinogens.
Topics: Acetyltransferases; Biotransformation; Carcinogens; Chromosomes; Clinical Trials as Topic; Drug Eval | 1980 |
[Intensive chemotherapy of pulmonary tuberculosis].
Topics: Adolescent; Adult; Aminosalicylic Acid; Antibiotics, Antitubercular; Antitubercular Agents; Clinical | 1980 |
[Results of controlled clinical trials of intensive isoniazid therapy].
Topics: Clinical Trials as Topic; Follow-Up Studies; Humans; Injections, Intravenous; Isoniazid; Tuberculosi | 1980 |
[Complex hospital treatment of pulmonary tuberculosis].
Topics: Adolescent; Adult; Aminosalicylic Acid; Antitubercular Agents; Clinical Trials as Topic; Drug Admini | 1980 |
Rifampin-isoniazid therapy of alcoholic and nonalcoholic tuberculous patients in a U.S. Public Health Service Cooperative Therapy Trial.
Topics: Alcoholism; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Clinical Trials as | 1980 |
[Review of the current state of knowledge on prophylactic use of INH].
Topics: Adolescent; Adult; Age Factors; Chemical and Drug Induced Liver Injury; Child; Clinical Trials as To | 1980 |
[Preventive use of INH in patients with pulmonary fibrosis. Part I. Objectives, methods, material, patient acceptance and the tolerance of the treatment].
Topics: Adult; Clinical Trials as Topic; Evaluation Studies as Topic; Female; Humans; Isoniazid; Male; Metho | 1980 |
[Preventive use of INH in patients with pulmonary fibrosis. Part II. Results of treatment. Discussion].
Topics: Adult; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Pu | 1980 |
Chemotherapy of tuberculosis for the 1980's.
Topics: Animals; Antitubercular Agents; Clinical Trials as Topic; Humans; Isoniazid; Rifampin; Time Factors; | 1980 |
Short-course (6 month) cooperative tuberculosis study in Poland: results 18 months after completion of treatment.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Hu | 1980 |
[Urgent problems of antibacterial treatment of pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Eth | 1981 |
Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. Second report of the 4th study. East African/British Medical Research Councils Study.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedu | 1981 |
A controlled study of the effect of a domiciliary tuberculosis chemotherapy programme in a rural community in south India.
Topics: Adolescent; Adult; Aminosalicylic Acid; Child; Child, Preschool; Clinical Trials as Topic; Female; H | 1981 |
Ethambutol plus isoniazid for the treatment of pulmonary tuberculosis--a controlled trial of our regimens.
Topics: Adolescent; Adult; Aged; Child; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Fol | 1981 |
A controlled trial of six months chemotherapy in pulmonary tuberculosis. First Report: results during chemotherapy. British Thoracic Association.
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Humans; | 1981 |
Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis: the results up to 30 months.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedu | 1981 |
BTA short-course chemotherapy studies.
Topics: Clinical Trials as Topic; Ethambutol; Female; Hepatitis; Humans; Isoniazid; Liver Function Tests; Ma | 1981 |
Short-course chemotherapy. The Arkansas experience.
Topics: Adolescent; Adult; Aged; Arkansas; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; | 1981 |
A study of the characteristics and course of sputum smear-negative pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combi | 1981 |
Nine-month chemotherapy for pulmonary tuberculosis.
Topics: Adult; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol | 1982 |
Short-course chemotherapy for pulmonary tuberculosis. A 100-day interrupted regimen.
Topics: Adult; Antibiotics, Antitubercular; Clinical Trials as Topic; Drug Administration Schedule; Drug Com | 1981 |
Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
Topics: Adolescent; Adult; Aged; Alcoholism; Clinical Trials as Topic; Denmark; Drug Therapy, Combination; E | 1982 |
Chemoprophylaxis.
Topics: Adult; Child; Clinical Trials as Topic; Humans; Isoniazid; Tuberculosis, Pulmonary | 1982 |
Chemotherapy for tuberculosis today.
Topics: Antitubercular Agents; Clinical Trials as Topic; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifamp | 1982 |
[Comparative study of the treatment of pulmonary tuberculosis with isoprodian and pyrazinamide as well as isoprodian and rifampicin].
Topics: Adult; Aged; Antitubercular Agents; Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; I | 1982 |
Ethambutol compared to rifampin in original treatment of pulmonary tuberculosis.
Topics: Adolescent; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Humans; I | 1980 |
Factors influencing the effects of the initial phase of tuberculosis chemotherapy.
Topics: Adult; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1980 |
[Clinical trial of a combination of three drugs in fixed proportions in the treatment of tuberculosis. Groupe de Travail sur la Chimiothérapie de la Tuberculose].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Drug Tol | 1995 |
Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans. The Makerere University-Case Western University Research Collaboration.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Drug Eruptions; Drug Hypersensitivity; Dru | 1994 |
An uncontrolled trial of pefloxacin in the retreatment of patients with pulmonary tuberculosis.
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Ison | 1995 |
A comparison of two short course tuberculosis chemotherapy regimens, both using Rifater during an intensive phase, with a 3 year follow-up.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Combinations; Female; Follow-Up Studies; Humans; Ison | 1995 |
[Analysis of course and treatment results after treatment of pulmonary tuberculosis with early introduction of interrupted observation--preliminary report].
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, C | 1995 |
[Contemporary methods in the diagnosis and treatment of intrathoracic tuberculosis in children].
Topics: Administration, Oral; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Follow-Up Stud | 1994 |
Study of the effect of concomitant food on the bioavailability of rifampicin, isoniazid and pyrazinamide.
Topics: Adolescent; Adult; Biological Availability; Cross-Over Studies; Dietary Carbohydrates; Dietary Fats; | 1995 |
Treatment of pulmonary disease caused by Mycobacterium kansasii: results of 18 vs 12 months' chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; | 1995 |
[Compliance and tolerance of new antitubercular short-term chemopreventive regimens in childhood--a pilot project].
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Drug Administration Schedule; Drug Thera | 1994 |
[Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Mid | 1994 |
[Pathogenetic therapy of pulmonary tuberculosis in adolescents].
Topics: Administration, Oral; Adolescent; Antibiotics, Antitubercular; Antioxidants; Drug Therapy, Combinati | 1994 |
A prospective evaluation of antituberculosis therapy in patients with human immunodeficiency virus infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Therapy, Combination; Etha | 1994 |
[Evaluation of the streptomycin twice weekly with INH and RFP for initial therapy of pulmonary tuberculosis].
Topics: Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambu | 1994 |
Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Drug Therapy, Comb | 1993 |
The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessment.
Topics: Adolescent; Adult; Colony Count, Microbial; Female; Humans; Isoniazid; Male; Microbial Sensitivity T | 1993 |
[A comparative study of rifapentine treatment and three years follow-up on initial pulmonary tuberculous].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Et | 1993 |
Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis.
Topics: Adult; Aged; Ciprofloxacin; Drug Therapy, Combination; Ethambutol; Female; HIV Seropositivity; HIV-1 | 1993 |
[Combined chemotherapy of patients with tuberculosis - new regimens and dosage forms].
Topics: Antitubercular Agents; Dosage Forms; Drug Administration Schedule; Drug Combinations; Drug Therapy, | 1993 |
Bioavailability of isoniazid, rifampicin and pyrazinamide (in free combination or fixed-triple formulation) in intermittent antituberculous chemotherapy.
Topics: Adult; Biological Availability; Capsules; Drug Administration Schedule; Drug Combinations; Half-Life | 1993 |
Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Resistance, Microbial; Female; Humans; Isoniazi | 1993 |
Two-year follow-up of persons with HIV-1- and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West Africa.
Topics: Adolescent; Adult; Africa, Western; AIDS-Related Opportunistic Infections; Antibiotics, Antitubercul | 1995 |
[The present situation, treatment and prognosis of drug-resistant pulmonary tuberculosis. Cooperative Study Unit of Chemotherapy of Tuberculosis of the National Sanitoria in Japan].
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Female; Humans; Isoniazid; Life Style; Male; | 1995 |
Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Ciproflo | 1996 |
[Multicenter transversal study of tuberculosis and drug resistance in Madrid (October 1993-April 1994)].
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple; Et | 1996 |
Pharmacokinetics of isoniazid in pulmonary tuberculosis--a comparative study at two dose levels.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Child; Dose-Response Relationship, Drug; Drug Th | 1996 |
A controlled trial of a 4-weekly supplement of rifampicin, pyrazinamide and streptomycin in the continuation phase of a 7-month daily chemotherapy regimen for pulmonary tuberculosis. Tanzania/British Medical Research Council Collaborative Investigation.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Black People; Body Weight; Drug Administration Sched | 1996 |
Relapse after short-course chemotherapy of patients with sputum smear-positive pulmonary tuberculosis under routine conditions with additional information on side effects and contact tracing.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Contact Tracing; Drug Admin | 1996 |
Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosis.
Topics: Acetylation; Adult; Alleles; Antitubercular Agents; Arylamine N-Acetyltransferase; Female; Genotype; | 1997 |
A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Double-Blind Method; Female; HI | 1997 |
A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Therapy, Combination; Fema | 1997 |
A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Therapy, Combination; Fema | 1997 |
A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Therapy, Combination; Fema | 1997 |
A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Therapy, Combination; Fema | 1997 |
The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis.
Topics: Acetylation; Adult; Antitubercular Agents; Colony Count, Microbial; Dose-Response Relationship, Drug | 1997 |
The early bactericidal activity of ciprofloxacin in patients with pulmonary tuberculosis.
Topics: Adult; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Colony Count, Microbial; Drug Th | 1997 |
Early bactericidal activity of isoniazid in pulmonary tuberculosis. Optimization of methodology. The DATRI 008 Study Group.
Topics: Adult; Antitubercular Agents; Colony Count, Microbial; Drug Administration Schedule; Female; Humans; | 1997 |
A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antitubercular Agents; Child; Drug Administration Sch | 1997 |
Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Administration Schedule; F | 1998 |
Prospective study of corticosteroid as an adjunct in the treatment of endobronchial tuberculosis in adults.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Bronchoscopy; Chi-Square Distribution; Drug Therapy, | 1997 |
Is vitamin B6 supplementation of isoniazid therapy useful in childhood tuberculosis.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Democratic Republic of the Congo; Drug T | 1998 |
Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Tr
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Administration Schedule; D | 1998 |
Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Tr
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Administration Schedule; D | 1998 |
Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Tr
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Administration Schedule; D | 1998 |
Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Tr
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Administration Schedule; D | 1998 |
Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis. Initial report.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; F | 1998 |
[Lomefloxacin in complex treatment of acute progressive form of pulmonary tuberculosis].
Topics: Acute Disease; Adolescent; Adult; Animals; Anti-Infective Agents; Antibiotics, Antitubercular; Antit | 1998 |
Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antigens, Fungal; Antitubercular Agents; C | 1998 |
Twice weekly tuberculosis preventive therapy in HIV infection in Zambia.
Topics: Adult; AIDS-Related Opportunistic Infections; Antibiotic Prophylaxis; Antibiotics, Antitubercular; A | 1998 |
[Long-term efficacy of full course intermittent short-course chemotherapy on new smear positive tuberculosis patients].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; | 1997 |
[Effectiveness of isoniazid inhalation in patients with endobronchial tuberculosis].
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Bronchial Disease | 1999 |
Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Combinations; Follow-Up Studies; Humans; I | 1999 |
Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium.
Topics: Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; Dr | 1999 |
Clinical and serological studies of tuberculosis patients in Argentina receiving immunotherapy with Mycobacterium vaccae (SRL 172).
Topics: Adjuvants, Immunologic; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Argentina; BCG Va | 1999 |
Adherence to isoniazid prophylaxis in the homeless: a randomized controlled trial.
Topics: Adult; Aged; Antitubercular Agents; Female; Health Promotion; Housing; Humans; Ill-Housed Persons; I | 2000 |
Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Interim report: no activity of isoniazid in the continuation phase.
Topics: Acetylation; Antitubercular Agents; Arylamine N-Acetyltransferase; Drug Therapy, Combination; Genoty | 2000 |
Twice weekly vs. daily chemotherapy for childhood tuberculosis.
Topics: Antitubercular Agents; Child, Preschool; Drug Administration Schedule; Female; Humans; Infant; Isoni | 2000 |
A multicentre study of the early bactericidal activity of anti-tuberculosis drugs.
Topics: Adult; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Micr | 2000 |
The use of high-dose isomazid in intermittent regime TB treatment--some preliminary findings.
Topics: Antitubercular Agents; Drug Resistance; Drug Therapy, Combination; Humans; Isoniazid; Pilot Projects | 2000 |
Supervised preventive therapy for latent tuberculosis infection in illegal immigrants in Italy.
Topics: Adolescent; Adult; Antitubercular Agents; Emigration and Immigration; Female; Humans; Isoniazid; Ita | 2000 |
First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; HIV S | 2001 |
Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
Topics: Adolescent; Adult; Antitubercular Agents; Developing Countries; Drug Administration Schedule; Drug T | 2000 |
Treatment of isoniazid-resistant tuberculosis in southeastern Texas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Cohort S | 2001 |
Safety and bactericidal activity of rifalazil in patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Fema | 2001 |
The early bactericidal activity of amikacin in pulmonary tuberculosis.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Colony Count, Microbial; | 2001 |
[Controlled clinical study on efficacy of fixed-dose compounds rifater/rifinah in antituberculous chemotherapy].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid | 1998 |
Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Therapy, Combi | 2001 |
[Clinical research of pasinizid on retreated sputum positive pulmonary tuberculosis in senilities].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Clinical Protocols; Drug Therapy, | 2001 |
A simplified method for detecting isoniazid compliance in patients receiving antituberculosis chemotherapy.
Topics: Acetylation; Adult; Antitubercular Agents; Arylamine N-Acetyltransferase; Biotransformation; Chromat | 2002 |
Treatment of childhood tuberculosis with a six month directly observed regimen of only two weeks of daily therapy.
Topics: Adolescent; Antibiotics, Antitubercular; Antitubercular Agents; Child; Child, Preschool; Directly Ob | 2002 |
Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Chil | 2002 |
Side-effects of drugs used in directly observed treatment short-course in newly diagnosed pulmonary tuberculosis subjects in Nigerians: a controlled clinical study.
Topics: Adolescent; Adult; Antitubercular Agents; Clinical Protocols; Directly Observed Therapy; Drug Therap | 2002 |
Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug | 1975 |
Short-course treatment in pulmonary tuberculosis.
Topics: Adolescent; Adult; Africa, Eastern; Antitubercular Agents; Humans; Isoniazid; Middle Aged; Pyrazinam | 1975 |
Controlled trial of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis in Singapore.
Topics: Adolescent; Adult; Clinical Trials as Topic; Culture Techniques; Drug Administration Schedule; Drug | 1975 |
Comparative trial of thiacetazone with isoniazid and paraaminosalicyclic acid (PAS) with isoniazid in the treatment of pulmonary tuberculosis in Nigerians.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Drug Therapy, Combination; Female; Humans; Isoniazid; | 1975 |
Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Dr | 1976 |
Ethambutol plus isoniazid compared with rifampicin plus isoniazid in antituberculosis continuation treatment.
Topics: Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Rifampin; | 1977 |
Short-course chemotherapy in pulmonary tuberculosis.
Topics: Clinical Trials as Topic; Developing Countries; Drug Therapy, Combination; Humans; Isoniazid; Pyrazi | 1977 |
Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis: first report: Third East African/British Medical Research Councils study.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedu | 1978 |
Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. First report of 4th study. East African and British Medical Research Councils.
Topics: Adolescent; Adult; Africa, Eastern; Aged; Clinical Trials as Topic; Drug Administration Schedule; Dr | 1978 |
Sputum-smear-negative pulmonary tuberculosis: controlled trial of 3-month and 2-month regimens of chemotherapy.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Male; | 1979 |
The chemotherapy of pulmonary tuberculosis: a review.
Topics: Aminosalicylic Acid; Antitubercular Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Et | 1979 |
Comparative trial of ethambutol and thiacetazone in childhood tuberculosis.
Topics: Adolescent; Child; Child, Preschool; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol | 1979 |
Experimental data on the antimicrobial activity of Isoprodian (PTH).
Topics: Antitubercular Agents; Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Evaluation; Drug E | 1978 |
Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report.
Topics: Adolescent; Adult; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Dr | 1978 |
U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Drug E | 1979 |
U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Drug E | 1979 |
U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Drug E | 1979 |
U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Drug E | 1979 |
Efficacy of once-weekly isoniazid-streptomycin in preventing relapse of pulmonary tuberculosis.
Topics: Adult; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Recurre | 1977 |
Trial of two intermittent short-course regimens (78 doses) in the initial treatment of pulmonary tuberculosis.
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Ison | 1977 |
[Express intravenous administration of a complex of antituberculosis preparations in the treatment of destructive pulmonary tuberculosis].
Topics: Adolescent; Aminosalicylic Acid; Animals; Antitubercular Agents; Clinical Trials as Topic; Dogs; Dru | 1977 |
[Intravenous chemotherapy of destructive pulmonary tuberculosis using high doses of isoniazid].
Topics: Adult; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Injections, Intravenous; Isoniazid | 1977 |
A study of two twice-weekly and a once-weekly continuation regimen of tuberculosis chemotherapy, including a comparison of two durations of treatment. 2. Second report: the results at 36 months.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acid; Aminosalicylic Acids; Clinical Trials as Topic; Czecho | 1977 |
Preventive therapy with isoniazid for "inactive" tuberculosis.
Topics: Antitubercular Agents; Clinical Trials as Topic; Humans; Isoniazid; Patient Compliance; Placebos; Tu | 1978 |
Prophylaxis with isoniazid in inactive tuberculosis. A Veterans Administration Cooperative Study XII.
Topics: Antitubercular Agents; Clinical Trials as Topic; Double-Blind Method; Humans; Isoniazid; Placebos; T | 1978 |
The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide.
Topics: Acetylation; Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Clinical Trials as Top | 1978 |
[Late results of the antibacterial therapy of fibrous-cavernous pulmonary tuberculosis].
Topics: Adult; Aerosols; Antitubercular Agents; Chronic Disease; Clinical Trials as Topic; Drug Evaluation; | 1978 |
[Intermittent chemotherapy method in pulmonary tuberculosis].
Topics: Adult; Aminosalicylic Acid; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Fe | 1978 |
Clinical results obtained with Isoprodian in the treatment of new cases of pulmonary tuberculosis.
Topics: Antitubercular Agents; Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Evaluation; Drug T | 1978 |
The efficacy of preventive treatment with isoniazid in a high risk group. Results form an international Trial under the auspices of IUAT.
Topics: Clinical Trials as Topic; Drug Evaluation; Humans; Isoniazid; Placebos; Pulmonary Fibrosis; Time Fac | 1978 |
[Clinical pharmacology of isoniazid (a review of the literature)].
Topics: Acetylation; Clinical Trials as Topic; Drug Evaluation; Ethnicity; Female; Humans; Individuality; Is | 1979 |
[Ambulatory and hospitalintermittent intravenous chemotherapy of pulmonary tuberculosis in a rural district].
Topics: Adolescent; Adult; Ambulatory Care; Aminosalicylic Acid; Antitubercular Agents; Clinical Trials as T | 1979 |
Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Alanine Transaminase; Antitubercular Agents; Clinical Trials as Topic; Drug Thera | 1979 |
[Controlled trial of 6 to 8 month chemotherapeutic regimens in the treatment of pulmonary tuberculosis. A study of Hong Kong Chest Service/British Medical Research Council/].
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Hong Kong; H | 1978 |
[Short term chemotherapy of tuberculosis. Evaluation of an 18-week-long treatment including pyrazinamide (preliminary results)].
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Ison | 1978 |
Containment of tuberculosis. Preventive therapy with isoniazid, and contact investigation.
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Epidemiologic Methods | 1979 |
Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis: the results up to 24 months.
Topics: Adolescent; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Resi | 1979 |
Controlled trial of intermittent regimens of rifampin plus isoniazid for pulmonary tuberculosis in Singapore. The results up to 30 months.
Topics: Adolescent; Adult; Antibodies; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, C | 1977 |
[Treatment of open cavernous pulmonary tuberculosis (author's transl)].
Topics: Dapsone; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Prothionamide; | 1979 |
[A pilot and a controlled study of the influence of ethambutol on serum urate concentration and uric acid clearance (author's transl)].
Topics: Alcoholism; Body Weight; Creatinine; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tubercul | 1979 |
A comparative study of daily and twice-weekly continuation regimens of tuberculosis chemotherapy, including a comparison of two durations of sanatorium treatment.
Topics: Adolescent; Adult; Aged; Animals; Antitubercular Agents; Clinical Trials as Topic; Drug Administrati | 1976 |
[A preliminary report on the clinical efficacy of isoprodian (author's transl)].
Topics: Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Evaluation; Humans; Isoniazid; Isonicotin | 1976 |
[Isoniazio, prothionamide and diafenylsulphone (isoprodian) in the therapy of previously untreated pulmonary (author's transl)].
Topics: Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Evaluation; Female; Humans; Isoniazid; Is | 1976 |
[Clinical experience with isoprodian in the treatment of adult pulmonary tuberculosis (author's transl)].
Topics: Adult; Aged; Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Evaluation; Female; Humans; | 1976 |
Studies of immediate adverse reactions to different doses of a slow-release preparation of isoniazid.
Topics: Adult; Clinical Trials as Topic; Delayed-Action Preparations; Ethambutol; Female; Humans; Isoniazid; | 1976 |
Controlled clinical trial of four 6-month regimens of chemotherapy for pulmonary tuberculosis. Second report. Second East African/British Medical Research Council Study.
Topics: Adolescent; Clinical Trials as Topic; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoniazi | 1976 |
Tuberculosis in Scotland: a national sample survey (1968-70). 2. A two-year follow-up of newly-diagnosed respiratory tuberculosis notified in 1968.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aminosalicylic Acid; Clinical Trials as Topic; Drug Therapy, C | 1976 |
A study of two twice-weekly and once-weekly continuation regimen of tuberculosis chemotherapy, including a comparison of two durations of treatment. 1. First report: the results at 18 months.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acid; Aminosalicylic Acids; Clinical Trials as Topic; Drug T | 1976 |
The IUAT trial on isoniazid preventive treatment in persons with fibrotic lung lesions.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Female; Germany, West; Humans; Isoniazid; Male | 1976 |
Short-duration treatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Ambulatory Care; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Ma | 1977 |
[The role of preventive chemotherapy in the present tuberculosis epidemiology of GDR (author's transl)].
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Germany, East; Humans; Infant; Infant, Newborn; | 1977 |
Isoniazid levels in black patients dosed with a matrix preparation (Tebesium).
Topics: Adolescent; Adult; Aged; Black People; Delayed-Action Preparations; Female; Humans; Isoniazid; Male; | 1977 |
[Hepatotoxic side-effects of rifampicin; a comparative clinical study (author's transl)].
Topics: Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoni | 1977 |
Proceedings: Short course chemotherapy in pulmonary tuberculosis: a controlled trial by the British Thoracic and Tuberculosis Association. (A report from one of the three clinical co-ordinators).
Topics: Clinical Trials as Topic; Drug Evaluation; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tu | 1975 |
Controlled trial of 6- and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong.
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Combinations; Drug Resistance, Microbial; Female; | 1975 |
Combined chemotherapy including rifabutin for rifampicin and isoniazid resistant pulmonary tuberculosis. G.E.T.I.M. (Group for the Study and Treatment of Resistant Mycobacterial Infection).
Topics: Adult; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; | 1992 |
The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Colony Count, Microbial; Dose-Response Relationship, Drug; | 1992 |
A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Hong Kong Chest Service/British Medical Research Council.
Topics: Adult; Aged; Antitubercular Agents; Chronic Disease; Dose-Response Relationship, Drug; Drug Resistan | 1992 |
Fibrinogen and antithrombin III blood levels fluctuations during isoniazid or isoniazid plus rifampicin administration.
Topics: Adult; Antithrombin III; Blood Coagulation; Drug Combinations; Enzymes; Female; Fibrinogen; Humans; | 1992 |
Prospective comparative study of ofloxacin or ethambutol for the treatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Combinations; Drug Resistance, Microbial; Ethambuto | 1992 |
A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council.
Topics: Adult; Aged; Alanine Transaminase; Disease Susceptibility; Double-Blind Method; Follow-Up Studies; H | 1992 |
Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hon
Topics: Adolescent; Adult; Drug Administration Schedule; Drug Combinations; Drug Resistance, Microbial; Drug | 1991 |
Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
Topics: Adolescent; Adult; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; | 1991 |
[Complex treatment of patients with destructive pulmonary tuberculosis including intramuscular administration of isoniazid].
Topics: Adult; Aged; Drug Therapy, Combination; Ethambutol; Humans; Injections, Intramuscular; Isoniazid; Mi | 1991 |
Short-course chemotherapy for pulmonary tuberculosis under routine programme conditions: a comparison of regimens of 28 and 36 weeks duration in Algeria. Algerian Working Group/British Medical Research Council Cooperative Study.
Topics: Adolescent; Adult; Aged; Algeria; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, | 1991 |
[Nine month chemotherapy with INH and rifampicin for non-cavitary pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Child; Drug Therapy, Combination; Female; Human | 1991 |
[A therapeutic trial of a combination of 3 essential drugs in a short course of chemotherapy in tuberculosis. Results 6 months after the end of treatment].
Topics: Drug Combinations; Drug Resistance, Microbial; Follow-Up Studies; Humans; Isoniazid; Mycobacterium t | 1990 |
Five year results of a 3-month and two 5-month regimens for the treatment of sputum-positive pulmonary tuberculosis in south India.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Micro | 1990 |
USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results.
Topics: Adult; Antitubercular Agents; Centers for Disease Control and Prevention, U.S.; Data Interpretation, | 1990 |
Short-course chemotherapy for pulmonary tuberculosis with a rifampicin-isoniazid-pyrazinamide combination tablet.
Topics: Adult; Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Male; | 1990 |
[Tisamide in the complex treatment of tuberculosis].
Topics: Adult; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifamp | 1990 |
A randomized trial of fully intermittent vs. daily followed by intermittent short course chemotherapy for childhood tuberculosis.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Follo | 1990 |
Comparison of daily and twice-weekly regimens to treat pulmonary tuberculosis.
Topics: Administration, Oral; Brazil; Costs and Cost Analysis; Drug Administration Schedule; Drug Evaluation | 1989 |
Acceptability, compliance, and adverse reactions when isoniazid, rifampin, and pyrazinamide are given as a combined formulation or separately during three-times-weekly antituberculosis chemotherapy.
Topics: Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Patie | 1989 |
[Therapeutic trial of a combination of isoniazid, rifampicin and pyrazinamide in the first 2 months of treatment of pulmonary tuberculosis].
Topics: Adolescent; Adult; Antitubercular Agents; Clinical Trials as Topic; Drug Combinations; Drug Therapy, | 1989 |
A controlled trial of 3-month, 4-month, and 6-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 5 years. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedu | 1989 |
[Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
Topics: Adult; Antitubercular Agents; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Middle | 1989 |
[Preliminary results of a study on shortening periods of treatment and temporary disability of patients with tuberculosis of the respiratory organs].
Topics: Antitubercular Agents; Clinical Trials as Topic; Disability Evaluation; Humans; Isoniazid; Length of | 1989 |
[Short term treatment of infantile pulmonary tuberculosis].
Topics: Antitubercular Agents; BCG Vaccine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Huma | 1989 |
Random variation in tuberculin sensitivity in schoolchildren. Serial skin testing before and after preventive treatment for tuberculosis.
Topics: Adolescent; Child; Dapsone; Drug Combinations; Ethambutol; Female; Humans; Hypersensitivity, Delayed | 1989 |
Clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
Topics: Adolescent; Adult; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Dr | 1985 |
Five-year follow-up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combi | 1988 |
Adrenal function in tuberculosis.
Topics: Acute Disease; Adolescent; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aged; Child; Child, P | 1986 |
Controlled clinical trial of a regimen of two durations for the treatment of isoniazid resistant pulmonary tuberculosis.
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; | 1988 |
Pulmonary tuberculosis treated with isoprodian and rifampicin or pyrazinamide.
Topics: Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Thera | 1987 |
Short-course chemotherapy of pulmonary tuberculosis in pneumoconiotic patients.
Topics: Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Iso | 1987 |
[Results of a shortened (6 months) schedule of treatment of pulmonary tuberculosis using INH, RMP and PZA].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Female; Humans; Isoniazid; | 1987 |
United States Public Health Service Tuberculosis Therapy Trial 21: preliminary results of an evaluation of a combination tablet of isoniazid, rifampin and pyrazinamide.
Topics: Clinical Trials as Topic; Drug Combinations; Female; Humans; Isoniazid; Male; Patient Compliance; Py | 1987 |
Tolerability and efficacy of isoprodian-containing antituberculosis regimens.
Topics: Adult; Antitubercular Agents; Child; Clinical Trials as Topic; Dapsone; Drug Combinations; Humans; I | 1986 |
Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedu | 1986 |
Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis: final report. East and Central African/British Medical Research Council Fifth Collaborative Study.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; | 1986 |
A controlled clinical trial of 3- and 5-month regimens in the treatment of sputum-positive pulmonary tuberculosis in South India. Tuberculosis Research Centre, Madras, and National Tuberculosis Institute, Bangalore.
Topics: Adolescent; Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Clinical Trials as | 1986 |
A four-drug regimen for initial treatment of cavitary disease caused by Mycobacterium avium complex.
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Foll | 1986 |
[Daily ultrashort chemotherapy and intermittent short-term chemotherapy with 4 drugs of communicable pulmonary tuberculosis treated for the first time. Results of a cooperative multicenter study].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedu | 1986 |
Controlled clinical trial of three short-course regimens of chemotherapy for pulmonary tuberculosis in Nigeria--a preliminary report.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedu | 1986 |
Controlled clinical trial of two 6-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Tanzania/British Medical Research Council Study.
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Resistance, Microbial; Female; Humans; Isoniazid; | 1985 |
Operational evaluation of treatment for tuberculosis. Results of 8- and 12-month regimens in Peru.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Clinical Trials as Topic; Drug Th | 1985 |
[The short course therapies by Ryoken's method. 9 month and 12 month regimens including rifampicin (RFP) plus isoniazid (INH) in bacteriologically proved pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combi | 1985 |
[Which is the best drug combination for the short-term therapy of tuberculosis? A prospective randomized study with 190 patients].
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug | 1985 |
[Controlled study comparing 3 daily chemotherapy regimens for six months in pulmonary tuberculosis in routine practice in Algiers. Results at 30 months].
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combinati | 1985 |
Pharmacokinetics of oral and intravenous rifampicin during chronic administration.
Topics: Administration, Oral; Adolescent; Adult; Aged; Biological Availability; Drug Therapy, Combination; E | 1985 |
Isoniazid with thiacetazone (thioacetazone) in the treatment of pulmonary tuberculosis in East Africa--second report of fifth investigation. Aco-operative study in East African hospitals, clinics and laboratories with the collaboration of the East African
Topics: Acute Disease; Africa, Eastern; Clinical Trials as Topic; Humans; Isoniazid; Streptomycin; Thioaceta | 1970 |
Isoniazid with thiacetazone (thioacetazone) in the treatment of pulmonary tuberculosis in East Africa--fifth investigation. A co-operative study in East African hospitals, clinics and laboratories with the collaboration of the East African and British Med
Topics: Adolescent; Adult; Africa, Eastern; Aged; Chemical and Drug Induced Liver Injury; Clinical Trials as | 1970 |
The therapy of pulmonary tuberculosis in Kenya: a comparison of the results achieved in controlled clinical trials with those achieved by the routine treatment services.
Topics: Adolescent; Adult; Antitubercular Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Fema | 1970 |
A controlled clinical trial of the role of thiacetazone-containing regimens in the treatment of pulmonary tuberculosis in Singapore. Singapore Tuberculosis Services-Brompton Hospital-British Medical Research Council Investigation.
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Resistance, Microbial; Female; Humans; Isoniazid; | 1971 |
General considerations in intermittent drug therapy of pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Clinical Trials as Topic; Ethambutol; Ethionamide; Huma | 1971 |
Controlled clinical trial of short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis.
Topics: Administration, Oral; Adolescent; Adult; Antitubercular Agents; Clinical Trials as Topic; Drug Combi | 1972 |
Isoniazid with thiacetazone in the treatment of pulmonary tuberculosis in East Africa.
Topics: Clinical Trials as Topic; Drug Combinations; Humans; Isoniazid; Streptomycin; Thioacetazone; Time Fa | 1972 |
Collective studies from the whole of the Soviet Union on controlled chemotherapy of pulmonary tuberculosis.
Topics: Ambulatory Care; Aminosalicylic Acids; Clinical Trials as Topic; Drug Combinations; Evaluation Studi | 1972 |
Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Second report.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Resistance, Microbial; Female; Humans; Isoniazi | 1973 |
Isoniazid with thiacetazone (thioacetazone) in the treatment of pulmonary tuberculosis in East Africa. Third Report of Fifth Investigation. A co-operative study in East Africian hospitals, clinics and laboratories with the collaboration of the East Africa
Topics: Africa, Eastern; Clinical Trials as Topic; Drug Resistance, Microbial; Follow-Up Studies; Humans; In | 1973 |
Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Third report. East African-British Medical Research Councils.
Topics: Adolescent; Adult; Africa, Eastern; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Dr | 1974 |
Interaction aspects of antimycobacterial drugs in the chemotherapy of tuberculosis. I. Role of individual antituberculous drugs in drug regimens used in the chemotherapy of human tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Clinical Trials as Topic; Cycloserine; Drug Evaluation; | 1974 |
Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis.
Topics: Administration, Oral; Adolescent; Adult; Africa; Clinical Trials as Topic; Drug Combinations; Drug E | 1974 |
[Short-term treatment of pulmonary tuberculosis].
Topics: Adolescent; Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Evaluation S | 1974 |
[Controlled therapeutic study of 5 intermittent chemotherapy regimens for pulmonary tuberculosis. 4th international study of the UICT].
Topics: Adolescent; Aminosalicylic Acids; Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Com | 1974 |
A study of adverse reactions to high dosage intermittent thiacetazone.
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Drug The | 1974 |
A controlled clinical trial of the role of thiacetazone-containing regimens in the treatment of pulmonary tuberculosis in Singapore: second report.
Topics: Adolescent; Adult; Bacteriological Techniques; Clinical Trials as Topic; Drug Evaluation; Drug Resis | 1974 |
Isoniazid plus thioacetazone compared with two regimens of isoniazid plus PAS in the domiciliary treatment of pulmonary tuberculosis in South Indian patients.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Home Care Services; Humans; India; Isoniazid; Thioac | 1966 |
Efficacy of thiacetazone plus isoniazid in Hong Kong: a Hong Kong tuberculosis treatment service-British Medical Research Council investigation.
Topics: Adolescent; Adult; Aminosalicylic Acids; Clinical Trials as Topic; Drug Resistance, Microbial; Drug | 1968 |
A summary of the results of East African-British Medical Research Council studies of thiacetazone-containing regimens.
Topics: Africa, Eastern; Antitubercular Agents; Clinical Trials as Topic; Costs and Cost Analysis; Drug Syne | 1968 |
Antituberculous treatment of erythema induratum Bazin.
Topics: Adult; Age Factors; Aged; Aminosalicylic Acids; Female; Follow-Up Studies; Humans; Isoniazid; Leg Ul | 1970 |
Daily and intermittent regimens: third IUAT chemotherapy investigation. A controlled trial of three regimens of self-administered and supervised chemotherapy for pulmonary tuberculosis. Clinical aspects.
Topics: Humans; Isoniazid; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1970 |
Co-operative controlled trial of a standard regimen of streptomycin, PAS and isoniazid and three alternative regimens of chemotherapy in Britain. A report from the British Medical Research Council.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Chemical and Drug Induced Liver Injury; Clinical Tria | 1973 |
[Proceedings: Results of a controlled trial of intermittent ambulatory therapy of infectious pulmonary tuberculosis with comparison of various maintenance regimens].
Topics: Adolescent; Adult; Aged; Ambulatory Care; Aminosalicylic Acids; Antitubercular Agents; Clinical Tria | 1973 |
Comparison of two regimens of simplified two-stage chemotherapy in previously untreated pulmonary tuberculosis.
Topics: Adolescent; Aminosalicylic Acids; Clinical Trials as Topic; Drug Resistance, Microbial; Humans; Ison | 1973 |
A controlled comparison of two fully supervised once-weekly regimens in the treatment of newly diagnosed pulmonary tuberculosis.
Topics: Adolescent; Adult; Aminosalicylic Acids; Clinical Trials as Topic; Drug Hypersensitivity; Drug Resis | 1973 |
Rifampin in initial treatment of pulmonary tuberculosis. A.U.S. Public Health Service tuberculosis therapy trial.
Topics: Adolescent; Adult; Alanine Transaminase; Bacteriological Techniques; Clinical Trials as Topic; Drug | 1974 |
Isoniazid chemoprophylaxis of latent primary tuberculosis: in five trial centres in France from 1959 to 1969.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; France; Headache; Humans; Isoniazid; Male; Mycob | 1973 |
[Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thioc
Topics: Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Hypersensitivity; Drug Therap | 1974 |
Isoniazid-induced vitamin B6 deficiency. Metabolic studies and preliminary vitamin B6 excretion studies.
Topics: Aspartate Aminotransferases; Blood Urea Nitrogen; Erythrocytes; Humans; Isoniazid; Leukocyte Count; | 1967 |
Serum proteins in pulmonary tuberculosis.
Topics: Adrenocorticotropic Hormone; Adult; Black or African American; Blood Protein Disorders; Blood Protei | 1967 |
Ethambutol in re-treatment of pulmonary tuberculosis.
Topics: Adult; Anti-Bacterial Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Fema | 1968 |
Evaluation of results of chemotherapy in tuberculosis with special consideration of ethambutol.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Cycloserine; Drug Combinations; Electronic Data Proc | 1970 |
Isoniazid prophylaxis among Alaskan Eskimos: a progress report.
Topics: Alaska; Economics, Medical; Humans; Inuit; Isoniazid; Placebos; Time Factors; Tuberculosis, Pulmonar | 1974 |
Drug-induced heart failure in advanced pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Heart Fail | 1974 |
[Rifampicin in the treatment of lung and kidney tuberculosis].
Topics: Adult; Aged; Aminosalicylic Acids; Clinical Trials as Topic; Drug Combinations; Ethambutol; Female; | 1972 |
Rifampicin blood serum levels and half-life during prolonged administration in tuberculous patients.
Topics: Administration, Oral; Adult; Aminosalicylic Acids; Analysis of Variance; Clinical Trials as Topic; D | 1972 |
Controlled therapeutic trial with the combination rifampicin-isoniazid given for six months to previously untreated patients with pulmonary tuberculosis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Argentina; Clinical Trials as Topic; Drug Combination | 1972 |
Rifampin in original treatment of pulmonary tuberculosis. A United States Public Health Service cooperative therapy trial.
Topics: Administration, Oral; Adult; Age Factors; Alanine Transaminase; Clinical Trials as Topic; Drug Combi | 1972 |
[Evaluation of high dose INH twice weekly regimen in the original treatment for moderately advanced pulmonary tuberculosis. A report of the 12th series B study of the controlled trials].
Topics: Adult; Aminosalicylic Acids; Clinical Trials as Topic; Evaluation Studies as Topic; Female; Humans; | 1972 |
Ethambutol in the initial treatment of pulmonary tuberculosis. U.S. Public Health Service tuberculosis therapy trials.
Topics: Adolescent; Adult; Aminosalicylic Acids; Clinical Trials as Topic; Ethambutol; Evaluation Studies as | 1973 |
Preventive treatment of untreated, nonactive tuberculosis in an Eskimo population.
Topics: Alaska; Bacteriological Techniques; Clinical Trials as Topic; Humans; Inuit; Isoniazid; Placebos; Ra | 1972 |
A comparative study of daily and twice-weekly continuation regimens of tuberculosis chemotherapy, including a comparison of two durations of sanatorium treatment. 2. Second report: the results from 12 to 24 months.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aminosalicylic Acids; Clinical Trials as Topic; Czech | 1973 |
[Effects of rifampicin on the menstrual cycle and on oestrogen excretion in patients taking oral contraceptives].
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptives, Oral; Estriol; Estrogens; Estrone; Etha | 1973 |
[Comparison of three regimens, INH-SM-PAS, INH-SM-RFP and INH-PAS-RFP, in the original treatment cases of pulmonary tuberculosis. Report of the 13th series study (original treatment study)].
Topics: Adult; Aminosalicylic Acids; Clinical Trials as Topic; Humans; Isoniazid; Middle Aged; Rifampin; Str | 1973 |
Effect of isoniazid on reproduction.
Topics: Adolescent; Adult; Birth Weight; Clinical Trials as Topic; Female; Fertility; Fetus; Humans; Isoniaz | 1973 |
[Proceedings: Significance and limits of controlled clinical research (in pulmonary tuberculosis)].
Topics: Aminosalicylic Acids; Antitubercular Agents; Clinical Trials as Topic; Drug Combinations; Ethambutol | 1973 |
[Treatment of tuberculosis with streptomycin and isoniazide combined with either aminosalyl or rifampicin].
Topics: Alcoholism; Aminosalicylic Acids; Bilirubin; Drug Therapy, Combination; Humans; Isoniazid; Patient D | 1973 |
Rifampin therapy of pulmonary tuberculosis in patients not treated previously with antituberculous drugs.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Isoniazid; Rifamp | 1974 |
Preliminary results of a controlled therapeutic trail administering INH-RMP once-weekly, after--or without--an initial period of continuous treatment.
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Gastrointestinal Diseases; Heada | 1973 |
Controlled clinical evaluation of three intermittent regimens employing low-dosage schedules of rifampicin in original treatment of pulmonary tuberculosis. Preliminary data on effectiveness and side effects.
Topics: Antibody Formation; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; | 1973 |
Immunological and haematological investigations on patients with adverse reactions during treatment with RMP plus INH once-weekly.
Topics: Antibody Formation; Binding Sites, Antibody; Blood Cell Count; Clinical Trials as Topic; Erythrocyte | 1973 |
Epidemiologic evaluation of chemoprophylaxis against tuberculosis.
Topics: Adult; Clinical Trials as Topic; Female; Follow-Up Studies; Greenland; Humans; Isoniazid; Male; Plac | 1974 |
[Comparative study (in a controlled therapeutic trial) of 3 intermittent regimens, after an initial period of daily administration, in the repeated treatment of pulmonary tuberculosis (results)].
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Tuberc | 1973 |
[Preliminary results of a therapeutic trial concerning the administration of isoniazid + rifampicin once a week, immediately or after an initial period of continuous treatment].
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Tuberculosis, Pulm | 1973 |
Rifampicin plus isoniazid, rifampicin plus PAS, and isoniazid plus PAS in the initial treatment of pulmonary tuberculosis. A controlled multicenter clinical trial.
Topics: Adult; Aminosalicylic Acids; Blood Proteins; Blood Sedimentation; Body Weight; Clinical Trials as To | 1974 |
Treatment of pulmonary tuberculosis in children--a controlled study.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Clinical Trials as Topic; Drug Therapy, | 1974 |
[Controlled intermittent treatment of pulmonary tuberculosis using streptomycin, isoniazid and PAS once, twice or 3 times a week].
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Clinical Trials as Topic; Foll | 1973 |
[Short-term chemotherapy of pulmonary tuberculosis. Pilot study].
Topics: Adult; Antitubercular Agents; Brazil; Clinical Trials as Topic; Drug Resistance, Microbial; Drug The | 1974 |
[Madras study on intermittent oral chemotherapy using ethambutol and isoniazid].
Topics: Adolescent; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Evaluation Studies as T | 1974 |
Serum enzyme changes in patients receiving antituberculosis therapy with rifampicin or p-aminosalicylic acid, plus isoniazid and streptomycin.
Topics: Alkaline Phosphatase; Aminosalicylic Acids; Aspartate Aminotransferases; Bilirubin; Clinical Trials | 1974 |
Controlled comparison of oral twice-weekly and oral daily isoniazid plus PAS in newly diagnosed pulmonary tuberculosis.
Topics: Adolescent; Adult; Aminosalicylic Acids; Clinical Trials as Topic; Drug Resistance, Microbial; Femal | 1973 |
Effect of pyridoxine on vitamin B6 concentrations and glutamic-oxaloacetic transaminase activity in whole blood of tuberculous patients receiving high-dosage isoniazid.
Topics: Aspartate Aminotransferases; Clinical Trials as Topic; Humans; Isoniazid; Pyridoxine; Tuberculosis, | 1967 |
Results of a trial in Morocco of intermittent treatment of pulmonary tuberculosis with combined streptomycin and isoniazid intramuscularly.
Topics: Clinical Trials as Topic; Drug Synergism; Humans; Injections, Intramuscular; Isoniazid; Morocco; Str | 1968 |
Madras study of supervised once-weekly chemotherapy in the treatment of pulmonary tuberculosis: clinical aspects.
Topics: Clinical Trials as Topic; Drug Synergism; Humans; India; Isoniazid; Streptomycin; Time Factors; Tube | 1968 |
Clinical experience in Algeria of intermittent treatment of pulmonary tuberculosis with isoniazid and streptomycin twice-weekly.
Topics: Algeria; Clinical Trials as Topic; Drug Synergism; Humans; Injections, Intramuscular; Isoniazid; Str | 1968 |
Clinical experience of intermittent treatment in the United Kingdom.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Humans; Isoniazid; Pyrazinamide; Streptomycin; Tuber | 1968 |
Comparison of the clinical usefulness of ethionamide and prothionamide in initial treatment of tuberculosis: tenth series of controlled trials.
Topics: Aminosalicylic Acids; Antitubercular Agents; Clinical Trials as Topic; Culture Media; Drug Resistanc | 1968 |
[Evaluation of the early results of chemotherapy of newly discovered pulmonary tuberculosis with the combination of streptomycin, isoniazid and isoxyl].
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Humans; Isoniazid; Phenylthiourea; Streptomycin; Tub | 1968 |
Long-term effects of isoniazid prophylaxis.
Topics: Adolescent; Adult; Aged; Alaska; Child; Child, Preschool; Clinical Trials as Topic; Female; Follow-U | 1968 |
Long-term results of the chemoprophylactic trial in Greenland.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Follow-Up Studies; Greenland; Humans; Isoniazid; | 1968 |
Long term isoniazid prophylaxis. Controlled trial on INH prophylaxis after recent tuberculin conversion in young adults.
Topics: Adult; Clinical Trials as Topic; Disease Outbreaks; Follow-Up Studies; Humans; Isoniazid; Male; Mili | 1968 |
A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.
Topics: Clinical Trials as Topic; Cycloserine; Ethionamide; Humans; Isoniazid; Prospective Studies; Pyrazina | 1968 |
[Preliminary clinical experiments with thioamid of alpha-propyl-isonocotinic acid (Trevintix) in pulmonary tuberculosis].
Topics: Adolescent; Adult; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Tolerance; | 1969 |
A four-year follow-up of patients with quiescent pulmonary tuberculosis at the end of a year of chemotherapy with twice-weekly isoniazid plus streptomycin or daily isoniazid plus pas.
Topics: Aminosalicylic Acids; Body Weight; Clinical Trials as Topic; Drug Resistance, Microbial; Follow-Up S | 1969 |
A controlled comparison of four regimens of streptomycin plus pyrazinamide in the retreatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Aspartate Aminotransferases; Clinical Trials as Topic; Drug Resistance, Microbial | 1969 |
Comparative controlled trial of rimactane in pulmonary tuberculosis.
Topics: Adolescent; Adult; Blood Sedimentation; Body Weight; Clinical Trials as Topic; Drug Synergism; Femal | 1969 |
A clinical trial of ethambutol plus capreomycin in the treatment of atypical tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Cycloserine; Ethambutol; Ethionamide; | 1969 |
Controlled chemoprophylaxis trials in tuberculosis. A general review.
Topics: Adolescent; Adult; Age Factors; Alaska; Anemia; Child; Child, Preschool; Clinical Trials as Topic; D | 1970 |
The effect of isoniazid on performance in school.
Topics: Achievement; Adolescent; Age Factors; Body Weight; Child; Clinical Trials as Topic; Ethnicity; Femal | 1970 |
Rifampicin in newly detected, untreated cases of pulmonary tuberculosis.
Topics: Clinical Trials as Topic; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Humans; Isoniazid; | 1969 |
Controlled study on rifampicin in first treatment of fresh cases of pulmonary tuberculosis.
Topics: Body Weight; Clinical Trials as Topic; Drug Synergism; Ethambutol; Humans; Isoniazid; Rifampin; Stre | 1969 |
A cooperative study on rifampicin in original treatment of advanced pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Ethambutol; Humans; Isoniazid; Middle Aged; Rifam | 1969 |
[Initial provisional record of a controlled trial of isoniazid-rifomycin-thiocarlide versus isoniazid-streptomycin-thiocarlide in active pulmonary tuberculosis not yet treated].
Topics: Clinical Trials as Topic; Drug Synergism; Humans; Isoniazid; Phenylthiourea; Rifampin; Streptomycin; | 1969 |
Aspects of the tuberculosis situation in Denmark, especially chemoresistance.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Denmark; Follow-Up Studies; Humans; Isoniazid; Strep | 1969 |
[56 recent pulmonary tuberculosis cases treated with combined rifampicin-isoniazid in a controlled experiment].
Topics: Adult; Clinical Trials as Topic; Drug Synergism; Female; Humans; Isoniazid; Male; Rifampin; Tubercul | 1969 |
[Reduction of fresh forms of pulmonary tuberculosis by the classical treatment and by combined antibiotics including rifampicin (comparative study of a personal survey)].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Clinical Trials as Topic; Drug Synergism; Ethamb | 1969 |
[Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
Topics: Adult; Aminosalicylic Acids; Clinical Trials as Topic; Female; Humans; Isoniazid; Male; Rifampin; St | 1970 |
Clinical applications of ethambutol.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Child, Preschool; Clinical Trials as Topic; Cycloseri | 1969 |
Estimating the population consuming isoniazid by urine test.
Topics: Administration, Oral; Age Factors; Clinical Trials as Topic; Humans; Isoniazid; Methods; Placebos; T | 1971 |
Computer-aided procedures in a multi-centre co-operative controlled clinical trial in pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Computers; Drug Resistance, Microbial; Ethambutol; H | 1971 |
Controlled clinical trials with Isoxyl.
Topics: Clinical Trials as Topic; Cycloserine; Drug Combinations; Drug Synergism; Ethionamide; Evaluation St | 1970 |
Clinical data on 4-4' diisoamyloxythiocarbanilide (Isoxyl).
Topics: Adult; Clinical Trials as Topic; Drug Combinations; Drug Synergism; Female; Humans; Isoniazid; Lung; | 1970 |
On the clinical effectiveness of Isoxyl.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Drug Combinations; Drug Resistance, Microbial; Drug | 1970 |
Sputum excretion of tubercle bacilli as early criterion in the evaluation of the therapeutic effectiveness of antituberculous drugs, illustrated by its use in a controlled trial of single-drug regimens.
Topics: Administration, Oral; Adult; Aminosalicylic Acids; Antitubercular Agents; Clinical Trials as Topic; | 1970 |
A comparative study of daily and twice-weekly continuation regimens of tuberculosis chemotherapy, including a comparison of two durations of sanatorium treatment. 1. First report: the results at 12 months.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Clinical Trials as Topic; Czechoslovakia; Drug Combin | 1971 |
Effects of chemoprophylaxis on minimal pulmonary tuberculosis lesions of doubtful activity.
Topics: Adolescent; Adult; Clinical Trials as Topic; Female; Humans; India; Isoniazid; Male; Middle Aged; Pl | 1971 |
Two controlled studies of the efficacy of isoniazid alone in preventing relapse in patients with bacteriologically quiescent pulmonary tuberculosis at the end of one year of chemotherapy.
Topics: Clinical Trials as Topic; Follow-Up Studies; Humans; India; Isoniazid; Recurrence; Tuberculosis, Pul | 1971 |
Results and tolerance of prolonged rifampicin treatment in recent and chronic forms of pulmonary tuberculosis.
Topics: Chronic Disease; Clinical Trials as Topic; Drug Combinations; Drug Resistance, Microbial; Ethambutol | 1971 |
Comparison of single and divided daily doses of isoniazid in original treatment of minimal and noncavitary moderately advanced pulmonary tuberculosis. XVIII. A report of the Veterans Administration-Armed Forces Cooperative Study on the chemotherapy of tub
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Drug Administration Schedule; Female; Follow-Up Studies | 1967 |
Comparison of single and divided daily dosages of isoniazid and PAS in the treatment of pulmonary tuberculosis. XV. A report of the Veterans Administration-Armed Forces Cooperative. Study on the chemotherapy of tuberculosis.
Topics: Adult; Aged; Aminosalicylic Acids; Clinical Trials as Topic; Humans; Isoniazid; Male; Middle Aged; M | 1966 |
Madras study of supervised once-weekly chemotherapy in the treatment of pulmonary tuberculosis: laboratory aspects.
Topics: Clinical Trials as Topic; Drug Resistance, Microbial; Drug Synergism; Humans; India; Isoniazid; Myco | 1968 |
[Comparative results of treatment of pulmonary tuberculosis with the compounds of benzoyl-PAS-Ca-isoniazide and streptomycin-isoniazid].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Drug Synergism; Humans; Iso | 1969 |
A controlled clinical trial of the drug treatment of new cases of pulmonary tuberculosis.
Topics: Adolescent; Adult; Aminosalicylic Acids; Clinical Trials as Topic; Follow-Up Studies; Humans; Isonia | 1968 |
[Changes in the bacteriologic findings in patients treated with rifomycin, alone or associated with other drugs].
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Humans; Isoniazid; Myc | 1968 |
Rifampin in initial treatment of pulmonary tuberculosis. A U.S. Public Health Service tuberculosis therapy trial.
Topics: Administration, Oral; Adolescent; Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Amino | 1971 |
The Australian rifampicin trial.
Topics: Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Clinical Trials as Topic; Eosinophilia | 1971 |
Results of rifampicin in 25 treated patients.
Topics: Clinical Trials as Topic; Drug Combinations; Humans; Isoniazid; Mycobacterium tuberculosis; Preopera | 1971 |
Rifampicin, ethambutol, ethionamide and hydronsan in advanced pulmonary tuberculosis.
Topics: Adolescent; Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubi | 1972 |
Ethambutol/INH. in the initial treatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Aminosalicylic Acids; Costs and Cost Analysis; Ethambutol; Female; Humans; Isonia | 1971 |
A 5-year study of patients with pulmonary tuberculosis in a concurrent comparison of home and sanatorium treatment for one year with isoniazid plus PAS.
Topics: Aminosalicylic Acids; Follow-Up Studies; Home Care Services; Humans; India; Isoniazid; Tuberculosis, | 1966 |
The place of BCG vaccine in the management of infants born of tuberculous mothers.
Topics: Adolescent; Adult; BCG Vaccine; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; | 1969 |
[Preliminary observations on the therapeutic effect of rifampycin associated with streptomycin or isoniazid].
Topics: Adolescent; Adult; Drug Synergism; Humans; Isoniazid; Male; Radiography; Rifampin; Streptomycin; Tub | 1968 |
A controlled comparison of a twice-weekly and three once-weekly regimens in the initial treatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Child; Humans; India; Isoniazid; Microbial Sensitivity Tests; Middle Aged; Pyrazi | 1970 |
Chemoprophylaxis of tuberculosis: when is the benefit worth the risk and cost?
Topics: Adolescent; Adult; Chemical and Drug Induced Liver Injury; Child; Costs and Cost Analysis; Denmark; | 1971 |
[The influence of the simultaneous administration of 5-bromosalicylohydroxamic acid (T-40) and isonicotinic acid hydrazide on the concentration of free isonicotinic acid hydrazide in the urine of patients with pulmonary tuberculosis].
Topics: Antitubercular Agents; Clinical Trials as Topic; Humans; Isoniazid; Metabolism; Tuberculosis, Pulmon | 1965 |
The use of isoniazid among household contacts of open cases of pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Infant; | 1965 |
[On therapeutic effects of morphazinamide, used alone and in association, in recent and chronic pulmonary tuberculosis].
Topics: Antitubercular Agents; Clinical Trials as Topic; Cycloserine; Humans; Isoniazid; Pyrazines; Tubercul | 1965 |
[Combined streptomycin and isoniazid in high weekly doses in pulmonary tuberculosis].
Topics: Clinical Trials as Topic; Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1965 |
Clinical evaluation of ethambutol in pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Blood; Clinical Trials as Topic; Drug Resistance, Microbial; Ethambuto | 1966 |
Ethionamide, 500 mg. daily, plus isoniazid, 500 mg. or 300 mg. daily in previously untreated patients with pulmonary tuberculosis.
Topics: Clinical Trials as Topic; Ethionamide; Humans; Isoniazid; Tuberculosis, Pulmonary | 1967 |
Prednisone as an adjunct in the chemotherapy of lymph node-bronchial tuberculosis in childhood: a double-blind study. II. Further term observation.
Topics: Aminosalicylic Acids; Bronchial Diseases; Bronchoscopy; Child; Child, Preschool; Clinical Trials as | 1967 |
Epidemiological basis of tuberculosis eradication. 4. The isoniazid trial in Greenland.
Topics: Adolescent; Adult; Clinical Trials as Topic; Follow-Up Studies; Greenland; Humans; Isoniazid; Placeb | 1966 |
Corticosteroids in pulmonary tuberculosis. II. Importance of background factors.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Humans; Isoniazid; Methylprednisolone; Placebos; Tub | 1967 |
Corticosteroids in pulmonary tuberculosis. 3. Indications.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Humans; Isoniazid; Methylprednisolone; Placebos; Tub | 1967 |
Results and randomized original treatment in cases of pulmonary tuberculosis with isoniazid-streptomycin versus isoniazid-thiocarlide.
Topics: Adolescent; Adult; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Middle Aged; Phenylt | 1970 |
A comparative trial with combinations of rifampicin, ethambutol and isoniazid (Hydronsan) in previously untreated cases of pulmonary tuberculosis.
Topics: Adolescent; Adult; Drug Synergism; Ethambutol; Female; Humans; Isoniazid; Liver Function Tests; Male | 1971 |
[Comparative results of medium and increased doses of isoniazid in the triple treatment of overt pulmonary tuberculosis].
Topics: Adult; Culture Techniques; Drug Synergism; Female; Humans; Isoniazid; Male; Middle Aged; Phenylthiou | 1968 |
Comparison of ethionamide with isoniazid in original treatment cases of pulmonary tuberculosis. XIV. A report of the Veterans Administration--Armed Forces cooperative study.
Topics: Adult; Aged; Ethionamide; Humans; Isoniazid; Middle Aged; Streptomycin; Tuberculosis, Pulmonary | 1966 |
4204 other studies available for isoniazid and Pulmonary Consumption
| Article | Year |
|---|---|
Synthesis and evaluation of nitrofuranylamides as novel antituberculosis agents.
Topics: Amides; Animals; Antitubercular Agents; Databases, Factual; Furans; Intramolecular Transferases; Mic | 2004 |
Synthesis and evaluation of cyclic secondary amine substituted phenyl and benzyl nitrofuranyl amides as novel antituberculosis agents.
Topics: Administration, Oral; Animals; Antitubercular Agents; Benzamides; Biological Availability; Drug Eval | 2005 |
Identification of new diamine scaffolds with activity against Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Biological Availability; Combinatorial Chemistry Techniques; Diamine | 2006 |
Synergistic activity of R207910 combined with pyrazinamide against murine tuberculosis.
Topics: Animals; Antitubercular Agents; Colony Count, Microbial; Diarylquinolines; Drug Synergism; Female; L | 2007 |
Evaluation of a 2-pyridone, KRQ-10018, against Mycobacterium tuberculosis in vitro and in vivo.
Topics: Animals; Antitubercular Agents; Biological Availability; Interferon-gamma; Mice; Mice, Inbred C57BL; | 2008 |
Efficacy of quinoxaline-2-carboxylate 1,4-di-N-oxide derivatives in experimental tuberculosis.
Topics: Animals; Antitubercular Agents; Cyclic N-Oxides; Disease Models, Animal; Drug Resistance, Bacterial; | 2008 |
Metronidazole lacks antibacterial activity in guinea pigs infected with Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Colony Count, Microbial; Female; Guinea Pigs; Isoniazid; Lung; Metro | 2008 |
Fast standardized therapeutic-efficacy assay for drug discovery against tuberculosis.
Topics: Acetamides; Animals; Antitubercular Agents; Aza Compounds; Disease Models, Animal; Drug Discovery; E | 2010 |
Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis.
Topics: Acute Disease; Administration, Oral; Animals; Antitubercular Agents; Bacterial Proteins; Biological | 2014 |
Synthesis of novel 1,2,3-triazole derivatives of isoniazid and their in vitro and in vivo antimycobacterial activity evaluation.
Topics: Animals; Antitubercular Agents; Dose-Response Relationship, Drug; Isoniazid; Mice; Microbial Sensiti | 2014 |
Discovery and preclinical evaluations of JBD0131, a novel nitrodihydro-imidazooxazole anti-tuberculosis agent.
Topics: Antitubercular Agents; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, | 2022 |
Early phase of effective treatment induces distinct transcriptional changes in Mycobacterium tuberculosis expelled by pulmonary tuberculosis patients.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosi | 2021 |
Application of loop-mediated isothermal amplification and next-generation sequencing in the diagnosis of maternal tuberculosis with multiple negative tests: A case report.
Topics: Adult; Antibiotics, Antitubercular; Female; High-Throughput Nucleotide Sequencing; Humans; Infant, N | 2021 |
Evaluation of Berberine as an Adjunct to TB Treatment.
Topics: Animals; Antitubercular Agents; Berberine; Cytokines; Dendritic Cells; Drug Therapy, Combination; Fe | 2021 |
Microencapsulated Isoniazid-Loaded Metal-Organic Frameworks for Pulmonary Administration of Antituberculosis Drugs.
Topics: A549 Cells; Administration, Inhalation; Antitubercular Agents; Capsules; Cell Survival; Dose-Respons | 2021 |
Evaluation of diagnostic components and management of childhood pulmonary tuberculosis: a prospective study from Istanbul, Turkey.
Topics: Humans; Isoniazid; Prospective Studies; Tuberculin Test; Tuberculosis; Tuberculosis, Pulmonary; Turk | 2022 |
Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis - United States, 2022.
Topics: Antitubercular Agents; Centers for Disease Control and Prevention, U.S.; Drug Administration Schedul | 2022 |
Time to start of tuberculosis treatment in penitentiary system of Kyrgyz Republic: A retrospective cohort study.
Topics: Humans; Isoniazid; Kyrgyzstan; Mycobacterium tuberculosis; Prisons; Retrospective Studies; Rifampin; | 2022 |
High Intrapulmonary Rifampicin and Isoniazid Concentrations Are Associated With Rapid Sputum Bacillary Clearance in Patients With Pulmonary Tuberculosis.
Topics: Adult; Antitubercular Agents; Bacillus; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Sputu | 2022 |
Barriers and facilitators for isoniazid preventive therapy (IPT) administration in children under 5 years of age in the Dominican Republic.
Topics: Antitubercular Agents; Child; Child, Preschool; Dominican Republic; HIV Infections; Humans; Isoniazi | 2022 |
Drug concentration at the site of disease in children with pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Child; Ethambutol; Humans; Infant; Isoniazid; Pyrazinamide; South Afri | 2022 |
Intelligence Classification Algorithm-Based Drug-Resistant Pulmonary Tuberculosis Computed Tomography Imaging Features and Influencing Factors.
Topics: Adult; Algorithms; Antitubercular Agents; Humans; Intelligence; Isoniazid; Lung; Middle Aged; Rifamp | 2022 |
Early line-probe assay using DNA specimens in patients with pulmonary TB.
Topics: DNA; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculo | 2022 |
Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis.
Topics: Antitubercular Agents; Arylamine N-Acetyltransferase; Ethionamide; Humans; Isoniazid; Mycobacterium | 2022 |
Increasing TB preventive treatment in children.
Topics: Antibiotic Prophylaxis; Antitubercular Agents; Child; Humans; Isoniazid; Tuberculosis, Pulmonary | 2022 |
Distribution and Pattern of Anti-Tubercular Drug Resistance in Patients with Pulmonary Tuberculosis in Mymensingh Region of Bangladesh.
Topics: Antitubercular Agents; Bangladesh; Cross-Sectional Studies; Drug Resistance; Ethambutol; Humans; Iso | 2022 |
Feasibility, Ease-of-Use, and Operational Characteristics of World Health Organization-Recommended Moderate-Complexity Automated Nucleic Acid Amplification Tests for the Detection of Tuberculosis and Resistance to Rifampicin and Isoniazid.
Topics: Feasibility Studies; Humans; Isoniazid; Mycobacterium tuberculosis; Nucleic Acid Amplification Techn | 2023 |
Untargeted metabolomics of pulmonary tuberculosis patient serum reveals potential prognostic markers of both latent infection and outcome.
Topics: Chromatography, Liquid; Humans; Isoniazid; Latent Infection; Prognosis; Rifampin; Tandem Mass Spectr | 2022 |
Untargeted metabolomics of pulmonary tuberculosis patient serum reveals potential prognostic markers of both latent infection and outcome.
Topics: Chromatography, Liquid; Humans; Isoniazid; Latent Infection; Prognosis; Rifampin; Tandem Mass Spectr | 2022 |
Untargeted metabolomics of pulmonary tuberculosis patient serum reveals potential prognostic markers of both latent infection and outcome.
Topics: Chromatography, Liquid; Humans; Isoniazid; Latent Infection; Prognosis; Rifampin; Tandem Mass Spectr | 2022 |
Untargeted metabolomics of pulmonary tuberculosis patient serum reveals potential prognostic markers of both latent infection and outcome.
Topics: Chromatography, Liquid; Humans; Isoniazid; Latent Infection; Prognosis; Rifampin; Tandem Mass Spectr | 2022 |
Implementation of an integrated care strategy for child contacts of tuberculosis patients: a quasi-experimental study protocol.
Topics: Child; Child, Preschool; Delivery of Health Care, Integrated; Humans; Isoniazid; Latent Tuberculosis | 2023 |
Prevalence of latent tuberculosis infection and incidence of tuberculin conversion among school contacts older than 5 years in the City of Buenos Aires.
Topics: Adolescent; Child; Humans; Incidence; Isoniazid; Latent Tuberculosis; Prevalence; Tuberculin; Tuberc | 2023 |
Initiation and adherence to isoniazid preventive therapy in children under 5 years of age in Manhiça, Southern Mozambique.
Topics: Adult; Antitubercular Agents; Child; Child, Preschool; Health Facilities; HIV Infections; Humans; Is | 2022 |
Real-world experience of adverse reactions-necessitated rifampicin-sparing treatment for drug-susceptible pulmonary tuberculosis.
Topics: Ethambutol; Fluoroquinolones; Humans; Isoniazid; Retrospective Studies; Rifampin; Tuberculosis, Pulm | 2023 |
Evaluation of treatment regimens and long-term clinical outcomes in patients with isoniazid-resistant pulmonary tuberculosis: a 5-year follow-up.
Topics: Antitubercular Agents; Follow-Up Studies; Humans; Isoniazid; Recurrence; Retrospective Studies; Trea | 2023 |
Molecular diversity of Mycobacterium tuberculosis isolates in Treatment-experienced Patients from Andhra Pradesh, India.
Topics: Humans; India; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Pul | 2023 |
Clinical performance of nucleotide MALDI-TOF-MS in the rapid diagnosis of pulmonary tuberculosis and drug resistance.
Topics: Drug Resistance; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Nucleotides; Rifampin; S | 2023 |
Community-supported self-administered tuberculosis treatment combined with active tuberculosis screening: a pilot experience in Conakry, Guinea.
Topics: Antitubercular Agents; Child; Child, Preschool; Female; Guinea; Humans; Isoniazid; Male; Tuberculosi | 2023 |
Influence of sex on the exposure to isoniazid in patients with pulmonary tuberculosis.
Topics: Acetyltransferases; Antitubercular Agents; Female; Humans; Isoniazid; Male; Phenotype; Tuberculosis, | 2023 |
Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in China.
Topics: Adult; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Bacterial Proteins; Catalas | 2020 |
Individualising therapy for drug-sensitive tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Is | 2019 |
Can phenotypic data complement our understanding of antimycobacterial effects for drug combinations?
Topics: Antitubercular Agents; Isoniazid; Logistic Models; Microbial Viability; Models, Theoretical; Mycobac | 2019 |
Effect of diabetes mellitus on TB drug concentrations in Tanzanian patients.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Diabetes Complications; Diabetes Mellitus; Fe | 2019 |
Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Bacterial Load; Diagnostic Tests, Routine; Drug Ther | 2019 |
Lack of Weight Gain During the First 2 Months of Treatment and Human Immunodeficiency Virus Independently Predict Unsuccessful Treatment Outcomes in Tuberculosis.
Topics: Adult; Antitubercular Agents; Brazil; Ethambutol; Female; HIV Seropositivity; Humans; Isoniazid; Mal | 2020 |
Contact evaluation and isoniazid preventive therapy among close and household contacts of tuberculosis patients in Lima, Peru: an analysis of routine data.
Topics: Adolescent; Antitubercular Agents; Child; Child Health Services; Child, Preschool; Contact Tracing; | 2020 |
Effect of Liposomal Delivery of Oxidized Dextran with Isonicotinic Acid Hydrazide on Component Profile of Pulmonary Extracellular Matrix in Mice with BCG-Induced Granulomatosis.
Topics: Animals; BCG Vaccine; Dextrans; Extracellular Matrix; Glycosaminoglycans; Granuloma, Respiratory Tra | 2019 |
Remodeling of the Extracellular Matrix of the Liver in Mice with BCG-Induced Granulomatosis after Administration of Liposome-Encapsulated Composition of Oxidized Dextran and Isonicotinic Acid Hydrazide.
Topics: Animals; BCG Vaccine; Collagen; Dextrans; Extracellular Matrix; Hyaluronoglucosaminidase; Hydroxypro | 2019 |
Phenotypic isoniazid resistance and associated mutations in pediatric tuberculosis.
Topics: Antitubercular Agents; Child; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Female; | 2019 |
Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
Topics: Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, | 2020 |
Evaluation of the BD MAX™ MDR-TB assay in a real-world setting for the diagnosis of pulmonary and extra-pulmonary TB.
Topics: Antibiotics, Antitubercular; Drug Resistance, Bacterial; Female; Humans; Isoniazid; Male; Microbial | 2020 |
Improved Mycobacterium tuberculosis clearance after the restoration of IFN-γ
Topics: Adolescent; Adult; Animals; Antibodies; Antitubercular Agents; Bacterial Load; CD4-Positive T-Lympho | 2020 |
Incidence, treatment, and outcomes of isoniazid mono-resistant Mycobacterium tuberculosis infections in Alberta, Canada from 2007-2017.
Topics: Adult; Alberta; Antitubercular Agents; Cohort Studies; Drug Resistance, Bacterial; Emigrants and Imm | 2020 |
Treatment outcome of tuberculosis treatment regimens in Kandahar, Afghanistan.
Topics: Adolescent; Adult; Afghanistan; Antitubercular Agents; Cohort Studies; Cough; Drug Therapy, Combinat | 2020 |
Genetic diversity and drug resistance pattern of Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients in the Benishangul Gumuz region and its surroundings, Northwest Ethiopia.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Multiple, | 2020 |
Efficacy of Inhalations of Antituberculous Compositions with Different Length of Experimental Therapy Course in Mice.
Topics: Administration, Inhalation; Animals; Antitubercular Agents; Dextrans; Disease Models, Animal; Drug A | 2020 |
Simultaneous detection of Mycobacterium tuberculosis complex and resistance to Rifampicin and Isoniazid by MDR/MTB ELITe MGB® Kit for the diagnosis of tuberculosis.
Topics: Antibiotics, Antitubercular; Biopsy; Drug Resistance, Bacterial; Genotype; Humans; Isoniazid; Microb | 2020 |
Antifibrotics Effect of Liposome-Encapsulated Composition of Oxidized Dextran and Isonicotinic Acid Hydrazide in Mice with BCG-Induced Granulomatosis Depends on Administration Route.
Topics: Animals; Antitubercular Agents; BCG Vaccine; Dextrans; Drug Compounding; Granuloma, Respiratory Trac | 2020 |
Location of Pulmonary Mycobacteria Tuberculosis and Effectiveness of Various Dextrazide Compositions in Treatment of Mice with BCG-Induced Granulomatosis.
Topics: Animals; Antitubercular Agents; BCG Vaccine; Dextrans; Drug Combinations; Granuloma, Respiratory Tra | 2020 |
Mesenchymal stem cells offer a drug-tolerant and immune-privileged niche to Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Cells, Cult | 2020 |
Awareness and perspectives on expansion of latent TB management among public-sector physicians and medical trainees in Delhi, India.
Topics: Adult; Antitubercular Agents; Attitude of Health Personnel; Clinical Competence; Cross-Sectional Stu | 2020 |
An Unexpected Cause of Conjunctivitis in an Adolescent.
Topics: Adolescent; Antitubercular Agents; Conjunctivitis; Diagnosis, Differential; Ethambutol; Glucocortico | 2020 |
Machine learning reveals that Mycobacterium tuberculosis genotypes and anatomic disease site impacts drug resistance and disease transmission among patients with proven extra-pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Drug Resistance, Bacterial; Fem | 2020 |
Performance of the Roche cobas MTB Assay for the Molecular Diagnosis of Pulmonary Tuberculosis in a High HIV Burden Setting.
Topics: Adolescent; Adult; Aged; Biological Assay; Cohort Studies; Cost of Illness; Female; HIV Infections; | 2020 |
Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Cross-Sectional Studies; Ethiopia | 2020 |
A case series of three patients presenting with isoniazid induced toxicity and N-acetyl transferase 2 gene mutation: A management conundrum for programmatic therapy of tuberculosis in India.
Topics: Adolescent; Adult; Antitubercular Agents; Arylamine N-Acetyltransferase; Chemical and Drug Induced L | 2020 |
Complication of Mycobacterium tuberculosis treatment: Isoniazid-induced pneumonitis.
Topics: Adult; Antitubercular Agents; Bronchoscopy; Duration of Therapy; Humans; Isoniazid; Lung; Male; Myco | 2020 |
Effect of interval between food intake and drug administration at fasting condition on the plasma concentrations of first-line anti-tuberculosis drugs in Chinese population.
Topics: Administration, Oral; Adult; Antitubercular Agents; China; Drug Administration Schedule; Eating; Eth | 2020 |
Transmission analysis of a large tuberculosis outbreak in London: a mathematical modelling study using genomic data.
Topics: Antitubercular Agents; Disease Outbreaks; Drug Resistance, Bacterial; Genome, Bacterial; High-Throug | 2020 |
Evaluation of 6-Month Versus Continuous Isoniazid Preventive Therapy for Mycobacterium tuberculosis in Adults Living With HIV/AIDS in Malawi.
Topics: Adult; Antitubercular Agents; Drug Administration Schedule; HIV Infections; Humans; Incidence; Isoni | 2020 |
Variations in rifampicin and isoniazid resistance associated genetic mutations among drug naïve and recurrence cases of pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Male; | 2021 |
Genetic diversity of the Mycobacterium tuberculosis complex strains from newly diagnosed tuberculosis patients in Northwest Ethiopia reveals a predominance of East-African-Indian and Euro-American lineages.
Topics: Adult; Africa, Eastern; Americas; Animals; Drug Resistance, Bacterial; Ethiopia; Female; Genetic Var | 2021 |
Treatment outcomes and factors associated with unfavourable outcome among previously treated tuberculosis patients with isoniazid resistance in four regions of Cameroon.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Cameroon; Child; Child, Preschool | 2020 |
Accuracy of molecular drug susceptibility testing amongst tuberculosis patients in Karakalpakstan, Uzbekistan.
Topics: Antibiotics, Antitubercular; Capreomycin; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Ison | 2021 |
A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis.
Topics: Area Under Curve; Drug Monitoring; Humans; Isoniazid; Specimen Handling; Tuberculosis, Pulmonary | 2021 |
Closing the loop in child TB contact management: completion of TB preventive therapy outcomes in western Kenya.
Topics: Antitubercular Agents; Child; HIV Infections; Humans; Isoniazid; Kenya; Retrospective Studies; Tuber | 2021 |
Pulmonary tuberculosis screening in anti-retroviral treated adults living with HIV in Kenya.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Female; | 2021 |
Biofilm formation in the lung contributes to virulence and drug tolerance of Mycobacterium tuberculosis.
Topics: Animals; Biofilms; Cellulase; Cellulose; Disease Models, Animal; Drug Resistance, Multiple, Bacteria | 2021 |
Cytocompatibility and cellular interactions of chondroitin sulfate microparticles designed for inhaled tuberculosis treatment.
Topics: Administration, Inhalation; Animals; Antitubercular Agents; Cell Line; Chondroitin Sulfates; Drug Ca | 2021 |
Low uptake of isoniazid window prophylaxis in patients exposed to a health-care worker with pulmonary tuberculosis in a paediatric ward.
Topics: Child; Child, Preschool; Humans; Infant; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculo | 2021 |
Sputum microbiota as a potential diagnostic marker for multidrug-resistant tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; DNA, Bacterial; Female; Humans; Isoniazid; Male; Mic | 2021 |
Five-year microevolution of a multidrug-resistant Mycobacterium tuberculosis strain within a patient with inadequate compliance to treatment.
Topics: Adult; Antitubercular Agents; Argentina; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoni | 2021 |
Molecular epidemiology and drug-resistance of tuberculosis in Luodian revealed by whole genome sequencing.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; China; Drug Resistance, Bacterial | 2021 |
A Clinical Prediction Model for Unsuccessful Pulmonary Tuberculosis Treatment Outcomes.
Topics: Antitubercular Agents; HIV Infections; Humans; Isoniazid; Models, Statistical; Prognosis; Treatment | 2022 |
WNT6/ACC2-induced storage of triacylglycerols in macrophages is exploited by Mycobacterium tuberculosis.
Topics: Acetyl-CoA Carboxylase; Animals; Antitubercular Agents; Enzyme Inhibitors; Foam Cells; Host Microbia | 2021 |
Distribution and antibiotic sensitivity pattern of Mycobacterium tuberculosis isolates from children, enrolled in a tertiary care hospital.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Ethambutol; Humans; Infant; Infant, Newb | 2021 |
Direct Detection of Rifampin and Isoniazid Resistance in Sputum Samples from Tuberculosis Patients by High-Resolution Melt Curve Analysis.
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Bacterial; Fatty Acid Synthesis Inhibitors; | 2017 |
Association of CYP2B6 gene polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese population.
Topics: Adult; Alleles; Antitubercular Agents; Asian People; Chemical and Drug Induced Liver Injury; Cytochr | 2017 |
Assessments of serum copper and zinc concentration, and the Cu/Zn ratio determination in patients with multidrug resistant pulmonary tuberculosis (MDR-TB) in Côte d'Ivoire.
Topics: Adolescent; Adult; Antitubercular Agents; Copper; Cote d'Ivoire; Female; Humans; Isoniazid; Male; Mi | 2017 |
Metformin Adjunctive Therapy Does Not Improve the Sterilizing Activity of the First-Line Antitubercular Regimen in Mice.
Topics: Animals; Antitubercular Agents; Bacterial Load; Disease Models, Animal; Drug Synergism; Drug Therapy | 2017 |
Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study.
Topics: Adult; Antitubercular Agents; Bacterial Proteins; Cameroon; Cross-Sectional Studies; Female; Genotyp | 2017 |
Poncet's disease in human immunodeficiency virus: a case report.
Topics: Adult; Antibiotics, Antitubercular; Antiretroviral Therapy, Highly Active; Arthritis, Reactive; Etha | 2017 |
Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Drug Combinations; Ethambutol; HIV Infections | 2017 |
Assessment of treatment response by colony forming units, time to culture positivity and the molecular bacterial load assay compared in a mouse tuberculosis model.
Topics: Animals; Antitubercular Agents; Bacterial Load; Colony Count, Microbial; Disease Models, Animal; DNA | 2017 |
Efficacy of ultra-short course chemotherapy for new smear positive drug susceptible pulmonary tuberculosis: study protocol of a multicenter randomized controlled clinical trial.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Human | 2017 |
Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy.
Topics: Animals; Antitubercular Agents; Clostridiales; Drug Combinations; Dysbiosis; Gastrointestinal Microb | 2017 |
Massive choroidal granuloma as the presenting feature of disseminated tuberculosis in immunocompetent patients.
Topics: Adolescent; Adult; Antitubercular Agents; Choroid Diseases; Drug Combinations; Ethambutol; Female; G | 2018 |
Serum levels of soluble urokinase plasminogen activator receptor (suPAR) as a marker of tuberculosis treatment efficacy.
Topics: Adult; Aged; Antitubercular Agents; Biomarkers; Drug Monitoring; Drug Therapy, Combination; Ethambut | 2017 |
Band pattern analysis of mutations in rifampicin resistance strain of Mycobacterium tuberculosis by Line Probe assay in patients from Delhi, India.
Topics: Antibiotics, Antitubercular; Bacterial Proteins; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug | 2017 |
Effect of Isoniazid Resistance on the Tuberculosis Treatment Outcome.
Topics: Adult; Antitubercular Agents; Drug Resistance, Bacterial; Female; Humans; Isoniazid; Male; Microbial | 2018 |
Rapid identification of a Mycobacterium tuberculosis full genetic drug resistance profile through whole genome sequencing directly from sputum.
Topics: Adult; Antitubercular Agents; Drug Resistance, Bacterial; Female; Humans; Isoniazid; Mutation; Mycob | 2017 |
Assessment of Bactericidal Drug Activity and Treatment Outcome in a Mouse Tuberculosis Model Using a Clinical Beijing Strain.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Femal | 2017 |
Prospective cohort study of the feasibility and yield of household child tuberculosis contact screening in Uganda.
Topics: Algorithms; Antitubercular Agents; Child, Preschool; Cohort Studies; Contact Tracing; Cough; Feasibi | 2017 |
NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humans.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Fibrosis; Foam Cells; Humans; Hypoxia; Isoni | 2017 |
A community-based isoniazid preventive therapy for the prevention of childhood tuberculosis in Ethiopia.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Contact Tracing; Ethiopia; Family Charac | 2017 |
The clinical recovery of tuberculosis patients undergoing specific treatment is associated with changes in the immune and neuroendocrine responses.
Topics: Adult; Antitubercular Agents; C-Reactive Protein; Case-Control Studies; Dehydroepiandrosterone; Etha | 2017 |
Cohort profile of a study on outcomes related to tuberculosis and antiretroviral drug concentrations in Uganda: design, methods and patient characteristics of the SOUTH study.
Topics: Adult; Anti-Retroviral Agents; Antitubercular Agents; Biomedical Research; CD4 Lymphocyte Count; Coh | 2017 |
Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence.
Topics: Adult; Anti-Retroviral Agents; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Female; | 2017 |
Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis.
Topics: Adult; Age Distribution; Aged; Alcohol Drinking; Aminosalicylic Acid; Antitubercular Agents; Cohort | 2017 |
Assessment and management of active and latent TB.
Topics: Antitubercular Agents; Contact Tracing; Humans; Isoniazid; Latent Tuberculosis; Mass Screening; Prac | 2016 |
TB-PCR and drug resistance pattern in BALF in smear-negative active pulmonary TB.
Topics: Adult; Aged; Antitubercular Agents; Bronchoalveolar Lavage Fluid; Drug Resistance, Bacterial; Female | 2017 |
Time to Sputum Culture Conversion and Treatment Outcomes Among Patients with Isoniazid-Resistant Tuberculosis in Atlanta, Georgia.
Topics: Adult; Antitubercular Agents; Cohort Studies; Drug Therapy, Combination; Female; Fluoroquinolones; H | 2017 |
High-dose isoniazid in the shorter-course multidrug-resistant tuberculosis regimen in the Republic of Moldova.
Topics: Antitubercular Agents; Humans; Isoniazid; Moldova; Mycobacterium tuberculosis; Rifampin; Tuberculosi | 2017 |
Review of people with retinal vasculitis and positive QuantiFERON
Topics: Adolescent; Adult; Antitubercular Agents; Child; Female; Glucocorticoids; Humans; Interferon-gamma R | 2018 |
Genetic diversity of multidrug-resistant Mycobacterium tuberculosis strains isolated from tuberculosis patients in Iran using MIRU-VNTR technique.
Topics: Alleles; Antitubercular Agents; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genetic Loci; | 2017 |
Prescription practice of anti-tuberculosis drugs in Yunnan, China: A clinical audit.
Topics: Adult; Aged; Antitubercular Agents; Asian People; China; Clinical Audit; Ethambutol; Female; Fluoroq | 2017 |
Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis.
Topics: Anti-HIV Agents; Antitubercular Agents; Child; Drug Administration Schedule; Drug Combinations; Drug | 2018 |
Outcomes of pulmonary tuberculosis in patients with discordant phenotypic isoniazid resistance testing.
Topics: Aged; Antitubercular Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Fema | 2017 |
A retrospective study on tuberculosis treatment outcomes at Jinka General Hospital, southern Ethiopia.
Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Drug Combinations; Ethambutol; Ethiopia; Fema | 2017 |
A Painful Red Eye.
Topics: Alcoholism; Antitubercular Agents; Conjunctival Diseases; Ethambutol; Eye Pain; Glucocorticoids; Hum | 2018 |
Treatment outcomes and tolerability of the revised WHO anti-tuberculosis drug dosages for children.
Topics: Antitubercular Agents; Child, Preschool; Cohort Studies; Female; HIV Infections; Humans; Infant; Inf | 2018 |
Antituberculosis Treatment in a Patient with Celiac Disease.
Topics: Aged; Antitubercular Agents; Celiac Disease; Diarrhea; Diet, Gluten-Free; Drug Compounding; Drug Sub | 2018 |
Molecular epidemiology and drug sensitivity pattern of Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients in and around Ambo Town, Central Ethiopia.
Topics: Adolescent; Adult; Cross-Sectional Studies; Ethambutol; Ethiopia; Female; Humans; Isoniazid; Male; M | 2018 |
Tuberculin skin test conversion and primary progressive tuberculosis disease in the first 5 years of life: a birth cohort study from Cape Town, South Africa.
Topics: Adjuvants, Immunologic; Antitubercular Agents; BCG Vaccine; Child, Preschool; Cohort Studies; Humans | 2018 |
Tuberculosis treatment outcome and predictors in northern Ethiopian prisons: a five-year retrospective analysis.
Topics: Adolescent; Adult; Aftercare; Anti-Retroviral Agents; Antitubercular Agents; Coinfection; Directly O | 2018 |
Bacterial risk factors for treatment failure and relapse among patients with isoniazid resistant tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Cohort Studies; Female; Humans; Isoniazid; Male; Middle Ag | 2018 |
Isoniazid induced early-onset of motor dominant neuropathy and treatment with high dose of pyridoxine.
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Female; Humans; Isoniazid; Peripheral Nervous | 2018 |
Defining the best regimen to treat isoniazid-resistant tuberculosis.
Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Mycobacterium tuberculosis; Rif | 2018 |
[Management and treatment difficulties of multi-drug resistant pulmonary tuberculosis in a pediatric case].
Topics: Adult; Antitubercular Agents; Female; Humans; Infant; Isoniazid; Mycobacterium tuberculosis; Pyrazin | 2018 |
Moxifloxacin Replacement in Contemporary Tuberculosis Drug Regimens Is Ineffective against Persistent Mycobacterium tuberculosis in the Cornell Mouse Model.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Femal | 2018 |
Experimental platform utilising melting curve technology for detection of mutations in Mycobacterium tuberculosis isolates.
Topics: Antitubercular Agents; Base Sequence; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Micro | 2018 |
National position statement for the management of latent tuberculosis infection.
Topics: Antitubercular Agents; Australia; Chemoprevention; Communicable Disease Control; Disease Notificatio | 2017 |
Prevalence and patterns of drug resistance among pulmonary tuberculosis patients in Hangzhou, China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; China; Drug Resistance, Mu | 2018 |
Ethambutol and isoniazid induced severe neurotoxicity in a patient undergoing continuous ambulatory peritoneal dialysis.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Kidney Failure, Chronic; Male; Optic Ne | 2018 |
Left lung hypoplasia with a right tuberculous pleural effusion after childbirth: A case report.
Topics: Abnormalities, Multiple; Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Lung; | 2018 |
Activity of DNA-targeted C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates against aerobically and hypoxically grown Mycobacterium tuberculosis under acidic and neutral conditions.
Topics: Anaerobiosis; Antitubercular Agents; Benzodiazepines; Cell Line; Humans; Isoniazid; Mycobacterium tu | 2018 |
Perianal ulcerative skin tuberculosis: A case report.
Topics: Aged; Antitubercular Agents; Ethambutol; Fissure in Ano; Humans; Isoniazid; Male; Mycobacterium tube | 2018 |
GM-CSF targeted immunomodulation affects host response to M. tuberculosis infection.
Topics: Animals; Antibodies, Neutralizing; Antitubercular Agents; Cattle; Disease Models, Animal; Granulocyt | 2018 |
Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study.
Topics: Adolescent; Adult; Antitubercular Agents; Case-Control Studies; Child; Drug Resistance, Multiple, Ba | 2018 |
[Relationship between the weight of hospitalized patients with pulmonary tuberculosis and the oral dose of isoniazid].
Topics: Administration, Oral; Adult; Aged; Antitubercular Agents; Body Weight; Drug Dosage Calculations; Fem | 2018 |
Toxicity associated with tuberculosis chemotherapy in the REMoxTB study.
Topics: Adult; Antitubercular Agents; Clinical Protocols; Ethambutol; Female; HIV Seropositivity; Humans; In | 2018 |
Performance of an Xpert-based diagnostic algorithm for the rapid detection of drug-resistant tuberculosis among high-risk populations in a low-incidence setting.
Topics: Adult; Aged; Algorithms; Antitubercular Agents; Communicable Disease Control; Drug Resistance, Bacte | 2018 |
Drug resistance pattern in Mycobacterium tuberculosis to the first line drugs of pulmonary tuberculosis patients at Hazara Region, Pakistan.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosi | 2018 |
Burden, spectrum and outcomes of children with tuberculosis diagnosed at a district-level hospital in South Africa.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Coinfection; Comorbidity; Cost of Illnes | 2018 |
Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment.
Topics: Adult; Antitubercular Agents; Diabetes Mellitus; Female; Glycated Hemoglobin; Humans; Isoniazid; Mal | 2018 |
Xpert MTB/RIF assay did not improve diagnosis of pulmonary tuberculosis among child contacts in Rwanda.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Bacteriological Techniques; Child; Child, Preschool; | 2018 |
Drug-induced optic neuropathy in a case of extensively drug-resistant pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Isoniaz | 2018 |
Optic Perineuritis Due to Tuberculosis.
Topics: Adult; Antitubercular Agents; Bronchoscopy; Drug Therapy, Combination; Humans; Isoniazid; Magnetic R | 2019 |
[Tuberculosis and the eye in Belgium: Report of 3 cases].
Topics: Adult; Antitubercular Agents; Belgium; Biopsy; Child, Preschool; Diagnosis, Differential; Drug Thera | 2018 |
Barriers to screening and isoniazid preventive therapy for child contacts of tuberculosis patients.
Topics: Antitubercular Agents; Child, Preschool; Contact Tracing; Female; Health Knowledge, Attitudes, Pract | 2018 |
Isoniazid-induced pure red cell aplasia.
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Dyspnea; Fatigue; Humans; Isoniazid; Male; Re | 2018 |
Evaluation of the intensified tuberculosis case finding guidelines for children living with HIV.
Topics: Ambulatory Care; Anti-Retroviral Agents; Antitubercular Agents; Child; Child, Preschool; Female; Fol | 2018 |
Intra-individual effects of food upon the pharmacokinetics of rifampicin and isoniazid.
Topics: Adult; Antitubercular Agents; Biological Variation, Individual; Eating; Fasting; Female; Food-Drug I | 2019 |
Differentially Detectable Mycobacterium tuberculosis Cells in Sputum from Treatment-Naive Subjects in Haiti and Their Proportionate Increase after Initiation of Treatment.
Topics: Adult; Antitubercular Agents; Colony Count, Microbial; Drug Therapy, Combination; Female; Haiti; Hum | 2018 |
Ethionamide Pharmacokinetics/Pharmacodynamics-derived Dose, the Role of MICs in Clinical Outcome, and the Resistance Arrow of Time in Multidrug-resistant Tuberculosis.
Topics: Antitubercular Agents; Ethionamide; Humans; Isoniazid; Levofloxacin; Monte Carlo Method; Mutation; S | 2018 |
Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse Model.
Topics: Animals; Antitubercular Agents; Aza Compounds; Bacterial Load; Boron Compounds; Disease Models, Anim | 2019 |
Intestinal dysbiosis compromises alveolar macrophage immunity to Mycobacterium tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Disease Models, Animal; Drug-Related Side Effects and Adverse | 2019 |
High-dose rifampicin in tuberculosis: Experiences from a Dutch tuberculosis centre.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Area Under Curve; Central Nervous | 2019 |
Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naïve patients in Nairobi, Kenya.
Topics: Adolescent; Adult; Antitubercular Agents; Capreomycin; Cross-Sectional Studies; Drug Resistance, Bac | 2019 |
Congenital tuberculosis in an extremely preterm infant and prevention of nosocomial infection.
Topics: Adult; Antitubercular Agents; Cross Infection; Female; Humans; Infant, Extremely Premature; Infant, | 2019 |
Emergence of Heteroresistance Mycobacterium Tuberculosis in Saudi Arabia.
Topics: Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Genotype; Huma | 2020 |
Drug resistance and pathogenic spectrum of patients coinfected with nontuberculous mycobacteria and human-immunodeficiency virus in Chengdu, China.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Aged, 80 and over; Antitubercular Agents; China; Cl | 2019 |
Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization.
Topics: Adult; Antitubercular Agents; Decision Support Techniques; Disease Progression; Drug Administration | 2019 |
Inhalable chitosan microparticles for simultaneous delivery of isoniazid and rifabutin in lung tuberculosis treatment.
Topics: A549 Cells; Administration, Inhalation; Antitubercular Agents; Cell Line, Tumor; Chitosan; Drug Carr | 2019 |
High prevalence of multi drug resistant tuberculosis in people living with HIV in Western India.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Cross-Sectio | 2019 |
Insight into genetic diversity of Mycobacterium tuberculosis in Kandy, Sri Lanka reveals predominance of the Euro-American lineage.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Drug Resistance, Bacterial; Genetic Variation; H | 2019 |
A Rare Case of a Tuberculosis Patient with Sarcoidosis.
Topics: Adult; Antitubercular Agents; Deprescriptions; Ethambutol; Female; Glucocorticoids; Humans; Isoniazi | 2019 |
Model-Based Relationship between the Molecular Bacterial Load Assay and Time to Positivity in Liquid Culture.
Topics: Antitubercular Agents; Bacterial Load; Biological Assay; Biomarkers, Pharmacological; Computer Simul | 2019 |
Tuberculosis in Poland in 2017
Topics: Adolescent; Adult; Age Distribution; Aged; Antitubercular Agents; Child; Child, Preschool; Drug Resi | 2019 |
Can mycobacterial katG genetic changes in isoniazid-resistant tuberculosis influence human disease features?
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Bacterial Proteins; Catalase; Chi-Square Dist | 2013 |
Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Resistance, Bacterial; Epidemiological Monitoring; Et | 2013 |
Early specific host response associated with starting effective tuberculosis treatment in an infection controlled placebo controlled mouse study.
Topics: Animals; Antitubercular Agents; Cytokines; Female; Host Specificity; Isoniazid; Metagenome; Mice; Mi | 2013 |
Current integration of tuberculosis (TB) and HIV services in South Africa, 2011.
Topics: Anti-HIV Agents; Antitubercular Agents; Community Health Services; Cross-Sectional Studies; HIV Infe | 2013 |
Isoniazid- and streptomycin-resistant miliary tuberculosis complicated by intracranial tuberculoma in a Japanese infant.
Topics: Antitubercular Agents; Drug Substitution; Drug Therapy, Combination; Ethambutol; Ethionamide; Female | 2013 |
Efficacy of nitazoxanide against clinical isolates of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; M | 2013 |
High prevalence of tuberculosis and insufficient case detection in two communities in the Western Cape, South Africa.
Topics: Adolescent; Adult; Antitubercular Agents; Comorbidity; Directly Observed Therapy; Female; Health Sur | 2013 |
Pharmacokinetics of first-line tuberculosis drugs in Tanzanian patients.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; T | 2013 |
Activity of matrix metalloproteinases during antimycobacterial therapy in mice with simulated tuberculous inflammation.
Topics: Animals; Antitubercular Agents; Inflammation; Isoniazid; Male; Matrix Metalloproteinase 2; Matrix Me | 2013 |
Drug resistance among new smear-positive pulmonary tuberculosis cases in Thailand.
Topics: Adult; Antitubercular Agents; Cohort Studies; Female; HIV Infections; Humans; Isoniazid; Male; Micro | 2013 |
Isoniazid, rifampin, and pyrazinamide plasma concentrations in relation to treatment response in Indonesian pulmonary tuberculosis patients.
Topics: Adult; Antitubercular Agents; Area Under Curve; Drug Evaluation; Drug Therapy, Combination; Female; | 2013 |
Isoniazid, rifampin, and pyrazinamide plasma concentrations in relation to treatment response in Indonesian pulmonary tuberculosis patients.
Topics: Adult; Antitubercular Agents; Area Under Curve; Drug Evaluation; Drug Therapy, Combination; Female; | 2013 |
Isoniazid, rifampin, and pyrazinamide plasma concentrations in relation to treatment response in Indonesian pulmonary tuberculosis patients.
Topics: Adult; Antitubercular Agents; Area Under Curve; Drug Evaluation; Drug Therapy, Combination; Female; | 2013 |
Isoniazid, rifampin, and pyrazinamide plasma concentrations in relation to treatment response in Indonesian pulmonary tuberculosis patients.
Topics: Adult; Antitubercular Agents; Area Under Curve; Drug Evaluation; Drug Therapy, Combination; Female; | 2013 |
Undetected multidrug-resistant tuberculosis amplified by first-line therapy in mixed infection.
Topics: Aged; Antitubercular Agents; Coinfection; Culture Techniques; Delayed Diagnosis; Drug Resistance, Mu | 2013 |
Identification of a small molecule with activity against drug-resistant and persistent tuberculosis.
Topics: Alcohol Oxidoreductases; Amino Acid Sequence; Animals; Antitubercular Agents; Bacterial Proteins; Be | 2013 |
Ethnic variation in inflammatory profile in tuberculosis.
Topics: Adult; Antibiotics, Antitubercular; Antigens, Bacterial; Asian People; Bacterial Load; Black People; | 2013 |
Line probe assay for detection of rifampicin and isoniazid resistant tuberculosis in Pakistan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; DNA, Bacterial; Female; Ge | 2012 |
Serum drug concentrations predictive of pulmonary tuberculosis outcomes.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Area Under Curve; Female; Humans; Isoniazid; Male; M | 2013 |
Evaluation of the potential role of a new mutation in mabA in modifying the response of Mycobacterium tuberculosis to isoniazid.
Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Reductase; Antitubercular Agents; Base Sequence; Drug Resistance, B | 2013 |
Plasma concentrations of isoniazid and rifampin are decreased in adult pulmonary tuberculosis patients with diabetes mellitus.
Topics: Adult; Antitubercular Agents; Biological Availability; Diabetes Mellitus, Type 2; Drug Administratio | 2013 |
A case of skin and lung tuberculosis: diagnostic difficulties.
Topics: Antitubercular Agents; Bronchitis; Bronchoalveolar Lavage Fluid; Bronchoscopy; CD4-CD8 Ratio; Diagno | 2013 |
Genotype diversity of Mycobacterium isolates from children in Jimma, Ethiopia.
Topics: Adolescent; Adult; Antitubercular Agents; Bacterial Typing Techniques; Child; Child, Preschool; Drug | 2013 |
Olfactory disturbance related to pyrazinamide.
Topics: Antitubercular Agents; Drug Combinations; Humans; Isoniazid; Male; Middle Aged; Olfaction Disorders; | 2014 |
Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis treatment.
Topics: Adolescent; Adult; Aged; Drug Resistance, Bacterial; Female; Humans; Isoniazid; Male; Microbial Sens | 2014 |
Pharmacokinetics and serum concentrations of antimycobacterial drugs in adult Turkish patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antitubercular Agents; Area Under Curve; Directly Obs | 2013 |
Comparison of time to positive and colony counting in an early bactericidal activity study of anti-tuberculosis treatment.
Topics: Adult; Antitubercular Agents; Automation, Laboratory; Colony Count, Microbial; Drug Monitoring; Drug | 2013 |
The impact of isoniazid resistance on the treatment outcomes of smear positive re-treatment tuberculosis patients in the state of Andhra Pradesh, India.
Topics: Adult; Demography; Drug Resistance, Bacterial; Female; Humans; India; Isoniazid; Male; Middle Aged; | 2013 |
Effect of mycobacterial drug resistance patterns on patients' survival: a cohort study in Thailand.
Topics: Adolescent; Adult; Aged; Anti-Retroviral Agents; Antitubercular Agents; Child; Child, Preschool; Dia | 2013 |
Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Clone Cells; DNA, Bacterial; Drug | 2013 |
Isoniazid, rifampicin and pyrazinamide plasma concentrations 2 and 6 h post dose in patients with pulmonary tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Drug Ther | 2013 |
[Thrombocytopenia induced by rifampicin not previously sensitized: a case presentation].
Topics: Adult; Antibiotics, Antitubercular; Ethambutol; Female; Humans; Immunization; Isoniazid; Purpura, Th | 2013 |
Polymeric complexes of isonicotinic acid hydrazide with antituberculosis effects.
Topics: Animals; Antitubercular Agents; Cobalt; Coordination Complexes; Drug Evaluation, Preclinical; Isonia | 2013 |
[A clinical investigation of seven patients with pulmonary tuberculosis who developed mixed liver injury during oral anti-tuberculosis treatment].
Topics: Aged; Aged, 80 and over; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy | 2013 |
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated from south-central in China.
Topics: Academic Medical Centers; Alleles; Amino Acid Substitution; Antitubercular Agents; Bacterial Protein | 2014 |
Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Case-Control Studies; China; Drug | 2014 |
Does an isoniazid prophylaxis register improve tuberculosis contact management in South African children?
Topics: Adult; Child; Female; Housing; Humans; Isoniazid; Male; Registries; South Africa; Tuberculosis, Pulm | 2013 |
[Drunkenness caused by isoniazid in a tuberculosis patient with extrapulmonary lesions on hemodialysis: a case report].
Topics: Alcoholic Intoxication; Antitubercular Agents; Humans; Isoniazid; Kidney Failure, Chronic; Male; Mid | 2013 |
Management of children exposed to Mycobacterium tuberculosis: a public health evaluation in West Java, Indonesia.
Topics: Antitubercular Agents; Child; Child, Preschool; Female; Health Expenditures; Health Knowledge, Attit | 2013 |
Strategy to limit sampling of antituberculosis drugs instead of determining concentrations at two hours postingestion in relation to treatment response.
Topics: Antitubercular Agents; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Pulmon | 2014 |
Reply to "strategy to limit sampling of antituberculosis drugs instead of determining concentrations at two hours postingestion in relation to treatment response".
Topics: Antitubercular Agents; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Pulmon | 2014 |
[Molecular genetic analysis of the isoniazid-resistant strains of M. tuberculosis circulating over the Saratov region].
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Drug Resistance, Bacterial; Female; Humans; Iso | 2013 |
Correlation of N-acetyltransferase 2 genotype with isoniazid acetylation in Polish tuberculosis patients.
Topics: Acetylation; Amino Acid Substitution; Antitubercular Agents; Arylamine N-Acetyltransferase; Biologic | 2013 |
[Antimicrobial resistance in tuberculosis].
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; | 2013 |
The incidence of liver injury in Uyghur patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1.
Topics: Adult; Antitubercular Agents; Arylamine N-Acetyltransferase; Chemical and Drug Induced Liver Injury; | 2014 |
Unfinished battle with childhood tuberculosis: is it curable with less drugs and shorter duration?
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Human | 2013 |
Detection of drug resistant Mycobacterium tuberculosis among patients with and without HIV infection in a rural setting.
Topics: Antitubercular Agents; Case-Control Studies; Coinfection; Drug Resistance, Bacterial; Drug Resistanc | 2013 |
Bacillus Calmette-Guérin and isoniazid preventive therapy protect contacts of patients with tuberculosis.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antitubercular Agents; BCG Vaccine; Child; | 2014 |
[Hypothermia due to anti-tuberculosis drugs: first case].
Topics: Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Comb | 2014 |
[Alopecia areata in a patient treated with antitubercular drugs].
Topics: Administration, Cutaneous; Alopecia Areata; Antitubercular Agents; Child; Drug Therapy, Combination; | 2014 |
Optimization of the microscopic observation drug susceptibility assay for four first-line drugs using Mycobacterium tuberculosis reference strains and clinical isolates.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tub | 2014 |
Clinical features and outcomes of isoniazid mono-resistant pulmonary tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Drug Resistance, Bacterial; Female; Humans; Isoniazid; Male; Mid | 2014 |
Reduced emergence of isoniazid resistance with concurrent use of thioridazine against acute murine tuberculosis.
Topics: Animals; Antipsychotic Agents; Antitubercular Agents; Disease Models, Animal; Drug Repositioning; Dr | 2014 |
Preventive treatment for tuberculosis in people with HIV.
Topics: AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Female; HIV In | 2014 |
Prevalence of extended treatment in pulmonary tuberculosis patients receiving first-line therapy and its association with recurrent tuberculosis in Beijing, China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; China; Cohort Studies; Cost of Il | 2014 |
Antimycobacterial drugs modulate immunopathogenic matrix metalloproteinases in a cellular model of pulmonary tuberculosis.
Topics: Antitubercular Agents; Azithromycin; Bronchoalveolar Lavage Fluid; Epithelial Cells; Fibroblasts; Fl | 2014 |
A home tracing program for contacts of people with tuberculosis or HIV and patients lost to care.
Topics: Ambulatory Care Facilities; Antitubercular Agents; Bacteriological Techniques; Contact Tracing; HIV | 2014 |
Sterilizing activity of thioridazine in combination with the first-line regimen against acute murine tuberculosis.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Female; Isoniazid | 2014 |
Association of serum levels of iron, copper, and zinc, and inflammatory markers with bacteriological sputum conversion during tuberculosis treatment.
Topics: Adult; Antitubercular Agents; Biomarkers; C-Reactive Protein; Copper; Ethambutol; Hemoglobins; Host- | 2014 |
Novel bronchoscopic balloon dilation for patients with bronchostenosis caused by bronchial tuberculosis: a case report.
Topics: Antitubercular Agents; Bronchial Diseases; Bronchoscopy; Constriction, Pathologic; Dilatation; Etham | 2014 |
Isoniazid, pyrazinamide and rifampicin content variation in split fixed-dose combination tablets.
Topics: Chemistry, Pharmaceutical; Drug Combinations; Humans; Isoniazid; Pyrazinamide; Quality Control; Rifa | 2014 |
Lichenoid drug reaction to isoniazid presenting as exfoliative dermatitis in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antitubercular Agents; Dermatitis, Exfoliative; Drug Erup | 2015 |
Taima (stop) TB: the impact of a multifaceted TB awareness and door-to-door campaign in residential areas of high risk for TB in Iqaluit, Nunavut.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Canada; Child; Child, Preschool; | 2014 |
Pulmonary tuberculoma in a patient with chronic hepatitis C: a clinical pitfall in the treatment strategy.
Topics: Antitubercular Agents; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up St | 2014 |
Nitrotriazole- and imidazole-based amides and sulfonamides as antitubercular agents.
Topics: Amides; Animals; Antitubercular Agents; Cell Line; Drug Evaluation, Preclinical; Drug Resistance, Ba | 2014 |
Evaluation of the GenoType(®) MTBDRplus line probe assay on sputum-positive samples in routine settings in China.
Topics: Antitubercular Agents; Bacteriological Techniques; Chi-Square Distribution; China; DNA Mutational An | 2014 |
Congenital tuberculosis and management of exposure in neonatal and pediatric intensive care units.
Topics: Air Microbiology; Antitubercular Agents; Contact Tracing; Cross Infection; Female; Gestational Age; | 2014 |
[Tenosynovitis confirmed by MRI during anti-tuberculous treatment suspected due to isoniazid--2 case reports and literature review].
Topics: Aged; Antitubercular Agents; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Middle Aged; Tenos | 2014 |
False-positive rifampicin resistance on Xpert® MTB/RIF caused by a silent mutation in the rpoB gene.
Topics: Aged; Amikacin; Amino Acid Sequence; Antibiotics, Antitubercular; Bacterial Proteins; DNA-Directed R | 2014 |
Isoniazid prevented active tuberculosis in patients with HIV treated with antiretroviral therapy.
Topics: AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Female; HIV In | 2014 |
Effects of dosage, comorbidities, and food on isoniazid pharmacokinetics in Peruvian tuberculosis patients.
Topics: Adolescent; Adult; Anti-HIV Agents; Antitubercular Agents; Area Under Curve; Comorbidity; Diabetes M | 2014 |
Classical against molecular-genetic methods for susceptibility testing of antituberculotics.
Topics: Aminoglycosides; Antitubercular Agents; Culture Media; DNA, Bacterial; Drug Resistance, Multiple, Ba | 2015 |
[Epidemiology of bacillary pulmonary tuberculosis according to HIV status of patients followed in the department of infectious diseases Conakry (Guinea)].
Topics: Adult; Antitubercular Agents; CD4 Lymphocyte Count; Comorbidity; Female; Guinea; HIV Infections; Hos | 2014 |
Correlates of treatment outcomes and drug resistance among pulmonary tuberculosis patients attending tertiary care hospitals of Kolkata, India.
Topics: Adolescent; Adult; Age Factors; Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Bac | 2014 |
Differences in clinical features of two immigrant populations with tuberculosis.
Topics: Adult; Antitubercular Agents; Asia; Comorbidity; Crowding; Drug Resistance, Bacterial; Drug Therapy, | 2015 |
Investigating gender disparities in the profile and treatment outcomes of tuberculosis in Ebonyi state, Nigeria.
Topics: Adult; Antitubercular Agents; Cohort Studies; Coinfection; Ethambutol; Female; Health Status Dispari | 2015 |
Treatment options and outcomes of hospitalised tuberculosis patients: a nationwide study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Ethambut | 2015 |
Serum drug concentrations of INH and RMP predict 2-month sputum culture results in tuberculosis patients.
Topics: Adult; Aged; Alberta; Antitubercular Agents; Female; Humans; Isoniazid; Male; Middle Aged; Retrospec | 2015 |
Pure red cell aplasia due to anti-erythropoietin antibodies or isoniazid? A case report from a 94-year-old man.
Topics: Aged, 80 and over; Anemia; Antitubercular Agents; Bone Marrow Examination; Erythrocyte Transfusion; | 2015 |
[The therapeutic effect of regimens containing isoniazid and rifampicin for pulmonary tuberculosis with single isoniazid or rifampicin resistance].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ethambutol; Female; Humans; Isoni | 2014 |
[Fixed drug eruption after taking ethambutol].
Topics: Adult; Antitubercular Agents; Drug Eruptions; Drug Therapy, Combination; Ethambutol; Humans; Hypopig | 2015 |
Treatment outcome of patients with isoniazid mono-resistant tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Drug Resistance, Bacterial; Female; Humans; Isoniazid; Male; Mid | 2015 |
Drug-induced hepatotoxicity of anti-tuberculosis drugs and their serum levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antitubercular Agents; Aspartate A | 2015 |
An unusual case of isoniazid toxicity.
Topics: Aged; Antitubercular Agents; Brain Diseases; Humans; Isoniazid; Male; Tuberculosis, Pulmonary | 2015 |
Inhalable chitosan nanoparticles as antitubercular drug carriers for an effective treatment of tuberculosis.
Topics: Administration, Inhalation; Animals; Antibiotics, Antitubercular; Chitosan; Disease Models, Animal; | 2016 |
Challenges to delivery of isoniazid preventive therapy in a cohort of children exposed to tuberculosis in Timor-Leste.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child, Preschool; Contact Tracing; Female; Humans; I | 2015 |
Six- vs. eight-month anti-tuberculosis regimen for pulmonary tuberculosis under programme conditions.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Logistic Mod | 2015 |
Dual infection with pulmonary tuberculosis and Lophomonas blattarum in India.
Topics: Antiprotozoal Agents; Antitubercular Agents; Bronchoalveolar Lavage; Ceftriaxone; Dose-Response Rela | 2015 |
Diabetes and Other Risk Factors for Multi-drug Resistant Tuberculosis in a Mexican Population with Pulmonary Tuberculosis: Case Control Study.
Topics: Adult; Ambulatory Care Facilities; Antibiotics, Antitubercular; Bacterial Typing Techniques; Case-Co | 2015 |
Effective anti-tuberculosis therapy correlates with plasma small RNA.
Topics: Adult; Antitubercular Agents; Biomarkers; Coinfection; Ethambutol; Female; Gene Expression Profiling | 2015 |
Adequate design of pharmacokinetic-pharmacodynamic studies will help optimize tuberculosis treatment for the future.
Topics: Antitubercular Agents; Dietary Fats; Female; Food-Drug Interactions; Humans; Isoniazid; Male; Rifamp | 2015 |
Reply to "adequate design of pharmacokinetic-pharmacodynamic studies will help optimize tuberculosis treatment for the future".
Topics: Antitubercular Agents; Dietary Fats; Female; Food-Drug Interactions; Humans; Isoniazid; Male; Rifamp | 2015 |
Therapeutic efficacy of liposomes containing 4-(5-pentadecyl-1,3,4-oxadiazol-2-yl)pyridine in a murine model of progressive pulmonary tuberculosis.
Topics: Animals; Antitubercular Agents; Cholesterol; Disease Models, Animal; Isoniazid; Liposomes; Male; Mic | 2015 |
Performance of Genotype MTBDRplus in the Detection of Resistance to Rifampicin and Isoniazid Among Clinical Mycobacteria Isolates in Ilorin, Nigeria.
Topics: Adult; Antitubercular Agents; Bacterial Proteins; DNA, Bacterial; Drug Resistance, Multiple, Bacteri | 2015 |
Multi drug and other forms of drug resistant tuberculosis are uncommon among treatment naïve tuberculosis patients in Tanzania.
Topics: Adolescent; Adult; Antitubercular Agents; Cross-Sectional Studies; Female; Humans; Isoniazid; Male; | 2015 |
Isoniazid induced convulsions at therapeutic dose in an alcoholic and smoker patient.
Topics: Adult; Alcoholism; Anticonvulsants; Antitubercular Agents; Humans; Isoniazid; Male; Pyridoxine; Risk | 2015 |
Effectiveness of RHZE-FDC (fixed-dose combination) compared to RH-FDC + Z for tuberculosis treatment in Brazil: a cohort study.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Brazil; Cohort Studies; Drug Combinations; Et | 2015 |
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children.
Topics: Adolescent; Antitubercular Agents; Area Under Curve; Child; Child, Preschool; Ethambutol; Ethnicity; | 2015 |
Isoniazid induced acute pancreatitis in a young girl.
Topics: Antitubercular Agents; Child; Female; Humans; Isoniazid; Pancreatitis, Acute Necrotizing; Tomography | 2015 |
Preventing tuberculosis transmission at a maternity hospital by targeted screening radiography of migrants.
Topics: Adult; Antibiotic Prophylaxis; Antitubercular Agents; Disease Transmission, Infectious; Female; Hosp | 2015 |
A clonal outbreak of tuberculosis in a homeless population in the interior of British Columbia, Canada, 2008-2015.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; British Columbia; Contact Tracing; Disease Ou | 2015 |
[The experience of application of test system "TB-Biochip" in the Tambov oblast].
Topics: DNA, Bacterial; Humans; Isoniazid; Microarray Analysis; Microbial Sensitivity Tests; Mutation; Mycob | 2015 |
Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation.
Topics: Adolescent; Adult; Antitubercular Agents; Bacterial Proteins; Coinfection; Disease Outbreaks; DNA-Di | 2015 |
Advanced stage of chronic kidney disease is risk of poor treatment outcome for smear-positive pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Cardiovascular Diseases; Child; D | 2015 |
Pyridoxine induced rosacea-like dermatitis.
Topics: Antitubercular Agents; Drug Combinations; Drug Eruptions; Female; Humans; Isoniazid; Middle Aged; Py | 2015 |
Preclinical and Clinical Evidence of Mycobacterium tuberculosis Persistence in the Hypoxic Niche of Bone Marrow Mesenchymal Stem Cells after Therapy.
Topics: Adapalene; Animals; Antitubercular Agents; Bone Marrow Cells; Cell Hypoxia; Down-Regulation; Female; | 2015 |
IL-37 Expression is Upregulated in Patients with Tuberculosis and Induces Macrophages Towards an M2-like Phenotype.
Topics: Antitubercular Agents; Arginase; B7-2 Antigen; Cell Differentiation; Cells, Cultured; Ethambutol; Fe | 2015 |
Pulmonary Infection Caused by Mycobacterium shinjukuense.
Topics: Aged; Antitubercular Agents; Bronchoalveolar Lavage Fluid; DNA, Bacterial; Ethambutol; Female; Genot | 2015 |
Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, northwest Ethiopia.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Multiple, | 2015 |
Blood levels of isoniazid in Indian children with tuberculosis.
Topics: Antitubercular Agents; Child; Child, Preschool; Female; Humans; India; Isoniazid; Male; Prospective | 2015 |
Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State.
Topics: Adolescent; Adult; Antitubercular Agents; Case-Control Studies; Directly Observed Therapy; Ethiopia; | 2015 |
Evaluation of GenoType MTBDRplus for the rapid detection of drug-resistant tuberculosis in Ghana.
Topics: Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ghana; Humans; | 2015 |
A Girl with Recurrent Pleural Effusion: Immunological Rebound or Isoniazid Induced Lupus?
Topics: Adolescent; Antitubercular Agents; Female; Humans; Isoniazid; Lupus Erythematosus, Systemic; Pleural | 2014 |
Effect of isoniazid preventive therapy on tuberculosis or death in persons with HIV: a retrospective cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Cohort Studies; Ethiopia; Female; | 2015 |
Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Female; Genetic V | 2015 |
Nosocomial exposure to active pulmonary tuberculosis in a neonatal intensive care unit.
Topics: Antitubercular Agents; Chemoprevention; Cross Infection; Disease Transmission, Infectious; Female; H | 2015 |
Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Drug Resistance, Multiple, Bacterial; Ethionami | 2015 |
The relationship between chitotriosidase activity and tuberculosis.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Biomarkers; Case-Control Studies; China; Etha | 2015 |
Roflumilast, a Type 4 Phosphodiesterase Inhibitor, Shows Promising Adjunctive, Host-Directed Therapeutic Activity in a Mouse Model of Tuberculosis.
Topics: Aminopyridines; Animals; Antitubercular Agents; Benzamides; Cyclopropanes; Disease Models, Animal; F | 2015 |
Serum Levels of Antituberculosis Drugs and Their Effect on Tuberculosis Treatment Outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Chromatography, Liquid; Drug Moni | 2016 |
Serum Levels of Antituberculosis Drugs and Their Effect on Tuberculosis Treatment Outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Chromatography, Liquid; Drug Moni | 2016 |
Serum Levels of Antituberculosis Drugs and Their Effect on Tuberculosis Treatment Outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Chromatography, Liquid; Drug Moni | 2016 |
Serum Levels of Antituberculosis Drugs and Their Effect on Tuberculosis Treatment Outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Chromatography, Liquid; Drug Moni | 2016 |
[The effect of renal replacement therapy on the plasma concentration of antituberculosis drugs].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Female; Humans; Isoniazid; Kidney Diseases; Male; Mi | 2015 |
Rifampicin-moxifloxacin interaction in tuberculosis treatment: a real-life study.
Topics: Adult; Aged; Antitubercular Agents; Drug Interactions; Drug Therapy, Combination; Extensively Drug-R | 2015 |
[Molecular diagnosis of Mycobacterium tuberculosis complex resistant to isoniazid and rifampicin in Burkina Faso].
Topics: Adolescent; Adult; Antitubercular Agents; Burkina Faso; Female; Humans; Isoniazid; Male; Middle Aged | 2015 |
Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Cross-Sectional Studies; Early Diagnosis; Ethiopia; | 2015 |
The concordance between phenotypic and genotypic M. tuberculosis drug susceptibility tests results: observational study.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; Genotype; Humans; | 2015 |
Treatment Outcomes with Fluoroquinolone-Containing Regimens for Isoniazid-Resistant Pulmonary Tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; F | 2016 |
Determinants of the Sympatric Host-Pathogen Relationship in Tuberculosis.
Topics: Adolescent; Adult; Age Factors; Aged; Antitubercular Agents; Child; Child, Preschool; DNA, Intergeni | 2015 |
Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction.
Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Area Under Curve; Biological Availability; Biotransfo | 2016 |
Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction.
Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Area Under Curve; Biological Availability; Biotransfo | 2016 |
Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction.
Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Area Under Curve; Biological Availability; Biotransfo | 2016 |
Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction.
Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Area Under Curve; Biological Availability; Biotransfo | 2016 |
Outbreak of isoniazid-resistant tuberculosis in an immigrant community in Spain.
Topics: Adult; Antitubercular Agents; BCG Vaccine; Bolivia; Contact Tracing; Disease Outbreaks; Emigrants an | 2016 |
[Vesicular eruption in a patient under antituberculosis treatment].
Topics: Adolescent; Antitubercular Agents; Drug Eruptions; Drug Therapy, Combination; Humans; Isoniazid; Mal | 2016 |
Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of Tuberculosis.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Co | 2016 |
A rare cause of pulmonary tuberculosis.
Topics: Animals; Antitubercular Agents; Cattle; Drug Therapy, Combination; Ethambutol; Female; Humans; Immun | 2015 |
Cost-effectiveness of isoniazid preventive therapy for HIV-infected pregnant women in India.
Topics: Adolescent; Adult; Antitubercular Agents; Cost-Benefit Analysis; Female; HIV Infections; Humans; Ind | 2016 |
The Ethics of Isolation for Patients With Tuberculosis in Australia.
Topics: Adult; Antitubercular Agents; Australia; Ethics, Institutional; Family; Humans; Isoniazid; Male; Myc | 2016 |
Pulmonary Delivery of Anti-Tubercular Drugs Using Ligand Anchored pH Sensitive Liposomes for the Treatment of Pulmonary Tuberculosis.
Topics: Administration, Inhalation; Aniline Compounds; Animals; Antitubercular Agents; Cells, Cultured; Cipr | 2016 |
Repeat exposure to active tuberculosis and risk of re-infection.
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Emergency Service, Hospital; E | 2016 |
Latent Tuberculosis Infection and the Risk of Subsequent Cancer.
Topics: Adult; Aged; Antitubercular Agents; Case-Control Studies; Female; Humans; Isoniazid; Latent Tubercul | 2016 |
Global Urine Metabolomics in Patients Treated with First-Line Tuberculosis Drugs and Identification of a Novel Metabolite of Ethambutol.
Topics: Adult; Aged; Aged, 80 and over; Aminobutyrates; Antitubercular Agents; Biotransformation; Case-Contr | 2016 |
Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; China; Cohort Studies; Drug Resistance, Bacterial; Drug Th | 2016 |
Phenotypically Adapted Mycobacterium tuberculosis Populations from Sputum Are Tolerant to First-Line Drugs.
Topics: Adaptation, Physiological; Antitubercular Agents; Biological Assay; Cryopreservation; Drug Resistanc | 2016 |
Comparing isogenic strains of Beijing genotype Mycobacterium tuberculosis after acquisition of Isoniazid resistance: A proteomics approach.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Drug Resistance, Bacterial; Gene Expression Pro | 2016 |
Adjunctive Phosphodiesterase-4 Inhibitor Therapy Improves Antibiotic Response to Pulmonary Tuberculosis in a Rabbit Model.
Topics: Animals; Antitubercular Agents; Drug Combinations; Drug Synergism; Female; Isoniazid; Phosphodiester | 2016 |
Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin-Mono-Resistant Pulmonary Tuberculosis in Lima, Peru.
Topics: Adult; Antitubercular Agents; Drug Resistance, Bacterial; Female; Humans; Isoniazid; Male; Peru; Pre | 2016 |
High Incidence of Tuberculosis in the Absence of Isoniazid and Cotrimoxazole Preventive Therapy in Children Living with HIV in Northern Ethiopia: A Retrospective Follow-Up Study.
Topics: Adolescent; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Child, Preschool; E | 2016 |
Safety and Adherence for 12 Weekly Doses of Isoniazid and Rifapentine for Pediatric Tuberculosis Infection.
Topics: Adolescent; Antibiotics, Antitubercular; Antitubercular Agents; Child; Child, Preschool; Drug Admini | 2016 |
Isoniazid cerebellitis in a peritoneal dialysis patient.
Topics: Antitubercular Agents; Cerebellar Diseases; Cerebellar Nuclei; Humans; Isoniazid; Kidney Failure, Ch | 2016 |
Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivo.
Topics: Animals; Cell Line; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Isoniazid; Lu | 2016 |
Positive Allergy Study (Intradermal, Patch, and Lymphocyte Transformation Tests) in a Case of Isoniazid-Induced DRESS.
Topics: Antitubercular Agents; Drug Hypersensitivity Syndrome; Humans; Intradermal Tests; Isoniazid; Male; P | 2016 |
Use of Lot Quality Assurance Sampling to Ascertain Levels of Drug Resistant Tuberculosis in Western Kenya.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Female; Humans; Ison | 2016 |
Uptake of Isoniazid Preventive Therapy among Under-Five Children: TB Contact Investigation as an Entry Point.
Topics: Algorithms; Antitubercular Agents; Child, Preschool; Communicable Disease Control; Contact Tracing; | 2016 |
Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Combinations; Female; Isoniazid; Mice; | 2016 |
Comparison of Two Molecular Assays For Detecting Smear Negative Pulmonary Tuberculosis.
Topics: Antitubercular Agents; Bacteriological Techniques; Drug Resistance, Bacterial; Humans; Isoniazid; My | 2016 |
Drug resistance-conferring mutations in Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia.
Topics: Adolescent; Antitubercular Agents; Bacterial Proteins; Drug Resistance, Bacterial; Ethiopia; Female; | 2016 |
Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3.
Topics: Animals; Antitubercular Agents; Bacterial Load; Bacterial Proteins; Biological Transport; Ciprofloxa | 2016 |
Tuberculosis Treatment Outcome and Drug Resistance in Lambaréné, Gabon: A Prospective Cohort Study.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Coinfection; Drug Resistance, Mul | 2016 |
Pre-Multidrug-Resistant Mycobacterium tuberculosis Infection Causing Fatal Enteric Disease in a Dog from a Family with History of Human Tuberculosis.
Topics: Animals; Antitubercular Agents; Dog Diseases; Dogs; Drug Resistance, Multiple, Bacterial; Enteritis; | 2017 |
Implementation of isoniazid preventive therapy in children aged under 5 years exposed to tuberculosis in Benin.
Topics: Age Factors; Antitubercular Agents; Benin; Child, Preschool; Drug Administration Schedule; Feasibili | 2016 |
A mixed-methods evaluation of adherence to preventive treatment among child tuberculosis contacts in Indonesia.
Topics: Antitubercular Agents; Caregivers; Child, Preschool; Contact Tracing; Drug Administration Schedule; | 2016 |
Donor-derived tuberculosis (TB): isoniazid-resistant TB transmitted from a lung transplant donor with inadequately treated latent infection.
Topics: Adult; Allografts; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antitubercular Agents; Bacteremia; | 2016 |
HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Area Under Cur | 2016 |
A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy.
Topics: Acetylation; Antitubercular Agents; Arylamine N-Acetyltransferase; Biological Availability; Biotrans | 2016 |
Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB.
Topics: Antitubercular Agents; Area Under Curve; Bacterial Load; Bacteriological Techniques; Biomarkers; Eth | 2016 |
Tuberculous cellulitis: diseases behind cellulitislike erythema.
Topics: Aged, 80 and over; Antitubercular Agents; Cellulitis; Diagnosis, Differential; Ethambutol; Humans; I | 2016 |
[EVALUATION OF THE EFFICIENCY OF TREATMENT AND THE CHOICE OF CONTROL COMPUTED TOMOGRAPHY TIME IN CHILDREN WITH MINOR FORMS OF INTRATHORACIC TUBERCULOSIS].
Topics: Antitubercular Agents; Child; Child, Preschool; Comparative Effectiveness Research; Drug Monitoring; | 2010 |
[THE SENSITIVITY AND SPECIFICITY OF THE MOLECULAR GENOTYPE MTBDRPL US ASSAY (HAIN LIFESCIENCE GMBH, GERMANY) FOR RAPID DIAGNOSIS OF DRUG SUSCEPTIBILITY IN MYCOBACTERIUM TUBERCULOSIS ON SPUTUM SPECIMENS].
Topics: Antitubercular Agents; Bacterial Proteins; Bacterial Typing Techniques; Catalase; DNA-Directed RNA P | 2010 |
Drug-resistant tuberculosis in Central Mozambique: the role of a rapid genotypic susceptibility testing.
Topics: Adult; Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Extensively Drug-Resistant Tub | 2016 |
Impacts of 12-dose regimen for latent tuberculosis infection: Treatment completion rate and cost-effectiveness in Taiwan.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Cost-Benefit Analysis; Directly Observed Therapy; Dr | 2016 |
Comprehensive cost of treating one patient with MDR/pre-XDR-TB in Wellington, New Zealand.
Topics: Adult; Amikacin; Aminosalicylic Acid; Anti-Bacterial Agents; Antitubercular Agents; Bronchoscopy; Cl | 2016 |
The antifibrotic drug pirfenidone promotes pulmonary cavitation and drug resistance in a mouse model of chronic tuberculosis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antitubercular Agents; Drug Resistance, Bacterial; | 2016 |
Whole Genome Sequence Analysis of a Large Isoniazid-Resistant Tuberculosis Outbreak in London: A Retrospective Observational Study.
Topics: Adult; Child; Disease Outbreaks; DNA, Bacterial; Genome, Bacterial; Humans; Isoniazid; London; Minis | 2016 |
Association between TXNRD1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a prospective study.
Topics: Adult; Age Factors; Alleles; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Ethambut | 2016 |
Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.
Topics: AIDS-Related Opportunistic Infections; Algorithms; Bacteriological Techniques; Cost-Benefit Analysis | 2016 |
Evaluation of the Abbott RealTime MTB and RealTime MTB INH/RIF Assays for Direct Detection of Mycobacterium tuberculosis Complex and Resistance Markers in Respiratory and Extrapulmonary Specimens.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivit | 2016 |
Drug susceptibility profiles of pulmonary Mycobacterium tuberculosis isolates from patients in informal urban settlements in Nairobi, Kenya.
Topics: Adolescent; Adult; Antitubercular Agents; Cities; Cross-Sectional Studies; Drug Resistance, Bacteria | 2016 |
Outcome of culture-confirmed isoniazid-resistant rifampicin-susceptible tuberculosis in children.
Topics: Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Follow | 2016 |
[Current situation of primary prophylaxis with isoniazid (INH) in children who are contacts of patients with bacillary pulmonary tuberculosis in Abidjan (Cote d'Ivoire)].
Topics: Adolescent; Adult; Chemoprevention; Child; Child, Preschool; Contact Tracing; Cote d'Ivoire; Cross-S | 2016 |
Clofazimine has delayed antimicrobial activity against Mycobacterium tuberculosis both in vitro and in vivo.
Topics: Animals; Antitubercular Agents; Bacterial Load; Clofazimine; Isoniazid; Lung; Mice; Mice, Inbred BAL | 2017 |
From the Cover: Characterization of Isoniazid-Specific T-Cell Clones in Patients with anti-Tuberculosis Drug-Related Liver and Skin Injury.
Topics: Adolescent; Aged; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Clone Cells; Female | 2017 |
Role of Risorine in the Treatment of Drug - Susceptible Pulmonary Tuberculosis: A Pilot Study.
Topics: Adult; Alkaloids; Antitubercular Agents; Benzodioxoles; Cytochrome P-450 Enzyme Inhibitors; Drug Com | 2016 |
Drug-resistant tuberculosis among previously treated patients in Yangon, Myanmar.
Topics: Adult; Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; Drug Resis | 2016 |
Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
Topics: Antitubercular Agents; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Humans; Isonia | 2016 |
Intestinal Pneumatosis Associated with Tuberculosis after Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Bronchoalveolar Lavage Fluid; | 2017 |
Diagnosis of Pulmonary Tuberculosis and Detection of Resistance to Rifampin and Isoniazid through Direct Molecular Methods in Stool Samples.
Topics: Adolescent; Adult; Case-Control Studies; Child; Feces; Female; Humans; Isoniazid; Male; Middle Aged; | 2016 |
Isoniazid Mono-Resistant Tuberculosis: Impact on Treatment Outcome and Survival of Pulmonary Tuberculosis Patients in Southern Mexico 1995-2010.
Topics: Adult; Antitubercular Agents; Female; Humans; Isoniazid; Male; Mexico; Middle Aged; Prospective Stud | 2016 |
Anti-TB drug concentrations and drug-associated toxicities among TB/HIV-coinfected patients.
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Coinfection; Female; HIV Infec | 2017 |
Anti-TB drug concentrations and drug-associated toxicities among TB/HIV-coinfected patients.
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Coinfection; Female; HIV Infec | 2017 |
Anti-TB drug concentrations and drug-associated toxicities among TB/HIV-coinfected patients.
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Coinfection; Female; HIV Infec | 2017 |
Anti-TB drug concentrations and drug-associated toxicities among TB/HIV-coinfected patients.
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Coinfection; Female; HIV Infec | 2017 |
Treatment outcomes of fixed-dose combination versus separate tablet regimens in pulmonary tuberculosis patients with or without diabetes in Qatar.
Topics: Adult; Antitubercular Agents; Diabetes Complications; Dose-Response Relationship, Drug; Drug Therapy | 2017 |
Clinical Characteristics of Coexisting Pulmonary Thromboembolism in Patients With Respiratory Tuberculosis.
Topics: Aged; Antitubercular Agents; Blood Sedimentation; C-Reactive Protein; Comorbidity; Drug Resistance, | 2017 |
Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.
Topics: Adult; Antitubercular Agents; Coinfection; Drug Interactions; Drug Therapy, Combination; Female; HIV | 2017 |
Factors Influencing Tuberculosis Treatment Outcome in Adult Patients Treated with Thrice-Weekly Regimens in India.
Topics: Adult; Antitubercular Agents; Arylamine N-Acetyltransferase; Drug Dosage Calculations; Drug Therapy, | 2017 |
Failure to reach therapeutic levels of rifampicin and isoniazid by recommended dosages.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Humans; Isoniazid; Middle Aged; Rifampin; Tre | 2017 |
Accidental isoniazid poisoning--a report.
Topics: Acidosis; Adolescent; Adult; Antitubercular Agents; Drug Overdose; Electroencephalography; Gastric L | 2008 |
Primary drug resistance against Mycobacterium tuberculosis in Karachi.
Topics: Adolescent; Adult; Antitubercular Agents; Bronchoscopy; Drug Resistance, Multiple, Bacterial; Ethamb | 2008 |
Induction of a specific strong polyantigenic cellular immune response after short-term chemotherapy controls bacillary reactivation in murine and guinea pig experimental models of tuberculosis.
Topics: Animals; Antigens, Bacterial; Antitubercular Agents; BCG Vaccine; Female; Guinea Pigs; Humans; Inter | 2008 |
Induction of a specific strong polyantigenic cellular immune response after short-term chemotherapy controls bacillary reactivation in murine and guinea pig experimental models of tuberculosis.
Topics: Animals; Antigens, Bacterial; Antitubercular Agents; BCG Vaccine; Female; Guinea Pigs; Humans; Inter | 2008 |
Induction of a specific strong polyantigenic cellular immune response after short-term chemotherapy controls bacillary reactivation in murine and guinea pig experimental models of tuberculosis.
Topics: Animals; Antigens, Bacterial; Antitubercular Agents; BCG Vaccine; Female; Guinea Pigs; Humans; Inter | 2008 |
Induction of a specific strong polyantigenic cellular immune response after short-term chemotherapy controls bacillary reactivation in murine and guinea pig experimental models of tuberculosis.
Topics: Animals; Antigens, Bacterial; Antitubercular Agents; BCG Vaccine; Female; Guinea Pigs; Humans; Inter | 2008 |
Radiolabeling and evaluation of alginate blend-isoniazid microspheres by 99mTc for the treatment of tuberculosis in rabbit model.
Topics: Alginates; Animals; Antitubercular Agents; Delayed-Action Preparations; Drug Carriers; Drug Stabilit | 2008 |
Pellagra: will we see it more frequently?
Topics: Antitubercular Agents; Female; Humans; Isoniazid; Middle Aged; Pellagra; Pyridoxine; Tuberculosis, P | 2009 |
Impact of the interaction of R207910 with rifampin on the treatment of tuberculosis studied in the mouse model.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Diarylquinolin | 2008 |
Genotypic analysis of isoniazid and rifampin resistance in drug-resistant clinical Mycobacterium tuberculosis complex isolates in southern Turkey.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Codon; DNA-Directed RNA Polymerases; DNA, Bacte | 2008 |
Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in peri-urban Kampala, Uganda.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antibodies, Bacterial; Bacterial Typing Techniques; | 2008 |
The results of purified protein derivative test in ankylosing spondylitis patients: clinical features, HRCT results and relationship with TNF-blocker usage.
Topics: Adult; Aged; Antibodies, Monoclonal; Antitubercular Agents; Arthritis, Gouty; Arthritis, Rheumatoid; | 2008 |
Enhanced bactericidal activity of rifampin and/or pyrazinamide when combined with PA-824 in a murine model of tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Disease Models | 2008 |
[Monitoring of chemotherapy in patients with pulmonary tuberculosis by the blood bacteriostatic activity-determining test].
Topics: Antitubercular Agents; Follow-Up Studies; Humans; Isoniazid; Mycobacterium tuberculosis; Retrospecti | 2008 |
Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Topics: Adult; Antitubercular Agents; Combined Modality Therapy; Drug Administration Schedule; Drug Resistan | 2009 |
Drug resistance profile of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Jos, Nigeria.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Myco | 2009 |
Your diagnosis? A 12-year-old girl with latent tuberculosis presenting with nausea, vomiting and increasing frontal headache.
Topics: Antitubercular Agents; Cerebellar Neoplasms; Child; Combined Modality Therapy; Diagnosis, Differenti | 2009 |
An unusual case of a pleural effusion with an abdominal mass.
Topics: Adult; Antitubercular Agents; Drainage; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Ma | 2008 |
Tuberculosis in a patient on temozolomide: a case report.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antibiotics, Antitubercular; Ant | 2009 |
[Effectiveness and tolerance of antituberculosis treatment regimens without isoniazid and rifampicin: analysis of 85 cases].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Female; Humans; Isoniazid; Male; Middle Aged; Retros | 2008 |
Mycobacterium tuberculosis and nontuberculous mycobacterial isolates among patients with recent HIV infection in Mozambique.
Topics: Adult; Antitubercular Agents; CD4 Lymphocyte Count; Ethambutol; Female; HIV Infections; Humans; Ison | 2008 |
M. tuberculosis Central Asian Strain 1 MDR isolates have more mutations in rpoB and katG genes compared with other genotypes.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA Probes; DNA-Directed RNA Polymerases; Drug | 2009 |
Prevalence and dissemination of the Ser315Thr substitution within the KatG enzyme in isoniazid-resistant strains of Mycobacterium tuberculosis isolated in Uruguay.
Topics: Amino Acid Substitution; Antitubercular Agents; Bacterial Proteins; Catalase; Drug Resistance, Bacte | 2008 |
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis.
Topics: Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; R | 2008 |
[Hixozide, a novel combined antituberculosis preparation].
Topics: Animals; Antitubercular Agents; Cells, Cultured; Disease Models, Animal; Drug Combinations; Drug Eva | 2008 |
Gynecomastia: a rare adverse effect of isoniazid.
Topics: Adolescent; Antitubercular Agents; Diagnosis, Differential; Gynecomastia; Humans; Isoniazid; Male; P | 2008 |
Evolution in the resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Nicaragua.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Health Surveys; Humans; Isoniazid; Mycobacterium | 2009 |
Tuberculosis incidence among contacts of active pulmonary tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Brazil; Carrier State; Cohort Studies; Disease Transmissio | 2009 |
[Distribution of mutations in the rpoB, katG, inhA, ahpC gene of rifampicin and isoniazid resistant M. tuberculosis strains isolated in Kyrgyz Republic].
Topics: Antibiotics, Antitubercular; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; Drug Resist | 2008 |
[Drug-resistant pulmonary tuberculosis at the penitentiaries].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple | 2008 |
[A role of the HLA-DRB1* genotype in the complex therapy of pulmonary tuberculosis].
Topics: Alleles; Antibiotics, Antitubercular; Antitubercular Agents; Disease Progression; Drug Resistance, B | 2008 |
[Acute respiratory distress syndrome: a manifestation of immune reconstitution in an HIV-negative patient with tuberculosis].
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Female; HIV Seronegativity; Humans; Isoniaz | 2009 |
Do we have evidence for policy changes in the treatment of children with latent tuberculosis infection?
Topics: Antitubercular Agents; Child; Cost-Benefit Analysis; Drug Administration Schedule; Drug Costs; Evide | 2009 |
[Optimization of chemotherapy regimens in children with primary pulmonary tuberculosis].
Topics: Adolescent; Age Factors; Antibiotics, Antitubercular; Antitubercular Agents; Child; Child, Preschool | 2009 |
A case of lung tuberculosis in a patient with rheumatoid arthritis treated with infliximab after antituberculosis chemoprophylaxis with isoniazid.
Topics: Aged; Antibiotic Prophylaxis; Antibodies, Monoclonal; Antitubercular Agents; Arthritis, Rheumatoid; | 2009 |
Radiographic manifestations of culture-positive pulmonary tuberculosis: cavitary or non-cavitary?
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Comorbidity; Diabetes Mellitus; Drug Resistan | 2009 |
First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Topics: Adolescent; Aged; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Female; Humans; Iran; | 2009 |
Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Cambodia; HIV Infections; HIV Seroposi | 2009 |
Lung carcinogenesis induced by chronic tuberculosis infection: the experimental model and genetic control.
Topics: Animals; Antitubercular Agents; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Chronic D | 2009 |
Coccidioides immitis and Mycobacterium tuberculosis diagnosed by endoscopic ultrasound.
Topics: Adult; Antibiotics, Antitubercular; Antifungal Agents; Antitubercular Agents; Coccidioides; Coccidio | 2009 |
[Practical value of the TB-biochip MDR test system in the rapid identification of multidrug-resistant M. tuberculosis strains].
Topics: Amino Acid Substitution; Antibiotics, Antitubercular; Bacterial Proteins; Catalase; DNA-Directed RNA | 2009 |
Study of NAT2 gene polymorphisms in an Indian population: association with plasma isoniazid concentration in a cohort of tuberculosis patients.
Topics: Acetylation; Adult; Amplified Fragment Length Polymorphism Analysis; Antitubercular Agents; Arylamin | 2009 |
Isoniazid induced gynaecomastia: a case report.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Gynecomastia; Humans; Isoniazid; Male; | 2009 |
[Fever and thin-walled cavitary lung lesions].
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Fever; Humans; Isoniazid; Male; | 2009 |
Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Botswana; CD4 Lymphocyte Count; E | 2009 |
Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Botswana; CD4 Lymphocyte Count; E | 2009 |
Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Botswana; CD4 Lymphocyte Count; E | 2009 |
Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Botswana; CD4 Lymphocyte Count; E | 2009 |
Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Botswana; CD4 Lymphocyte Count; E | 2009 |
Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Botswana; CD4 Lymphocyte Count; E | 2009 |
Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Botswana; CD4 Lymphocyte Count; E | 2009 |
Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Botswana; CD4 Lymphocyte Count; E | 2009 |
Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Botswana; CD4 Lymphocyte Count; E | 2009 |
Risk factors for failure to complete a course of latent tuberculosis infection treatment in Salvador, Brazil.
Topics: Adolescent; Adult; Antitubercular Agents; Brazil; Child; Child, Preschool; Female; Follow-Up Studies | 2009 |
Limited utility of name-based tuberculosis contact investigations among persons using illicit drugs: results of an outbreak investigation.
Topics: Adult; Aged; Cluster Analysis; Cocaine-Related Disorders; Comorbidity; Contact Tracing; Crack Cocain | 2009 |
Isoniazid-resistant disseminated Mycobacterium tuberculosis in a Jamaican infant with HIV/AIDS.
Topics: Antitubercular Agents; HIV Infections; Humans; Infant; Isoniazid; Jamaica; Male; Mycobacterium tuber | 2008 |
Sterilizing activity of R207910 (TMC207)-containing regimens in the murine model of tuberculosis.
Topics: Animals; Antitubercular Agents; Diarylquinolines; Disease Models, Animal; Drug Therapy, Combination; | 2009 |
Pulmonary tuberculosis presenting as fever without source in a pediatric patient with acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Azithromycin; Child, Preschoo | 2009 |
Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Isoni | 2009 |
Penitentiary population of Mycobacterium tuberculosis in Kyrgyzstan: exceptionally high prevalence of the Beijing genotype and its Russia-specific subtype.
Topics: Adult; Antibiotics, Antitubercular; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genetic Va | 2009 |
Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Drug Therapy, Combination; | 2009 |
Activity of the phenothiazine methdilazine alone or in combination with isoniazid or streptomycin against Mycobacterium tuberculosis in mice.
Topics: Animals; Antitubercular Agents; Isoniazid; Lung; Male; Mice; Mycobacterium tuberculosis; Organ Size; | 2009 |
[Modulatory effect of isoniazid and rifampicin in vitro on cytokine secretion in pulmonary tuberculosis].
Topics: Adolescent; Adult; Antitubercular Agents; Cytokines; Female; Follow-Up Studies; Humans; Isoniazid; L | 2009 |
Carry on doctor.
Topics: Adolescent; Antibiotics, Antitubercular; Female; Humans; Isoniazid; Lung; Radiography; Rifampin; Thr | 2009 |
Low rates of hepatotoxicity in HIV-infected children on anti-retroviral therapy with and without isoniazid prophylaxis.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antitubercular Agents; Child, Preschool; Fem | 2010 |
Experimental ocular tuberculosis in guinea pigs.
Topics: Aerosols; Animals; Antitubercular Agents; Disease Models, Animal; DNA, Bacterial; Guinea Pigs; Isoni | 2009 |
Should moxifloxacin be substituted for isoniazid as a first-line antituberculosis drug?
Topics: Antitubercular Agents; Aza Compounds; Drug Administration Schedule; Fluoroquinolones; Humans; Isonia | 2009 |
Molecular characterization of INH-resistant Mycobacterium tuberculosis isolates by PCR-RFLP and multiplex-PCR in North India.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA, Bacterial; Drug Resistance, Bacterial; Hum | 2009 |
Polymorphic exact tandem repeat A (PETRA): a newly defined lineage of mycobacterium tuberculosis in israel originating predominantly in Sub-Saharan Africa.
Topics: Africa South of the Sahara; Antitubercular Agents; Bacterial Typing Techniques; Computational Biolog | 2009 |
[Relapse rate of tuberculosis treated with standard regimen of chemotherapy].
Topics: Adolescent; Aged; Aged, 80 and over; Child; Diabetes Complications; Drug Administration Schedule; Fe | 2009 |
Contact screening and chemoprophylaxis in India's Revised Tuberculosis Control Programme: a situational analysis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Communicable Disease Contro | 2009 |
Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs.
Topics: Antitubercular Agents; Bacterial Proteins; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Ethambutol; Ge | 2010 |
Non conversion of sputum smears in new smear positive pulmonary tuberculosis patients in Yaoundé, Cameroon.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Came | 2009 |
Frequency and tolerance of antituberculosis treatment according to national guidelines for prevention of risk of tuberculosis due to tumor necrosis factor blocker treatment.
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Female; Hu | 2010 |
Evaluation of standard chemotherapy in the guinea pig model of tuberculosis.
Topics: Animals; Animals, Outbred Strains; Antitubercular Agents; Biomarkers; CD8-Positive T-Lymphocytes; Di | 2010 |
Intestinal barrier function and serum concentrations of rifampin, isoniazid and pyrazinamide in patients with pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Case-Control Studies; Female; Humans; Intestinal Absorption; Isoniazid | 2009 |
Point-of-care Arkansas method for measuring adherence to treatment with isoniazid.
Topics: Adult; Antitubercular Agents; Brazil; Female; Humans; Isoniazid; Male; Medication Adherence; Sensiti | 2010 |
Point-of-care Arkansas method for measuring adherence to treatment with isoniazid.
Topics: Adult; Antitubercular Agents; Brazil; Female; Humans; Isoniazid; Male; Medication Adherence; Sensiti | 2010 |
Point-of-care Arkansas method for measuring adherence to treatment with isoniazid.
Topics: Adult; Antitubercular Agents; Brazil; Female; Humans; Isoniazid; Male; Medication Adherence; Sensiti | 2010 |
Point-of-care Arkansas method for measuring adherence to treatment with isoniazid.
Topics: Adult; Antitubercular Agents; Brazil; Female; Humans; Isoniazid; Male; Medication Adherence; Sensiti | 2010 |
Point-of-care Arkansas method for measuring adherence to treatment with isoniazid.
Topics: Adult; Antitubercular Agents; Brazil; Female; Humans; Isoniazid; Male; Medication Adherence; Sensiti | 2010 |
Point-of-care Arkansas method for measuring adherence to treatment with isoniazid.
Topics: Adult; Antitubercular Agents; Brazil; Female; Humans; Isoniazid; Male; Medication Adherence; Sensiti | 2010 |
Point-of-care Arkansas method for measuring adherence to treatment with isoniazid.
Topics: Adult; Antitubercular Agents; Brazil; Female; Humans; Isoniazid; Male; Medication Adherence; Sensiti | 2010 |
Point-of-care Arkansas method for measuring adherence to treatment with isoniazid.
Topics: Adult; Antitubercular Agents; Brazil; Female; Humans; Isoniazid; Male; Medication Adherence; Sensiti | 2010 |
Point-of-care Arkansas method for measuring adherence to treatment with isoniazid.
Topics: Adult; Antitubercular Agents; Brazil; Female; Humans; Isoniazid; Male; Medication Adherence; Sensiti | 2010 |
Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis.
Topics: Amino Acid Substitution; Antitubercular Agents; Bacterial Proteins; Catalase; Drug Resistance, Bacte | 2010 |
Tuberculosis in UK prisoners: a challenge for control.
Topics: Antitubercular Agents; Humans; Isoniazid; Prisoners; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2010 |
Pregnancy during TNFalpha antagonist therapy: beware the rifampin-oral contraceptive interaction. Report of two cases.
Topics: Adult; Antirheumatic Agents; Antitubercular Agents; Contraceptives, Oral; Drug Interactions; Female; | 2010 |
Alpha-galactosylceramide as a therapeutic agent for pulmonary Mycobacterium tuberculosis infection.
Topics: Animals; Antigens, CD1d; Antitubercular Agents; Drug Therapy, Combination; Female; Galactosylceramid | 2010 |
Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; | 2011 |
In vitro evaluation of inhalable isoniazid-loaded surfactant liposomes as an adjunct therapy in pulmonary tuberculosis.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Adsorption; Animals; Antitubercular Agents; Biocompatible Materi | 2010 |
In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Cell Line, Tumor; Colony Count, Microbial; Drug Evaluation, Preclini | 2010 |
[A 95 year old woman with bilateral nodular pulmonary pattern].
Topics: Aged, 80 and over; Antitubercular Agents; Drug Therapy, Combination; Dyspnea; Emergencies; Fatal Out | 2012 |
Impact of adverse drug reaction and predictivity of quality of life status in tuberculosis.
Topics: Antitubercular Agents; British Columbia; Ethambutol; Female; Humans; Isoniazid; Longitudinal Studies | 2010 |
The deadly synergy of HIV and tuberculosis.
Topics: Anti-Retroviral Agents; Antitubercular Agents; Global Health; Health Policy; HIV Infections; Humans; | 2010 |
Posttreatment reactivation of tuberculosis in mice caused by Mycobacterium tuberculosis disrupted in mce1R.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Disease Models, Animal; Female; Humans; Isoniazi | 2010 |
[Phenotypic characterization of pyrazinamide-resistant Mycobacterium tuberculosis isolated in Poland].
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Ison | 2010 |
A nodulo-ulcerative lesion on the nose.
Topics: Aged, 80 and over; Antitubercular Agents; Chronic Disease; Ethambutol; Female; Humans; Isoniazid; Lu | 2010 |
Therapeutic drug monitoring for slow response to tuberculosis treatment in a state control program, Virginia, USA.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Cohort Studies; Drug Monitoring; Ethambutol; Female; | 2010 |
[Epidemiology of the resistance of Mycobacterium tuberculosis to antituberculosis drugs at the main hospital in Dakar, Senegal. A 4-year retrospective study (2000-2003)].
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Therapy, Combination; Etha | 2010 |
Pericarditis induced by prophylactic administration of isoniazid in a patient with rheumatoid arthritis.
Topics: Antirheumatic Agents; Antitubercular Agents; Arthritis, Rheumatoid; Humans; Isoniazid; Male; Methotr | 2011 |
A relook at preventive therapy for tuberculosis in children.
Topics: Antitubercular Agents; Breast Feeding; Child; Child, Preschool; Female; Humans; Infant, Newborn; Iso | 2011 |
Symptom and chest radiographic screening for infectious tuberculosis prior to starting isoniazid preventive therapy: yield and proportion missed at screening.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Female; HIV Infections; Humans; | 2010 |
Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Comorbidity; Cross-Sectional Studies; Epidemics; Eth | 2010 |
Isoniazid blood levels in patients with pulmonary tuberculosis at a tuberculosis referral center.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antitubercular Agents; Body Weight; Drug Monitoring; Fe | 2011 |
Costs and consequences of additional chest x-ray in a tuberculosis prevention program in Botswana.
Topics: Antitubercular Agents; Botswana; Cost-Benefit Analysis; Drug Resistance, Multiple, Bacterial; Health | 2011 |
Inhalable microparticles modify cytokine secretion by lung macrophages of infected mice.
Topics: Administration, Inhalation; Animals; Bronchoalveolar Lavage Fluid; Cytokines; Enzyme-Linked Immunoso | 2011 |
[Sputum smear conversion during intensive TB treatment phase according to HIV status, in hospitalised patients in Togo].
Topics: Adult; Antitubercular Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Ethambutol; Female; F | 2011 |
Variability in the population pharmacokinetics of isoniazid in South African tuberculosis patients.
Topics: Adult; Antitubercular Agents; Biological Availability; Black People; Clinical Trials as Topic; Femal | 2011 |
Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient mice.
Topics: Animals; Anti-Inflammatory Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cortisone; Di | 2011 |
Mycobacterium tuberculosis cluster with developing drug resistance, New York, New York, USA, 2003-2009.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Cluster Analysis; Disease Outbreaks; Drug Res | 2011 |
An apparently healthy young man with a peculiar-looking chest radiograph.
Topics: Adult; Antibiotics, Antitubercular; Drug Therapy, Combination; Ethambutol; Fever; HIV Seropositivity | 2011 |
[Contact tracing and prophylaxis of tuberculosis].
Topics: Antitubercular Agents; Contact Tracing; Humans; Interferon-gamma; Isoniazid; Latent Tuberculosis; Ma | 2011 |
[Pulmonary paragonimiasis].
Topics: Adult; Animals; Anthelmintics; Antitubercular Agents; Caulobacteraceae; Delayed Diagnosis; Ecuador; | 2011 |
Married to M. tuberculosis: risk of infection and disease in spouses of smear-positive tuberculosis patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Female; Humans; Isoniazid; Mala | 2011 |
[Cutaneous reaction after pyrazinamide initiation].
Topics: Adult; Antitubercular Agents; Drug Combinations; Drug Eruptions; Drug Therapy, Combination; Dysgeusi | 2011 |
Isoniazid-induced pellagra.
Topics: Antitubercular Agents; Child; Drug Therapy, Combination; Humans; Isoniazid; Male; Niacinamide; Pella | 2011 |
Pulmonary tuberculosis in infants less than one year old: implications for early diagnosis.
Topics: Antitubercular Agents; Early Diagnosis; Family; Female; Hospitals, Pediatric; Hospitals, Teaching; H | 2011 |
[Apoptosis-inducing action of antituberculosis drugs of the main group in vitro].
Topics: Antitubercular Agents; Apoptosis; Ethambutol; Humans; Isoniazid; Lymphocytes; Rifampin; Tuberculosis | 2010 |
Clinical response of newly diagnosed HIV seropositive & seronegative pulmonary tuberculosis patients with the RNTCP Short Course regimen in Pune, India.
Topics: Adult; Antitubercular Agents; Communicable Disease Control; Directly Observed Therapy; Enzyme-Linked | 2011 |
Metabolic regulation of mycobacterial growth and antibiotic sensitivity.
Topics: Acetyl Coenzyme A; Anaerobiosis; Animals; Antitubercular Agents; Bacterial Load; Bacterial Proteins; | 2011 |
Multifocal tuberculosis revealed by multiple cutaneous gummas in the immunocompetent.
Topics: Antitubercular Agents; Clavicle; Drug Therapy, Combination; Ethambutol; Humans; Immunocompetence; Is | 2011 |
Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology.
Topics: Animals; Antitubercular Agents; Blotting, Western; Colony-Forming Units Assay; Cyclic Nucleotide Pho | 2011 |
Drug susceptibility of Mycobacterium tuberculosis in patients with AIDS at a tertiary care hospital in northern India.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Antitubercular Agents; CD4 Lymphoc | 2011 |
Shorter treatment duration for selected patients with multidrug-resistant tuberculosis.
Topics: Aged; Antitubercular Agents; Cohort Studies; Drug Administration Schedule; Female; Hong Kong; Humans | 2011 |
Changes in the epidemiology of tuberculosis: the influence of international migration flows.
Topics: Adult; Africa; Age Distribution; Aged; Aged, 80 and over; Antitubercular Agents; Comorbidity; Diabet | 2011 |
Tuberculosis contact screening and isoniazid preventive therapy in a South Indian district: operational issues for programmatic consideration.
Topics: Adult; Child, Preschool; Cities; Contact Tracing; Housing; Humans; India; Isoniazid; Public Health P | 2011 |
Tuberculous damaged lung in a child.
Topics: Antitubercular Agents; Child; Drug Therapy, Combination; Ethambutol; Female; Granuloma; Humans; Ison | 2011 |
The impact and cost-effectiveness of strategies to detect drug-resistant tuberculosis.
Topics: Antitubercular Agents; Cost-Benefit Analysis; Decision Support Techniques; HIV Infections; Humans; I | 2012 |
Plasma drug activity assay for treatment optimization in tuberculosis patients.
Topics: Adult; Antitubercular Agents; Cohort Studies; Drug Monitoring; Humans; Isoniazid; Microbial Sensitiv | 2011 |
Plasma drug activity assay for treatment optimization in tuberculosis patients.
Topics: Adult; Antitubercular Agents; Cohort Studies; Drug Monitoring; Humans; Isoniazid; Microbial Sensitiv | 2011 |
Plasma drug activity assay for treatment optimization in tuberculosis patients.
Topics: Adult; Antitubercular Agents; Cohort Studies; Drug Monitoring; Humans; Isoniazid; Microbial Sensitiv | 2011 |
Plasma drug activity assay for treatment optimization in tuberculosis patients.
Topics: Adult; Antitubercular Agents; Cohort Studies; Drug Monitoring; Humans; Isoniazid; Microbial Sensitiv | 2011 |
Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions.
Topics: Animals; Antitubercular Agents; Aza Compounds; Biological Availability; Disease Models, Animal; Drug | 2012 |
Successful use of tocilizumab in a patient with nephrotic syndrome due to a rapidly progressing AA amyloidosis secondary to latent tuberculosis.
Topics: Adult; Amyloidosis; Antibodies, Monoclonal, Humanized; Antitubercular Agents; Biopsy; Colon; Humans; | 2011 |
Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients.
Topics: Acetylation; Adult; Antitubercular Agents; Arylamine N-Acetyltransferase; Brazil; Case-Control Studi | 2011 |
Palatal ulceration as the first sign of pulmonary tuberculosis: a case report.
Topics: Adult; Antitubercular Agents; Chronic Disease; Humans; Isoniazid; Male; Mouth Mucosa; Mycobacterium | 2012 |
A novel metabolite of antituberculosis therapy demonstrates host activation of isoniazid and formation of the isoniazid-NAD+ adduct.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Biotransformation; Catalase; Chromatography, Liq | 2012 |
Lack of adherence to isoniazid chemoprophylaxis in children in contact with adults with tuberculosis in Southern Ethiopia.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Contact Tracing; Ethiopia; Female; Human | 2011 |
When tuberculosis comes back: who develops recurrent tuberculosis in california?
Topics: Adult; Antitubercular Agents; California; Drug Therapy, Combination; Female; HIV; HIV Infections; Hu | 2011 |
[Sudden decrease in visual acuity and pulmonary infiltrates].
Topics: Adrenal Cortex Hormones; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Laser Coagulation; Ma | 2012 |
Adherence to isoniazid preventive therapy in children exposed to tuberculosis: a prospective study from Guinea-Bissau.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Contact Tracing; Female; Follow-Up Studi | 2011 |
Importance of confirming data on the in vivo efficacy of novel antibacterial drug regimens against various strains of Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; I | 2012 |
Genotype MTBDRplus for direct detection of Mycobacterium tuberculosis and drug resistance in strains from gold miners in South Africa.
Topics: Adult; Antitubercular Agents; Bacterial Proteins; Cross-Sectional Studies; DNA-Directed RNA Polymera | 2012 |
Resistance patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Nairobi.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Resistance, Bacterial; Fem | 2012 |
φ(2)GFP10, a high-intensity fluorophage, enables detection and rapid drug susceptibility testing of Mycobacterium tuberculosis directly from sputum samples.
Topics: Antitubercular Agents; Bacteriophages; Genes, Reporter; Genetic Vectors; Green Fluorescent Proteins; | 2012 |
First evaluation of an improved assay for molecular genetic detection of tuberculosis as well as rifampin and isoniazid resistances.
Topics: Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; DNA, Bacterial; Humans; Iso | 2012 |
An isoniazid analogue promotes Mycobacterium tuberculosis-nanoparticle interactions and enhances bacterial killing by macrophages.
Topics: Animals; Antitubercular Agents; Biological Availability; Cells, Cultured; Drug Compounding; Drug Del | 2012 |
Genetic variants in antioxidant pathway: risk factors for hepatotoxicity in tuberculosis patients.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Basic-Leucine Zipper Transcription Factors; C | 2012 |
[Neonatal exposure to active pulmonary tuberculosis in a maternity ward: screening and clinical course of a cohort of exposed infants].
Topics: Antitubercular Agents; Cohort Studies; Cross Infection; Female; Follow-Up Studies; Humans; Infant; I | 2012 |
Reduced antituberculosis drug concentrations in HIV-infected patients who are men or have low weight: implications for international dosing guidelines.
Topics: Adolescent; Adult; Age Factors; Aged; Antitubercular Agents; Birth Weight; Drug Resistance, Multiple | 2012 |
Reduced antituberculosis drug concentrations in HIV-infected patients who are men or have low weight: implications for international dosing guidelines.
Topics: Adolescent; Adult; Age Factors; Aged; Antitubercular Agents; Birth Weight; Drug Resistance, Multiple | 2012 |
Reduced antituberculosis drug concentrations in HIV-infected patients who are men or have low weight: implications for international dosing guidelines.
Topics: Adolescent; Adult; Age Factors; Aged; Antitubercular Agents; Birth Weight; Drug Resistance, Multiple | 2012 |
Reduced antituberculosis drug concentrations in HIV-infected patients who are men or have low weight: implications for international dosing guidelines.
Topics: Adolescent; Adult; Age Factors; Aged; Antitubercular Agents; Birth Weight; Drug Resistance, Multiple | 2012 |
A case of isoniazid-induced thrombocytopenia: recovery with immunoglobulin therapy.
Topics: Antitubercular Agents; Humans; Immunization, Passive; Immunoglobulins, Intravenous; Isoniazid; Male; | 2012 |
Prevalence of peripheral neuropathy in antiretroviral therapy naïve HIV-positive patients and the impact on treatment outcomes--a retrospective study from a large urban cohort in Johannesburg, South Africa.
Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Coinfection; Female; HIV Infections; HIV-1; Humans; I | 2012 |
Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection.
Topics: Adult; Animals; Antitubercular Agents; Apoptosis; Bronchoalveolar Lavage Fluid; Calcium; Cell Line, | 2012 |
Mouse model for efficacy testing of antituberculosis agents via intrapulmonary delivery.
Topics: Administration, Inhalation; Animals; Antitubercular Agents; Female; Isoniazid; Lung; Mice; Mice, Inb | 2012 |
Drug susceptibility profiles of Mycobacterium tuberculosis isolates at Mangalore.
Topics: Antitubercular Agents; Ethambutol; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mycobacter | 2010 |
Early-onset severe isoniazid-induced motor-dominant neuropathy: a case report.
Topics: Adult; Antitubercular Agents; Humans; Isoniazid; Male; Motor Neuron Disease; Peripheral Nervous Syst | 2012 |
Relatively low primary drug resistant tuberculosis in southwestern Ethiopia.
Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Cross-Sectional Studies; Drug Resistance, Mul | 2012 |
[Paradoxical radiologic progression despite appropriate anti-tuberculous therapy].
Topics: Aged; Antitubercular Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Ethambutol; Humans; Isoniaz | 2012 |
Chemoprophylaxis with isoniazid in liver transplant recipients.
Topics: Adult; Aged; Antitubercular Agents; Chi-Square Distribution; Drug Administration Schedule; Drug Ther | 2012 |
Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Disease Models, Animal; Drug Administra | 2012 |
Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [¹⁸F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography.
Topics: Animals; Antitubercular Agents; Bacterial Load; Disease Models, Animal; Fluorodeoxyglucose F18; Gran | 2012 |
In vitro and in vivo activity of clofazimine against Mycobacterium tuberculosis persisters.
Topics: Animals; Antitubercular Agents; Aza Compounds; Chronic Disease; Clofazimine; Disease Models, Animal; | 2012 |
Well-quantified tuberculosis exposure is a reliable surrogate measure of tuberculosis infection.
Topics: Adult; Age Factors; Antitubercular Agents; Chi-Square Distribution; Child; Child, Preschool; Communi | 2012 |
Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting.
Topics: Antitubercular Agents; Child; Child, Preschool; Cost-Benefit Analysis; Decision Support Techniques; | 2013 |
Primary isoniazid resistance in Mycobacterium bovis disease: a prospect of concern.
Topics: Abattoirs; Adult; Agriculture; Antitubercular Agents; Drug Resistance, Bacterial; Female; Humans; In | 2012 |
Outcome of neonates exposed to active pulmonary tuberculosis.
Topics: Antitubercular Agents; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Isoniazid; Male; | 2012 |
Feasibility of a fixed-dose regimen of pyrazinamide and its impact on systemic drug exposure and liver safety in patients with tuberculosis.
Topics: Antitubercular Agents; Area Under Curve; Body Weight; Drug Dosage Calculations; Ethnicity; Female; H | 2012 |
Management of and risk factors related to hepatotoxicity during tuberculosis treatment.
Topics: Adult; Age Factors; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Comorbidity; Drug | 2012 |
Use of multiplex allele-specific polymerase chain reaction (MAS-PCR) to detect multidrug-resistant tuberculosis in Panama.
Topics: Alleles; Antitubercular Agents; Bacterial Proteins; Catalase; Drug Resistance, Multiple, Bacterial; | 2012 |
Study of rifampicin and isoniazid resistance mutation genes of M. tuberculosis isolates in Nepal.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; DNA, Bacterial; D | 2011 |
A case of latent tuberculosis reactivation in a patient treated with ustekinumab without concomitant isoniazid chemoprophylaxis in the PEARL trial.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antitubercular Agents; Dermatologic Agents; Humans; Isoniaz | 2013 |
Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques.
Topics: Animals; Antiprotozoal Agents; Antitubercular Agents; Disease Models, Animal; Dose-Response Relation | 2012 |
Seizures with single therapeutic dose of isoniazid.
Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Male; Seizures; Tuberculo | 2012 |
Pyrazinamide may improve fluoroquinolone-based treatment of multidrug-resistant tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; | 2012 |
Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; B-Lymphocytes; Cohort Studies; Complement C1q; Compl | 2013 |
Development and characterization of ligand-appended liposomes for multiple drug therapy for pulmonary tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Delivery Systems; Drug Therapy, Combination; Humans; Isoniazid; | 2013 |
Therapeutic immunization against Mycobacterium tuberculosis is an effective adjunct to antibiotic treatment.
Topics: Adjuvants, Immunologic; Animals; Antigens, Bacterial; Antitubercular Agents; Bacterial Proteins; Che | 2013 |
Adherence to and outcome of isoniazid chemoprophylaxis among household contact children of adults having pulmonary tuberculosis in Alexandria, Egypt.
Topics: Adult; Chemoprevention; Child; Cross-Sectional Studies; Egypt; Humans; Isoniazid; Tuberculosis, Pulm | 2012 |
[A case of Stevens-Johnson syndrome (SJS) progressive toxic epidermal necrolysis (TEN) onset during hyposensitization therapy for pulmonary tuberculosis complicated with dermatomyositis].
Topics: Dermatomyositis; Desensitization, Immunologic; Exanthema; Female; Humans; Immunoglobulins, Intraveno | 2012 |
Description of pediatric tuberculosis evaluated in a referral center in istanbul Turkey.
Topics: Adolescent; BCG Vaccine; Child; Child, Preschool; Female; Humans; Infant; Isoniazid; Male; Mycobacte | 2012 |
Eliminating tuberculosis one neighborhood at a time.
Topics: Adolescent; Adult; Antitubercular Agents; Black or African American; Child; Disease Eradication; Fem | 2013 |
[Directly observed treatment for tuberculosis in a Buenos Aires City hospital].
Topics: Adult; Antitubercular Agents; Argentina; Directly Observed Therapy; Drug Therapy, Combination; Etham | 2012 |
Latent infection treatment to prevent TB transmission in school settings.
Topics: Antitubercular Agents; Humans; Isoniazid; Latent Tuberculosis; Schools; Taiwan; Tuberculin Test; Tub | 2012 |
Multidrug-resistant tuberculosis in children: evidence from global surveillance.
Topics: Adolescent; Adult; Age Distribution; Antitubercular Agents; Child; Child, Preschool; Female; Humans; | 2013 |
The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study.
Topics: Adult; Antitubercular Agents; Bacterial Typing Techniques; Cohort Studies; Drug Resistance, Multiple | 2012 |
Diabetes is associated with drug-resistant tuberculosis in Eastern Taiwan.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Cross-Sectional Studies; Di | 2013 |
Tuberculosis treatment survival of HIV positive TB patients on directly observed treatment short-course in Southern Ethiopia: a retrospective cohort study.
Topics: Adult; Anti-Retroviral Agents; Antitubercular Agents; Coinfection; Drug Administration Schedule; Fem | 2012 |
Different immunosuppressive mechanisms in multi-drug-resistant tuberculosis and non-tuberculous mycobacteria patients.
Topics: Adult; Aged; Antigens, Bacterial; Antigens, CD; Bacterial Proteins; Cells, Cultured; Cytokines; Fema | 2013 |
[Mycobacterium xenopi lung infection in a patient with multiple lung cysts that responded well to chemotherapy: a case report].
Topics: Adult; Clarithromycin; Cysts; Ethambutol; Humans; Isoniazid; Lung Diseases; Male; Mycobacterium Infe | 2012 |
Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region.
Topics: Adult; Amikacin; Antitubercular Agents; Capreomycin; Ethionamide; Extensively Drug-Resistant Tubercu | 2013 |
Will tuberculosis become resistant to all antibiotics?
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivit | 2001 |
Plummeting lenses in the TB clinic.
Topics: Antitubercular Agents; Child; Folic Acid; Homocystinuria; Humans; Isoniazid; Lens Subluxation; Male; | 2002 |
Pulmonary alveolar proteinosis and tuberculosis in a diabetic patient: a rare or a seldom diagnosed association?
Topics: Adult; Diabetes Complications; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Pulmonary Alve | 2002 |
[Chemotherapy with isoniazid and rifampicin for pulmonary tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Japan; Pyrazinamide; Reference | 2002 |
[Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Drug Res | 2002 |
[Type of isoniazid (INH) acetylation determined in tuberculosis patients treated at the Institute of Tuberculosis and Lung Diseases in Warsaw during the years 1990-1997].
Topics: Acetylation; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Dose-Response Relationship, Drug | 2002 |
Solitary pontine tuberculoma.
Topics: Aged; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; | 2002 |
Tuberculosis re-treatment outcomes within the public service in Nairobi, Kenya.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; AIDS-Related Opportunistic Infections; Antitubercular Ag | 2002 |
Isoniazid-resistant cavitary tuberculosis in a physician following isoniazid prophylaxis.
Topics: Adult; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Infecti | 2002 |
[Pulmonary tuberculosis presenting as tubercular lupus].
Topics: Adolescent; Antitubercular Agents; Biopsy; Drug Combinations; Female; Humans; Isoniazid; Lupus Vulga | 2002 |
[Myrin P in the combined treatment of tuberculosis].
Topics: Adolescent; Adult; Antitubercular Agents; Drug Combinations; Drug Resistance, Multiple, Bacterial; E | 2002 |
Two cases of pulmonary tuberculosis caused by Mycobacterium tuberculosis subsp canetti.
Topics: Adult; Antitubercular Agents; Bacterial Typing Techniques; DNA Fingerprinting; Humans; Isoniazid; Ma | 2002 |
Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Child; Drug Therapy, Co | 2002 |
Inhibition of Mycobacterium tuberculosis glutamine synthetase as a novel antibiotic strategy against tuberculosis: demonstration of efficacy in vivo.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Colony Count, Microbial; Disease Models, Anim | 2003 |
[Treatment of patients with destructive pulmonary tuberculosis with concomitant diabetes mellitus].
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Diabetes Complications; Diabetes Mellitus | 2002 |
[Optimization of indirect endolymphatic injection of isoniazid in pulmonary tuberculosis].
Topics: Adolescent; Antitubercular Agents; Female; Humans; Injections, Intralymphatic; Isoniazid; Male; Midd | 2002 |
[Pathogenetic mechanisms of action of tarry substances and Mycobacterium tuberculosis in guinea pigs and rats].
Topics: Animals; Antitubercular Agents; Arginase; Drug Combinations; Guinea Pigs; Isoniazid; Liver; Lung; My | 2002 |
Determination of the acetylator phenotype in Moroccan tuberculosis patients using isoniazid as metabolic probe.
Topics: Acetylation; Adolescent; Adult; Aged; Antitubercular Agents; Arylamine N-Acetyltransferase; Female; | 2002 |
Molecular fingerprinting of isoniazid-resistant Mycobacterium tuberculosis isolates from chest diseases hospital in Kuwait.
Topics: Antitubercular Agents; Bacterial Proteins; Bacterial Typing Techniques; DNA Fingerprinting; DNA Tran | 2002 |
[The evolution of threshold values of air conduction in the extended high frequency range (9-18 kHz) in patients suffering from the pulmonary tuberculosis treated with combination of SM, INH, RFM, and PZA].
Topics: Adult; Antitubercular Agents; Audiometry, Pure-Tone; Auditory Threshold; Case-Control Studies; Deafn | 2002 |
Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Confidence Intervals; D | 2003 |
Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Confidence Intervals; D | 2003 |
Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Confidence Intervals; D | 2003 |
Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Confidence Intervals; D | 2003 |
[Problems of epidemiology, diagnosis and treatment of caseous pneumonia].
Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents; Antitubercular Agents; Drug Combinations; Drug The | 2002 |
Pyrazinamide and rifampin vs isoniazid for the treatment of latent tuberculosis: improved completion rates but more hepatotoxicity.
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Chemical and Drug Induc | 2003 |
Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Directly Observed Therapy; Ethambutol; Follow-Up | 2002 |
Drug resistance and genotypes of strains of Mycobacterium tuberculosis isolated from human immunodeficiency virus-infected and non-infected tuberculosis patients in Bauru, São Paulo, Brazil.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Brazil; DNA Fingerprinting; Fem | 2002 |
Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antitubercular Agents; Chemical and Drug In | 2003 |
[Preliminary study on isoniazid-epiroprim combination in a tuberculosis murine model].
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, | 2002 |
Drug-resistant Mycobacterium tuberculosis among new tuberculosis patients, Yangon, Myanmar.
Topics: AIDS-Related Opportunistic Infections; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; My | 2003 |
Encephalopathy caused by isoniazid in a patient with end stage renal disease with extrapulmonary tuberculosis.
Topics: Antitubercular Agents; Humans; Isoniazid; Kidney Failure, Chronic; Male; Middle Aged; Neurotoxicity | 2003 |
The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996-2000.
Topics: Antitubercular Agents; Cycloserine; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial | 2003 |
[Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Directly Observed Therapy; Drug Resistance, Mult | 2002 |
Low level of compliance with tuberculosis treatment in children: monitoring by urine tests.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Child; Drug Therapy, Combination; Humans; Isonia | 2003 |
[Antituberculous measures according to the results of Mantoux test].
Topics: Adolescent; Algorithms; Antitubercular Agents; BCG Vaccine; Child; Humans; Isoniazid; Tuberculin Tes | 2003 |
Treatment outcome of tuberculosis among Saudi nationals: role of drug resistance and compliance.
Topics: Antibiotics, Antitubercular; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Prevalence | 2003 |
[Tuberculous peripheral multifocal choroiditis].
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antitubercular Agents; Choroiditis; Drug Therapy, Co | 2003 |
Long-term tolerance and effectiveness of moxifloxacin therapy for tuberculosis: preliminary results.
Topics: Aged; Anti-Infective Agents; Antitubercular Agents; Aza Compounds; Drug Therapy, Combination; Female | 2003 |
[Pulmonary cryptococcosis combined with pulmonary tuberculosis].
Topics: Cryptococcosis; Diabetes Complications; Diagnosis, Differential; Drug Therapy, Combination; Ethambut | 2003 |
Results of an extended tuberculosis screening programme among sixth formers in a London school--more questions than answers.
Topics: Adolescent; Adult; Antitubercular Agents; BCG Vaccine; Drug Resistance, Microbial; Female; Guideline | 2003 |
Role of isoniazid in once-weekly rifapentine treatment of pulmonary tuberculosis.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Biological Availability; Controlled Clinical Tri | 2003 |
Use of isoniazid for latent tuberculosis infection in a public health clinic.
Topics: Adolescent; Adult; Age Factors; Aged; Alcoholism; Antitubercular Agents; Chemical and Drug Induced L | 2003 |
Isoniazid-induced anaphylaxis.
Topics: Adult; Anaphylaxis; Antitubercular Agents; Humans; Isoniazid; Male; Prisoners; Skin Tests; Tuberculo | 2003 |
Follow-up of compliance with tuberculosis treatment in children: monitoring by urine tests.
Topics: Antitubercular Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administratio | 2003 |
[The short-term and long-term treatment outcomes in patients with pulmonary tuberculosis positive for drug-resistant and sensitive strains].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Drug Therapy, Combination; | 2003 |
[Follow-up observation on relapse of smear negative pulmonary tuberculosis after short-course chemotherapy].
Topics: Antitubercular Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male | 2003 |
[A case of isoniazid sodium methanesulfonate induced interstitial pneumonia].
Topics: Aged; Antitubercular Agents; Humans; Isoniazid; Lung Diseases, Interstitial; Male; Tuberculosis, Pul | 2003 |
[Remission of pulmonary alveolar proteinosis during antituberculosis chemotherapy].
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Pulmon | 2003 |
Development of tuberculosis in a patient treated with infliximab who had received prophylactic therapy with isoniazid.
Topics: Aged; Antibodies, Monoclonal; Antirheumatic Agents; Antitubercular Agents; Arthritis, Rheumatoid; Dr | 2003 |
[Therapy strategy in the treatment of patients with drug-resistant pulmonary tuberculosis].
Topics: Antibiotics, Antitubercular; Antiviral Agents; Aprotinin; Humans; Isoniazid; Rifampin; Tuberculosis, | 2003 |
Isoniazid for latent tuberculosis infection: approaching 40 and reaching its prime.
Topics: Antitubercular Agents; Drug Monitoring; Humans; Isoniazid; Safety; Tuberculosis, Pulmonary | 2003 |
Chemotherapeutic potential of orally administered poly(lactide-co-glycolide) microparticles containing isoniazid, rifampin, and pyrazinamide against experimental tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Area Under Curve; Biocompatible Materia | 2003 |
Reactivation of latent tuberculosis infection in TNF-deficient mice.
Topics: Animals; Cell Migration Inhibition; Chemokines; Down-Regulation; Granuloma; Isoniazid; Lymphocyte Ac | 2003 |
TREATMENT of pulmonary tuberculosis with isoniazid; an interim report to the Medical Research Council by their Tuberculosis Chemotherapy Trials Committee.
Topics: Biomedical Research; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
ISONIAZID in pulmonary tuberculosis.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Therapeutic value of isonicotinic acid hydrazide in pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[First clinical results obtained with isoniazid in the treatment of pulmonary tuberculosis; preliminary note].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Bacteriological evolution of patients treated with isoniazid; preliminary note].
Topics: Biological Evolution; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Hematological studies in patients treated with isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Tuberculous empyema and isoniazid instilled locally].
Topics: Empyema, Tuberculous; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pul | 1952 |
[Treatment of pulmonary tuberculosis with intrabronchial instillations of isoniazid; preliminary note].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
ISONICOTINIC acid hydrazide.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Preliminary clinical results of the therapy of tuberculosis with isonicotinic acid hydrazide].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[First therapeutic tests of isonicotinic acid hydrazide in pulmonary tuberculosis].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Clinical-radiological, hemato-medullary and biological report on isonicotinic acid hydrazide therapy of tuberculosis].
Topics: Adrenal Medulla; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Early results of isonicotinic acid hydrazide therapy].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[First case of resistence against rimifon].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
Hazards of isoniazid therapy in epileptics; report of one case.
Topics: Epilepsy; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
Control study of comparative efficacy of isoniazid, streptomycin-isoniazid, and streptomycin-paraaminosalicylic acid in pulmonary tuberculosis therapy. I. Report on twelve-week observations on 526 patients.
Topics: Aminosalicylic Acid; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tube | 1952 |
Isoniazid in pulmonary tuberculosis; its use with and without streptomycin.
Topics: Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
ISONIAZID.
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Isonicotinic acid hydrazide in the treatment of pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Early clinical and radiological results of isonicotinic acid hydrazide therapy of pulmonary tuberculosis].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Isonicotinic acid hydrazide in the treatment of pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Laboratory observations with the aid of culture on the treatment of tuberculosis with isonicotinic acid hydrazide].
Topics: Isoniazid; Laboratories; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Streptomycin and isonicotinic acid hydrazide in the treatment of pulmonary tuberculosis].
Topics: Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Clinical experience in therapy of pulmonary tuberculosis with isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
Isonicotinic acid hydrazide in the treatment of pulmonary tuberculosis.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Further date on isonicotinic acid hydrazide; posology and mechanism of action].
Topics: Isoniazid; Niacin; Nicotinic Acids; Phoeniceae; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
Effects of isonicotinic acid hydrazide in mentally ill patients.
Topics: Isoniazid; Mental Disorders; Mentally Ill Persons; Niacin; Nicotinic Acids; Tuberculosis; Tuberculos | 1953 |
[Acquired resistance of Mycobacterium tuberculosis to isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosi | 1952 |
[Experiences at the Institute Carlo Forlanini with a new chemical preparation in the treatment of tuberculosis; isonicotinic acid hydrazide].
Topics: Academies and Institutes; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Considerations on rapid elision of tuberculous caverns during the treatment with isonicotinic acid hydrazide].
Topics: Caves; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Observations on appearance of new foci or foci which appear as such during the treatment of pulmonary tuberculosis with isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
ISONICOTINIC acid hydrazide; further experiences by a human guinea-pig.
Topics: Guinea Pigs; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Results of 20 cases of pulmonary tuberculosis treated with isonicotinic acid hydrazide; suggestions about this drug].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Treatment of pulmonary tuberculosis with isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Isonicotinic acid hydrazide in the treatment of silicotuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Silicotuberculosis; Tuberculosis; Tuberculosis, Pulmo | 1952 |
[Results of isonicotinic acid hydrazide therapy (in certain cases associated with streptomycin) of 70 cases of pulmonary and extra-pulmonary tuberculosis; three months follow-up].
Topics: Follow-Up Studies; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tuberc | 1952 |
[Failure in the treatment with isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
Isonicotinic acid hydrazide in tuberculosis in man.
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Miliary; Tuberculosis, Pulmonary | 1952 |
Development of drug resistance to isoniazid in cases of pulmonary tuberculosis.
Topics: Drug Resistance; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonar | 1952 |
Isoniazid in the treatment of pulmonary tuberculosis.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[First experiences with the isonicotinic acid hydrazide preparation Neoteben].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
Isoniazid therapy in pulmonary tuberculosis.
Topics: Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Therapy of tuberculosis with isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
Control study of comparative efficacy of isoniazid streptomycin-isoniazid, and streptomycin-para-aminosalicylic acid in pulmonary tuberculosis therapy.
Topics: Aminosalicylic Acid; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis, Pulm | 1953 |
[Antituberculous hemagglutination during the treatment with isonicotinic acid hydrazide].
Topics: Hemagglutination; Hemagglutination Tests; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tubercul | 1952 |
Isonicotinic acid hydrazide in pulmonary tuberculosis.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Isonicotinic acid hydrazide in chronic cavitary pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Preliminary findings in the application of rimifon in the treatment of pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Prophylaxis of tuberculosis with isonicotinic acid hydrazide in subjects living with patients affected with open tuberculosis].
Topics: Isoniazid; Life; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Isonicotinic acid hydrazide in the treatment of pulmonary tuberculosis; initial results].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
Isonicotinic acid hydrazide in advanced pulmonary tuberculosis.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Results of first trials with isonicotinic acid hydrazide in several cases of pulmonary tuberculosis at the Sousa Martins Sanatorium].
Topics: Animals; Dolphins; Hospitals; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmon | 1952 |
[Effects of isonicotinic acid hydrazide (neoteben, rimifon) on humoral blood picture in pulmonary tuberculosis].
Topics: Isoniazid; Niacin; Nicotinic Acids; Thoracic Cavity; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Report on a three month period of clinical tests of isonicotinic acid hydrazide in pulmonary tuberculosis in adults].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Bacterial sensitivity in pulmonary tuberculosis under isonicotinic acid hydrazide therapy].
Topics: Isoniazid; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Tuberculosis, Pulmonary | 1952 |
[Isonicotinic acid hydrazide therapy in selected tuberculosis cases in the McKnight State Sanatorium in Texas].
Topics: Hospitals; Isoniazid; Niacin; Nicotinic Acids; Texas; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[First results with isonicotinic acid hydrazide in laryngopulmonary tuberculosis].
Topics: Character; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Peripheral blood picture in patients treated with isonicotinic acid hydrazide for pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Certain considerations on the action of isonicotinic acid hydrazide in pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Observations and study on the treatment of pulmonary tuberculosis with isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
Therapy of pulmonary tuberculosis with isoniazid alone and in combination with streptomycin and with para-amino-salicylic acid.
Topics: Amino Acids; Aminosalicylic Acid; Isoniazid; Salicylic Acid; Streptomycin; Tuberculosis; Tuberculosi | 1952 |
[Isonicotinic acid hydrazide therapy of pulmonary tuberculosis].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Our experience with the treatment of pulmonary tuberculosis with the isonicotinic acid hydrazide, rimifon, for three months].
Topics: Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
Isoniazid in the treatment of pulmonary tuberculosis.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
Isonicotinic acid hydrazide in pulmonary tuberculosis.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[First clinical observations and results of rimifon].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Preliminary anatomo-histological observations on the effects of isonicotinic acid hydrazide in various tuberculous processes].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Therapeutic effect of isonicotinic acid hydrazide on various tuberculous processes in adolescent].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Effect of isonicotinic acid hydrazide on the circulatory apparatus in pulmonary tuberculosis].
Topics: Cardiovascular System; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
ISONIAZID in the treatment of pulmonary tuberculosis; second report to the Medical Research Council by their Tuberculosis Chemotherapy Trials Committee.
Topics: Biomedical Research; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
STREPTOMYCIN and isoniazid.
Topics: Aminosalicylic Acid; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tube | 1953 |
[Study of 130 cases of grave pulmonary tuberculosis treated for a minimum of 3 months with isonicotinic acid hydrazide (Rimifon)].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[First clinical observations of the patients treated with rimifon].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Results in isonicotinic acid hydrazide therapy of pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Effect of isonicotinic acid hydrazide in tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Rimifon].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Tuberculosis chemotherapy with rimifon (Roche)].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
Isoniazid in pulmonary tuberculosis.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[First results of the treatment of pulmonary tuberculosis with isonicotinic acid hydrazide in the sanatorium of Bhannès].
Topics: Hospitals; Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[First clinical results in the treatment of pulmonary tuberculosis with isonicotinic acid hydrazide].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
Isoniazid in the treatment of tuberculosis.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[First clinical observations on patients treated with Rimifon].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Meningeal; Tuberculosis, Pulmonary | 1952 |
[On the combined chemotherapy of pulmonary tuberculosis with special reference to the isonicotinic acid hydrazide (Neoteben)].
Topics: Drug Therapy, Combination; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Effect of the purity of isonicotinic acid hydrazide in the genesis of secondary phenomena in tuberculosis therapy; preventive note].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Therapy of pulmonary tuberculosis with isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Clinical results after three months of isonicotinic acid hydrazide therapy in the Sanatorium of Pineta di Sortenna].
Topics: Hospitals; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Effect of isonicotinic acid hydrazide therapy on the adrenal cortex].
Topics: Adrenal Cortex; Isoniazid; Niacin; Nicotinic Acids; Steroids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Isonicotinic acid hydrazide and liver function; value of some colloidal lability tests].
Topics: Digestion; Isoniazid; Liver; Liver Function Tests; Niacin; Nicotinic Acids; Tuberculosis; Tuberculos | 1952 |
[Middlebrook Dubos reaction in pulmonary tuberculosis subjects treated with isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Medullary blood picture in pulmonary tuberculosis subjects treated with isonicotinic acid hydrazide].
Topics: Adrenal Medulla; Bone Marrow; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmon | 1952 |
[Isonicotinic acid hydrazide].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Notes on isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Clinical results obtained in tuberculosis with isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
Isonicotinic acid hydrazide; some sensory disturbances during therapy.
Topics: Isoniazid; Neuritis; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
Preliminary report on isoniazid.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
Isonicotinic acid hydrazide in pulmonary tuberculosis; review of twenty cases.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Experience at the Institute Carlo Forlanini with isonicotinic acid hydrazide therapy of tuberculosis].
Topics: Academies and Institutes; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
Control study of comparative efficacy of isoniazid, streptomycin-isoniazid, and streptomycin-para-aminosalicylic acid in pulmonary tuberculosis therapy. III. Report on twenty-eight-week observations on 649 patients with streptomycin-susceptible infectio
Topics: Aminosalicylic Acid; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis, Pulm | 1953 |
[Isonicotinic acid hydrazide and capillary fragility].
Topics: Capillaries; Capillary Fragility; Cardiovascular System; Isoniazid; Niacin; Nicotinic Acids; Tubercu | 1952 |
[Study of antituberculous synthetics from the standpoint of bacteriostasis in vitro; bacteriostatic activity of isonicotinic acid hydrazide and its antituberculous activity in vivo].
Topics: In Vitro Techniques; Isoniazid; Niacin; Nicotinic Acids; Resins, Plant; Resins, Synthetic; Thiram; T | 1953 |
[Isonicotinic acid hydrazide in therapy of pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
Toxic hepatitis with jaundice occuring in a patient treated with isoniazid.
Topics: Chemical and Drug Induced Liver Injury; Hepatitis; Hepatitis A; Isoniazid; Jaundice; Niacin; Nicotin | 1953 |
Pyricidin (isoniazid) in the treatment of pulmonary tuberculosis.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
Isonicotinic acid hydrazide in the treatment of pulmonary tuberculosis.
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Variations of the Thorn index caused by isonicotinic acid hydrazide].
Topics: Adrenal Cortex; Adrenal Cortex Function Tests; Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculo | 1952 |
[Experiences in the treatment of tuberculous empyema with isonicotinic acid hydrazide].
Topics: Empyema, Tuberculous; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Early results in cases of three patients with isonicotinic acid hydrazide].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
ISONICOTINIC acid hydrazide; further experiences.
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
Isonicotinic acid hydrazide in the treatment of pulmonary tuberculosis; preliminary report of the Veterans Administration-Army-Navy cooperative study.
Topics: Isoniazid; Military Personnel; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary; Unite | 1952 |
[Tissue reaction in pulmonary tuberculosis during isonicotinic acid hydrazide therapy].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Results obtained in 89 hospitalized patients by isonicotinic acid hydrazide therapy of pulmonary tuberculosis].
Topics: Isoniazid; Niacin; Nicotinic Acids; Patients; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Purpura and meningeal reaction in two pulmonary tuberculosis patients treated with isonicotinic acid hydrazide].
Topics: IgA Vasculitis; Isoniazid; Niacin; Nicotinic Acids; Purpura; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isonicotinic acid hydrazide therapy of miliary tuberculosis, tuberculous meningitis and malignant primary infections].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Meningeal; Tuberculosis, | 1952 |
[Effect of isonicotinic acid hydrazide in ineffective pneumothorax due to persistent insufflated caverns].
Topics: Caves; Insufflation; Isoniazid; Niacin; Nicotinic Acids; Pneumothorax; Pneumothorax, Artificial; Tub | 1952 |
[Isonicotinic hydrazide (rimifon) in therapy of advanced tuberculosis].
Topics: Anti-Bacterial Agents; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Rimifon in the treatment of tuberculosis].
Topics: Collapse Therapy; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
Peripheral neuropathy due to isoniazid; report of two cases.
Topics: Disease; Isoniazid; Niacin; Nicotinic Acids; Peripheral Nerves; Peripheral Nervous System Diseases; | 1953 |
[Experiences with isonicotinic acid hydrazide in the treatment of pulmonary tuberculosis in children].
Topics: Child; Humans; Infant; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pu | 1952 |
[Considerations on first results in the treatment of pulmonary tuberculosis in children with isonicotinic acid hydrazide].
Topics: Child; Humans; Infant; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pu | 1952 |
[Hemoptysis complicating isonicotinic acid hydrazide therapy].
Topics: Hemoptysis; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Clinical studies on isonicotinic acid hydrazide].
Topics: Biomedical Research; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Results of isonicotinic acid hydrazide therapy of 97 cases of tuberculosis in a sanatorium].
Topics: Hospitals; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Impressions on the effect of isonicotinic acid hydrazide therapy of pulmonary tuberculosis].
Topics: Isoniazid; Niacin; Nicotinic Acids; Social Behavior; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Isonicotinic acid hydrazide in the treatment of pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[First research on sub-occipital or intraspinal injection of isonicotinic acid hydrazide in animals and man and first impressions on the activity of the preparation in tuberculous meningitis and primary tuberculosis in children].
Topics: Child; Infant; Injections, Spinal; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, M | 1952 |
[Isoniazid in the treatment of pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Present results of tuberculosis therapy by isonicotinic acid hydrazide in children (Nicozyd)].
Topics: Child; Humans; Infant; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Observations on a case of pulmonary tuberculosis treated with isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Use of isonicotinic acid hydrazide in bronchial tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Use of isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Use of PAS with isonicotinic acid hydrazide in pulmonary tuberculosis].
Topics: Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Tuberculin sensitivity in the course of treatment with isoniazid].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculin; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Observations on the treatment of pulmonary tuberculosis with rimifon].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Treatment of pulmonary tuberculosis with isonicotinic acid hydrazide; preliminary results in 50 patients].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Dramatic cure of secondary lingual tuberculosis and unchanged pulmonary and general picture in the treatment with isonicotinic acid hydrazide].
Topics: Isoniazid; Lupus Vulgaris; Niacin; Nicotinic Acids; Tongue Diseases; Tuberculosis; Tuberculosis, Pul | 1953 |
[Results of the treatment of pulmonary tuberculosis with phthivazide; preliminary communication].
Topics: Communication; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Six months experience with the treatment of pulmonary tuberculosis with isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
Toxic psychosis due to overdosage of isonicotinic acid hydrazide.
Topics: Humans; Isoniazid; Mental Disorders; Niacin; Nicotinic Acids; Psychoses, Substance-Induced; Psychoti | 1953 |
[Experience with isonicotinic acid hydrazide; results of 6 months of treatment].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Studies on the effect of isonicotinic acid hydrazide in 44 cases of pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Treatment of pulmonary tuberculosis with isonicotinic acid hydrazide for six months in a sanatorium].
Topics: Aminosalicylic Acid; Anti-Bacterial Agents; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberc | 1953 |
Isoniazid and streptomycin in the treatment of pulmonary tuberculosis.
Topics: Aminosalicylic Acid; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tube | 1953 |
[Isoniazid in the treatment of sixty-two cases of pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Failure of isonicotinic acid hydrazide therapy in pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Half year experience in the application of isonicotinic acid hydrazide in the treatment of pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Preliminary results of isonicotinic acid hydrazide therapy of pulmonary tuberculosis].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Ioniazide (isonicotinic acid hydrazide) therapy in Finnish sanatoria].
Topics: Hospitals; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
Treatment of advanced caseouspneumonic tuberculosis with isonicotinic acid hydrazides.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
Isonicotinic acid hydrazide in excisional surgery of the tuberculous lung.
Topics: Isoniazid; Niacin; Nicotinic Acids; Pulmonary Surgical Procedures; Tuberculosis; Tuberculosis, Pulmo | 1953 |
Chronic pulmonary tuberculosis complicated by Hodgkin's disease and treated with isoniazid and streptomycin: autopsy findings in a case.
Topics: Autopsy; Hodgkin Disease; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; | 1953 |
[First remote results of isonicotinic acid hydrazide therapy of pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Possible hemoptoic effect of isonicotinic acid hydrazide].
Topics: Hemoptysis; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Stimulation of the development of Mycobacterium tuberculosis in subjects of prolonged isonicotinic acid hydrazide therapy].
Topics: Isoniazid; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonar | 1953 |
[Treatment of pulmonary tuberculosis with isoniazid].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Effect of isonicotinic acid hydrazide therapy of tuberculosis on changes of blood proteins on colloidal lability test].
Topics: Blood Proteins; Isoniazid; Liver Function Tests; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis | 1953 |
[Our first results in treatment of pulmonary tuberculosis with isoniazid].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Results obtained in 60 tuberculotics treated with isonicotinic acid hydrazide with or without streptomycin and with or without collapse therapy].
Topics: Collapse Therapy; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tuberculosis, Pulm | 1953 |
The surgical pathology of isoniazid-treated pulmonary tuberculosis.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Pathology, Surgical; Tuberculosis, Pulmonary | 1953 |
[Anatomo-histological study of subjects treated with isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Treatment of tuberculosis with isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isonicotinic acid hydrazide in pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[First impressions of the application of sodium methanesulfonate of isonicotinic acid hydrazide (T 170) in pulmonary tuberculosis].
Topics: Isoniazid; Mesylates; Niacin; Nicotinic Acids; Sodium; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isonicotinic acid hydrazide in pulmonary tuberculosis in childhood and adolescence].
Topics: Child; Humans; Infant; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
A study on therapeutic evaluation of isoniazid in the treatment of pulmonary tuberculosis.
Topics: Isoniazid; Niacin; Nicotinic Acids; North Carolina; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[On isonicotinic acid hydrazide therapy of tuberculosis in puberty].
Topics: Child; Humans; Infant; Isoniazid; Niacin; Nicotinic Acids; Puberty; Sexual Maturation; Tuberculosis; | 1953 |
Drug fever due to administration of isoniazid.
Topics: Fever; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
Control study of comparative efficacy of isoniazid, streptomycin-isoniazid, and streptomycin; para-aminosalicylic acid in pulmonary tuberculosis therapy. IV. Report on forty-week observations on 583 patients with streptomycin susceptible infections.
Topics: Aminosalicylic Acid; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tube | 1953 |
Isoniazid serum concentrations and total hemoglobin and methemoglobin values in tuberculous patients on two dosage regimens of isoniazid therapy.
Topics: Hemoglobins; Isoniazid; Methemoglobin; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonar | 1953 |
Toxicity of isoniazid.
Topics: Isoniazid; Neuritis; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[The clinical results of isonicotinic acid hydrazide therapy in pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Clinical studies on the treatment of tuberculosis with a new isonicotinic acid hydrazide preparation; glutizine].
Topics: Biomedical Research; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Study of 130 cases of grave pulmonary tuberculosis treated with rimifon for at least three months].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isoniazid].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isonicotinic acid hydrazide in tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isonicotinic acid hydrazide in treatment of childhood tuberculosis].
Topics: Child; Humans; Infant; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pu | 1953 |
[Control of tuberculosis and isonicotinic acid hydrazide].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Treatment of pulmonary tuberculosis with isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isonicotinic acid hydrazide in tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
Isoniazid in the treatment of pulmonary tuberculosis.
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
Observations and experiences with isonicotinic acid hydrazide (INH).
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
EMERGENCE of bacterial resistance in pulmonary tuberculosis under treatment with isoniazid, streptomycin plus P.A.S. and streptomycin plus isoniazid.
Topics: Aminosalicylic Acid; Bacterial Infections; Isoniazid; Mycobacterium tuberculosis; Niacin; Nicotinic | 1953 |
[Preliminary observations on forty-six rimifon treatments at the Sanatorium Saint-Georges de Mont-Joli].
Topics: Hospitals; Humans; Isoniazid; Saints; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Critical evaluation of the isonicotinic acid hydrazide therapy of pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isonicotinic acid hydrazide therapy of tuberculosis].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Miliary; Tuberculosis, Pulmo | 1953 |
[Isonicotinic acid hydrazide in exudative pleuritis].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Pleurisy; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Clinical results of 3 months of isonicotinic acid hydrazide therapy].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Significance of some clinical and laboratory findings during isonicotinic acid hydrazide therapy].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculin; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Behavior of the blood protein picture in tuberculous subjects treated with isonicotinic acid hydrazide].
Topics: Blood Proteins; Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Remote results of streptomycin and PAS therapy of pulmonary caverns; comparison with early results of isonicotinic acid hydrazide].
Topics: Aminosalicylic Acid; Caves; Humans; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; | 1953 |
[Report on isonicotinic acid hydrazide therapy of 70 cases of pulmonary tuberculosis].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isonicotinic acid hydrazide and hemorrhages in tuberculosis].
Topics: Hemorrhage; Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Effect of isonicotinic acid hydrazide in pulmonary tuberculosis].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isonicotinic acid hydrazide in infantile tuberculosis].
Topics: Child; Humans; Infant; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Meningeal; Tu | 1953 |
[Changes in tuberculin allergy during isonicotinic acid hydrazide therapy].
Topics: Drug Hypersensitivity; Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculin; Tuberculosis; Tubercu | 1953 |
[Effect of isonicotinic acid hydrazide on hemogenic test in tuberculous and normal subjects].
Topics: Blood; Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isonicotinic acid hydrazide in exsudative pleuritis].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Pleurisy; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Blood and bone marrow picture in subjects of pulmonary tuberculosis during isonicotinic acid hydrazide therapy].
Topics: Blood; Bone Marrow; Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonar | 1953 |
Observations on the effect of isoniazid in acute and chronic tuberculous pulmonary lesions.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Relation between allergic reactivity and the clinical and radiological picture in a group of patients treated with isonicotinic acid hydrazide].
Topics: Isoniazid; Niacin; Nicotinic Acids; Radiology; Tuberculin; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Properties of isonicotinic acid hydrazide; resistant strains of Mycobacterium tuberculosis during the treatment of pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosi | 1953 |
[Isoniazid in phthisiology; immediate results and therapeutic combinations].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Results of the treatment of tuberculosis with isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Preliminary report on the results of isoniazid treatment in pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[The significance of the recent lesion factor in the effectiveness of pulmonary tuberculosis therapy with isoniazid].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
A large-scale trial of isoniazid in pulmonary tuberculosis.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isonicotinic acid hydrazide in the treatment of pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isonicotinic acid hydrazide therapy of pulmonary tuberculosis].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Our clinical impressions of isonicotinic acid hydrazide].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Studies on action of isonicotinic acid hydrazide in pulmonary tuberculosis; six-month follow-up].
Topics: Follow-Up Studies; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Twelve months of the treatment of tuberculous meningitis and of pulmonary tuberculosis with isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Meningeal; Tuberculosis, | 1953 |
[Treatment of 414 cases of pulmonary tuberculosis with isoniazid].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Development of resistance of Mycobacterium tuberculosis in pulmonary tuberculosis during isoniazid therapy].
Topics: Isomerism; Isoniazid; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosi | 1953 |
[First results of isoniazid therapy at the Station de Passy].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Effect of isoniazid tuberculosis; biological and clinical tolerance].
Topics: Drug Tolerance; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Results of isonicotinic acid hydrazide therapy; report of 160 cases].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Considerations on the treatment of pulmonary tuberculosis with isoniazid].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isoniazid].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Therapeutic results in the treatment of pulmonary tuberculosis and of tuberculous meningitis with isoniazid in the military hospital in Vannes].
Topics: Hospitals, Military; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Meni | 1953 |
[Chronic tuberculosis and isoniazid].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Development of sensitivity to isonicotinic acid isomers in pulmonary tuberculosis treated with isoniazid].
Topics: Isomerism; Isoniazid; Isonicotinic Acids; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmo | 1953 |
[Antithyroid action of paraaminosalicylic acid and isonicotinic acid hydrazide].
Topics: Aminosalicylic Acid; Hyperthyroidism; Hypothyroidism; Isoniazid; Niacin; Nicotinic Acids; Thyroid Gl | 1953 |
[The action of isoniazid on pulmonary tuberculosis; review of 100 cases].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isoniazid perfusions].
Topics: Aminosalicylic Acid; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Tuberculosis and isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
ISONIAZID in the treatment of pulmonary tuberculosis; a summary of the second report of the Tuberculosis Chemotherapy Trials Committee of the Medical Research Council.
Topics: Biomedical Research; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isonicotinic acid hydrazide therapy in cases of bronchial tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Preliminary experiences with rimifon therapy of pulmonary tuberculosis].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Our experiences with isonicotinic acid hydrazide in surgery of pulmonary tuberculosis].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Clinical observations in isonicotinic acid hydrazide therapy of pulmonary tuberculosis with nicozide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
Observations on the clinical results of isonicotinic acid hydrazide therapy in pulmonary tuberculosis.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Side-effects in isoniazid therapy of tuberculosis in children].
Topics: Child; Humans; Infant; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pu | 1953 |
Peripheral neuropathy in tuberculosis patients treated with isoniazid.
Topics: Isoniazid; Niacin; Nicotinic Acids; Peripheral Nerves; Peripheral Nervous System Diseases; Tuberculo | 1953 |
[Treatment of primary tuberculosis in early infancy by antibiotics and particularly by isoniazid].
Topics: Anti-Bacterial Agents; Child; Humans; Infant; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tube | 1953 |
[Therapy of pulmonary tuberculosis with isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Respiratory function in patients treated with isonicotinic acid hydrazide].
Topics: Isoniazid; Niacin; Nicotinic Acids; Respiration; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
Isonicotinyl hydrazine in the treatment of pulmonary tuberculosis in children; a preliminary report.
Topics: Child; Humans; Infant; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Experiences with isonicotinic acid hydrazide therapy of tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Results of isonicotinic acid hydrazide therapy of pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Use of isonicotinic acid hydrazide in chronic pulmonary tuberculosis; results and side-effects].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
Isoniazid in pulmonary tuberculosis, with special reference to X-ray findings after four and six months' treatment.
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary; X-Rays | 1953 |
[Isonicotinic acid hydrazide in therapy of complicated tracheo-bronchial adenopathy].
Topics: Child; Humans; Infant; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[A year of isonicotinic acid hydrazide treatment in early and chronic pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Report on the use of isonicotinic acid hydrazide for nine months].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Results of artificial pneumoperitoneum improved by use of combined streptomycin and isonicotinic acid hydrazide in the treatment of serious bilateral pulmonary tuberculosis].
Topics: Anti-Bacterial Agents; Insufflation; Isoniazid; Niacin; Nicotinic Acids; Pneumoperitoneum; Pneumoper | 1953 |
[Considerations on the treatment of pulmonary tuberculosis with isonicotinic acid hydrazide].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Resistance to isoniazid].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Comparative clinical results of the combination of isonicotinic acid hydrazide and PAS in pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Tuberculin inactivation by rimifon].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculin; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Mycobacterium tuberculosis resistant to rimifon in a patient hitherto untreated with isoniazid; probable bovine origin].
Topics: Animals; Cattle; Isoniazid; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Probability; Tuberc | 1953 |
[Treatment of pulmonary tuberculosis with isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Experiences with isonicotinic acid hydrazide therapy of pulmonary tuberculosis in adult].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Effect of isonicotinic acid hydrazide on pulmonary tuberculous caverns].
Topics: Caves; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Critical evaluation of isoniazid in the treatment of tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Clinico-bacteriological contribution to isonicotinic acid hydrazide therapy of tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isonicotinic acid hydrazide-resistant tubercle bacilli in the course of therapy of pulmonary tuberculosis].
Topics: Bacillus; Gram-Positive Bacteria; Isoniazid; Lacticaseibacillus casei; Mycobacterium tuberculosis; N | 1953 |
ISONIAZID in combination with streptomycin or with P.A.S. in the treatment of pulmonary tuberculosis; fifth report to the Medical Research Council by their Tuberculosis Chemotherapy Trials Committee.
Topics: Aminosalicylic Acid; Biomedical Research; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tubercul | 1953 |
[Clinical and bacteriological study of 90 cases of grave pulmonary tuberculosis treated with isonicotinic acid hydrazide (Rimifon) for three months and longer].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isoniazid (INH) therapy].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Chemotherapy of tuberculosis with isonicotinic acid hydrazide derivatives].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isonicotinic acid hydrazide; clinical and experimental tests].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
CONTROL study of isoniazid: factors influencing the response of pulmonary tuberculosis to chemotherapy; a United States Public Health Service cooperative investigation.
Topics: Isoniazid; Niacin; Nicotinic Acids; Public Health; Tuberculosis; Tuberculosis, Pulmonary; United Sta | 1953 |
Isonicotinic acid hydrazide (rimifon) in the treatment of tuberculosis.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isonicotinic acid hydrazide in recent pulmonary tuberculosis at first hospitalization].
Topics: Hospitalization; Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Results of the treatment of pulmonary tuberculosis with oral isoniazid].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Results of application of phthivazide in tuberculosis].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
Isonicotinic acid hydrazide in pulmonary tuberculosis.
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Clinical observations during therapy with isonicotinic acid hydrazide (neotoben and rimifon); and a contribution to its biological effectiveness].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Comments on 130 cases of pulmonary tuberculosis treated with isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Appearance of giant and regressive bullae during antibiotic therapy with special reference to isoniazid therapy of diffuse tuberculous lesions of the lung].
Topics: Anti-Bacterial Agents; Blister; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tubercu | 1953 |
[Blood coagulability changes in subjects treated with isonicotinic acid hydrazide].
Topics: Blood Coagulation; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Relation between schizophrenia and tuberculosis in therapy with a new anti-tuberculous chemical agent: isonicotinic acid hydrazide].
Topics: Isoniazid; Niacin; Nicotinic Acids; Rorschach Test; Schizophrenia; Tuberculosis; Tuberculosis, Pulmo | 1953 |
[Isonicotinic acid hydrazide in tuberculosis in mental patients; neuropsychiatric findings].
Topics: Isoniazid; Mental Disorders; Mentally Ill Persons; Niacin; Nicotinic Acids; Tuberculosis; Tuberculos | 1953 |
[Endobronchial administration of aqueous solution of isonicotinic acid hydrazide in local therapy of pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Clinical and bacteriological study of 90 sever cases of pulmonary tuberculosis treated by isoniazid for three months or more].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Therapy of pulmonary tuberculosis in adults with isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
A study of the effects of isoniazid on the emotions of tuberculous patients.
Topics: Emotions; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
Susceptibility to isoniazid and pathogenicity of tubercle bacilli.
Topics: Bacillus; Humans; Isoniazid; Lacticaseibacillus casei; Mycobacterium tuberculosis; Niacin; Nicotinic | 1953 |
[Tuberculous serofibrinous pleurisy; treatment with isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Pleurisy; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
The treatment of pulmonary tuberculosis with isonicotinic acid hydrazide.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
Treatment of 10 cases of pulmonary tuberculosis in Africans with isoniazid.
Topics: Black People; Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Two cases of pulmonary tuberculosis treated with combined dihydrostreptomycin and isoniazid (redutyl)].
Topics: Dihydrostreptomycin Sulfate; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculos | 1953 |
ISONIAZID in pulmonary tuberculosis; report on a trial conducted under the auspices of the Medical Research Council of Ireland.
Topics: Biomedical Research; Ireland; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmon | 1953 |
Isonicotinic acid hydrazide and para-aminosalicylic acid in the treatment of pulmonary tuberculosis.
Topics: Aminosalicylic Acid; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
The use of isoniazid as a prophylactic antibacterial agent in pulmonary resection for tuberculosis; preliminary report.
Topics: Anti-Bacterial Agents; Isoniazid; Niacin; Nicotinic Acids; Pulmonary Surgical Procedures; Tuberculos | 1953 |
[Results of the treatment of pulmonary tuberculosis with isoniazid].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isonicotinic acid hydrazide in the therapy of tuberculous serositis].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Serositis; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
Effects of isoniazid on patients with tuberculosis and mental illness.
Topics: Isoniazid; Mental Disorders; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[New method of associated streptomycin-isonicotinic acid hydrazide therapy of pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Resistance acquired by the Koch bacillus during isoniazid therapy of pulmonary tuberculosis].
Topics: Bacillus; Humans; Isoniazid; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Tuberculosis; Tube | 1953 |
[Results of the combined therapy with rimifon, streptomycin and paraaminosalicylic acid in tuberculosis].
Topics: Aminosalicylic Acid; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tube | 1953 |
[Elimination of a large tuberculous cavern by isonicotinic acid hydrazide therapy].
Topics: Biological Transport; Caves; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmona | 1953 |
[Results in the treatment of pulmonary tuberculosis with isonicotinic acid hydrazide; report of 200 cases in dispensaries].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Treatment of pulmonary tuberculosis with isoniazid; experience with 450 patients].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Use of oral and aerosol isonicotinic acid hydrazide in some cases of cavitary tuberculosis].
Topics: Aerosols; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Recent data on isonicotinic acid hydrazide therapy of pulmonary tuberculosis; importance of associated antibiotic therapy].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis | 1953 |
[Experimental and clinical anti-tuberculous activity of a compound of stable salt of dihydrostreptomycin and isonicotinic acid hydrazide].
Topics: Dihydrostreptomycin Sulfate; Isoniazid; Niacin; Nicotinic Acids; Sodium Chloride, Dietary; Streptomy | 1953 |
Nydrazid, isoniazid, in treatment of tuberculous mental defectives.
Topics: Intellectual Disability; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, | 1953 |
[Tuberculous purulent pleurisy cured with isonicotinic acid hydrazide].
Topics: Empyema, Tuberculous; Isoniazid; Niacin; Nicotinic Acids; Pleurisy; Tuberculosis; Tuberculosis, Pulm | 1953 |
PROGRESS report on therapeutic and toxic effects of combinations of isoniazid, streptomycin, and para-aminosalicylic acid; United States Public Health Service cooperative investigation of antimicrobial therapy of tuberculosis.
Topics: Aminosalicylic Acid; Anti-Infective Agents; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Research | 1954 |
Streptomycin and PAS vs. streptomycin, PAS and isoniazid in the treatment of pulmonary tuberculosis.
Topics: Aminosalicylic Acid; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tube | 1954 |
[Death in a case of epilepsy with pulmonary tuberculosis treated with isonicotinic acid hydrazide].
Topics: Epilepsy; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary; Urologic Diseas | 1953 |
[Statistical study of various disorders caused by isonicotinic acid hydrazide in pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Clinical experience obtained with isoniazid in hospital practice].
Topics: Aminosalicylic Acid; Hospitals; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tube | 1953 |
[Isonicotinic acid hydrazide in cavitary pulmonary tuberculosis].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isonicotinic acid hydrazide in the treatment of pulmonary tuberculosis].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[The electrophoretic curve in tuberculosis with psychosis during isonicotinic acid hydrazide therapy].
Topics: Blood Proteins; Electrophoresis; Humans; Isoniazid; Mental Disorders; Niacin; Nicotinic Acids; Psych | 1953 |
[Results in isoniazid treatment of chronic pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Initial isonicotinic acid hydrazide resistance and its evolution in subjects previously treated or not treated with other antibiotics].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Isoniazid; Mycobacterium tuberculosis; Niacin; N | 1953 |
[Six month results of isoniazid therapy of 45 cases of pulmonary tuberculosis in women].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isonicotinic acid hydrazide therapy of pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
Clinical and bacteriological studies on isonicotinic acid hydrazine (rimifon); 36 patients with pulmonary tuberculosis treated for three months and observed for six.
Topics: Hydrazines; Isoniazid; Isonicotinic Acids; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulm | 1953 |
[Hemorrhages and coagulation disorders in pulmonary tuberculosis treated with isoniazid].
Topics: Blood Coagulation; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Blood protein modifications in tuberculosis treated with isonicotinic acid hydrazide].
Topics: Blood Proteins; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Side effects of combined isoniazid and streptomycin in therapy of pulmonary tuberculosis].
Topics: Anti-Bacterial Agents; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tuberculosis, | 1954 |
[Clinical results obtained in the Sanatorio di Chieti by isonicotinic acid hydrazide therapy during the period April-August 1952].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Diabetic metabolic disorders occurring during thiosemicarbazone and isoniazid therapy].
Topics: Diabetes Mellitus; Isoniazid; Niacin; Nicotinic Acids; Thiosemicarbazones; Tuberculosis; Tuberculosi | 1953 |
[Side-effects in overdosage of isonicotinic acid hydrazide].
Topics: Central Nervous System; Drug Overdose; Isoniazid; Nervous System; Niacin; Nicotinic Acids; Tuberculo | 1953 |
[Periodic disease in a lobectomized pulmonary tuberculosis patient having received 600 grams of streptomycin and Friedmann's treatment: rimifon therapy].
Topics: Familial Mediterranean Fever; Fever; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; | 1953 |
[One year of isonicotinic acid hydrazide therapy of tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Potassium iodide and methyl antigen in chronic pulmonary tuberculosis; variation of the number of radiologic and bacilloscopic improvements according to the method of treatment by streptomycin and isoniazid].
Topics: Iodides; Isoniazid; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Potassium Iodide; Streptomy | 1953 |
[Clinical study of a derivative of isoniazid: G 605].
Topics: Hydrazines; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Aerosol therapy (PAS and isoniazid) in the treatment of pulmonary tuberculosis].
Topics: Aerosols; Aminosalicylic Acid; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmo | 1953 |
[Combined therapy: pneumoperitoneum, isoniazid and PAS in cavitary pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Isoniazid; Niacin; Nicotinic Acids; Pneumoperitoneum; Pneumoperitoneum, Artific | 1953 |
On treatment of pulmonary tuberculosis with isonicotinic acid hydrazide (INAH).
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Treatment of pulmonary tuberculosis with isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
The clinical effect of isoniazid and iproniazid in the treatment of pulmonary tuberculosis.
Topics: Iproniazid; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
A controlled study of isoniazid and iproniazid.
Topics: Aminosalicylic Acid; Iproniazid; Isoniazid; Niacin; Nicotinic Acids; Research Design; Streptomycin; | 1953 |
[Paper electrophoretic studies in the treatment of pulmonary tuberculosis with isoniazid].
Topics: Electrophoresis; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Thrombopenic purpura in isonicotinic acid hydrazide medication].
Topics: Isoniazid; Niacin; Nicotinic Acids; Purpura; Purpura, Thrombocytopenic; Tuberculosis; Tuberculosis, | 1953 |
[Serum protein reaction in tuberculous meningitis and tuberculosis in children treated with isonicotinic acid hydrazide].
Topics: Blood Proteins; Child; Infant; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Menin | 1953 |
[A year of isoniazid therapy of pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Controls during and after isoniazid therapy of pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
Toxicity of isonicotinic acid hydrazides in pulmonary tuberculosis; toxicity of isoniazid and iproniazid used alone and in combination with streptomycin or p-aminosalicylic acid.
Topics: Aminosalicylic Acid; Iproniazid; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberc | 1954 |
Observations on the combined use of pyrazinamide (Aldinamide) and isoniazid in the treatment of pulmonary tuberculosis; a clinical study.
Topics: Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Anatomopathological aspects of pulmonary tuberculosis treated with isoniazid and with combined therapy].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis | 1953 |
[On isoniazid therapy of tuberculosis in adults].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isoniazid therapy of tuberculosis in children].
Topics: Child; Humans; Infant; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pu | 1953 |
[Clinical observations on isonicotinic acid hydrazide therapy].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Combined antibiotic therapy and chemotherapy of pulmonary tuberculosis with special reference to dihydrostreptomycin, paratebin and isoniazid].
Topics: Anti-Bacterial Agents; Dihydrostreptomycin Sulfate; Isoniazid; Niacin; Nicotinic Acids; Penicillins; | 1953 |
[Isoniazid; experiences in the treatment of pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
Preliminary report on the serial EEGs of pulmonary tuberculous patients treated with isoniazid.
Topics: Electroencephalography; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Cases of angio-paralytic hemorrhagic diathesis during isonicotinic acid hydrazide therapy].
Topics: Hemorrhagic Disorders; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Treatment of pulmonary tuberculosis with isonicotinic acid hydrazide using continuous and shock methods].
Topics: Isoniazid; Niacin; Nicotinic Acids; Shock; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
RECIPE: streptomycin, PAS and isoniazid.
Topics: Aminosalicylic Acid; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tube | 1954 |
[Development of resistance in administration of isonicotinic acid hydrazide alone and in combination].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Treatment of pulmonary tuberculosis with isonicotinic acid hydrazide using Wrocław shock method].
Topics: Isoniazid; Niacin; Nicotinic Acids; Shock; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Personal experiences in therapy of pulmonary tuberculosis with isoniazid].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
Isoniazid in the home treatment of tuberculous patients.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
[Isoniazid and its psychological effects].
Topics: Depression; Feeding and Eating Disorders; Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; | 1954 |
[Treatment of pulmonary tuberculosis with isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
The present status of isoniazid in the treatment of pulmonary tuberculosis.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
Isoniazid in pulmonary tuberculosis.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
A controlled study of isoniazid and iproniazid.
Topics: Iproniazid; Isoniazid; Niacin; Nicotinic Acids; Research Design; Tuberculosis; Tuberculosis, Pulmona | 1954 |
[Treatment of pulmonary tuberculosis with Hansen's disease by streptomycin-isoniazid injections].
Topics: Isoniazid; Leprosy; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Combined therapy of the pulmonary tuberculosis with streptomycin, PAS and isoniazid].
Topics: Aminosalicylic Acid; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tube | 1953 |
Isonicotinic acid hydrazide compounds in the therapy of pulmonary tuberculosis.
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
The present status of isoniazid in the treatment of tuberculosis.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Striae cutis atrophicae in connection with endocrine disorders in the treatment of tuberculosis with isonicotinic acid hydrazide; clinical aspects and pathogenesis. I].
Topics: Endocrine System Diseases; Isoniazid; Niacin; Nicotinic Acids; Skin Diseases; Tuberculosis; Tubercul | 1954 |
[Isonicotinic acid hydrazide combined with streptomycin and PAS in therapy of pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Humans; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tubercu | 1954 |
[Behavior of erythrocyte sedimentation rate and the reticulocyte curve in pulmonary tuberculosis patients treated with isonicotinic acid hydrazide].
Topics: Aged; Blood Sedimentation; Erythrocytes; Humans; Isoniazid; Niacin; Nicotinic Acids; Reticulocytes; | 1954 |
[Adrenal cortex function examined by Thorn test in subjects of various forms of pulmonary tuberculosis before and after isonicotinic acid hydrazide therapy].
Topics: Adrenal Cortex; Adrenal Cortex Function Tests; Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculo | 1954 |
[Isoniazid therapy of silicosis with tuberculosis].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Silicosis; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Tuberculosis and adrenal cortex. III. Urinary excretion of 17-ketosteroids and 11-hydroxysteroids after isonicotinic acid hydrazide therapy of pulmonary tuberculosis].
Topics: 17-Ketosteroids; Adrenal Cortex; Hydroxysteroids; Isoniazid; Niacin; Nicotinic Acids; Steroids; Tube | 1953 |
[Combination of various antituberculous drugs with isoniazid and its effects on hydrazide resistance].
Topics: Aminosalicylic Acid; Antitubercular Agents; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberc | 1954 |
[Late course of chronic cavitary pulmonary tuberculosis treated with isoniazid].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
Management of primary tuberculosis in infancy: isoniazid in the prevention of complications.
Topics: Child; Disease Management; Humans; Infant; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tubercu | 1953 |
Cystlike cavities with isoniazid therapy in pulmonary tuberculosis.
Topics: Dental Caries; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
Isoniazid therapy of tuberculous patients as a preparation for pulmonary resection.
Topics: Isoniazid; Niacin; Nicotinic Acids; Pulmonary Surgical Procedures; Tuberculosis; Tuberculosis, Pulmo | 1954 |
The clinical effect of isoniazid and iproniazid in the treatment of pulmonary tuberculosis.
Topics: Iproniazid; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Electron-microscopical examinations of sputum for tubercle bacilli after rimifon therapy].
Topics: Bacillus; Electrons; Isoniazid; Microscopy; Microscopy, Electron; Mycobacterium tuberculosis; Niacin | 1954 |
Isoniazid and weight gain: a pilot investigation.
Topics: Body Weight; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary; Weight Gain | 1954 |
[Mechanism of cure of tuberculous caverns during the treatment with isonicotinic acid hydrazide].
Topics: Caves; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
Clinical observations on the use of isoniazid in tuberculosis.
Topics: Aminosalicylic Acid; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Sulfones; Tubercul | 1954 |
Treatment of pulmonary tuberculosis with isoniazid and iproniazide.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
Management of isoniazid intolerance.
Topics: Disease Management; Gastrointestinal Diseases; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tub | 1954 |
[100 Cases of different forms of pulmonary tuberculosis treated with isoniazid alone; radiologic findings].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Lessons of 15 months treatment of pulmonary tuberculosis with isoniazid].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Some cases of purpura appearing during isonicotinic acid hydrazide therapy].
Topics: Humans; IgA Vasculitis; Isoniazid; Niacin; Nicotinic Acids; Purpura; Tuberculosis; Tuberculosis, Pul | 1954 |
[Aggravation in tuberculosis treated with rimifon].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Results of isonicotinic acid hydrazide therapy of pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Bacteriological negativity and persistent lesions in tuberculous patients treated with isoniazid].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Modification of allergic reactions during isonicotinic acid hydrazide therapy of various forms of pulmonary tuberculosis].
Topics: Hypersensitivity; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Peripheral blood picture in pulmonary tuberculosis treated with isoniazid].
Topics: Blood; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
Some observations on the results of high isoniazid dosage in pulmonary tuberculosis.
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Local treatment of the tuberculous empyema with isonicotinic acid hydrazide].
Topics: Empyema, Tuberculous; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pul | 1954 |
[Hemorrhagic diathesis as a side-effect of isoniazid therapy].
Topics: Hemorrhagic Disorders; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Toxic, outbreak and course of a psychosis caused by isoniazid therapy].
Topics: Disease Outbreaks; Isoniazid; Mental Disorders; Niacin; Nicotinic Acids; Psychoses, Substance-Induce | 1954 |
[Radiologic opacity typical of a spontaneously regressed tuberculoma in the course of primary infection, in an Eskimo child under treatment with rimifon and streptomycin].
Topics: Child; Humans; Inuit; Isoniazid; Radiography; Streptomycin; Tuberculoma; Tuberculosis; Tuberculosis, | 1954 |
[Clinical experiences in therapy of tuberculosis with isonicotinic acid hydrazide. II..].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Results of treating pulmonary tuberculosis with the combination of isonicotinic acid hydrazide and streptomycin].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Results of the therapy of 70 pulmonary tuberculosis patients with isoniazid alone and with streptomycin and PAS].
Topics: Aminosalicylic Acid; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tube | 1953 |
[Neuro-psychic disturbances and epileptic seizures in the course of isoniazid therapy; electro-encephalographic control].
Topics: Electroencephalography; Epilepsy; Isoniazid; Niacin; Nicotinic Acids; Psychoses, Substance-Induced; | 1953 |
Paranoid state during therapy with isoniazid in pulmonary.
Topics: Isoniazid; Mental Disorders; Niacin; Nicotinic Acids; Psychoses, Substance-Induced; Psychotic Disord | 1954 |
[Striae cutis atrophicae in connection with endocrine disorders in the treatment of tuberculosis with isoniazid; clinical aspects and pathogenesis. II..].
Topics: Endocrine System Diseases; Isoniazid; Niacin; Nicotinic Acids; Skin Diseases; Tuberculosis; Tubercul | 1954 |
[Early results of large doses of isoniazid in therapy of pulmonary tuberculosis in children].
Topics: Child; Humans; Infant; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Isonicotinic acid hydrazide in primary pulmonary tuberculosis: preliminary communication].
Topics: Communication; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Results of treatment of ulcerocaseous pulmonary tuberculosis by combination of streptomycin, isoniazid and PAS, administered at least six months].
Topics: Aminosalicylic Acid; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tube | 1954 |
[Tests at the Forlanini Institute of combined antibiotic therapy of early forms of pulmonary tuberculosis, with special reference to combined streptomycin-isoniazid].
Topics: Anti-Bacterial Agents; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tuberculosis, | 1953 |
[New observations on chemical casectomy produced by isonicotinic acid hydrazide and evolution of cases during two years].
Topics: Biological Evolution; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
Isoniazid resistance in patients with pulmonary tuberculosis treated on isoniazid alone.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
Culture media for tubercle bacilli during chemotherapy with isoniazid.
Topics: Bacillus; Culture Media; Hemoglobins; Isoniazid; Niacin; Nicotinic Acids; Serum Albumin; Tuberculosi | 1954 |
[The effects of isoniazid on chronic cavernous pulmonary tuberculosis compared with conteben].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Thioacetazone; Thiosemicarbazones; Tuberculosis; Tube | 1954 |
Early ambulatory treatment of pulmonary tuberculosis with isoniazid.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
Metabolism of isoniazid in man as related to the occurrence of peripheral neuritis.
Topics: Isoniazid; Neuritis; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
The course of pulmonary tuberculosis during long-term single-drug (isoniazid) therapy.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
The serogram in pulmonary tuberculosis; electrophoretic serum protein fraction changes during isoniazid therapy; a preliminary report.
Topics: Blood Proteins; Electrophoresis; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis, Pulmonary | 1954 |
Laboratory diagnostic procedures employed on sputum specimens from ambulatory tuberculous patients treated with isoniazid.
Topics: Bacteriology; Diagnostic Tests, Routine; Isoniazid; Mycobacterium tuberculosis; Niacin; Nicotinic Ac | 1954 |
[Isoniazid resistance in various clinical pictures].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
A study on therapeutic evaluation of isoniazid in treatment of pulmonary tuberculosis.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
Primary tuberculosis in African children and the value of isoniazid in treatment.
Topics: Black People; Child; Humans; Infant; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Treatment of 102 cases of tuberculosis with isonicotinic acid hydrazide].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Follow-up after one year of isoniazid and PAS-dihydrostreptomycin therapy of pulmonary tuberculosis; a brief orientation].
Topics: Aminosalicylic Acid; Dihydrostreptomycin Sulfate; Follow-Up Studies; Isomerism; Isoniazid; Niacin; N | 1954 |
The chemotherapy of pulmonary tuberculosis with pyrazinamide used alone and in combination with streptomycin, para-aminosalicylic acid, or isoniazid.
Topics: Aminosalicylic Acid; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Streptomycin; Tube | 1954 |
Studies on the use of high dose of isoniazid. I. Toxicity studies.
Topics: Isoniazid; Neuritis; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
Peripheral neuritis in tuberculous patients treated with isoniazid.
Topics: Isoniazid; Neuritis; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
United States Public Health service cooperative investigation of antimicrobial therapy of tuberculosis, V. Report on thirty-two-week observations on combinations of isoniazid, streptomycin, and para-aminosalicylic acid.
Topics: Aminosalicylic Acid; Anti-Infective Agents; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Streptomy | 1954 |
[Preliminary results in isoniazid and streptomycin therapy of extensive hematogenous dissemination of tuberculosis].
Topics: Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Meningeal; Tuberculosis, Miliary; Tuberculosis, | 1954 |
Roentgenologic changes of the lung associated with isoniazid therapy in pulmonary tuberculosis.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Clinical and experimental effects indicating the use of isonicotinic acid hydrazide in tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Isonicotinic acid hydrazide in tuberculosis associated with diabetes mellitus; effect on glucose metabolism and on course of tuberculosis].
Topics: Diabetes Complications; Glucose; Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculo | 1954 |
[Treatment for tuberculous empyema with isonicotinic acid hydrazide].
Topics: Empyema, Tuberculous; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pul | 1954 |
[Possibility of closure of pulmonary tuberculous cavitation by isoniazid therapy].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[First results of the use of isoniazid, streptomycin, PAS, with and without association of collapse in therapy in pulmonary tuberculosis in a group of Indian and Eskimo male adults and children].
Topics: Aminosalicylic Acid; Humans; Inuit; Isoniazid; Niacin; Nicotinic Acids; Shock; Streptomycin; Tubercu | 1954 |
Pyrazinamide-isoniazid in tuberculosis. I. Results in 58 patients with pulmonary lesions one year after the start of therapy.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
Bacterial resistance to isoniazid and marsilid in treatment of pulmonary tuberculosis; results of trials.
Topics: Bacterial Infections; Isoniazid; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Tuberculosis; | 1954 |
[Clinical report on a new chemo-antibiotic combination in therapy of tuberculosis: streptomycin-PAS-isoniazid].
Topics: Aminosalicylic Acid; Anti-Bacterial Agents; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberc | 1954 |
Isoniazid and P. A. S. in chronic pulmonary tuberculosis: a warning.
Topics: Aminosalicylic Acid; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tuberculosis, P | 1954 |
[Combined antibiotic therapy of pulmonary tuberculosis in the Forlanini Institute with special reference to streptomycin-isoniazid therapy].
Topics: Anti-Bacterial Agents; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tuberculosis, | 1954 |
[Clinical results of isoniazid in the treatment of pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Combined streptomycin, dihydrostreptomycin and sodium methanesulfonate of isoniazid in therapy of pulmonary tuberculosis].
Topics: Anti-Bacterial Agents; Dihydrostreptomycin Sulfate; Humans; Isoniazid; Mesylates; Niacin; Nicotinic | 1954 |
[Bronchial tuberculosis as possible complication of isonicotinic acid hydrazide therapy of tuberculous pulmonary caverns; clinical study].
Topics: Caves; Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Isonicotinic acid hydrazide and glucide metabolism].
Topics: Carbohydrate Metabolism; Carbohydrates; Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tu | 1954 |
[Peroral chemotherapy of pulmonary tuberculosis; experience with a combination of heterocyclic thiosemicarbazone and isoniazid].
Topics: Isoniazid; Niacin; Nicotinic Acids; Thiosemicarbazones; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Clinical and radiologic development of two cases of caseous bronchopneumonia treated with a combination of streptomycin, isoniazid and paraaminosalicylic acid].
Topics: Aminosalicylic Acid; Bronchopneumonia; Child; Humans; Infant; Isoniazid; Niacin; Nicotinic Acids; Ra | 1954 |
[Isonicotinic acid hydrazide in pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Results of three months of combined streptomycin, PAS and isoniazid therapy of pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Anti-Bacterial Agents; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberc | 1954 |
[Treatment of pulmonary tuberculosis by isonicotinyl isopropyl hydrazine].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Excellent results of isoniazid therapy of a case of peritoneal tuberculosis with pulmonary tuberculosis].
Topics: Disease; Isoniazid; Niacin; Nicotinic Acids; Peritoneal Diseases; Peritoneum; Peritonitis, Tuberculo | 1954 |
Isonicotinic acid hydrazide hypersensitivity with pyrexial reaction; report of a case.
Topics: Hypersensitivity; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
Adrenal cortical function during isoniazid therapy for pulmonary tuberculosis.
Topics: Adrenal Cortex; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
Tuberculous pneumonia due to organisms resistant to streptomycin and isoniazid.
Topics: Aminosalicylic Acid; Bacteriology; Humans; Isoniazid; Niacin; Nicotinic Acids; Pneumonia; Streptomyc | 1954 |
Clinical evaluation of isoniazid.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
Isonicotinic acid hydrazide therapy against pulmonary tuberculosis; studies in the light of a control series.
Topics: Isoniazid; Light; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Edematigenic effect of isoniazid on the tuberculous lung; anatomo-pathological study].
Topics: Edema; Isoniazid; Niacin; Nicotinic Acids; Pneumonia; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Changes in capillary resistance by isoniazid].
Topics: Capillaries; Capillary Resistance; Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tubercu | 1954 |
[18 Months of clinical experience with isoniazid in pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Clinical study of the effect of isoniazid on the carbohydrate metabolism tuberculous diabetics].
Topics: Carbohydrate Metabolism; Carbohydrates; Diabetes Complications; Diabetes Mellitus; Humans; Isoniazid | 1954 |
[Results of a first follow-up study of pulmonary tuberculosis patients treated with isoniazid].
Topics: Follow-Up Studies; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmon | 1954 |
The use of oxytetracycline in preventing or delaying isoniazid resistance in pulmonary tuberculosis; a report to the Research Committee of the Tuberculosis Society of Scotland.
Topics: Isoniazid; Niacin; Nicotinic Acids; Oxytetracycline; Research; Scotland; Tuberculosis; Tuberculosis | 1954 |
[Two cases of toxic manifestations in the treatment of pulmonary tuberculosis with isonicotinic acid hydrazide].
Topics: Isoniazid; Kidney; Niacin; Nicotinic Acids; Seizures; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[The fate of isoniazid-resistant tubercle bacilli in tuberculous patients].
Topics: Bacillus; Bacteriology; Humans; Isoniazid; Lung; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis | 1954 |
[Isoniazid therapy of primary tuberculosis].
Topics: Child; Humans; Infant; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Additional experiences in isoniazid therapy of pulmonary tuberculosis in adolescence].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Various aspects of liver function during isoniazid therapy of tuberculosis].
Topics: Isoniazid; Liver; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
Medical treatment of tuberculosis: streptomycin, isoniazid, and para-aminosalicylic acid in the treatment of pulmonary tuberculosis.
Topics: Aminosalicylic Acid; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tube | 1954 |
[Isoniazid and isoniazid combined with PAS in therapy of pulmonary tuberculosis; clinical and bacteriologic studies].
Topics: Aminosalicylic Acid; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Report on the treatment of pulmonary tuberculosis with the isoniazid methanesulfonate].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Treatment of tuberculosis with isoniazid].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Relapses after isoniazid treatment].
Topics: Aminosalicylic Acid; Collapse Therapy; Isoniazid; Niacin; Nicotinic Acids; Recurrence; Thiosemicarba | 1954 |
[Supposed mechanism of weight-increasing effect of isonicotinic acid hydrazide].
Topics: Body Weight; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Early results of isonicotinic acid hydrazide of the most severe forms of pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Synergistic action of isoniazid and PAS in the treatment of pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulm | 1954 |
[Effectiveness of phthivazide therapy on tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Effects of isoniazid on blood circulation].
Topics: Blood Circulation; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmon | 1954 |
[Culture failure and isoniazid therapy].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Behavior of granulocytic peroxidases during isonicotinic acid hydrazide therapy of pulmonary tuberculosis].
Topics: Granulocytes; Isoniazid; Niacin; Nicotinic Acids; Oxidoreductases; Peroxidases; Tuberculosis; Tuberc | 1954 |
VARIOUS combinations of isoniazid with streptomycin or with P.A.S. in the treatment of pulmonary tuberculosis; seventh report to the Medical Research Council by their Tuberculosis Chemotherapy Trials Committee.
Topics: Aminosalicylic Acid; Biomedical Research; Dermatologic Agents; Isoniazid; Niacin; Nicotinic Acids; S | 1955 |
Experiences in the management of long-standing chronic cases of pulmonary tuberculosis treated with isoniazid for one year.
Topics: Disease Management; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
Isoniazids versus streptomycin.
Topics: Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
[Isonicotinic acid hydrazide and pulmonary tuberculosis; clinico-radiological and immunobiochemical study].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Combined treatment of cavitary pulmonary tuberculosis with isoniazid and intravenous infusions of PAS].
Topics: Aminosalicylic Acid; Infusions, Intravenous; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuber | 1954 |
The prevalence of streptomycin- and isoniazid-resistant strains of Mycobacterium tuberculosis in patients with newly discovered and untreated active pulmonary tuberculosis.
Topics: Humans; Isoniazid; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Prevalence; Streptomycin; Tu | 1955 |
[First trails of combined isoniazid and PAS in tuberculosis].
Topics: Aminosalicylic Acid; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
[Isoniazid in the treatment of tuberculosis; our experience].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
EXPERIMENTS with isoniazid as a preventive measure against tuberculosis.
Topics: Biomedical Research; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
[Evolution towards a polycystic aspect of the lesions of a bronchogenic seeding under the influence of isoniazid therapy].
Topics: Biological Evolution; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
[Prolonged antibiotic therapy of pulmonary tuberculosis with isoniazid combined with streptomycin or PAS; indications for pneumothorax].
Topics: Aminosalicylic Acid; Anti-Bacterial Agents; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Pneumotho | 1955 |
[Effect of isonicotinic acid hydrazide on tuberculous patients with mental disorders].
Topics: Isoniazid; Mental Disorders; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
[Isoniazid in the treatment of infantile tuberculosis].
Topics: Child; Humans; Infant; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pu | 1955 |
[Clinical experience with a new isoniazid derivative].
Topics: Hydrazines; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
Urinary complications occurring during isoniazid treatment.
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary; Urologic Diseases | 1955 |
[Intralaryngeal instillations of isonicotinic acid hydrazide in the treatment of tuberculous cavities].
Topics: Dental Caries; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
Pulmonary tuberculosis due to bacilli resistant to streptomycin and isoniazid.
Topics: Bacillus; Bacteriology; Humans; Isoniazid; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Sput | 1955 |
[Psychoses caused by isoniazid].
Topics: Isoniazid; Mental Disorders; Niacin; Nicotinic Acids; Psychoses, Substance-Induced; Psychotic Disord | 1955 |
[Behavior of blood coagulation in tuberculous children treated with isoniazid. I].
Topics: Blood Coagulation; Child; Infant; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pu | 1955 |
[Changed induced by vitamin E in blood coagulation in tuberculous children treated with isoniazid. II].
Topics: Blood Coagulation; Child; Infant; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pu | 1955 |
Fatal tuberculous meningitis developing during isoniazid-streptomycin therapy.
Topics: Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tuberculosis, Meningeal; Tuberculosi | 1955 |
Clinical trial of P.A.S. salt of isoniazid in treatment of pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
Hepatitis following isoniazid.
Topics: Hepatitis; Hepatitis A; Isoniazid; Jaundice; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pu | 1955 |
Conventional therapy versus the continuous and concurrent use of streptomycin, isoniazid, and para-aminosalicylic acid plus early surgery in the treatment of tuberculosis.
Topics: Aminosalicylic Acid; Anti-Bacterial Agents; Antibiotics, Antitubercular; Dermatologic Agents; Isonia | 1955 |
[Bullous images in tuberculosis with isoniazid].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Radiography; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
[Hemorrhagic thrombopenia caused by isoniazid].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Purpura; Purpura, Thrombocytopenic; Thrombocytopenia; Tu | 1955 |
[Results of isoniazid in psychiatry; clinical study].
Topics: Isoniazid; Mental Disorders; Niacin; Nicotinic Acids; Psychiatry; Tuberculosis; Tuberculosis, Pulmon | 1955 |
Pyrazinamide-isoniazid in tuberculosis. III. Observations with reduced dosage of pyrazinamide.
Topics: Clinical Protocols; Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pu | 1955 |
Isoniazid in pulmonary tuberculosis.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
[Combined isoniazid and glutamic acid; study of their clinical use].
Topics: Anti-Bacterial Agents; Glutamates; Glutamic Acid; Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberc | 1955 |
Streptomycin, isoniazid, and para-aminosalicylic acid in the treatment of pulmonary tuberculosis.
Topics: Aminosalicylic Acid; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tube | 1956 |
[Phagocytosis in tuberculous patients before and after isoniazid alone or combined with streptomycin].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Phagocytosis; Streptomycin; Tuberculosis; Tuberculosis, | 1955 |
Experimental infective pneumoconiosis. III. Coal-mine dust and isoniazid-resistant tubercle bacilli of moderate virulence.
Topics: Bacillus; Coal; Dust; Humans; Isoniazid; Lung; Mining; Pneumoconiosis; Tuberculosis; Tuberculosis, P | 1955 |
Experimental infective pneumoconiosis. IV. Massive pulmonary fibrosis produced by coal-mine dust and isoniazid-resistant tubercle bacilli of low virulence.
Topics: Bacillus; Coal; Dust; Isoniazid; Mining; Pneumoconiosis; Pulmonary Fibrosis; Tuberculosis; Tuberculo | 1955 |
[Peripheral nerve disorders in pulmonary tuberculosis patients treated with isoniazid and its derivatives].
Topics: Disease; Isoniazid; Niacin; Nicotinic Acids; Peripheral Nerves; Peripheral Nervous System Diseases; | 1955 |
[Peripheral blood picture in the treatment of pulmonary tuberculosis with isonicotinic acid hydrazide].
Topics: Blood; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
Isonicotinic acid hydrazide and streptomycin in the treatment of pulmonary tuberculosis.
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
[Use of isonicotinic acid hydrazide by inhalatory route].
Topics: Aerosols; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
[Vesiculose caverns appearing during treatment of pulmonary tuberculosis with isoniazid].
Topics: Caves; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
[Isoniazid and PAS in the treatment of pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulm | 1955 |
[Three years of experience with combined isoniazid and PAS therapy of pulmonary tuberculosis; caustic study].
Topics: Aminosalicylic Acid; Anti-Bacterial Agents; Caustics; Humans; Isoniazid; Niacin; Nicotinic Acids; Tu | 1955 |
[Results of isoniazid treatment in the presence of resistant Mycobacterium strains].
Topics: Isoniazid; Mycobacterium; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
[Neurological complications following isonicotinic acid hydrazide therapy of pulmonary tuberculosis].
Topics: Isoniazid; Nervous System; Nervous System Diseases; Niacin; Nicotinic Acids; Tuberculosis; Tuberculo | 1956 |
[Long-term results of intracavitary treatment with isoniazid].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
[Recovery of tuberculous cavities treated with antibiotics (isoniazid) with preservation of their lumen, chemical casectomy].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis | 1955 |
[Treatment of pulmonary tuberculosis with isoniazid combined with PAS].
Topics: Aminosalicylic Acid; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
[Isoniazid- and streptomycin resistance of Mycobacterium tuberculosis in tuberculous lesions of the lung treated with resection after chemotherapy. I. Frequency of resistance in chemotherapy with prolonged action; study of 285 cases].
Topics: Isoniazid; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tubercul | 1955 |
[Further experience in the treatment of pulmonary tuberculosis of adult type in puberty with isonicotinic acid hydrazides].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Puberty; Sexual Maturation; Tuberculosis; Tuberculosi | 1955 |
[Isoniazid (INH) therapy of primary tuberculosis].
Topics: Child; Humans; Infant; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pu | 1955 |
[Comparative research on the results of ambulatory treatment of pulmonary tuberculosis with conteben/pasalon, respectively isonicotinic acid hydrazide].
Topics: Aminosalicylic Acid; Isoniazid; Niacin; Nicotinic Acids; Thioacetazone; Thiosemicarbazones; Tubercul | 1955 |
[Urinary corticoids and ketosteroids in patients with tuberculosis in relation to isoniazid therapy].
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Isoniazid; Ketosteroids; Niacin; Nicotinic Acids; Steroids; | 1955 |
[Observations on a streptomycin-isoniazid (streptotibin) combination in treatment of pulmonary tuberculosis].
Topics: Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Polyneuritis caused by isoniazid].
Topics: Isoniazid; Neuritis; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
[An epidemic of epileptic seizures in a sanatorium environment; possible role of alcoholism and isoniazid].
Topics: Alcoholism; Epilepsy; Hospitals, Special; Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; | 1955 |
[Rectal administration of isoniazid-eucaliptol in therapy of pulmonary tuberculosis].
Topics: Administration, Rectal; Eucalyptus; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tub | 1955 |
[Water and electrolyte metabolism in pulmonary tuberculosis before and after treatment with isonicotinic acid hydrazide. I].
Topics: Electrolytes; Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary; Wat | 1955 |
[Treatment of pulmonary tuberculosis in its various clinical forms with streptomycin, para-aminosalicylic acid (PAS), thiosemicarbazone (TB1) and isoniazid].
Topics: Aminosalicylic Acid; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Thiosemicarbazones; Tuberculo | 1955 |
[Isoniazid therapy in chronic fibro-cavernous pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
[Combination of streptomycin, PAS and isoniazid in the treatment of cavitary and bacillary pulmonary tuberculosis; immediate results].
Topics: Aminosalicylic Acid; Isoniazid; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Streptomycin; T | 1955 |
A pathologic and bacteriologic study of cavitary pulmonary tuberculosis treated with streptomycin and isoniazid.
Topics: Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
Pyrazinamide-isoniazid: comparison with isoniazid-para-aminosalicylic acid in active pulmonary tuberculosis with the choice of regimens determined by chance.
Topics: Aminosalicylic Acid; Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Pyrimidines; Tuberculosis; Tu | 1956 |
Tuberculous meningitis developing in the course of isoniazid therapy.
Topics: Child; Infant; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Meningeal; | 1956 |
[A case of contralateral pneumothorax following intracavitary administration of isoniazid in patients with mediastinal hernia].
Topics: Hernia; Isoniazid; Niacin; Nicotinic Acids; Pneumothorax; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
Effects of isonicotinic acid hydrazides on mental status of tuberculous patients.
Topics: Isoniazid; Niacin; Nicotinic Acids; Psychoses, Substance-Induced; Psychotic Disorders; Tuberculosis; | 1956 |
[About isoniazid resistance].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Results obtained in the treatment of pulmonary tuberculosis with isoniazid calcium methanesulfonate].
Topics: Calcium, Dietary; Isoniazid; Mesylates; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmona | 1956 |
[Results obtained in the treatment of pulmonary tuberculosis with isoniazid calcium methanesulfonate].
Topics: Calcium, Dietary; Isoniazid; Mesylates; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmona | 1956 |
[Bacteriological survey of pulmonary tuberculosis treated with isoniazid, alone and in combination].
Topics: Data Collection; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Clinical experience with dipasic and isoniazid-PAS compounds in therapy of tuberculosis].
Topics: Aminosalicylic Acid; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulm | 1956 |
[Delayed action of isoniazid on old pulmonary tuberculosis: report on new cases].
Topics: Delayed-Action Preparations; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculos | 1956 |
[Ambulatory treatment of various forms of pulmonary tuberculosis with streptomycin and isonicotinic acid hydrazide combination].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Does isoniazid change the prognosis of primary infection in its pulmonary lymph node form?].
Topics: Aminosalicylic Acid; Child; Communicable Diseases; Humans; Infant; Isoniazid; Lymph Nodes; Niacin; N | 1955 |
Treatment of pulmonary tuberculosis on a combined regimen of para-amino-salicylic acid, streptomycin and isonicotinic acid hydrazide.
Topics: Aminosalicylic Acid; Isoniazid; Niacin; Nicotinic Acids; Salicylic Acid; Streptomycin; Tuberculosis; | 1956 |
[Isoniazid treatment of pulmonary tuberculosis as seen in electrophoretic blood protein determination].
Topics: Blood Protein Electrophoresis; Blood Proteins; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tub | 1956 |
[Incidence of isoniazid on histopathology of pulmonary tuberculosis].
Topics: Incidence; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis, Pulmonary | 1956 |
[Clinical experience with an isoniazid-thiosemicarbazone combination in pulmonary tuberculosis in adults].
Topics: Isoniazid; Niacin; Nicotinic Acids; Thiosemicarbazones; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
Further observations on the prevalence of streptomycin- and isoniazid-resistant strains of Mycobacterium tuberculosis in patients with newly discovered and untreated active pulmonary tuberculosis.
Topics: Humans; Isoniazid; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Prevalence; Streptomycin; Tu | 1956 |
Some observations on the utility of simian pulmonary tuberculosis in defining the therapeutic potentialities of isoniazid.
Topics: Humans; Isoniazid; Lung; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Biological dynamism of tuberculous processes in relation to streptomycin and isoniazid therapy].
Topics: Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[A case of primary tuberculosis caused by isoniazid resistant Mycobacterium tuberculosis with weakened virulence].
Topics: Child; Humans; Infant; Isoniazid; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Tuberculosis; | 1956 |
[Clinical experiences in the treatment of pulmonary tuberculosis with a thiosemicarbazone-isoniazid combination].
Topics: Isoniazid; Niacin; Nicotinic Acids; Thiosemicarbazones; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Remarkable effect of cortisone on functional signs in a case of tuberculosis in infant].
Topics: Child; Cortisone; Humans; Infant; Isoniazid; Lung; Physical Examination; Streptomycin; Tuberculosis; | 1956 |
[Remarkable effect of cortisone on functional signs in a case of tuberculosis in infant].
Topics: Child; Cortisone; Humans; Infant; Isoniazid; Lung; Physical Examination; Streptomycin; Tuberculosis; | 1956 |
[Remarkable effect of cortisone on functional signs in a case of tuberculosis in infant].
Topics: Child; Cortisone; Humans; Infant; Isoniazid; Lung; Physical Examination; Streptomycin; Tuberculosis; | 1956 |
[Remarkable effect of cortisone on functional signs in a case of tuberculosis in infant].
Topics: Child; Cortisone; Humans; Infant; Isoniazid; Lung; Physical Examination; Streptomycin; Tuberculosis; | 1956 |
[Incidence of resistance of Koch bacillus to antibiotics during primary infection].
Topics: Aminosalicylic Acid; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacillus; Child; Communicab | 1956 |
[Incidence of resistance of Koch bacillus to antibiotics during primary infection].
Topics: Aminosalicylic Acid; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacillus; Child; Communicab | 1956 |
[Incidence of resistance of Koch bacillus to antibiotics during primary infection].
Topics: Aminosalicylic Acid; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacillus; Child; Communicab | 1956 |
[Incidence of resistance of Koch bacillus to antibiotics during primary infection].
Topics: Aminosalicylic Acid; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacillus; Child; Communicab | 1956 |
[Tentative appraisal of the effect of isoniazid on the course of pulmonary tuberculosis, by means of a statistical study of the deaths in the Serviço de Tisiologia of the Hospitais Civis de Lisboa from 1950 to 1954].
Topics: Death; Humans; Isoniazid; Tuberculosis, Pulmonary | 1956 |
[Tentative appraisal of the effect of isoniazid on the course of pulmonary tuberculosis, by means of a statistical study of the deaths in the Serviço de Tisiologia of the Hospitais Civis de Lisboa from 1950 to 1954].
Topics: Death; Humans; Isoniazid; Tuberculosis, Pulmonary | 1956 |
[Tentative appraisal of the effect of isoniazid on the course of pulmonary tuberculosis, by means of a statistical study of the deaths in the Serviço de Tisiologia of the Hospitais Civis de Lisboa from 1950 to 1954].
Topics: Death; Humans; Isoniazid; Tuberculosis, Pulmonary | 1956 |
[Tentative appraisal of the effect of isoniazid on the course of pulmonary tuberculosis, by means of a statistical study of the deaths in the Serviço de Tisiologia of the Hospitais Civis de Lisboa from 1950 to 1954].
Topics: Death; Humans; Isoniazid; Tuberculosis, Pulmonary | 1956 |
[Indications and results of prolonged bronchoclysis in pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Indications and results of prolonged bronchoclysis in pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Indications and results of prolonged bronchoclysis in pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Indications and results of prolonged bronchoclysis in pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Combined anti-inflammatory and antituberculous chemotherapy in one medication; clinical and therapeutic study].
Topics: Aminopyrine; Anti-Inflammatory Agents; Isoniazid; Phenylbutazone; Tuberculosis; Tuberculosis, Pulmon | 1956 |
[Combined anti-inflammatory and antituberculous chemotherapy in one medication; clinical and therapeutic study].
Topics: Aminopyrine; Anti-Inflammatory Agents; Isoniazid; Phenylbutazone; Tuberculosis; Tuberculosis, Pulmon | 1956 |
[Combined anti-inflammatory and antituberculous chemotherapy in one medication; clinical and therapeutic study].
Topics: Aminopyrine; Anti-Inflammatory Agents; Isoniazid; Phenylbutazone; Tuberculosis; Tuberculosis, Pulmon | 1956 |
[Combined anti-inflammatory and antituberculous chemotherapy in one medication; clinical and therapeutic study].
Topics: Aminopyrine; Anti-Inflammatory Agents; Isoniazid; Phenylbutazone; Tuberculosis; Tuberculosis, Pulmon | 1956 |
The effect of tebafen on pulmonary tuberculosis.
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Thiosemicarbazones; Tuberculosis, Pulmonary | 1955 |
The effect of tebafen on pulmonary tuberculosis.
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Thiosemicarbazones; Tuberculosis, Pulmonary | 1955 |
The effect of tebafen on pulmonary tuberculosis.
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Thiosemicarbazones; Tuberculosis, Pulmonary | 1955 |
The effect of tebafen on pulmonary tuberculosis.
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Thiosemicarbazones; Tuberculosis, Pulmonary | 1955 |
[Combined ACTH-antibiotic therapy in various forms of chronic tuberculous empyema].
Topics: Adrenocorticotropic Hormone; Aminosalicylic Acid; Anti-Bacterial Agents; Empyema, Tuberculous; Isoni | 1956 |
[Combined ACTH-antibiotic therapy in various forms of chronic tuberculous empyema].
Topics: Adrenocorticotropic Hormone; Aminosalicylic Acid; Anti-Bacterial Agents; Empyema, Tuberculous; Isoni | 1956 |
[Combined ACTH-antibiotic therapy in various forms of chronic tuberculous empyema].
Topics: Adrenocorticotropic Hormone; Aminosalicylic Acid; Anti-Bacterial Agents; Empyema, Tuberculous; Isoni | 1956 |
[Combined ACTH-antibiotic therapy in various forms of chronic tuberculous empyema].
Topics: Adrenocorticotropic Hormone; Aminosalicylic Acid; Anti-Bacterial Agents; Empyema, Tuberculous; Isoni | 1956 |
[Behavior of various serological tests in tuberculotics treated with PAS and PAS plus isoniazid by intravenous perfusions].
Topics: Aminosalicylic Acid; Blood; Humans; Isoniazid; Serologic Tests; Tuberculosis; Tuberculosis, Pulmonar | 1956 |
[Behavior of various serological tests in tuberculotics treated with PAS and PAS plus isoniazid by intravenous perfusions].
Topics: Aminosalicylic Acid; Blood; Humans; Isoniazid; Serologic Tests; Tuberculosis; Tuberculosis, Pulmonar | 1956 |
[Behavior of various serological tests in tuberculotics treated with PAS and PAS plus isoniazid by intravenous perfusions].
Topics: Aminosalicylic Acid; Blood; Humans; Isoniazid; Serologic Tests; Tuberculosis; Tuberculosis, Pulmonar | 1956 |
[Behavior of various serological tests in tuberculotics treated with PAS and PAS plus isoniazid by intravenous perfusions].
Topics: Aminosalicylic Acid; Blood; Humans; Isoniazid; Serologic Tests; Tuberculosis; Tuberculosis, Pulmonar | 1956 |
The rationale of aerosol mist therapy in pulmonary tuberculosis.
Topics: Aerosols; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1956 |
The rationale of aerosol mist therapy in pulmonary tuberculosis.
Topics: Aerosols; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1956 |
The rationale of aerosol mist therapy in pulmonary tuberculosis.
Topics: Aerosols; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1956 |
The rationale of aerosol mist therapy in pulmonary tuberculosis.
Topics: Aerosols; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1956 |
[The efficacy of chemotherapeutic and antibiotic treatment in combination with pneumothorax in cavitary pulmonary tuberculosis].
Topics: Anti-Bacterial Agents; Humans; Isoniazid; Pneumothorax; Pneumothorax, Artificial; Streptomycin; Tube | 1956 |
[The efficacy of chemotherapeutic and antibiotic treatment in combination with pneumothorax in cavitary pulmonary tuberculosis].
Topics: Anti-Bacterial Agents; Humans; Isoniazid; Pneumothorax; Pneumothorax, Artificial; Streptomycin; Tube | 1956 |
[The efficacy of chemotherapeutic and antibiotic treatment in combination with pneumothorax in cavitary pulmonary tuberculosis].
Topics: Anti-Bacterial Agents; Humans; Isoniazid; Pneumothorax; Pneumothorax, Artificial; Streptomycin; Tube | 1956 |
[The efficacy of chemotherapeutic and antibiotic treatment in combination with pneumothorax in cavitary pulmonary tuberculosis].
Topics: Anti-Bacterial Agents; Humans; Isoniazid; Pneumothorax; Pneumothorax, Artificial; Streptomycin; Tube | 1956 |
[Comparative examinations in the treatment of pulmonary tuberculosis with combined PAS-INH therapy and an isoniazid-PAS compound].
Topics: Aminosalicylic Acid; Humans; Isoniazid; Physical Examination; Psychotherapy, Multiple; Tuberculosis, | 1956 |
[Comparative examinations in the treatment of pulmonary tuberculosis with combined PAS-INH therapy and an isoniazid-PAS compound].
Topics: Aminosalicylic Acid; Humans; Isoniazid; Physical Examination; Psychotherapy, Multiple; Tuberculosis, | 1956 |
[Comparative examinations in the treatment of pulmonary tuberculosis with combined PAS-INH therapy and an isoniazid-PAS compound].
Topics: Aminosalicylic Acid; Humans; Isoniazid; Physical Examination; Psychotherapy, Multiple; Tuberculosis, | 1956 |
[Comparative examinations in the treatment of pulmonary tuberculosis with combined PAS-INH therapy and an isoniazid-PAS compound].
Topics: Aminosalicylic Acid; Humans; Isoniazid; Physical Examination; Psychotherapy, Multiple; Tuberculosis, | 1956 |
[Indirect appraisal of the contagiosity of isoniazid-treated pulmonary tuberculosis patients by study of contamination methods in primary tuberculosis of children].
Topics: Child; Humans; Isoniazid; Lung; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Indirect appraisal of the contagiosity of isoniazid-treated pulmonary tuberculosis patients by study of contamination methods in primary tuberculosis of children].
Topics: Child; Humans; Isoniazid; Lung; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Indirect appraisal of the contagiosity of isoniazid-treated pulmonary tuberculosis patients by study of contamination methods in primary tuberculosis of children].
Topics: Child; Humans; Isoniazid; Lung; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Indirect appraisal of the contagiosity of isoniazid-treated pulmonary tuberculosis patients by study of contamination methods in primary tuberculosis of children].
Topics: Child; Humans; Isoniazid; Lung; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Giant, pseudocystic cells and current treatment of pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Giant Cells; Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Giant, pseudocystic cells and current treatment of pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Giant Cells; Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Giant, pseudocystic cells and current treatment of pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Giant Cells; Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Giant, pseudocystic cells and current treatment of pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Giant Cells; Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Three cases of alcoholic polyneuritis combined with pulmonary tuberculosis; favorable effect of isoniazid therapy on polyneuritis].
Topics: Alcoholic Neuropathy; Alcoholism; Humans; Isoniazid; Neuritis; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Three cases of alcoholic polyneuritis combined with pulmonary tuberculosis; favorable effect of isoniazid therapy on polyneuritis].
Topics: Alcoholic Neuropathy; Alcoholism; Humans; Isoniazid; Neuritis; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Three cases of alcoholic polyneuritis combined with pulmonary tuberculosis; favorable effect of isoniazid therapy on polyneuritis].
Topics: Alcoholic Neuropathy; Alcoholism; Humans; Isoniazid; Neuritis; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Three cases of alcoholic polyneuritis combined with pulmonary tuberculosis; favorable effect of isoniazid therapy on polyneuritis].
Topics: Alcoholic Neuropathy; Alcoholism; Humans; Isoniazid; Neuritis; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Role of acetylation in the efficiency of para-aminosalicylic acidisoniazid therapy in pulmonary tuberculosis].
Topics: Acetylation; Aminosalicylic Acid; Female; Humans; Isoniazid; Parity; Protein Processing, Post-Transl | 1956 |
[Role of acetylation in the efficiency of para-aminosalicylic acidisoniazid therapy in pulmonary tuberculosis].
Topics: Acetylation; Aminosalicylic Acid; Female; Humans; Isoniazid; Parity; Protein Processing, Post-Transl | 1956 |
[Role of acetylation in the efficiency of para-aminosalicylic acidisoniazid therapy in pulmonary tuberculosis].
Topics: Acetylation; Aminosalicylic Acid; Female; Humans; Isoniazid; Parity; Protein Processing, Post-Transl | 1956 |
[Role of acetylation in the efficiency of para-aminosalicylic acidisoniazid therapy in pulmonary tuberculosis].
Topics: Acetylation; Aminosalicylic Acid; Female; Humans; Isoniazid; Parity; Protein Processing, Post-Transl | 1956 |
The use of corticosteroids in combination with isonicotinic acid hydrazide in the treatment of advanced bilateral progressive cavitary pulmonary tuberculosis; second report with discussion.
Topics: Adrenal Cortex Hormones; Glucocorticoids; Humans; Isoniazid; Prednisone; Tuberculosis; Tuberculosis, | 1956 |
The use of corticosteroids in combination with isonicotinic acid hydrazide in the treatment of advanced bilateral progressive cavitary pulmonary tuberculosis; second report with discussion.
Topics: Adrenal Cortex Hormones; Glucocorticoids; Humans; Isoniazid; Prednisone; Tuberculosis; Tuberculosis, | 1956 |
The use of corticosteroids in combination with isonicotinic acid hydrazide in the treatment of advanced bilateral progressive cavitary pulmonary tuberculosis; second report with discussion.
Topics: Adrenal Cortex Hormones; Glucocorticoids; Humans; Isoniazid; Prednisone; Tuberculosis; Tuberculosis, | 1956 |
The use of corticosteroids in combination with isonicotinic acid hydrazide in the treatment of advanced bilateral progressive cavitary pulmonary tuberculosis; second report with discussion.
Topics: Adrenal Cortex Hormones; Glucocorticoids; Humans; Isoniazid; Prednisone; Tuberculosis; Tuberculosis, | 1956 |
[Tolerance of nicoteben comp. therapy in pulmonary tuberculosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Gastrointestinal Tract; Humans; Is | 1956 |
[Tolerance of nicoteben comp. therapy in pulmonary tuberculosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Gastrointestinal Tract; Humans; Is | 1956 |
[Tolerance of nicoteben comp. therapy in pulmonary tuberculosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Gastrointestinal Tract; Humans; Is | 1956 |
[Tolerance of nicoteben comp. therapy in pulmonary tuberculosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Gastrointestinal Tract; Humans; Is | 1956 |
[Results of rotation therapy in chronic pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Isoniazid; Rotation; Streptomycin; Tuberculosis, Pulmonary | 1956 |
[Results of rotation therapy in chronic pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Isoniazid; Rotation; Streptomycin; Tuberculosis, Pulmonary | 1956 |
[Results of rotation therapy in chronic pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Isoniazid; Rotation; Streptomycin; Tuberculosis, Pulmonary | 1956 |
[Results of rotation therapy in chronic pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Isoniazid; Rotation; Streptomycin; Tuberculosis, Pulmonary | 1956 |
[Streptohydrazide in the treatment of pulmonary tuberculosis].
Topics: Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1956 |
[Streptohydrazide in the treatment of pulmonary tuberculosis].
Topics: Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1956 |
[Streptohydrazide in the treatment of pulmonary tuberculosis].
Topics: Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1956 |
[Streptohydrazide in the treatment of pulmonary tuberculosis].
Topics: Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1956 |
[Preoperative intrabronchial administration of isoniazid in surgery of pulmonary tuberculosis].
Topics: Humans; Isoniazid; Pulmonary Surgical Procedures; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Preoperative intrabronchial administration of isoniazid in surgery of pulmonary tuberculosis].
Topics: Humans; Isoniazid; Pulmonary Surgical Procedures; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Preoperative intrabronchial administration of isoniazid in surgery of pulmonary tuberculosis].
Topics: Humans; Isoniazid; Pulmonary Surgical Procedures; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Preoperative intrabronchial administration of isoniazid in surgery of pulmonary tuberculosis].
Topics: Humans; Isoniazid; Pulmonary Surgical Procedures; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
Isoniazid salt of calcium para-aminosalicylic acid in pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Calcium; Humans; Isoniazid; Sodium Chloride; Sodium Chloride, Dietary; Tubercu | 1956 |
Isoniazid salt of calcium para-aminosalicylic acid in pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Calcium; Humans; Isoniazid; Sodium Chloride; Sodium Chloride, Dietary; Tubercu | 1956 |
Isoniazid salt of calcium para-aminosalicylic acid in pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Calcium; Humans; Isoniazid; Sodium Chloride; Sodium Chloride, Dietary; Tubercu | 1956 |
Isoniazid salt of calcium para-aminosalicylic acid in pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Calcium; Humans; Isoniazid; Sodium Chloride; Sodium Chloride, Dietary; Tubercu | 1956 |
[The isoniazid in the treatment of pulmonary tuberculosis].
Topics: Humans; Isoniazid; Tuberculosis, Pulmonary | 1956 |
[The isoniazid in the treatment of pulmonary tuberculosis].
Topics: Humans; Isoniazid; Tuberculosis, Pulmonary | 1956 |
[The isoniazid in the treatment of pulmonary tuberculosis].
Topics: Humans; Isoniazid; Tuberculosis, Pulmonary | 1956 |
[The isoniazid in the treatment of pulmonary tuberculosis].
Topics: Humans; Isoniazid; Tuberculosis, Pulmonary | 1956 |
[Evolution of pulmonary tuberculosis in patients with isoniazid-resistant bacilli in sputum].
Topics: Bacillus; Humans; Isoniazid; Sputum; Tuberculosis, Pulmonary | 1956 |
[Evolution of pulmonary tuberculosis in patients with isoniazid-resistant bacilli in sputum].
Topics: Bacillus; Humans; Isoniazid; Sputum; Tuberculosis, Pulmonary | 1956 |
[Evolution of pulmonary tuberculosis in patients with isoniazid-resistant bacilli in sputum].
Topics: Bacillus; Humans; Isoniazid; Sputum; Tuberculosis, Pulmonary | 1956 |
[Evolution of pulmonary tuberculosis in patients with isoniazid-resistant bacilli in sputum].
Topics: Bacillus; Humans; Isoniazid; Sputum; Tuberculosis, Pulmonary | 1956 |
[Comparative study of the results of tuberculostatic agents with and without prednisolone in therapy of common phthisis].
Topics: Aminosalicylic Acid; Antitubercular Agents; Humans; Isoniazid; Prednisolone; Streptomycin; Tuberculo | 1956 |
[Comparative study of the results of tuberculostatic agents with and without prednisolone in therapy of common phthisis].
Topics: Aminosalicylic Acid; Antitubercular Agents; Humans; Isoniazid; Prednisolone; Streptomycin; Tuberculo | 1956 |
[Comparative study of the results of tuberculostatic agents with and without prednisolone in therapy of common phthisis].
Topics: Aminosalicylic Acid; Antitubercular Agents; Humans; Isoniazid; Prednisolone; Streptomycin; Tuberculo | 1956 |
[Comparative study of the results of tuberculostatic agents with and without prednisolone in therapy of common phthisis].
Topics: Aminosalicylic Acid; Antitubercular Agents; Humans; Isoniazid; Prednisolone; Streptomycin; Tuberculo | 1956 |
[Clinical experiences with pyrazinamide].
Topics: Aminosalicylic Acid; Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Streptomycin; Tuberculosis; T | 1956 |
[Further observations on pyrazinamide].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Dermatologic Agents; Isoniazid; Pyrazinamide; Tu | 1956 |
[Ambulant chemotherapy of pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Isoniazid; Thiosemicarbazones; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
Cycloserine combined with other antituberculous agents in the treatment of pulmonary tuberculosis.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Cycloserine; Dermatologic Agents; Humans; Isonia | 1957 |
The effect of isoniazid therapy on pyridoxine metabolism in children.
Topics: Biochemical Phenomena; Child; Humans; Infant; Isoniazid; Pyridoxine; Tuberculosis; Tuberculosis, Pul | 1957 |
[Diagnostic value of the inoculation of guinea pigs with pathological matter containing isoniazid-resistant tubercle bacilli].
Topics: Bacillus; Guinea Pigs; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Experimental studies on the effects of isoniazid at the Naples School of Phthisiology].
Topics: Isoniazid; Schools; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
Pyrazinamide together with oxytetracycline in patients with tubercle bacilli resistant to streptomycin, PAS and isoniazid.
Topics: Aminosalicylic Acid; Bacillus; Isoniazid; Lacticaseibacillus casei; Niacin; Nicotinic Acids; Oxytetr | 1957 |
The anti-tuberculosis activity of sulfoniazide.
Topics: Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Result of the treatment of pulmonary tuberculosis with phthivazide].
Topics: Humans; Isoniazid; Tuberculosis, Pulmonary | 1956 |
[Exacerbation and resistance to isonicotinic acid hydrazide in patients with pulmonary tuberculosis treated by antibacterial drugs combined with corticotherapy].
Topics: Anti-Bacterial Agents; Cortisone; Humans; Isoniazid; Lung; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Clinical course of pulmonary tuberculosis in patients from whom isoniazid-resistant Mycobacteria of different catalase activity was isolated].
Topics: Catalase; Humans; Isoniazid; Mycobacterium; Mycobacterium tuberculosis; Tuberculosis, Pulmonary | 1956 |
[Phagocytosis in the course of tuberculosis. II. Behavior of phagocytosis as compared with M. tuberculosis in tuberculosis treated with antibiotics & chemotherapy].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Humans; Isoniazid; Mycobacterium tuberculosis; P | 1956 |
[Preliminary experiences in treatment of tuberculosis with the combination preparation nicoteben comp].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Isoniazid; Methotrexate; P | 1957 |
Endocrine function during treatment of pulmonary tuberculosis with INH.
Topics: Adrenal Cortex; Isoniazid; Steroids; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Combined isoniazid-heterocyclic thiosemicarbazone treatment of tuberculosis].
Topics: Combined Modality Therapy; Humans; Isoniazid; Niacin; Nicotinic Acids; Thiosemicarbazones; Tuberculo | 1957 |
[Experiences in the treatment of pulmonary tuberculosis with a metallic derivative of isoniazid (INH+INH-Co or isonicco)].
Topics: Cobalt; Humans; Isoniazid; Tuberculosis, Pulmonary | 1957 |
[Outcome of tuberculous pneumonia treated by antibiotics].
Topics: Aminosalicylic Acid; Anti-Bacterial Agents; Antibiotics, Antitubercular; Dermatologic Agents; Isonia | 1957 |
The diffusion of antibiotics in tuberculous lesions of the lung.
Topics: Humans; Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Report on the use of the Gewo preparation dipasic in various forms of pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Isoniazid; Tuberculosis, Pulmonary | 1957 |
[Local isoniazid therapy of tuberculous pleural empyema].
Topics: Empyema, Tuberculous; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
Pyrazinamide-isoniazid in patients with previous isoniazid therapy.
Topics: Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
INHA-PAS in the screening test.
Topics: Aminosalicylic Acid; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
The treatment of certain forms of tuberculosis with a combination of prednisone (or hydrocortisone) and antibiotics.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Dermatologic Agents; Humans; Hydrocortisone; Iso | 1957 |
[Chemotherapy of pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Isoniazid; Tuberculosis, Pulmonary | 1957 |
The combined use of isoniazid and nupasal-213 in pulmonary tuberculosis; a study of the toxic effects and the development of cross-resistance between isoniazid and nupasal-213 in the treatment of pulmonary tuberculosis.
Topics: Humans; Isoniazid; Tuberculosis, Pulmonary | 1957 |
[Treatment of destructive forms of pulmonary tuberculosis with isoniazid in combination with PAS and streptomycin].
Topics: Aminosalicylic Acid; Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1957 |
[Treatment of pulmonary tuberculosis with high alternating dosage of pyrazinamide and isoniazid].
Topics: Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[High-dosage isoniazid therapy of pulmonary tuberculosis with alternating treatment with antibacterial drugs].
Topics: Aminosalicylic Acid; Anti-Bacterial Agents; Isoniazid; Tuberculosis, Pulmonary | 1957 |
[Clinical trials of a preparation of pyrizinamide and isoniazid base].
Topics: Alkalies; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Studies of 30 case histories of pulmonary tuberculosis patients treated with dipasic (GEWO 339)].
Topics: Aminosalicylic Acid; Isoniazid; Tuberculosis, Pulmonary | 1957 |
[Chemotherapy of pulmonary tuberculosis with special reference to new results of resistance & virulence research].
Topics: Aminosalicylic Acid; Isoniazid; Research; Streptomycin; Thiosemicarbazones; Tuberculosis; Tuberculos | 1957 |
Discussion on the modern outlook in the management of pulmonary tuberculosis: chemotherapy.
Topics: Aminosalicylic Acid; Disease Management; Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1957 |
[Clinical evaluation of 31 cases of pulmonary tuberculosis with isoniazid-resistant bacilli in adults].
Topics: Adult; Bacillus; Humans; Isoniazid; Lacticaseibacillus casei; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
The treatment of pulmonary tuberculosis with dipasic.
Topics: Aminosalicylic Acid; Isoniazid; Tuberculosis, Pulmonary | 1957 |
[Domiciliary & ambulant therapy of pulmonary tuberculosis].
Topics: Collapse Therapy; Humans; Isoniazid; Tuberculosis, Pulmonary | 1957 |
Sensitization to P.A.S., streptomycin, and isoniazid.
Topics: Hypersensitivity; Immune System Diseases; Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulmo | 1957 |
The rising incidence of isoniazid resistance: its clinical significance.
Topics: Incidence; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Experiences with isoniazid-PAS in the treatment of cavernous and exsudative pulmonary tuberculoses in children and adolescents].
Topics: Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Antibacterial isoniazid loading as a test of tubercular activity].
Topics: Anti-Bacterial Agents; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Pyrazinamide-isoniazid mixture in the treatment of chronic pulmonary tuberculosis].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Chemoprophylaxis of tuberculosis].
Topics: Biomedical Research; Chemoprevention; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Sensitivity to streptomycin & isoniazid & virulence of M. tuberculosis isolated from patients with pulmonary post-primary tuberculosis diagnosed for the first time and not yet treated with antibiotics & chemotherapy].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Humans; Isoniazid; Mycobacterium tuberculosis; S | 1957 |
[First results in the cure of pulmonary tuberculosis obtained with the combination of nicotinic aldehyde thiosemicarbazone & isoniazid].
Topics: Aldehydes; Isoniazid; Thiosemicarbazones; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
Cyanacethydrazide therapy in pulmonary tuberculosis.
Topics: Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
Comparative efficacy of the concurrent use of pyrazinamide and isoniazid with that of other forms of therapy in the treatment of pulmonary tuberculosis.
Topics: Isoniazid; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
The case for the use of isoniazid alone in the treatment of pulmonary tuberculosis in East Africa.
Topics: Africa, Eastern; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
Quantitative studies on human urinary metabolites of tryptophan as affected by isoniazid and deoxypyridoxine.
Topics: Body Fluids; Humans; Isoniazid; Tryptophan; Tuberculosis; Tuberculosis, Pulmonary; Vitamin B 6 | 1957 |
Atypical histologic aspects of pulmonary tuberculosis as related to attenuation or loss of pathogenicity of isoniazid-resistant strains of M. tuberculosis.
Topics: Humans; Isoniazid; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Pulmonary; Virulence | 1957 |
[PIRAZINAMIDE-ISONIAZID combined therapy for pulmonary tuberculosis; original treatment in cases with unified background factors. I].
Topics: Fibrinogen; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Pyrazinamide & pyrazinamide with isoniazid in pulmonary tuberculosis; comparison with other chemotherapeuticantibiotic combinations].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Cyanacetic acid hydrazide associated with dihydrostreptomycin in the treatment of pulmonary tuberculosis].
Topics: Aminosalicylic Acids; Dihydrostreptomycin Sulfate; Humans; Hydrazines; Isoniazid; Tuberculosis; Tube | 1957 |
[Cortisone and derivatives in therapy of pulmonary tuberculosis; case reports].
Topics: Anti-Bacterial Agents; Cortisone; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Failures in tuberculosis therapy and supplementary antibiotic therapy].
Topics: Anti-Bacterial Agents; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
Clinical implications of isoniazid blood levels in pulmonary tuberculosis.
Topics: Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Duration of results in chemotherapy of pulmonary tuberculosis, with special consideration of isoniazid].
Topics: Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Continuous clinical & bacteriological studies on results of prolonged isoniazid & PAS therapy of pulmonary tuberculosis].
Topics: Biomedical Research; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Concentration of phthivazid in the blood, urine, and pathological foci during inhalation therapy].
Topics: Body Fluids; Isoniazid; Respiratory Therapy; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
Prophylactic effects of isoniazid on primary tuberculosis in children; a preliminary report.
Topics: Child; Humans; Infant; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Treatment of tuberculosis with an INH-thiosemicarbazone preparation].
Topics: Isoniazid; Thiosemicarbazones; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Relations between clinical and bacteriological findings in isoniazid-resistance].
Topics: Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Tests of combined isoniazid and heterocyclic thiosemicarbazone therapy].
Topics: Isoniazid; Niacin; Nicotinic Acids; Thiosemicarbazones; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Comparative effects of combined and continuous streptomycin-PAS and streptomycin-PAS-isoniazid therapy on closure of tuberculous caverns].
Topics: Caves; Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
Possible superinfection with isoniazid-resistant tubercle bacilli.
Topics: Bacillus; Gram-Positive Bacteria; Isoniazid; Lacticaseibacillus casei; Medical Records; Superinfecti | 1958 |
[Combined pyrazinamide and isoniazid in therapy of pulmonary tuberculosis].
Topics: Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Appearance of gynecomastia in pulmonary tuberculosis patients during isoniazid therapy].
Topics: Gynecomastia; Humans; Isoniazid; Male; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Problem of treatment of pulmonary tuberculosis with stroke doses of isoniazid].
Topics: Isoniazid; Stroke; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
Cystic cavities in pulmonary tuberculosis treated with isoniazid.
Topics: Dental Caries; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
Further experience with single-drug (isoniazid) therapy in chronic pulmonary tuberculosis; initial therapy with high-dose isoniazid.
Topics: Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[Behavior of leukocyte osmotic resistance in tuberculous patients treated with isoniazid].
Topics: Isoniazid; Leukocytes; Osmosis; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
A preliminary report on the safety and therapeutic activity of a salizid INH derivative.
Topics: Isoniazid; Neuritis; Safety; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
Cycloserine-isoniazid combination therapy in virgin cases of pulmonary tuberculosis.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Cycloserine; Dermatologic Agents; Isoniazid; Tub | 1958 |
[Effect of cyanacetic acid hydrazide in anti-tuberculosis therapy on indices of organic resistance; clinico-functional studies].
Topics: Blood Sedimentation; Hydrazines; Isoniazid; Oxygen; Phagocytosis; Tuberculosis; Tuberculosis, Pulmon | 1957 |
[Recent work on the para-aminosalicylic salt of isoniazid].
Topics: Isoniazid; Sodium Chloride, Dietary; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
A case of pulmonary tuberculosis due to isoniazid-resistant, guinea-pig attenuated, Myco. tuberculosis.
Topics: Guinea Pigs; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Results of prolonged treatment with isoniazid].
Topics: Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Experimental disturbance of mycobacterial virulence induced by isonicotinic acid hydrazide therapy and its relation to the clinical picture in human pulmonary tuberculosis].
Topics: Humans; Isoniazid; Mycobacterium tuberculosis; Tuberculosis, Pulmonary; Virulence | 1957 |
[Clinical results of the treatment of pulmonary tuberculosis with combination isoniazid & T40; frequency of appearance of isoniazid resistant tubercle bacilli].
Topics: Bacillus; Isoniazid; Lacticaseibacillus casei; Salicylates; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Early results in the treatment of pulmonary tuberculosis with a combination of d-cycloserine & isoniazid in a Sino-Vietnamese environment].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Cycloserine; Dermatologic Agents; Isoniazid; Tub | 1957 |
[Isoniazid & hyaluronidase aerosol in bronchial tuberculosis].
Topics: Aerosols; Humans; Hyaluronoglucosaminidase; Isoniazid; Lung; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Allergic edema due to isoniazid therapy of pulmonary tuberculosis].
Topics: Edema; Immune System Diseases; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Ultrasonic aerosols in medicine; comparative blood level determination after inhalation & peroral administration of isoniazid in pulmonary tuberculosis].
Topics: Aerosols; Humans; Isoniazid; Medicine; Tuberculosis; Tuberculosis, Pulmonary; Ultrasonics | 1957 |
Sputkm conversion and the metabolism of isoniazid.
Topics: Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[Chromoblastomycosis cured in a tuberculous patient during isoniazid therapy].
Topics: Blastomycosis; Chromoblastomycosis; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
Pathogenicity of isoniazid-resistant tubercle bacilli.
Topics: Bacillus; Humans; Isoniazid; Lung; Tuberculosis; Tuberculosis, Pulmonary; Virulence | 1958 |
[Use of hyaluronidase to enhance effectiveness of isonicotinic acid hydrazide after intrabronchial instillation].
Topics: Hyaluronoglucosaminidase; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[Comparison of the early results of treatment of infiltrative & fibronodular pulmonary tuberculosis with massive doses of isoniazid alone & with pneumothorax].
Topics: Humans; Isoniazid; Lung; Pneumothorax; Pneumothorax, Artificial; Tuberculosis; Tuberculosis, Pulmona | 1958 |
[Chemotherapy of pulmonary tuberculosis with nicoteben-compositum].
Topics: Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[Clinical contribution to chemotherapy of pulmonary tuberculosis with reference to isoniazid and PAS].
Topics: Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[Several cases of primary tuberculosis in children treated with isoniazid & heterocyclic thiosemicarbazone].
Topics: Child; Humans; Infant; Isoniazid; Niacin; Nicotinic Acids; Thiosemicarbazones; Tuberculosis; Tubercu | 1958 |
Seromucoid (serum mucoprotein) values in patients undergoing hinconstarch therapy.
Topics: Blood Proteins; Fungi; Isoniazid; Mucoproteins; Orosomucoid; Starch; Thiosemicarbazones; Tuberculosi | 1958 |
[Radiological records of the results of combined pyrazinamide-streptomycin-isoniazid therapy].
Topics: Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Radiology; Streptomycin; Tuberculosis; Tuberculosi | 1958 |
[The effect of isonicotinic acid hydrazide (INAH) on cavities and caseous lesions, especially the effect on caseous material].
Topics: Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[Clinical results of combined phenylbutazone & isoniazid therapy in pulmonary tuberculosis].
Topics: Isoniazid; Phenylbutazone; Psychotherapy, Multiple; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
Chemotherapy of tuberculosis. III. Verazide in the treatment of pulmonary tuberculosis.
Topics: Antitubercular Agents; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[Four cases of lichen planus during streptomycin, PAS and isoniazid therapy].
Topics: Isoniazid; Lichen Planus; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
The treatment of pulmonary tuberculosis with prolonged streptomycin, sodium P-aminosalicylate and isoniazid.
Topics: Aminosalicylic Acid; Humans; Isoniazid; Sodium; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
Isoniazid treatment of early ambulant cases of pulmonary tuberculosis.
Topics: Early Ambulation; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[Studies on the changes of the daily amount of tubercle bacilli present in sputum and its resistance against drugs, when patients have been treated with anti-tuberculous agents. I. Combined therapy with pyrazinamide and isonicotinic acid hydrazide].
Topics: Bacillus; Humans; Isoniazid; Lung; Pyrazinamide; Sputum; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
Massive-dose isoniazid with pyridoxine in chronic pulmonary tuberculosis.
Topics: Humans; Isoniazid; Pyridoxine; Tuberculosis; Tuberculosis, Pulmonary; Vitamin B 6 | 1958 |
The treatment of pulmonary tuberculosis with isoniazid and reduced dose of p-aminosalicylic acid.
Topics: Aminosalicylic Acid; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[Isoniazid chemotherapy and chemoprophylaxis of tuberculosis].
Topics: Chemoprevention; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[Large doses of isoniazid in therapy of pulmonary buberculosis].
Topics: Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary; Vitamin B 6 | 1958 |
Studies of the PAS salt of isoniazid in the treatment of tuberculosis.
Topics: Isoniazid; Sodium Chloride; Sodium Chloride, Dietary; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
Clinical use of a single daily dose of para-aminosalicylic acid in association with isoniazid.
Topics: Aminosalicylic Acid; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
An evaluation of chemotherapy in pulmonary tuberculosis. I. High doses of isoniazid with PAS and pyridoxine.
Topics: Isoniazid; Pyridoxine; Tuberculosis; Tuberculosis, Pulmonary; Vitamin B 6 | 1958 |
An evaluation of chemotherapy in pulmonary tuberculosis. II. Daily streptomycin plus high doses of isoniazid with PAS and pyridoxine.
Topics: Isoniazid; Pyridoxine; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary; Vitamin B 6 | 1958 |
[Studies on the changes of the daily amount of tubercle bacilli present in sputum and its resistance against drugs, when patients have been treated with anti-tuberculous agents. III. Combined therapy with streptomycin, PAS and isoniazid].
Topics: Bacillus; Humans; Isoniazid; Sputum; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[Initial sensitivity to streptomycin & isoniazid of Mycobacterium tuberculosis isolated from patients with primary pulmonary tuberculosis not yet treated].
Topics: Humans; Isoniazid; Mycobacterium tuberculosis; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[Research on resected lung preparations. II. Relation between isoniazid treatment, biology of causative agent & structure of tuberculous foci].
Topics: Humans; Isoniazid; Lung; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[The correct way to use combined antituberculosis drugs; on alpha-ethylisonicotinic acid thioamide, a new antituberculosis drug active against isoniazid-resistant bacteria].
Topics: Antitubercular Agents; Bacteria; Humans; Isoniazid; Niacin; Nicotinic Acids; Thioamides; Tuberculosi | 1958 |
[The action of streptomycin and isoniazid on tuberculous caverns].
Topics: Caves; Humans; Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[Comparative evaluation of immediate results following tubazide and phthivazide therapy of pulmonary tuberculosis in a sanatorium; preliminary communication].
Topics: Communication; Hospitals; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[A molecular combination of isoniazid and PAS in therapy of tuberculosis].
Topics: Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[Epidemiological significance of isoniazid resistance in open tuberculosis].
Topics: Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[Isoniazid & recurrence of tuberculosis in diabetics].
Topics: Diabetes Complications; Diabetes Mellitus; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
Report on the use of isoniazid and cycloserine in 84 cases of pulmonary tuberculosis.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Cycloserine; Dermatologic Agents; Isoniazid; Tub | 1959 |
Pyrazinamide in low dosage in combination with isoniazid or paraaminosalicylic acid in the treatment of pulmonary tuberculosis.
Topics: Aminosalicylic Acid; Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, P | 1959 |
[Problems connected with combination therapy of pulmonary tuberculosis; bacteriological results of monotherapy with isoniazid & combination therapy with isoniazid & streptomycin].
Topics: Combined Modality Therapy; Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[Behavior of the clinical and serum protein picture in tuberculous patients treated with a heavy metal derivative of isoniazid].
Topics: Blood Proteins; Cobalt; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[Clinical study of the use of isonicotinoylhydrazones combined with isonicotinic acid hydrazide in therapy of pulmonary tuberculosis].
Topics: Biomedical Research; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[Isonicotinylhydrazone of furyl-2-methyl ketone].
Topics: Furans; Humans; Isoniazid; Ketones; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[First clinical results of an isoniazid derivative (isonicotinylhydrazone of furyl-2-methyl ketone) in pulmonary tuberculosis].
Topics: Furans; Humans; Isoniazid; Ketones; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[Preventive chemotherapy of tuberculosis by isoniazid].
Topics: Biomedical Research; Chemoprevention; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[Treatment of pulmonary tuberculosis by isoniazid-para-aminosalicylate].
Topics: Antitubercular Agents; Humans; Isoniazid; Tuberculosis, Pulmonary | 1958 |
Association between carcinoma of the bladder and pulmonary tuberculosis: evaluation of PAS and INH as carcinogenic agents.
Topics: Aminosalicylic Acid; Carcinogens; Carcinoma; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonar | 1959 |
[Isoniazid load test for evaluation of tuberculous activity; clinical findings].
Topics: Humans; Isoniazid; Lung; Tuberculosis; Tuberculosis, Pulmonary | 1959 |
COMPARATIVE trial of isoniazid in combination with sulphone or PAS in the treatment of acute pulmonary tuberculosis in East Africans; a co-operative investigation in East African hospitals and laboratories with the collaboration of the British Medical Res
Topics: Biomedical Research; Cooperative Behavior; Humans; Isoniazid; Sulfones; Tuberculosis; Tuberculosis, | 1959 |
The use of pyrazinamide plus isoniazid in the treatment of pulmonary tuberculosis.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1959 |
[Combined treatment of pulmonary tuberculosis with isoniazid, streptomycin & elpimed & their effect on formation of resistance].
Topics: Combined Modality Therapy; Humans; Immunization, Passive; Isoniazid; Serum; Streptomycin; Tuberculos | 1959 |
The effect of isoniazid upon the growth of tubercle bacilli from pulmonary lesions.
Topics: Bacillus; Isoniazid; Lacticaseibacillus casei; Physiological Phenomena; Tuberculosis; Tuberculosis, | 1959 |
Toxic psychosis due to isoniazid; report of three cases with studies of patterns of isoniazid inactivation in the serum.
Topics: Isoniazid; Mental Disorders; Psychoses, Substance-Induced; Psychotic Disorders; Tuberculosis; Tuberc | 1959 |
[Study of liver function in children during prolonged isoniazid therapy].
Topics: Child; Humans; Infant; Isoniazid; Liver; Tuberculosis; Tuberculosis, Pulmonary | 1959 |
[Tests of liver function during pyrazinamide therapy].
Topics: Child; Humans; Infant; Isoniazid; Liver; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberc | 1959 |
[Cycloserine and isoniazid combination in therapy of chronic pulmonary tuberculosis].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Cycloserine; Dermatologic Agents; Isoniazid; Tub | 1959 |
[Observations on the treatment of pulmonary tuberculosis with sulfoniazid].
Topics: Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1959 |
[Effect of cortisone derivatives on pleural & meningeal permeability to isoniazid].
Topics: Cortisone; Isoniazid; Permeability; Pleura; Prednisone; Tuberculosis; Tuberculosis, Meningeal; Tuber | 1959 |
[Effect of streptomycin, PAS and rimifon on ocular adaptation in pulmonary tuberculosis].
Topics: Adaptation, Ocular; Aminosalicylic Acid; Eye; Head; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1959 |
Cycloserine-isoniazid in the ambulatory treatment of active tuberculosis after failure of previous chemotherapy.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Cycloserine; Dermatologic Agents; Isoniazid; Tub | 1959 |
Isoniazid and para-aminosalicylic acid toxicity in 513 cases: a study including high doses of INH and gastrointestinal intolerance to PAS.
Topics: Aminosalicylic Acid; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1959 |
Combined drug treatment of tuberculosis. II. Studies of antimicrobially-active isoniazid and streptomycin serum levels in adult tuberculous patients.
Topics: Adult; Combined Modality Therapy; Humans; Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulmo | 1959 |
Observations on cycloserineisoniazid in pulmonary tuberculosis.
Topics: Cycloserine; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
The effects of prednisolone, INAH, and a combination of the two on experimental tuberculous cavities in the guinea-pig. 3.
Topics: Guinea Pigs; Isoniazid; Lung; Prednisolone; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
[Effects of prednisolone and or isoniazid on experimental pulmonary cavitary tuberculosis in guinea pigs. I].
Topics: Animals; Guinea Pigs; Isoniazid; Lung; Prednisolone; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
[On the treatment of freshly diagnosed active pulmonary tuberculosis with special reference to gluronazide].
Topics: Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
[Clinico-biological observations on the use of verazide in the therapy of pulmonary tuberculosis].
Topics: Antitubercular Agents; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
Report on the use of cycloserine and isoniazid in twenty-seven cases of pulmonary tuberculosis in psychotic patients.
Topics: Cycloserine; Isoniazid; Mental Disorders; Psychotic Disorders; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
[Controlled trial of 3 types of oral treatment of pulmonary tuberculosis conducted at Morocco in Tangiers. (I.N.H. and Ethionamide, I.N.H. and P.A.S., I.N.H. only). Preliminary results after 1 year of observation].
Topics: Administration, Oral; Aminosalicylic Acid; Antitubercular Agents; Ethionamide; Isoniazid; Morocco; T | 1961 |
[On the therapeutic use of sulfoniazid in tuberculosis].
Topics: Humans; Isoniazid; Kidney; Tuberculosis; Tuberculosis, Pulmonary; Tuberculosis, Renal | 1961 |
[On excretion in the urine of the products of transformation of the hydrazide of isonicotinic acid, phtivazid and metazid in patients with tuberculosis of the lungs].
Topics: Antihypertensive Agents; Body Fluids; Humans; Isoniazid; Isonicotinic Acids; Tuberculosis; Tuberculo | 1960 |
Retreatment of pulmonary tuberculosis. Experiences with various combinations of pyrazinamide, cycloserine, and kanamycin in patients excreting tubercle bacilli resistant to both streptomycin and isoniazid.
Topics: Anti-Bacterial Agents; Bacillus; Cycloserine; Humans; Isoniazid; Kanamycin; Pyrazinamide; Retreatmen | 1960 |
The differential diagnosis of toxic depression in pulmonary tuberculosis.
Topics: Depression; Depressive Disorder; Diagnosis, Differential; Humans; Isoniazid; Tuberculosis; Tuberculo | 1960 |
[Clinical experiences with nicoteben treatment of 578 patients with pulmonary tuberculosis].
Topics: Isoniazid; Thiosemicarbazones; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
[Combined treatment of pulmonary tuberculosis with DSM pantothenate, INH and PAS in continuous infusion].
Topics: Aminosalicylic Acid; Combined Modality Therapy; Isoniazid; Manipulation, Osteopathic; Streptomycin; | 1960 |
Progress in the second and third years of patients with quiescent pulmonary tuberculosis after a year of chemotherapy at home or in sanatorium, and influence of further chemotherapy on the relapse rate.
Topics: Aged; Chronic Disease; Drug Therapy, Combination; Follow-Up Studies; Hospitals; Humans; India; Isoni | 1961 |
Prophylactic isoniazid in nurses in a tuberculosis hospital.
Topics: Hospitals, Chronic Disease; Humans; Isoniazid; Nurses; Nursing; Occupational Diseases; Tuberculosis; | 1960 |
Comparative study of isoniazid versus no chemotherapy in the prevention of relapse of chronic cavitary tuberculosis.
Topics: Biomedical Research; Chronic Disease; Isoniazid; Recurrence; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
[Treatment of pulmonary tuberculosis with high dosage of isoniazid derivative (Na-methansulfonate-IHMS) combined with PAS. The results of primary treatment of infiltrative caseous lesions].
Topics: Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
Drugs other than streptomycin, para-aminosalicylic acid, and isoniazid in the surgical treatment of pulmonary tuberculosis.
Topics: Aminosalicylic Acid; Antitubercular Agents; Isoniazid; Pulmonary Surgical Procedures; Streptomycin; | 1961 |
Characteristics of mycobacterial populations found in the sputum of tuberculous patients after prolonged isoniazid therapy.
Topics: Humans; Isoniazid; Sputum; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
[Experiences with the treatment of pulmonary tuberculosis with INH--ultrasonic aerosols].
Topics: Aerosols; Humans; Isoniazid; Respiratory Therapy; Tuberculosis, Pulmonary; Ultrasonic Therapy; Ultra | 1960 |
[Isoniazid, ultrasonics-aerosol in the treatment of pulmonary tuberculosis].
Topics: Aerosols; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary; Ultrasonic Therapy; Ultrasonics | 1961 |
[Treatment of fulminating forms of pulmonary tuberculosis with isoniazid alone or in combination with PAS and streptomycin. 5-year observations].
Topics: Antitubercular Agents; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1960 |
Retreatment of tuberculous patients: an experience with the combined use of high doses of isoniazid, pyrazinamide and cycloserine.
Topics: Cycloserine; Isoniazid; Pyrazinamide; Retreatment; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
Initial chemotherapy in pulmonary tuberculosis: daily streptomycin with high isoniazid dosage in previously untreated cases.
Topics: Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
[Treatment of pulmonary tuberculosis with PAS, isoniazid and streptomycin by venous infusions. Hematic concentrations and clinical results].
Topics: Humans; Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
[The association of nicotinaldehyde thiosemicarbazone and isoniazid in the treatment of pulmonary tuberculosis in adults].
Topics: Aldehydes; Isoniazid; Niacin; Nicotinic Acids; Thiosemicarbazones; Tuberculosis; Tuberculosis, Pulmo | 1959 |
One-half gram of streptomycin daily with isoniazid and PAS used as a re-treatment regimen in pulmonary tuberculosis.
Topics: Antitubercular Agents; Clinical Protocols; Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1961 |
Effect of cortisone plus antituberculosis agents on tuberculous pneumonia in guinea pigs.
Topics: Animals; Antitubercular Agents; Cortisone; Guinea Pigs; Isoniazid; Lung; Pneumonia; Streptomycin; Tu | 1961 |
[Microbiological method in the determination of isonicotinic acid hydrazide (INH) level in the blood and its role in patients with pulmonary tuberculosis].
Topics: Humans; Isoniazid; Tuberculosis, Pulmonary | 1961 |
[Results of metazid treatment of patients with pulmonary tuberculosis].
Topics: Antihypertensive Agents; Isoniazid; Tuberculosis, Pulmonary | 1960 |
[Active I.N.H. in the serum and liver function test resuls. Study of 60 subjects].
Topics: Humans; Isoniazid; Liver Function Tests; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
[Attempted therapy of pulmonary tuberculosis with large doses of INH associated with pyridoxine].
Topics: Isoniazid; Pyridoxine; Tuberculosis, Pulmonary; Vitamin B 6 | 1960 |
High dose isoniazid in original and retreatment chemotherapy for pulmonary tuberculosis: clinical, electrophoretic, and bacteriological studies.
Topics: Electrophoresis; Isoniazid; Retreatment; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
[The future of tuberculous patients treated with isoniazid every three days].
Topics: Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
Control study of biologically active isoniazid in serum of children with primary tuberculosis.
Topics: Child; Humans; Infant; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
[Effects of prednisolone and/or isoniazid on experimental pulmonary cavitary tuberculosis in guinea pigs. II].
Topics: Animals; Guinea Pigs; Isoniazid; Lung; Prednisolone; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
Endobronchial instillation of isonicotinic acid hydrazide in chronic cavitary pulmonary tuberculosis.
Topics: Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
[Individual differences in the pattern of resistance development of tubercle bacilli to streptomycin, PAS and isoniazid in tuberculous patients].
Topics: Antitubercular Agents; Bacillus; Individuality; Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, | 1960 |
[Corticoids in the treatment of pulmonary tuberculosis. Animal experimental studies. II. The effect of prednisolone on guinea pig tuberculosis treated with isonicotinic acid and streptomycin].
Topics: Adrenal Cortex Hormones; Animals; Guinea Pigs; Isoniazid; Isonicotinic Acids; Lung; Prednisolone; St | 1961 |
Progress in the second year of patients with quiescent pulmonary tuberculosis after a year of chemotherapy at home or in sanatorium, and influence of further chemotherapy on the relapse rate.
Topics: Aged; Aminosalicylic Acid; Antitubercular Agents; Chronic Disease; Drug Therapy, Combination; Follow | 1960 |
The treatment of pulmonary tuberculosis with isoniazid and sulfadimethoxine: a controlled study.
Topics: Isoniazid; Research Design; Sulfadimethoxine; Sulfanilamide; Sulfanilamides; Sulfonamides; Tuberculo | 1961 |
[Treatment of pulmonary tuberculosis with the combination of nicotinaldehyde-thiosemicarbazone and isoniazid. Personal experience].
Topics: Aldehydes; Isoniazid; Niacin; Nicotinic Acids; Thiosemicarbazones; Tuberculosis, Pulmonary | 1960 |
[Effects of working conditions on chemotherapy of pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Isoniazid; Occupational Medicine; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
[Chemoprophylaxis of tuberculosis].
Topics: Biomedical Research; Chemoprevention; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
Ineffectiveness of nicotinamide and isoniazid in the treatment of pulmonary tuberculosis.
Topics: Isoniazid; Niacin; Niacinamide; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
A comparison between the behavior of Eskimos and non-Eskimos to the administration of isoniazid.
Topics: Disease; Humans; Inuit; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
[Dynamics of double medicinal resistance of Mycobacterium tuberculosis in patients with cavernous pulmonary tuberculosis].
Topics: Isoniazid; Mycobacterium tuberculosis; Streptomycin; Tuberculosis, Pulmonary | 1960 |
Bacterial resistance to streptomycin, PAS and isoniazid in untreated patients with symptomatic pulmonary tuberculosis in Ashanti.
Topics: Aminosalicylic Acid; Bacterial Infections; Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulm | 1960 |
The initiation of chemotherapy in pulmonary tuberculosis in West Africans. Hospital and ambulant treatment compared using streptomycyclidine-isonicotinic acid hydrazide.
Topics: Hospitals; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
[Treatment of pulmonary tuberculosis. Massive doses of isoniazid].
Topics: Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
An evaluation of chemotherapy in pulmonary tuberculosis. High doses of isoniazid and PAS versus daily streptomycin with high doses of isoniazid and PAS.
Topics: Aminosalicylic Acid; Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
[On the frequency and nature of medicinal resistance of Mycobacterium tuberculosis in patients with pulmonary tuberculosis during antibacterial therapy].
Topics: Anti-Bacterial Agents; Isoniazid; Mycobacterium tuberculosis; Streptomycin; Tuberculosis, Pulmonary | 1960 |
Pyrazinamide-isoniazid treated tuberculous patients: a five year follow-up.
Topics: Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1959 |
[Note on the utilization of streptomyclidine isonicotinyl hydrazide (SH) in pulmonary tuberculosis].
Topics: Anti-Bacterial Agents; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1960 |
Safe high dosage isoniazid therapy.
Topics: Isoniazid; Tuberculosis; Tuberculosis, Pulmonary; Vitamin B 6 | 1959 |
Streptovaricin and isoniazid in the treatment of pulmonary tuberculosis.
Topics: Anti-Bacterial Agents; Isoniazid; Streptovaricin; Tuberculosis; Tuberculosis, Pulmonary | 1959 |
Phenylbutazone and isoniazid in pulmonary tuberculosis.
Topics: Isoniazid; Phenylbutazone; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
A clinical evaluation of thiocarbanidin and isoniazid in the treatment of pulmonary tuberculosis.
Topics: Antitubercular Agents; Isoniazid; Thiourea; Tuberculosis; Tuberculosis, Pulmonary | 1959 |
[Gonadotropin excretion in pulmonary tuberculosis in men before and during isoniazid treatment].
Topics: Body Fluids; Gonadotropins; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
[Association of nicotinaldehydethiosemicarbazone and isoniazid in the treatment of pulmonary tuberculosis. (Preliminary communication)].
Topics: Communication; Isoniazid; Thiosemicarbazones; Tuberculosis, Pulmonary | 1959 |
Treatment of pulmonary tuberculosis with isoniazid and pyrazinamide: experience in 114 cases.
Topics: Humans; Isoniazid; Pyrazinamide; Tuberculosis, Pulmonary | 1959 |
A comparison of isoniazid-cycloserine with isoniazid-PAS in the therapy of cavitary pulmonary tuberculosis. X. A report of the Veterans Administration-Armed Forces cooperative study.
Topics: Biomedical Research; Cycloserine; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary; United S | 1960 |
A retrospective study of cases of pulmonary tuberculosis developing drug resistance.
Topics: Drug Resistance; Isoniazid; Retrospective Studies; Streptomycin; Tuberculosis; Tuberculosis, Multidr | 1960 |
[Immediate results of the treatment of patients with pulmonary tuberculosis with tubazid, metazid and phthivazid].
Topics: Antitubercular Agents; Humans; Isoniazid; Tuberculosis, Pulmonary | 1959 |
[The chemoprophylaxis of pulmonary tuberculosis. What must one think of it?].
Topics: Chemoprevention; Humans; Isoniazid; Thinking; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
Evaluation of cycloserine with high dosage of isoniazid in chronic treatment-failure pulmonary tuberculosis.
Topics: Cycloserine; Isoniazid; Treatment Failure; Tuberculosis; Tuberculosis, Pulmonary | 1959 |
[Trial of treatment of recent pulmonary tuberculosis patients by isoniazid in massive doses (15 mg kg) without pyridoxine].
Topics: Isoniazid; Pyridoxine; Tuberculosis; Tuberculosis, Pulmonary | 1959 |
[Loss of consciousness with relapse during treatment with Rimifon].
Topics: Child; Chronic Disease; Coma; Consciousness; Humans; Infant; Isoniazid; Recurrence; Tuberculosis; Tu | 1961 |
The treatment of chronic cavitating pulmonary tuberculosis by long-term chemotherapy.
Topics: Aminosalicylic Acid; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1961 |
Intermittent isoniazid therapy for mice.
Topics: Animals; Isoniazid; Lung; Mice; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
[Results of hormono-chemo-antibiotic therapy in pulmonary tuberculosis].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anti-Bacterial Agents; Isoniazid; Streptomycin | 1961 |
[Endobronchial treatment of caverns in the lungs].
Topics: Caves; Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1962 |
[Is resistance break-through possible after INH and PAS long-term therapy in pulmonary tuberculosis by the use of INHA-PAS?].
Topics: Aminosalicylic Acid; Isoniazid; Tuberculosis, Pulmonary | 1961 |
Response of patients infected with isoniazid-resistant tubercle bacilli to treatment with isoniazid plus PAS or isoniazid alone.
Topics: Bacillus; Humans; India; Isoniazid; Sputum; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis.
Topics: Antitubercular Agents; Biological Assay; Female; Hospitalization; Humans; India; Isoniazid; Male; Re | 1961 |
Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis. 3. Serum concentrations of isoniazid produced by three regimens of isoniazid alone and one of isoniazid plus PAS.
Topics: Humans; India; Isoniazid; Microbial Sensitivity Tests; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
[The effect of combined streptomycin pantothenate and INH therapy on the otovestibular system in chronic pulmonary tuberculosis patients].
Topics: Humans; Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary; Vestibule, Labyrinth | 1962 |
Combined streptomycin and thiacetazone in the treatment of pulmonary tuberculosis resistant to isoniazid and PAS.
Topics: Anti-Bacterial Agents; Isoniazid; Streptomycin; Thioacetazone; Thiosemicarbazones; Tuberculosis; Tub | 1961 |
[Observations on the behavior of some biological indices in pulmonary tuberculosis patients during treatment with microdoses of streptomycin and isoniazid by intradermal route].
Topics: Injections, Intradermal; Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
[Effect of therapy of pulmonary tuberculosis with a combination of Neoiscotin and Erycon].
Topics: Isoniazid; Sulfanilamide; Sulfanilamides; Sulfonamides; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
Preliminary study of the therapeutic effects of a single weekly high dose of isoniazid on twenty-nine patients with active pulmonary tuberculosis.
Topics: Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1962 |
[Corticoids in the treatment of lung tuberculosis. Animal experimental studies. VI. Comparative studies on the fine morphological structures of experimentally induced tubercle under prednisolone-streptomycin or isonicotinic acid hydrazidestreptomycin and
Topics: Adrenal Cortex Hormones; Animals; Guinea Pigs; Isoniazid; Isonicotinic Acids; Prednisolone; Streptom | 1962 |
Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis. 2. Clinical implications in the treatment of pulmonary tuberculosis with isoniazid either alone or in combination with PAS.
Topics: Humans; India; Isoniazid; Tuberculosis, Pulmonary | 1961 |
Study of eosinophilia in pulmonary tuberculosis during antibiotic and chemotherapy.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Eosinophilia; Isoniazid; Streptomy | 1962 |
[Studies on the virulence of isoniazid-resistant tubercle bacilli. On the difference in virulence in airborne infection and intravenous infection].
Topics: Bacillus; Isoniazid; Lung; Tuberculosis; Tuberculosis, Pulmonary; Virulence | 1961 |
Ethionamide in re-treatment of eleven patients with pulmonary tuberculosis.
Topics: Ethionamide; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1962 |
The virulence in the guinea-pig of isoniazid-sensitive tubercle bacilli isolated from South Indian patients before treatment and after three months of chemotherapy.
Topics: Bacillus; Guinea Pigs; Hospitalization; Humans; India; Isoniazid; Mycobacterium tuberculosis; Resear | 1961 |
[On results of the use of INH-sulfisomezole (especially in relation to the surgical treatment of pulmonary tuberculosis)].
Topics: Isoniazid; Sulfamethoxazole; Sulfanilamide; Sulfanilamides; Sulfonamides; Tuberculosis; Tuberculosis | 1961 |
[On ambulant therapy of pulmonary tuberculosis in the aged].
Topics: Aged; Aged, 80 and over; Aminosalicylic Acid; Exercise Therapy; Humans; Isoniazid; Streptomycin; Tub | 1962 |
[Combined ethylisothiamide-isoniazid perfusion in the therapy of chronic pulmonary tuberculosis].
Topics: Anti-Bacterial Agents; Antitubercular Agents; Humans; Isoniazid; Tuberculosis, Pulmonary | 1962 |
[Corticoids in the treatment of pulmonary tuberculosis. III. Comparative studies on the different course of vaccination tuberculosis in guinea pigs during prednisolone or isonicotinic acid hydrazide-streptomycin and isonicotinic acid hydrazidestreptomycin
Topics: Adrenal Cortex Hormones; Animals; Guinea Pigs; Humans; Isoniazid; Isonicotinic Acids; Prednisolone; | 1962 |
Progress in the second year of patients with quiescent pulmonary tuberculosis after a year of domiciliary chemotherapy, and influence of further chemotherapy on the relapse rate.
Topics: Aminosalicylic Acid; Chronic Disease; Humans; India; Isoniazid; Recurrence; Tuberculosis; Tuberculos | 1961 |
[Attack therapy of common pulmonary tuberculosis by perfusions of ethioniamide and isoniazid].
Topics: Animals; Antitubercular Agents; Behavior, Animal; Ethionamide; Isoniazid; Perfusion; Social Behavior | 1962 |
[Treatment of isoniazid-resistant tuberculosis].
Topics: Drug Resistance; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tuberculosis; Tubercul | 1962 |
[Identification of the sources of contagion in various cases of primary tuberculosis resistance].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[Comparative results of INH therapy in large doses and routine doses in 160 cases of pulmonary tuberculosis].
Topics: Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
A randomized study of the effects of corticosteroid therapy on healing of pulmonary tuberculosis as judged by clinical, roentgenographic, and physiologic measurements.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Isoniazid; Prednisolone; Strepto | 1963 |
[Comparison of hospital treatment and ambulant therapy in patients receiving chemotherapy for the first time].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1962 |
[On results of examination of drug resistant tubercle bacilli in the sputum before chemotherapy of tuberculosis. 2].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Bacillus; Drug Resistance; Drug Resistance, Microbial; Hu | 1962 |
[Studies on the metabolism of phosphate compounds in experimental pulmonary tuberculosis and the effect of various kinds of antitubercular agents].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Isoniazid; Phosphates; Streptomyci | 1963 |
[Various problems regarding ambulant chemotherapy].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulm | 1962 |
[Streptomycin, dihydrostreptomycin, P.A.S. and isoniazid. Intolerance in the treatment of pulmonary tuberculosis].
Topics: Antitubercular Agents; Dihydrostreptomycin Sulfate; Drug Tolerance; Humans; Isoniazid; Streptomycin; | 1962 |
Chemotherapy of pulmonary tuberculosis.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Humans; Isoniazid; Streptomycin; Tuberculosis; Tuberculos | 1962 |
[Treatment with 1st-line drugs (streptomycin, INH and PAS) in pulmonary tuberculotics without previous treatment. (Preliminary report)].
Topics: Humans; Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1962 |
Successful treatment of advanced isonizid- and streptomycin-resistant pulmonary tuberculosis with ethionamide, pyrazinamide, and isoniazid.
Topics: Drug Resistance; Drug Resistance, Microbial; Ethionamide; Humans; Isoniazid; Pyrazinamide; Streptomy | 1962 |
[Bronchial tuberculosis since the use of isoniazid].
Topics: Bronchial Diseases; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1962 |
The tate of patients with drug-resistant tubercle bacilli and pulmonary tuberculosis.
Topics: Anti-Bacterial Agents; Bacillus; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Ethionami | 1962 |
[Antitubercular activity of the calcium methansulfonate of isonicotinic acid hydrazide].
Topics: Antitubercular Agents; Calcium, Dietary; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[On prolonged antibacterial treatment of patients with fresh forms of destructive pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Humans; Isoniazid; Streptomycin; T | 1962 |
[On the treatment of adult-type pulmonary tuberculosis during puberty with isoniazid plus pyrazinamide].
Topics: Adult; Humans; Isoniazid; Puberty; Pyrazinamide; Sexual Maturation; Tuberculosis, Pulmonary | 1962 |
[On the effect of antitubercular preparations on thiamine metabolism in pulmonary tuberculosis patients].
Topics: Antitubercular Agents; Humans; Isoniazid; Lung; Thiamine; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
Initial resistance to isoniazid para-aminosal-icylic acid and streptomycin in two areas in Kenya.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Resistance; Drug Resistance, Microbial; Humans; Ison | 1962 |
[Failure of ambulatory drug treatment for tuberculosis].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1962 |
[The importance of medical treatment of pulmonary tuberculosis from a new viewpoint].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Dihydrostreptomycin Sulfate; Ethionamide; Ip | 1962 |
Development of drug resistance to isoniazid during desensitization: a report of two cases.
Topics: Drug Resistance; Drug Resistance, Microbial; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
The action of bromosalicylhydroxamic acid (T40) on the biological level of INH and on the emergence of INH-resistant bacilli in combined treatment of tuberculosis.
Topics: Bacillus; Drug Resistance; Drug Resistance, Microbial; Humans; Hydroxamic Acids; Isoniazid; Salicyli | 1962 |
[Corticosteroid treatment of primary tuberculosis].
Topics: Adrenal Cortex Hormones; Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1963 |
[Ambulant treatment or hospitalization. An investigation of ambulant chemotherapy].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Hospitalization; Humans; Isoniazid; Streptomycin; Tubercu | 1962 |
[Utilization of isonicotylhydrazide p-aminosalicylate (Rd 328) in high doses in the treatment of pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1962 |
Ambulatory chemotherapy in a developing country: clinical and epidemiological studies.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Developing Countries; Epidemiologic Studies; Isoniazid; T | 1963 |
[Drug resistance in patients with pulmonary tuberculosis converted to positive during the course of original treatment and its clinical course].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Resistance; Drug Resistance, Microbial; Isoniazid; S | 1962 |
[Results in the comparison of ambulant therapy and hospitalization].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Hospitalization; Humans; Isoniazid; Streptomycin; Tubercu | 1962 |
[Resistance and survival of bacilli in relapses of pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Bacillus; Drug Resistance; Drug Resistance, Microbial; Hu | 1963 |
The treatment of pulmonary tuberculosis amongst Africans in Bulawayo. III. Criteria of selection for out-patient status.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Isoniazid; Outpatients; Tuberculosis; Tuberculosis, Pulmo | 1963 |
[Reappraisal of a combination of chemotherapy and irritation treatment in pulmonary tuberculosis].
Topics: Humans; Isoniazid; Lung; Radiotherapy; Tuberculosis; Tuberculosis, Pulmonary | 1962 |
[Comparative study of different therapeutic procedures in the treatment of pulmonary tuberculotics with bacilli resistant to isoniazid and streptomycin].
Topics: Bacillus; Drug Resistance; Drug Resistance, Microbial; Humans; Isoniazid; Lacticaseibacillus casei; | 1962 |
[Even ambulatory INH therapy is problematical].
Topics: Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
The fate of the patient with isoniazid-resistant tuberculosis.
Topics: Drug Resistance; Drug Resistance, Microbial; Humans; Isoniazid; Tuberculosis; Tuberculosis, Multidru | 1962 |
[Pyrazinamide in association with streptomycin, PAS and isoniazid in the therapy of pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Humans; Isoniazid; Pyrazinamide; Streptomycin; Tuberculos | 1962 |
Preliminary report of the combined treatment of pulmonary tuberculosis with old tuberculin and INH.
Topics: Humans; Isoniazid; Tuberculin; Tuberculosis, Pulmonary | 1962 |
[On the virulence of bacilli highly resistant to INH. Observations for 1 year after airborne infection].
Topics: Bacillus; Drug Resistance; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tuberculosis | 1963 |
[Significance of the inactivation of isonicotinic acid hydrazide preparations in the therapy of recent cases of pulmonary tuberculosis].
Topics: Humans; Isoniazid; Tuberculosis, Pulmonary | 1963 |
A detailed survey of one hundred cases of pulmonary tuberculosis on domiciliary treatment in the Nyeri District of Kenya.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Humans; Isoniazid; Kenya; Outpatient Clinics, Hospital; O | 1963 |
The operative treatment of pulmonary tuberculosis in conjunction with specific drugs. Results from the years 1949 to 1955.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Isoniazid; Pneumonectomy; Streptomycin; Thoracoplasty; Tu | 1962 |
[Limits of ambulant therapy from the standpoint of hospital treatment].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulm | 1962 |
[The effect of irregular use of antitubercular medication by outpatients on the effectiveness of subsequent sanatorial therapy].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Isoniazid; Outpatients; Streptomyc | 1962 |
[Results of 5-year long-term ambulant INH therapy].
Topics: Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[Directions for the treatment of children with primary pulmonary and hilar lymph node tuberculosis].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Child; Humans; Isoniazid; Lymph Nodes; Streptomycin; Tube | 1963 |
Chemoprophylaxis of tuberculosis.
Topics: Biomedical Research; Chemoprevention; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
[The choice of drug to be combined with INH in the initial drug therapy of tuberculosis patients].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Isoniazid; Streptomycin; Thiosemicarbazones; Tuberculosis | 1962 |
[Recovery results in primary INH resistance].
Topics: Drug Resistance; Drug Resistance, Microbial; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonar | 1963 |
[The review of medical treatment of pulmonary tuberculosis].
Topics: Adrenal Cortex Hormones; Antitubercular Agents; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
The present status of the treatment of pulmonary tuberculosis.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Humans; Isoniazid; Streptomycin; T | 1963 |
[Various biological tests on several groups of subjects with tuberculosis subjected respectively to monotherapy with isoniazid, viomycin, pyrazinamide, cycloserine, ethioniamide and kanamycin].
Topics: Cycloserine; Ethionamide; Isoniazid; Kanamycin; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary; | 1962 |
[Comparative effects of prednisone and dexamethasone (associated with bacteriostatics) in the clinical course and plasma parameters in pulmonary tuberculosis patients].
Topics: Blood Chemical Analysis; Dexamethasone; Isoniazid; Plasma; Prednisone; Streptomycin; Tuberculosis; T | 1962 |
JAUNDICE DUE TO ETHIONAMIDE.
Topics: Ethionamide; Geriatrics; Isoniazid; Jaundice; Streptomycin; Toxicology; Tuberculosis; Tuberculosis, | 1963 |
CRYPTOCOCCAL MENINGO-ENCEPHALITIS.
Topics: Amphotericin B; Cryptococcosis; Encephalitis; Humans; Isoniazid; Meningoencephalitis; Streptomycin; | 1963 |
[ON THERAPY DURING EMPLOYMENT IN PULMONARY TUBERCULOSIS IN THE AGED, WITH SPECIAL REFERENCE TO CASES WHERE TREATMENT WAS INEFFECTIVE].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Employment; Geriatrics; Hospitalization; Humans; Isoniazi | 1963 |
A CONTROLLED TRIAL OF ISONIAZID PROPHYLAXIS IN MENTAL INSTITUTIONS.
Topics: Hospitals; Hospitals, Psychiatric; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[SYMPOSIUM: COUNTER-MEASURES IN INTRACTABLE PULMONARY TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Ethionamide; Isoniazi | 1963 |
[THE PROBLEM OF INFECTION WITH DRUG-RESISTANT MICROORGANISMS-TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Resistance; Drug Resistance, Microbial; Isoniazid; J | 1963 |
[RESULTS OF TREATMENT FOR PULMONARY TUBERCULOSIS WITH PRIMARY DRUG RESISTANCE IN OUR SANATORIUM].
Topics: Bacteriological Techniques; Drug Resistance; Drug Resistance, Microbial; Isoniazid; Japan; Kanamycin | 1963 |
[RECURRENCE FOLLOWING CONSERVATIVE THERAPEUTIC PROCEDURES FOR BACILLARY PULMONARY TUBERCULOSIS IN ELDERLY PATIENTS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Isoniazid; Mycobacterium tuberculo | 1963 |
FRACTIONIZATION OF 17-KETOSTEROIDS IN URINE OF PATIENTS TREATED WITH ISONIAZID.
Topics: 17-Ketosteroids; Androsterone; Chromatography; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmon | 1963 |
CATALASE ACTIVITY OF MYCOBACTERIUM TUBERCULOSIS AND PULMONARY TUBERCULOSIS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Catalase; Drug Resistance; Drug Resistance, Microbial; Is | 1963 |
[SHORT-TERM HOSPITALIZATION IN THE TREATMENT OF ADULT PULMONARY TUBERCULOSIS IN MOROCCO. ITS CAUSES, ITS FORMS, ITS IMMEDIATE RESULTS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Hospitalization; Humans; Isoniazid; Morocco; Radiography, | 1963 |
[SELECTION OF KOCH BACILLI GENETICALLY RESISTANT TO ISONIAZID AND STREPTOMYCIN. OTHER ADVERSE PHENOMENA APPEARING IN THE COURSE OF TREATMENT WITH ISONIAZ AND STREPTOMYCIN].
Topics: Catalase; Drug Resistance; Drug Resistance, Microbial; Isoniazid; Mycobacterium tuberculosis; Pharma | 1963 |
[PRELIMINARY REPORT ON CLINICAL FINDINGS ON THE COMBINED TREATMENT OF PULMONARY TUBERCULOSIS WITH ISOXYL, A NEW TUBERCULOSTATIC].
Topics: Antitubercular Agents; Combined Modality Therapy; Cycloserine; Humans; Isoniazid; Oxytetracycline; P | 1963 |
[CONTROLLED TUBERCULOSTATIC THERAPY IN PREVIOUSLY UNTREATED TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulm | 1963 |
COMBINED DRUG THERAPY OF PULMONARY TUBERCULOSIS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Therapy, Combination; Isoniazid; Streptomycin; Tuber | 1963 |
SOME OBSERVATIONS IN RELATION TO PROPERDIN SYSTEM. III. RELATION BETWEEN SERUM PROPERDIN LEVEL AND ANTI-TUBERCULOUS DRUG THERAPY IN HUMAN PULMONARY TUBERCULOSIS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Blood Chemical Analysis; Isoniazid; Liver; Properdin; Str | 1963 |
[TREATMENT OF PULMONARY TUBERCULOSIS WITH LARGE DOSES OF INH].
Topics: Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[RESULTS OF THE TREATMENT OF RECENT PULMONARY TUBERCULOSIS WITH LARGE DOSES OF INH].
Topics: Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[LEUCOCYTE FUNCTIONS IN PATIENTS WITH PULMONARY TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Carbon; Isoniazid; Leukocyte Count | 1962 |
MODERN DRUG TREATMENT OF MYCOBACTERIAL DISEASES.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Cycloseri | 1963 |
TOXICITY IN NEWLY DIAGNOSED CASES OF PULMONARY TUBERCULOSIS TREATED WITH ETHIONAMIDE.
Topics: Ethionamide; Isoniazid; Streptomycin; Toxicology; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[RESULTS OF PRELIMINARY ANTIMICROBIAL THERAPY WITH CLASSICAL DRUGS IN RECENT PULMONARY TUBERCULOSIS IN ADOLESCENTS AND ADULTS].
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Anti-Infective Agents; Humans; Isoniazid; Str | 1962 |
VIRULENCE IN THE GUINEA-PIG, SUSCEPTIBILITY TO HYDROGEN PEROXIDE, AND CATALASE ACTIVITY OF ISONIAZID-SENSITIVE TUBERCLE BACILLI FROM SOUTH INDIAN AND BRITISH PATIENTS.
Topics: Animals; Bacillus; Catalase; Drug Resistance; Drug Resistance, Microbial; England; Guinea Pigs; Hydr | 1963 |
PULMONARY ALVEOLAR MICROLITHIASIS IN A CHILD OF THIRTEEN YEARS.
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Calcification, Physiologic; Calcinosis; Calcu | 1963 |
[OUR EXPERIENCES WITH DIATHYMOSULFONE + ISONIAZID TREATMENT IN VARIOUS FORMS OF TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Isoniazid; Lymph Nodes; Pneumonia; | 1963 |
SIDE EFFECTS OF AN ANTITUBERCULOUS FIVE-DRUG REGIMEN: ETHIONAMIDE, CYCLOSERINE, PYRAZINAMIDE, VIOMYCIN AND ISONIAZID.
Topics: Amyloidosis; Antitubercular Agents; Cycloserine; Deafness; Drug Hypersensitivity; Duodenal Ulcer; Et | 1963 |
RATIONALE OF ECONOMY ON THE DIET IN TUBERCULOSIS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Diet; Diet Therapy; Isoniazid; Streptomycin; Tuberculosis | 1963 |
A CASE OF TUBERCULOUS MENINGITIS DEVELOPED DURING THE COURSE OF CHEMOTHERAPY FOR PULMONARY TUBERCULOSIS.
Topics: Antitubercular Agents; Cerebrospinal Fluid; Humans; Isoniazid; Prednisone; Tuberculosis; Tuberculosi | 1963 |
COLLATERAL SUSCEPTIBILITY OF ISONIAZID-RESISTANT TUBERCLE BACILLI TO NITROFURANS.
Topics: Bacillus; Drug Resistance; Drug Resistance, Microbial; Furazolidone; Humans; Isoniazid; Lacticaseiba | 1963 |
[EXPERIENCE WITH A NONSPECIFIC ANTIINFLAMMATORY AGENT IN PULMONARY TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Inflammatory Agents; Cycloserine; Drug Resistance; D | 1963 |
[THERAPEUTIC RESULTS IN 180 ALCOHOLIC PATIENTS WITH PULMONARY TUBERCULOSIS].
Topics: Adrenocorticotropic Hormone; Alcoholism; Aminosalicylic Acid; Aminosalicylic Acids; Empyema; Empyema | 1963 |
[PREVENTION OF DRUG RESISTANCE FREQUENTLY OCCURRING IN AGED TUBERCULOSIS PATIENTS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Resistance; Drug Resistance, Microbial; Geriatrics; | 1963 |
ORAL OUT-PATIENT CHEMOTHERAPY FOR PULMONARY TUBERCULOSIS IN WEST AFRICANS.
Topics: Africa; Africa, Western; Aminosalicylic Acid; Aminosalicylic Acids; Body Weight; Drug Resistance; Dr | 1963 |
[SHOULD PRIMARY TUBERCULOSIS BE TREATED?].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Child; Humans; Infant; Infant, Newborn; Isoniazid; Predni | 1963 |
[ON SOME CHANGES OF THE BLOOD CELL COMPOSITION IN ADULT TUBERCULOSIS PATIENTS].
Topics: Adult; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Drug Hypersensitivity; Eosi | 1963 |
[TREATMENT WITH FIRST LINE DRUGS (S.M.), (I.N.H.) AND (P.A.S.) IN PATIENTS WITH PULMONARY TUBERCULOSIS NEVER TREATED BEFORE].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Resistance; Drug Resistance, Microbial; Isoniazid; S | 1963 |
DRUG RESISTANT MYCOBACTERIAL INFECTION AND ITS RESPONSE TO TREATMENT.
Topics: Cycloserine; Drug Resistance; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium; Mycobact | 1963 |
[PROLONGED CLINICAL AND ROENTGENOLOGICAL FOLLOW-UP OF CHILDREN WITH 1ST SIGNS OF TUBERCULIN ALLERGY].
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Child; Follow-Up Studies; Humans; Hypersensit | 1963 |
[PULMONARY TUBERCULOSIS AND METACORTICOID DIABETES].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Dexamethasone; Diabetes Mellitus; Diet; Diet Therapy; Gou | 1963 |
[APROPOS OF 70 TUBERCULOUS MOSLEMS].
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; France; Isoniazid; Lung; Pneumonectomy; Pneum | 1963 |
[CONTRIBUTIONS TO A NEW METHOD OF EVALUATING EARLY THERAPEUTIC RESULTS IN PATIENTS WITH PULMONARY TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Hungary; Isoniazid; Pneumonectomy; Statistics as Topic; S | 1963 |
[EVALUATION OF OUR CASES OF UROGENITAL TUBERCULOSIS DURING THE PAST 5 AND ONE HALF YEARS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Female; Humans; Hungary; Isoniazid; Kidney; Male; Nephrec | 1963 |
[RESEARCH ON LUNG RESECTION PREPARATION. 3. RELATIONS BETWEEN GERM BIOLOGY, GERM NUMBERS AND FOCAL STRUCTURE AFTER INH TREATMENT].
Topics: Humans; Isoniazid; Lung; Mycobacterium tuberculosis; Pathology; Pneumonectomy; Tuberculosis; Tubercu | 1963 |
[CLINICAL VALUE OF THE DETERMINATION OF THE ACTIVE INH LEVEL BY THE VERTICAL DIFFUSION METHOD IN TUBERCULOUS PATIENTS].
Topics: Blood Chemical Analysis; Diffusion; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[BACTERIOLOGICAL STUDIES ON PULMONARY TUBERCULOSIS IN THE AGED].
Topics: Bacteriological Techniques; Catalase; Drug Resistance; Drug Resistance, Microbial; Geriatrics; Human | 1963 |
[COMPARATIVE THERAPEUTIC STUDIES IN EXUDATIVE PLEURISY].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Blood Sedimentation; Humans; Iso | 1963 |
RECENT ADVANCES IN TREATMENT OF ORGAN TUBERCULOSIS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Child; Cycloserine; Ethionamide; I | 1964 |
[ON THE ETIOPATHOGENESIS OF THE BULLOUS FORMATIONS OF THE TUBERCULAR LUNG].
Topics: Autoantibodies; Isoniazid; Pathology; Pulmonary Emphysema; Toxicology; Tuberculosis; Tuberculosis, P | 1963 |
[STUDIES ON COMBINED INH-ETHIONAMIDE TREATMENT OF PULMONARY TUBERCULOSIS WITH LOW ETHIONAMIDE DOSAGE].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Ethionamide; Humans; Isoniazid; Sputum; Streptomycin; Tub | 1963 |
(CHEMOTHERAPEUTIC ORIGINAL AND RE-TREATMENT OF PULMONARY TUBERCULOSIS.)
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Ethionamide; Isoniazi | 1963 |
COMBINED TREATMENT OF PULMONARY TUBERCULOSIS WITH GLYCYRRHIZIN AND INH.
Topics: Combined Modality Therapy; Glycyrrhiza; Glycyrrhizic Acid; Humans; Isoniazid; Tuberculosis; Tubercul | 1963 |
[THE FATE OF OUR PATIENTS WITH INFECTIOUS CAVERNOUS PROCESSES REGISTERED MORE THAN 6 YEARS AGO].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Isoniazid; Outpatient Clinics, Hospital; Radiography, Tho | 1963 |
TREATMENT AND CURRENT STATUS OF TUBERCULOUS PERITONITIS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Black People; Humans; Isoniazid; Peritoneum; Peritonitis, | 1963 |
THE PREVENTION AND TREATMENT OF ISONIAZID TOXICITY IN THE THERAPY OF PULMONARY TUBERCULOSIS. 2. AN ASSESSMENT OF THE PROPHYLACTIC EFFECT OF PYRIDOXINE IN LOW DOSAGE.
Topics: Developing Countries; Humans; India; Isoniazid; Pyridoxine; Tuberculosis, Pulmonary; Vitamin B Compl | 1963 |
A COMPARISON OF THE VIRULENCE IN THE GUINEA-PIG OF TUBERCLE BACILLI FROM THAI AND BRITISH PATIENTS.
Topics: Animals; Autopsy; Bacillus; Drug Resistance; Drug Resistance, Microbial; Guinea Pigs; India; Isoniaz | 1963 |
[BACTERIOLOGICAL RESULTS OF CHEMOTHERAPY OF PRIMARY PULMONARY TUBERCULOSIS IN SCHOOL CHILDREN].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Child; Isoniazid; Poland; Statistics as Topic; Streptomyc | 1963 |
[HYPERSENSITIVITY REACTIONS IN TREATMENT WITH BASIC ANTIBACTERIAL DRUGS].
Topics: Adrenocorticotropic Hormone; Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Corti | 1963 |
[DETERMINATION OF XANTHURENIC ACID AFTER THE TRYPTOPHAN LOADING TEST IN PULMONARY TUBERCULOTICS TREATED WITH ISONIAZID].
Topics: Blood Chemical Analysis; Humans; Isoniazid; Metabolism; Tryptophan; Tuberculosis; Tuberculosis, Pulm | 1963 |
[CASE OF PULMONARY TUBERCULOSIS MISDIAGNOSED AS LUNG METASTASIS OF MALIGNANT CHORIOCARCINOMA].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Choriocarcinoma; Diagnosis, Differ | 1963 |
[PULMONARY TUBERCULOSIS MISDIAGNOSED AS OTHER DISEASES].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Diagnosis, Differenti | 1963 |
INFLUENCE OF PRETREATMENT BACTERIAL RESISTANCE TO ISONIAZID, THIACETAZONE OR PAS ON THE RESPONSE TO CHEMOTHERAPY OF AFRICAN PATIENTS WITH PULMONARY TUBERCULOSIS.
Topics: Accidents; Accidents, Occupational; Africa; Africa, Eastern; Bacterial Infections; Humans; Isoniazid | 1963 |
A CONTROLLED CLINICAL TRIAL OF ISONIAZID AND HETEROCYCLIC THIOSEMICARBAZONE COMPARED WITH ISONIAZID AND PAS IN PULMONARY TUBERCULOSIS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Bacteriological Techniques; Diabetes Insipidus; Drug Hype | 1963 |
CHEMOTHERAPY FOR PATIENTS WITH CULTURES RESISTANT TO STREPTOMYCIN, ISONIAZID AND PAS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Czechoslovakia; Drug Resistance; Drug Resist | 1963 |
THE VIRULENCE IN THE GUINEA-PIG OF TUBERCLE BACILLI FROM PATIENTS WITH PULMONARY TUBERCULOSIS IN HONG KONG.
Topics: Bacillus; Bacteriological Techniques; China; Drug Resistance; Drug Resistance, Microbial; Guinea Pig | 1963 |
BLOOD CONCENTRATIONS OF PAS PRODUCED BY A MIXTURE OF PAS AND THE PHENYL ESTER OF PAS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Blood Chemical Analysis; Isoniazid; Silicotuberculosis; S | 1963 |
[DIRECT ANTIBIOTIC TREATMENT OF TUBERCULOUS CAVERNS DURING DRAINAGE AND CAVERNOTOMY].
Topics: Anti-Bacterial Agents; Caves; Drainage; Isoniazid; Neomycin; Streptomycin; Tuberculosis; Tuberculosi | 1963 |
[RESULTS OF 8 DIFFERENT ANTITUBERCULAR TREATMENTS. FIRST KNOWN PULMONARY ATTACK IN 495 PATIENTS].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Humans; I | 1963 |
[CLINICAL PICTURE AND TREATMENT OF PULMONARY TUBERCULOSIS IN PATIENTS WITH CONGENITAL HEART DEFECT].
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Angiocardiography; Cardiac Surgical Procedure | 1963 |
[COURSE OF DISSEMINATED PULMONARY TUBERCULOSIS IN ANTIBACTERIAL TREATMENT].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Humans; Isoniazid; Pneumoperitoneu | 1963 |
[ULTRASONICS IN COMBINED TREATMENT OF DESTRUCTIVE PULMONARY TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Bronchography; Isoniazid; Pleurisy | 1963 |
[APROPOS OF RESIDUAL THIN-WALLED CAVITIES].
Topics: Adrenocorticotropic Hormone; Aminosalicylic Acid; Aminosalicylic Acids; Bronchography; Isoniazid; Ra | 1963 |
[ON FUNCTIONAL HEPATIC CHANGES IN PULMONARY TUBERCULOSIS PATIENTS TREATED WITH ANTIBACTERIAL PREPARATIONS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Blood Proteins; Blood Sedimentatio | 1963 |
[OUR HOSPITAL TREATMENT OF SEVERE PULMONARY TUBERCULOSIS].
Topics: Humans; Hyaluronoglucosaminidase; Isoniazid; Respiratory Therapy; Tuberculosis; Tuberculosis, Pulmon | 1963 |
[ANTIMYCOBACTERIAL ACTIVITY OF ISOXYL. II. EXPERIMENTS WITH GUINEA PIGS AND RABBITS].
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Guinea Pigs; Isoniazid; Mycobacterium bovis; | 1964 |
A MILD FORM OF TUBERCULOUS MENINGITIS.
Topics: Bacteriological Techniques; Biopsy; Cerebrospinal Fluid; Diagnosis; Isoniazid; Lymph Nodes; Streptom | 1964 |
[MULTIPLE SENSITIZATION TO ANTIBACTERIAL DRUGS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anaphylaxis; Anti-Bacterial Agents; Caffeine; Drug Erupti | 1963 |
[ON THE INCIDENCE OF PRIMARY DRUG RESISTANCE IN PATIENTS WITH PULMONARY TUBERCULOSIS].
Topics: Antitubercular Agents; Drug Resistance; Drug Resistance, Microbial; Guinea Pigs; Incidence; Isoniazi | 1963 |
[SPONTANEOUS MEDIASTINAL EMPHYSEMA (HAMMAN'S SYNDROME)].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Asthma; Bronchoscopy; Humans; Iatrogenic Disease; Isoniaz | 1963 |
[MYXEDEMA IN THE COURSE OF ANTITUBERCULOSIS THERAPY].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Argentina; Isoniazid; Myxedema; St | 1963 |
RAPID CLEARING IN HEMATOGENOUS PULMONARY TUBERCULOSIS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Black People; Humans; Hydrocortisone; Isoniazid; Predniso | 1964 |
[BACTERIAL SENSITIVITY TO ANTIMICROBIAL AGENTS IN PULMONARY TUBERCULOSIS. II. THERAPEUTIC RESULTS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Infective Agents; Drug Resistance; Drug Resistance, | 1963 |
[CONSIDERATIONS ON THE USE OF LIQUID HYDRAZIDE IN AEROSOL FORM AS THE SOLE MEDICATION AND AS AN ADJUVANT TO 1ST-LINE TUBERCULOSTATIC AGENTS BY ORAL ROUTE, IN THE TREATMENT OF PULMONARY AND LARYNGEAL TUBERCULOSIS. EXPERIENCE WITH 31 CASES].
Topics: Aerosols; Antitubercular Agents; Humans; Isoniazid; Penicillins; Radiography, Thoracic; Streptomycin | 1963 |
[ON THE SUBJECT OF SURGICAL TREATMENT OF PATIENTS AFFLICTED WITH PULMONARY TUBERCULOSIS AND RESISTANT TO THE MAJOR ANTIBIOTICS. THE ROLE OF KANAMYCIN].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Antibiotics, Antitubercular; Cyclo | 1963 |
[THE COMBINATION INH AND ISONICOTINYLADEHYDE-THIOSEMICARBAZONE IN THE TREATMENT OF TUBERCULOSIS IN CHILDHOOD].
Topics: Aldehydes; Aminosalicylic Acid; Aminosalicylic Acids; Child; Humans; Infant; Isoniazid; Niacin; Nico | 1963 |
[SYSTEMATIC DETERMINATION OF ACTIVE ISONIAZID IN THE BLOOD SERUM. (DATA FROM A SERIES OF 1,000 PATIENTS)].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Biometry; Blood Chemical Analysis; Isoniazid; Serum; Stat | 1963 |
[THE FATE OF 306 TUBERCULOUS CAVERNS TREATED BY CHEMOTHERAPY. II. REMOTE RESULTS (5 TO 9 YEAR FOLLOW-UP)].
Topics: Caves; Follow-Up Studies; Humans; Isoniazid; Lung; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[CLINICAL STUDY OF 323 CASES OF TUBERCULOSIS DUE TO ISONIAZID-RESISTANT BACILLI].
Topics: Bacillus; Drug Resistance; Drug Resistance, Microbial; Isoniazid; Tuberculosis; Tuberculosis, Pulmon | 1963 |
[THE EFFECTIVENESS OF TREATMENT WITH COMBINED ISONIAZID AND PARA-AMINOSALICYLIC ACID (PAS) AND WITH ISONIAZID AND PARA-AMINOBENZOIC ACID (PABA) IN EXPERIMENTAL TUBERCULOSIS IN GUINEA PIGS].
Topics: 4-Aminobenzoic Acid; Aminosalicylic Acid; Aminosalicylic Acids; Animals; Guinea Pigs; Humans; Isonia | 1963 |
[A CASE OF AN UNUSUALLY SEVERE SENSITIZATION TO ANTIBACTERIAL DRUGS].
Topics: Adolescent; Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agent | 1963 |
[SOME CLINICAL ASPECTS OF DRUG RESISTANCE OF TUBERCLE BACILLI ISOLATED FROM PATIENTS WITH FIBRO-CAVERNOUS TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Bacillus; Culture Media; Drug Resistance; Drug Resistance | 1963 |
NONTHROMBOPENIC PURPURA RESULTING FRON SENSITIVITY TO ISONIAZID.
Topics: IgA Vasculitis; Isoniazid; Purpura; Toxicology; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
THE LACK OF EFFECT OF ISONIAZID ON THE BLOOD AMMONIA CONCENTRATION.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Ammonia; Blood Chemical Analysis; Isoniazid; Liver Cirrho | 1964 |
THE GUINEA PIG VIRULENCE OF INDIAN TUBERCLE BACILLI.
Topics: Animals; Bacillus; Drug Resistance; Drug Resistance, Microbial; Guinea Pigs; India; Isoniazid; Mycob | 1964 |
CHOROIDAL TUBERCLES. A CLUE TO HEMATOGENOUS TUBERCULOSIS.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Black People; Choroid; Humans; I | 1964 |
SOME PROBLEMS IN THE MANAGEMENT OF TUBERCULOSIS.
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; | 1964 |
D-CYCLOSERINE IN THE TREATMENT OF PULMONARY TUBERCULOSIS RESISTANT TO THE STANDARD DRUGS: A STUDY OF 116 CASES.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Drug Resistance; Drug Resistance, Microbial; | 1964 |
[EXPERIENCES WITH LUNG RESECTION IN TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anesthetics; Bronchoscopy; Collapse Therapy; Electrocardi | 1963 |
[CURRENT TREATMENT OF TUBERCULOUS CAVITATION. STUDY OF 237 CASES TREATED IN THE SANATORIUM].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Isoniazid; Lung; Pneumonectomy; Streptomycin; Thoracoplas | 1963 |
CULTIVATION OF ACID-FAST ORGANISMS FROM TUBERCULOUS PATIENTS AFTER PROLONGED AND INTENSIVE TREATMENT.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Bacteriological Techniques; Humans; Isoniazid; Mycobacter | 1964 |
CONGENITAL DEFECTS AMONG CHILDREN BORN TO WOMEN UNDER SUPERVISION OR TREATMENT FOR PULMONARY TUBERCULOSIS.
Topics: Abnormalities, Drug-Induced; Aminosalicylic Acid; Aminosalicylic Acids; Communicable Diseases; Conge | 1964 |
[INTOLERANCE PHENOMENA IN ISONIAZID USE].
Topics: Diabetes Mellitus; Diarrhea; Drug Hypersensitivity; Isoniazid; Toxicology; Tuberculosis; Tuberculosi | 1963 |
CONCOMITANT BRONCHOGENIC CARCINOMA AND TUBERCULOSIS OF THE LUNG OCCURRING IN A SOLITARY COIN LESION.
Topics: Carcinoma, Bronchogenic; Humans; Isoniazid; Lung; Pathology; Pneumonectomy; Radiography, Thoracic; S | 1964 |
[APROPOS OF GUIDES FOR THE PREVENTIVE THERAPY OF NEWBORN INFANTS INFECTED WITH TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Child; Humans; Infant; Infant, Newborn; Infant, Newborn, | 1963 |
[VARIATIONS OF BLOOD SODIUM, POTASSIUM AND CALCIUM IN PULMONARY TUBERCULOSIS PATIENTS TREATED WITH ISONICOTINIC ACID HYDRAZIDE].
Topics: Blood Chemical Analysis; Calcium; Calcium, Dietary; Humans; Isoniazid; Potassium; Sodium; Sodium, Di | 1963 |
[EFFECT OF ANTIBACTERIAL DRUGS ON THE LEVEL OF 11-HYDROXYSTEROIDS IN THE BLOOD SERUM IN PULMONARY TUBERCULOSIS PATIENTS. (PRELIMINARY COMMUNICATION)].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Blood Che | 1963 |
[ON BACTERIAL SENSITIVITY TO ANTIMICROBIAL AGENTS IN PULMONARY TUBERCULOSIS. ON THE MICROBIAL TESTS. I].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Infective Agents; Drug Resistance; Drug Resistance, | 1963 |
[ON BACTERIAL SENSITIVITY TO ANTIMICROBIAL AGENTS IN PULMONARY TUBERCULOSIS. THERAPEUTIC RESULTS. II].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Infective Agents; Drug Resistance; Drug Resistance, | 1963 |
[ANTIMICROBIAL SCREEN IN PHTHISIOLOGICAL SURGERY].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Infective Agents; Antitubercular Agents; Collapse Th | 1963 |
BROCK-SUCKOW POLYPOSIS OF THE COLON (OBLITERATIVE ARTERIOLARSCLEROSIS OF THE COLON?).
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Arteriosclerosis Obliterans; Biopsy; Black People; Coloni | 1964 |
[ANTIBACTERIAL TREATMENT IN PATIENTS AFFLICTED WITH PULMONARY TUBERCULOSIS CAUSED BY MYCOBACTERIA RESISTANT TO THE MAJOR CHEMO-ANTIBIOTICS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Antibiotics, Antitubercular; Colla | 1963 |
["PERSISTANCE" OF THE "SENSITIVE" KOCH BACILLI. CLINICO-EXPERIMENTAL STUDY].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Bacteriology; Biomedical Research; Dihydrostreptomycin Su | 1963 |
[OUR EXPERIENCE WITH STEROIDS IN THE TREATMENT OF PULMONARY TUBERCULOSIS].
Topics: Bacteriology; Drug Resistance; Drug Resistance, Microbial; Isoniazid; Methylprednisolone; Radiograph | 1963 |
[CYCLOSERINE IN THE TREATMENT OF PULMONARY TUBERCULOSIS. OBSERVATIONS IN 45 PATIENTS].
Topics: Bacteriology; Cycloserine; Isoniazid; Radiography, Thoracic; Sputum; Toxicology; Tuberculosis; Tuber | 1963 |
[BACTERIOLOGICAL STUDY OF 20 SPECIMENS OF RESECTION FOR PULMONARY TUBERCULOSIS IN PATIENTS TREATED WITH CHEMIANTIBIOTICS. (WITH ANATOMIC REFERENCES)].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Bacteriology; Drug Resist | 1963 |
[TUBERCULOUS MENINGITIS. TREATMENT IN CHILDREN WITH CYCLOSERINE AND HYDRAZIDE].
Topics: Cerebrospinal Fluid; Child; Cycloserine; Humans; Infant; Isoniazid; Lymph Nodes; Mexico; Pharmacolog | 1963 |
[VITAMIN B DEFICIENCIES IN PULMONARY TUBERCULOUS PATIENTS TREATED BY ANTIBACILLARY MEDICATIONS].
Topics: Aspartate Aminotransferases; Clinical Enzyme Tests; Dermatology; Diagnosis; Gynecomastia; Humans; Is | 1963 |
[THE RESULTS OBTAINED WITH THE COMBINATION OF PYRAZINAMIDE AND ISONIAZID IN THE TREATMENT OF PULMONARY TUBERCULOSIS].
Topics: Humans; Isoniazid; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
CLINICOPATHOLOGICAL STUDY OF RESECTED TUBERCULOUS LUNGS.
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Child; Humans; India; Isoniazid; Lung; Pathol | 1964 |
TUBERCULOSIS IN CHILDHOOD, THE CHANGING PATTERN.
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; BCG Vaccine; Child; Drug Resistance; Drug Res | 1964 |
[THE FREQUENCY OF APPEARANCE AND MICROBIOLOGICAL CLASSIFICATION OF ATYPICAL ACID-FAST BACILLI CULTURED FROM PATIENT MATERIAL].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Bacteriological Techniques; Catalase; Classification; Dru | 1964 |
[TREATMENT OF THE TUBERCULOUS AND DIABETIC WITH CHLORPROPAMIDE].
Topics: Chlorpropamide; Diabetes Mellitus; Geriatrics; Isoniazid; Streptomycin; Toxicology; Tuberculosis; Tu | 1964 |
[BASIC CONCEPTS FOR THE DIAGNOSIS, PROPHYLAXIS AND TREATMENT OF T.B.C].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Argentina; BCG Vaccine; Diagnosis; Epidemiology; Isoniazi | 1964 |
ATYPICAL PULMONARY TUBERCULOSIS CAUSED BY UNCLASSIFIED MYCOBACTERIA.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Black People; Humans; Isoniazid; Mycobacterium Infections | 1964 |
ACTIVITY IN RADIOGRAPHICALLY UNCHANGED TUBERCULOUS LESIONS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Isoniazid; Radiography, Thoracic; Tuberculosis; Tuberculo | 1964 |
A CONTINUING STUDY OF PRIMARY DRUG RESISTANCE IN TUBERCULOSIS IN A VETERAN POPULATION WITHIN THE UNITED STATES. I.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Resistance; Drug Resistance, Microbial; Isoniazid; M | 1964 |
[LOCAL ANTIBIOTIC THERAPY OF TUBERCULOUS LESIONS. TREATMENT OF COMMON PULMONARY TUBERCULOSIS BY AEROSOL ANTIBIOTICS AND SPREADING FACTORS].
Topics: Aerosols; Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Antibiotics, Antitubercu | 1964 |
[MAGNANTYL IN PNEUMO-PHTHISIOLOGY].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Animals; Deficiency Diseases; Ethionamide; Fishes; Humans | 1964 |
ETHIONAMIDE AND ISONIAZID IN PREVIOUSLY UNTREATED CASES OF PULMONARY TUBERCULOSIS.
Topics: Ethionamide; Isoniazid; Toxicology; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
TREATMENT OF PROGRESSIVE PRIMARY TUBERCULOSIS WITH ISONIAZID ALONE.
Topics: Child; Infant; Infant, Newborn; Isoniazid; South Africa; Statistics as Topic; Tuberculosis; Tubercul | 1964 |
[THE NUMBER OF PATIENTS WITH CHRONIC FIBROUS-CAVERNOUS PULMONARY TUBERCULOSIS AND THEIR TREATMENT UNDER DISPENSARY CONDITIONS].
Topics: Antitubercular Agents; Drug Resistance; Drug Resistance, Microbial; Humans; Isoniazid; Statistics as | 1963 |
[OSTEOARTICULAR TUBERCULOSIS: ITS RELATIONS TO PLEUROPULMONARY ANTECEDENTS].
Topics: Humans; Isoniazid; Italy; Physiology; Statistics as Topic; Tuberculosis; Tuberculosis, Osteoarticula | 1963 |
[PRESENT STATUS OF TUBERCULOSIS AMONG THE INHABITANTS OF THE AMAMI ISLANDS. 3. RESULTS OF BACTERIOLOGICAL EXAMINATION].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Resistance; Drug Resistance, Microbial; Epidemiology | 1963 |
[THE STATUS OF TUBERCULOSIS IN JAPAN].
Topics: BCG Vaccine; Humans; Isoniazid; Japan; Mass Screening; Mycobacterium bovis; Tuberculosis; Tuberculos | 1963 |
[CONSERVATIVE TREATMENT OF PULMONARY TUBERCULOSIS DIFFICULT TO CURE IN ELDERLY PATIENTS UNFIT FOR SURGERY].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Ethionamide; Geriatrics; Isoniazid; Japan; K | 1963 |
[TREATMENT OF TUBERCULOSIS AND DIABETES BECOMING SIMILAR].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Diabetes Mellitus; Ethionamide; Isoniazid; P | 1964 |
CLINICAL ASPECTS, MEDICAL AND SURGICAL, IN THE MANAGEMENT OF BATTEY-TYPE PULMONARY DISEASE.
Topics: Bronchiectasis; Calcification, Physiologic; Drug Resistance; Drug Resistance, Microbial; Epidemiolog | 1964 |
[THE LEVEL OF FREE INH IN THE BLOOD SERUM DURING ITS SIMULTANEOUS ADMINISTRATION WITH 5-BROMOSALICYLOHYDROXAMIC ACID (T4O)].
Topics: Antitubercular Agents; Blood Chemical Analysis; Humans; Hydroxamic Acids; Isoniazid; Serum; Tubercul | 1964 |
[1-YEAR RESULTS OF ANTIBACTERIAL THERAPY OF RECENTLY DISCOVERED CAVERNOUS PULMONARY TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Drug Resistance; Drug Resistance, | 1964 |
[1-YEAR RESULTS OF ANTIBACTERIAL THERAPY OF RECENTLY DISCOVERED CAVERNOUS PULMONARY TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Drug Resistance; Drug Resistance, | 1964 |
[INITIAL RESISTANCE TO ANTIBIOTICS IN PULMONARY TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Antibiotics, Antitubercular; Drug | 1964 |
[TRIPLE SCHEMA IN THE TREATMENT OF TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Hypersensitivity; Drug Resistance; Drug Resistance, | 1964 |
[PREVALENCE OF BACTERIAL RESISTANCE AT THE KOCH PAVILLION].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Resistance; Drug Resistance, Microbial; Epidemiology | 1964 |
[ATYPICAL MYCOBACTERIA OF HUMAN ORIGIN. (REPORT OF 2 CASES)].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Bacteriology; Cerebrospinal Fluid; Drug Resistance; Drug | 1964 |
THE EFFECT OF SYSTEMATIC ADMINISTRATION OF INH ON PRIMARY TUBERCULOSIS IN CHILDHOOD. PRESENTATION OF A "5-YEAR TRIAL".
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Biomedical Research; Child; France; Humans; I | 1963 |
ANTIMICROBIAL THERAPY OF PULMONARY TUBERCULOSIS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Infective Agents; Cycloserine; Dihydrostreptomycin S | 1963 |
[D-CYCLOSERINE IN THE TREATMENT OF PULMONARY TUBERCULOSIS. (ARE TUBERCULOSTATICS OF THE 2D GROUP NECESSARY?].
Topics: Cycloserine; Isoniazid; Mycobacterium bovis; Streptomycin; Thiosemicarbazones; Tuberculosis; Tubercu | 1964 |
[THERAPY OF PULMONARY TUBERCULOSIS BY THE ADMINISTRATION OF HIGH DOSES OF INH].
Topics: Blood Chemical Analysis; Humans; Isoniazid; Sputum; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
[ON THE TREATMENT OF DIFFERENT TYPES OF RHEUMATIC DISEASES IN PULMONARY TUBERCULOSIS AND LUNG TUMORS].
Topics: Agranulocytosis; Aminosalicylic Acid; Aminosalicylic Acids; Isoniazid; Leukopenia; Lung; Lung Neopla | 1964 |
[THE EFFECTIVENESS OF LONG-TERM ANTIBACTERIAL THERAPY OF PATIENTS WITH PULMONARY TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Isoniazid; Streptomycin; Tuberculo | 1963 |
[CLINICO-RADIOLOGICAL RESULTS WITH CORTICO-ANTIBIOTIC THERAPY COMBINED WITH ACTH IN A CASE STUDY OF YOUNG SUBJECTS WITH PULMONARY TUBERCULOSIS].
Topics: Adolescent; Adrenocorticotropic Hormone; Anti-Bacterial Agents; Biomedical Research; Cortisone; Huma | 1964 |
PULMONARY RESECTION AS TREATMENT FOR HAEMORRHAGE IN TUBERCULOSIS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Blood Transfusion; Hemorrhage; Iso | 1964 |
[COMBINED PROTECTION OF CHILDREN LIVING IN AN ENVIRONMENT INFECTED WITH TUBERCULOSIS].
Topics: Adolescent; BCG Vaccine; Child; Communicable Disease Control; Erythema Nodosum; Hungary; Infant; Iso | 1964 |
[THE EFFECTIVENESS OF PROLONGED ANTIBACTERIAL THERAPY OF RECENT FORMS OF PULMONARY TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Biometry; Isoniazid; Lithuania; St | 1964 |
[PROGNOSIS IN INFILTRATIVE FORMS OF PULMONARY TUBERCULOSIS AND METHODS OF THEIR THERAPY].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Humans; Isoniazid; Prognosis; Radiography, Thoracic; Tube | 1964 |
[FF-725 AND TUBERCULOSTATICS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Ethionamide; Gastroenterology; Isoniazid; Muscle Relaxant | 1964 |
[THE DECREASE OF SPECIFIC HYPERERGY IN PULMONARY TUBERCULOSIS PATIENTS TREATED BY ANTITUBERCULAR DRUGS].
Topics: Antitubercular Agents; Blood Protein Electrophoresis; Clinical Enzyme Tests; Humans; Isoniazid; Lipa | 1963 |
SINGLE DAILY DOSE REGIMEN OF ISONIAZID AND PAS IN THE TREATMENT OF PULMONARY TUBERCULOSIS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Bacteriology; Drug Tolerance; Isoniazid; Sputum; Statisti | 1964 |
[CONSTANT FIGHT AGAINST TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; BCG Vaccine; Child; Communicable Disease Control; Humans; | 1964 |
[THE MEDICAL TREATMENT OF COMMON PULMONARY TUBERCULOSIS IN THE ADULT].
Topics: Adrenocorticotropic Hormone; Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Ethionamide; Is | 1964 |
[LOCAL ANTIBIOTIC THERAPY OF PULMONARY TUBERCULOSIS LESIONS (INTRABRONCHIAL INSTILLATIONS)].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Ethionamide; Isoniazid; Kanamycin; | 1964 |
[SUICIDE AFTER PROLONGED USE OF CYCLOSERINE].
Topics: Cycloserine; Depression; Depressive Disorder; Ethionamide; Isoniazid; Pyridoxine; Suicide; Toxicolog | 1964 |
[THE USE OF ANTIBACILLARY DRUGS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Drug Resistance; Drug Resistance, Microbial; | 1964 |
PROLONGED STREPTOMYCIN AND ISONIAZID FOR PULMONARY TUBERCULOSIS.
Topics: Deafness; Isoniazid; Pantothenic Acid; Psychoses, Substance-Induced; Psychotic Disorders; Statistics | 1964 |
[SIDE-EFFECTS OF ANTIBACTERIAL PREPARATIONS IN PATIENTS WITH PULMONARY TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Cycloserine; Drug Eruptions; Drug | 1963 |
[EXPERIENCE IN TUBERCULOSIS CONTROL WORK].
Topics: Adolescent; Armenia; BCG Vaccine; Child; Humans; Isoniazid; Mycobacterium bovis; Preventive Medicine | 1964 |
[STUDY OF THE ABSORPTION, BLOOD CONCENTRATION AND EXCRETION IN THE URINE OF THE BULGARIAN ANTITUBERCULAR PREPARATION INHA-17].
Topics: Antitubercular Agents; Blood Chemical Analysis; Body Fluids; Humans; Isoniazid; Metabolism; Tubercul | 1964 |
[CONSERVATIVE AND SURGICAL TREATMENT OF TUBERCULOUS SYNOVITIS IN ADULTS].
Topics: Adrenocorticotropic Hormone; Aminosalicylic Acid; Aminosalicylic Acids; Chloramphenicol; Drug Therap | 1963 |
[SURGICAL TREATMENT OF TUBERCULOUS OSTEITIS IN THE REGION OF THE HIP AND KNEE JOINTS].
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Casts, Surgical; Child; Drug Therapy; Hip; Hu | 1963 |
[TOXIC EFFECT OF CYCLOSERINE].
Topics: Alanine Transaminase; Aminosalicylic Acid; Aminosalicylic Acids; Aspartate Aminotransferases; Centra | 1963 |
[USE OF PYRIDOXINE IN THE TREATMENT OF SIDE EFFECTS OF ANTITUBERCULAR AGENTS].
Topics: Antitubercular Agents; Cycloserine; Depression; Drug Therapy; Eye Manifestations; Isoniazid; Paresth | 1963 |
[TRACHEOSTOMY IN THE SURGERY OF THE SEVERE TUBERCULOUS PATIENT. ITS PREVIOUS INDICATION].
Topics: Acid-Base Equilibrium; Drug Resistance; Drug Resistance, Microbial; Humans; Isoniazid; Mortality; Ox | 1964 |
[EFFECTIVENESS OF ANTIBACTERIAL TREATMENT OF TUBERCULOUS PATIENTS WITH AND WITHOUT ASSOCIATED HORMONAL PREPARATIONS].
Topics: Adrenocorticotropic Hormone; Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Corti | 1963 |
[ON CASES OF HIGHLY VIRULENT AND NORMALLY VIRULENT BOVINE PULMONARY TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Animals; Antitubercular Agents; Cattle; Isoniazid; Lymph | 1964 |
[BACILLI COUNT--A DIRECTIVE FOR TUBERCULOSTATIC THERAPY].
Topics: Antitubercular Agents; Bacillus; Bacteriological Techniques; Culture Media; Humans; Isoniazid; Mycob | 1964 |
A SPUTUM SURVEY OF CASES OF PULMONARY TUBERCULOSIS TWO TO THREE YEARS AFTER STARTING TREATMENT IN A RURAL AREA IN KENYA.
Topics: Child; Drug Resistance; Drug Resistance, Microbial; Health Surveys; Humans; Infant; Isoniazid; Kenya | 1964 |
[CLINICAL DATA ON CHRONIC RECURRENT PANCREATIC NECROSIS].
Topics: Alcoholism; Cycloserine; Isoniazid; Pancreatic Diseases; Pancreatitis; Pneumonectomy; Streptomycin; | 1964 |
[RESEARCH ON THE BEHAVIOR OF TUBERCULIN ALLERGY DURING TREATMENT WITH RIFAMYCIN SV].
Topics: Animals; Biomedical Research; Guinea Pigs; Hypersensitivity; Isoniazid; Pharmacology; Research; Rifa | 1964 |
[ASSOCIATION OF PULMONARY TUBERCULOSIS AND DIABETES MELLITUS].
Topics: Diabetes Mellitus; Humans; Hypoglycemic Agents; Insulin; Insulin, Long-Acting; Isoniazid; Kanamycin; | 1964 |
SOME OBSERVATIONS IN RELATION TO THE PROPERDIN SYSTEM. V. COMPARATIVE STUDIES ON SERUM PROTEIN PATTERN OF HUMAN PULMONARY TUBERCULOSIS PATIENTS UNDER CONVENTIONAL ANTI-TUBERCULAR THERAPY.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Blood Protein Electrophoresis; Blood Proteins; Chromatogr | 1963 |
ACQUIRED ESOPHAGOBRONCHIAL FISTULA OF INFECTIOUS ORIGIN.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Biopsy; Bronchial Fistula; Bronchi | 1964 |
EFFECTIVENESS OF CAPREOMYCIN AGAINST EXPERIMENTAL TUBERCULOSIS OF MICE AND GUINEA PIGS.
Topics: Antitubercular Agents; Capreomycin; Guinea Pigs; Isoniazid; Kanamycin; Mice; Mycobacterium bovis; Ph | 1964 |
[THE TREATMENT OF TUBERCULOSIS WITH 2ND LINE DRUGS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Antibiotics, Antitubercular; Cyclo | 1964 |
[ANTIMICROBIAL TREATMENT OF TUBERCULOSIS WITH SUBSIDIARY DRUGS. 2ND LINE DRUGS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Infective Agents; Antitubercular Agents; Bacteriolog | 1964 |
[INFORMATION ON A NEW TECHNIQUE FOR ANTITUBERCULOSIS THERAPY].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Audiometry; Drug Resistance; Drug | 1964 |
[QUANTIFICATION OF XANTHURENIC ACID IN THE URINE OF TUBERCULOSIS PATIENTS UNDERGOING TREATMENT WITH ISONIAZID].
Topics: Body Fluids; Isoniazid; Metabolism; Tryptophan; Tuberculosis; Tuberculosis, Pulmonary; Urine; Vitami | 1964 |
RECOVERABILITY OF ACID-FAST BACILLI FROM RESECTED PULMONARY TUBERCULOUS LESIONS AS RELATED TO THE DURATION OF PREOPERATIVE ANTITUBERCULOUS DRUG THERAPY.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Bacteriological Techniques; Humans | 1964 |
PULMONARY TUBERCULOSIS.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Child; Cycloserine; Drug Resista | 1964 |
PULMONARY ASPERGILLOSIS. A CASE REPORT.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Aspergillosis; Humans; Isoniazid; Lung Diseases, Fungal; | 1964 |
PULMONARY TUBERCULOSIS IN GUINEA PIGS BY TRANS-TRACHEAL INOCULATION.
Topics: Animals; Drug Resistance; Drug Resistance, Microbial; Guinea Pigs; Isoniazid; Lung; Mortality; Mycob | 1964 |
LIPOID PNEUMONIA: REVIEW OF LITERATURE WITH A CASE REPORT.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Child; Diagnosis, Differential; Humans; Isoniazid; Lipids | 1964 |
[SOME CONSIDERATIONS ON THE RESISTANCE OF KOCH BACILLI TO ANTIBIOTICS AND ON ITS PRACTICAL IMPORTANCE].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance; Drug Res | 1964 |
FURTHER EXPERIMENTS ON LONG-TERM CHEMOTHERAPY OF ADVANCED MURINE TUBERCULOSIS, WITH EMPHASIS ON INTERMITTENT REGIMES.
Topics: Animals; Drug Resistance; Drug Resistance, Microbial; Isoniazid; Mice; Pathology; Research; Streptom | 1964 |
A CONTROLLED COMPARISON OF STREPTOMYCIN PLUS PYRAZINAMIDE AND STREPTOMYCIN PLUS PAS IN THE RETREATMENT OF PATIENTS EXCRETING ISONIAZID-RESISTANT ORGANISMS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Bacteriology; Biomedical Research; Drug Resistance; Drug | 1964 |
TREATMENT OF PATIENTS WITH CULTURES RESISTANT TO THE PRIMARY ANTI-TUBERCULOSIS DRUGS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Bacteriological Techniques; Biomed | 1964 |
[LUNG TUBERCULOMAS].
Topics: Adolescent; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Bronchoscopy; | 1963 |
A STUDY ON PROBLEMS OF RESISTANCE. 2. INVESTIGATIONS INTO THE EMERGENCE OF RESISTANCE OF TUBERCLE BACILLI TO ISONIAZID.
Topics: Bacillus; Culture Media; Drug Resistance; Drug Resistance, Microbial; Isoniazid; Lacticaseibacillus | 1964 |
[CURRENT PROBLEMS IN THE ANTITUBERCULOSIS CAMPAIGN].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Humans; Isoniazid; Italy; Morbidit | 1964 |
MONOTHERAPY WITH 4-4'DIISOAMYLOXYTHIO-CARBANILIDE (ISOXYL).
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Biomedical Research; Blood Sedimen | 1964 |
[APROPOS OF ETHIONAMIDE JAUNDICE].
Topics: Alanine Transaminase; Alcoholism; Aminosalicylic Acid; Aminosalicylic Acids; Aspartate Aminotransfer | 1964 |
[TRIAL OF OXYPHENBUTAZONE, NEW ANTI-INFLAMMATORY TREATMENT OF PULMONARY AND PLEURAL TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Blood Cell Count; Blood Glucose; Blood Sedimentation; Ema | 1964 |
[D.A.T.C. IN PULMONARY TUBERCULOSIS IN NON-TREATED PATIENTS].
Topics: Antitubercular Agents; Argentina; Drug Resistance; Drug Resistance, Microbial; Humans; Isoniazid; Ph | 1964 |
[CLINICAL TRIAL OF A NEW TYPE OF TUBERCULIN (PREPARED WITH KOCH BACILLI RESISTANT TO ISONIAZID].
Topics: Biomedical Research; Drug Resistance; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium t | 1964 |
[TREATMENT TRIALS IN PULMONARY TUBERCULOSIS COMBINING ISONIAZID, ADMINISTERED 2 TIMES A WEEK, AND A THIOCARBANILIDE IN DAILY FORM].
Topics: Anilides; Antitubercular Agents; Biomedical Research; Drug Resistance; Drug Resistance, Microbial; I | 1964 |
THE CLINICAL SIGNIFICANCE OF LOW DEGREES OF DRUG RESISTANCE IN PULMONARY TUBERCULOSIS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Bacteriological Techniques; Drug Resistance; Drug Resista | 1964 |
A STUDY ON PRIMARILY DRUG-RESISTANT STRAINS OF TUBERCLE BACILLI IN SHANGHAI. THE INCIDENCE AND VIRULENCE OF THE RESISTANT BACILLI.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Bacillus; Bacteriological Techniques; China; Drug Resista | 1964 |
[ANTITUBERCULOUS ACTIVITY OF DEXTRO-2,2'-(ETHYLENEDIIMINO)-DI-1-BUTANOL (ETHAMBUTOL). (II) COMBINED EFFECT OF ETHAMBUTOL AND ISONIAZID].
Topics: 1-Butanol; Animals; Antitubercular Agents; Drug Resistance; Drug Resistance, Microbial; Ethambutol; | 1964 |
[EXPERIMENTAL STUDIES ON EFFECT OF COMBINED USE OF 1314TH AND INH TO INH-RESISTANT TUBERCLE BACILLI. 2. COMBINATION EFFECT IN THE EXPERIMENTAL TUBERCULOSIS OF MICE].
Topics: Animals; Bacillus; Drug Resistance; Drug Resistance, Microbial; Ethionamide; Isoniazid; Mice; Pathol | 1964 |
[DETERMINATION OF THE CLINICAL RECOVERY OF TUBERCULOSIS OF THE LUNGS IN ADULTS].
Topics: Adult; Humans; Isoniazid; Physiological Phenomena; Radiography, Thoracic; Tuberculin Test; Tuberculo | 1964 |
[EFFECTIVENESS OF ANTIBACTERIAL THERAPY IN PATIENTS WITH TUBERCULOSIS OF THE LUNGS DURING THE PRESENCE OF PRIMARY DRUG RESISTANCE OF MYCOBACTERIA TUBERCULOSIS].
Topics: Anti-Bacterial Agents; Drug Resistance; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium | 1964 |
[STATUS OF THE CARDIOVASCULAR SYSTEM IN AGED PATIENTS WITH PULMONARY TUBERCULOSIS DURING ANTIBACTERIAL TREATMENT].
Topics: Anti-Bacterial Agents; Antitubercular Agents; Blood Pressure; Cardiovascular Diseases; Cardiovascula | 1964 |
[ON SIDE EFFECTS IN THE TREATMENT OF TUBERCULOSIS WITH VARIOUS ISONICOTINIC ACID DERIVATIVES].
Topics: Drug Therapy; Isoniazid; Isonicotinic Acids; Toxicology; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
[IMMEDIATE AND REMOTE RESULTS OF ANTIBACTERIAL TREATMENT OF PULMONARY TUBERCULOSIS IN MIDDLE-AGED AND ELDERLY PATIENTS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Drug Therapy; Geriatrics; Isoniazi | 1964 |
[DETECTION AND TREATMENT OF TUBERCULOUS MENINGITIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Blood-Brain Barrier; Cerebrospinal Fluid; Clinical Labora | 1964 |
[HEMORRHAGIC PURPURA IN THE COURSE AND CHEMO-ANTIBIOTIC THERAPY OF PULMONARY TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Geriatrics; Isoniazid; Purpura; St | 1963 |
A CLINICAL EVALUATION OF THE ROLE OF CORTICOSTEROIDS IN THE MANAGEMENT OF RESISTANT CASES OF PULMONARY TUBERCULOSIS.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Biomedical Research; Humans; Iso | 1964 |
RELAPSE IN TREATED CASES OF PULMONARY TUBERCULOSIS. II. SIX-YEAR FOLLOW-UP OF 109 PATIENTS DISCHARGED FROM THE HOSPITAL WITH MEDICAL APPROVAL, 1955-1956.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Collapse Therapy; Follow-Up Studies; Isoniazid; Pneumonec | 1964 |
PULMONARY TUBERCULOSIS IN RETROSPECT AND PROSPECT.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Resistance; Drug Resistance, Microbial; History; His | 1964 |
[ETHYLACETYLACETATE ISONICOTINOYLHYDRAZONE (PREPARATION T-428) IN THE TREATMENT OF PULMONARY TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Therapy; Isoniazid; Streptomycin; Tuberculosis; Tube | 1964 |
[CLINICAL EXPERIENCE WITH D.A.T.C].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Drug Resistance; Drug Resistance, | 1964 |
[TREATMENT OF PULMONARY TUBERCULOSIS WITH SUBSIDIARY DRUGS].
Topics: Antitubercular Agents; Humans; Isoniazid; Phenylthiourea; Streptomycin; Toxicology; Tuberculosis; Tu | 1964 |
[HISTOCHEMICAL STUDY OF SUCCINIC DEHYDROGENASE IN TUBERCULOSIS].
Topics: Animals; Histocytochemistry; Isoniazid; Liver; Lung; Mycobacterium bovis; Pathology; Pharmacology; R | 1964 |
MAJOR SURGERY FOR PULMONARY TUBERCULOSIS: FINAL REPORT.
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Bronchial Diseases; Disability Evaluation; Em | 1964 |
[POISONING WITH THERAPEUTIC DOSES OF ISONICOTINIC ACID HYDRAZIDE AND TRECATOR IN A 9-YEAR-OLD CHILD].
Topics: Child; Ethionamide; Isoniazid; Lymph Nodes; Toxicology; Tuberculosis; Tuberculosis, Lymph Node; Tube | 1964 |
[TUBERCULOUS EXSUDATIVE PLEURISY IN ADVANCED AGE].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Blood Cell Count; Calcium; Geriatrics; Humans; Isoniazid; | 1964 |
[COMBINATION OF ETHIONAMIDE AND P-AMINOSALICYLIC ACID IN THE TREATMENT OF PULMONARY TUBERCULOSIS WITH GERMS RESISTANT TO ISONIAZID AND STREPTOMYCIN].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Resistance; Drug Resistance, Microbial; Ethionamide; | 1963 |
[ON THE PROBLEM OF PRIMARY RESISTANCE].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Clinical Laboratory Techniques; Drug Resistance; Drug Res | 1964 |
[INH THERAPY IN INH RESISTANCE].
Topics: Antitubercular Agents; Clinical Laboratory Techniques; Drug Resistance; Drug Resistance, Microbial; | 1964 |
HEMOLYTIC ANEMIA DUE TO AMINOSALICYLIC ACID. ANEMIA WITH METHEMOGLOBINEMIA.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anemia; Anemia, Hemolytic; Child; Diseases in Twins; Gluc | 1964 |
[DIAGNOSTIC AND THERAPEUTIC PROBLEMS OF OPEN CAVERN HEALING].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Caves; Clinical Laboratory Techniques; Drug Therapy; Ison | 1963 |
[REMOTE RESULTS OF DRUG-INDUCED CAVITY CLOSURE].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Therapy; Isoniazid; Pneumonectomy; Pneumothorax; Pne | 1964 |
MULTIPLE DEFICIENCY STATE ASSOCIATED WITH ISONIAZID THERAPY.
Topics: Anxiety; Depression; Ethionamide; Feeding and Eating Disorders; Isoniazid; Mental Disorders; Niacin; | 1964 |
[THERAPEUTIC OUTLINE FOR THE TUBERCULOUS PATIENT].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Therapy; Isoniazid; Streptomycin; Tuberculosis; Tube | 1964 |
[CHEMO-ANTIBIOTIC THERAPY OF TUBERCULOSIS IN DIABETICS AND ITS REPERCUSSIONS ON GLUCIDE METABOLISM].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Blood Glucose; Carbohydrate Metabo | 1964 |
[BRONCHIAL INSTILLATIONS OF CHEMOANTIBIOTICS IN THE TREATMENT OF TUBERCULOUS CAVITIES].
Topics: Adolescent; Bronchi; Dosage Forms; Drug Therapy; Humans; Isoniazid; Radiography, Thoracic; Streptomy | 1964 |
[DIFFUSE BULLOUS DYSTROPHY OF THE TUBERCULOUS LUNG, ISONIAZID AND ADRENAL HYPERCORTICISM].
Topics: 17-Ketosteroids; Adolescent; Adrenocortical Hyperfunction; Isoniazid; Radiography, Thoracic; Toxicol | 1964 |
[ADRENAL HYPERFUNCTION IN ISONICOTINIC ACID HYDRAZIDE THERAPY].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adrenocortical Hyperfunction; Drug Therapy; | 1964 |
[CLINICO-ROENTGENOLOGICAL AND PATHOMORPHOLOGICAL CHARACTERISTICS OF CURED CAVERNS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Caves; Drug Therapy; Isoniazid; Lung; Pathology; Pneumone | 1964 |
[AEROSOL THERAPY WITH THE USE OF 3 ANTITUBERCULAR AND ANTISPASMODIC PREPARATIONS IN THE TREATMENT OF PULMONARY TUBERCULOSIS].
Topics: Aerosols; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Drug Therapy; Ephedrine; | 1964 |
[THYROID FUNCTION IN PATIENTS WITH PULMONARY TUBERCULOSIS AND ITS MODIFICATION DURING THE COURSE OF ANTIBACTERIAL THERAPY].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Drug Therapy; Hyperthyroidism; Hyp | 1964 |
[TREATMENT OF BRONCHIAL TUBERCULOSIS WITH CORTISONE AEROSOLS].
Topics: Aerosols; Bronchial Diseases; Cortisone; Drug Therapy; Humans; Isoniazid; Respiratory Therapy; Strep | 1964 |
[CLINICAL TRIAL OF 3 TYPES OF ORAL TREATMENT OF PULMONARY TUBERCULOSIS. (ISONIAZID+ETHIONAMIDE, ISONIAZID + PAS, ISONIAZID ALONE)].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Biomedical Research; Clinical Laboratory Techniques; Drug | 1964 |
EXPERIENCE WITH ENDOBRONCHIAL MEDICATION.
Topics: Bronchi; Bronchoscopy; Catheterization; Cough; Humans; Isoniazid; Lung; Reflex; Streptomycin; Tuberc | 1964 |
[PATHOMORPHOLOGICAL INDICES OF IMMUNOREACTIVE CHARACTERISTICS OF THE ORGANISM DURING ANTIBACTERIAL THERAPY OF TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Child; Drug Therapy; Isoniazid; Mo | 1964 |
ALTERNATING REGIMENS OF STREPTOMYCIN-PYAZINAMIDE, ISONIAZID-PARA-AMINOSALICYLIC ACID AT BATTEY STATE HOSPITAL.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Resistance; Drug Resistance, Microbial; Drug Therapy | 1964 |
[CLINICAL MEDITATIONS ON "BACTERIAL RESISTANCE" IN CHEMO-ANTIBIOTIC THERAPY OF PULMONARY TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Bacterial Infections; Drug Resista | 1964 |
[CASE OF ENCEPHALOMYELORADICULONEURITIS FOLLOWING DIARRHEA].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Diarrhea; Drug Therapy; Encephalitis; Isoniazid; Kanamyci | 1964 |
[INCIDENCE AND DETERMINATION OF PHENOMENA OF BLOCKAGE IN RELATION TO ORIGINAL PROCESSES OF PULMONARY TUBERCULOSIS AND THEIR THERAPEUTIC TREATMENT].
Topics: Collapse Therapy; Humans; Incidence; Isoniazid; Italy; Statistics as Topic; Streptomycin; Thoracopla | 1964 |
EPIDEMIOLOGY AND CLINICAL COURSE OF 41 PATIENTS TREATED FOR PULMONARY DISEASE DUE TO UNCLASSIFIED MYCOBACTERIA.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Epidemiology; Humans; Isoniazid; Lung Diseases; Mycobacte | 1964 |
PRIMARY DRUG RESISTANCE.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Bacteriological Techniques; Child; Drug Resistance; Drug | 1964 |
ADRENAL CORTICOSTEROIDS IN LIFE-THREATENING PULMONARY TUBERCULOSIS.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Cachexia; Drug Therapy; Hydrocor | 1964 |
THE RESULTS OF DIFFERENT METHODS OF CHEMOTHERAPY IN THE TREATMENT OF PULMONARY TUBERCULOSIS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; China; Drug Therapy; Isoniazid; Sputum; Statistics as Top | 1964 |
ANNUAL CHANGE OF DRUG RESISTANCE CASES VIEWED THROUGH A JAPANESE NATIONAL SANATORIUM.
Topics: Dihydrostreptomycin Sulfate; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Humans; Ison | 1964 |
INFECTION OF MICE WITH MYCOBACTERIUM TUBERCULOSIS, STRAIN H37RA.
Topics: Animals; Isoniazid; Lung; Mice; Mycobacterium bovis; Mycobacterium tuberculosis; Pharmacology; Pyraz | 1964 |
[EFFECTIVENESS OF CHEMOTHERAPY IN PATIENTS WITH PULMONARY TUBERCULOSIS WITH VARIOUS COMBINATIONS AND SEQUENCE OF DRUGS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Dermatologic Agents; Drug Therapy; Isoniazid; Streptomyci | 1964 |
BILATERAL PULMONARY RESECTION FOR TUBERCULOSIS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Biomedical Research; Brain; Brain Damage, Chronic; Drug T | 1964 |
THE CLINICAL SIGNIFICANCE OF PRIMARY DRUG RESISTANCE IN TUBERCULOSIS AS JUDGED IN A MILITARY POPULATION, 1960-1963.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Resistance; Drug Resistance, Microbial; Drug Therapy | 1964 |
THE EFFECT OF MEASLES, GAMMA GLOBULIN MODIFIED MEASLES, AND ATTENUATED MEASLES VACCINE ON THE COURSE OF TREATED TUBERCULOSIS IN CHILDREN.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Biomedical Research; Child; Drug Therapy; gamma-Globulins | 1965 |
[ENZYMATIC STUDY OF THE LIVER IN PULMONARY TUBERCULOSIS. RESEARCH ON A POSSIBLE HEPATOTOXIC EFFECT OF ANTIBACTERIAL MEDICATIONS].
Topics: Alanine Transaminase; Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Aspartate Am | 1964 |
STUDIES WITH A NEW ANTITUBERCULOSIS DRUG.
Topics: Antitubercular Agents; Biomedical Research; Drug Therapy; Ethionamide; Humans; Isoniazid; Streptomyc | 1964 |
CONTROLLED CLINICAL TRIAL OF 4-4 DIISOAMYLOXYTHIOCARBANILIDE IN THE TREATMENT OF PULMONARY TUBERCULOSIS.
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Asian People; Bacterio | 1964 |
TREATMENT OF PULMONARY TUBERCULOSIS BY CAPREOMYCIN AND PAS: A SMALL PRELIMINARY TRIAL.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Drug Resistance; Drug | 1964 |
CHEMOTHERAPY OF PREVIOUSLY TREATED PATIENTS WITH PULMONARY TUBERCULOSIS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Drug Hypersensitivity; Drug Resistance; Drug | 1964 |
PREGNANCY AND PULMONARY TUBERCULOSIS: OBSERVATIONS ON THE DOMICILIARY MANAGEMENT OF 238 PATIENTS IN INDIA.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Therapy; Female; Home Care Services; Humans; India; | 1964 |
THE PROBLEM AND MANAGEMENT OF DRUG-RESISTANT CASES OF PULMONARY TUBERCULOSIS IN KENYA.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Drug Resistance; Drug Resistance, | 1964 |
RE-TREATMENT OF DRUG-RESISTANT PULMONARY TUBERCULOSIS AT BATTEY STATE HOSPITAL.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Drug Resistance; Drug Resistance, Microbial; | 1964 |
PRIMARY DRUG RESISTANCE AND PULMONARY TUBERCULOSIS. EMERGENCE OF PRIMARY DRUG RESISTANCE.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Resistance; Drug Resistance, Microbial; Finland; Iso | 1964 |
A PRELIMINARY REPORT ON A NEW ANTITUBERCULOUS DRUG 4-AMINO-2-HYDROXY-PHENYL-1, 3, 4,-OXADIAZOL-2-OL WS 127.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Biomedical Research; Blood; Cyclos | 1964 |
INDICATIONS FOR THE PROPHYLACTIC USE OF ISONIAZID.
Topics: California; Drug Therapy; Humans; Isoniazid; Preventive Medicine; Radiography, Thoracic; Safe Sex; S | 1964 |
A CASE OF RED CELL APLASIA OCCURRING AS A RESULT OF ANTITUBERCULOUS THERAPY.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anemia; Anemia, Aplastic; Blood Cell Count; Bone Marrow C | 1964 |
A CONTROLLED TRIAL OF ETHIONAMIDE WITH ISONIAZID IN THE TREATMENT OF PULMONARY TUBERCULOSIS IN HONG KONG.
Topics: Adolescent; Ethionamide; Hong Kong; Humans; Isoniazid; Tuberculosis, Pulmonary | 1964 |
TUBERCULOSIS IN THE GURKHAS OF NEPAL.
Topics: Asia, Western; Asian People; Communicable Disease Control; Drug Therapy; Isoniazid; Military Medicin | 1964 |
RESULTS OF CHEMOTHERAPY AND PARTIAL LUNG RESECTION FOR PULMONARY TUBERCULOSIS IN GURKHA SOLDIERS: A FIVE YEAR FOLLOW UP.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Asia, Western; Asian People; Drug Therapy; Follow-Up Stud | 1964 |
VIRULENCE IN THE GUINEA-PIG AND SENSITIVITY TO PAS AND THIACETAZONE OF TUBERCLE BACILLI FROM SOUTH INDIAN PATIENTS WITH PULMONARY TUBERCULOSIS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Animals; Bacillus; Bacteriological Techniques; Guinea Pig | 1964 |
[ON PRIMARY DRUG RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS IN PATIENTS WITH PULMONARY TUBERCULOSIS].
Topics: Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Humans; Isoniazid; Mycobacterium tubercul | 1964 |
[TREATMENT OF TUBERCULOUS PATIENTS EXPECTORATING, MYCOBACTERIUM TUBERCULOSIS RESISTANT TO ANTIBIOTICS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Antibiotics, Antitubercular; Cyclo | 1964 |
ANTITUBERCULOUS DRUGS AND SIDEROBLASTIC ANAEMIA.
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Anemia; Anemia, Hypochromic; Anemia, Siderobl | 1965 |
[FIRST EXPERIENCES IN THE USE OF RIFAMYCIN SV ASSOCIATED WITH PAS USING THE METHOD OF VENOUS PERFUSION. CLINICAL CONTRIBUTION].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Therapy; Humans; Infusions, Parenteral; Isoniazid; R | 1964 |
ACONCURRENT COMPARISON OF INTERMITTENT (TWICE-WEEKLY) ISONIAZID PLUS STREPTOMYCIN AND DAILY ISONIAZID PLUS PAS IN THE DOMICILIARY TREATMENT OF PULMONARY TUBERCULOSIS; TUBERCULOSIS CHEMOTHERAPY CENTRE, MADRAS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Developing Countries; Drug Therapy; Home Care Services; H | 1964 |
THE EMERGENCE OF ISONIAZID-RESISTANT CULTURES IN PATIENTS WITH PULMONARY TUBERCULOSIS DURING TREATMENT WITH ISONIAZID ALONE OR ISONIAZID PLUS PAS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Resistance; Drug Resistance, Microbial; Drug Therapy | 1964 |
[BACTERIOLOGICAL FINDINGS IN SUBJECTS AFFECTED BY CHRONIC PULMONARY TUBERCULOSIS (FINDINGS ON PATIENTS HOSPITALIZED IN THE ISTITUTO "C. FORLANINI" IN THE 3 YEAR PERIOD 1960-62)].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Bacteriological Techniques; Cycloserine; Drug Resistance; | 1964 |
TREATMENT OF TUBERCULOUS PLEURAL EFFUSION WITH LOCAL INSTILLATION OF HYDROCORTISONE.
Topics: Drug Therapy; Humans; Hydrocortisone; Isoniazid; Pleura; Pleural Effusion; Streptomycin; Tuberculosi | 1965 |
[EXPERIMENTAL STUDY OF THE HEALING MECHANISM OF TUBERCULOUS CAVERNS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Caves; Dogs; Electroencephalography; Isoniazid; Lung; Ner | 1964 |
[STUDY OF AMBULATORY TREATMENT OF PULMONARY TUBERCULOSIS WITH THE COMBINATION OF 1906 CIBA (DPT) AND INH].
Topics: Drug Therapy; Isoniazid; Phenylthiourea; Thiourea; Toxicology; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
DRUG RESISTANCE IN PULMONARY TUBERCULOSIS; TREATMENT WITH ETHIONAMIDE IN VARIOUS DRUG COMBINATIONS.
Topics: Cycloserine; Drug Combinations; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Drug Tole | 1965 |
TREATMENT OF PULMONARY TUBERCULOSIS. A COMPARATIVE STUDY WITH A NEW DRUG.
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Biomedical Research; Child; Drug Therapy; Hum | 1965 |
SPECIFIC DRUG THERAPY IN PULMONARY TUBERCULOSIS: ILLUSTRATED BY CLINICAL, RADIOLOGICAL, BACTERIOLOGICAL AND PATHOLOGICAL OBSERVATIONS IN RESECTED PATIENTS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Bacteriological Techniques; Drug Resistance; Drug Resista | 1964 |
UNITED STATES PUBLIC HEALTH SERVICE TRIALS OF ISONIAZID PROPHYLAXIS.
Topics: Alaska; Biomedical Research; Child; Communicable Disease Control; Drug Therapy; Humans; Isoniazid; P | 1964 |
[ENDOCRINE-METABOLIC COMPLICATIONS OF ANTIBACTERIAL CHEMOTHERAPY. ISONIAZID AND CUSHING'S SYNDROME].
Topics: Anti-Bacterial Agents; Cushing Syndrome; Drug Therapy; Isoniazid; Toxicology; Tuberculosis; Tubercul | 1964 |
[EFFECTIVENESS OF THE TREATMENT OF PULMONARY TUBERCULOSIS WITH ANTITUBERCULAR AGENTS IN DIFFERENT CONDITIONS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Biometry; Drug Therapy; Isoniazid; | 1964 |
DOMICILIARY CHEMOTHERAPY FOR PULMONARY TUBERCULOSIS IN DEVELOPING COUNTRIES (BASED ON EXPERIENCE IN NIGERIA).
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Developing Countries; Drug Therapy; Economics; Isoniazid; | 1964 |
CHEMOTHERAPY OF PULMONARY TUBERCULOSIS WITH COAL-WORKERS PNEUMOCONIOSIS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anthracosis; Coal; Drug Therapy; Isoniazid; Silicotubercu | 1964 |
[THE TREATMENT OF PNEUMOCONIO-TUBERCULOSIS IN COAL MINERS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Coal; Drug Therapy; France; Isoniazid; Silicotuberculosis | 1964 |
[THE PROBLEM OF CHEMOPROPHYLAXIS AND THE RESULTS OF LARGE SCALE EXPERIMENTS].
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Chemoprevention; Child; Communicable Disease | 1964 |
NEWER EXPERIMENTAL DATA ON CHEMOPROPHYLAXIS, WITH SPECIAL REGARD TO THE INFLUENCE OF TREATMENT ON ACQUIRED IMMUNITY.
Topics: Adaptive Immunity; Chemoprevention; Child; Communicable Disease Control; Drug Therapy; Isoniazid; Tu | 1964 |
CHEMOPROPHYLAXIS OF TUBERCULOSIS FOR ADULTS IN JAPAN.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Chemoprevention; Communicable Disease Control; Drug Thera | 1964 |
[CONSIDERATIONS ON THE APPLICATION OF ANTITUBERCULAR CHEMOPROPHYLAXIS IN RUMANIA].
Topics: Antitubercular Agents; Chemoprevention; Child; Communicable Disease Control; Drug Therapy; Isoniazid | 1964 |
THE EXTERNAL MANIFESTATIONS OF OCULAR TUBERCULOSIS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Bacteriological Techniques; Child; Conjunctiva; Diagnosis | 1964 |
[INVOLUTION OF CAVERNOUS PULMONARY TUBERCULOSIS IN DOGS AFTER CHEMOTHERAPY].
Topics: Dogs; Isoniazid; Lung; Pathology; Pharmacology; Radiography; Research; Streptomycin; Tuberculosis; T | 1964 |
[QUANTITATIVE RESISTANCE DETERMINATION WITH MICROBIAL COUNTING METHODS].
Topics: Drug Resistance; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tuberculosis; Sputum; | 1965 |
THE VIRULENCE OF TUBERCLE BACILLI FROM PATIENTS WITH PULMONARY TUBERCULOSIS IN INDIA AND OTHER COUNTRIES.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Animals; Bacillus; Guinea Pigs; India; Isoniazid; Mycobac | 1964 |
CHEMOTHERAPY OF TUBERCULOSIS: A BACTERIOLOGIST'S VIEWPOINT.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Bacteriol | 1965 |
PRELIMINARY REPORT ON THIACETAZONE WITH ISONIAZID FOR MASS-TREATMENT OF PULMONARY TUBERCULOSIS.
Topics: Drug Therapy; Humans; Isoniazid; Thioacetazone; Thiosemicarbazones; Toxicology; Tuberculosis; Tuberc | 1965 |
[ON PARTICIPATION OF THE SANITARY-EPIDEMIOLOGICAL SERVICE IN TUBERCULOSIS CONTROL].
Topics: Communicable Disease Control; Drug Therapy; Humans; Isoniazid; Mass Chest X-Ray; Statistics as Topic | 1964 |
THE USE OF ETHIONAMIDE IN COMBINED DRUG REGIMENS IN THE RE-TREATMENT OF ISONIAZID-RESISTANT PULMONARY TUBERCULOSIS.
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resi | 1965 |
[FAMILIAL CONTAMINATION DUE TO PULMONARY TUBERCULOSIS CARRIERS OF ISONIAZID-RESISTANT BACILLI].
Topics: Bacillus; Carrier State; Epidemiology; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
CHEMOTHERAPY OF TUBERCULOSIS.
Topics: Carcinogens; Drug Therapy; Isoniazid; Lung Neoplasms; Mice; Neoplasms; Toxicology; Tuberculosis; Tub | 1965 |
[THE TRYPTOPHAN TEST IN TUBERCULOTICS TREATED WITH ISONIAZID AND A COMBINATION OF ISONIAZID AND PYRIDOXINE].
Topics: Drug Therapy; Humans; Isoniazid; Pyridoxine; Tryptophan; Tuberculosis; Tuberculosis, Pulmonary | 1965 |
THIACETAZONE PLUS ISONIAZID IN DOMICILIARY TREATMENT OF PULMONARY TUBERCULOSIS IN HYDERABAD.
Topics: Antitubercular Agents; Clinical Laboratory Techniques; Drug Resistance; Drug Resistance, Microbial; | 1965 |
TUBERCULOSIS IN WESTERN SAMOA AND TOKELAU ISLANDS.
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Child; Drug Therapy; Geriatrics; Humans; Inde | 1965 |
[THE EARLY TREATMENT OF PULMONARY TUBERCULOSIS: EXPERIMENTAL STUDY].
Topics: Animals; Isoniazid; Lagomorpha; Lung; Pharmacology; Rabbits; Research; Streptomycin; Tuberculosis; T | 1964 |
[ISONIAZID TREATMENT IN CASES OF ISONIAZID RESISTANCE].
Topics: Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Isoniazid; Tuberculosis; Tuberculosis, Pu | 1964 |
PATHOLOGICAL FINDINGS IN A TUBERCULOUS BABOON.
Topics: Animals; Drug Therapy; Isoniazid; Lung; Monkey Diseases; Papio; Pathology; Radiography, Thoracic; Tu | 1965 |
[RESISTANCE OF M. TUBERCULOSIS TO STREPTOMYCIN AND PHTHIVAZID AND INCIDENCE OF POSTOPERATIVE COMPLICATIONS IN PATIENTS WITH PULMONARY TUBERCULOSIS].
Topics: Antitubercular Agents; Drug Resistance; Drug Resistance, Microbial; Humans; Incidence; Isoniazid; My | 1964 |
A CONTROLLED CLINICAL TRIAL OF ETHIONAMIDE, CYCLOSERINE AND PYRAZINAMIDE IN PREVIOUSLY TREATED PATIENTS WITH PULMONARY TUBERCULOSIS.
Topics: Cycloserine; Drug Therapy; Ethionamide; Isoniazid; Pyrazinamide; Radiography, Thoracic; Streptomycin | 1965 |
COMPARISON OF PAS, THIACETAZONE OR 4-4 DIISOAMYLOXYTHIOSEMICARBANILIDE WITH STREPTOMYCIN AND ISONIAZID IN PREVIOUSLY UNTREATED PATIENTS WITH PULMONARY TUBERCULOSIS.
Topics: Isoniazid; Japan; Streptomycin; Thioacetazone; Toxicology; Tuberculosis, Pulmonary | 1965 |
A CONTROLLED TRIAL OF ISONIAZID AND 4-4 DIISOAMYLOXYTHIOSEMICARBANILIDE COMPARED WITH ISONIAZID AND PAS AND ISONIAZID, STREPTOMYCIN AND PAS.
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Drug Therapy; Geriatri | 1965 |
TREATMENT OF PULMONARY TUBERCULOSIS WITH A COMBINATION OF THIACETAZONE AND ISONIAZID. A PRELIMINARY REPORT.
Topics: Antitubercular Agents; Drug Therapy; Humans; Isoniazid; Thioacetazone; Thiosemicarbazones; Tuberculo | 1965 |
SOME DIFFICULTIES IN THE TREATMENT OF TUBERCULOUS ALCOHOLICS.
Topics: Alcoholics; Alcoholism; Aminosalicylic Acid; Aminosalicylic Acids; Drug Therapy; Humans; Isoniazid; | 1965 |
CHEMOTHERAPY OF PULMONARY TUBERCULOSIS IN ADULTS: THE CHOICE OF DRUGS IN RELATION TO DRUG SUSCEPTIBILITY. A STATEMENT OF THE COMMITTEE ON THERAPY.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Drug Resistance; Drug Resistance, | 1965 |
SERUM IRON, COPPER, IRON-BINDING CAPACITY AND MARROW HEMOSIDERIN IN PULMONARY TUBERCULOSIS.
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Blood; Blood Chemical Analysis; Blood Sedimen | 1965 |
[The problem of endocrine disorders during isoniazid treatment].
Topics: Cushing Syndrome; Endocrine System Diseases; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuber | 1954 |
[Blood iron level in isoniazid therapy of pulmonary tuberculosis].
Topics: Blood; Humans; Iron; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
Optic atrophy after administration of isoniazid with P.A.S.
Topics: Disease; Isoniazid; Niacin; Nicotinic Acids; Optic Atrophy; Optic Nerve; Optic Nerve Diseases; Tuber | 1955 |
[Allergometric variations during antibacterial therapy with isoniazid associated with PAS].
Topics: Aminosalicylic Acid; Anti-Bacterial Agents; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculo | 1954 |
[Case of possible primary isoniazid resistance].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Increasing frequency of resistance to isoniazid in patients arriving at the sanatorium].
Topics: Hospitals; Isoniazid; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosi | 1954 |
[Treatment of pulmonary tuberculosis with high doses of isoniazid; report on 100 cases].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Potassium iodide and methyl antigen in chronic pulmonary tuberculosis after treatment with streptomycin and isoniazid; comparative study and counter-test].
Topics: Antibodies; Antigens; Iodides; Isoniazid; Niacin; Nicotinic Acids; Potassium Iodide; Streptomycin; T | 1954 |
[Results of three months of combined isoniazid and PAS therapy of pulmonary tuberculosis; comparison with isoniazid therapy alone and with combined isoniazid, streptomycin and PAS].
Topics: Aminosalicylic Acid; Anti-Bacterial Agents; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberc | 1954 |
[Use of subcontinuous isoniazid and hyaluronidase aerosols in very grave pulmonary tuberculosis; a year and a half of tests].
Topics: Aerosols; Hyaluronoglucosaminidase; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, | 1954 |
Topical isoniazid-streptomycin aerosol in the treatment of pulmonary tuberculosis.
Topics: Aerosols; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
Isoniazid treatment of pulmonary tuberculosis in out-patients: a clinical trial.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Outpatients; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
The treatment of primary tuberculosis in children; results of a controlled study using isoniazid.
Topics: Child; Humans; Infant; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
Isoniazid in the treatment of primary pulmonary tuberculosis.
Topics: Child; Humans; Infant; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
[PAS-isoniazid and PAS-streptomycin combined therapy, a comparison of two case series].
Topics: Aminosalicylic Acid; Isoniazid; Niacin; Nicotinic Acids; Research Design; Streptomycin; Tuberculosis | 1955 |
[The effects of tuberculostatics on the carbohydrates metabolism, demonstrated by the sample of isonicotinic acid hydrazide].
Topics: Carbohydrate Metabolism; Carbohydrates; Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tu | 1955 |
[Sensitivity and resistance of Mycobacterium tuberculosis before and during isoniazid therapy].
Topics: Isomerism; Isoniazid; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosi | 1953 |
[Herpes zoster as a results of isonicotinic acid hydrazide; contribution to the enurotropictoxic effects of INH].
Topics: Herpes Zoster; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[The treatment of pulmonary tuberculosis of the adult type in puberty with isonicotinic acid hydrazide (INH)].
Topics: Adolescent; Disease; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Puberty; Sexual Maturation; Tube | 1954 |
[Preliminary clinical results of isoniazid therapy].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
Isoniazid in single and multiple drug regimens in the treatment of pulmonary tuberculosis of recent origin.
Topics: Aminosalicylic Acid; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tube | 1955 |
[The question of side effects intrathecal and oral isoniazid treatment in children].
Topics: Child; Humans; Infant; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tuberculosis, | 1955 |
[Development of resistance of Mycobacterium tuberculosis to isonicotinic acid hydrazide during the treatment of pulmonary tuberculosis].
Topics: Isomerism; Isoniazid; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosi | 1954 |
[Comparative results of continuous treatment of ulcero-nodular tuberculosis for 10 months with isoniazid-PAS and with isoniazidstreptomycin].
Topics: Aminosalicylic Acid; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tuberculosis, P | 1955 |
ISONIAZID (INH), PAS and streptomycin in pulmonary tuberculosis; a control study on 443 cases.
Topics: Aminosalicylic Acid; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Streptomycin; Tuberculosis; Tube | 1955 |
Intrapleural administration of isoniazid in tuberculous empyema; concentration in serum and pleural fluid.
Topics: Blood; Empyema, Tuberculous; Exudates and Transudates; Isoniazid; Niacin; Nicotinic Acids; Tuberculo | 1955 |
[Variations of blood proteins in evaluation of therapeutic effects of isonicotinic acid hydrazide in pulmonary tuberculosis].
Topics: Blood Proteins; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
[The question of isoniazid binding to blood proteins].
Topics: Blood Proteins; Electrophoresis; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pul | 1955 |
[Passage of isonicotinic acid hydrazide from mother to newborn; determination of isoniazid in milk, maternal blood and follicular blood].
Topics: Blood; Female; Humans; Isoniazid; Milk, Human; Mothers; Nicotinic Acids; Placenta; Pregnancy; Tuberc | 1955 |
[Some apparently unusual secondary effects of isonicotinic acid hydrazide on the digestive tract].
Topics: Colitis; Constipation; Gastrointestinal Tract; Humans; Isoniazid; Niacin; Nicotinic Acids; Peptic Ul | 1955 |
The treatment of pulmonary tuberculosis with iproniazid (1-isonicotinyl-2-isopropyl hydrazine) and isoniazid (isonicotinyl hydrazine).
Topics: Hydrazines; Iproniazid; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
The clinical significance of positive cultures and of isoniazid-resistant tubercle bacilli during the treatment of pulmonary tuberculosis; report to the Tuberculosis Chemotherapy Trials Committee of the Medical Research Council.
Topics: Bacillus; Biomedical Research; Gram-Positive Bacteria; Isoniazid; Mycobacterium tuberculosis; Niacin | 1955 |
[The contagiosity of adult pulmonary tuberculotics treated by isoniazid. Recent control by the study of 140 cases of primary tuberculosis in children observed in 1957 and 1958].
Topics: Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
[A plan for the treatment of pulmonary tuberculosis. II. Experiences in 173 patients with streptomycin and isoniazid-senstive tubercle bacilli].
Topics: Animals; Bacillus; Gram-Positive Bacteria; Insecta; Isoniazid; Lacticaseibacillus casei; Streptomyci | 1959 |
[A plan for the treatment of pulmonary tuberculosis. I. Experiences in 173 patients with streptomycin- and isoniazid-sensitive tubercle bacilli].
Topics: Animals; Bacillus; Gram-Positive Bacteria; Insecta; Isoniazid; Lacticaseibacillus casei; Streptomyci | 1959 |
[On the effect of INH metabolism on the therapy of pulmonary tuberculosis].
Topics: Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
[Further clinical studies on the effect of isonicotinic acid hydrazide paraaminosalicylate (dipashin) on the course of pulmonary tuberculosis with regard to bacillary sensitivity to isonicotinic acid hydrazide].
Topics: Bacillus; Biomedical Research; Gram-Positive Bacteria; Humans; Isoniazid; Lacticaseibacillus casei; | 1959 |
The effect of rubeola on tuberculosis under antimicrobial therapy. I. Primary pulmonary tuberculosis treated with isoniazid.
Topics: Anti-Infective Agents; Child; Infant; Isoniazid; Measles; Tuberculosis; Tuberculosis, Pulmonary | 1959 |
[On the treatment of childhood forms of tuberculosis with tebafen (GT3)].
Topics: Child; Humans; Infant; Isoniazid; Thiosemicarbazones; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
Isorilone in chronic pulmonary tuberculosis.
Topics: Isoniazid; Sulfanilamide; Sulfanilamides; Sulfonamides; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
Massive dose INH in chronic resistant pulmonary tuberculosis.
Topics: Humans; Isoniazid; Tuberculosis, Pulmonary | 1959 |
Results of therapy with thiocarbanidin used with isoniazid or streptomycin.
Topics: Antitubercular Agents; Isoniazid; Streptomycin; Thiourea; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
Cycloserine-isoniazid in the treatment of chronic, resistant pulmonary tuberculosis.
Topics: Cycloserine; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
Usefulness of a combined isoniazid, para-aminosalicylic acid and pyridoxine preparation.
Topics: Aminosalicylic Acid; Anti-Bacterial Agents; Isoniazid; Pyridoxine; Tuberculosis; Tuberculosis, Pulmo | 1959 |
[Antitubercular chemoprophylaxis with Omodel Zorini's method in silicotic patients].
Topics: Antitubercular Agents; Chemoprevention; Humans; Isoniazid; Silicosis; Tuberculosis; Tuberculosis, Pu | 1960 |
Streptovaricin and isoniazid in the treatment of pulmonary tuberculosis.
Topics: Anti-Bacterial Agents; Isoniazid; Streptovaricin; Tuberculosis; Tuberculosis, Pulmonary | 1959 |
[Clinical course of pulmonary tuberculosis in the established bacillary resistance to INH].
Topics: Animals; Bacillus; Gram-Positive Bacteria; Humans; Insecta; Isoniazid; Lacticaseibacillus casei; Tub | 1960 |
The prevalence of bacterial resistance to isoniazid and to PAS in patients with acute pulmonary tuberculosis presenting for treatment in East Africa.
Topics: Acute Disease; Africa, Eastern; Aminosalicylic Acid; Bacterial Infections; Isoniazid; Prevalence; Tu | 1960 |
[Relationship between the clinical course of pulmonary tuberculosis and the sensitivity or resistance of tubercle bacilli to isoniazid].
Topics: Animals; Bacillus; Gram-Positive Bacteria; Humans; Insecta; Isoniazid; Lacticaseibacillus casei; Tub | 1959 |
Comparison of isoniazid alone with isoniazid--PAS in the original chemotherapy of noncavitary pulmonary tuberculosis. Results from the Veterans Administration-Armed Forces co-operative study on the chemotherapy of tuberculosis.
Topics: Aminosalicylic Acid; Humans; Isoniazid; Military Personnel; Tuberculosis; Tuberculosis, Pulmonary; U | 1959 |
[Results of the treatment of pulmonary tuberculosis with the preparation napashin with regard to the preservation of isonicotinic acid hydrazide resistance in bacilli].
Topics: Aminosalicylic Acids; Bacillus; Humans; Isoniazid; Lacticaseibacillus casei; Preservation, Biologica | 1959 |
[Primary pulmonary tuberculosis treated with pyrazinamide. Immediate clinical and radiological results and results after prolonged treatment with streptomycin and isoniazid].
Topics: Humans; Isoniazid; Pyrazinamide; Radiology; Streptomycin; Tuberculosis, Pulmonary | 1959 |
Cycloserine and isoniazid in childhood tuberculous infections.
Topics: Child; Cycloserine; Infant; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
Treatment of pulmonary tuberculosis with cycloserine and isoniazid: a preliminary report.
Topics: Cycloserine; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
Pulmonary tuberculosis treated with high doses of INH plus glutamic acid.
Topics: Glutamates; Glutamic Acid; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
Oxytetracycline and isoniazid combination as original treatment of pulmonary tuberculosis.
Topics: Isoniazid; Oxytetracycline; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
[The use of sulfoniazide in forms of pulmonary tuberculosis in childhood].
Topics: Child; Humans; Infant; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1959 |
Drug resistance in out-patients treated with sodium PAS and isoniazid cachets.
Topics: Aminosalicylic Acid; Drug Resistance; Isoniazid; Outpatients; Sodium; Sodium, Dietary; Tuberculosis; | 1959 |
A concurrent comparison of isoniazid plus PAS with three regimens of isoniazid alone in the domiciliary treatment of pulmonary tuberculosis in South India.
Topics: Aminosalicylic Acid; Humans; India; Isoniazid; Tuberculosis, Pulmonary | 1960 |
Case reports of the Massachusetts General Hospital. Case 42-1961.
Topics: Hospitals, General; Isoniazid; Liver; Massachusetts; Medical Records; Peptic Ulcer Hemorrhage; Tuber | 1961 |
Morphological study of the chemotherapeutic effect on the experimental pulmonary tuberculosis of rabbits.
Topics: Animals; Isoniazid; Lagomorpha; Lung; Rabbits; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
The open-negative tuberculous patient.
Topics: Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1962 |
[Amyloid goiter with increased thyroid function in a patient with pulmonary tuberculosis].
Topics: Goiter; Humans; Hyperthyroidism; Isoniazid; Medical Records; Streptomycin; Tuberculosis; Tuberculosi | 1962 |
[Experience with "Elpimed" as an adjuvant in streptomycin and isoniazid therapy of pulmonary tuberculosis].
Topics: Adjuvants, Immunologic; Adjuvants, Pharmaceutic; Blood; Immunization, Passive; Isoniazid; Streptomyc | 1961 |
[The effect of early treatment with isoniazid on the protective effect against reinfection in the mouse].
Topics: Animals; Isoniazid; Mice; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
[Reversible pyridoxine-sensitive symptomatic sideroachrestic anemia during isoniazid therapy of caseous lymph node tuberculosis with exudative pleurisy].
Topics: Anemia; Humans; Isoniazid; Lymph Nodes; Medical Records; Pleurisy; Pyridoxine; Tuberculosis; Tubercu | 1962 |
[Modern chemotherapy of pulmonary tuberculosis (a summary of WHO & NTA statements)].
Topics: Aminosalicylic Acid; Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1962 |
[Concentration of free isoniazid in the blood of pulmonary tuberculosis patients].
Topics: Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
Isoniazid in primary tuberculosis in infancy. A controlled clinical trial.
Topics: Child; Humans; Infant; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
[Studies on the antitubercular action of N-acetyl-D-glucosaminyl-isonicotinic acid hydrazide (AG-INH)].
Topics: Antitubercular Agents; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
[Pulmonary resections in tuberculosis. The use of isoniazid, ethioniamide, streptomycin and cycloserine].
Topics: Antitubercular Agents; Cycloserine; Ethionamide; Humans; Isoniazid; Pneumonectomy; Pulmonary Surgica | 1961 |
[Pulmonary tuberculosis caused by isoniazid-resistant bacilli before any treatment whatsoever in a hospital service in Paris].
Topics: Animals; Bacillus; Gram-Positive Bacteria; Insecta; Isoniazid; Lacticaseibacillus casei; Mycobacteri | 1962 |
The effect of isoniazid prophylaxis on tuberculosis morbidity among household contacts of previously known cases of tuberculosis.
Topics: Family Characteristics; Humans; Isoniazid; Morbidity; Tuberculosis; Tuberculosis, Pulmonary | 1962 |
[Combined therapy of massive doses of isoniazid, pyrazinamide, and sulfisoxazole for patients with pulmonary tuberculosis resistant to streptomycin, paraaminosalicylic acid, and isoniazid].
Topics: Aminosalicylic Acid; Humans; Isoniazid; Psychotherapy, Multiple; Pyrazinamide; Streptomycin; Sulfani | 1961 |
[Reparative processes in the lungs in primary tuberculosis in children treated with antibacterial preparations].
Topics: Aminosalicylic Acid; Anti-Bacterial Agents; Child; Infant; Isoniazid; Streptomycin; Tuberculosis; Tu | 1961 |
Standards of therapy for tuberculosis, 1962.
Topics: Chemoprevention; Humans; Isoniazid; Lung; Pulmonary Surgical Procedures; Time Factors; Tuberculosis; | 1962 |
[Sulfadimethoxine and INH combined therapy. Basc principles and clinical aspects].
Topics: Isoniazid; Psychotherapy, Multiple; Sulfadimethoxine; Sulfanilamide; Sulfanilamides; Sulfonamides; T | 1962 |
The course of pulmonary tuberculosis in patients excreting organisms which have acquired resistance. Response to continued treatment for a second year with isoniazid alone or with isoniazid plus PAS.
Topics: 4-Aminobenzoic Acid; Guinea Pigs; Humans; India; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1962 |
The virulence in the guinea-pig of tubercle bacilli isolated before treatment from South Indian patients with pulmonary tuberculosis. 3. Virulence related to pretreatment status of disease and to response to chemotherapy.
Topics: Aged; Antitubercular Agents; Bacillus; Guinea Pigs; Humans; India; Isoniazid; Tuberculosis; Tubercul | 1961 |
The role of diet in the treatment of pulmonary tuberculosis. An evaluation in a controlled chemotherapy study in home and sanatorium patients in South India.
Topics: Antitubercular Agents; Body Weight; Diet; Disease Management; Humans; India; Isoniazid; Nutrition As | 1961 |
Multiplication of Mycobacterium tuberculosis in the lungs and its modification by immunity and by isoniazid.
Topics: Isoniazid; Lung; Mycobacterium tuberculosis; Tuberculin; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
[Cycloserine-viomycin association in the treatment of pulmonary tuberculosis caused by isoniazid- and streptomycin-resistant bacilli (first results)].
Topics: Bacillus; Cycloserine; Humans; Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary; Viomy | 1961 |
[Cycloserine-viomycin combination in the treatment of pulmonary tuberculosis caused by isoniazid and streptomycin resistant bacilli. (1st results)].
Topics: Bacillus; Cycloserine; Isoniazid; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1961 |
[Gastric resection and pulmonary tuberculosis. X. Isoniazid chemioprophylaxis according to the Omodei Zorini method in gastric-resected and non-resected gastroduodenal ulcer patients].
Topics: Gastrectomy; Humans; Isoniazid; Peptic Ulcer; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
[Combined therapy with INH and TB 1 for pulmonary tuberculosis].
Topics: Isoniazid; Psychotherapy, Multiple; Thiosemicarbazones; Tuberculosis; Tuberculosis, Pulmonary | 1962 |
[A clinical study on tuberculosis among young adults in Japan: analysis on patients admitted to national hospitals in Kanto- and Kinki-areas in the year 2000].
Topics: Adult; Age Factors; Antitubercular Agents; Drug Resistance, Bacterial; Female; Hospitals, Public; Hu | 2003 |
Detection of a point mutation associated with high-level isoniazid resistance in Mycobacterium tuberculosis by using real-time PCR technology with 3'-minor groove binder-DNA probes.
Topics: 3' Untranslated Regions; Antitubercular Agents; DNA Probes; Drug Resistance, Bacterial; Humans; Ison | 2003 |
[Use of isofon in combined treatment of patients with acutely progressive forms of tuberculosis].
Topics: Acute Disease; Adjuvants, Immunologic; Antitubercular Agents; Arrhythmias, Cardiac; Disease Progress | 2003 |
[Accelerated determination of blood bacteriostatic activity in patients with tuberculosis by using the semiliquid culture medium].
Topics: Antitubercular Agents; Culture Media; Humans; Isoniazid; Mycobacterium tuberculosis; Serum Bacterici | 2003 |
Passive versus active tuberculosis case finding and isoniazid preventive therapy among household contacts in a rural district of Malawi.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child, Preschool; Comorbidity; Contact Tracing; Cros | 2003 |
Management and outcome of tuberculosis patients who fail treatment under routine programme conditions in Malawi.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Isoniazid; Malawi; Mycobacterium tuberculosis; Re | 2003 |
Strategies for effective education in a jail setting: the Tuberculosis Prevention Project.
Topics: Antitubercular Agents; Carrier State; Health Education; Health Educators; Health Services Accessibil | 2003 |
Is there a role for chest radiography in identification of asymptomatic tuberculosis in HIV-infected people?
Topics: Adult; Antitubercular Agents; Comorbidity; Evaluation Studies as Topic; Health Care Costs; HIV Infec | 2003 |
Value of chest radiography in a tuberculosis prevention programme for HIV-infected people, Botswana.
Topics: Adolescent; Adult; Ambulatory Care; Antitubercular Agents; Botswana; Comorbidity; Evaluation Studies | 2003 |
[Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Topics: Adult; Aged; Antitubercular Agents; Cohort Studies; Drug Therapy, Combination; Female; Humans; Isoni | 2003 |
Catalase-peroxidase activity has no influence on virulence in a murine model of tuberculosis.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Disease Models, Animal; Drug Resistance, Bacteri | 2003 |
Relative versus absolute noncontagiousness of respiratory tuberculosis on treatment.
Topics: Academic Medical Centers; Adult; Alberta; Antibiotics, Antitubercular; Antitubercular Agents; Colony | 2003 |
Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Humans; Isoniazid; Mycobacterium tuberculosis; Sputum; Tomography, X-Ray Comp | 2003 |
Chest radiography and thoracic computed tomography findings in children who have family members with active pulmonary tuberculosis.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Family; Female; Humans; Infant; Isoniazi | 2003 |
[Efficacy of tuberculosis contacts investigation and treatment, especially of preventive therapy in infants and young children].
Topics: Child, Preschool; Contact Tracing; Female; Humans; Infant; Isoniazid; Male; Retrospective Studies; T | 2003 |
Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base.
Topics: Administration, Oral; Animals; Antitubercular Agents; Biological Availability; Chlorocebus aethiops; | 2004 |
Somatic complaints and isoniazid (INH) side effects in Latino adolescents with latent tuberculosis infection (LTBI).
Topics: Acculturation; Adolescent; Adolescent Behavior; Analysis of Variance; Antitubercular Agents; Califor | 2004 |
[Isoniazid-induced pleuro-pericarditis].
Topics: Antitubercular Agents; Humans; Isoniazid; Male; Middle Aged; Pericarditis; Pleural Diseases; Tubercu | 2003 |
[Clinical forms of new cases of tuberculosis at Kaunas Romainiai Tuberculosis Hospital in 1998-2001].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Child; | 2004 |
Hydrazine derivatives of isonicotinic acid (rimifon marsilid) in the treatment of active progressive caseous-pneumonic tuberculosis; a preliminary report.
Topics: Hydrazines; Isoniazid; Isonicotinic Acids; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulm | 1952 |
[First results of isonicotinic acid hydrazide therapy of tuberculosis at the Institute C. Forlanini].
Topics: Academies and Institutes; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
Isonicotinic acid hydrazide in (INAH) in tuberculosis.
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
CURRENT status of isonicotinic acid hydrazide in the treatment of tuberculosis.
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
ISONIAZID in pulmonary tuberculosis.
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Early changes in cutaneous allergy in tubercular subjects treated with isonicotinic acid hydrazide].
Topics: Dermatitis, Atopic; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
ISONICOTINIC acid hydrazide.
Topics: Fistula; Isoniazid; Niacin; Nicotinic Acids; Trachea; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Preliminary therapeutic experiences with isonicotinic acid hydrazide in pulmonary tuberculosis].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Observations on 8 cases of pulmonary tuberculosis treated with isonicotinic acid hydrazide during 30 days].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Preliminary results of the treatment of pulmonary tuberculosis with isonicotinic acid hydrazide].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Resistance, of Mycobacterium tuberculosis to isonicotinic acid hydrazide in the treatment of cavitary pulmonary tuberculosis].
Topics: Biochemical Phenomena; Isoniazid; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Tuberculosis; | 1952 |
[First impressions of use of isonicotinic acid hydrazide in pulmonary tuberculosis bedridden subjects in the Rasori Sanatorium].
Topics: Isoniazid; Nervous System Diseases; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[First clinical report on therapeutic use of isonicotinic acid hydrazide in human tuberculosis].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[First clinical results of treatment of 50 cases of pulmonary tuberculosis with isonicotinic acid hydrazide].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[First clinico-radiological report on the effect of isonicotinic acid hydrazide in pulmonary tuberculosis].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Isonicotinic acid hydrazide therapy of pulmonary tuberculosis].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Use of isonicotinic acid hydrazide in collapse therapy and exeresis in pulmonary tuberculosis].
Topics: Collapse Therapy; Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Complications and incidents in isonicotinic acid hydrazide therapy of pulmonary tuberculosis].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[First clinical tests of isonicotinic acid hydrazide in the Sanatoria of the Piedmont].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Suboccipital or spinal infection of isonicotinic acid hydrazide in animals and humans and first report on the activity of the drug in tubercular meningitis and primary pulmonary tuberculosis in children].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Meningeal; Tuberculosis, Pulmonary | 1952 |
[Comparison of early therapeutic results of pulmonary tuberculosis with rimifon].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Isonicotinic acid hydrazide therapy of pulmonary tuberculosis].
Topics: Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
Cavitatory pulmonary tuberculosis in a 52-day-old infant.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Asia; Drug Therapy, Combination; Female; Humans; | 2004 |
[Molecular genetic characteristics of rifampicin-resistant Mycobacterium tuberculosis isolates in Novosibirsk].
Topics: Antitubercular Agents; Codon; Drug Therapy, Combination; Humans; Isoniazid; Mycobacterium tuberculos | 2003 |
Transmission of tuberculosis from patient to healthcare workers in the anaesthesia context.
Topics: Anesthesia, General; Antitubercular Agents; Female; Humans; Infectious Disease Transmission, Patient | 2004 |
Direct detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis in auramine-rhodamine-positive sputum specimens by real-time PCR.
Topics: Antitubercular Agents; Benzophenoneidum; DNA, Bacterial; Drug Resistance, Bacterial; Genotype; Human | 2004 |
Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Guinea Pigs; Humans; Isoniazid; Liposomes; M | 2004 |
[Detection of KatG 315 gene mutation associated with isoniazid resistance in Mycobacterium tuberculosis by template-directed dye-terminator incorporation with fluorescence polarization detection technology].
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Drug Resistance, Bacterial; Fluorescence Polari | 2004 |
Resistant Mycobacterium bovis Bacillus Calmette-Guérin disease: implications for management of Bacillus Calmette-Guérin Disease in human immunodeficiency virus-infected children.
Topics: Animals; Antitubercular Agents; BCG Vaccine; Cattle; DNA-Directed RNA Polymerases; Drug Resistance, | 2004 |
Empirical treatment for tuberculosis: survey of cases treated over 2 years in a London area.
Topics: Adult; Antibiotic Prophylaxis; Antitubercular Agents; BCG Vaccine; Blood Sedimentation; Ethnicity; F | 2004 |
[Experience with fenazid in perperas with respiratory tuberculosis and post-tuberculous changes in the lung].
Topics: Adult; Female; Hemoglobins; Humans; Isoniazid; Lung; Postpartum Period; Pregnancy; Pregnancy Complic | 2004 |
[Etiopathogenetic therapy in adolescent patients with drug-resistant Mycobacterium tuberculosis in respiratory tuberculosis].
Topics: Adolescent; Anti-Bacterial Agents; Genotype; Humans; Isoniazid; Kanamycin; Mycobacterium tuberculosi | 2004 |
Treatment of latent TB infection for close contacts as a complementary TB control strategy in Singapore.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Antitubercular Agents; BCG Vaccine; Carrier State; Child; | 2004 |
Characteristics and outcome of tuberculosis patients whose sputum smears are positive at or after 5 months of treatment.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; Health Surveys; Humans; Isoniaz | 2004 |
Rifapentine for the treatment of tuberculosis: is it all it can be?
Topics: Antibiotics, Antitubercular; Dose-Response Relationship, Drug; Drug Combinations; Half-Life; Humans; | 2004 |
Finding gold in the muddy waters of public health reports.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Communicable Disease Control; Drug Combinations; | 2004 |
Acceptance of screening and completion of treatment for latent tuberculosis infection among refugee claimants in Canada.
Topics: Adolescent; Adult; Age Factors; Antitubercular Agents; Emigration and Immigration; Female; Humans; I | 2004 |
Prescriptions and dosages of anti-tuberculosis drugs in the National Tuberculosis Control Programme of Malawi.
Topics: Administration, Oral; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Body Weight; Commun | 2004 |
Preventing drug-resistant tuberculosis with a fixed dose combination of isoniazid and rifampin.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Directly Observed Therapy; Drug Combinations; Dr | 2004 |
A 32-year-old man with tuberculosis, fever, and rash.
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Drug Hypersensitivity; Ethambutol; Exanthema; | 2004 |
Poncet's disease--a novel cause of non-compliance with anti-tuberculous drugs.
Topics: Adult; Antitubercular Agents; Arthritis, Infectious; Humans; Isoniazid; Male; Treatment Refusal; Tub | 2004 |
[Study on the epidemiology and determinants of drug-resistant tuberculosis in northern rural area of Jiangsu province].
Topics: Adult; Antitubercular Agents; China; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethambut | 2004 |
Improving tuberculosis therapy completion after jail: translation of research to practice.
Topics: Adult; Antitubercular Agents; Cohort Studies; Female; Humans; Isoniazid; Male; Patient Compliance; P | 2005 |
[Use of regional lymphotropic therapy in the treatment of pulmonary tuberculosis in HIV-infected individuals].
Topics: Acquired Immunodeficiency Syndrome; Adult; Antitubercular Agents; Humans; Isoniazid; Lymphatic Syste | 2004 |
[Efficiency of an intensive stage of chemotherapy for tuberculosis in elderly and senile patients].
Topics: Age Factors; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Diabetes C | 2004 |
[Bactericidal therapy in patients with tuberculosis].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Chlortetracycline; Drug R | 2004 |
[Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Female; | 2004 |
Tuberculosis: medical management update.
Topics: Adult; Antitubercular Agents; Child; Dental Staff; Ethambutol; Humans; Infectious Disease Transmissi | 2004 |
[Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug R | 2004 |
Mucoepidermoid carcinoma of the lung presenting as a cavitary lesion.
Topics: Antitubercular Agents; Carcinoma, Mucoepidermoid; Fatal Outcome; Female; Humans; Isoniazid; Lung Neo | 2004 |
Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; Drug Resistance, | 2004 |
Efficacy and safety of Efavirenz in HIV patients on Rifampin for tuberculosis.
Topics: Adult; Alkynes; Anti-HIV Agents; Antibiotics, Antitubercular; Antiretroviral Therapy, Highly Active; | 2004 |
PCR-RFLP analysis of a point mutation in codons 315 and 463 of the katG gene of Mycobacterium tuberculosis isolated from patients in Silesia, Poland.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Codon; Drug Resistance, Bacterial; Humans; Ison | 2004 |
The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis.
Topics: Antitubercular Agents; Directly Observed Therapy; Drug Resistance, Bacterial; Drug Resistance, Multi | 2004 |
Childhood turberculosis: reflections from the front line.
Topics: Antitubercular Agents; Chemoprevention; Child; Community Health Planning; Female; Humans; Infant; Is | 2004 |
Studies of early bactericidal activity: new insights into isoniazid pharmacokinetics.
Topics: Antitubercular Agents; Humans; Isoniazid; Mycobacterium tuberculosis; Time Factors; Tuberculosis, Pu | 2004 |
The influence of human N-acetyltransferase genotype on the early bactericidal activity of isoniazid.
Topics: Adolescent; Adult; Antitubercular Agents; Arylamine N-Acetyltransferase; Female; Genotype; Humans; I | 2004 |
[The importance of a careful examination of all persons in close contact with newly diagnosed infectious tuberculosis].
Topics: Adult; Antitubercular Agents; Child, Preschool; Family; Female; Humans; Isoniazid; Male; Middle Aged | 2004 |
Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
Topics: Antitubercular Agents; Drug Resistance, Multiple; Ethambutol; Humans; India; Isoniazid; Microbial Se | 2003 |
Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients.
Topics: Antitubercular Agents; Drug Resistance, Multiple; Ethambutol; Humans; India; Isoniazid; Microbial Se | 2003 |
Tuberculosis control and the private health sector in Bolivia: a survey of pharmacies.
Topics: Antitubercular Agents; Bolivia; Communicable Disease Control; Community Pharmacy Services; Cooperati | 2004 |
Drug-resistant tuberculosis in HIV-infected persons: Italy 1999-2000.
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Bacterial; Drug Re | 2004 |
New multiplex PCR for rapid detection of isoniazid-resistant Mycobacterium tuberculosis clinical isolates.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Drug Resistance, Bacterial; Humans; Isoniazid; | 2005 |
[Case of pulmonary tuberculosis in late stage of pregnancy].
Topics: Adult; Antitubercular Agents; Cesarean Section; Cross Infection; Drug Therapy, Combination; Ethambut | 2004 |
[Pulmonary Mycobacterium fortuitum infection with multiple nodular shadows in a healthy man].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium fortuitum; My | 2004 |
Explaining risk factors for drug-resistant tuberculosis in England and Wales: contribution of primary and secondary drug resistance.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Case-Control Studies; Child; Chil | 2004 |
[Primary prevention and treatment of latent tuberculosis infection with isoniazid: efficacy of a control program, 1997-2002].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Female; Humans; Isoniazid; Male; Middle Aged; | 2005 |
Treatment outcome of new culture positive pulmonary tuberculosis in Norway.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Cohort Studies; Drug Resist | 2005 |
Drug-resistance tuberculosis among the foreign-born in Canada.
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Canada; Drug Resistance | 2005 |
Drug-sensitivity profile of clinical Mycobacterium tuberculosis isolates--a retrospective study from a chest-disease institute in India.
Topics: Adult; Aged; Antitubercular Agents; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; India | 2005 |
[Problems of the epidemiology, diagnosis, and treatment of caseous pneumonia].
Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents; Antitubercular Agents; Diagnosis, Differential; Di | 2004 |
[Effectiveness of an intensive chemotherapy stage in new cases of pulmonary tuberculosis and diabetes mellitus].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Data Interpretation, Statistical; Diabetes Melli | 2004 |
Development of a pyrosequencing approach for rapid screening of rifampin, isoniazid and ethambutol-resistant Mycobacterium tuberculosis.
Topics: Antibiotics, Antitubercular; Codon; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Microb | 2005 |
Susceptibilities of Mycobacterium tuberculosis to isoniazid and rifampin on blood agar.
Topics: Agar; Antitubercular Agents; Blood; Culture Media; Humans; Isoniazid; Microbial Sensitivity Tests; M | 2005 |
Tuberculous peritonitis developing during chemotherapy for pulmonary and intestinal tuberculosis: a case report.
Topics: Antibiotics, Antitubercular; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Laparoscopy; | 2005 |
Delayed response to anti-tuberculosis treatment in a patient on infliximab.
Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Antitubercular Agents; Drug Interactions; Human | 2005 |
Spoligotyping of Mycobacterium tuberculosis isolates from patients with pulmonary tuberculosis in Mumbai, India.
Topics: Adult; Antitubercular Agents; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Genotype | 2005 |
Isoniazid- and rifampin-resistant tuberculosis in San Diego County, California, United States, 1993-2002.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; California; Child; Female; Hu | 2005 |
Results of a national study on anti-mycobacterial drug resistance in El Salvador.
Topics: Age Distribution; Antibiotics, Antitubercular; Directly Observed Therapy; El Salvador; Female; Human | 2005 |
Isoniazid pharmacokinetics in children treated for respiratory tuberculosis.
Topics: Adolescent; Adult; Aging; Analysis of Variance; Antitubercular Agents; Area Under Curve; Arylamine N | 2005 |
Protective effect of a 50% hydroalcoholic fruit extract of Emblica officinalis against anti-tuberculosis drugs induced liver toxicity.
Topics: Animals; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Fruit; Hepatocytes; Humans; | 2005 |
Rifampicin resistance in tuberculosis outbreak, London, England.
Topics: Antitubercular Agents; Base Sequence; Disease Outbreaks; DNA-Directed RNA Polymerases; Drug Resistan | 2005 |
Imipenem for treatment of tuberculosis in mice and humans.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Drug Resistance, Mu | 2005 |
Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana.
Topics: Adult; Antitubercular Agents; Botswana; Comorbidity; Ethambutol; Female; HIV Infections; Humans; Iso | 2005 |
[The clinical and pharmacokinetic features of lymphotropic therapy in patients with new-onset pulmonary tuberculosis].
Topics: Adult; Antitubercular Agents; Drug Administration Schedule; Female; Humans; Isoniazid; Lymph Nodes; | 2005 |
[Tuberculosis of young children with sensory changes. (Report of two cases)].
Topics: Aminosalicylic Acid; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Faci | 1976 |
Development of multidrug resistance during treatment of isoniazid-resistant tuberculosis.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; | 2005 |
The influence of NAT2 genotypes on the plasma concentration of isoniazid and acetylisoniazid in Chinese pulmonary tuberculosis patients.
Topics: Antitubercular Agents; Arylamine N-Acetyltransferase; China; Chromatography, High Pressure Liquid; G | 2006 |
[Combined regular chemotherapy and lesion management under bronchofiberscope in proliferative endobronchial tuberculosis].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Bronchitis; Bronchoscopy; Combined Modality Therapy; | 2005 |
[The characteristics of the sensitivity of Mycobacterium tuberculosis to rifampicin and isoniazid through determination of mutations in the genes rpoB, katG, inhA, oxyR, and kasA by different molecular biological assays].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; DNA, Bacterial; Drug Resistance, Bacterial; Drug | 2005 |
[Isoniazid acetylation in a group of Tunisian patients. Report of 620 patients].
Topics: Acetylation; Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Female; Humans; Ison | 2005 |
Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Aza Compounds; Colony Count, Microbial; Drug The | 2005 |
DNA microarray genotyping of N-acetyltransferase 2 polymorphism using carbodiimide as the linker for assessment of isoniazid hepatotoxicity.
Topics: Antitubercular Agents; Arylamine N-Acetyltransferase; Asian People; Chemical and Drug Induced Liver | 2006 |
Molecular analysis of isoniazid, rifampin and streptomycin resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Düzce, Turkey.
Topics: Amino Acid Substitution; Antitubercular Agents; Bacterial Proteins; Base Sequence; Catalase; DNA-Dir | 2005 |
Reactivation of tuberculosis after apparently adequate chemoprophylaxis.
Topics: Adolescent; Antitubercular Agents; Chemoprevention; Contact Tracing; Disease Transmission, Infectiou | 2005 |
Adherence to anti-tuberculosis chemoprophylaxis and treatment in children.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Contact Tracing; Drug Thera | 2006 |
Treatment outcomes by drug resistance and HIV status among tuberculosis patients in Ho Chi Minh City, Vietnam.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Resistance, Ba | 2006 |
Initial drug susceptibility profile of M. tuberculosis among patients under TB programme in South India.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; M | 2006 |
[Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Humans; Incidence; Isoniazid; Moscow; Mycobacter | 2005 |
[Reserves for enhancing the efficiency of treatment for pulmonary tuberculosis in adolescents].
Topics: Adolescent; Antitubercular Agents; Child; Female; Humans; Isoniazid; Male; Tuberculosis, Pulmonary | 2006 |
Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroqui | 2006 |
The impact of smoking on adherence to treatment for latent tuberculosis infection.
Topics: Adolescent; Adult; Africa, Northern; Antitubercular Agents; Confidence Intervals; Female; Humans; In | 2006 |
[Stevens-Johnson syndrome and toxic epidermal necrolysis after intake of rifampicin-isoniazid: report of 8 cases in HIV-infected patients in Togo].
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Female; HIV In | 2005 |
Potent twice-weekly rifapentine-containing regimens in murine tuberculosis.
Topics: Animals; Antitubercular Agents; Aza Compounds; Drug Administration Schedule; Drug Therapy, Combinati | 2006 |
Potent twice-weekly rifapentine-containing regimens in murine tuberculosis.
Topics: Animals; Antitubercular Agents; Aza Compounds; Drug Administration Schedule; Drug Therapy, Combinati | 2006 |
Potent twice-weekly rifapentine-containing regimens in murine tuberculosis.
Topics: Animals; Antitubercular Agents; Aza Compounds; Drug Administration Schedule; Drug Therapy, Combinati | 2006 |
Potent twice-weekly rifapentine-containing regimens in murine tuberculosis.
Topics: Animals; Antitubercular Agents; Aza Compounds; Drug Administration Schedule; Drug Therapy, Combinati | 2006 |
Potent twice-weekly rifapentine-containing regimens in murine tuberculosis.
Topics: Animals; Antitubercular Agents; Aza Compounds; Drug Administration Schedule; Drug Therapy, Combinati | 2006 |
Potent twice-weekly rifapentine-containing regimens in murine tuberculosis.
Topics: Animals; Antitubercular Agents; Aza Compounds; Drug Administration Schedule; Drug Therapy, Combinati | 2006 |
Potent twice-weekly rifapentine-containing regimens in murine tuberculosis.
Topics: Animals; Antitubercular Agents; Aza Compounds; Drug Administration Schedule; Drug Therapy, Combinati | 2006 |
Potent twice-weekly rifapentine-containing regimens in murine tuberculosis.
Topics: Animals; Antitubercular Agents; Aza Compounds; Drug Administration Schedule; Drug Therapy, Combinati | 2006 |
Potent twice-weekly rifapentine-containing regimens in murine tuberculosis.
Topics: Animals; Antitubercular Agents; Aza Compounds; Drug Administration Schedule; Drug Therapy, Combinati | 2006 |
Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa.
Topics: Adult; Antitubercular Agents; Cross-Sectional Studies; Gold; HIV Infections; Humans; Isoniazid; Male | 2006 |
Multidrug-resistant tuberculosis in military recruits.
Topics: Adult; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Milit | 2006 |
Rapid susceptibility test for Mycobacterium tuberculosis to isoniazid and rifampin with resazurin method in screw-cap tubes.
Topics: Antitubercular Agents; Drug Resistance, Microbial; False Positive Reactions; Humans; Indicators and | 2006 |
Adherence to isoniazid preventive chemotherapy: a prospective community based study.
Topics: Adult; Antitubercular Agents; Child, Preschool; Community Health Services; Drug Administration Sched | 2006 |
[Characteristics of Mycobacterium tuberculosis clinical strains genotype A1].
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymera | 2006 |
CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Arylamine N-Acetyltransferase; Base Sequence; Chemic | 2006 |
Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Administration Schedule; H | 2006 |
Cost-effectiveness of including tuberculin skin testing in an IPT program for HIV-infected persons in Uganda.
Topics: Antitubercular Agents; Cost-Benefit Analysis; HIV Infections; Humans; Isoniazid; Program Evaluation; | 2006 |
Cost-effectiveness of tuberculosis evaluation and treatment of newly-arrived immigrants.
Topics: Adult; Aged; Antitubercular Agents; California; Cohort Studies; Communicable Disease Control; Contac | 2006 |
[Isoniazid induced neuropathy: consider prevention].
Topics: Acetylation; Achilles Tendon; Adult; Antiretroviral Therapy, Highly Active; Antitubercular Agents; E | 2006 |
Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection.
Topics: Antitubercular Agents; Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Humans; Isoniazid; | 2006 |
Intracellular growth and drug susceptibility of Mycobacterium tuberculosis in macrophages.
Topics: Animals; Antitubercular Agents; Guinea Pigs; Humans; Isoniazid; Macrophages; Mice; Microbial Sensiti | 2007 |
Scanning laser polarimetry in pulmonary tuberculosis patients on chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Diagnostic Techniques, Ophthalmological; Etha | 2006 |
Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Disease Models, Animal; Drug Therapy, C | 2006 |
Moving forward with evidence and controversies: the challenges of MDR-TB.
Topics: Antibiotics, Antitubercular; Humans; Isoniazid; Microbial Sensitivity Tests; Rifampin; Tuberculosis, | 2006 |
Timely diagnosis of MDR-TB under program conditions: is rapid drug susceptibility testing sufficient?
Topics: Antibiotics, Antitubercular; Confounding Factors, Epidemiologic; Drug Resistance, Multiple, Bacteria | 2006 |
Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
Topics: Adolescent; Adult; Age Factors; Aged; Analysis of Variance; Anti-Bacterial Agents; Antibiotics, Anti | 2006 |
Impact of DOTS expansion on tuberculosis related outcomes and costs in Haiti.
Topics: Antitubercular Agents; Cost of Illness; Directly Observed Therapy; Drug Therapy, Combination; Ethamb | 2006 |
Exposure to open tuberculosis on a neonatal unit.
Topics: Adult; Antibiotic Prophylaxis; Antitubercular Agents; Breast Feeding; Disease Transmission, Infectio | 2006 |
Ocular tuberculosis in acquired immunodeficiency syndrome.
Topics: Abscess; Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; CD4 Lympho | 2006 |
Use of nonlinear mixed-effects analysis for improved precision of early pharmacodynamic measures in tuberculosis treatment.
Topics: Antitubercular Agents; Humans; Isoniazid; Models, Biological; Nonlinear Dynamics; Pyrazinamide; Rifa | 2006 |
Acute isoniazid toxicity and the need for adequate pyridoxine supplies.
Topics: Acute Disease; Adult; Antidotes; Antitubercular Agents; Drug Overdose; Drugs, Essential; Humans; Inf | 2006 |
[Evaluation of the efficiency of activity of the liposomal form of isoniazid against different types of mycobacteria in vitro].
Topics: Antitubercular Agents; Humans; In Vitro Techniques; Isoniazid; Liposomes; Lung; Mycobacterium tuberc | 2006 |
Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB.
Topics: Adult; Antitubercular Agents; Bacteriophages; Biological Assay; Culture Media; Drug Resistance, Bact | 2007 |
Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis.
Topics: Adalimumab; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Ag | 2006 |
National anti-tuberculosis drug resistance survey, 2002, in Myanmar.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Cross-Sectional Studies; Ethambutol; Female; Health | 2006 |
Within-host population dynamics of antibiotic-resistant M. tuberculosis.
Topics: Algorithms; Anti-Bacterial Agents; Computer Simulation; Drug Resistance, Microbial; Drug Therapy, Co | 2007 |
[Adverse neurotoxic reactions of chemotherapy for tuberculosis and their treatment].
Topics: Adult; Antitubercular Agents; Female; Follow-Up Studies; Glutamates; Humans; Incidence; Intercellula | 2006 |
Extension of the intensive phase reduces unfavourable outcomes with the 8-month thioacetazone regimen.
Topics: Antitubercular Agents; Follow-Up Studies; Humans; Isoniazid; Mycobacterium tuberculosis; Prospective | 2006 |
Treatment failure in tuberculosis.
Topics: Adolescent; BCG Vaccine; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Health Surveys | 2007 |
[Effect of use of bone marrow cells in therapy for experimental tuberculosis].
Topics: Animals; Antitubercular Agents; Bone Marrow Transplantation; Combined Modality Therapy; Disease Mode | 2006 |
Consider rifampin BUT be cautious.
Topics: Antitubercular Agents; Humans; Isoniazid; Multicenter Studies as Topic; Patient Compliance; Randomiz | 2006 |
Enhancement of treatment completion for latent tuberculosis infection with 4 months of rifampin.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Cohort Studies; Drug Administration Schedule; Drug | 2006 |
Rapid antibiotic susceptibility testing of Mycobacterium tuberculosis: its utility in resource poor settings.
Topics: Antitubercular Agents; Colorimetry; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensiti | 2006 |
Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Cohort Studies; Directly Observed Therapy; | 2007 |
Chapter 4: childhood contact screening and management.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Breast Feeding; Child; Child, Preschoo | 2007 |
Outcomes of multidrug-resistant tuberculosis treatment in HIV-positive patients in New York City, 1990-1997.
Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Capreomycin; Clinical Trials as | 2007 |
Moxifloxacin-induced arthropathy.
Topics: Aged, 80 and over; Antitubercular Agents; Arthritis; Aza Compounds; Drug Therapy, Combination; Fluor | 2007 |
Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Drug Res | 2007 |
Non-adherence to tuberculosis treatment.
Topics: Antitubercular Agents; Child, Preschool; Humans; Infant; Isoniazid; Patient Compliance; Research Des | 2007 |
Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait.
Topics: Antitubercular Agents; Base Sequence; Codon; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniaz | 2007 |
[A case of tuberculosis showing immune reconstitution syndrome after the initiation of antiretroviral therapy for HIV infection].
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antitubercular Agents; Drug Therapy, Com | 2007 |
Primary and acquired drug resistance in childhood tuberculosis.
Topics: Adolescent; Afghanistan; Antitubercular Agents; Child; Child Welfare; Ethambutol; Female; Gastric Ju | 2006 |
[Aseptic cerebral venous thrombosis and multiple cerebral tuberculomas associated with pulmonary miliary tuberculosis].
Topics: Acenocoumarol; Aged; Anticoagulants; Antitubercular Agents; Confusion; Drug Therapy, Combination; Fe | 2007 |
Sputum conversion among patients with pulmonary tuberculosis: are there implications for removal of respiratory isolation?
Topics: Adult; Aged; Antitubercular Agents; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; F | 2007 |
[Reduced mycobacterial resistance to antituberculous drugs in the experiment and clinic: immediate and long-term results].
Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agent | 2007 |
Intestinal permeability and malabsorption of rifampin and isoniazid in active pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Case-Control Studies; Chromatography, High Pressure | 2006 |
PCR-restriction fragment length polymorphism for rapid, low-cost identification of isoniazid-resistant Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Drug Resistance, Bacterial; Humans; Isoniazid; | 2007 |
Trend of anti-tuberculosis drug resistance in Korea, 1994-2004.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Ethambutol; Humans; Isoniazid; Korea; Middle | 2007 |
[The new combined antituberculous drug: the original combined antituberculous drug dioxazid].
Topics: Animals; Antitubercular Agents; Drug Combinations; Female; Isoniazid; Male; Mycobacterium tuberculos | 2007 |
Haemorheological variables in Nigeria pulmonary tuberculosis patients undergoing therapy.
Topics: Adult; Blood Sedimentation; Blood Viscosity; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; I | 2007 |
The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid.
Topics: Acetylation; Adult; Antitubercular Agents; Area Under Curve; Arylamine N-Acetyltransferase; Female; | 2007 |
Clinical characteristics of tuberculosis in patients with liver cirrhosis.
Topics: Adult; Aged; Antibiotics, Antitubercular; Case-Control Studies; Drug Therapy, Combination; Female; H | 2007 |
[The significance of spoligotyping method in epidemiological investigations of tuberculosis].
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Bacterial Typing Techniques; Cluster Analysis | 2007 |
Tuberculous sacro-ileitis: two cases and radiological findings.
Topics: Abscess; Adult; Antitubercular Agents; Arthritis, Infectious; Brucellosis; Diagnosis, Differential; | 2007 |
[Treatment and outcomes of tuberculosis with multidrug resistance of MBT in children and adolescents].
Topics: Adolescent; Amikacin; Antitubercular Agents; Child; Drug Resistance, Multiple; Drug Therapy, Combina | 2007 |
Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Argentina; Clinical Trials as Topic; Cycloserine | 2007 |
Activity of ketoconazole against Mycobacterium tuberculosis in vitro and in the mouse model.
Topics: Administration, Oral; Animals; Antibiotics, Antitubercular; Antitubercular Agents; Drug Evaluation, | 2007 |
[Analysis of mutations of multidrug-resistant M. tuberculosis strains in patients with tuberculosis in the Kyrghyz Republic].
Topics: Adult; Amino Acid Substitution; Antitubercular Agents; Bacterial Proteins; Catalase; DNA Mutational | 2007 |
[Reasons for drug-resistant tuberculosis emergence].
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple; Humans; Isoniazid; Myc | 2007 |
[Principles in the performance of chemotherapy in dispensary group VI children and adolescents].
Topics: Adolescent; Antitubercular Agents; Child; Dose-Response Relationship, Drug; Drug Administration Sche | 2007 |
Primary tuberculosis in children. 1. Incidence of primary drug-resistant disease in 332 children observed between the years 1961 and 1964 at the Kings County Medical Center of Brooklyn.
Topics: Aminosalicylic Acid; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Bacterial; Fem | 1966 |
Fatal hemorrhagic intracranial TB in a renal transplant recipient despite INH prophylaxis.
Topics: Antitubercular Agents; Fatal Outcome; Follow-Up Studies; Humans; Intracranial Hemorrhages; Isoniazid | 2007 |
[Case of fatal liver failure due to anti-tuberculous therapy].
Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Fatal Outcome; Female; Humans; I | 2007 |
[Detection of mutation in NAT II gene as a method of determination of izoniazyd (INH) acetylation type in human population].
Topics: Acetylation; Arylamine N-Acetyltransferase; Genotype; Humans; Isoniazid; Liver; Mutation; Polymerase | 2007 |
katG mutations in isoniazid-resistant strains of Mycobacterium tuberculosis isolates from Belarusian patients.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Codon; DNA Primers; DNA, Bacterial; Drug Resist | 2007 |
[Primary resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Kinshasa, (DRC)].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Cross-Sectional Studies; Democratic Republic | 2007 |
[Case of pulmonary infection with Mycobacterium chelonae in healthy breast-feeding woman].
Topics: Adult; Antitubercular Agents; Breast Feeding; Clarithromycin; Drug Resistance, Bacterial; Drug Thera | 2007 |
Pattern of adverse drug reactions experienced by tuberculosis patients in a tertiary care teaching hospital in Western Nepal.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Antitubercular Agents; Aspa | 2008 |
[Frequency of MDR-TB/XDR-TB strains isolated from chronic pulmonary tuberculosis patients in Japan].
Topics: Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Japan; Microbial Sensitivity Tests; Mycobac | 2007 |
[A surgically treated case of ileus caused by small intestinal tuberculosis during treatment for pulmonary tuberculosis].
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Ileal Diseases; Ileus; Isoniazid; Male; Pyrazinami | 2007 |
Treatment of isoniazid-resistant pulmonary tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug T | 2008 |
Extensive transmission of an isoniazid-resistant strain of Mycobacterium tuberculosis in Sweden.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Cluster Analysis; Contact Tracing | 2008 |
Neuroimaging findings in isoniazid central nervous system toxicity, presumed intramyelinic edema.
Topics: Antitubercular Agents; Blood Cell Count; Brain Edema; Central Nervous System Diseases; Child, Presch | 2008 |
[Adherence and effectiveness of the treatment of latent tuberculosis infection with isoniazid for 9 months in a cohort of 755 patients].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Cohort Studies; Female; Hum | 2008 |
The effect of isoniazid containing regimen on CYP2E1 during antituberculosis therapy.
Topics: Adult; Antitubercular Agents; Chlorzoxazone; Chromatography, High Pressure Liquid; Cytochrome P-450 | 2005 |
An unusual case of chylothorax complicating childhood tuberculosis.
Topics: Antitubercular Agents; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Bronchoscopy; Chest Tub | 2008 |
Evaluation of the GenoCard as a tool for transport and storage of samples for tuberculosis molecular drug susceptibility testing.
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Isoni | 2008 |
Outcomes in HIV-infected patients who develop tuberculosis after starting antiretroviral treatment in Malawi.
Topics: Anti-Retroviral Agents; Antitubercular Agents; Child; Comorbidity; HIV Infections; Humans; Isoniazid | 2008 |
[Tubazide poisoning and emergency first aid].
Topics: Adult; Antidotes; Emergencies; First Aid; Humans; Isoniazid; Male; Tuberculosis, Pulmonary | 1966 |
[Peculiarities of the course of gastric ulcer in patients with pulmonary tuberculosis].
Topics: Adrenal Cortex Hormones; Aged; Gastric Mucosa; Humans; Isoniazid; Male; Middle Aged; Stomach Ulcer; | 1966 |
[The importance of the inactivation of phthivazid in the mechanism of resistance to it in Mycobacterium tuberculosis].
Topics: Adolescent; Adult; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Middle Aged; Tubercu | 1966 |
[Effect and treatment problems of secondary antitubercular agents].
Topics: Antitubercular Agents; Costs and Cost Analysis; Drug Resistance, Microbial; Ethambutol; Ethionamide; | 1966 |
[The efficacy of treatment of diffuse infiltrative-pneumonic pulmonary tuberculosis].
Topics: Adolescent; Adult; Aminosalicylic Acids; Humans; Isoniazid; Tuberculosis, Pulmonary | 1966 |
[Methodology of regional chemotherapy of the lung].
Topics: Animals; Dogs; Fibrinolysis; Humans; Isoniazid; Perfusion; Tuberculosis, Pulmonary | 1966 |
[The fate of students with minimal, apparently inactive, pulmonary tuberculosis in a 5-year follow-up study].
Topics: Aminosalicylic Acids; Follow-Up Studies; Humans; Isoniazid; Mass Chest X-Ray; Poland; Prognosis; Stu | 1966 |
[Observations on cases with minimal tuberculosis of doubtful activity with or without chemotherapy].
Topics: Aminosalicylic Acids; Antitubercular Agents; Humans; Isoniazid; Radiography; Tuberculosis, Pulmonary | 1966 |
Observations concerning 487 patients returned to active military service after treament for pulmonary tuberculosis: progress report.
Topics: Adult; Aminosalicylic Acids; Female; Humans; Isoniazid; Male; Military Medicine; Pennsylvania; Pneum | 1967 |
Two possibilities of further reduction in mortality from tuberculosis.
Topics: Humans; Hungary; Isoniazid; Oxytetracycline; Tuberculosis, Pulmonary | 1967 |
Therapeutic bronchography in the treatment of bronchopulmonary tuberculosis.
Topics: Bronchography; Catheterization; Contrast Media; Evaluation Studies as Topic; Humans; Isoniazid; Tube | 1967 |
Folate deficiency associated with drug therapy for tuberculosis.
Topics: Adult; Anemia, Macrocytic; Cycloserine; Female; Folic Acid Deficiency; Humans; Isoniazid; Male; Midd | 1967 |
Acute tuberculous panophthalmitis.
Topics: Acetazolamide; Aged; Aminosalicylic Acids; Atropine; Choroid Neoplasms; Exophthalmos; Female; Glauco | 1967 |
Isoniazid hypersensitivity reaction involving the eyes. Report of a case.
Topics: Adult; Conjunctiva; Drug Hypersensitivity; Female; Hemorrhage; Humans; Isoniazid; Optic Neuritis; Tu | 1967 |
Non-teratogenicity of antituberculous drugs.
Topics: Abnormalities, Drug-Induced; Aminosalicylic Acids; Antitubercular Agents; Drug Synergism; Ethionamid | 1967 |
Non-pulmonary tuberculosis in the west of Scotland, 1963-65.
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Scotland; Strepto | 1967 |
Primary resistance to major antituberculous drugs in patients with pulmonary tuberculosis in the years 1957-1964.
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Europe; Humans; Isoniazid; Poland; Retrospective S | 1967 |
Serum cholesterol and serum lipids in patients with far advanced active pulmonary tuberculosis on three drugs--preliminary report.
Topics: Aminosalicylic Acids; Cholesterol; Diet; Humans; Isoniazid; Lipids; Streptomycin; Tuberculosis, Pulm | 1967 |
Hilar adenopathy in tuberculosis.
Topics: Adolescent; Adult; Aminosalicylic Acids; Black or African American; Blood Sedimentation; Child, Pres | 1967 |
Tuberculin skin testing in San Francisco schools, 1956-1966: an epidemiologic analysis.
Topics: Asian People; BCG Vaccine; Black or African American; California; Child; Community Health Services; | 1967 |
[Eosinophilic infiltrations of the lung as a radiologic manifestation of hypersensitivity to streptomycin, PAS and INH].
Topics: Aged; Aminosalicylic Acids; Antitubercular Agents; Drug Hypersensitivity; Eosinophilia; Female; Huma | 1967 |
Cycloserine plus ethionamide in the treatment of patients excreting isoniazid-resistant tubercle bacilli following previous chemotherapy.
Topics: Adult; Cycloserine; Drug Resistance, Microbial; Ethionamide; Female; Humans; Isoniazid; Male; Sputum | 1967 |
Pyridoxine-responsive sideroblastic anemia due to antituberculous drugs.
Topics: Anemia, Sideroblastic; Antitubercular Agents; Cycloserine; Humans; Isoniazid; Male; Middle Aged; Pyr | 1967 |
[Results of treatment of pulmonary tuberculosis under conditions of compulsory isolation].
Topics: Adolescent; Adult; Aminosalicylic Acids; Humans; Isoniazid; Middle Aged; Prisons; Streptomycin; Tube | 1967 |
[On the carcinogenic capacity of isonicotinic acid hydrazide].
Topics: Aged; Animals; Ear Neoplasms; Humans; Isoniazid; Lung Neoplasms; Lupus Vulgaris; Male; Middle Aged; | 1967 |
Intermittent chemotherapy with isoniazid and streptomycin in Algiers.
Topics: Adolescent; Adult; Aged; Algeria; Ambulatory Care; Body Weight; Drug Resistance, Microbial; Female; | 1967 |
Intensification of tuberculosis control through a community-wide approach: Rowan County, Kentucky.
Topics: Adolescent; Adult; Child; Costs and Cost Analysis; Female; Humans; Isoniazid; Kentucky; Male; Mass C | 1967 |
Tuberculosis in a large office.
Topics: Adult; Colorado; Female; Humans; Isoniazid; Male; Middle Aged; Tuberculosis, Pulmonary | 1967 |
[Leukergy in patients with pulmonary tuberculosis treated for the first time with antitubercular drugs].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Female; Humans; Isoniazid; Leukocytes; Male; Middle | 1967 |
[The value of serum level determinations for INH].
Topics: Humans; Isoniazid; Tuberculosis, Pulmonary | 1967 |
[Studies on the treatment of experimental chronic tuberculosis with steroid hormone as a stimulation therapy and the distribution of 14C-labeled isoniazid in the tuberculous mice].
Topics: Animals; Carbon Isotopes; Chronic Disease; Ethionamide; Female; Isoniazid; Kanamycin; Lung; Mice; Pr | 1967 |
Pulmonary alveolar proteinosis. Treatment in a case complicated by tuberculosis.
Topics: Acetylcysteine; Aminosalicylic Acids; Cycloserine; Ethionamide; Heparin; Humans; Isoniazid; L-Lactat | 1967 |
Pyrazinamide-isoniazid: its apparent influence on the reactivation rate in pulmonary tuberculosis.
Topics: Adult; Aminosalicylic Acids; Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Middle Aged; | 1967 |
[Results of treatment by a combination of thiocarlide and isoniazid in previously untreated pulmonary tuberculosis].
Topics: Adolescent; Adult; Aminosalicylic Acids; Female; Humans; Isoniazid; Male; Middle Aged; Phenylthioure | 1967 |
Patient cooperation in taking medicines. A study involving isoniazid and aminosalicylic acid.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Female; Humans; Isoniazid; Male; Middle Aged; Outpati | 1967 |
Folic acid and vitamin B12 in tuberculosis.
Topics: Adult; Aminosalicylic Acids; Anemia, Macrocytic; Female; Folic Acid; Folic Acid Deficiency; Humans; | 1967 |
[Early results of non-effective chemotherapy with second-line drugs in pulmonary tuberculosis].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Humans; Isoniazid; Tuberculosis, Pulmonary | 1967 |
[Basic and clinical study of 2-propyl isonicotinic thioamide (1321 Th)].
Topics: Adolescent; Adult; Animals; Drug Resistance, Microbial; Ethionamide; Female; Humans; In Vitro Techni | 1967 |
[Long-term results of antiturcular chemoprophylaxis and its current uses].
Topics: BCG Vaccine; Humans; Isoniazid; Tuberculosis, Pulmonary | 1967 |
Minor epidemics of tuberculosis.
Topics: Adolescent; Adult; Aged; Australia; BCG Vaccine; Child; Child, Preschool; Cross Infection; Female; H | 1967 |
Tuberculosis maintenance therapy with isoniazid and ethambutol.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Mid | 1980 |
Tuberculosis.
Topics: Adolescent; Adult; Child; Female; Humans; Isoniazid; Tuberculosis, Pulmonary; United Kingdom | 1983 |
[Method of maximum concentration of antibacterial drugs in the treatment of destructive pulmonary tuberculosis].
Topics: Adolescent; Adult; Aminosalicylic Acid; Antitubercular Agents; Child; Dihydrostreptomycin Sulfate; D | 1980 |
[Modified method for indicating antitubercular agents in the urine in tuberculosis].
Topics: Ambulatory Care; Antitubercular Agents; Humans; Isoniazid; Reagent Strips; Tuberculosis, Pulmonary | 1980 |
Aplastic anaemia associated with anti-tuberculosis chemotherapy.
Topics: Acridines; Adult; Aminosalicylic Acid; Anemia, Aplastic; Antitubercular Agents; Drug Therapy, Combin | 1982 |
Drug-resistant Mycobacterium tuberculosis in Korean isolates.
Topics: Adult; Capreomycin; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Korea; Mycobacterium | 1982 |
Electrophysiological evidence of peripheral nerve damage in patients treated with isoniazid.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Drug Combinations; Electromyography; Female; Humans | 1982 |
Cytogenetic effects of chemotherapy with three combinations of anti-tubercular drugs involving isoniazid, thiacetazone, para-aminosalicylic acid and streptomycin on human lymphocytes: chromosome aberrations, sister chromatid exchanges and mitotic index.
Topics: Aminosalicylic Acid; Antitubercular Agents; Chromosome Aberrations; Crossing Over, Genetic; Drug Eva | 1983 |
[Antitubercular agents].
Topics: Antimetabolites; Antitubercular Agents; DNA; Ethambutol; Ethionamide; Folic Acid Antagonists; Humans | 1984 |
[Therapeutic results in lung diseases caused by atypical mycobacteria].
Topics: Antitubercular Agents; Capreomycin; Drug Therapy, Combination; Erythromycin; Ethambutol; Ethionamide | 1984 |
Tuberculosis in hospital.
Topics: Adult; BCG Vaccine; Child; Cross Infection; Disease Outbreaks; Female; Humans; Infant; Infant, Newbo | 1984 |
Genetic effects of drug interaction in tuberculosis patients and their fate.
Topics: Aminosalicylic Acid; Antitubercular Agents; Cells, Cultured; Chromosome Aberrations; Crossing Over, | 1984 |
Ethambutol-induced hyperuricaemia.
Topics: Adolescent; Adult; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Ag | 1984 |
[Toxicity in the current treatment of pulmonary tuberculosis in children].
Topics: Adolescent; Antitubercular Agents; Blood Coagulation Disorders; Chemical and Drug Induced Liver Inju | 1984 |
[Current treatment of pulmonary tuberculosis].
Topics: Adult; Aged; Antitubercular Agents; Child; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tu | 1984 |
[Isoniazid inactivation in 2 ethnic groups].
Topics: Biotransformation; Ethnicity; Humans; Isoniazid; Kazakhstan; Russia; Tuberculosis, Pulmonary | 1984 |
Positive tuberculin skin tests and isoniazid chemoprophylaxis.
Topics: Adult; Chemical and Drug Induced Liver Injury; Female; Humans; Isoniazid; Middle Aged; Neuritis; Nur | 1984 |
Compliance of patients and physicians: experience and lessons from tuberculosis-II.
Topics: Attitude of Health Personnel; Drug Administration Schedule; Drug Information Services; Drug Therapy, | 1983 |
A continuing study of primary drug-resistant tuberculosis among children observed at the Kings County Hospital Medical Center between the years 1961 and 1980.
Topics: Aminosalicylic Acid; Antitubercular Agents; Child; Drug Resistance, Microbial; Humans; Isoniazid; My | 1983 |
Control and prevention of tuberculosis: a code of practice.
Topics: Adolescent; Adult; BCG Vaccine; Child; Cross Infection; Emigration and Immigration; Humans; Isoniazi | 1983 |
[Present findings on the determination of mycobacterial resistance].
Topics: Adult; Antitubercular Agents; Drug Resistance, Microbial; Humans; Isoniazid; Middle Aged; Mycobacter | 1983 |
Tuberculin reaction in children treated with isoniazid.
Topics: Child; Child, Preschool; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Isoniazid; Mycobacte | 1983 |
Antituberculosis drug resistance in south Texas.
Topics: Adolescent; Adult; Age Factors; Aged; Antitubercular Agents; Child; Child, Preschool; Drug Resistanc | 1983 |
Pharmacokinetics of antituberculosis drugs after oral isolated and simultaneous administration in triple combination.
Topics: Administration, Oral; Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; H | 1983 |
[Results of intermittent treatment of tuberculosis and Mycobacteria shedding in children].
Topics: Adolescent; Child; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Mycobacterium tub | 1983 |
[Pharmacokinetics of antitubercular agents in man].
Topics: Absorption; Antitubercular Agents; Half-Life; Humans; Isoniazid; Kinetics; Mycobacterium tuberculosi | 1984 |
Short-course chemotherapy for tuberculosis with mainly twice-weekly isoniazid and rifampin. Community physicians' seven-year experience with mainly outpatients.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Chemical and Drug Induced Liver Injury; Drug Administratio | 1984 |
Drug-resistance encountered in the retreatment of Mycobacterium tuberculosis infections.
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; H | 1984 |
[Effectiveness of controlled chemoprophylaxis of children with increased risk of tuberculosis].
Topics: Child; Humans; Isoniazid; Risk; Russia; Time Factors; Tuberculin Test; Tuberculosis, Pulmonary; Urba | 1980 |
[Chemoprophylaxis of tuberculosis in stock breeders and its effectiveness].
Topics: Agricultural Workers' Diseases; Humans; Isoniazid; Kazakhstan; Risk; Time Factors; Tuberculosis, Pul | 1981 |
[Interrelation between isoniazid inactivation and the genetic blood marker (ABO)].
Topics: ABO Blood-Group System; Ethnicity; Genetic Markers; Humans; Isoniazid; Kazakhstan; Phenotype; Tuberc | 1981 |
Isoniazid-induced exfoliative dermatitis.
Topics: Aged; Dermatitis, Exfoliative; Drug Eruptions; Humans; Isoniazid; Male; Tuberculosis, Pulmonary | 1982 |
Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.
Topics: Acetylation; Adult; Aged; Female; Humans; Isoniazid; Male; Middle Aged; Phenotype; Sulfamethazine; T | 1984 |
[Severe neurological toxicity (coma, convulsions, distal motor neuropathy) secondary to the association of accidental poisoning by isoniazid and a protocol containing high doses of vincristine].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Hepatic Encephalopathy; Human | 1984 |
[Short-course chemotherapy for tuberculosis in Chile. Operational considerations].
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; P | 1984 |
[Short-course treatment of tuberculosis on a 7-month schedule with an initial intensive phase of 1 month (TA-81)].
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; H | 1984 |
Tuberculosis in Cuba.
Topics: Adolescent; Adult; Aged; Ambulatory Care; BCG Vaccine; Child; Child, Preschool; Cuba; Drug Therapy, | 1984 |
Serum total bile acid levels in patients receiving rifampicin and isoniazid.
Topics: Adolescent; Adult; Bile Acids and Salts; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; | 1984 |
[Effectiveness of the rapid intravenous administration of rifampicin and isoniazid and of the intramuscular administration of streptomycin in disseminated destructive pulmonary tuberculosis in dogs].
Topics: Animals; Dogs; Drug Evaluation, Preclinical; Drug Therapy, Combination; Guinea Pigs; Injections, Int | 1984 |
[Preventive chemotherapy of intrapulmonary residual tuberculosis with isoniazid--example of failed compliance by the physician].
Topics: Aged; Compliance; Elasticity; Female; Humans; Isoniazid; Male; Middle Aged; Physicians; Switzerland; | 1984 |
[A case of pulmonary tuberculosis followed by interesting clinical findings].
Topics: Child; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Isoniazid; Mediastinal Ne | 1984 |
[Five year follow-up study on the short-course chemotherapy for pulmonary tuberculosis in Niigata Prefecture].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Therapy, Combination; Follow-Up Studies; Humans; Iso | 1984 |
A successful supervised outpatient short-course tuberculosis treatment program in an open refugee camp on the Thai-Cambodian border.
Topics: Adolescent; Adult; Ambulatory Care Facilities; Antitubercular Agents; Cambodia; Child; Drug Therapy, | 1984 |
Pemphigus foliaceus induced by rifampicin.
Topics: Humans; Isoniazid; Male; Middle Aged; Pemphigus; Pyridoxine; Rifampin; Tuberculosis, Pulmonary | 1984 |
[Clinical pharmacology of isoniazid].
Topics: Acetylation; Adult; Humans; Isoniazid; Kinetics; Time Factors; Tuberculosis, Pulmonary | 1984 |
[The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].
Topics: Acetylation; Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Phenotype; Sampling Studies; | 1984 |
[Isoniazid concentrations in the blood, resected lung tissue and the gallbladder bed in relation to the method of administration to pulmonary tuberculosis patients with stomach and liver diseases].
Topics: Cholecystitis; Gallbladder; Humans; Isoniazid; Liver Diseases; Lung; Pneumonectomy; Stomach Diseases | 1984 |
[Prevention of tuberculosis in 1984].
Topics: Adolescent; Adult; Aged; BCG Vaccine; Carrier State; Child; Child, Preschool; Female; Humans; Infant | 1984 |
[Tuberculosis treatment today].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tubercul | 1984 |
[Difficulties in the treatment of pulmonary tuberculosis in a patient rapidly inactivating isoniazid (INH)].
Topics: Drug Resistance; Humans; Isoniazid; Male; Middle Aged; Time Factors; Tuberculosis, Pulmonary | 1984 |
[Studies on short-course chemotherapy of tuberculosis. II. Liver function during 6-month chemotherapy of tuberculosis with hydrazide, rifampicin and pyrazinamide].
Topics: Humans; Isoniazid; Liver; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1984 |
Management of tuberculosis in elderly persons.
Topics: Aged; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Rifampin; Streptomycin; Tubercul | 1984 |
Mimi, Violetta and the "captain of all the men of death" INH (isoniazid) poisoning.
Topics: Adult; Dose-Response Relationship, Drug; Humans; Isoniazid; Tuberculosis, Pulmonary | 1984 |
Drug treatment of tuberculosis.
Topics: Drug Resistance, Microbial; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1984 |
Hepatotoxicity from isoniazid and rifampin among children treated for tuberculosis.
Topics: Adolescent; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; | 1983 |
Short-course chemotherapy for tuberculosis in children.
Topics: Adolescent; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female | 1983 |
[Changes in the isoniazid inactivation index during antituberculosis treatment in children].
Topics: Adrenal Cortex Hormones; Child; Child, Preschool; Drug Interactions; Drug Therapy, Combination; Eryt | 1983 |
[Rifampin in the treatment of children with newly detected intrathoracic tuberculosis].
Topics: Aminosalicylic Acid; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Isoniazid; | 1984 |
Fatal hepatitis after treatment with isoniazid and rifampicin in a patient on anticonvulsant therapy.
Topics: Anticonvulsants; Chemical and Drug Induced Liver Injury; Drug Interactions; Drug Therapy, Combinatio | 1983 |
Undesirable side effects of isoniazid and rifampin in largely twice-weekly short-course chemotherapy for tuberculosis.
Topics: Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Female; | 1983 |
[Prevention of tuberculosis. Synthesis].
Topics: BCG Vaccine; Humans; Isoniazid; Tuberculosis, Pulmonary | 1983 |
The tolerability and efficacy of a 6-month antituberculosis regimen containing rifampicin, isoniazid and pyrazinamide.
Topics: Adolescent; Adult; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Isoniazid; Male; Middl | 1983 |
[The effect of isoniazid and PAS on various biochemical indices of liver function in patients with tuberculosis].
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Female; Humans; Isoniazid; Liver; Liver Funct | 1983 |
Hyperuricaemia induced by ethambutol.
Topics: Adolescent; Adult; Aged; Child; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambu | 1983 |
[Tuberculin conversion--what to do?].
Topics: Humans; Isoniazid; Tuberculin Test; Tuberculosis, Pulmonary | 1983 |
Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii.
Topics: Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid | 1983 |
[Comparison of 3 6-month chemotherapy regimes in pulmonary tuberculosis in routine practice in Algiers. 18th-month results].
Topics: Adolescent; Adult; Antitubercular Agents; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, | 1983 |
[Value of determining plasma INH during antitubercular treatment. Retrospective analysis of 204 cases].
Topics: Acetylation; Adult; Chemical and Drug Induced Liver Injury; Depression; Female; Humans; Isoniazid; K | 1983 |
[Intravenous injection of isoniazid and PAS twice weekly to outpatients with tuberculosis in rural areas].
Topics: Ambulatory Care; Aminosalicylic Acid; Aminosalicylic Acids; Drug Therapy, Combination; Humans; Injec | 1983 |
[Short-term treatment of tuberculosis with and without pyrazinamide in the second phase (TA-80)].
Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Rifampin; Strepto | 1983 |
[The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].
Topics: Acetylation; Humans; Isoniazid; Tuberculosis, Pulmonary | 1984 |
[Sensitizing effect of rifampicin in combination with isoniazid and streptomycin on microcirculation].
Topics: Adolescent; Adult; Capillaries; Drug Therapy, Combination; Humans; Isoniazid; Male; Middle Aged; Rif | 1984 |
[Evolution of the treatment of tuberculosis].
Topics: Ambulatory Care; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Dr | 1984 |
[Antituberculosis activity today].
Topics: BCG Vaccine; Humans; Isoniazid; Public Health; Risk; Tuberculosis, Pulmonary | 1984 |
[Efficacy of pharmaceutical prevention in population groups at high risk for tuberculosis].
Topics: Adolescent; Child; Humans; Isoniazid; Recurrence; Tuberculosis, Pulmonary | 1984 |
Shortest possible acceptable effective chemotherapy in ambulatory patients with pulmonary tuberculosis. Part II. Results during the 24 months after the end of chemotherapy.
Topics: Ambulatory Care; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Eth | 1984 |
[Effect of ultrasonic aerosols of streptomycin and isoniazid on the bronchial tree of patients with intrathoracic tuberculosis].
Topics: Adolescent; Adult; Aerosols; Aged; Bronchi; Female; Humans; Isoniazid; Male; Middle Aged; Streptomyc | 1984 |
Incidence of isoniazid acetylation phenotypes in North Indians.
Topics: Acetylation; Adult; Aging; Alcohol Drinking; Female; Humans; India; Isoniazid; Kinetics; Male; Middl | 1984 |
[A study on short-course chemotherapy for pulmonary tuberculosis. Initial intensive regimens containing streptomycin].
Topics: Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; F | 1984 |
Long-term effectiveness of intermittent therapy for tuberculosis: final report of three Denver studies.
Topics: Aged; Antitubercular Agents; Colorado; Drug Administration Schedule; Drug Therapy, Combination; Etha | 1980 |
Drug resistance among previously treated tuberculosis patients, a brief report.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Hu | 1980 |
[L-transformation of the mycobacterial population in the process of treating patients with newly detected destructive pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; L Forms; | 1980 |
Short-course treatment regimens for patients with tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Is | 1980 |
Resistant mycobacterium tuberculosis: report of a family in Connecticut.
Topics: Adolescent; Connecticut; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Middle Aged; M | 1980 |
The early bactericidal activity of drugs in patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Therapy, Comb | 1980 |
The early bactericidal activity of drugs in patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Therapy, Comb | 1980 |
The early bactericidal activity of drugs in patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Therapy, Comb | 1980 |
The early bactericidal activity of drugs in patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Therapy, Comb | 1980 |
The early bactericidal activity of drugs in patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Therapy, Comb | 1980 |
The early bactericidal activity of drugs in patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Therapy, Comb | 1980 |
The early bactericidal activity of drugs in patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Therapy, Comb | 1980 |
The early bactericidal activity of drugs in patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Therapy, Comb | 1980 |
The early bactericidal activity of drugs in patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Therapy, Comb | 1980 |
[Therapeutic effects of treatment with RFP on previously treated cases of pulmonary tuberculosis (author's transl)].
Topics: Adult; Aged; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; | 1980 |
Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis.
Topics: Culture Media; Humans; Hydrogen-Ion Concentration; Isoniazid; Mycobacterium tuberculosis; Rifampin; | 1981 |
[The problem of infectiousness of tuberculosis patients during chemotherapy].
Topics: Cycloserine; Drug Resistance, Microbial; Ethambutol; Female; Gastric Juice; Humans; Isoniazid; Male; | 1981 |
[Changes in the primary resistance to Mycobacterium tuberculosis in Piedmont 1965-1979].
Topics: Antibiotics, Antitubercular; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Italy; Kanam | 1981 |
Studies in short-course chemotherapy for tuberculosis. Basis for short-course chemotherapy.
Topics: Animals; Drug Therapy, Combination; Humans; Isoniazid; Mice; Mice, Inbred Strains; Mycobacterium tub | 1981 |
Survey of pulmonary tuberculosis in south and west Wales (1976-8).
Topics: Adolescent; Adult; Aged; Aminosalicylic Acid; Child; Child, Preschool; Drug Administration Schedule; | 1982 |
Cutaneous tuberculosis.
Topics: Adult; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Sputum; Tubercul | 1982 |
The prevalence of tuberculosis and drug resistance among Haitians.
Topics: Adolescent; Adult; Age Factors; Aged; Antitubercular Agents; Child; Child, Preschool; Drug Resistanc | 1982 |
[Significance of the copiousness of bacteria excretion in newly detected patients with destructive pulmonary tuberculosis].
Topics: Drug Resistance, Microbial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculos | 1982 |
Genitourinary tuberculosis.
Topics: Adult; Biopsy; Blood Sedimentation; Endoscopy; Female; Humans; Immunization; Infertility; Isoniazid; | 1982 |
Activity of amikacin against Mycobacteria in vitro and in murine tuberculosis.
Topics: Amikacin; Animals; Female; Isoniazid; Kanamycin; Mice; Mycobacterium; Mycobacterium tuberculosis; No | 1982 |
Sensitivity to streptomycin, isoniazid and para-aminosalicylic acid of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Child; Drug Resistance, Microbial; Female; Hu | 1982 |
[Double antibacterial therapy in untreated tuberculosis. Retrospective study of 120 unselected patients treated between 1972 and 1974].
Topics: Animals; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Ma | 1982 |
[Chemotherapy of tuberculosis--compliance, side effects and incidence of recurrence].
Topics: Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid | 1983 |
Tuberculosis therapy.
Topics: Chemical and Drug Induced Liver Injury; Drug Resistance, Microbial; Drug Therapy, Combination; Human | 1983 |
Incidence of chromosomal aberrations in patients under combined tuberculostatic chemotherapy.
Topics: Antitubercular Agents; Chromosome Aberrations; Drug Therapy, Combination; Ethambutol; Humans; Isonia | 1983 |
[A clinical study on the chemotherapy for pulmonary tuberculosis in diabetics].
Topics: Adult; Aged; Diabetes Complications; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Mid | 1983 |
Short course chemotherapy for tuberculosis: treatment of choice?
Topics: Costs and Cost Analysis; Drug Combinations; Humans; Isoniazid; Patient Compliance; Rifampin; Tubercu | 1983 |
Tuberculosis and its control: lessons to be learned from past experience, and implications for leprosy control programmes.
Topics: Adolescent; Adult; BCG Vaccine; Child; Child, Preschool; Developing Countries; Drug Resistance, Micr | 1983 |
Histamine poisoning on ingestion of tuna fish.
Topics: Adult; Animals; Female; Fish Products; Histamine; Humans; Isoniazid; Middle Aged; Tuberculosis, Pulm | 1983 |
Hepatic complications of antituberculosis therapy revisited.
Topics: Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug Thera | 1983 |
Modern issues in the therapy of tuberculosis.
Topics: Drug Resistance; Female; Humans; Isoniazid; Pregnancy; Pregnancy Complications, Infectious; Rifampin | 1983 |
Chemoprophylaxis of tuberculosis.
Topics: Chemical and Drug Induced Liver Injury; Drug Resistance; Humans; Isoniazid; Risk; Tuberculosis, Pulm | 1983 |
[Results of complex chemotherapy of pulmonary tuberculosis using rapid intravenous injections of isoniazid].
Topics: Adult; Female; Humans; Injections, Intravenous; Isoniazid; Male; Middle Aged; Tuberculosis, Pulmonar | 1983 |
[Rifampicin in the treatment of newly detected adolescent pulmonary tuberculosis patients].
Topics: Adolescent; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; | 1983 |
[Long-term results of an early temporary pneumoperitoneum and chemotherapy in patients with destructive pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Humans; Isoniazid; Pneumoperitoneum, Artificial; Recurrence; Time Factors; Tube | 1983 |
Therapy of tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Child; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis; | 1983 |
Chemoprophylaxis of pulmonary tuberculosis. Current recommendations and controversies.
Topics: Adult; Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Middle Aged; Radiography; Risk; Tu | 1983 |
Chemotherapy for pulmonary tuberculosis. A short-course regimen and its rationale.
Topics: Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Risk; Time Factors; Tuberculosis, Pulmonary; | 1983 |
Chemotherapy of tuberculosis: TB or not TB?
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1981 |
Adverse effects of antituberculosis drugs causing changes in treatment.
Topics: Antitubercular Agents; Humans; Isoniazid; Kanamycin; Pyrazinamide; Rifampin; Streptomycin; Tuberculo | 1982 |
Acute isoniazid poisoning in childhood.
Topics: Adolescent; Child, Preschool; Coma; Female; Humans; Infant; Isoniazid; Male; Paraldehyde; Pyridoxine | 1980 |
[Remote results of the use of short-term artificial pneumothorax and intravenous intermittent chemotherapy in tuberculosis].
Topics: Adolescent; Adult; Aminosalicylic Acid; Aminosalicylic Acids; Child; Drug Therapy, Combination; Fema | 1980 |
Isoniazid-rifampin--induced fulminant liver disease in an infant.
Topics: Chemical and Drug Induced Liver Injury; Humans; Infant; Isoniazid; Male; Rifampin; Tuberculosis, Pul | 1980 |
Hepatotoxicity of rifampicin and isoniazid in children treated for tuberculosis.
Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injur | 1980 |
[Value of the immunological tests in the diagnosis of adverse effects of tuberculostatic therapy].
Topics: Adolescent; Adult; Aminosalicylic Acid; Aminosalicylic Acids; Cell Migration Inhibition; Drug Hypers | 1980 |
Drugs for tuberculosis.
Topics: Adult; Antitubercular Agents; Child; Drug Therapy, Combination; Humans; Infant; Isoniazid; Tuberculo | 1982 |
[Pyridoxine metabolism in pulmonary tuberculosis patients under rifampicin therapy in combination with isoniazid].
Topics: Adolescent; Adult; Aged; Blood Cells; Drug Therapy, Combination; Female; Free Radicals; Humans; Ison | 1982 |
Short-course chemotherapy for tuberculosis.
Topics: Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Self Administr | 1982 |
Cavitary lung infection caused by Mycobacterium flavescens.
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Melanoma; Middle Aged; Mycobacterium | 1982 |
[Dynamics of various immunobiochemical and encephalographic indices during polychemotherapy of pulmonary tuberculosis patients].
Topics: Adolescent; Adult; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Rifampin; | 1982 |
Successful intermittent treatment of smear-positive pulmonary tuberculosis in six months: a cooperative study in Poland.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoniazid; Middle Age | 1982 |
Tuberculous pericarditis developing during chemotherapy.
Topics: Child; Ethambutol; Humans; Isoniazid; Male; Pericarditis, Tuberculous; Prednisone; Rifampin; Strepto | 1982 |
[Duration of the treatment of tuberculosis in 1981].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis, Pulmonar | 1982 |
Tuberculosis: a portal through which to view the future.
Topics: Air Pollution; Attitude of Health Personnel; Bed Rest; Economics, Medical; Humans; Isoniazid; Resear | 1982 |
[Current notes on the clinical aspects of tuberculosis].
Topics: Diagnosis, Differential; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Patient Compli | 1982 |
Short-course chemotherapy for pulmonary tuberculosis. Points of interest.
Topics: Adult; Ambulatory Care; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; F | 1982 |
The role of low dosage prothionamide with and without 4,4'-diamino diphenyl sulphone for use with isoniazid in the treatment of experimental mouse tuberculosis.
Topics: Animals; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Isoniazid; Isonic | 1982 |
[Chemotherapy effectiveness in destructive pulmonary tuberculosis in the middle-aged and elderly using different methods of administering the preparations].
Topics: Aged; Aminosalicylic Acid; Antitubercular Agents; Chronic Disease; Drug Evaluation; Ethionamide; Fem | 1982 |
[Incidence of hepatotoxic side effects during antituberculous therapy (INH, RMP, EMB) in relation to the acetylator phenotype (author's transl)].
Topics: Acetylation; Chemical and Drug Induced Liver Injury; Ethambutol; Humans; Isoniazid; Phenotype; Rifam | 1982 |
[Prevention, detection and treatment of pulmonary tuberculosis].
Topics: Antitubercular Agents; Humans; Isoniazid; Switzerland; Tuberculosis, Pulmonary | 1982 |
Effect of rifampicin and isoniazid on vitamin D metabolism.
Topics: Adult; Aged; Antipyrine; Calcium; Drug Interactions; Female; Humans; Isoniazid; Kinetics; Male; Midd | 1982 |
Pulmonary disease due to Mycobacterium xenopi. Report of two cases.
Topics: Aged; Alcoholism; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycob | 1982 |
Antituberculosis drug levels after jejunoileal bypass.
Topics: Antitubercular Agents; Ethambutol; Female; Humans; Ileum; Isoniazid; Jejunum; Middle Aged; Obesity; | 1982 |
Modern treatment of tuberculosis.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combi | 1982 |
Determination of rifampicin, desacetylrifampicin, isoniazid and acetylisoniazid by high-performance liquid chromatography: application to human serum extracts, polymorphonucleocytes and alveolar macrophages.
Topics: Chromatography, High Pressure Liquid; Humans; Isoniazid; Macrophages; Neutrophils; Rifampin; Tubercu | 1982 |
[Microbiological evaluation of the abacillary state in the combined therapy of destructive pulmonary tuberculosis in experimental animals].
Topics: Aminosalicylic Acid; Animals; Dogs; Drug Therapy, Combination; Isoniazid; Lung; Lymph Nodes; Rifampi | 1982 |
[Chemotherapy in combination with the rapid intravenous administration of isoniazid in pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Evaluation; Drug Therapy, Combination; Female; | 1982 |
[Clinical description of the relapse of tuberculosis].
Topics: Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Middle Aged; Recurrence; Rifampin; Time | 1982 |
[Acetylation phenotype of isoniazid in Morocco. Preliminary study of 100 cases].
Topics: Acetylation; Drug Tolerance; Humans; Isoniazid; Morocco; Phenotype; Time Factors; Tuberculosis, Pulm | 1982 |
[Mycobacterium malmoense in the Federal Republic of Germany].
Topics: Aged; Agglutination Tests; Amides; Germany, West; Humans; Hydrolases; Isoniazid; Lipids; Male; Middl | 1982 |
[Concentration of streptomycin and isoniazid in the blood of patients over 50 with pulmonary tuberculosis after administration of the drugs in ultrasonic aerosols].
Topics: Aerosols; Age Factors; Aged; Humans; Isoniazid; Middle Aged; Streptomycin; Tuberculosis, Pulmonary; | 1982 |
[Simultaneous study of the induction effect of rifampicin and the phenotype for acetylation of isoniazid in 21 patients with tuberculosis undergoing a combination treatment].
Topics: Acetylation; Acetyltransferases; Adult; Aged; Drug Therapy, Combination; Enzyme Induction; Ethambuto | 1980 |
Histamine poisoning in tuberculous patients after ingestion of tuna fish.
Topics: Adult; Animals; Drug Interactions; Female; Fishes; Foodborne Diseases; Histamine; Humans; Isoniazid; | 1980 |
[Urinary excretion of blastomogenic tryptophan metabolites in tubazide- and phthivazid-treated patients].
Topics: Carcinogens; Drug Evaluation; Humans; Isoniazid; Pyridoxine; Thiamine; Time Factors; Tryptophan; Tub | 1981 |
Isoniazid phenotyping in Munda and Oraon tribes of Chhotanagpur division suffering from pulmonary tuberculosis by sulphadimidine acetylation test.
Topics: Acetylation; Female; Humans; India; Isoniazid; Male; Phenotype; Sulfamethazine; Tuberculosis, Pulmon | 1980 |
[Short-course chemotherapy for pulmonary tuberculosis. 1. Clinical effect of RFP, INH and EB regimen for 9 months in the original treatment for pulmonary tuberculosis (author's transl)].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Evaluation; Drug Therapy, Combination; Ethamb | 1980 |
[ Effectiveness of treating newly detected tuberculosis without seasonal prophylactic chemotherapy].
Topics: Adolescent; Adult; Aged; Aminosalicylic Acid; Child; Drug Therapy, Combination; Female; Follow-Up St | 1980 |
[Short-term intensive therapy of destructive pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Animals; Antitubercular Agents; Dogs; Drug Administration Schedule; Drug Therap | 1980 |
[Rapid intravenous injections of an isoniazid solution in the combination treatment of pulmonary tuberculosis].
Topics: Adult; Aged; Humans; Injections, Intravenous; Isoniazid; Male; Middle Aged; Solutions; Time Factors; | 1981 |
[Active fraction of isonicotinic acid hydrazide in the blood of tuberculosis patients during its combined use with PAS].
Topics: Adolescent; Adult; Aged; Aminosalicylic Acid; Aminosalicylic Acids; Drug Therapy, Combination; Femal | 1981 |
Plasma concentrations of isoniazid in children with tuberculous infections.
Topics: Administration, Oral; Adolescent; Adult; Child; Child, Preschool; Drug Therapy, Combination; Female; | 1981 |
Nosocomial tuberculosis in physicians: an analysis of direct costs of prevention and disease.
Topics: Adult; BCG Vaccine; Costs and Cost Analysis; Cross Infection; Humans; Isoniazid; Physicians; Tubercu | 1981 |
The hepatotoxicity of isoniazid among the three acetylator phenotypes.
Topics: Acetylation; Adult; Alanine Transaminase; Chemical and Drug Induced Liver Injury; Humans; Isoniazid; | 1981 |
Tuberculosis among elderly persons: an outbreak in a nursing home.
Topics: Aged; Arkansas; Carrier State; Disease Outbreaks; Female; Humans; Isoniazid; Male; Nursing Homes; Tu | 1981 |
Combined action of isoniazid and para-aminosalicylic acid in vivo on human chromosomes in lymphocyte cultures.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cells, Cultured; Chromosome Aberrations; Chromosomes; Dru | 1981 |
[Intensive antibacterial therapy of postoperative reactivation of pulmonary tuberculosis].
Topics: Adult; Female; Humans; Isoniazid; Lung; Male; Middle Aged; Postoperative Complications; Powders; Pun | 1981 |
[Reparative processes during treatment of destructive pulmonary tuberculosis by maximum drug concentrations].
Topics: Animals; Antitubercular Agents; Dogs; Isoniazid; Lung; Prednisolone; Rifampin; Streptomycin; Tubercu | 1981 |
[Liver damage from tuberculosis treatment].
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Ethambutol; Humans; Isoniazid; Liver; | 1981 |
[Remote results of short-term treatment of pulmonary tuberculosis with a combination of isoniazid, rifampin and ethambutol].
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; I | 1980 |
[Results of treatment of newly detected pulmonary tuberculosis with rifampin combined with isoniazid and ethambutol].
Topics: Adult; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Mi | 1980 |
[Blood coagulation state in destructive pulmonary tuberculosis patients under different methods of chemotherapy].
Topics: Adolescent; Adult; Antitubercular Agents; Blood Coagulation; Drug Therapy, Combination; Female; Huma | 1981 |
[Ways of increasing chemotherapy effectiveness in pulmonary tuberculosis].
Topics: Adolescent; Adult; Antitubercular Agents; Drug Evaluation; Ethambutol; Female; Humans; Isoniazid; Ma | 1981 |
Pulmonary actinomycosis. Rapid improvement with isoniazid and rifampin.
Topics: Actinomycosis; Adult; Diagnosis, Differential; Humans; Isoniazid; Lung Diseases; Male; Rifampin; Tub | 1981 |
Clinical experience with isobutol: a new molecular combination of ethambutol-INH.
Topics: Adolescent; Adult; Drug Combinations; Drug Evaluation; Ethambutol; Female; Humans; Isoniazid; Male; | 1981 |
Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity.
Topics: Acetylation; Adult; Antipyrine; Calcium; Humans; Isoniazid; Kidney; Liver; Male; Mixed Function Oxyg | 1981 |
Short course chemotherapy for tuberculosis.
Topics: Costs and Cost Analysis; Drug Therapy, Combination; Humans; Isoniazid; Patient Compliance; Rifampin; | 1981 |
Shortest possible acceptable, effective ambulatory chemotherapy in pulmonary tuberculosis: preliminary report I.
Topics: Ambulatory Care; Antitubercular Agents; Drug Administration Schedule; Ethionamide; Female; Humans; I | 1981 |
Short-course (6-month) cooperative tuberculosis study in Poland: results 30 months after completion of treatment.
Topics: Adolescent; Adult; Aged; Drug Administration Schedule; Ethambutol; Female; Humans; Isoniazid; Male; | 1981 |
Tuberculosis prophylaxis with isoniazid.
Topics: Adult; Humans; Isoniazid; Tuberculosis, Pulmonary | 1981 |
Isoniazid-rifampin regimens for tuberculosis.
Topics: Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1981 |
[Problems in treatment of pulmonary tuberculosis: in terms of bacteriologic relapse (author's transl)].
Topics: Drug Therapy, Combination; Humans; Isoniazid; Recurrence; Rifampin; Tuberculosis, Pulmonary | 1980 |
[Kinetics of isoniazid metabolism after intravenous administration].
Topics: Animals; Biological Availability; Dogs; Humans; Injections, Intravenous; Isoniazid; Kinetics; Metabo | 1981 |
[Pharmacokinetic characteristics of streptomycin and isoniazid administered in ultrasonic aerosols to patients with respiratory organ tuberculosis].
Topics: Aerosols; Humans; Isoniazid; Kinetics; Lung; Streptomycin; Time Factors; Tuberculosis, Pulmonary; Ul | 1981 |
Tuberculosis surveillance of hospital personnel.
Topics: Adolescent; Adult; Female; Humans; Isoniazid; Male; Middle Aged; Ohio; Personnel, Hospital; Populati | 1981 |
[Use of steroid preparations in the combined treatment of destructive pulmonary tuberculosis].
Topics: Anabolic Agents; Animals; Drug Evaluation; Drug Therapy, Combination; Guinea Pigs; Humans; Isoniazid | 1981 |
Preliminary results of six-month regimens studied in the United States and in Poland.
Topics: Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; D | 1981 |
Isoniazid toxicity. Pyridoxine controlled seizures in a dialysis patient.
Topics: Female; Humans; Isoniazid; Middle Aged; Pyridoxine; Renal Dialysis; Seizures; Tuberculosis, Pulmonar | 1981 |
[Isoniazid pharmacokinetics in the combined chemotherapy of tuberculosis].
Topics: Antitubercular Agents; Drug Interactions; Drug Therapy, Combination; Humans; Isoniazid; Kinetics; Ti | 1981 |
Treatment of pulmonary infections caused by mycobacteria of the Mycobacterium avium-intracellulare complex.
Topics: Adult; Aged; Aminosalicylic Acid; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; | 1981 |
[The pharmacokinetics of isoniazid in children (author's transl)].
Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; Drug Administration Schedule; Female; Half- | 1981 |
[Histological characteristics of tuberculous cavity treated with rifampicin--a comparative study with cases treated by primary drugs (author's transl)].
Topics: Adolescent; Adult; Aminosalicylic Acid; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Stre | 1981 |
[Hydrazide-rifampicin: hepatotoxicity in children].
Topics: Chemical and Drug Induced Liver Injury; Child; Drug Therapy, Combination; Female; Humans; Isoniazid; | 1981 |
[Light and electron microscopy studies of the liver in tuberculosis patients receiving rifampin and isoniazid].
Topics: Drug Therapy, Combination; Humans; Isoniazid; Liver; Rifampin; Tuberculosis, Pulmonary | 1981 |
[Rate of acetylation of isoniazid in pulmonary tuberculosis and its relationship with effect and side-effects of treatment (author's transl)].
Topics: Acetylation; Adolescent; Adult; Female; Humans; Isoniazid; Male; Middle Aged; Tuberculosis, Pulmonar | 1981 |
Nontuberculous mycobacterial endobronchitis in children.
Topics: Bronchitis; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Isoniazid; Male; My | 1980 |
Tuberculosis in the elderly: treating the "white plague".
Topics: Adolescent; Adult; Age Factors; Aged; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, | 1980 |
Short-course chemotherapy for tuberculosis with largely twice weekly isoniazid-rifampin.
Topics: Drug Administration Schedule; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1980 |
Rifampin and AFB: yes or no?
Topics: Drug Therapy, Combination; Gram-Negative Anaerobic Bacteria; Humans; Isoniazid; Rifampin; Tuberculos | 1980 |
Congenital miliary tuberculosis proved by open lung biopsy specimen and successfully treated.
Topics: Biopsy; Female; Humans; Infant, Newborn; Isoniazid; Lung; Male; Pregnancy; Pregnancy Complications, | 1980 |
Isoniazid toxicity and pyridoxine.
Topics: Drug Therapy, Combination; Humans; Isoniazid; Psychoses, Substance-Induced; Pyridoxine; Tuberculosis | 1980 |
[Rapid intravenous administration of isoniazid in treating newly detected destructive pulmonary tuberculosis].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aminosalicylic Acid; Drug Therapy, Combination; Evalu | 1980 |
[Patterns of the healing processes of the tuberculotic lung cavern].
Topics: Animals; Dogs; Isoniazid; Pyridoxine; Rifampin; Time Factors; Tuberculosis, Pulmonary; Wound Healing | 1980 |
Tuberculosis therapy and enzyme induction in man.
Topics: Acetylation; Adult; Aged; Antipyrine; Antitubercular Agents; Enzyme Induction; Ethambutol; Female; H | 1980 |
[Fibrosis formation in the lungs in tuberculosis during chemotherapy].
Topics: Adult; Antitubercular Agents; Female; Humans; Isoniazid; Male; Pulmonary Fibrosis; Radiography; Time | 1980 |
Neutropenia with each standard antituberculosis drug in the same patient.
Topics: Aged; Agranulocytosis; Antibiotics, Antitubercular; Ethambutol; Humans; Isoniazid; Leukocyte Count; | 1980 |
Tuberculosis in patients having dialysis.
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Renal Dialysis; Streptomycin; Tuberculosis | 1980 |
Tuberculosis in patients having dialysis.
Topics: Ethambutol; Half-Life; Humans; Isoniazid; Kidney Failure, Chronic; Renal Dialysis; Streptomycin; Tub | 1980 |
[Pulmonary tuberculosis in 3 Swedish children].
Topics: Adolescent; Child; Child, Preschool; Ethambutol; Female; Humans; Isoniazid; Male; Radiography; Rifam | 1980 |
[Effectiveness of chemotherapy of chronic forms of pulmonary tuberculosis under hospital conditions].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Ethambutol; Follow-Up Studies; Hospitalization; Huma | 1980 |
Preventing chemotherapy for tuberculosis: a good thing overdone?
Topics: Aged; Child; Female; Humans; Isoniazid; Male; Tuberculin Test; Tuberculosis, Pulmonary | 1980 |
[Acute liver insufficiency caused by rifampicin-isoniazid].
Topics: Child; Hepatic Encephalopathy; Humans; Isoniazid; Male; Rifampin; Tuberculosis, Pulmonary | 1980 |
[Rifampicin and isoniazid concentration in the blood and resected lungs in tuberculosis with combined use of the preparations].
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Humans; Isoniazid; Lung; Middle Aged; Pneumonect | 1980 |
Monitoring regularity of drug intake in tuberculous patients by means of simple urine tests.
Topics: Color; Drug Administration Schedule; Humans; Isoniazid; Patient Compliance; Pyrazinamide; Rifampin; | 1980 |
Late effects following isoniazid therapy.
Topics: Adolescent; Adult; Female; Follow-Up Studies; Humans; Isoniazid; Liver Cirrhosis; Neoplasms; Time Fa | 1980 |
Short-course chemotherapy with isoniazid and rifampin.
Topics: Adult; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Tubercu | 1980 |
An advance in treatment of tuberculosis.
Topics: Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Tuberculosis, | 1980 |
[Principles of rational tuberculosis chemotherapy].
Topics: Aminosalicylic Acid; Animals; Antitubercular Agents; Drug Evaluation; Drug Evaluation, Preclinical; | 1980 |
[A case of acute hepatitis occurred during treatment with isoniazid and rifampicin (author's transl)].
Topics: Acute Disease; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Humans; Isoniazid; | 1980 |
[New aspects of chemotherapy of tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Prothionamide; Rifa | 1980 |
[Tracheobronchial administration of isoniazid after preliminary inhalation anesthesia].
Topics: Anesthesia, Inhalation; Biological Availability; Bronchi; Humans; Isoniazid; Trachea; Tuberculosis, | 1980 |
[Experimental study of therapeutic effect of various antibacterial drug combinations].
Topics: Animals; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Guinea Pigs | 1980 |
[Liposomes as vehicles of antitubercular drugs - a new appraoch to experimental chemotherapy of tuberculosis].
Topics: Animals; Biological Availability; Half-Life; Injections, Intravenous; Isoniazid; Liposomes; Mice; Tu | 1980 |
Isoniazid preventive therapy: Retrospect and prospect.
Topics: Adolescent; Adult; Age Factors; Aged; Chemical and Drug Induced Liver Injury; Child; Child, Preschoo | 1980 |
A service program of antituberculosis chemotherapy with five drugs for four months in the treatment of drug addicts and prisoners with pulmonary tuberculosis in Hong Kong. Hong Kong Chest Service/British Medical Research Council.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Ethambutol; Heroin | 1980 |
Controlled double-blind study of the effect of rifampin on humoral and cellular immune responses in patients with pulmonary tuberculosis and in tuberculosis contacts.
Topics: Adolescent; Adult; Antibody Formation; Double-Blind Method; Female; Humans; Immunity, Cellular; Ison | 1980 |
Clinical approach to the choice of antimicrobial therapy, case #20, Part B: Fever in pregnancy.
Topics: Adult; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Pregnancy; Pregnancy Complications, Infec | 1980 |
[Report on 13 cases (including 3 deaths) of liver damage induced by rifampicin (author's transl)].
Topics: Adult; Chemical and Drug Induced Liver Injury; Child, Preschool; Dose-Response Relationship, Drug; F | 1980 |
[Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Drug Hypersensitivity; | 1980 |
[Side effect of isoniazid on the central nervous system].
Topics: Aged; Humans; Isoniazid; Male; Parkinson Disease, Secondary; Tuberculosis, Pulmonary | 1980 |
Short course chemotherapy.
Topics: Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1980 |
Fever response of patients on therapy for pulmonary tuberculosis.
Topics: Alcoholism; Antitubercular Agents; Bacterial Infections; Drug Therapy, Combination; Ethambutol; Fema | 1981 |
Tuberculosis in chronic renal failure.
Topics: Humans; Isoniazid; Kidney Failure, Chronic; Tuberculosis, Pulmonary | 1980 |
Tuberculous meningitis developing during course of chemotherapy for tuberculosis including isoniazid--report of two cases.
Topics: Adult; Antitubercular Agents; Female; Humans; Isoniazid; Male; Tuberculosis, Meningeal; Tuberculosis | 1980 |
[Isoprodian in ambulatory therapy of pulmonary tuberculosis].
Topics: Adult; Ambulatory Care; Dapsone; Drug Combinations; Female; Humans; Isoniazid; Isonicotinic Acids; M | 1980 |
Short-course chemotherapy for tuberculosis.
Topics: Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1981 |
Hepatotoxicity from isoniazid and rifampin in inner-city AIDS patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Alanine Transaminase; Alcoholism; Antitubercular Agent | 1995 |
Isoniazid preventive therapy for pulmonary tuberculosis sequelae: which patients up to which age?
Topics: Adult; Age Factors; Aged; Antitubercular Agents; Decision Support Techniques; Humans; Incidence; Iso | 1995 |
Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis.
Topics: Acetaminophen; Adult; Capreomycin; Ciprofloxacin; Drug Combinations; Drug Overdose; Ethambutol; Fema | 1994 |
Recurrent acute pancreatitis induced by isoniazid.
Topics: Acute Disease; Adult; Amylases; Humans; Isoniazid; Male; Pancreatitis; Recurrence; Tuberculosis, Pul | 1994 |
Oxidative stress during antituberculous therapy in young and elderly patients.
Topics: Adult; Age Factors; Aged; Allantoin; Antitubercular Agents; Drug Therapy, Combination; Female; Human | 1995 |
[Biological properties of Mycobacterium tuberculosis in relation to sensitivity to antibacterial preparations].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; | 1995 |
Aging and hepatotoxicity of isoniazid and rifampin in pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Alanine Transaminase; Aspartate Aminotransferases | 1995 |
Relapse rates in tuberculosis patients.
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; | 1995 |
Guidelines for treatment and prevention of TB.
Topics: Humans; Isoniazid; Practice Guidelines as Topic; Tuberculin Test; Tuberculosis, Pulmonary | 1995 |
Drugs for tuberculosis.
Topics: Adult; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Combinations; Ethambutol; Hum | 1995 |
[Analysis of restriction fragment length polymorphism (RFLP) in epidemiology of tuberculosis].
Topics: Antitubercular Agents; Bacteriological Techniques; Colombia; Drug Resistance, Microbial; Ethambutol; | 1995 |
Tuberculosis chemoprophylaxis and physicians.
Topics: Aged; Attitude of Health Personnel; Chemical and Drug Induced Liver Injury; Drug Utilization; Female | 1995 |
Underutilization of isoniazid chemoprophylaxis in tuberculosis contacts 50 years of age and older. A prospective analysis.
Topics: Age Distribution; Age Factors; Chemical and Drug Induced Liver Injury; Drug Utilization; Female; Hum | 1995 |
[Pathogenesis and control of tuberculosis in the era of AIDS].
Topics: Acquired Immunodeficiency Syndrome; Humans; Isoniazid; Microbial Sensitivity Tests; Rifampin; Strept | 1994 |
Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Base Sequence; DNA, Bacterial; Drug Resistance, Microb | 1995 |
[Changes in the granuloma in the experimental treatment of tuberculosis with a prolonged form of isoniazid].
Topics: Animals; Chronic Disease; Delayed-Action Preparations; Dextrans; Disease Models, Animal; Drug Combin | 1993 |
Mycobacterial testing in clinical laboratories that participate in the College of American Pathologists' Mycobacteriology E survey: results of a 1993 questionnaire.
Topics: Centers for Disease Control and Prevention, U.S.; Drug Resistance, Multiple; Humans; Isoniazid; Labo | 1995 |
Short-course chemotherapy for tuberculous pleural effusion and culture-negative pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Fe | 1995 |
Silicotuberculosis: long-term outcome after short-course chemotherapy.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoniazid; Male; | 1995 |
Antituberculous therapy and acute liver function.
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Hong Kong; Humans; Isoni | 1995 |
Acute isoniazid neurotoxicity in an urban hospital.
Topics: Acute Disease; Adolescent; Child; Female; Humans; Infant, Newborn; Infusions, Intravenous; Isoniazid | 1995 |
[Ofloxacin-cycloserine-protionamide-INH combination against treatment refractory lung tuberculosis].
Topics: Adult; AIDS-Related Opportunistic Infections; Cycloserine; Dose-Response Relationship, Drug; Drug Ad | 1995 |
Isoniazid chemoprophylaxis for dual HIV-TB infection: a cautionary tale.
Topics: Adult; AIDS-Related Opportunistic Infections; Homosexuality, Male; Humans; Isoniazid; Male; Risk Fac | 1995 |
Community infection ratio as indicator for tuberculosis control.
Topics: BCG Vaccine; Child; Community-Acquired Infections; Humans; Isoniazid; Peru; Tuberculin Test; Tubercu | 1995 |
[Therapy of tuberculosis in the adult].
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Dose-Response Relationship, Dru | 1995 |
[Effectiveness of isoniazid in tuberculosis chemoprophylaxis in children with rising tuberculin sensitivity].
Topics: Adolescent; Age Factors; Child; Child, Preschool; Female; Humans; Isoniazid; Male; Time Factors; Tub | 1995 |
BCG vaccination status of children with tuberculous meningitis and the use of unsupervised isoniazid prophylaxis.
Topics: Adult; BCG Vaccine; Child; Child, Preschool; Humans; Infant; Isoniazid; Tuberculosis, Meningeal; Tub | 1995 |
Replacement of one lung by a large bulla in active tuberculosis.
Topics: Aged; Drug Therapy, Combination; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Pulm | 1995 |
Antituberculous therapy and acute liver function.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Isoniazid; L | 1995 |
Anti-tuberculous therapy and acute liver failure.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Female; Hepatic Encephalopathy; Humans; Imm | 1995 |
Catalase expression, katG, and MIC of isoniazid for Mycobacterium tuberculosis isolates from São Paulo, Brazil.
Topics: Bacterial Proteins; Base Sequence; Blotting, Southern; Brazil; Catalase; DNA Primers; Drug Resistanc | 1995 |
Rapid identification of a point mutation of the Mycobacterium tuberculosis catalase-peroxidase (katG) gene associated with isoniazid resistance.
Topics: Bacterial Proteins; Base Sequence; Catalase; DNA Primers; Drug Resistance, Microbial; Genes, Bacteri | 1995 |
Crescentic fibrillary glomerulonephritis associated with intermittent rifampin therapy for pulmonary tuberculosis.
Topics: Acute Kidney Injury; Adult; Biopsy; Drug Therapy, Combination; Glomerulonephritis; Humans; Isoniazid | 1994 |
Acute tubular necrosis following endosulphan insecticide poisoning.
Topics: Aged; Anti-Bacterial Agents; Endosulfan; Fatal Outcome; Humans; Isoniazid; Kidney Tubular Necrosis, | 1995 |
High initial and acquired drug resistance in pulmonary tuberculosis in Turkey.
Topics: Adolescent; Adult; Age Distribution; Aged; Antitubercular Agents; Child; Drug Resistance, Microbial; | 1994 |
[Pulmonary tuberculosis in infants. Apropos of 6 cases].
Topics: BCG Vaccine; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Pyrazin | 1994 |
Rifampin-induced severe thrombocytopenia in a patient with pulmonary tuberculosis.
Topics: Adult; Drug Administration Schedule; Ethambutol; Humans; Isoniazid; Male; Rifampin; Thrombocytopenia | 1994 |
The downside of isoniazid chemoprophylaxis.
Topics: Child; Developing Countries; Humans; Isoniazid; Tuberculosis, Pulmonary | 1995 |
Cytogenetic study of tuberculosis patients before and after tuberculostatic drug treatment.
Topics: Adult; Antitubercular Agents; Cell Division; Chromosome Aberrations; Drug Combinations; Female; Huma | 1995 |
Isoniazid is not always the cause of hepatitis during treatment of tuberculosis.
Topics: Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Tubercul | 1994 |
[Compliance of asylum seekers with an expanded border health screening program in the Basel-Stadt canton 1992-1993].
Topics: Adolescent; Adult; BCG Vaccine; Child; Hepatitis B Core Antigens; Humans; Immunization; Isoniazid; M | 1994 |
4-, 5- and 6-month regimens containing isoniazid, rifampicin, pyrazinamide and streptomycin for treatment of pulmonary tuberculosis under program conditions in Hong Kong.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; F | 1994 |
Screening and treatment of tuberculosis in a methadone maintenance treatment program.
Topics: Adult; AIDS-Related Opportunistic Infections; Comorbidity; Female; Heroin Dependence; Humans; Isonia | 1994 |
[Possibilities and prospects of intravascular irradiation of blood by helium-neon laser in patients with pulmonary tuberculosis].
Topics: Adolescent; Adult; Blood; Female; Humans; Isoniazid; Lasers; Liver; Male; Middle Aged; Mycobacterium | 1993 |
[Use of levamisole electrophoresis in chemical prophylaxis in adolescents with a change in tuberculin reaction].
Topics: Adolescent; Female; Humans; Iontophoresis; Isoniazid; Levamisole; Male; Time Factors; Tuberculin; Tu | 1993 |
TB treatment: yesterday, today and ... tomorrow.
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tub | 1994 |
Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Clinical Pro | 1994 |
[Two pulmonary tuberculosis cases with HIV infection].
Topics: Adult; Female; HIV Infections; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Streptomycin; Tuberc | 1994 |
Clinical features, diagnosis, and treatment of tuberculosis in infants.
Topics: Drug Therapy, Combination; Female; Humans; Infant; Isoniazid; Male; Mycobacterium tuberculosis; Pyra | 1994 |
Superinfection with rifampin-isoniazid-streptomycin-ethambutol (RISE)-resistant tuberculosis in three patients with AIDS: confirmation by polymerase chain reaction fingerprinting.
Topics: Adult; AIDS-Related Opportunistic Infections; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacte | 1994 |
Human immunodeficiency virus type-1 infection in Zambian children with tuberculosis: changing seroprevalence and evaluation of a thioacetazone-free regimen.
Topics: Adolescent; Child; Child, Preschool; Drug Hypersensitivity; Drug Therapy, Combination; Female; HIV I | 1994 |
Tuberculosis preventive therapy in HIV-infected individuals. A joint statement of the International Union Against Tuberculosis and Lung Disease (IUATLD) and the Global Programme on AIDS and the Tuberculosis Programme of the World Health Organization (WHO)
Topics: Contraindications; Hepatitis, Chronic; HIV Infections; Humans; Isoniazid; Tuberculin Test; Tuberculo | 1994 |
[Mechanisms of anti-inflammatory activity of antioxidants in lung tuberculosis].
Topics: 11-Hydroxycorticosteroids; Animals; Butylated Hydroxytoluene; Drug Therapy, Combination; Isoniazid; | 1994 |
Tuberculosis prophylaxis in HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Child; Drug Therapy, Combination; Humans; Isoniazid; P | 1993 |
Pulmonary tuberculosis or MOTT infection in kidney transplant recipients.
Topics: Adult; Cyclosporine; Ethambutol; Humans; Isoniazid; Kidney Transplantation; Mycobacterium Infections | 1994 |
Tuberculosis in renal transplant recipients.
Topics: Adult; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Kidney Transplantation; Lymph Nodes | 1994 |
Toxic optic neuropathy associated with ethambutol: implications for current therapy.
Topics: Blindness; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Optic Nerve Diseases; Tuberculosis, Pul | 1994 |
Follow-up of tuberculosis patients undergoing standard anti-tuberculosis chemotherapy by using a polymerase chain reaction.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoniazid; Mycobacteriu | 1994 |
Characteristics of patients with drug resistant and drug sensitive tuberculosis in East London between 1984 and 1992.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; Isoniazid; London; Lung; Male; Middle Ag | 1994 |
Tuberculosis and HIV infection.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; CD4-Positive T-Lymphocyte | 1993 |
Serum concentrations of rifampicin and isoniazid in tuberculosis.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Half-Life; Humans; Infant; I | 1993 |
An outbreak of tuberculosis in a captive herd of Arabian oryx (Oryx leucoryx): management.
Topics: Animals; Antelopes; Disease Outbreaks; Ethambutol; Female; Isoniazid; Male; Pregnancy; Rifampin; Sau | 1994 |
An epidemic of tuberculosis in an elementary school, Sanremo, Italy, 1993.
Topics: Adult; Child; Contact Tracing; Disease Outbreaks; Drug Therapy, Combination; Epidemiologic Methods; | 1994 |
Treatment of tuberculosis in patients with pre-existing liver disease or following hepatotoxic drug reactions.
Topics: Chemical and Drug Induced Liver Injury; Clinical Protocols; Contraindications; Humans; Isoniazid; Li | 1993 |
[A tuberculosis epidemic in one kindergarten].
Topics: Adult; BCG Vaccine; Child; Disease Outbreaks; Female; Humans; Isoniazid; Japan; Male; Schools, Nurse | 1993 |
The third epidemic--multidrug-resistant tuberculosis.
Topics: Adult; Age Factors; Comorbidity; Disease Outbreaks; Drug Resistance, Microbial; Ethambutol; Female; | 1994 |
[The microbiological diagnosis of tuberculosis in areas under strict radiation control].
Topics: Air Pollution, Radioactive; Animals; Bronchoalveolar Lavage Fluid; Drug Resistance, Microbial; Guine | 1993 |
Tuberculosis preventive therapy in HIV-infected individuals. A Joint Statement of the WHO Tuberculosis Programme and the Global Programme on AIDS, and the International Union Against Tuberculosis and Lung Disease (IUATLD).
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Child, Preschool; | 1993 |
[Clinical aspects and outcome of recurrent pulmonary tuberculosis].
Topics: Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; R | 1993 |
Chemotherapy of tuberculosis for patients with renal impairment.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Kidney Failure, Chronic; Pyrazinamide; Rifampi | 1993 |
Drug susceptibility in Mycobacterium tuberculosis of a sample of patients in Guinea Bissau.
Topics: Drug Resistance, Microbial; Ethambutol; Guinea-Bissau; Humans; In Vitro Techniques; Isoniazid; Mycob | 1993 |
Cost-effectiveness analysis of three short-course anti-tuberculosis programmes compared with a standard regimen in Thailand.
Topics: Adolescent; Adult; Antitubercular Agents; Cost-Benefit Analysis; Drug Administration Schedule; Femal | 1993 |
Antituberculous drugs in kidney transplant recipients treated with cyclosporine.
Topics: Aged; Antitubercular Agents; Cyclosporine; Drug Interactions; Ethambutol; Humans; Isoniazid; Kidney | 1993 |
A study of primary drug resistance in pulmonary tuberculosis in west Malaysia 1984-1987.
Topics: Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Malaysia; Microbial Sensitivity Tests; My | 1993 |
[Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin)].
Topics: Benin; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium; Rifampin; Streptomy | 1993 |
[Retreatment of pulmonary tuberculosis--duration of chemotherapy].
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Drug Resistance; Female; Follow-Up Studies; | 1993 |
Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Administration Schedule; Dru | 1993 |
[Testing for heterogeneity in genetic polymorphism of N-acetylation using isoniazid by metameters--probit, logit, and arcsine transformation].
Topics: Acetylation; Adolescent; Adult; Aged; Aged, 80 and over; Data Interpretation, Statistical; Female; H | 1993 |
The emergence of drug-resistant tuberculosis in New York City.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Antitubercular Agents; Centers for Disease Co | 1993 |
CDC recommends four-drug treatment of tuberculosis in multidrug-resistant era.
Topics: Adult; Centers for Disease Control and Prevention, U.S.; Child; Drug Therapy; Drug Therapy, Combinat | 1993 |
Prevalence of initial drug resistance in tuberculosis patients attending a chest hospital.
Topics: Adolescent; Adult; Drug Resistance; Ethambutol; Female; Hospitals, Special; Humans; India; Isoniazid | 1993 |
No role for short term tuberculosis chemoprophylaxis for travellers.
Topics: AIDS-Related Opportunistic Infections; Humans; Isoniazid; Travel; Tuberculosis, Multidrug-Resistant; | 1993 |
Preventive therapy for the patient with both universal indication and contraindication for isoniazid.
Topics: Adult; Contraindications; Delphi Technique; Drug Therapy, Combination; Ethambutol; Female; Hepatic E | 1993 |
Intracellular levels and extracellular release of lysosomal enzymes from peripheral blood monocytes in pulmonary tuberculosis patients.
Topics: Acetylglucosaminidase; Adolescent; Drug Therapy, Combination; Ethambutol; Female; Glucuronidase; Hum | 1993 |
Reversible seizures and mental status changes in a dialysis patient on isoniazid preventive therapy.
Topics: Aged; Confusion; Female; Humans; Isoniazid; Peritoneal Dialysis, Continuous Ambulatory; Pyridoxine; | 1993 |
Utilization of antituberculosis drugs expressed in defined daily doses in Klenovnik Hospital in the period between 1983 and 1987.
Topics: Antitubercular Agents; Croatia; Drug Therapy, Combination; Drug Utilization; Ethambutol; Hospitals, | 1993 |
Bacteriological investigations for short-course chemotherapy under the tuberculosis programme in two districts of India.
Topics: Adolescent; Adult; Aged; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Isoniazid; M | 1993 |
[Multiresistant tuberculosis].
Topics: Humans; Isoniazid; Male; Nicotine; Smoking; Tuberculosis, Pulmonary | 1993 |
Increased insulin requirement in a patient with type 1 diabetes on rifampicin.
Topics: Blood Glucose; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Humans; Insulin; Isonia | 1993 |
[Morphological features of tissue reactions in combined treatment of experimental tuberculosis induced by xenobiotics].
Topics: Animals; Drug Therapy, Combination; Guinea Pigs; Isoniazid; Polycyclic Compounds; Sodium Glutamate; | 1995 |
A clinical and pharmacokinetic case study of an interaction of levodopa and antituberculous therapy in Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Antitubercular Agents; Dopa Decarboxylase; Homovanillic Acid; Humans | 1995 |
[Interesting case of pulmonary alveolar proteinosis].
Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Bronchoalveolar Lavage; Drug Therapy, Combinatio | 1995 |
[Controversy over tuberculosis therapy in HIV infected patients. Isoniazide therapy--brief chemotherapy].
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Administration Schedule; Drug The | 1995 |
Treatment of pulmonary disease caused by Mycobacterium kansasii: results of 18 vs 12 months' chemotherapy.
Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Mycobacterium Infections, Nontu | 1995 |
Alopecia side-effect of antituberculosis drugs.
Topics: Adult; AIDS-Related Opportunistic Infections; Alopecia; Antitubercular Agents; Drug Therapy, Combina | 1996 |
Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Colony Count, Microbial; Dose-Response Relationship, | 1996 |
Relationship of isoniazid resistance to human immunodeficiency virus infection in patients with tuberculosis.
Topics: Antitubercular Agents; Confidence Intervals; Drug Resistance, Microbial; Ethnicity; Female; HIV Infe | 1996 |
[Efficacy and tolerance of the treatment of tuberculosis in the aged].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Dru | 1996 |
[Biological characteristics of mycobacterial agent in homeless patients with pulmonary tuberculosis].
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Female; Humans; Ill-Housed Persons; | 1996 |
Clinical manifestations of tuberculosis in renal transplant patients.
Topics: Adult; Antitubercular Agents; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Hu | 1996 |
Acute isoniazid overdose in a compliant adolescent patient.
Topics: Child; Drug Overdose; Female; Humans; Isoniazid; Patient Compliance; Patient Education as Topic; Sel | 1996 |
Management of an outbreak of tuberculosis in a small community.
Topics: Adult; Aged; Antitubercular Agents; Contact Tracing; Diagnosis, Differential; Disease Outbreaks; Hum | 1996 |
Clinical manifestation and outcome of tuberculosis in children with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; AIDS-Related Opportunistic Infections; Antibiotics, | 1996 |
Short-course therapy of pulmonary tuberculosis: doctor's compliance.
Topics: Adult; Alcoholism; Ambulatory Care; Antitubercular Agents; Clinical Competence; Drug Combinations; F | 1996 |
Multidrug resistant tuberculosis outbreak in Buenos Aires. DNA fingerprinting analysis of isolates.
Topics: Acquired Immunodeficiency Syndrome; Adult; Argentina; Disease Outbreaks; DNA Fingerprinting; DNA, Ba | 1996 |
Hospital transmission of multidrug-resistant Mycobacterium tuberculosis in Rosario, Argentina.
Topics: Acquired Immunodeficiency Syndrome; Adult; Argentina; Chronic Disease; Cross Infection; DNA Fingerpr | 1996 |
[Is multidrug-resistant tuberculosis an emergent infection in Buenos Aires?].
Topics: Acquired Immunodeficiency Syndrome; Argentina; Female; Humans; Isoniazid; Male; Rifampin; Tuberculos | 1996 |
Prevalence of tuberculin reactivity and prevalence of risk factors for the development of active tuberculosis in a nursing home in Puerto Rico.
Topics: Aged; Aged, 80 and over; Antitubercular Agents; Cross-Sectional Studies; Female; Geriatric Assessmen | 1996 |
[Tuberculosis risk groups among children and principles of approach to chemoprophylaxis].
Topics: Adolescent; Age Factors; Antitubercular Agents; Child; Child, Preschool; Female; Humans; Isoniazid; | 1996 |
[Effectiveness of regional lymphotropic therapy in combined treatment of tuberculosis in adolescents].
Topics: Adolescent; Animals; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; | 1996 |
Testing of Mycobacterium tuberculosis susceptibility to ethambutol, isoniazid, rifampin, and streptomycin by using Etest.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Evaluati | 1996 |
Tuberculosis in Siberia: 2. Diagnosis, chemoprophylaxis and treatment.
Topics: Adult; Antitubercular Agents; Child; Drug Therapy, Combination; Humans; Isoniazid; Pneumonectomy; Ra | 1996 |
The duration of excretion of viable bacilli in elderly patients on treatment for cavitating pulmonary tuberculosis.
Topics: Aged; Antitubercular Agents; Black People; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacteriu | 1996 |
Human immunodeficiency virus infection in children with tuberculosis in Santo Domingo, Dominican Republic: prevalence, clinical findings, and response to antituberculosis treatment.
Topics: AIDS Serodiagnosis; Antibiotics, Antitubercular; Antitubercular Agents; Child, Preschool; Dominican | 1996 |
Detection and identification of non-tuberculous mycobacterial infections in 6,472 tuberculosis suspected patients.
Topics: Adolescent; Adult; Age Factors; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Bacteriolo | 1996 |
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group.
Topics: Adrenal Cortex Hormones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitu | 1996 |
katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Finland; Humans; Isoniazid; Mutation; Mycobacteri | 1996 |
Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antitubercular Agents; Arthralgia; Child; C | 1996 |
Multiple small bowel perforations in a patient on treatment of tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Combinations; Female; Humans; Intestinal Perforation; Isoniazid; | 1996 |
Concurrent mucosal leishmaniasis and pulmonary tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Contraindications; Drug Therapy, Combin | 1996 |
Rifampin preventive therapy for tuberculosis in Boston's homeless.
Topics: Adult; Antibiotics, Antitubercular; Boston; Cohort Studies; Disease Outbreaks; Drug Therapy, Combina | 1996 |
Erythema induratum of Bazin.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Erythema Induratum; Female; Humans; Immunohistochemi | 1996 |
Grand rounds--Hammersmith Hospital. Persistent fever in pulmonary tuberculosis.
Topics: Antitubercular Agents; Chronic Disease; Drug Resistance; Fever; Humans; Intestinal Absorption; Isoni | 1996 |
Changes in the size of adrenal glands in acute pulmonary tuberculosis with therapy.
Topics: Adolescent; Adrenal Glands; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Female; Human | 1996 |
[Tuberculosis of the middle ear: a rare extrapulmonary manifestation].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Diagnosis, Differential; Ear Diseases; Ear, Midd | 1996 |
Periodontal indices of patients taking isoniazid and rifampin: a pilot study.
Topics: Adult; Antitubercular Agents; Humans; Isoniazid; Male; Military Personnel; Periodontal Index; Pilot | 1997 |
[Can we improve the prevention of tuberculosis? Analysis of the application of chemoprophylaxis].
Topics: Adult; Antitubercular Agents; Female; HIV Infections; Humans; Isoniazid; Male; Tuberculosis, Pulmona | 1996 |
[Detection of tuberculosis in children of new risk groups and efficacy of chemoprophylaxis].
Topics: Adolescent; Antitubercular Agents; Chemoprevention; Child; Follow-Up Studies; Humans; Isoniazid; Mor | 1996 |
[Rationale for the use of regional lymphotropic therapy in the management of tuberculosis in adolescents].
Topics: Adolescent; Antitubercular Agents; Axilla; Drug Therapy, Combination; Follow-Up Studies; Humans; Inj | 1996 |
Directly observed isoniazid preventive therapy for released jail inmates.
Topics: Adult; Antitubercular Agents; Female; Humans; Isoniazid; Male; Outcome and Process Assessment, Healt | 1997 |
[The combination of amoxicillin-clavulanic acid and ofloxacin in the treatment of multidrug-resistant Mycobacterium tuberculosis].
Topics: Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Clavulanic | 1997 |
A continuing survey of drug-resistant tuberculosis, New York City, April 1994.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercula | 1997 |
Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Resistance, Microbial; Evaluation Studie | 1997 |
'Multidrug'-resistant tuberculosis. It is time to focus on the private sector of medicine.
Topics: Antitubercular Agents; Clinical Protocols; Drug Combinations; Drug Resistance, Microbial; Humans; In | 1997 |
Retreatment tuberculosis cases. Factors associated with drug resistance and adverse outcomes.
Topics: Adult; Aged; Antitubercular Agents; Cause of Death; Clinical Protocols; Cohort Studies; Female; Fore | 1997 |
Rifampin preventive therapy for tuberculosis infection: experience with 157 adolescents.
Topics: Adolescent; Adult; Alanine Transaminase; Antibiotic Prophylaxis; Antibiotics, Antitubercular; Drug R | 1997 |
Persistent fever in pulmonary tuberculosis. Several factors were not considered.
Topics: Antitubercular Agents; Fever; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1997 |
The cost-effectiveness of preventing tuberculosis in physicians using tuberculin skin testing or a hypothetical vaccine.
Topics: Adult; Aged; Antitubercular Agents; BCG Vaccine; Cause of Death; Chemoprevention; Cooperative Behavi | 1997 |
[Tuberculosis in asylum seekers in The Netherlands].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Emigration and Immigr | 1997 |
Increased risk of tuberculosis transmission in families with microepidemics.
Topics: Adult; Chemoprevention; Cohort Studies; Family Health; Humans; Isoniazid; Patient Compliance; Tuberc | 1997 |
[Liver injury under tuberculostatic treatment].
Topics: Aged; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Combinations; Female; Huma | 1997 |
Tuberculosis: old lessons unlearnt?
Topics: Antitubercular Agents; Drug Combinations; Drug Monitoring; Global Health; Health Priorities; Humans; | 1997 |
[Treatment of tuberculosis patients with massive bacterial excretion].
Topics: Administration, Inhalation; Antitubercular Agents; Humans; Isoniazid; Mycobacterium tuberculosis; Sp | 1997 |
Pyrazinamide-induced granulomatous hepatitis.
Topics: Antitubercular Agents; Biopsy; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Gr | 1997 |
[The results of retreatment of pulmonary tuberculosis using a short 6-month protocol 1985-1991 in the pneumo-phthisiology department of the Point G hospital in Bamako].
Topics: Adolescent; Adult; Age Factors; Antibiotics, Antitubercular; Antitubercular Agents; Child; Drug Comb | 1997 |
Genome and MIC stability in Mycobacterium tuberculosis and indications for continuation of use of isoniazid in multidrug-resistant tuberculosis.
Topics: Antitubercular Agents; Catalase; DNA Fingerprinting; Drug Resistance, Microbial; Drug Resistance, Mu | 1997 |
Problems of diagnosis and treatment of tuberculosis following renal transplantation.
Topics: Adolescent; Adult; Antitubercular Agents; Bronchoalveolar Lavage Fluid; Drug Therapy, Combination; E | 1997 |
[Pulmonary tuberculosis caused by Mycobacterium bovis with primary resistance to Isoniazide and pyrazinamide].
Topics: Adult; Antitubercular Agents; Humans; Isoniazid; Male; Mycobacterium bovis; Pyrazinamide; Tuberculos | 1997 |
A woman with productive cough, dyspnea, and a past history of surgery for tuberculosis.
Topics: Aged; Antibiotics, Antitubercular; Antitubercular Agents; Cough; Dyspnea; Female; Humans; Isoniazid; | 1997 |
[Isolation obligation and therapy in tuberculosis].
Topics: Antitubercular Agents; Bronchoalveolar Lavage Fluid; Female; Humans; Isoniazid; Mycobacterium tuberc | 1997 |
[Effects of intermittent short-course chemotherapy under full-course supervision on the treatment of smear positive pulmonary tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; | 1996 |
Isoniazid prophylaxis for high-risk patients with anergy and HIV infection.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; HIV Infections; Humans; Isoniazid; Tub | 1997 |
Isoniazid prophylaxis for high-risk patients with anergy and HIV infection.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; HIV Infections; Humans; Isoniazid; Res | 1997 |
[A severe form of urinary tuberculosis in children].
Topics: Adolescent; Antitubercular Agents; Atrophy; Bacteriuria; BCG Vaccine; Child; Cystitis; Hematuria; Hu | 1997 |
Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.
Topics: Antitubercular Agents; Clinical Laboratory Information Systems; Drug Therapy, Combination; Ethambuto | 1997 |
Attendance versus compliance with tuberculosis treatment in an occupational setting--a pilot study.
Topics: Antibiotics, Antitubercular; Chi-Square Distribution; Cross-Sectional Studies; Drug Monitoring; Fals | 1997 |
[Surgical treatment of patients with multi-resistant pulmonary tuberculosis--case reports].
Topics: Adult; Antitubercular Agents; Bronchial Fistula; Drug Therapy, Combination; Ethambutol; Fatal Outcom | 1997 |
[Reasons for chronic expectoration--case reports].
Topics: Adult; Aged; Antitubercular Agents; Capreomycin; Cycloserine; Drug Resistance, Microbial; Drug Thera | 1997 |
[Thrombocytopenia following a re-introduction of rifampicin in a daily treatment. Apropos of a case].
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Chemical and Drug Induced Liver Injury; D | 1995 |
Questions about a placebo-controlled trial of preventive therapy for tuberculosis in HIV-infected Ugandans.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Ethics, Medical; Haiti; HIV Infections | 1998 |
Questions about a placebo-controlled trial of preventive therapy for tuberculosis in HIV-infected Ugandans.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Control Groups; Ethics C | 1998 |
Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; | 1998 |
Acceptance of isoniazid preventive treatment by close contacts of tuberculosis cases: a 692-subject Italian study.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Emigration and Immigration; Humans; Infant; Isonia | 1998 |
A resected case of Mycobacterium szulgai pulmonary disease.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamy | 1998 |
Crescentic glomerulonephritis due to rifampin treatment in a patient with pulmonary atypical mycobacteriosis.
Topics: Antibiotics, Antitubercular; Drug Therapy, Combination; Glomerulonephritis; Humans; Isoniazid; Lepro | 1998 |
How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.
Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; Drug Admi | 1998 |
Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?
Topics: Adult; Ambulatory Care; Antibiotics, Antitubercular; Antitubercular Agents; Cohort Studies; Confiden | 1998 |
Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Cohort Studies; Female; HIV Inf | 1998 |
Short-course chemotherapy for isoniazid-resistant pulmonary tuberculosis.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combi | 1998 |
Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patients.
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Drug Monitoring; Drug Therapy, Comb | 1998 |
[Relationship between INH-resistance and katG mutation in M. tuberculosis].
Topics: Antitubercular Agents; Bacterial Proteins; Drug Resistance, Microbial; Genes, Bacterial; Humans; Iso | 1996 |
[Analysis of short-term effects of short-course intermittent chemotherapies of the World Bank Loaned Project].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; My | 1996 |
[Pulmonary tuberculosis in children: its age-dependent aspects].
Topics: Adolescent; Age Distribution; Anti-Bacterial Agents; Antibiotics, Antitubercular; Child; Child, Pres | 1998 |
[Epidemiologic followup of cases of tuberculosis in the medical-social centers of Paris for the year 1994].
Topics: Adolescent; Adult; Africa; Antibiotics, Antitubercular; Antitubercular Agents; BCG Vaccine; Female; | 1998 |
[A case of isoniazid-induced pneumonitis].
Topics: Antitubercular Agents; Humans; Isoniazid; Lung Diseases, Interstitial; Male; Middle Aged; Tuberculos | 1998 |
Initial drug regimens for the treatment of tuberculosis: evaluation of physician prescribing practices in New Jersey, 1994 to 1995.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Data Collection; Drug Therapy, Combination; Ethnicit | 1998 |
Isoniazid levels in the bronchoalveolar lavage fluid of patients with pulmonary tuberculosis.
Topics: Adult; Aged; Bronchoalveolar Lavage Fluid; Female; Humans; Isoniazid; Male; Middle Aged; Radiography | 1998 |
[Recurrent tuberculosis in a psychiatric hospital, recurrent outbreaks during 1987-1996].
Topics: Antitubercular Agents; Disease Outbreaks; Drug Therapy, Combination; Follow-Up Studies; Hospitals, P | 1998 |
Survey of drug-resistant tuberculosis in northwestern Russia from 1984 through 1994.
Topics: Antibiotics, Antitubercular; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Isoniazi | 1998 |
Effectiveness of short-course, intermittent chemotherapy for tuberculosis in young infants aged less than 6 months.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Female; Humans; Infant; Infant, Newborn; Is | 1998 |
[Eruption after the 1st dose of standard antitubercular chemotherapy. Thoughts on pyrazinamide].
Topics: Aged; Antitubercular Agents; Child; Drug Combinations; Drug Eruptions; Ethambutol; Exanthema; Female | 1998 |
[Resistance and multiresistance to antitubercular drugs in Argentina and in other Latin American countries].
Topics: Acquired Immunodeficiency Syndrome; Antitubercular Agents; Argentina; Drug Resistance, Microbial; Dr | 1998 |
Resistance of Mycobacterium tuberculosis to antituberculosis drugs in the Central Region of Thailand, 1996.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Drug Resistance, Microbial | 1998 |
Sequential evaluation of serum adenosine deaminase in patients treated for tuberculosis.
Topics: Adenosine Deaminase; Adolescent; Adult; Antitubercular Agents; Biomarkers; Drug Therapy, Combination | 1998 |
Phenomenon of rifampicin-induced discolouration of body fluids.
Topics: Aged; Antibiotics, Antitubercular; Antitubercular Agents; Chromogenic Compounds; Drug Interactions; | 1993 |
[Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
Topics: Antitubercular Agents; Drug Resistance, Multiple; Humans; Isoniazid; Male; Middle Aged; Mycobacteriu | 1998 |
Detection of Mycobacterium tuberculosis in gastric aspirates collected from children: hospitalization is not necessary.
Topics: Adolescent; Age Factors; Ambulatory Care Facilities; Child; Child, Preschool; Drug Resistance, Micro | 1998 |
Drug-resistant tuberculosis in Budapest.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combin | 1998 |
Reducing the impact of tuberculosis transmission in institutions: beyond infection control measures.
Topics: Antitubercular Agents; BCG Vaccine; Cross Infection; Humans; Infection Control; Isoniazid; Tuberculo | 1998 |
Primary tuberculous tracheitis.
Topics: Antitubercular Agents; Cough; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Pyrazinamide; Resp | 1998 |
[Cutaneous leukocytoclastic vasculitis in a patient with pulmonary tuberculosis].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Middle Aged | 1998 |
[Treatment of newly diagnosed patients with infiltrative and disseminated pulmonary tuberculosis].
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Fe | 1998 |
[Resistance of mycobacterial tuberculosis complex to the main antibacillary agent in Yaounde, Cameroon].
Topics: Adolescent; Adult; Antitubercular Agents; Cameroon; Drug Resistance, Microbial; Drug Resistance, Mul | 1998 |
Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society.
Topics: Adult; Antitubercular Agents; Child; Child, Preschool; Disease Notification; Drug Administration Sch | 1998 |
Longitudinal trends in serum levels of mycobacterial secretory (30 kD) and cytoplasmic (65 kD) antigens during chemotherapy of pulmonary tuberculosis patients.
Topics: Antibodies, Bacterial; Antigens, Bacterial; Antitubercular Agents; Drug Therapy, Combination; Enzyme | 1998 |
[Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)].
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Th | 1995 |
Shock and cerebral infarct after rifampin re-exposure in a patient infected with human immunodeficiency virus.
Topics: Adult; Anaphylaxis; Antibiotics, Antitubercular; Antitubercular Agents; Cerebral Infarction; Drug Hy | 1998 |
Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.
Topics: Adult; Aged; Antitubercular Agents; Cohort Studies; Drug Administration Schedule; Drug Resistance, M | 1998 |
Tuberculosis of the pyriform fossa--a rare entity.
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans | 1998 |
Acceptance and safety of directly observed versus self-administered isoniazid preventive therapy in aboriginal peoples in British Columbia.
Topics: Adult; Antitubercular Agents; British Columbia; Female; Humans; Indians, North American; Isoniazid; | 1998 |
Preventive therapy for tuberculosis in Western Australia.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Female; Humans; Infant; Isoniazid | 1998 |
The management of pulmonary tuberculosis in adults notified in Scotland in 1993.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Clinical Protocols; Disease Notif | 1998 |
A case for Bacillus Calmette-Guérin vaccine in United States-born children.
Topics: Antitubercular Agents; BCG Vaccine; Child; Child, Preschool; Disease Transmission, Infectious; Drug | 1999 |
Therapeutic dilemma: crescentic mesangiocapillary glomerulonephritis type 1 in a patient on antituberculous therapy with rifampicin.
Topics: Aged; Antitubercular Agents; Clarithromycin; Female; Glomerulonephritis, Membranoproliferative; Huma | 1999 |
[Clinical and pathological analysis of liver injury resulting from rifampin and isoniazid].
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Biopsy; Chemical and Dr | 1997 |
Molecular evidence for heterogeneity of the multiple-drug-resistant Mycobacterium tuberculosis population in Scotland (1990 to 1997).
Topics: Alleles; Antitubercular Agents; Bacterial Proteins; Base Sequence; DNA Primers; DNA-Directed RNA Pol | 1999 |
Isoniazid and rifampicin rarely cause acute pancreatitis in patients with tuberculosis.
Topics: Acute Disease; Antitubercular Agents; Humans; Isoniazid; Pancreatitis; Rifampin; Tuberculosis, Pulmo | 1999 |
Good news and not such good news.
Topics: Antitubercular Agents; Drug Combinations; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, P | 1999 |
Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana.
Topics: Adolescent; Adult; Antitubercular Agents; Botswana; Child; Comorbidity; Disease Outbreaks; Female; H | 1999 |
[Examining fibrotic process in lung during treatment of chronic murine tuberculosis with lysosomotropic drug isonaizid].
Topics: Animals; Antitubercular Agents; Chronic Disease; Disease Models, Animal; Fibrosis; Follow-Up Studies | 1999 |
Isoniazid-induced pellagra and the N-acetyltransferase gene genotype.
Topics: Arylamine N-Acetyltransferase; Genotype; Humans; Isoniazid; Male; Middle Aged; Pellagra; Tuberculosi | 1999 |
Treatment of childhood tuberculosis.
Topics: Adult; Age Factors; Antibiotics, Antitubercular; Antitubercular Agents; BCG Vaccine; Child; Child, P | 1998 |
Isoniazid-induced bullous skin reaction.
Topics: Antitubercular Agents; Drug Eruptions; Humans; Isoniazid; Leg; Male; Middle Aged; Skin; Skin Disease | 1999 |
-Skin eruption after the first dose of antitubercular quadri-therapy: consideration of pyrazinamide-.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Child; Drug Combinations; Drug Eruptions; Ethamb | 1998 |
[Six-months chemotherapy (2HRZS or E/4HRE) of new cases of pulmonary tuberculosis--six year experiences on its effectiveness, toxicity, and acceptability].
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Diabetes Complications; Drug T | 1999 |
[Improvements in the treatment and management of control the occurrence of multidrug-resistance tuberculosis].
Topics: Antitubercular Agents; Humans; Isoniazid; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, | 1997 |
[Efficacy of unfixed continuation phase short-course chemotherapy].
Topics: Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Follo | 1997 |
Is cough alone adequate to screen HIV-positive persons for tuberculosis preventive therapy in developing countries?
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Cough; Feasibility Studies; Female; Hu | 1999 |
Tuberculosis prevention in methadone maintenance clinics. Effectiveness and cost-effectiveness.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Cost-Benefit Analysis; Drug The | 1999 |
The spectrum of mycobacterial disease in a Dublin teaching hospital.
Topics: Adult; Antitubercular Agents; Female; Hospitals, Teaching; Humans; Isoniazid; Lung Neoplasms; Male; | 1999 |
Four-month, four-drug preventive therapy for inactive pulmonary tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Ad | 1999 |
Clinical problem-solving. A little math helps the medicine go down.
Topics: Adult; Antitubercular Agents; Bayes Theorem; Cost-Benefit Analysis; Diagnosis, Differential; Fatigue | 1999 |
First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisons.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Azerbaijan; Dietary Supplements; Ethambut | 1999 |
The threat of multidrug resistance: is tuberculosis ever untreatable or uncontrollable?
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Humans; Isoniazid; Patient Compliance; Rifampin; | 1999 |
An epidemiological review of tuberculosis in the Puerto Rican population.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antitubercular Agents; Canada; Child; | 1999 |
[A case of transient isoniazid-induced myoclonic seizures].
Topics: Aged; Antitubercular Agents; Electroencephalography; Humans; Isoniazid; Magnetic Resonance Imaging; | 1999 |
Health culture and the clinical encounter: Vietnamese refugees' responses to preventive drug treatment of inactive tuberculosis.
Topics: Adult; Antitubercular Agents; Asian; Attitude to Health; Cultural Characteristics; Female; Health Kn | 1999 |
Pyridoxine ineffective in isoniazid-induced psychosis.
Topics: Antitubercular Agents; Humans; Isoniazid; Male; Middle Aged; Psychoses, Substance-Induced; Pyridoxin | 1999 |
Immunoglobulin A nephropathy complicating pulmonary tuberculosis.
Topics: Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Creatinine; Drug Therapy, Combination; Fl | 1999 |
Extensive transmission of Mycobacterium tuberculosis from a child.
Topics: Adult; Antitubercular Agents; Child; Contact Tracing; Emigration and Immigration; Family Characteris | 1999 |
[A case of pulmonary tuberculosis with acute renal failure caused by readministration of rifampicin].
Topics: Acute Kidney Injury; Aged; Antibiotics, Antitubercular; Drug Therapy, Combination; Ethambutol; Human | 1999 |
Chronic ulceration of the tongue and laryngitis: first clinical sign of asymptomatic pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Laryngitis; Male; Pyrazi | 1999 |
Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk community.
Topics: Adult; Antitubercular Agents; Community Health Services; Drug Administration Schedule; Female; Healt | 1999 |
[Effects of INH (Isoniazid) inhalation in patients with endobronchial tuberculosis (EBTB)].
Topics: Administration, Inhalation; Adult; Aged; Antitubercular Agents; Bronchial Diseases; Constriction, Pa | 1999 |
Reply to Davis and colleagues: Twice weekly, directly observed treatment for HIV-infected and uninfected tuberculosis patients: cohort study in rural South Africa.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Resistance, Mu | 1999 |
[Enhancing treatment efficiency of patients with pulmonary tuberculosis by regional lymphotropic therapy].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Diuretics; Drug Therapy, Combination; Female; Fibrin | 1999 |
[Efficiency of lomefloxacine in combined treatment of patients with multiresistant pulmonary tuberculosis complicated with nonspecific bronchopulmonary infection].
Topics: Adult; Anti-Infective Agents; Antitubercular Agents; Fluoroquinolones; Humans; Isoniazid; Middle Age | 1999 |
[Intradermal reaction to tuberculin: application, interpretation and therapeutic implications].
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Child; Child, Preschool; Humans; In | 2000 |
Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Resistance; Dr | 1999 |
Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity.
Topics: Adult; Aged; Antitubercular Agents; Arylamine N-Acetyltransferase; Asian People; Chemical and Drug I | 2000 |
How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?
Topics: Adult; Antitubercular Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Admin | 2000 |
Delayed death from pulmonary tuberculosis: unsuspected subtherapeutic drug levels.
Topics: Absorption; Antibiotics, Antitubercular; Antitubercular Agents; Critical Care; Critical Illness; Fat | 2000 |
No evidence for multiple-drug prophylaxis for tuberculosis compared with isoniazid alone in Southeast Asian refugees and migrants: completion and compliance are major determinants of effectiveness.
Topics: Adult; Antitubercular Agents; Asia, Southeastern; Cohort Studies; Drug Therapy, Combination; Female; | 2000 |
[Tuberculosis and mycobacterioses--current problems].
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; BCG Vaccine; Bulgaria; HIV-1; Humans; | 1999 |
Criteria for the control of drug-resistant tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple; Humans; Isoniazid; Models, Theoretical; Practice G | 2000 |
[Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis].
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercula | 2000 |
Durable cure for tuberculosis: rifalazil in combination with isoniazid in a murine model of Mycobacterium tuberculosis infection.
Topics: Animals; Antitubercular Agents; Colony Count, Microbial; Dexamethasone; Disease Models, Animal; Drug | 2000 |
Spinal intramedullary tuberculous lesion: medical management. Report of four cases.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Clinical Protocols; Female; F | 2000 |
Kinetics of circulating antibodies, immune complex and specific antibody-secreting cells in tuberculosis patients during 6 months of antimicrobial therapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibodies, Bacterial; Antibody-Producing Cells; Antigen-Antibod | 2000 |
[Treatment of multidrug resistant tuberculosis in Santakiskes tuberculosis hospital].
Topics: Adult; Aged; Antitubercular Agents; Chronic Disease; Female; Hospitals, State; Humans; Incidence; Is | 2000 |
[Efficiency of shorter chemotherapy courses for intrathoracic tuberculosis in children].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combinati | 2000 |
[Fenazide efficiency in combined chemotherapy of new and relapsing pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Evaluation; Ferrous Compound | 2000 |
The frequency of tuberculosis in adult allogeneic stem cell transplant recipients in Turkey.
Topics: Adolescent; Adult; Antitubercular Agents; Female; Graft vs Host Disease; Hematopoietic Stem Cell Tra | 2000 |
[Intracranial tuberculomas developing during treatment of pulmonary tuberculosis: case report].
Topics: Adult; Antitubercular Agents; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Pyrazinamide; Rif | 2000 |
Tuberculosis preventive therapy: perspective from a multi-ethnic community.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Female; Health Knowledge, Attitud | 2000 |
Relation of leptin and tumor necrosis factor alpha to body weight changes in patients with pulmonary tuberculosis.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Body Mass Index; Body Weight; Drug Therap | 1999 |
Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Microbial; | 2000 |
Lipid biochemistry takes a stand against tuberculosis.
Topics: Acetyltransferases; Antitubercular Agents; Bacterial Proteins; Drug Therapy, Combination; Fatty Acid | 2000 |
[Effectiveness of the surgical treatment of patients with pulmonary tuberculosis and multidrug resistance of its causative agent].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Data Interpretation, Statistical; Drug Resistanc | 2000 |
Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Incidence; Iso | 2000 |
Twice weekly isoniazid and rifampin treatment of latent tuberculosis infection in Canadian plains Aborigines.
Topics: Adolescent; Adult; American Indian or Alaska Native; Antitubercular Agents; Child; Child, Preschool; | 2000 |
Primary and acquired resistance of Mycobacterium tuberculosis in Western Mexico.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Isoniazid; Mex | 2000 |
Tuberculosis exposure in a day-care center: recommended management.
Topics: Adult; Antitubercular Agents; Child; Child Day Care Centers; Child, Preschool; Contact Tracing; Envi | 2000 |
Isoniazid prophylaxis in lung transplantation.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Humans; Hypersensitivity, Delayed; Isoniazid; Lung T | 2000 |
Treatment of latent tuberculosis infection in patients aged > or =35 years.
Topics: Adolescent; Adult; Alanine Transaminase; Arthralgia; Cohort Studies; Exanthema; Fatigue; Follow-Up S | 2000 |
The comparison of tuberculosis treatments: a short course therapy and the directly observed short course treatment (DOTS), East Java Province, Indonesia.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; | 2000 |
Antepartum or postpartum isoniazid treatment of latent tuberculosis infection.
Topics: Adult; Antitubercular Agents; Cohort Studies; Costs and Cost Analysis; Decision Support Techniques; | 2000 |
Evaluation of Mycobacterium tuberculosis transmission from a pediatrician and initial compliance to prophylaxis of contacts in an outpatient pediatric clinic.
Topics: Ambulatory Care Facilities; Antibiotic Prophylaxis; Antitubercular Agents; Child, Preschool; Female; | 2000 |
Twelve months of isoniazid compared with four months of isoniazid and rifampin for persons with radiographic evidence of previous tuberculosis: an outcome and cost-effectiveness analysis.
Topics: Antitubercular Agents; Cost-Benefit Analysis; Drug Administration Schedule; Drug Costs; Drug Therapy | 2000 |
[The morphological reactions in the lungs during the chemotherapy of experimental tuberculosis].
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Drug Evaluation, Preclinical; Drug Ther | 2000 |
Active tuberculosis in individuals infected with human immunodeficiency virus after isoniazid prophylaxis.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Haiti; Humans; Ison | 2000 |
Tuberculosis drug resistance in England and Wales. How much is 'home-grown'?
Topics: Antitubercular Agents; Drug Therapy, Combination; England; Humans; Isoniazid; Practice Patterns, Phy | 2000 |
Tuberculosis after renal transplantation.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Huma | 2000 |
Paradoxical worsening of tuberculosis after anti-TB therapy in a kidney transplant recipient.
Topics: Adult; Antitubercular Agents; Disease Progression; Drug Therapy, Combination; Ethambutol; Female; Hu | 2000 |
[The effectiveness of pyrazinamide-containing six-month short course chemotherapy].
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Diabe | 2000 |
[Multiresistant tuberculosis caused by Mycobacterium bovis and human immunodeficiency virus infection. Are there new therapeutic possibilities?].
Topics: Acetamides; Adult; AIDS-Related Opportunistic Infections; Amoxicillin; Anti-Bacterial Agents; Anti-I | 2001 |
Surgical management of multidrug-resistant tuberculosis.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Female; Humans; Isoniazid; Male; Middle A | 2001 |
Tuberculosis treatment: dangerous regimens?
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; | 2001 |
Risk factors for hepatotoxicity during anti-tuberculosis chemotherapy in Asian populations.
Topics: Antitubercular Agents; Arylamine N-Acetyltransferase; Asian People; Chemical and Drug Induced Liver | 2001 |
Evaluation of mycobacteria growth indicator tube for direct and indirect drug susceptibility testing of Mycobacterium tuberculosis from respiratory specimens in a Siberian prison hospital.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Hospitals, State; Huma | 2001 |
Effects of pefloxacin on urinary and salivary concentrations of isoniazid in six healthy female volunteers.
Topics: Adult; Anti-Infective Agents; Antitubercular Agents; Female; Humans; Isoniazid; Mycobacterium tuberc | 2000 |
Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Micr | 2001 |
New TB drug approved.
Topics: Antitubercular Agents; Drug Combinations; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, P | 1995 |
Tuberculous infection in student nurses in Madrid, Spain.
Topics: Adult; Antitubercular Agents; Female; Humans; Incidence; Isoniazid; Male; Patient Isolation; Spain; | 2001 |
Mycolic acid index susceptibility method for Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Humans; Isoniazid; Microbial Sensitivity Tests; M | 2001 |
[Clinical study on the cases in which INH or RFP was discontinued during treatment for pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Chemical and Drug Induc | 2001 |
The treatment of multidrug-resistant tuberculosis in Turkey.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid | 2001 |
[Improved technology of chemotherapy of pulmonary tuberculosis complicated by other diseases].
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Gastrointestinal Diseases; Humans; Ison | 2001 |
Role of gamma/delta T-cells in the peripheral blood of patients with pulmonary tuberculosis.
Topics: Adult; Aged; Aged, 80 and over; Cells, Cultured; Female; Humans; Interferon-gamma; Isoniazid; Male; | 2001 |
[Effects of the enterosorbent SUMS-1 on isoniazid pharmacokinetics and lipid peroxidation in patients with pulmonary tuberculosis and drug-induced hepatic lesions].
Topics: Adult; alpha-Tocopherol; Antitubercular Agents; Ceruloplasmin; Chemical and Drug Induced Liver Injur | 2001 |
[Determination of drug resistance of Mycobacterium tuberculosis by methods of proportions and absolute concentrations].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Bacterial; Humans; Isoniazid; M | 2001 |
Simultaneous infection with multiple strains of Mycobacterium tuberculosis.
Topics: Adult; Antitubercular Agents; DNA Fingerprinting; Drug Resistance, Multiple; Female; Humans; Isoniaz | 2001 |
Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study. GISTA (Gruppo Italiano di Studio Tubercolosi e AIDS).
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Guideline Adherence; Humans; In | 2001 |
Tuberculosis preventative therapy as part of a care package for people living with HIV in a district of Thailand.
Topics: Adult; Antitubercular Agents; Cohort Studies; Comprehensive Health Care; Female; HIV Infections; Hum | 2001 |
[Effectiveness of chemotherapy of intrathoracic tuberculosis in children: late follow-up data].
Topics: Adolescent; Age Factors; Antibiotics, Antitubercular; Antitubercular Agents; Child; Child, Preschool | 2001 |
Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis.
Topics: Adult; Antibiotic Prophylaxis; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Female | 2001 |
[Tuberculosis outbreak in a junior high school in Kochi City--studies on factors relating to extent of tuberculosis infection and the efficacy of isoniazid chemoprophylaxis].
Topics: Adolescent; Adult; Antitubercular Agents; Disease Outbreaks; Female; Follow-Up Studies; Humans; Ison | 2001 |
Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis.
Topics: Administration, Inhalation; Animals; Antitubercular Agents; Chromatography, High Pressure Liquid; Ch | 2001 |
[A case of isoniazid-resistant tuberculosis diagnosed during chemoprophylaxis with isoniazid].
Topics: Adolescent; Disease Outbreaks; Drug Resistance, Bacterial; Humans; Isoniazid; Japan; Male; Mycobacte | 2001 |
Hypersensitivity syndrome from isoniazid with positive patch test.
Topics: Aged; Antitubercular Agents; Drug Hypersensitivity; Humans; Isoniazid; Male; Patch Tests; Syndrome; | 2001 |
[Features of isoniazid activation in patients with tuberculosis and diabetes mellitus].
Topics: Antitubercular Agents; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Isoniazid; Tube | 2001 |
[Blood bacteriostatic activity in patients with respiratory tuberculosis].
Topics: Antitubercular Agents; Chi-Square Distribution; Culture Media; Drug Resistance, Microbial; Humans; I | 2001 |
[Several possibilities of organizing multimodal treatment of patients with pulmonary tuberculosis].
Topics: Adolescent; Adult; Antigen-Antibody Complex; Antitubercular Agents; Combined Modality Therapy; Human | 2001 |
[Complex research studies in the testing of the effectiveness of phenaside].
Topics: Antitubercular Agents; Culture Media; Drug Resistance, Microbial; Humans; Isoniazid; Models, Theoret | 2001 |
Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Clinical Protocols; Drug Combinat | 2001 |
Would you know one if you met one?
Topics: Antitubercular Agents; Disease Progression; Humans; Isoniazid; Mycobacterium tuberculosis; Tuberculo | 2001 |
Efficacy of isoniazid prophylaxis in patients with systemic lupus erythematosus receiving long term steroid treatment.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antibiotic Prophylaxis; Antitubercular Agents; Child; C | 2002 |
Can serial qualitative polymerase chain reaction monitoring predict outcome of pulmonary tuberculosis treatment?
Topics: Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Pyrazinamide; | 2001 |
[Dissolved ozone treatment-induced change in the resistance of multi-resistant mycobacterial strain to isoniazid and rifampicin].
Topics: Antitubercular Agents; Cells, Cultured; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Myc | 2002 |
[A case of polymyositis complicated with pulmonary tuberculosis concerned with steroid resistance due to rifampin administration].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance; Ethambutol; Female; Humans; Iso | 2001 |
Isoniazid chemoprophylaxis in Indian scenario: need for a practical approach?
Topics: Adult; Antitubercular Agents; Child; Humans; India; Isoniazid; Randomized Controlled Trials as Topic | 2002 |
Another step on the path to better TB therapies.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Hong Kong; Humans; Isoniazid; Prognosis; Randomi | 2002 |
Tuberculosis in Thai prisons: magnitude, transmission and drug susceptibility.
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Cross-Sectional Studies; DNA Finger | 2002 |
Yield of continued monthly sputum evaluation among tuberculosis patients after culture conversion.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Chil | 2002 |
Screening childhood contacts of patients with smear-positive pulmonary tuberculosis in Malawi.
Topics: Adult; Antitubercular Agents; Child, Preschool; Family; Female; Humans; Infant; Isoniazid; Malawi; M | 2002 |
High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001.
Topics: Adolescent; Adult; Amino Acid Substitution; Antitubercular Agents; Bacterial Proteins; DNA, Bacteria | 2002 |
Complete sequencing of a genetic polymorphism in NAT2 in the Korean population.
Topics: Acetylation; Adolescent; Adult; Aged; Antitubercular Agents; Arylamine N-Acetyltransferase; Genotype | 2002 |
Tuberculous pericarditis in an infant evolving during triple chemotherapy.
Topics: Antitubercular Agents; Child, Preschool; Drug Therapy, Combination; Echocardiography; Female; Humans | 2002 |
Antimicrobial susceptibility testing of Mycobacterium tuberculosis to first-line drugs: comparisons of the MGIT 960 and BACTEC 460 systems.
Topics: Antitubercular Agents; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosi | 2002 |
Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Resistance, Bacterial; Etham | 2002 |
Molecular analysis of drug resistant TB.
Topics: Adolescent; Adult; Antitubercular Agents; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; T | 2002 |
Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis.
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Bacterial Typing Techniques; DNA Fi | 2002 |
Detection of isoniazid-resistant Mycobacterium tuberculosis strains by a multiplex allele-specific PCR assay targeting katG codon 315 variation.
Topics: Adolescent; Adult; Alleles; Antitubercular Agents; Bacterial Proteins; Base Sequence; Codon; DNA, Ba | 2002 |
A reiterative method for calculating the early bactericidal activity of antituberculosis drugs.
Topics: Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Clinical Trials as Topic; Colony Count, | 2002 |
Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
Topics: Adult; Antibiotics, Antitubercular; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuber | 2002 |
Elevation of plasma levels of lysosomal enzymes during treatment with rifampicin and isoniazid.
Topics: Acetylglucosaminidase; Alanine Transaminase; Female; gamma-Glutamyltransferase; Glucuronidase; Hexos | 1978 |
Short-course chemotherapy for pulmonary tuberculosis.
Topics: Africa, Eastern; Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Drug Thera | 1975 |
Letter: Short-course triple chemotherapy for tuberculosis.
Topics: Adult; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Peritonitis, Tubercu | 1975 |
Short-course chemotherapy for pulmonary tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Isoniazid; Pyr | 1975 |
[Anticonvulsant drugs and liver damage (Author's transl)].
Topics: Adult; Anticonvulsants; Antitubercular Agents; Autopsy; Chemical and Drug Induced Liver Injury; Chol | 1975 |
Letter: Short-course triple chemotherapy for tuberculosis.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Rifampin; Strep | 1975 |
Letter: Short-course triple chemotherapy for tuberculosis.
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Time Factors; Tuberculosis, Pulmonary | 1975 |
Hepatic complications of antituberculous therapy.
Topics: Aminosalicylic Acids; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Hypersensi | 1975 |
[The development of chemotherapy of pulmonary tuberculosis (author's transl)].
Topics: Capreomycin; Drug Therapy; Drug Therapy, Combination; Ethambutol; History, 20th Century; Isoniazid; | 1975 |
Tuberculosis in Tanzania: a national sampling survey of drug resistance and other factors.
Topics: Adolescent; Adult; Aminosalicylic Acids; Child; Child, Preschool; Drug Resistance, Microbial; Female | 1975 |
Initial resistance of Mycobacterium tuberculosis in Northern Nigeria.
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniaz | 1976 |
Letter: Induction of hepatic cortisol-6-hydroxylase by rifampicin.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Drug Antagonism; Drug Therapy, Combination; Enzyme In | 1976 |
[Comparison of 1.0g streptomycin, 0.5g streptomycin and 1.0g capreomycin three times a week combined with PAS and isoniazid in original treatment for pulmonary tuberculosis. Report of the 17th series of controlled trial of chemotherapy (author's transl)].
Topics: Adult; Capreomycin; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Strepto | 1976 |
Tuberculosis in Tanzania: a follow-up of a national sampling survey of drug resistance and other factors.
Topics: Adolescent; Adult; Child; Child, Preschool; Drug Resistance, Microbial; Female; Follow-Up Studies; H | 1977 |
Results at 5 years of a controlled comparison of a 6-month and a standard 18-month regimen of chemotherapy for pulmonary tuberculosis.
Topics: Drug Therapy, Combination; Humans; Isoniazid; Patient Dropouts; Recurrence; Rifampin; Streptomycin; | 1977 |
Short-course treatment in pulmonary tuberculosis.
Topics: Adolescent; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Time Factors; Tu | 1977 |
Short-course (6-month) treatment of pulmonary tuberculosis (Second East African/British Medical Research Council Study).
Topics: Africa, Eastern; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; | 1976 |
Short-term chemotherapy of pulmonary tuberculosis. A controlled trial. The Research Committee of the Tuberculosis Association of India.
Topics: Drug Therapy, Combination; Ethambutol; Humans; India; Isoniazid; Pyrazinamide; Streptomycin; Thioace | 1976 |
Intermittent chemotherapy with thiacetazone and isoniazid in the treatment of pulmonary tuberculosis.
Topics: Adult; Aminosalicylic Acid; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; | 1977 |
Short-course chemotherapy for tuberculosis.
Topics: Adult; Ambulatory Care; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; | 1979 |
Basic mechanisms of chemotherapy.
Topics: Aminosalicylic Acid; Animals; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combi | 1979 |
Antituberculous drugs.
Topics: Abnormalities, Drug-Induced; Antitubercular Agents; Dihydrostreptomycin Sulfate; Ethambutol; Ethiona | 1979 |
Primary and secondary resistance of mycobacterium tuberculosis in Eastern Botswana.
Topics: Antitubercular Agents; Botswana; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tuberc | 1979 |
[A new therapeutic approach to open pulmonary tuberculosis with a combination of isoniazid, prothionamid and dapson (author's transl)].
Topics: Adolescent; Adult; Dapsone; Drug Combinations; Drug Evaluation; Humans; Isoniazid; Isonicotinic Acid | 1978 |
Tuberculosis in Kenya: a second national sampling survey of drug resistance and other factors, and a comparison with the prevalence data from the first national sampling survey. An East African and British Medical Research Council Co-operative Investigati
Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; Developing Countries; Drug Resistance, Micr | 1978 |
[Healing of destructive pulmonary tuberculosis depending on bacteriostatic effect of various methods of treatment].
Topics: Administration, Oral; Adolescent; Adult; Aminosalicylic Acid; Aminosalicylic Acids; Female; Humans; | 1978 |
[Decrease of isoniazid-resistant Mycobacterium strains].
Topics: Drug Resistance, Microbial; Humans; Hungary; Isoniazid; Microbial Sensitivity Tests; Mycobacterium t | 1979 |
[Short course chemotherapy for pulmonary tuberculosis with duration for 6 months after sputum negative conversion. (Report 1)--Report of the 19--20th A series of controlled trial of chemotherapy--(author's transl)].
Topics: Adolescent; Adult; Aged; Drug Administration Schedule; Female; Humans; Isoniazid; Male; Middle Aged; | 1979 |
Daily short course (6 months) chemotherapy for treatment of pulmonary tuberculosis in Nigerians: a preliminary report.
Topics: Adolescent; Adult; Drug Combinations; Drug Therapy, Combination; Evaluation Studies as Topic; Female | 1978 |
Thoracic tuberculosis: clinical aspects.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acid; Child; Child, Preschool; Drug Interactions; Ethambutol | 1979 |
Canadian survey to determine the rate of drug resistance to isoniazid, PAS and streptomycin in newly detected untreated tuberculosis patients and retreatment cases.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Canada; Drug Resistance, Microbial; Emigration and Immigr | 1979 |
[Bacillary elimination in patients with destructive pulmonary tuberculosis treated with intrabronchial infusion of tuberculostatics].
Topics: Adult; Aged; Bronchi; Humans; Infusions, Parenteral; Isoniazid; Middle Aged; Mycobacterium tuberculo | 1979 |
Drug resistance in newly discovered untreated tuberculosis patients in Poland, 1974-1977.
Topics: Adult; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Mal | 1979 |
Treatment of pulmonary tuberculosis.
Topics: Adrenal Cortex Hormones; Adult; Aminosalicylic Acid; Child; Drug Combinations; Female; Humans; Isoni | 1979 |
Adverse reactions to short-course regimens containing streptomycin, isoniazid, pyrazinamide and rifampicin in Hong Kong.
Topics: Aminosalicylic Acids; Arthritis; Chemical and Drug Induced Liver Injury; Drug Eruptions; Drug Therap | 1976 |
[Organizing the introduction of the intensive therapy of pulmonary tuberculosis into the practice of Kuibyshev Province dispensaries].
Topics: Critical Care; Drug Tolerance; Hospitals, Special; Humans; Isoniazid; Russia; Tuberculosis, Pulmonar | 1978 |
Tuberculosis in Britain today.
Topics: Emigration and Immigration; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary; United | 1979 |
Pulmonary tuberculosis initial treatment.
Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmona | 1978 |
Daily and intermittent short-course regimens in the original treatment of pulmonary tuberculosis. Preliminary results. Cooperative comparative clinical study in Poland.
Topics: Adolescent; Adult; Aged; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Follow-Up S | 1978 |
Short-course intensive treatment of patients with destructive pulmonary tuberculosis.
Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Methods; Time Factors; Tubercul | 1978 |
Control of streptomycin and isoniazid in malnourished children treated for tuberculosis.
Topics: Administration, Oral; Child; Child, Preschool; Humans; Infant; Injections, Intramuscular; Isoniazid; | 1977 |
[Current problems in juvenile tuberculosis. 3. Early treatment of tuberculosis].
Topics: Antitubercular Agents; BCG Vaccine; Child; Child Nutritional Physiological Phenomena; Child, Prescho | 1977 |
Isoniazid induction of antinuclear antibodies. A prospective study.
Topics: Antibodies, Antinuclear; Female; Humans; Isoniazid; Male; Prospective Studies; Thoracic Diseases; Tu | 1978 |
Isoniazid hepatotoxicity in children.
Topics: Age Factors; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Child; Child, Pres | 1978 |
Tuberculosis.
Topics: Age Factors; Chemical and Drug Induced Liver Injury; Child; Humans; Isoniazid; Liver; Tuberculin Tes | 1979 |
Recent advances in antituberculosis chemotherapy.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tubercul | 1979 |
Bovine pulmonary tuberculosis in adults. A new view of an old infection.
Topics: Adult; Female; Humans; Infant, Newborn; Isoniazid; Mycobacterium bovis; Pregnancy; Pregnancy Complic | 1978 |
[Current short-term chemotherapy of tuberculosis. Fundamentals, assumptions, drug combinations, plan of treatment and prospects].
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Evaluation; Drug Therapy, Combination; Ethambutol; | 1978 |
Hepatic dysfunction during isoniazid chemoprophylaxis in renal allograft recipients.
Topics: Adolescent; Adult; Chemical and Drug Induced Liver Injury; Child; Hepatitis B Surface Antigens; Huma | 1979 |
Tuberculosis in renal transplant recipients.
Topics: Adult; Drug Administration Schedule; Female; Humans; Isoniazid; Kidney Failure, Chronic; Kidney Tran | 1979 |
Stability of bacteriophage type of Mycobacterium tuberculosis: absence of variation caused by experimental chemotherapy in mice and analysis of spontaneous variation.
Topics: Analysis of Variance; Animals; Bacteriophage Typing; Drug Resistance, Microbial; Isoniazid; Mice; Mu | 1977 |
[Secondary drug resistance of Mycobacterium tuberculosis in patients with chronic destructive forms of pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Resistance, Microbial; Female; Humans; Isoniazi | 1977 |
The character and results of comparative experimental therapy of tuberculosis in Macaca arctoides monkeys.
Topics: Animals; Haplorhini; Isoniazid; Macaca; Monkey Diseases; Streptomycin; Tuberculosis, Pulmonary | 1977 |
Synergy and rifampicin.
Topics: Drug Synergism; Escherichia coli; Humans; Isoniazid; Novobiocin; Proteus vulgaris; Pseudomonas aerug | 1977 |
[The different inactivation of isoniazid in intermittent chemotherapy (author's transl)].
Topics: Adult; Aged; Biotransformation; Body Weight; Drug Resistance, Microbial; Female; Humans; Isoniazid; | 1977 |
Occult tuberculous infection in children.
Topics: Adolescent; Aminosalicylic Acid; Child; Child, Preschool; Europe; Humans; Infant; Isoniazid; Mycobac | 1977 |
[Treatment of children with tuberculosis using Isoprodian].
Topics: Adolescent; Age Factors; Child; Child, Preschool; Dapsone; Drug Combinations; Drug Evaluation; Human | 1977 |
[Changes in the indication of surgical treatment for pulmonary tuberculosis in accordance with the introduction of rifampicin based on bacteriological findings on culture of resected specimens (author's transl)].
Topics: Humans; Isoniazid; Lung; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 1977 |
Nursery exposure of 528 newborns to a nurse with pulmonary tuberculosis.
Topics: Child, Preschool; Cross Infection; Female; Humans; Infant, Newborn; Isoniazid; Lung; Male; Middle Ag | 1978 |
[Bacterial isolation during chemotherapy of patients with pulmonary tuberculosis].
Topics: Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 1977 |
Impact of anti-tuberculosis legislation in Libya on the prevalence of primary and acquired resistance to the three main drugs at a majortuberculosis centre.
Topics: Adolescent; Adult; Age Factors; Aged; Aminosalicylic Acid; Aminosalicylic Acids; Drug Resistance, Mi | 1978 |
[Influence of high doses of isoniazid on Mycobacterium tuberculosis].
Topics: Humans; Isoniazid; Mycobacterium tuberculosis; Tuberculosis, Pulmonary | 1978 |
[Experience with the use of the express intravenous administration of isoniazid to tuberculosis patients].
Topics: Adult; Aged; Chronic Disease; Female; Humans; Injections, Intravenous; Isoniazid; Male; Middle Aged; | 1979 |
Tuberculosis chemoprophylaxis practices in metropolitan clinics.
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Female; Humans; Isoniazid; Liver; Liver Functio | 1979 |
Isoniazid liver injury during chemoprophylaxis in children.
Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injur | 1979 |
Isoniazid-induced fever.
Topics: Carcinoma, Squamous Cell; Drug Hypersensitivity; Fever; Humans; Isoniazid; Lung Neoplasms; Male; Mid | 1979 |
The Ottawa County project: a report of a tuberculosis screening project in a small mining community.
Topics: Aged; Humans; Isoniazid; Male; Mass Screening; Middle Aged; Mining; Oklahoma; Silicosis; Silicotuber | 1979 |
Hospital screening for tuberculosis: a quality assurance trial.
Topics: Hospitals, Federal; Humans; Indians, North American; Isoniazid; Medical Audit; New Mexico; Outcome a | 1979 |
Childhood cancer and drugs in pregnancy.
Topics: Adolescent; Adult; Child; Child, Preschool; Epilepsy; Female; Fetus; Humans; Infant; Infant, Newborn | 1979 |
Antimicrobial activity of antituberculosis agents against anaerobic bacteria.
Topics: Actinomyces; Antitubercular Agents; Bacteria; Bacteroides; Bacteroides fragilis; Clostridium; Ethamb | 1979 |
Defective leukotaxis in monocytes from patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Chemotaxis, Leukocyte; Chronic Disease; Dose-Response Relationship, Immunol | 1979 |
Short-course chemotherapy for tuberculosis.
Topics: Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1979 |
Short-course chemotherapy of tuberculosis with largely twice-weekly isoniazid-rifampin.
Topics: Adolescent; Adult; Aged; Drug Hypersensitivity; Humans; Isoniazid; Jaundice; Middle Aged; Rifampin; | 1979 |
Isoniazid-related liver disease. Occurrence with portal hypertension, hypoalbuminemia, and hypersplenism.
Topics: Ascites; Chemical and Drug Induced Liver Injury; Female; Humans; Hypersplenism; Hypertension, Portal | 1979 |
Group III atypical mycobacterial infections.
Topics: Adolescent; Adult; Aged; Child; Drug Resistance, Microbial; Female; Humans; Infant; Isoniazid; Male; | 1979 |
Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies.
Topics: Alaska; Dose-Response Relationship, Drug; Humans; Inuit; Isoniazid; Tuberculosis, Pulmonary | 1979 |
[Tuberculosis in American physicians. Considerable occupational risks, now as before].
Topics: BCG Vaccine; Female; Humans; Isoniazid; Male; Occupational Diseases; Physicians; Risk; Students, Med | 1979 |
[Inoperable bronchial carcinoma complicated by pulmonary tuberculosis: the results of concurrent radiotherapy and anti-tuberculous chemotherapy (author's transl)].
Topics: Adenocarcinoma; Aged; Bronchial Neoplasms; Female; Humans; Isoniazid; Male; Middle Aged; Neoplasm St | 1979 |
Phenotyping of South African black tuberculosis patients for inactivation of isoniazid.
Topics: Administration, Oral; Black People; Humans; Injections, Intramuscular; Isoniazid; Kinetics; Phenotyp | 1979 |
Evaluation of various isoniazid slow releasing matrix preparations for intermittent chemotherapy of tuberculosis.
Topics: Acetylation; Black People; Delayed-Action Preparations; Humans; Isoniazid; Kinetics; Phenotype; Time | 1979 |
[Therapy of tuberculosis].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Drug Resistance, Microbial; Ethambutol; Humans; I | 1979 |
Modified short-course (nine months) chemotherapy for pulmonary tuberculosis suitable for Developing Countries.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Developing Countries; Drug Administration Schedule; | 1979 |
Isoniazid acetylator phenotypes of Nigerians.
Topics: Acetylation; Adult; Black People; Female; Humans; Isoniazid; Male; Nigeria; Phenotype; Time Factors; | 1979 |
[Effect of intensive chemotherapy on bacterial excretion in fibrocavernous pulmonary tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Methods; Tuberculosis, Pulmonar | 1979 |
[Methodology and results of combination therapy of relapses of pulmonary tuberculosis].
Topics: Antitubercular Agents; Bronchi; Drug Therapy, Combination; Humans; Hydrocortisone; Injections; Isoni | 1979 |
[Effectiveness of the endobranchial administration of antibacterial drugs in the combination treatment of tuberculosis].
Topics: Adult; Antitubercular Agents; Bronchi; Drug Therapy, Combination; Evaluation Studies as Topic; Femal | 1979 |
[Long-term treatment of tuberculosis with isoprodian (author's transl)].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Dapsone; Drug Combinations; Drug Evaluation; Drug Re | 1979 |
Long-term results of medical treatment in Mycobacterium intracellulare infection.
Topics: Adult; Aged; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Mi | 1979 |
Practical application of short-course (6 month) regimens of chemotherapy for pulmonary tuberculosis in Kenyan nomads.
Topics: Adolescent; Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Kenya; Male; Rifamp | 1979 |
Modern management of tuberculosis.
Topics: Adolescent; Adult; Aminosalicylic Acid; Child; Cycloserine; Drug Administration Schedule; Drug Thera | 1979 |
Hepatic dysfunction in tuberculous patients treated with rifampicin and isoniazid.
Topics: Chemical and Drug Induced Liver Injury; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tube | 1979 |
[A study on short-course chemotherapy for pulmonary tuberculosis (Report 2)--6--9 month short-course chemotherapy (author's transl)].
Topics: Adult; Antibiotics, Antitubercular; Drug Administration Schedule; Drug Therapy, Combination; Female; | 1979 |
[Results of intermittent chemotherapy of patients with tuberculosis].
Topics: Adult; Aged; Female; Humans; Isoniazid; Male; Middle Aged; Streptomycin; Tuberculosis, Pulmonary | 1979 |
[Two cases of pulmonary tuberculosis having evolved after the first attack with triple therapy of isoniazid, rifampicin and ethambutol].
Topics: Adult; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosi | 1979 |
Pulmonary disease caused by Mycobacterium xenopi in an Australian man.
Topics: Australia; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacteriu | 1979 |
Tuberculosis in Kenya: follow-up of the second (1974) national sampling survey and a comparison with the follow-up data from the first (1964) national sampling survey. An East African and British Medical Research Council co-operative investigation.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Developing Countries; Drug Resistance, Microbial; | 1979 |
Toxic psychosis to isoniazid and ethionamide in a patient with pulmonary tuberculosis.
Topics: Adolescent; Ethionamide; Humans; Isoniazid; Male; Psychoses, Substance-Induced; Tuberculosis, Pulmon | 1979 |
[Perspective of tuberculosis control--role of preventive chemotherapy (author's transl)].
Topics: Diabetes Complications; Economics, Medical; Humans; Isoniazid; Tuberculosis, Pulmonary | 1979 |
The treatment of pulmonary tuberculosis. Current options.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Health Resources; Huma | 1979 |
Public health and preventive aspects of pulmonary tuberculosis. Infectiousness, epidemiology, risk factors, classification, and preventive therapy.
Topics: Adult; BCG Vaccine; Child; Humans; Immunosuppression Therapy; Isoniazid; Public Health; Risk; Tuberc | 1979 |
[Primary resistance to isoniazid (author's transl)].
Topics: Adult; Drug Resistance; Female; Germany, West; Humans; Isoniazid; Male; Middle Aged; Tuberculosis, P | 1979 |
[Effectiveness of combined therapy in patients with destructive tuberculosis of the lungs].
Topics: Adult; Female; Humans; Injections, Intravenous; Isoniazid; Male; Middle Aged; Tuberculosis, Pulmonar | 1979 |
A family cluster of tuberculosis.
Topics: Adult; Female; Humans; Infant; Isoniazid; Male; Tuberculosis, Pulmonary | 1979 |
Is isonicotinic acid hydrazide (INH) carcinogenic to man? A 24-year follow-up of 3371 tuberculosis cases.
Topics: Alcohol Drinking; Carcinogens; Denmark; Female; Follow-Up Studies; Humans; Isoniazid; Lung Neoplasms | 1979 |
[New information on the metabolism of isoniazide and rifampicin. Their therapeutical consequences (author's transl)].
Topics: Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1979 |
[Pregnancy and pulmonary tuberculosis].
Topics: BCG Vaccine; Ethambutol; Female; Humans; Infant, Newborn; Isoniazid; Pregnancy; Pregnancy Complicati | 1979 |
[Biotransformation of rifampicin in pulmonary tuberculosis patients].
Topics: Adolescent; Adult; Animals; Biotransformation; Drug Therapy, Combination; Female; Humans; Isoniazid; | 1977 |
Cerebrovascular accident after a "skipjack" reaction in a patient taking isoniazid.
Topics: Animals; Cerebrovascular Disorders; Fishes; Food Hypersensitivity; Humans; Isoniazid; Male; Meat; Mi | 1978 |
Chemotherapy for tuberculosis.
Topics: Humans; Isoniazid; Time Factors; Tuberculosis, Pulmonary | 1977 |
[Plasma levels of rifampicin and isoniazid and serum levels of aminotransferases in combined tuberculostatic treatment (author's transl)].
Topics: Adult; Aged; Ethambutol; Female; Humans; Isoniazid; Liver Diseases; Male; Prospective Studies; Rifam | 1977 |
Treatment of the intestinal tuberculosis.
Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isonia | 1977 |
[Effect of chemoprophylaxis on the morbidity of persons with past tuberculosis].
Topics: Adult; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Tuberculosis, Pulmonary | 1977 |
[New guidelines for pulmonary tuberculosis therapy].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Recurrence; Rifamp | 1978 |
Short-term intensive initial chemotherapy for pulmonary tuberculosis--preliminary report--can the duration of TB treatment be even shorter?
Topics: Adolescent; Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Is | 1978 |
Choosing the correct drug combinations against tuberculosis.
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulm | 1978 |
Current status of the chemotherapy of tuberculosis. Part II.
Topics: Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1978 |
[Iron metabolism in tuberculosis during complex treatment].
Topics: Adolescent; Adult; Chronic Disease; Drug Therapy, Combination; Ethionamide; Female; Humans; Iron; Is | 1978 |
Chromosome analyses in man in the course of chemoprophylaxis against tuberculosis and of antituberculosis chemotherapy with isoniazid.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Chromosome Aberrations; Chromosomes; Female; Human | 1978 |
[The hepatotoxicity of rifampicin and its modification through "essential" choline phospholipids].
Topics: Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Li | 1978 |
How safe is isoniazid?
Topics: Adult; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Female; Hepatitis, Viral, Hu | 1978 |
[Successful chemotherapy of avian mycobacteriosis with isoprodian (author's transl)].
Topics: Adult; Cycloserine; Dapsone; Drug Combinations; Humans; Isoniazid; Isonicotinic Acids; Male; Mycobac | 1978 |
Isoniazid and bile duct cancer.
Topics: Aged; Bile Duct Neoplasms; Humans; Isoniazid; Male; Middle Aged; Tuberculosis, Pulmonary | 1978 |
[The influence of rifampicin upon the metabolism of isoniazid (author's transl)].
Topics: Acetylation; Adolescent; Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Drug Intera | 1978 |
Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study.
Topics: Adult; Age Factors; Aged; Alcohol Drinking; Alkaline Phosphatase; Aspartate Aminotransferases; Bilir | 1978 |
[Tuberculosis of the peripheral lymph nodes].
Topics: Adolescent; Adult; Ethambutol; Female; Germany, West; Humans; Inguinal Canal; Isoniazid; Male; Middl | 1978 |
[Controlled clinical trial of three 6 month regimens of chemotherapy for pulmonary tuberculosis (preliminary report) (author's transl)].
Topics: Adolescent; Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Is | 1978 |
[Anemia with hypersideroblastosis during anti-tuberculosis therapy. Cure with vitamin therapy].
Topics: Aged; Anemia, Sideroblastic; Antitubercular Agents; Ascorbic Acid; Female; Humans; Isoniazid; Pyrido | 1978 |
[Determination of isoniazid in urine by a polarographic method].
Topics: Circadian Rhythm; Humans; Isoniazid; Polarography; Tuberculosis, Pulmonary | 1978 |
[Concentration and excretion of isoniazid and PAS in patients with tuberculosis depending on the functional status of the kidney].
Topics: Adolescent; Adult; Aged; Aminosalicylic Acid; Aminosalicylic Acids; Humans; Isoniazid; Kidney; Middl | 1978 |
A case of probable congenital tuberculosis successfully treated with rifampicin and INH.
Topics: Drug Therapy, Combination; Female; Humans; Infant; Isoniazid; Male; Rifampin; Tuberculosis, Pulmonar | 1978 |
[Acute renal failure with anuria of 30 days' duration after drinking ethyl alcohol during treatment with isoniazid].
Topics: Acute Kidney Injury; Alcohol Drinking; Anuria; Drug Interactions; Ethanol; Humans; Isoniazid; Male; | 1978 |
[Dynamics of pulmonary tuberculosis during hospital-stage chemotherapy of different duration].
Topics: Adult; Aminosalicylic Acid; Drug Therapy, Combination; Female; Hospitalization; Humans; Isoniazid; M | 1978 |
[State of the hypothalamo-pituitary-adrenal system in rabbits infected with tuberculosis and treated with etimizol].
Topics: Animals; Drug Therapy, Combination; Etimizol; Hypothalamo-Hypophyseal System; Imidazoles; Isoniazid; | 1978 |
Immunologic and medical considerations in tuberculin-sensitized pregnant patients.
Topics: Adult; Female; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Isoniazid; Lymphocyte Activati | 1978 |
Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
Topics: Acetylation; Adult; Age Factors; Alanine Transaminase; Alcoholism; Aspartate Aminotransferases; Bili | 1978 |
Will short-term TB therapy regimens work?
Topics: Antitubercular Agents; Arkansas; Drug Therapy, Combination; Humans; Isoniazid; Patient Compliance; R | 1978 |
Undetected tuberculosis in prison. Source of infection for community at large.
Topics: Arkansas; Humans; Isoniazid; Prisoners; Quality of Health Care; Tuberculosis, Pulmonary; United Stat | 1978 |
[Determination of the phenotype of INH inactivation in pulmonary tuberculosis by means of an indirect method on the model of sulfamethazine].
Topics: Acetylation; Biotransformation; Female; Humans; Isoniazid; Liver; Male; Phenotype; Sulfamethazine; T | 1978 |
[Intermittent chemotherapy of pulmonary tuberculosis (review of the literature)].
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Administration Schedule; Drug Evaluation; Drug Ther | 1978 |
[Intermittent chemotherapy of pulmonary tuberculosis with rifampicin and ethambutol].
Topics: Drug Evaluation; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Middle Aged; | 1978 |
[Treatment of newly detected destructive pulmonary tuberculosis by the method of rapid intravenous administration of isoniazid].
Topics: Adult; Female; Humans; Injections, Intravenous; Isoniazid; Male; Middle Aged; Tuberculosis, Pulmonar | 1978 |
[Content of various trace elements in experimental tuberculosis treated with isoniazid and complex compounds of copper and cobalt].
Topics: Animals; Cobalt; Copper; Drug Therapy, Combination; Isoniazid; Rabbits; Trace Elements; Tuberculosis | 1978 |
Psychosis due to isoniazid.
Topics: Adult; Humans; Isoniazid; Male; Middle Aged; Psychoses, Substance-Induced; Tuberculosis, Lymph Node; | 1978 |
Surgical experience with pulmonary tuberculosis patients receiving steroids.
Topics: Adrenal Cortex Hormones; Adult; Aged; Female; Humans; Isoniazid; Male; Middle Aged; Streptomycin; Tu | 1978 |
[Chemotherapeutic activity of isonicotinoyl hydrazide of phosphonacetic acid in experimental tuberculosis].
Topics: Animals; Drug Evaluation; Guinea Pigs; Isoniazid; Tuberculosis; Tuberculosis, Hepatic; Tuberculosis, | 1978 |
The incidence of the acetylator phenotype of isoniazid in healthy and in pulmonary tuberculosis subjects in Bihar.
Topics: Acetylation; Humans; Isoniazid; Phenotype; Sulfamethazine; Tuberculosis, Pulmonary | 1978 |
[Antitubercular chemoprophylaxis studied in the light of more than 20 years of use throughout the world].
Topics: BCG Vaccine; Europe; Hospitals, Psychiatric; Humans; Isoniazid; Liver; Silicotuberculosis; Tuberculo | 1978 |
[Tuberculosis of hematopoietic organs in the child. 2 cases with pulmonary involvement].
Topics: Adolescent; Child, Preschool; Drug Tolerance; Ethambutol; Female; Humans; Isoniazid; Male; Prognosis | 1978 |
Drug-resistant pulmonary tuberculosis.
Topics: Aged; Antitubercular Agents; Drug Resistance, Microbial; Humans; Isoniazid; Male; Streptomycin; Tube | 1978 |
[Isoprodiane therapy for previously untreated cavitating pulmonary tuberculosis (author's transl)].
Topics: Adolescent; Adult; Dapsone; Drug Combinations; Drug Evaluation; Female; Humans; Isoniazid; Isonicoti | 1979 |
Pitfalls in diagnosing and managing pulmonary diseases.
Topics: Adult; Aged; Chronic Disease; Diagnostic Errors; Female; Heparin; Humans; Isoniazid; Lung Diseases; | 1979 |
Toxic effects of isoniazid in tuberculosis chemoprophylaxis. Role of biochemical monitoring in 1,000 patients.
Topics: Adolescent; Adult; Aged; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Child; | 1979 |
[Obtaining active BCG substrains resistant to HINA].
Topics: Animals; BCG Vaccine; Drug Resistance, Microbial; Guinea Pigs; Humans; Isoniazid; Mice; Mycobacteriu | 1976 |
[Incidence of pulmonary tuberculosis in diabetics (author's transl)].
Topics: Adult; Body Weight; Diabetes Complications; Female; Humans; Isoniazid; Male; Middle Aged; Radiograph | 1975 |
[A study on prevalence of resistance to major drugs among newly admitted pulmonary tuberculosis patents in 1972. Part 1. Comparison of result in 1972 with those in 1957, '59, '61, '63, '66 and '69].
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Humans; Isoniazid; Japan; Mycobacterium tuberculos | 1975 |
Failure of isoniazid prophylaxis after exposure to isoniazid-resistant tuberculosis.
Topics: Adolescent; Adult; Aminosalicylic Acids; Drug Resistance, Microbial; Ethambutol; Female; Humans; Iso | 1975 |
Tuberculous meningitis developing after six months of treatment of pulmonary tuberculosis. Complication of infection with a drug-resistant strain in a two-year-old child.
Topics: Blood Glucose; Child, Preschool; Drug Resistance, Microbial; Ethambutol; Glucose; Humans; Isoniazid; | 1975 |
Tuberculosis: the new challenge to the practicing clinician.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Resistance, Microbial; Emigration and Immigra | 1975 |
[Comparison between SM daily and twice weekly treatment in the regimen of SM, INH and PAS--particularly considering the degree of drug resistance-- (report 1) (author's transl)].
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Isoniazid; Midd | 1975 |
Review of tuberculosis among the Orang Asli (Aborigines) in West Malaysia from 1951-1970.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Child; Child, Preschool; Female; Follow-Up Studies; H | 1975 |
Chemoprophylaxis in inactive tuberculosis: long-term evaluation of a Canadian trial.
Topics: Aminosalicylic Acids; Canada; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Follow-Up St | 1976 |
A continuing survey of primary drug resistance in tuberculosis, 1961 to 1968. A U.S. Public Health Service cooperative study.
Topics: Adult; Age Factors; Aged; Aminosalicylic Acids; Drug Resistance, Microbial; Female; Humans; Isoniazi | 1976 |
Cycloserine plus ethionamide plus pyrazinamide in the treatment of patients excreting isoniazid-resistant tubercle bacilli following previous chemotherapy.
Topics: Adult; Cycloserine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethionamide; Female; Huma | 1976 |
Isoniazid hepatitis in adolescents.
Topics: Adolescent; Alanine Transaminase; Animals; Bilirubin; Chemical and Drug Induced Liver Injury; Diseas | 1976 |
Study of adverse reactions to a once-weekly regimen of streptomycin plus a slow-release preparation of isoniazid in high dosage for six months.
Topics: Adolescent; Adult; Age Factors; Aged; Aminosalicylic Acids; Delayed-Action Preparations; Drug Therap | 1976 |
Retreatment of drug-sensitive relapses of pulmonary tuberculosis following chemotherapy with standard drugs.
Topics: Aminosalicylic Acid; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rec | 1976 |
Cultured peripheral lymphocytes: one biologic indicator of potential drug hazard.
Topics: Adolescent; Antimony; Antimony Potassium Tartrate; Child; Child, Preschool; Chromosomes, Human; Drug | 1976 |
Modern medical management of pulmonary tuberculosis.
Topics: Alcoholism; Ethambutol; Fever; Humans; Isoniazid; Rifampin; Tuberculin Test; Tuberculosis, Pulmonary | 1977 |
[Chronic primary tuberculosis of the lung in adolescents].
Topics: Adolescent; Child; Humans; Isoniazid; Male; Streptomycin; Thiosemicarbazones; Time Factors; Tubercul | 1977 |
A sensitive urine-test method for monitoring the ingestion of isoniazid.
Topics: Humans; Isoniazid; Isonicotinic Acids; Self Administration; Time Factors; Tuberculosis, Pulmonary | 1977 |
Close monitoring is essential during isoniazid prophylaxis.
Topics: Adult; Aged; Alcohol Drinking; Aspartate Aminotransferases; Bilirubin; Chemical and Drug Induced Liv | 1977 |
Why tuberculosis is still a health problem in the aged.
Topics: Age Factors; Aged; Ethambutol; Humans; Isoniazid; Nursing Homes; Patient Isolation; Radiography; Rif | 1977 |
[Treatment of new cases of pulmonary tuberculosis with a combination of isoprodian and ethambutol; clinical results (author's transl)].
Topics: Adult; Antitubercular Agents; Dapsone; Drug Combinations; Drug Therapy, Combination; Ethambutol; Hum | 1977 |
Management of tuberculosis: altered role of the primary care physician.
Topics: Adolescent; Adult; Aminosalicylic Acid; Antitubercular Agents; Child; Cycloserine; Ethambutol; Ethio | 1977 |
Clinical pulmonary tuberculosis in an asthmatic patient using a steroid aerosol.
Topics: Adult; Aerosols; Asthma; Beclomethasone; Dexamethasone; Humans; Isoniazid; Tuberculosis, Pulmonary | 1977 |
[A study on short-course chemotherapy for pulmonary tuberculosis. (Report I) (author's transl)].
Topics: Adult; Aminosalicylic Acid; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Rifampin; St | 1977 |
Chest radiographs during isoniazid therapy.
Topics: Child; Female; Humans; Isoniazid; Male; Radiation Injuries; Radiography, Thoracic; Tuberculin Test; | 1977 |
Controlled trial of 6-month and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong. The results up to 30 months.
Topics: Adolescent; Adult; Drug Administration Schedule; Drug Evaluation; Drug Resistance, Microbial; Hong K | 1977 |
[Chemotherapy of lung tuberculosis].
Topics: Cyclacillin; Ethambutol; Ethionamide; Humans; Isoniazid; Pyrazinamide; Streptomycin; Tuberculosis, P | 1977 |
[Inactivation of isoniazid before and after administration of streptomycin (author's transl)].
Topics: Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1977 |
Reactivation of tuberculosis in old age.
Topics: Adult; Aged; Child; Ethambutol; Female; Humans; Isoniazid; Male; Recurrence; Rifampin; Tuberculosis, | 1977 |
[Liver function in patients with pulmonary tuberculosis receiving maximal toeerable doses of isoniazid].
Topics: Adolescent; Adult; Humans; Isoniazid; Liver; Middle Aged; Tuberculosis, Pulmonary | 1977 |
[Pharmacokinetics of rifampicin in patients with pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Biotransformation; Drug Therapy, Combination; Drug Tolerance; Female; Human | 1977 |
Determination of the isoniazid acetylator phenotype in a West African population.
Topics: Acetylation; Black People; Humans; Isoniazid; Nigeria; Phenotype; Time Factors; Tuberculosis, Pulmon | 1977 |
[Basis for the administration of streptomycin and isoniazid in ultrasonic aerosols in the treatment of intrathoracic tuberculosis].
Topics: Aerosols; Antitubercular Agents; Biopharmaceutics; Humans; Isoniazid; Streptomycin; Time Factors; Tu | 1977 |
[2 case of reports on marked toxic effects of isoniazid].
Topics: Adult; Humans; Isoniazid; Male; Middle Aged; Tuberculosis, Pulmonary | 1977 |
[Liver function and INH and PAS metabolism in tuberculous adolescents with side reactions to chemotherapy].
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Female; Humans; Isoniazid; Liver; Liver Funct | 1977 |
Urinary tract cancer and isoniazid.
Topics: Female; Humans; Isoniazid; Kidney Neoplasms; Male; Maryland; Middle Aged; Tuberculosis, Pulmonary; U | 1977 |
[Serum levels of isoniazid in patients with tuberculosis (author's transl)].
Topics: Acetylation; Adolescent; Adult; Aldehydes; Blood Chemical Analysis; Colorimetry; Female; Humans; Iso | 1977 |
[A study on the intensive chemotherapy for previously untreated pulmonary tuberculosis--comparison of two regimens, SM-INH-RFP and SM-INH-EB (author's transl)].
Topics: Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; St | 1977 |
[Experience with fast intravenous administration of isoniazid at antituberculous dispensaries].
Topics: Adolescent; Adult; Humans; Injections, Intravenous; Isoniazid; Middle Aged; Tuberculosis, Pulmonary | 1977 |
[Decomposition of INH and cycloserin preparations in the body of patients with tuberculosis of the lungs].
Topics: Adult; Cycloserine; Humans; Isoniazid; Middle Aged; Tuberculosis, Pulmonary | 1977 |
Antituberculous therapy in pregnancy. Risks to the fetus.
Topics: Ethambutol; Female; Humans; Isoniazid; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, | 1977 |
[Clinical efficacy of intermittent chemotherapy with initial intensive regimen in original treatment for pulmonary tuberculosis. Report of the 18th series of controlled trial of chemotherapy (author's transl)].
Topics: Adult; Drug Administration Schedule; Ethambutol; Humans; Isoniazid; Middle Aged; Rifampin; Streptomy | 1977 |
Preventing tuberculosis.
Topics: Humans; Isoniazid; Tuberculin Test; Tuberculosis; Tuberculosis, Pulmonary | 1977 |
Practical management and control of tuberculosis.
Topics: Adult; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Child; Drug Therapy, Combinati | 1977 |
[Intravenous isoniazid-sodium glucuronate therapy of tuberculosis (author's transl)].
Topics: Administration, Oral; Humans; Infusions, Parenteral; Isoniazid; Tuberculosis, Pulmonary | 1977 |
Tuberculosis after gastrointestinal surgery.
Topics: Adolescent; Digestive System Surgical Procedures; Esophagitis, Peptic; Female; Hernia, Hiatal; Human | 1977 |
Tuberculosis chemoprophylaxis.
Topics: Asia, Southeastern; Drug Resistance; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1977 |
Letter: Tuberculosis care in general hospitals: Arizona's experience.
Topics: Economics, Medical; Hospitalization; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberc | 1976 |
An assessment of the carcinogenicity of isoniazid in patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Animals; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Isoniaz | 1976 |
[Effect of the aerosol inhalations of some antibacterial preparations on the cocco bacterial flora of the respiratory tract in pulmonary tuberculosis].
Topics: Aerosols; Aged; Aminosalicylic Acids; Bronchi; Chronic Disease; Drug Evaluation; Drug Resistance, Mi | 1976 |
Influence of immunosuppression on the action of antimycobacterial drugs in experimental tuberculosis. I. Effects of isoniazid, rifampicin and streptomycin on the survival of tuberculous mice immunosuppressed by azathioprine (Imuran).
Topics: Animals; Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Immunosu | 1976 |
Letter: Simultaneous administration of isoniazid and BCG to the infant of a tuberculous mother.
Topics: BCG Vaccine; Female; Humans; Infant, Newborn; Isoniazid; Pregnancy; Tuberculosis, Pulmonary | 1976 |
Chemotherapy for tuberculosis.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; | 1976 |
[Advances in anti-tuberculosis therapy (author's transl)].
Topics: Antitubercular Agents; Dapsone; Drug Synergism; Humans; Isoniazid; Prothionamide; Tuberculosis, Pulm | 1976 |
[Functional state of the liver and the metabolism of isoniazid and PASA in adolescents with intrathoracic tuberculosis].
Topics: Adolescent; Aminosalicylic Acids; Female; Humans; Isoniazid; Liver; Male; Time Factors; Tuberculosis | 1976 |
A tuberculosis treatment survey in Singapore: results at five-years.
Topics: Adult; Age Factors; Aminosalicylic Acids; Female; Follow-Up Studies; Humans; Isoniazid; Male; Patien | 1976 |
[The frequency and form of manifestation of liver damage under INH therapy].
Topics: Alcoholism; Alkaline Phosphatase; Bilirubin; Cholestasis; Hepatomegaly; Humans; Isoniazid; Liver; Tr | 1976 |
[Haematological effects of isoprodian (author's transl)].
Topics: Adult; Aged; Blood; Blood Cell Count; Dapsone; Drug Combinations; Female; Hematocrit; Hemoglobinomet | 1976 |
[Treatment of severe open cavitary pulmonary tuberculosis with a combination of rifampicin and isoprodian (author's transl)].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Dapsone; Drug Combinations; Drug Therapy, Combinatio | 1976 |
[Isoniazid metabolism and the indicators of bioelectric activity of the brain in patients with tuberculosis during treatment with increased doses of isoniazid].
Topics: Action Potentials; Brain; Humans; Isoniazid; Tuberculosis, Pulmonary | 1976 |
[Role of blood proteins in binding and inactivation of HINA].
Topics: Adolescent; Adult; Blood Proteins; Female; Half-Life; Humans; Isoniazid; Male; Middle Aged; Protein | 1976 |
The treatment of tuberculosis.
Topics: Aged; Antitubercular Agents; Hospitalization; Humans; Isoniazid; Middle Aged; Tuberculosis, Pulmonar | 1976 |
High-dose ethambutol: its role in intermittent chemotherapy. A six-year study.
Topics: Adult; Ambulatory Care; Drug Administration Schedule; Drug Combinations; Drug Evaluation; Drug Thera | 1976 |
Asthma, steroid therapy, isoniazid.
Topics: Adrenal Cortex Hormones; Asthma; Humans; Isoniazid; Skin Tests; Tuberculosis, Pulmonary | 1976 |
Guidelines for the investigation and management of tuberculosis contacts.
Topics: Air Microbiology; Epidemiologic Methods; Humans; Isoniazid; Radiography; Risk; Sputum; Tuberculosis, | 1976 |
Tuberculosis among urban black children: failure of comprehensive health care services to influence incidence rates.
Topics: Adolescent; Aminosalicylic Acid; Black or African American; Child; Child Health Services; Child, Pre | 1976 |
[Rifampicin in the treatment of chronic pulmonary tuberculosis].
Topics: Antitubercular Agents; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Huma | 1976 |
Algorithms in the diagnosis and management of exotic diseases. XVI. Tuberculosis.
Topics: Ethambutol; Humans; Isoniazid; Risk; Tuberculin Test; Tuberculosis, Pulmonary | 1976 |
Stevens-Johnson syndrome caused by isoniazid.
Topics: Adult; Female; Humans; Isoniazid; Prednisolone; Stevens-Johnson Syndrome; Tetracyclines; Tuberculosi | 1976 |
[Intrabronchial infusion of drugs in pulmonary tuberculosis].
Topics: Adult; Bronchi; Humans; Infusions, Parenteral; Isoniazid; Middle Aged; Tuberculosis, Pulmonary | 1976 |
Two cases of ethambutol nephrotoxicity.
Topics: Acute Kidney Injury; Aged; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Male; Middle Aged; Ri | 1976 |
A follow-up examination of patients with pulmonary tuberculosis resected on suspicion of tumour.
Topics: Adult; Age Factors; Aged; Aminosalicylic Acid; Aminosalicylic Acids; Denmark; Female; Follow-Up Stud | 1976 |
[Efficient schemes for treating pulmonary tuberculosis with isoniazid under bacteriostatic concentration control].
Topics: Adult; Biopharmaceutics; Dose-Response Relationship, Drug; Duodenal Ulcer; Female; Humans; Isoniazid | 1976 |
[Study of liver function in pulmonary tuberculosis with the aid of ueviridin test and the indicators of urinary excretion of antitubercular agents].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Humans; Isoniazid; Liver; Liver Function Tests; Tuberculo | 1976 |
[Remote results of prophylactic examination of patients with chronic destructive pulmonary tuberculosis].
Topics: Adult; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1976 |
[Electroencephalographic criteria for disorders in the functional state of the central nervous system in pulmonary tuberculosis patients undergoing intensive isoniazid therapy].
Topics: Adolescent; Adult; Brain Diseases; Electroencephalography; Female; Humans; Isoniazid; Male; Middle A | 1976 |
[Content of active fraction of HINA in the blood of patients with pulmonary tuberculosis and infectious hepatitis during treatment with isoniazid].
Topics: Adult; Female; Hepatitis A; Humans; Isoniazid; Male; Middle Aged; Tuberculosis, Pulmonary | 1976 |
Chemoprophylaxis trial in Canadian Eskimos.
Topics: Adult; Arctic Regions; Canada; Child; Ethambutol; Female; Humans; Inuit; Isoniazid; Male; Time Facto | 1976 |
[Use of ethamide in complex treatment of pulmonary tuberculosis].
Topics: Drug Therapy, Combination; Humans; Isoniazid; Kidney; Probenecid; Tuberculosis, Pulmonary | 1976 |
[Effectiveness of chemotherapy and short-term pneumoperitoneum in the treatment of destructive pulmonary tuberculosis].
Topics: Adolescent; Adult; Aminosalicylic Acid; Aminosalicylic Acids; Drug Therapy, Combination; Evaluation | 1976 |
[Comparative evaluation of different regimens of chemotherapy of pulmonary tuberculosis in middle-aged and old patients].
Topics: Age Factors; Aged; Aminosalicylic Acid; Antitubercular Agents; Drug Administration Schedule; Drug Ev | 1976 |
Isonicotinic acid hydrazide (INH) induced syndrome of lupus erythematosus.
Topics: Child, Preschool; Female; Humans; Isoniazid; Lupus Erythematosus, Systemic; Tuberculosis, Pulmonary | 1976 |
Cutaneous reactions to isoniazid.
Topics: Adult; Child; Erythema Multiforme; Female; Humans; Isoniazid; Stevens-Johnson Syndrome; Tuberculosis | 1976 |
Intermittent short course treatment of pulmonary tuberculosis: preliminary report.
Topics: Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1976 |
A Singapore study of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis (1).
Topics: Adult; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Singapore | 1976 |
Intermittent treatment using isoniazid and rifampicin once a week: final results of a controlled trial.
Topics: Drug Therapy, Combination; Follow-Up Studies; Germany, West; Humans; Isoniazid; Rifampin; Tuberculos | 1976 |
The possibility of reducing the duration of hospital treatment in patients with newly diagnosed minimal pulmonary tuberculosis.
Topics: Aminosalicylic Acid; Drug Therapy, Combination; Humans; Isoniazid; Length of Stay; Streptomycin; Tub | 1976 |
A slow-release preparation of isoniazid: pharmacological aspects.
Topics: Acetylesterase; Delayed-Action Preparations; Humans; Isoniazid; Liver; Tuberculosis, Pulmonary | 1976 |
Two-three years follow up study of pulmonary tuberculosis treated 6 months with rifampicin-containing regimens.
Topics: Adult; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoniazid; Poland; Rifampin; Streptomyc | 1976 |
Hepatitis cases in isoniazid treated groups and in a control group.
Topics: Adult; Chemical and Drug Induced Liver Injury; Female; Humans; Isoniazid; Male; Middle Aged; Tubercu | 1976 |
Isoniazid-associated hepatitis.
Topics: Adult; Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Middle Aged; Population Surveillan | 1976 |
Isoniazid prophylaxis and deaths in Baltimore, Maryland 1972.
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Female; Humans; Isoniazid; Male; Maryland; Midd | 1976 |
Isoniazid (INH) prophylaxis in inactive pulmonary tuberculosis: report of a Veterans Administration Cooperative Study.
Topics: Follow-Up Studies; Humans; Isoniazid; Tuberculosis, Pulmonary; United States | 1976 |
Practical results of standard first-line treatment in pulmonary tuberculosis : influence of primary resistance.
Topics: Algeria; Drug Resistance, Microbial; Humans; Isoniazid; Microbial Sensitivity Tests; Streptomycin; T | 1976 |
Short-course chemotherapy in pulmonary tuberculosis.
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Time Factors; Tube | 1976 |
Short course treatment with two drugs, isoniazid plus rifampicin for six months: a controlled clinical trial with two treatment regimens.
Topics: Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1976 |
Hong Kong tuberculosis treatment services/British Medical Research Council Study of 6- and 9-month regimens of daily and intermittent streptomycin, isoniazid and pyrazinamide for pulmonary tuberculosis.
Topics: Adult; Hong Kong; Humans; Isoniazid; Pyrazinamide; Streptomycin; Time Factors; Tuberculosis, Pulmona | 1976 |
Simplified short-course treatment of pulmonary tuberculosis: experience with a regimen of ethambutol, rifampicin and isoniazid for 2 months followed by isoniazid or rifampicin for 4 months.
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis, Pulm | 1976 |
[Sensitivo-sensorial neuritis during anti-tubercular treatment].
Topics: Adult; Ethambutol; Female; Humans; Isoniazid; Optic Neuritis; Tuberculosis, Pulmonary; Vision Disord | 1976 |
Primary drug resistance in pulmonary tuberculosis.
Topics: Adult; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Middle Aged; Streptomycin; Tuber | 1976 |
Orificial tuberculosis of the lip.
Topics: Adult; Biopsy; Ethambutol; Humans; Isoniazid; Lip Diseases; Male; Mouth Mucosa; Pyridoxine; Radiogra | 1975 |
[Treatment of tuberculosis in a patient with glycogenosis].
Topics: Child; Glycogen Storage Disease; Humans; Isoniazid; Male; Tuberculosis, Pulmonary | 1975 |
[Bronchoscopy in tuberculosis before and after treatment with NA 872].
Topics: Bromhexine; Bronchoscopy; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Time F | 1975 |
Pneumothorax complicating bullous emphysema in childhood tuberculosis.
Topics: Aminosalicylic Acids; Humans; Infant; Injections, Spinal; Isoniazid; Male; Pneumothorax; Pulmonary E | 1975 |
Hepatotoxicity of rifampicin and isoniazid in children.
Topics: Adolescent; Chemical and Drug Induced Liver Injury; Hepatic Encephalopathy; Humans; Isoniazid; Liver | 1975 |
[A state of "epileptoid pathological impulsiveness" secondary to occasional dyspyridoxinosis caused by prolonged administration of isoniazid].
Topics: Child; Electroencephalography; Epilepsy; Humans; Isoniazid; Male; Pyridoxine; Tuberculosis, Pulmonar | 1975 |
Patterns of antinuclear antibodies and lupus-activating drugs.
Topics: Antibodies, Antinuclear; Anticonvulsants; Antigens; Chlorpromazine; Female; Humans; Hydralazine; Iso | 1975 |
Tuberculosis control in an urban Black community.
Topics: Absenteeism; Adolescent; BCG Vaccine; Black or African American; Black People; Child; Child, Prescho | 1975 |
Puerperal tuberculosis.
Topics: Adult; Aminosalicylic Acids; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Pregnancy; Pr | 1975 |
Finding recent tuberculous infection in New Orleans. Results of tuberculin skin tests on New Orleans children from the inner city and Contact Investigation Program.
Topics: Age Factors; Child, Preschool; Humans; Infant; Isoniazid; Louisiana; Tuberculin Test; Tuberculosis, | 1976 |
[Role of pyridoxine in an express method of intensive intravenous treatment of tuberculosis].
Topics: Adolescent; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Isoniazid; Male; Pyr | 1975 |
[Isoniazid and PAS metabolism and bacteriostatic activity of blood in adolescents with intrathoracic tuberculosis].
Topics: Adolescent; Aminosalicylic Acids; Blood Bactericidal Activity; Female; Humans; Isoniazid; Male; Tube | 1975 |
[Current aspects in treatment of tuberculosis].
Topics: Adult; Child; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tube | 1976 |
Neonatal pyridoxine responsive convulsions due to isoniazid therapy.
Topics: Female; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Isoniazid; Male; Pregnancy; Preg | 1976 |
[Comparative data on the study of single and fractional use of antitubercular agents of the first order in the treatment of tuberculosis in children and adolescents].
Topics: Adolescent; Aminosalicylic Acids; Child; Drug Therapy, Combination; Humans; Isoniazid; Streptomycin; | 1976 |
Clinical aspects of atypical mycobacterial infection.
Topics: Adult; Aged; Child, Preschool; Cycloserine; Diagnosis, Differential; Ethambutol; Ethionamide; Female | 1975 |
Autoanalytic (colormetric) determinations of SGOT in isoniazid recipients are reliable.
Topics: Aspartate Aminotransferases; Autoanalysis; Colorimetry; Humans; Isoniazid; Tuberculosis, Pulmonary | 1975 |
Tuberculous enteritis. Review of a protean disease.
Topics: Adult; Aged; Child; Diagnosis, Differential; Diarrhea; Emigration and Immigration; Enteritis; Ethamb | 1975 |
Letter: Intermittent chemotherapy for adults with tuberculosis.
Topics: Age Factors; Drug Therapy, Combination; Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1975 |
Letter: Intermittent chemotherapy for adults with tuberculosis.
Topics: Drug Therapy, Combination; Humans; Isoniazid; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1975 |
Diagnosis and management of tuberculous cervical adenitis.
Topics: Adult; Aminosalicylic Acids; Biopsy; Diagnosis, Differential; Drainage; Ethambutol; Humans; Isoniazi | 1975 |
[Effect on short-term memory of classic antitubercular drugs used in the treatment of tuberculosis].
Topics: Adolescent; Adult; Antitubercular Agents; Female; Humans; Isoniazid; Male; Memory, Short-Term; Middl | 1975 |
[Various clinical pictures of miliary tuberculosis (author's transl)].
Topics: Adolescent; Adult; Aminosalicylic Acids; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; | 1975 |
Isoniazid-associated hepatitis--serum enzyme determinations and histologic features.
Topics: Adolescent; Adult; Aged; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Child; | 1975 |
An assessment of the need for follow-up of patients with pulmonary tuberculosis adequately treated by chemotherapy.
Topics: Aminosalicylic Acids; Attitude to Health; Follow-Up Studies; Isoniazid; Physician-Patient Relations; | 1975 |
The Jewish Hospital of St. Louis therapeutic grand rounds number 10. Chemoprophylaxis of tuberculosis.
Topics: Adult; BCG Vaccine; Ethambutol; Humans; Isoniazid; Male; Neuritis; Streptomycin; Tuberculin Test; Tu | 1975 |
[Launois-Bensaude disease; etiopathogenic discussion in a patient treated with tuberculostatic agents].
Topics: Adult; Antitubercular Agents; Ethambutol; Functional Laterality; Humans; Isoniazid; Lipomatosis; Mal | 1975 |
[Mechanism of excretion of HINA metabolites by the kidneys of patients with pulmonary tuberculosis].
Topics: Adult; Humans; Isoniazid; Kidney; Metabolic Clearance Rate; Tuberculosis, Pulmonary | 1975 |
[Determination of isoniazid concentration in the blood by polarofraphic method].
Topics: Humans; Isoniazid; Polarography; Tuberculosis, Pulmonary | 1975 |
[Mechanism of the action of ultrasonics in cavernous pulmonary tuberculosis in rabbits].
Topics: Animals; Isoniazid; Pyridoxine; Rabbits; Streptomycin; Tuberculosis, Pulmonary; Ultrasonic Therapy | 1975 |
Editorial: Isoniazid-associated hepatitis. Reconsideration of the indications for administration of isoniazid.
Topics: Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Ethambutol; Humans; Isonia | 1975 |
Goals and productivity of tuberculosis screening.
Topics: Arkansas; Female; Humans; Isoniazid; Male; Mass Screening; Methods; Tuberculin Test; Tuberculosis, P | 1975 |
Tuberculosis screening and chest x-ray films.
Topics: Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Mass Chest X-Ray; New York City; Tubercul | 1975 |
Practicalities in tuberculosis treatment. An epilogue.
Topics: Ethambutol; Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1975 |
[Surface-active properties of pulmonary surfactant in experimental pulmonary tuberculosis].
Topics: Animals; Dogs; Drug Therapy, Combination; Isoniazid; Lung; Pulmonary Surfactants; Pyridoxine; Surfac | 1975 |
[Value of ethivanamide combined with isonicotinic acid hydrazine in the intermittent treatment of pulmonary tuberculosis].
Topics: Drug Therapy, Combination; Ethionamide; Humans; Isoniazid; Time Factors; Tuberculosis, Pulmonary | 1975 |
Hong Kong Tuberculosis Treatment Services/British Medical Research Council study of short-course regimens of streptomycin, isoniazid and pyrazinamide: latest results.
Topics: Adult; Drug Evaluation; Humans; Isoniazid; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary | 1975 |
Two phase chemotherapy with streptomycin isoniazid and ethambutol, followed by isoniazid and ethambutol.
Topics: Adolescent; Adult; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Ag | 1975 |
Pregnancy and pulmonary tuberculosis.
Topics: Antitubercular Agents; BCG Vaccine; Birth Weight; Delivery, Obstetric; Ethambutol; Female; Humans; I | 1975 |
Ethionamide+cycloserine+pas vs isoniazid+streptomycin+pas in initial antiburerculosis chemotherapy followed by the standard regimen. A controlled study with special reference to the microscopic enumeration of bacillia as a criterion of efficacy.
Topics: Aminosalicylic Acids; Cycloserine; Drug Therapy, Combination; Ethionamide; Humans; Isoniazid; Strept | 1975 |
[Controlled intermittent chemotherapy with isoniazid and the second line preparations].
Topics: Adult; Aged; Antitubercular Agents; Drug Hypersensitivity; Evaluation Studies as Topic; Humans; Ison | 1975 |
Determination of the acetylator phenotype using matrix isoniazid.
Topics: Acetylation; Africa, Eastern; Black People; Delayed-Action Preparations; Humans; Isoniazid; Phenotyp | 1975 |
[Acute renal failure following para-aminosalicylic-acid therapy].
Topics: Acute Kidney Injury; Adult; Aminosalicylic Acids; Drug Therapy, Combination; Humans; Isoniazid; Male | 1975 |
[Viral hepatitis and pulmonary tuberculosis].
Topics: Aminosalicylic Acids; Hepatitis A; Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1975 |
Some bacteriologic aspects of the epidemiology of pulmonary and extrapulmonary tuberculosis.
Topics: Adult; Aminosalicylic Acids; Catalase; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; | 1976 |
Tuberculosis infection in a paediatric department.
Topics: Child; Child, Preschool; Cross Infection; Follow-Up Studies; Hospital Departments; Humans; Infant, N | 1976 |
Letter: The isoniazid problem.
Topics: Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Liver; Risk; Tuberculosis, Pulmonary | 1976 |
Letter: The isoniazid problem.
Topics: Adult; Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Liver; Risk; Tuberculosis, Pulmona | 1976 |
[The course of pulmonary tuberculosis in the initial phase of various intensive therapy combinations].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Administration Schedule; Drug Evaluation; Drug The | 1976 |
[The adverse effects of 2 therapy combinations (SM, PAS, INH, RMP, INH, EMB) in the intensive treatment phase of pulmonary tuberculosis].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; | 1976 |
Rifampin-induced methadone withdrawal.
Topics: Adult; Aged; Drug Interactions; Heroin Dependence; Humans; Isoniazid; Male; Methadone; Middle Aged; | 1976 |
[Late results of treatment with rifampicin combined with SM and INH in newly detected cases of pulmonary tuberculosis].
Topics: Adult; Drug Therapy, Combination; Humans; Isoniazid; Middle Aged; Rifampin; Streptomycin; Tuberculos | 1976 |
The prevalence of tuberculosis and positive tuberculin skin tests in a steroid-treated asthmatic population.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Asthma; Chicago; Child; Female; Humans; Isoniazid; Male; | 1976 |
[Letter: Gynecomastia caused by isoniazid. Value of determination of the inactivation phenotype].
Topics: Gynecomastia; Humans; Isoniazid; Male; Middle Aged; Phenotype; Tuberculosis, Pulmonary | 1976 |
[Side-effects in chemotherapy of pulmonary tuberculosis].
Topics: Adult; Aged; Alanine Transaminase; Aminosalicylic Acids; Chemical and Drug Induced Liver Injury; Cre | 1976 |
Discharge of tuberculosis patients from medical surveillance.
Topics: Humans; Isoniazid; Patient Care Planning; Societies, Medical; Tuberculosis, Pulmonary; United States | 1976 |
Determination of acetylator phenotype based on the ratio of acetylisoniazid to isoniazid in urine following an oral dose of ordinary isoniazid.
Topics: Acetylation; Administration, Oral; Humans; Isoniazid; Phenotype; Tuberculosis, Pulmonary | 1976 |
Fatal hepatic necrosis due to isoniazid chemoprophylaxis in a 15-year-old girl.
Topics: Adolescent; Adult; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Female; Hepa | 1976 |
Isoniazid inactivation in Black patients with tuberculosis.
Topics: Acetylation; Adult; Aged; Black People; Female; Half-Life; Humans; Isoniazid; Male; Middle Aged; Sou | 1976 |
Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania.
Topics: Acquired Immunodeficiency Syndrome; Adult; Comorbidity; Drug Combinations; Drug Eruptions; Drug Ther | 1992 |
Guidelines for the identification, investigation and treatment of individuals with concomitant tuberculosis and human immunodeficiency virus infection. Canadian Thoracic Society, the Tuberculosis Directors of Canada and the Department of National Health a
Topics: AIDS-Related Opportunistic Infections; Canada; Emigration and Immigration; Humans; Isoniazid; Mass S | 1992 |
Lymph node tuberculosis: 7-year experience in Veterans General Hospital, Taipei, Taiwan.
Topics: Adult; Age Factors; Aged; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Mi | 1992 |
Clinical significance of adrenal computed tomography in Addison's disease.
Topics: Addison Disease; Adrenal Glands; Adult; Aged; Atrophy; Female; Humans; Hydrocortisone; Isoniazid; Ma | 1992 |
Tolerance of ofloxacin in the treatment of pulmonary tuberculosis in presence of hepatic dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Drug Monitoring; Drug Therap | 1992 |
Fixed dose combination short course chemotherapy in the treatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Middle Age | 1992 |
Drug-resistant TB may bring epidemic.
Topics: Chromatography, High Pressure Liquid; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium t | 1992 |
Emergence during unsuccessful chemotherapy of multiple drug resistance in a strain of Mycobacterium tuberculosis.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Age | 1992 |
Cross-sectional survey of HIV infection among patients with tuberculosis in Nairobi, Kenya.
Topics: Adolescent; Adult; Cross-Sectional Studies; Drug Combinations; Drug Therapy, Combination; Female; HI | 1992 |
Case holding in patients with tuberculosis in Botswana.
Topics: Botswana; Drug Therapy, Combination; Humans; Isoniazid; National Health Programs; Patient Compliance | 1992 |
[An optimal method of pharmacological prevention of tuberculosis among adolescents].
Topics: Adolescent; Adolescent Medicine; Drug Administration Schedule; Female; Humans; Isoniazid; Male; Tube | 1992 |
Isoniazid preventive therapy of tuberculosis: decision analysis considering ethnicity and gender.
Topics: Adult; Decision Support Techniques; Female; Humans; Isoniazid; Male; Tuberculosis, Pulmonary | 1992 |
Bioavailability of rifampin in experimental murine tuberculosis.
Topics: Animals; Biological Availability; Isoniazid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; | 1992 |
Factors in hydrazine formation from isoniazid by paediatric and adult tuberculosis patients.
Topics: Acetylation; Adult; Chemical and Drug Induced Liver Injury; Child, Preschool; Humans; Hydrazines; In | 1992 |
[Therapy of pulmonary tuberculosis].
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; Humans; Inpatients; Isoniazid; | 1992 |
[Effect of plasmapheresis on the course of experimental tuberculosis and the tolerance of chemotherapy by patients with renal tuberculosis].
Topics: Animals; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Disease Models, Animal; | 1992 |
Tuberculosis. Back to a frightening future.
Topics: Bacterial Proteins; Catalase; Developing Countries; Drug Resistance, Microbial; Europe; Genes, Bacte | 1992 |
[Secondary sideroblastic anemia caused by long term administration of anti-tuberculous agents including isoniazid].
Topics: Anemia, Sideroblastic; Antitubercular Agents; Humans; Isoniazid; Male; Middle Aged; Tuberculosis, Pu | 1992 |
Culture-positive tuberculosis in Western Australia.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Resistance, Microbial; Emigration and Immigra | 1992 |
[A case of pulmonary tuberculosis associated with severe skin eruption, prominent eosinophilia, and liver dysfunction induced by streptomycin].
Topics: Adult; Chemical and Drug Induced Liver Injury; Drug Eruptions; Drug Therapy, Combination; Eosinophil | 1992 |
Hydrazine--a possible cause of isoniazid--induced hepatic necrosis.
Topics: Age Factors; Aged; Antitubercular Agents; Humans; Hydrazines; Isoniazid; Liver; Male; Necrosis; Tube | 1992 |
Perspective: preventive isoniazid therapy and the liver.
Topics: Adolescent; Aged; Chemical and Drug Induced Liver Injury; Female; Humans; Isoniazid; Male; Tuberculo | 1992 |
Tuberculosis rebounding.
Topics: BCG Vaccine; Humans; Isoniazid; Mycobacterium tuberculosis; Recombinant Proteins; Research; Tubercul | 1992 |
Resistance to antituberculosis drugs in treated patients in Lagos, Nigeria.
Topics: Adolescent; Adult; Aminosalicylic Acid; Antitubercular Agents; Child; Child, Preschool; Drug Resista | 1992 |
[Pulmonary infection caused by Mycobacterium gordonae (M. gordonae) in a healthy middle-aged male].
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infection | 1992 |
Contact investigation and isoniazid chemoprophylaxis in New York City, 1979-1987.
Topics: Contact Tracing; Cross-Sectional Studies; Follow-Up Studies; Humans; Incidence; Isoniazid; New York | 1992 |
[Isoniazid content of lungs in patients with pulmonary tuberculosis depending on the method of its administration as part of a comprehensive preoperative preparation].
Topics: Administration, Oral; Humans; Infusions, Intravenous; Isoniazid; Lung; Preoperative Care; Tuberculos | 1992 |
[A radiographic progression during and after initial chemotherapy for pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Female; Humans; Isoniazid; Male; Middle Aged; Radiog | 1992 |
Results of a directly observed intermittent isoniazid preventive therapy program in a shelter for homeless men.
Topics: Aged; Disease Outbreaks; Housing; Humans; Ill-Housed Persons; Isoniazid; Male; Middle Aged; Patient | 1992 |
High rate of rifampicin resistance of Mycobacterium tuberculosis in the Taif region of Saudi Arabia.
Topics: Adolescent; Adult; Age Factors; Aged; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; M | 1992 |
[Possibility of the treatment of tuberculosis with delayed-action polymeric isoniazid].
Topics: Animals; Biocompatible Materials; Dextrans; Drug Evaluation, Preclinical; Drug Implants; Guinea Pigs | 1990 |
Isoniazid preventive therapy for tuberculosis. Decision analysis considering ethnicity and gender.
Topics: Adult; Age Factors; Chemical and Drug Induced Liver Injury; Decision Support Techniques; Decision Tr | 1991 |
Effect of simultaneous isoniazid administration on pharmacokinetic parameters of pyrazinamide.
Topics: Adult; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Metabolic Clearance Rate; Middle | 1991 |
AIDS and tuberculosis in Spain. A report of 140 cases.
Topics: Acquired Immunodeficiency Syndrome; Drug Therapy, Combination; Ethambutol; Female; Humans; Incidence | 1991 |
[Anti-tuberculosis antibodies in the immunoenzyme test in relation to the effectiveness of chemotherapy of tuberculosis].
Topics: Adolescent; Adult; Aged; Antibodies, Bacterial; Drug Therapy, Combination; Female; Humans; Immunoenz | 1991 |
[Use of dimephosphon in pathogenetic therapy of experimental tuberculosis].
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Admin | 1991 |
Disturbance of the psychological balance during isoniazid preventive chemotherapy.
Topics: Adolescent; Adult; Child; Female; Humans; Isoniazid; Liver; Male; Psychoses, Substance-Induced; Tube | 1991 |
[Pathomorphological assessment of the therapeutic effect of mycobacteriophages in tuberculosis].
Topics: Animals; Isoniazid; L Forms; Lung; Lung Diseases; Mycobacteriophages; Mycobacterium tuberculosis; Ph | 1991 |
[New methods of prevention, diagnosis and treatment of tuberculosis in children].
Topics: Age Factors; Antitubercular Agents; BCG Vaccine; Child; Humans; Isoniazid; Tuberculosis, Pulmonary | 1991 |
[Dynamics of specific changes in recurrences of pulmonary tuberculosis in relation to chemotherapy schedules].
Topics: Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Is | 1991 |
[Standardized controlled antitubercular therapy and results in 755 patients].
Topics: Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid | 1991 |
Disseminated intravascular coagulopathy associated with rifampicin.
Topics: Adult; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Female; Humans; Isoniazid; | 1991 |
Phenytoin toxicity in a patient with isoniazid-induced hepatitis.
Topics: Adult; Chemical and Drug Induced Liver Injury; Drug Interactions; Epilepsy; Female; Humans; Isoniazi | 1991 |
Anti-tubercular treatment in patients with hepatitis.
Topics: Alanine Transaminase; Bilirubin; Drug Therapy, Combination; Ethambutol; Hepatitis, Viral, Human; Hum | 1991 |
[Early detection of tuberculosis and its pharmacological prevention in children from the epizootologically unfavorable territories].
Topics: Animals; Cattle; Child; Drug Synergism; Ethambutol; Humans; Isoniazid; Kazakhstan; Time Factors; Tub | 1991 |
[The efficacy of preventive chemotherapy in inhabitants of rural areas at increased risk of tuberculosis].
Topics: Humans; Isoniazid; Risk Factors; Rural Health; Tuberculosis, Pulmonary; Ukraine | 1991 |
Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons--Florida and New York, 1988-1991.
Topics: Acquired Immunodeficiency Syndrome; Cross Infection; Drug Resistance, Microbial; Ethambutol; Florida | 1991 |
[A differential method of pharmacological prevention of tuberculosis in children in a sanatorium].
Topics: Adolescent; Carrier State; Child; Ethambutol; Health Resorts; Humans; Isoniazid; Respiratory Tract I | 1991 |
[Chemotherapeutic regimens that were considered effective to cure pulmonary infection caused by Mycobacterium avium-Mycobacterium intracellulare complex].
Topics: Adult; Aged; Drug Therapy, Combination; Enviomycin; Ethambutol; Female; Humans; Isoniazid; Kanamycin | 1991 |
From the Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons--Florida and New York, 1988-1991.
Topics: Acquired Immunodeficiency Syndrome; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; | 1991 |
Isoniazid prophylaxis for young adults.
Topics: Adult; Humans; Isoniazid; Tuberculin Test; Tuberculosis, Pulmonary | 1991 |
[Adverse effect of etiotropic agents in patients with tuberculosis].
Topics: Alcohol Drinking; Drug Hypersensitivity; Ethionamide; Humans; Isoniazid; Rifampin; Tuberculosis, Pul | 1991 |
Tuberculosis screening in a nursing home: indications for preventive therapy.
Topics: Adult; Aged; Home Nursing; Humans; Isoniazid; Middle Aged; Risk Factors; Tuberculin Test; Tuberculos | 1991 |
Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Drug Administration Schedule; Drug Therapy, Combination; | 1991 |
Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenström's macroglobulinemia.
Topics: Aged; Blood Transfusion; Cryoglobulins; Erythrocyte Transfusion; Factor XIII; Factor XIII Deficiency | 1991 |
[Effects of isoniazid and rifampicin on cell elements of cultured intact pulmonary tissue from experimental animals].
Topics: Animals; Culture Techniques; Dogs; Isoniazid; Lung; Mice; Mycobacterium tuberculosis; Rifampin; Tube | 1991 |
Short course chemotherapy for pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Administration Schedule; Drug Therapy, Combination; | 1991 |
The management of pulmonary tuberculosis in adults notified in England and Wales in 1988. The British Thoracic Society Research Committee and the Medical Research Council Cardiothoracic Epidemiology Group.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; England; Humans; Iso | 1991 |
Efficacy of intermittent pyrazinamide in experimental murine tuberculosis.
Topics: Animals; Colony Count, Microbial; Drug Administration Schedule; Drug Therapy, Combination; Isoniazid | 1991 |
Relapse of tuberculosis in a patient with the acquired immunodeficiency syndrome despite 12 months of antituberculous therapy and continuation of isoniazid.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antitubercular Agents; Humans; Isoniazid; Male; Recurrenc | 1991 |
Six-months isoniazid-rifampin treatment for pulmonary tuberculosis in children.
Topics: Child; Costs and Cost Analysis; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Time Factors | 1991 |
Isoniazid resistant tuberculosis in a school outbreak: the protective effect of BCG.
Topics: Adolescent; Adult; BCG Vaccine; Child, Preschool; Disease Outbreaks; Drug Resistance, Microbial; Fem | 1991 |
The disposition of antituberculous drugs in plasma of elderly patients. I. Isoniazid and hydrazine metabolite.
Topics: Acetylation; Adult; Aged; Aged, 80 and over; Aging; Female; Humans; Isoniazid; Male; Middle Aged; Py | 1991 |
The disposition of antituberculous drugs in plasma of elderly patients. II. Isoniazid, rifampicin and pyrazinamide.
Topics: Adult; Aged; Aged, 80 and over; Aging; Female; Humans; Isoniazid; Male; Metabolic Clearance Rate; Mi | 1991 |
[Management of INH and RFP-resistant refractory tuberculosis].
Topics: Drug Resistance; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Ofloxacin; Rifamycins; | 1991 |
Perinatal prophylaxis of tuberculosis.
Topics: BCG Vaccine; Female; Humans; Infant, Newborn; Isoniazid; Mycobacterium tuberculosis; Tuberculin Test | 1990 |
Cutaneous tuberculosis: atypical skin lesions in immunodepressed patients.
Topics: Adult; Colitis, Ulcerative; Ethambutol; Humans; Isoniazid; Prednisone; Rifampin; Sulfasalazine; Tube | 1990 |
Chromosomal aberrations in tuberculosis patients before and after treatment with short-term chemotherapy.
Topics: Chromosome Aberrations; Drug Therapy, Combination; Humans; Isoniazid; Mutagens; Pyrazinamide; Rifamp | 1991 |
Tuberculosis in house staff. A decision analysis comparing the tuberculin screening strategy with the BCG vaccination.
Topics: BCG Vaccine; Decision Support Techniques; Humans; Internship and Residency; Isoniazid; Occupational | 1991 |
[Bilateral galactorrhea in chemoprophylactic treatment with isoniazid].
Topics: Adult; Female; Galactorrhea; Humans; Isoniazid; Tuberculosis, Pulmonary | 1990 |
A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Aspartate Aminotransferases; Cost-Benefit Analysis; | 1990 |
Smear-negative, culture-positive pulmonary tuberculosis. Six-month chemotherapy with isoniazid and rifampin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antitubercular Agents; Bacteriolo | 1990 |
The pathogenicity of Mycobacterium tuberculosis during chemotherapy.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combina | 1990 |
[Short- and long-term results of tuberculosis therapy with a fixed combination of isoniazide, prothionamide and diaminodiphenylsulfone combined with rifampicin].
Topics: Dapsone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Isonicotinic Acids | 1990 |
[In 76% of patients with active tuberculosis treated with triple therapy (isoniazid-rifampicin-pyrazinamide) cultural conversion precedes microscopic conversion].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Humans; Isoniazid; Ma | 1990 |
The mycobacteriology of pulmonary tuberculosis in South African gold miners.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Humans; Isoniazid; Male; Mining; Mycobacterium tu | 1990 |
Antituberculous drug resistance in central Haiti.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Drug Res | 1990 |
In-vitro activity of ofloxacin against Mycobacterium tuberculosis and its clinical efficacy in multiply resistant pulmonary tuberculosis.
Topics: Adult; Aged; Anti-Bacterial Agents; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Mid | 1990 |
A cost-effectiveness analysis of the routine use of isoniazid prophylaxis in patients with a positive Mantoux skin test.
Topics: Adolescent; Adult; Aged; Canada; Child; Cost-Benefit Analysis; Humans; Isoniazid; Middle Aged; Tuber | 1990 |
An outbreak of isoniazid resistant tuberculosis in Glasgow 1981-1988.
Topics: Alcoholism; Cluster Analysis; Disease Outbreaks; Drug Resistance, Microbial; Female; Humans; Ill-Hou | 1990 |
[The effect of anti-recurrence treatment with isoniazid in combination with etimizol on the immune reactivity of Group III ambulatory care patients].
Topics: Adult; Aged; Ambulatory Care; Drug Therapy, Combination; Etimizol; Female; Humans; Immunity; Isoniaz | 1990 |
[Optimization of methods and organization of the chemotherapeutic prevention of tuberculosis in children in family foci of infection].
Topics: Adolescent; Child; Child, Preschool; Family Health; Humans; Infant; Isoniazid; Rural Health; Tubercu | 1990 |
Exacerbation of isoniazid induced peripheral neuropathy by pyridoxine.
Topics: Acetylation; Arthritis, Rheumatoid; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium | 1990 |
[The treatment of primary tuberculosis].
Topics: Anti-Bacterial Agents; Child; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Tuberculosis, | 1990 |
Isoniazid-induced obsessive compulsive neurosis.
Topics: Child; Humans; Isoniazid; Male; Obsessive-Compulsive Disorder; Tuberculosis, Pulmonary | 1990 |
[An experimental study of the chemotherapeutic efficacy of flurenizid, a new antitubercular pharmaceutical].
Topics: Animals; Antitubercular Agents; Drug Therapy, Combination; Guinea Pigs; Heterocyclic Compounds; Ison | 1990 |
Any questions? How should a patient be managed who is being treated for sputum positive pulmonary tuberculosis and becomes jaundiced in the third week of chemotherapy?
Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Jaundice; Pyrazinamide; Rifampi | 1990 |
Effects of two pulmonary tuberculosis drug treatments and acetylator status on liver function in a Zimbabwean population.
Topics: Alanine Transaminase; Alkaline Phosphatase; Chemical and Drug Induced Liver Injury; Drug Therapy, Co | 1990 |
Effectiveness of multidrug therapies in tuberculosis.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculo | 1990 |
Six-month isoniazid-rifampin treatment for pulmonary tuberculosis in children.
Topics: Adolescent; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female | 1990 |
Decision analysis, public health policy, and isoniazid chemoprophylaxis for young adult tuberculin skin reactors.
Topics: Adult; Chemical and Drug Induced Liver Injury; Decision Support Techniques; Health Policy; Humans; I | 1990 |
[The pro-fibrotic and pro-oxidant action of isoniazid].
Topics: Animals; Isoniazid; Lipid Peroxidation; Pulmonary Fibrosis; Rats; Tuberculosis, Pulmonary | 1990 |
[Treatment of tuberculosis. Drug combinations, therapeutic problems and results in a 10-year case load].
Topics: Antitubercular Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male | 1990 |
[Clinico-laboratory diagnosis of adverse reactions in children to antitubercular drugs in different combinations].
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Drug Hypersensitivity; Drug Therapy, Com | 1990 |
[The elimination of chemotherapy side effects in pulmonary tuberculosis patients].
Topics: Adult; Antitubercular Agents; Central Nervous System; Drug Evaluation; Drug Therapy, Combination; Hu | 1990 |
Isoniazid-rifampin-induced hepatitis in hepatitis B carriers.
Topics: Carrier State; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Female | 1990 |
[Intolerance of chemotherapy of pulmonary tuberculosis in a patient with hysterical neurosis].
Topics: Adult; Drug Hypersensitivity; Female; Humans; Hypnosis; Hysteria; Isoniazid; Psychophysiologic Disor | 1990 |
[Clinico-pharmacokinetic interactions of rifampicin, pyrazinamide and isoniazide].
Topics: Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Humans; Infusions, Intravenous; I | 1990 |
[A high pressure liquid chromatography method for detecting the isoniazid derivative isonicotinoyl-hydrazine sodium glucuronide, free isoniazid and acetylisoniazid and its use in pharmacologic studies].
Topics: Acetylation; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Humans; I | 1990 |
[Significance of the acetylator phenotype and initial oral/intravenous rifampicin administration in the treatment of tuberculosis].
Topics: Acetylation; Administration, Oral; Ethambutol; Humans; Isoniazid; Metabolic Clearance Rate; Mixed Fu | 1990 |
[The effect of isoniazid on regional hemodynamics in the lesser circulation in patients with destructive pulmonary tuberculosis].
Topics: Adult; Hemodynamics; Humans; Isoniazid; Male; Pulmonary Circulation; Tuberculosis, Pulmonary | 1990 |
[Detection of a pathological cutaneous reaction to tuberculin in an adolescent].
Topics: Adolescent; Antitubercular Agents; BCG Vaccine; Drug Therapy, Combination; Humans; Isoniazid; Physic | 1990 |
[Six-month treatment of pulmonary tuberculosis in children. Review of 11 cases].
Topics: Antitubercular Agents; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Ethamb | 1990 |
Salivary levels of isoniazid and rifampicin in tuberculous patients.
Topics: Adolescent; Adult; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Saliva; Tuberculosis; Tub | 1990 |
Testing for isoniazid. An evaluation of the Arkansas method.
Topics: Arkansas; Colorimetry; Evaluation Studies as Topic; Humans; Indicators and Reagents; Isoniazid; Nico | 1990 |
[The efficacy of the treatment of newly diagnosed patients with destructive tuberculosis of the lungs using rifampicin in combination with other drugs].
Topics: Adult; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomyc | 1990 |
[Combined use of antitubercular drugs and metabolites of the tricarboxylic acid cycle in experimental tuberculosis].
Topics: Animals; Antitubercular Agents; Delayed-Action Preparations; Drug Evaluation, Preclinical; Drug Ther | 1990 |
[Treatment of disseminated destructive pulmonary tuberculosis by intracavernous administration of antibacterial drugs].
Topics: Adolescent; Adult; Antitubercular Agents; Child; Drug Therapy, Combination; Female; Humans; Isoniazi | 1990 |
[Characteristics of isoniazid pharmacokinetics in the blood of patients with pulmonary tuberculosis with concomitant chronic Trematode infections].
Topics: Adolescent; Adult; Aged; Biological Availability; Chronic Disease; Half-Life; Humans; Isoniazid; Liv | 1990 |
Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis.
Topics: Antitubercular Agents; Drug Evaluation; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; M | 1986 |
[Tuberculosis control in Malawi. Time distribution of cessation of treatment and proposals for reorientation of the program].
Topics: Ambulatory Care; Hospitalization; Humans; Isoniazid; Malawi; Patient Compliance; Referral and Consul | 1986 |
[The therapeutic efficacy of a streptomycin-hydrazide-thiacetazone regimen with different dosages of thiacetazone in pulmonary tuberculosis].
Topics: Drug Therapy, Combination; Humans; Isoniazid; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1986 |
180 doses in 26 weeks vs 56 doses in 24 weeks of chemotherapy in pulmonary tuberculosis: a preliminary report.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Female; Hu | 1988 |
An outbreak of tuberculosis in rural Delaware.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Delaware; Disease Outbreaks; Female; Humans; Infan | 1989 |
[Two cases of long-lasting SPCN status].
Topics: Adult; Drug Resistance; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Rifampin; Tuberculosis, | 1989 |
Isoniazid acetylation and polymorphism in humans.
Topics: Acetylation; Acetyltransferases; Adolescent; Adult; Female; Humans; Isoniazid; Male; Middle Aged; Ph | 1989 |
Phenytoin--isoniazid interaction.
Topics: Adult; Cerebellar Ataxia; Drug Synergism; Drug Therapy, Combination; Epilepsy, Tonic-Clonic; Humans; | 1989 |
[Genetic polymorphism of isoniazid acetylation in Chilean patients with tuberculosis].
Topics: Acetylation; Adolescent; Adult; Aged; Child; Chile; Female; Humans; Isoniazid; Male; Middle Aged; Ph | 1989 |
[Rifabutine in the treatment of mycobacterial infections resistant to rifampicin. Preliminary results. Group for the Study and Treatment of Resistant Mycobacterial Infections (GETIM)].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Drug Resistance, Microbial; Drug Therapy, Combinati | 1989 |
[Pulmonary opportunistic infections in patients with autoimmune diseases].
Topics: Adult; Aged; Autoimmune Diseases; Female; Humans; Isoniazid; Lung Diseases, Fungal; Male; Middle Age | 1989 |
[Hepatotoxicity of the combination of isoniazid-rifampicin in African children. Role of malnutrition and HB virus].
Topics: Adolescent; Africa; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug Combinatio | 1989 |
Attempted suicide following treatment with isoniazid.
Topics: Adult; Humans; Isoniazid; Male; Psychoses, Substance-Induced; Suicide, Attempted; Tuberculosis, Pulm | 1989 |
Hepatic function in relation to acetylator phenotype in children treated with antitubercular drugs.
Topics: Acetylation; Child; Child, Preschool; Female; Humans; Infant; Isoniazid; Liver; Male; Phenotype; Rif | 1989 |
[Tuberculosis: a current problem of primary concern].
Topics: Adult; Carrier State; Child; Child, Preschool; Female; Humans; Isoniazid; Male; Spain; Tuberculosis, | 1989 |
[A short course of chemotherapy in newly diagnosed and retreatment of smear-positive pulmonary tuberculosis in a rural area].
Topics: Adolescent; Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; | 1989 |
[Tuberculous ulcer of the tongue: clinical case].
Topics: Adult; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Tongue Diseases; Tuberculosis; Tuberculosi | 1989 |
[Immediate and long-term results of the combined treatment of patients with extensive destructive tuberculosis of the lungs].
Topics: Adult; Ethionamide; Female; Follow-Up Studies; Glucocorticoids; Humans; Isoniazid; Male; Middle Aged | 1989 |
[Experimental validation of the expediency of the use of ultra-high frequency therapy in combination with antibacterial drugs in infiltrative tuberculosis of the lungs].
Topics: Animals; Antitubercular Agents; Combined Modality Therapy; Isoniazid; Male; Microcirculation; Pulmon | 1989 |
[Polychemotherapy of patients with chronic destructive forms of pulmonary tuberculosis in interregional tuberculosis hospitals].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Rifamy | 1989 |
[Experience with intensive short-term chemotherapy of patients with recently diagnosed destructive pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazi | 1989 |
Importance of rifampicin in combined daily/intermittent chemotherapy for tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Dapsone; Drug Combinations; Drug Evaluation; Drug Th | 1989 |
[Effectiveness of intermittent chemotherapy in the combined treatment of patients with recently diagnosed destructive tuberculosis of the lungs].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Humans; Isoniazid | 1989 |
[Use of therapeutic pneumothorax in patients with progressive destructive tuberculosis of the lungs].
Topics: Adult; Evaluation Studies as Topic; Female; Humans; Isoniazid; Male; Pneumothorax, Artificial; Strep | 1989 |
[Treatment efficacy in destructive forms of pulmonary tuberculosis in relation to the methods of administering rifadin and isoniazid].
Topics: Administration, Inhalation; Administration, Oral; Adult; Bronchi; Drug Evaluation; Drug Therapy, Com | 1989 |
[Lymphotropic therapy in the combined treatment of pulmonary tuberculosis in children and adolescents].
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Human | 1989 |
[Studies on the effectiveness of a new model for treating tuberculosis with prolonged administration of isoniazid].
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Drug Administration Schedule; Drug Eval | 1989 |
[Original treatment of pulmonary tuberculosis by enviomycin (EVM)].
Topics: Adult; Age Factors; Aged; Drug Therapy, Combination; Enviomycin; Female; Humans; Isoniazid; Male; Mi | 1987 |
Lung cancer, tuberculin reactivity, and isoniazid.
Topics: Adult; Aged; Carcinoma, Small Cell; Female; Humans; Isoniazid; Lung Neoplasms; Male; Middle Aged; My | 1988 |
Pulmonary problems of pregnancy.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Asthma; Drug Therapy, Combination; Ethambutol; | 1985 |
[Sequential development of vitamin D metabolites under isoniazid and rifampicin therapy].
Topics: Adolescent; Adult; Alkaline Phosphatase; Calcitriol; Child; Child, Preschool; Female; gamma-Glutamyl | 1988 |
Smear- and culture-negative pulmonary tuberculosis: four-month short-course chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Arkansas; Drug Therapy, Combination; Female; | 1989 |
Pulmonary tuberculosis, cryoglobulinemia and immunecomplex glomerulonephritis.
Topics: Adult; Cryoglobulinemia; Drug Therapy, Combination; Glomerulonephritis; Humans; Immune Complex Disea | 1987 |
[Role of phospholipase A2 in regulating lipid peroxidation and the respiratory chain in experimental tuberculosis].
Topics: Animals; Butylated Hydroxytoluene; Drug Therapy, Combination; Electron Transport Complex IV; Isoniaz | 1985 |
Tuberculosis in Korea. The relationship between prior therapy and drug resistance.
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; E | 1986 |
[Comparative therapeutic activity of rifampicin and isoniazid in different densities of microbial population in the lungs of experimental animals].
Topics: Animals; Isoniazid; Lung; Mice; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 1986 |
Primary drug-resistant tuberculosis in children. Emergence of primary drug-resistant strains of M. tuberculosis to rifampin.
Topics: Adolescent; Child; Child, Preschool; Drug Resistance, Microbial; Ethambutol; Humans; Infant; Infant, | 1986 |
The Birmingham Tuberculosis Drug Resistance Register, 1956-1983.
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Resistance, Microbial; Emigration and Immigration; | 1986 |
Exogenous reinfection with tuberculosis in a shelter for the homeless.
Topics: Adult; Alcoholism; Boston; Drug Resistance, Microbial; Housing; Humans; Ill-Housed Persons; Isoniazi | 1986 |
Implications of emerging isoniazid resistance in Mycobacterium tuberculosis in Korea.
Topics: Drug Resistance, Microbial; Female; Humans; Isoniazid; Korea; Male; Military Personnel; Mycobacteriu | 1987 |
[Detection of pulmonary tuberculosis in adolescents in institutions of the general medical network and efficacy of its treatment].
Topics: Adolescent; Antitubercular Agents; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Rifa | 1987 |
Isoniazid and ethambutol as a cause of optic neuropathy.
Topics: Aged; Diabetes Mellitus, Type 2; Drug Synergism; Ethambutol; Humans; Isoniazid; Male; Mycobacterium | 1987 |
[Effectiveness of single and fractional administration of isoniazid in the treatment of dogs infected with isoniazid-resistant strains of Mycobacterium tuberculosis].
Topics: Animals; Dogs; Drug Administration Schedule; Drug Resistance, Microbial; Isoniazid; Mycobacterium tu | 1987 |
Drug resistance in tuberculosis control.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Isoniazid; Mut | 1987 |
[Prolonged-action antitubercular preparation].
Topics: Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Re | 1987 |
[Improved chemoprophylaxis of children from groups at increased risk of tuberculosis morbidity].
Topics: Adolescent; Child; Child, Preschool; Humans; Infant; Isoniazid; Mycobacterium tuberculosis; Risk Fac | 1988 |
Consensus: management of tuberculin-positive children without evidence of disease.
Topics: Child; Drug Administration Schedule; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tu | 1988 |
[Fully supervised ambulatory short-course chemotherapy with an intermittent regimen for newly diagnosed smear-positive pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combinat | 1987 |
[Long-term results of short-course chemotherapy in pulmonary tuberculosis (final report). The third study: comparative study of two regimens, 6RHZ and -6RHS (treatment was continued for 6 months after negative conversion of sputum by culture)].
Topics: Adult; Aged; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle A | 1988 |
Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat, India.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Humans; India; Isoniazid; Microbial Sensitivity T | 1988 |
The results of 9-month isoniazid-rifampin therapy for pulmonary tuberculosis under program conditions in San Francisco.
Topics: Adolescent; Adult; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniaz | 1988 |
INH and streptomycin in Ethiopian children with tuberculosis and different nutritional status.
Topics: Child; Child Nutritional Physiological Phenomena; Child, Preschool; Ethiopia; Humans; Infant; Infant | 1988 |
Airway obstruction secondary to tuberculosis lymph node erosion into the trachea: drainage via bronchoscopy.
Topics: Airway Obstruction; Bronchoscopy; Drainage; Female; Humans; Infant; Isoniazid; Pyrazinamide; Radiogr | 1988 |
[Indicators of antibody formation in patients with pulmonary tuberculosis and drug-resistant Mycobacteria].
Topics: Antibodies, Bacterial; Drug Resistance, Microbial; Humans; In Vitro Techniques; Isoniazid; Mycobacte | 1988 |
[New and future drugs in pulmonary tuberculosis].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Is | 1988 |
Complex interaction of rifampin and warfarin.
Topics: Adult; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Ison | 1988 |
Management and outcome of pulmonary tuberculosis in adults notified in England and Wales in 1983. Medical Research Council Tuberculosis and Chest Diseases Unit.
Topics: Adolescent; Adult; Antitubercular Agents; Bangladesh; Drug Administration Schedule; England; Ethambu | 1988 |
Rifampicin-isoniazid and delayed elimination of theophylline: a case report.
Topics: Delayed-Action Preparations; Drug Interactions; Drug Therapy, Combination; Humans; Isoniazid; Lung D | 1988 |
Secondary mania in a patient receiving isonicotinic acid hydrazide and pyridoxine: case report.
Topics: Adolescent; Bipolar Disorder; Drug Therapy, Combination; Humans; Isoniazid; Male; Pyridoxine; Tuberc | 1988 |
Compliance with anti-tuberculous therapy: a field trial of a pill-box with a concealed electronic recording device.
Topics: Adult; Drug Therapy, Combination; Electronics, Medical; Female; Humans; Isoniazid; Male; Patient Com | 1988 |
[Treatment of patients with destructive pulmonary tuberculosis using intramuscular isoniazid administration].
Topics: Administration, Oral; Adolescent; Adult; Antitubercular Agents; Drug Evaluation; Drug Therapy, Combi | 1988 |
[A case of isoniazid-induced systemic lupus erythematosus].
Topics: Aged; Humans; Isoniazid; Lupus Erythematosus, Systemic; Male; Tuberculosis, Pulmonary | 1988 |
[Improvement in the chemotherapy of pulmonary tuberculosis in adults and adolescents by the differential use of isoniazid].
Topics: Adolescent; Adult; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Isoniazid; Ma | 1988 |
[A case of Mycobacterium kansasii lung infection developed after treatment of Mycobacterium gordonae lung infection].
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infection | 1988 |
[Exacerbation of pulmonary tuberculosis after diagnostic bronchoscopy and its preventive medication].
Topics: Adult; Aged; Bronchoscopy; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; | 1988 |
[Short-course chemotherapy for tuberculosis in children and the partial follow-up study].
Topics: Adolescent; Child; Child, Preschool; Drug Administration Schedule; Follow-Up Studies; Humans; Infant | 1988 |
Antinuclear antibodies induced by isoniazid. A prospective study.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Antinuclear; Female; Humans; Isoniazid; Male; Middle Age | 1988 |
Decision analysis for isoniazid preventive therapy: take it or leave it?
Topics: Adult; Aged; Aged, 80 and over; Decision Support Techniques; Humans; Isoniazid; Middle Aged; Tubercu | 1988 |
Tuberculosis in hospital employees.
Topics: Adult; Cross Infection; Female; Humans; Isoniazid; Personnel, Hospital; Skin Tests; Tuberculosis, Pu | 1988 |
Comparison of antituberculosis drug regimens for lung disease caused by Mycobacterium avium complex.
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Therapy, Combination; Enviomycin; Female; Humans; I | 1988 |
[Phenotype of isoniazid acetylation and tolerance of antitubercular drugs].
Topics: Acetylation; Adult; Aged; Antitubercular Agents; Drug Tolerance; Female; Humans; Isoniazid; Male; Mi | 1988 |
Isoniazid preventive therapy for tuberculosis. Are we losing our enthusiasm?
Topics: Adolescent; Adult; Communicable Disease Control; Humans; Isoniazid; Tennessee; Tuberculosis, Pulmona | 1988 |
Comparison between serum isonicotinic acid hydrazide (INH) levels and urinary sulfadimidine (sulfamethazine) acetylation as predictors of INH acetylator status.
Topics: Acetylation; Acetyltransferases; Administration, Oral; Adolescent; Child; Child, Preschool; Humans; | 1988 |
[Intramuscular administration of a 10% isoniazid solution-- a new method of controlled chemotherapy].
Topics: Animals; Dogs; Drug Evaluation; Drug Evaluation, Preclinical; Humans; Injections, Intramuscular; Inj | 1987 |
[Clinico-pharmacological approach to rifampicin and isoniazid dosage].
Topics: Administration, Oral; Adolescent; Adult; Half-Life; Humans; Infusions, Intravenous; Isoniazid; Middl | 1987 |
Employee acceptance of INH prophylaxis.
Topics: Humans; Isoniazid; Occupational Diseases; Patient Acceptance of Health Care; Personnel, Hospital; Tu | 1987 |
[A case of interstitial pneumonia induced by isoniazid (INH)].
Topics: Aged; Humans; Isoniazid; Lymphocyte Activation; Male; Pulmonary Fibrosis; Tuberculosis, Pulmonary | 1987 |
Acetylation phenotype profile in north Indian children with pulmonary tuberculosis.
Topics: Acetylation; Adolescent; Child; Child, Preschool; Female; Humans; India; Infant; Isoniazid; Male; Ph | 1987 |
[Antituberculosis chemotherapy including ofloxacin in patients with pulmonary tuberculosis not treated previously].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Ofloxacin; Oxazines | 1986 |
Acetylation phenotype and hepatotoxicity in the treatment of tuberculosis in children.
Topics: Acetylation; Adolescent; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug Thera | 1986 |
[Dynamics of the clinical manifestations of early tuberculous intoxication in children during their treatment].
Topics: Child; Child, Preschool; Drug Evaluation; Follow-Up Studies; Health Resorts; Humans; Isoniazid; Time | 1986 |
[Treatment of infiltrative tuberculosis of the lungs using chemotherapy and galvanization of the degradation cavity].
Topics: Combined Modality Therapy; Drug Therapy, Combination; Electric Stimulation Therapy; Ethionamide; Hum | 1986 |
[Preventive chemotherapy].
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Cross-Sectional Studies; Drug Therapy | 1986 |
[Adverse effect of phthivazid in the treatment of children with tuberculosis].
Topics: Child; Dermatitis, Atopic; Female; Humans; Isoniazid; Tuberculosis, Pulmonary | 1987 |
[Use of inhalation of ultrasonic aerosols and galvanic current in the treatment of patients with pulmonary tuberculosis].
Topics: Administration, Inhalation; Aerosols; Combined Modality Therapy; Electric Stimulation Therapy; Human | 1987 |
[Use of ultrasonic aerosols in phthisiology and pulmonology].
Topics: Aerosols; Anti-Bacterial Agents; Humans; Isoniazid; Respiratory Tract Infections; Tuberculosis, Pulm | 1986 |
[Atypical mycobacterial pulmonary infections. Apropos of a case in a newborn infant].
Topics: Humans; Infant; Isoniazid; Male; Mycobacterium avium; Mycobacterium Infections, Nontuberculous; Rifa | 1987 |
New approach to treatment of pulmonary and extrapulmonary tuberculosis. Possible ramifications of cutaneous mycobacterial infections.
Topics: Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Cutaneous; Tuberc | 1987 |
[A case of allergic shock caused by readministration of rifampicin].
Topics: Adult; Drug Hypersensitivity; Female; Humans; Isoniazid; Rifampin; Shock, Septic; Tuberculosis, Pulm | 1987 |
[Prognosis of isoniazid-resistant patients of pulmonary tuberculosis].
Topics: Adult; Aged; Drug Resistance; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Age | 1987 |
[Indicators of INH inactivation determined using a biological method and its use in monitoring antitubercular treatment].
Topics: Acetylation; Adult; Biological Availability; Dose-Response Relationship, Drug; Female; Humans; Isoni | 1986 |
Isoniazid poisoning. A report of 2 cases.
Topics: Adolescent; Adult; Female; Humans; Isoniazid; Male; Tuberculosis, Pulmonary | 1987 |
[Traditional Chinese medicine and Western medicine in the treatment of sputum-positive tuberculosis; short-term follow-up studies].
Topics: Adolescent; Adult; Aged; Female; Follow-Up Studies; Humans; Isoniazid; Male; Medicine, Chinese Tradi | 1987 |
From the Centers for Disease Control. Conference on new approaches for tuberculosis preventive therapy.
Topics: Antitubercular Agents; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1987 |
[Chemotherapy of pulmonary tuberculosis. Sputum culture conversion in 8 weeks in 84% of patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Evaluation; Drug Therapy, Co | 1987 |
Decision analysis and INH therapy.
Topics: Aged; Decision Making; Humans; Isoniazid; Models, Biological; Tuberculosis, Pulmonary | 1987 |
[Investigation on bacteriological relapses in cases of pulmonary tuberculosis treated with INH and RFP--report of the 27th B series of controlled trials of chemotherapy. Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan
Topics: Adult; Aged; Female; Humans; Isoniazid; Male; Middle Aged; Recurrence; Rifampin; Time Factors; Tuber | 1987 |
Remission of pulmonary alveolar proteinosis during antituberculous chemotherapy.
Topics: Antitubercular Agents; Humans; Isoniazid; Male; Middle Aged; Pulmonary Alveolar Proteinosis; Rifampi | 1987 |
[Comparative evaluation of the effectiveness of treatment with rifampicin and isoniazid administered at various intervals].
Topics: Drug Administration Schedule; Humans; Injections, Intravenous; Isoniazid; Rifampin; Tuberculosis, Pu | 1987 |
Short-course antituberculous chemotherapy for pulmonary and pleural disease: 5 years' experience in clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Administration Schedule; Eth | 1987 |
[Pharmacokinetic bases for the drug-free prevention of drug-induced hepatitis in pulmonary tuberculosis patients].
Topics: Acetylation; Adolescent; Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug | 1987 |
Pharmacokinetics of antituberculosis drugs in patients.
Topics: Adult; Antitubercular Agents; Chromatography, High Pressure Liquid; Ethambutol; Humans; Isoniazid; M | 1987 |
[Role of chemical prevention of tuberculosis in current epidemiologic situations].
Topics: Adult; Carrier State; Humans; Isoniazid; Recurrence; Time Factors; Tuberculosis, Pulmonary | 1987 |
Stenotic tuberculous tracheitis treated with resection and anastomosis.
Topics: Constriction, Pathologic; Female; Humans; Isoniazid; Middle Aged; Rifampin; Tracheitis; Tuberculosis | 1986 |
Management of the incidentally discovered tuberculin reactor.
Topics: Adolescent; Adult; Humans; Isoniazid; Patient Compliance; Tuberculin Test; Tuberculosis, Pulmonary | 1986 |
[Short course chemotherapy in pulmonary tuberculosis on individual basis--final report].
Topics: Adult; Aged; Antibiotics, Antitubercular; Drug Administration Schedule; Female; Humans; Isoniazid; M | 1986 |
[Studies of short-term chemotherapy of tuberculosis. III. Early and late results of 6 months' treatment of tuberculosis. Analysis of failures and recurrences during 1-5 years' observation].
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Ma | 1986 |
Serum concentration of isoniazid administered with & without ethambutol in pulmonary tuberculosis patients.
Topics: Adolescent; Adult; Drug Interactions; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniaz | 1986 |
[Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].
Topics: Adult; Algeria; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Eth | 1986 |
[Antitubercular therapeutic regimens routinely prescribed in Bas-Rhin and results of treatment].
Topics: Adolescent; Adult; Age Factors; Ambulatory Care; Antitubercular Agents; Drug Administration Schedule | 1986 |
Short-course tuberculosis therapy--a new combination product.
Topics: Drug Combinations; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1986 |
Tuberculosis--a continuing problem.
Topics: BCG Vaccine; Health Workforce; Humans; Isoniazid; Occupational Diseases; Risk; Tuberculin Test; Tube | 1986 |
Serum haloperidol levels of schizophrenics receiving treatment for tuberculosis.
Topics: Adult; Drug Interactions; Haloperidol; Humans; Isoniazid; Metabolic Clearance Rate; Middle Aged; Rif | 1986 |
[Control of chemoprophylaxis of tuberculosis with isoniazid].
Topics: Follow-Up Studies; Humans; Isoniazid; Tuberculosis, Pulmonary | 1986 |
[Clinical course and effectiveness of treatment of destructive pulmonary tuberculosis in adolescents].
Topics: Adolescent; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Proth | 1986 |
Rifampin-induced acute renal failure.
Topics: Acute Kidney Injury; Antibodies; Blood Urea Nitrogen; Complement C3; Creatinine; Drug Therapy, Combi | 1986 |
[Studies on sputum conversion of smear-positive, previously untreated pulmonary tuberculosis: a comparison of short-course and standard chemotherapy regimens].
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Rifampin; | 1986 |
[Recent-term therapeutic effects of short-course chemotherapy in rural outpatients with smear positive tuberculosis].
Topics: Adolescent; Adult; Ambulatory Care; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Fe | 1986 |
Perspectives in adolescent tuberculosis: three decades of experience.
Topics: Adolescent; Adult; Calcinosis; Child; Female; Follow-Up Studies; Humans; Isoniazid; Male; Pregnancy; | 1986 |
Acute respiratory distress related to chemotherapy of advanced pulmonary tuberculosis: a study of two cases and review of the literature.
Topics: Adult; Antitubercular Agents; Blood Sedimentation; Ethambutol; Humans; Isoniazid; Male; Middle Aged; | 1986 |
[Effect of inhalation of aerosols of antitubercular preparations on pulmonary surfactant].
Topics: Adult; Aerosols; Female; Humans; Isoniazid; Lung; Male; Middle Aged; Pulmonary Surfactants; Streptom | 1986 |
[Long term results of short course chemotherapy in pulmonary tuberculosis--(1st study):twelve- and eighteen-month chemotherapy with rifampicin-isoniazid and ethambutol].
Topics: Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Ison | 1986 |
Isoniazid prophylaxis in hepatitis B carriers.
Topics: Adult; Alanine Transaminase; Asia, Southeastern; Carrier State; Child; Hepatitis B; Hepatitis B Surf | 1986 |
[Tuberculostatics-induced systemic lupus erythematosus].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lupus Eryth | 1986 |
Decision analysis for tuberculosis preventive treatment in nursing homes.
Topics: Aged; Decision Making; Humans; Isoniazid; Middle Aged; Nursing Homes; Probability; Prognosis; Tuberc | 1986 |
The use of rifampicin and isoniazid entrapped in liposomes for the treatment of Murine tuberculosis.
Topics: Animals; Drug Therapy, Combination; Isoniazid; Liposomes; Lung; Male; Mice; Mice, Inbred Strains; Ph | 1986 |
Hepatic toxicity in South Indian patients during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin and pyrazinamide.
Topics: Adolescent; Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Child, Pres | 1986 |
[Studies of serum rifampicin concentrations].
Topics: Adolescent; Adult; Aged; Chromatography, High Pressure Liquid; Female; Humans; Isoniazid; Male; Midd | 1986 |
Short-course chemotherapy of pulmonary tuberculosis: a new approach to drug dosage in the initial intensive phase.
Topics: Antitubercular Agents; Body Weight; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Rifa | 1986 |
[Effect of antituberculosis therapy on the course of syphilitic infection].
Topics: Adult; Drug Therapy, Combination; Humans; Isoniazid; Male; Rifampin; Syphilis; Tuberculosis, Pulmona | 1986 |
[Histamine-like reaction in tuberculosis patients eating fish containing much histamine under treatment with isoniazid in 277 cases].
Topics: Adult; Drug Interactions; Female; Fish Products; Foodborne Diseases; Histamine; Humans; Isoniazid; T | 1986 |
[Preventive chemotherapy in tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Prothionamide; Rifa | 1986 |
[Pharmacokinetics of isoniazid in patients with pulmonary tuberculosis and alcoholism].
Topics: Adult; Alcoholism; Humans; Isoniazid; Kinetics; Tuberculosis, Pulmonary | 1986 |
Long term study of the effect of rifampicin and isoniazid on vitamin D metabolism.
Topics: Adult; Aged; Calcifediol; Calcitriol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberc | 1985 |
Prevention and control of tuberculosis.
Topics: BCG Vaccine; Humans; Isoniazid; Mass Chest X-Ray; Tuberculin Test; Tuberculosis, Pulmonary | 1985 |
Safety of thrice-weekly rifampicin for tuberculosis in South-East Asian refugees.
Topics: Adolescent; Adult; Aged; Asia, Southeastern; Australia; Chemical and Drug Induced Liver Injury; Chil | 1985 |
Tuberculosis chemoprophylaxis for diabetics: are the benefits of isoniazid worth the risk?
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Decision Theory; Diabetes Complications; Female | 1985 |
Variability in the intradermal and in vitro lymphocyte responses to PPD in patients receiving isoniazid chemoprophylaxis.
Topics: Cross Infection; Female; Humans; Hypersensitivity, Delayed; Isoniazid; Leukocyte Migration-Inhibitor | 1985 |
The low yield of routine radiographic screening of tuberculin-positive hospital employees.
Topics: Adult; Cost-Benefit Analysis; Diagnostic Tests, Routine; Female; Hospital Bed Capacity, 300 to 499; | 1985 |
Infection and disease among contacts of tuberculosis cases with drug-resistant and drug-susceptible bacilli.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Child, Preschool; Drug Resistance, Microbial; Female; H | 1985 |
Primary drug-resistant tuberculosis in children. Correlation of drug-susceptibility patterns of matched patient and source case strains of Mycobacterium tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Microbial; Drug | 1985 |
The action of antituberculosis drugs in short-course chemotherapy.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Models, Biological | 1985 |
[Chemotherapy of patients with chronic destructive pulmonary tuberculosis in cases of mycobacterial resistance to rifampicin and isoniazid].
Topics: Adult; Animals; Chronic Disease; Drug Resistance, Microbial; Guinea Pigs; Humans; Isoniazid; Middle | 1985 |
Drugs for tuberculosis.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; T | 1986 |
Treatment of pulmonary tuberculosis in patients notified in England and Wales in 1978-9: chemotherapy and hospital admission. Medical Research Council Tuberculosis and Chest Diseases Unit.
Topics: Adolescent; Adult; Drug Therapy, Combination; England; Ethambutol; Female; Hospitalization; Humans; | 1985 |
Supervised intermittent chemotherapy for pulmonary tuberculosis in a rural area of China.
Topics: Adolescent; Adult; Aged; Ambulatory Care; China; Community Health Workers; Delivery of Health Care; | 1985 |
The impact of treatment programmes on the epidemiology of tuberculosis.
Topics: China; Chronic Disease; Developing Countries; Humans; India; Isoniazid; Netherlands; Patient Complia | 1985 |
Pyridoxine deficiency in children treated with isoniazid.
Topics: Child; Child Nutritional Physiological Phenomena; Child, Preschool; Electromyography; Female; Humans | 1985 |
Family tuberculosis contacts: resource-contingent management.
Topics: Adolescent; Adult; Child; Humans; Isoniazid; Middle Aged; Tuberculosis, Pulmonary | 1985 |
Isoniazid-resistant tuberculosis. A community outbreak and report of a rifampin prophylaxis failure.
Topics: Adult; Antitubercular Agents; Disease Outbreaks; Drug Resistance, Microbial; Drug Therapy, Combinati | 1985 |
Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes.
Topics: Aged; Arkansas; Cross Infection; Humans; Isoniazid; Length of Stay; Nursing Homes; Rifampin; Tubercu | 1985 |
[Effectiveness of various chemotherapy programs in patients with disseminated destructive pulmonary tuberculosis].
Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Female; Follow-Up Studies; Humans; Isoniazid; Mal | 1985 |
[Comparative evaluation of rifampicin and isoniazid penetration into the pathological foci of the lungs in tuberculosis patients].
Topics: Absorption; Adolescent; Adult; Child; Female; Humans; Isoniazid; Lung; Lymph Nodes; Male; Middle Age | 1985 |
[Course of serum alkaline phosphatase during treatment with isoniazid and rifampicin].
Topics: Adolescent; Alkaline Phosphatase; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans | 1985 |
[Pharmacokinetics of isoniazid in patients with pulmonary tuberculosis].
Topics: Administration, Oral; Biological Availability; Humans; Injections, Intravenous; Isoniazid; Kinetics; | 1985 |
Chemotherapeutic agents in pulmonary tuberculosis with special reference to isoniazid-ethambutol continuation therapy.
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1985 |
Pellagra encephalopathy among tuberculous patients: its relation to isoniazid therapy.
Topics: Adult; Aged; Brain; Brain Diseases; Drug Therapy, Combination; Humans; Isoniazid; Male; Middle Aged; | 1985 |
Tuberculosis in Tanzania--a national survey of newly notified cases. Tanzanian/British Medical Research Council Collaborative Study.
Topics: Adolescent; Adult; Child; Child, Preschool; Drug Resistance, Microbial; Female; Follow-Up Studies; H | 1985 |
Tuberculosis in an Indochinese refugee camp: epidemiology, management and therapeutic results.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Female | 1985 |
Pulmonary infection with Mycobacterium malmoense--a review of treatment and response.
Topics: Adult; Aged; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambuto | 1985 |
Field trial of short course chemotherapy for pulmonary tuberculosis: results at 30 months.
Topics: Adolescent; Adult; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampi | 1985 |
[Pharmacokinetics of isoniazid, rifampicin and streptomycin in tuberculosis patients with chronic cor pulmonale].
Topics: Administration, Oral; Adult; Chronic Disease; Female; Humans; Infusions, Parenteral; Isoniazid; Kine | 1985 |
[Chemoprophylaxis of persons in dispensary registration group VII taking into account the risk factors of tuberculosis reactivation].
Topics: Adult; Antitubercular Agents; Drug Evaluation; Female; Humans; Isoniazid; Male; Middle Aged; Recurre | 1985 |
[Changes in various parameters of homeostasis in patients with pulmonary tuberculosis after intra-arterial administration of antibacterial preparations].
Topics: Adult; Aminosalicylic Acid; Aminosalicylic Acids; Glomerular Filtration Rate; Humans; Injections, In | 1985 |
Ultrashort-course chemotherapy for culture-negative pulmonary tuberculosis--a qualified success.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; | 1985 |
Failure of a prothionamide-containing oral antituberculosis regimen.
Topics: Administration, Oral; Antitubercular Agents; Dapsone; Drug Combinations; Drug Therapy, Combination; | 1985 |
Influence of rifampicin and isoniazid on the kinetics of phenytoin.
Topics: Acetylation; Adult; Aged; Ethambutol; Female; Half-Life; Humans; Isoniazid; Kinetics; Male; Middle A | 1985 |
[Antituberculosis prevention with isoniazid].
Topics: Age Factors; Drug Administration Schedule; Health Status; Humans; Isoniazid; Risk; Tuberculin Test; | 1985 |
Nonculturable acid-fast forms in the sputum of patients with tuberculosis and chronic pulmonary disease.
Topics: Aged; Antitubercular Agents; Autopsy; Chronic Disease; Culture Media; Female; Hospitalization; Human | 1970 |
Characteristics of African M. tuberculosis.
Topics: Adolescent; Adult; Aminosalicylic Acids; Child; Child, Preschool; Drug Resistance, Microbial; Female | 1970 |
Tuberculosis of the cervical lymph nodes: clinical studies of children in East Africa.
Topics: Africa, Eastern; Child; Child, Preschool; Drug Synergism; Female; Humans; Infant; Isoniazid; Male; M | 1970 |
Thiacetazone in pulmonary tuberculosis with reference to its clinical intolerance.
Topics: Drug Eruptions; Gastrointestinal Diseases; Humans; Isoniazid; Streptomycin; Thioacetazone; Tuberculo | 1970 |
Tuberculosis in Kenya: a follow-up of a national sampling survey of drug resistance and other factors. An East African and British Medical Research Council co-operative investigation.
Topics: Adolescent; Adult; Aminosalicylic Acids; Antitubercular Agents; Child; Child, Preschool; Drug Resist | 1970 |
Regional variation in the guinea-pig virulence and other characteristics of tubercle bacilli.
Topics: Animals; Culture Media; Drug Resistance, Microbial; Guinea Pigs; Isoniazid; Mycobacterium tuberculos | 1970 |
Tuberculous infection.
Topics: Adolescent; Adult; Africa, Eastern; Aged; Costs and Cost Analysis; Delayed-Action Preparations; Deve | 1971 |
[Use of the proportion method in the determination of the sensitivity of Mycobacterium tuberculosis to antibacterial agents].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Humans; Isoniazid; Methods; | 1971 |
[Lupus and related syndromes: rare complication of long treatments with isoniazid and other antitubercular drugs (apropos of 2 new cases)].
Topics: Adult; Antibodies, Antinuclear; Antitubercular Agents; Autoantibodies; Humans; Isoniazid; Lupus Eryt | 1971 |
The first clinical experiences with ethambutol in chronic pulmonary tuberculosis and basilar meningitis.
Topics: Adult; Aminosalicylic Acids; Capreomycin; Chronic Disease; Cycloserine; Drug Combinations; Drug Resi | 1970 |
Clinical experience with ethambutol.
Topics: Aminosalicylic Acids; Blood Chemical Analysis; Capreomycin; Drug Combinations; Drug Hypersensitivity | 1970 |
Combination treatment with capreomycin of pretreated cavernous pulmonary tuberculosis.
Topics: Administration, Oral; Adult; Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Cycloserine; | 1970 |
Pharmacology of some slow-release preparations of isoniazid of potential use in intermittent treatment of tuberculosis.
Topics: Administration, Oral; Adult; Delayed-Action Preparations; Humans; Intestinal Absorption; Isoniazid; | 1972 |
[Cases of pulmonary tuberculosis in which kanamycin-resistant tubercle bacilli did not appear even after a long-term administration of kanamycin. Some consideration on the interpretation of drug resistance tests].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Dihydrostreptomycin Sulfate; Drug R | 1971 |
Shorter chemotherapy in tuberculosis.
Topics: Developing Countries; Drug Combinations; Economics; Humans; Isoniazid; Pyrazinamide; Rifampin; Strep | 1972 |
Intermittent isoniazid and thiacetazone in childhood tuberculosis with reference to clinical intolerance.
Topics: Child; Child, Preschool; Drug Hypersensitivity; Humans; Infant; Isoniazid; Thioacetazone; Tuberculos | 1972 |
Technical and bacteriological aspects of a continuous survey of drug resistance in tuberculosis in South Africa.
Topics: Aminosalicylic Acids; Computers; Cycloserine; Diffusion; Drug Resistance, Microbial; Ethionamide; Hu | 1972 |
Trends in the prevalence of primary drug resistance in pulmonary tuberculosis in France from 1962 to 1970: a national survey.
Topics: Adolescent; Adult; Africa, Northern; Age Factors; Aminosalicylic Acids; Antitubercular Agents; Cyclo | 1972 |
[Comparative trials of 3 ambulatory therapeutic methods for pulmonary tuberculosis in Senegal. (Preliminary results of TB1)].
Topics: Adult; Ambulatory Care; Antitubercular Agents; Female; Humans; Isoniazid; Male; Senegal; Socioeconom | 1971 |
Drug-induced systemic lupus erythematosus. A case with life-threatening pericardial tamponade.
Topics: Adult; Antibodies, Antinuclear; Cardiac Tamponade; Humans; Isoniazid; Lupus Erythematosus, Systemic; | 1972 |
General considerations in the choice and management of regimens of chemotherapy for pulmonary tuberculosis.
Topics: Ambulatory Care; Developing Countries; Drug Combinations; Economics, Medical; Hospitalization; Human | 1972 |
The regularity of attendance of male tuberculosis patients diagnosed at Mulago Hospital between January and July in 1968 and in 1970.
Topics: Adolescent; Adult; Age Factors; Attitude to Health; Cooperative Behavior; Economics, Medical; Hospit | 1972 |
A controlled study on progressive primary pulmonary tuberculosis in children treated for one year with dual drugs: streptomycin and isoniazid versus isoniazid and thiacetazone.
Topics: Adolescent; Child; Child, Preschool; Drug Combinations; Female; Follow-Up Studies; Humans; Infant; I | 1972 |
Toxic epidermal necrolysis as a result of anti-tubercular drugs.
Topics: Adult; Humans; Isoniazid; Male; Stevens-Johnson Syndrome; Streptomycin; Thioacetazone; Tuberculosis, | 1973 |
Initial treatment of tuberculosis with streptomycin and isoniazid combined with either aminosalyl or rifampicin.
Topics: Alcoholism; Aminosalicylic Acids; Bilirubin; Dihydrostreptomycin Sulfate; Humans; Isoniazid; Rifampi | 1973 |
Chemotherapy in Thailand.
Topics: Antitubercular Agents; Congresses as Topic; Drug Resistance, Microbial; Humans; Isoniazid; Socioecon | 1972 |
Supervised ambulatory treatment of tuberculosis with brief initial hospitalization.
Topics: Adolescent; Adult; Age Factors; Ambulatory Care; Aminosalicylic Acids; Capreomycin; Convalescence; D | 1973 |
PAS.
Topics: Aminosalicylic Acids; Drug Combinations; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Thio | 1973 |
[Proceedings: Ambulatory chemotherapy of tuberculosis in Finland (organization)].
Topics: Ambulatory Care; Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Ethambutol; Ethionamide; | 1973 |
A thiacetazone toxicity trial in Sarawak.
Topics: Adolescent; Adult; China; Drug Therapy, Combination; Ethnicity; Female; Humans; Isoniazid; Malaysia; | 1973 |
Causes of failure of domiciliary chemotherapy in pulmonary tuberculosis.
Topics: Adult; Age Factors; Aminosalicylic Acids; Cooperative Behavior; Drug Resistance, Microbial; Humans; | 1973 |
Rifampicin hepatitis. A clinical and histological study.
Topics: Adult; Aged; Alcoholism; Biopsy; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; | 1974 |
Short-course treatment in pulmonary tuberculosis.
Topics: Adolescent; Adult; Africa, Eastern; Antitubercular Agents; Humans; Isoniazid; Mycobacterium tubercul | 1973 |
Editorial: Tuberculosis retreats--slowly.
Topics: Adult; Child; Emigration and Immigration; Humans; India; Isoniazid; Pakistan; Tuberculosis, Pulmonar | 1974 |
An unusual case of massive hypertrophy of the breasts.
Topics: Adult; Breast Diseases; Female; Humans; Hypertrophy; Isoniazid; Pregnancy; Pregnancy Complications; | 1974 |
[The tuberculosis problem in Botswana].
Topics: BCG Vaccine; Botswana; Carrier State; Complementary Therapies; Disease Reservoirs; Drug Combinations | 1974 |
Follow-up of patients with pulmonary tuberculosis adequately treated by chemotherapy: is this really necessary?
Topics: Adult; Age Factors; Aminosalicylic Acids; Carcinoma, Bronchogenic; Female; Follow-Up Studies; Humans | 1974 |
Letter: In-vitro detection of hypersensitivity to antituberculous drugs.
Topics: Aminosalicylic Acids; Cell Migration Inhibition; Drug Hypersensitivity; Drug Therapy, Combination; H | 1974 |
Treatment of pulmonary tuberculosis.
Topics: Capreomycin; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cycloserine; Depression; Drug | 1974 |
Changes in cortisol metabolism following rifampicin therapy.
Topics: Addison Disease; Adipates; Adrenal Glands; Adult; Cortisone; Dose-Response Relationship, Drug; Drug | 1974 |
[Controlled study of the combination isoniazid-thioacetazone in the treatment of lung tuberculosis].
Topics: Adolescent; Adult; Antitubercular Agents; Child; Drug Evaluation; Drug Therapy, Combination; Humans; | 1974 |
Pulmonary tuberculosis: chemotherapy programmes and regimens of chemotherapy.
Topics: Aminosalicylic Acids; Antitubercular Agents; Appointments and Schedules; Developing Countries; Healt | 1974 |
Concurrent comparison of an unsupervised daily oral regimen of thiacetazone plus isoniazid and a fully supervised twice-weekly regimen of streptomycin plus isoniazid in the domiciliary treatment of pulmonary tuberculosis--a co-operative investigation.
Topics: Ambulatory Care; Drug Therapy, Combination; Humans; Isoniazid; Streptomycin; Thioacetazone; Tubercul | 1974 |
Treatment of isoniazid-resistant pulmonary tuberculosis with ethambutol, rifampicin and capreomycin: a co-operative study in England and Wales.
Topics: Adult; Aged; Capreomycin; Drug Resistance, Microbial; Drug Therapy, Combination; England; Ethambutol | 1974 |
The sensitivity to thiacetazone of tubercle bacilli isolated from patients with pulmonary tuberculosis in Sri Lanka.
Topics: Adolescent; Aminosalicylic Acids; Child; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male | 1974 |
A pilot study of two regimens of intermittent thiacetazone plus isoniazid in the treatment of pulmonary tuberculosis in East Africa.
Topics: Adolescent; Africa, Eastern; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Hy | 1974 |
Standard chemotherapy and its application in the tuberculosis programme.
Topics: Antitubercular Agents; Congresses as Topic; Drug Interactions; Drug Resistance, Microbial; Humans; I | 1972 |
Chemotherapy in Japan.
Topics: Aminosalicylic Acids; Antitubercular Agents; Congresses as Topic; Drug Interactions; Humans; Isoniaz | 1972 |
Chemotherapy in Taiwan.
Topics: Aminosalicylic Acids; Antitubercular Agents; Congresses as Topic; Drug Resistance, Microbial; Humans | 1972 |
Management of drug failure cases.
Topics: Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Collapse Therapy; Congresses as Topic; Cyc | 1972 |
[2d day of round-table conference on "perfected methods of antibacillary treatment of pulmonary tuberculosis"].
Topics: Aminosalicylic Acids; Chronic Disease; Congresses as Topic; Drug Therapy, Combination; Ethambutol; F | 1974 |
[Painful shoulder-hand syndrome. Drug-induced iatrogenic disease].
Topics: Adult; Aged; Humans; Iatrogenic Disease; Iproniazid; Isoniazid; Male; Middle Aged; Reflex Sympatheti | 1965 |
Isoniazid with thiacetazone (thioacetazone) in the treatment of pulmonary tuberculosis in East Africa--third investigation: the effect of an initial streptomycin supplement.
Topics: Adolescent; Adult; Africa, Eastern; Aged; Humans; Isoniazid; Middle Aged; Streptomycin; Thioacetazon | 1966 |
Comparative studies on various antituberculosis chemotherapies--from the results of the Tuberculosis Research Committee (Ryoken).
Topics: Aminosalicylic Acids; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Kanamycin; Radiography; | 1966 |
Intermittent chemotherapy.
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Cycloserine; Drug Synergism; Ethionamide; Guin | 1967 |
Comparative studies with isoniazid alone, isoniazid with thiacetazone and isoniazid with para-aminosalicylic acid in ambulatory treatment of pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Female; Humans; Isoniazid; Male; Piperazines; Thioacetazone; Thiosemicarbazone | 1967 |
Pellagra-like syndrome associated with isoniazid therapy.
Topics: Adult; Facial Dermatoses; Female; Hand Dermatoses; Humans; Isoniazid; Nicotinic Acids; Pellagra; Pig | 1967 |
Value of isoniazid-thiacetazone combination in unsupervised ambulatory cases of pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Female; Humans; Isoniazid; Male; Middle Aged; Thioacetazone; Tuberculosis, | 1967 |
Madras study of thiacetazone plus isoniazid in the domiciliary treatment of pulmonary tuberculosis.
Topics: Ambulatory Care; Aminosalicylic Acids; Drug Synergism; Humans; India; Isoniazid; Liver; Liver Functi | 1968 |
Experience with thiacetazone chemotherapy for tuberculosis in the Sudan.
Topics: Drug Synergism; Humans; Isoniazid; Streptomycin; Sudan; Thioacetazone; Tuberculosis, Pulmonary | 1968 |
Tuberculosis Chemotherapy Centre, Madras.
Topics: Antitubercular Agents; Cycloserine; Diet Therapy; Drug Resistance, Microbial; Ethionamide; Home Care | 1968 |
Streptomycin plus thiacetazone (thioacetazone) compared with streptomycin plus PAS and with isoniazid plus thiacetazone in the treatment of pulmonary tuberculosis in Rhodesia.
Topics: Adolescent; Adult; Aminosalicylic Acids; Antitubercular Agents; Dihydrostreptomycin Sulfate; Drug Re | 1968 |
Tuberculosis in Kenya: a national sampling survey of drug resistance and other factors.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Child; Child, Preschool; Drug Resistance, Microbial; | 1968 |
Thiacetazone-isoniazid combination in the treatment of pulmonary tuberculosus.
Topics: Adolescent; Adult; Humans; India; Isoniazid; Thioacetazone; Tuberculosis, Pulmonary | 1968 |
A controlled comparison of thiacetazone (thioacetazone) plus isoniazid with PAS plus isoniazid in Hong Kong.
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Drug Synergism; Hemoglobins; Hong Kong; Humans; Hy | 1968 |
Prevalence of drug resistance in patients with pulmonary tuberculosis presenting for the first time with symptoms at chest clinics in India. I. Findings in urban clinics among patients giving no history of previous chemotherapy.
Topics: Adolescent; Adult; Aged; Child; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Mass Sc | 1968 |
New drugs against tuberculosis.
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Mice; Rifampin; | 1969 |
A clinical trial of thiacetazone-INH combination in pulmonary tuberculosis in children.
Topics: Child; Child, Preschool; Female; Humans; Infant; Isoniazid; Male; Thioacetazone; Tuberculosis, Pulmo | 1968 |
[Comparative study of 2 types of oral therapy of pulmonary tuberculosis (ethionamide and isoniazid, thiacetazone and isoniazid)].
Topics: Adolescent; Adult; Aged; Economics; Ethionamide; Humans; Isoniazid; Middle Aged; Morocco; Thioacetaz | 1968 |
[Comparative significance of methods of detection of Mycobacterium tuberculosis in pathological material from patients under prolonged antibacterial therapy].
Topics: Drug Resistance, Microbial; Humans; Isoniazid; Methods; Microscopy, Fluorescence; Mycobacterium tube | 1968 |
The results from twelve to thirty-six months in patients submitted to two studies of primary chemotherapy for pulmonary tuberculosis in East Africa.
Topics: Adolescent; Adult; Africa, Eastern; Female; Follow-Up Studies; Home Care Services; Humans; Isoniazid | 1969 |
[Actual therapeutic problems in pulmonary tuberculosis].
Topics: Adult; Age Factors; Aged; Aminosalicylic Acids; Antitubercular Agents; Germany, West; Humans; Isonia | 1970 |
Hypertrophy of the breast, possibly related to medication: a case report.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Black People; Breast Diseases; Female; Human | 1970 |
[Hepatotoxicity of thiacetazone].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Humans; I | 1970 |
[Controlled triple therapy of tuberculosis. Preliminary report].
Topics: Adult; Dosage Forms; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Radiography; Thioacetazone; T | 1970 |
Three initial streptomycin supplements to standard isoniazid-thiacetazone chemotherapy. East African-British Medical Research Council investigation.
Topics: Adolescent; Adult; Aged; Humans; Isoniazid; Middle Aged; Streptomycin; Thioacetazone; Tuberculosis, | 1970 |
A controlled trial of three regimens of self-administered and supervised chemotherapy for pulmonary tuberculosis. A. General report.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Humans; Isoniazid; Middle Aged; Streptomycin; Thioac | 1970 |
[Anaphylactic bone marrow crisis following isoniazid therapy].
Topics: Agranulocytosis; Anemia, Hypochromic; Blood Cell Count; Blood Transfusion; Bone Marrow; Bone Marrow | 1970 |
Comparison of various drug regimens in domiciliary chemotherapy.
Topics: Adolescent; Adult; Costs and Cost Analysis; Home Care Services; Humans; Isoniazid; Middle Aged; Myco | 1970 |
Comparative activity of sisomicin against mycobacteria in vitro and against Mycobacterium tuberculosis in mice.
Topics: Amino Sugars; Animals; Anti-Bacterial Agents; Female; Gentamicins; Glycosides; Isoniazid; Mice; Myco | 1973 |
Correlation of in vitro and in vivo kinetics with clinical use of isoniazid, ethambutol, and rifampin.
Topics: Ethambutol; Humans; In Vitro Techniques; Isoniazid; Kinetics; Mycobacterium; Mycobacterium tuberculo | 1973 |
Steroid-responsive hypercalcemia in disseminated bone tuberculosis.
Topics: Acute Disease; Adult; Clavicle; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Hyperca | 1973 |
Productivity of prolonged follow-up after chemotherapy for tuberculosis.
Topics: Aminosalicylic Acids; Female; Follow-Up Studies; Humans; Isoniazid; Male; Mycobacterium tuberculosis | 1973 |
Primary drug-resistant tuberculosis in children, 1961 to 1971. A comparison of the frequency of primary drug-resistant tuberculosis among children observed during the period of transition from long-term to short-term hospitalization of adults with infecti
Topics: Aminosalicylic Acids; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; I | 1973 |
[Studies on the development of drug-resistant tubercle bacilli in experimental animal tuberculosis].
Topics: Animals; Drug Resistance, Microbial; Female; Guinea Pigs; Isoniazid; Mice; Microbial Sensitivity Tes | 1973 |
Preventive treatment of tuberculin-negative contacts.
Topics: Aminosalicylic Acids; Antitubercular Agents; BCG Vaccine; Child; Female; Humans; Infant; Isoniazid; | 1973 |
Exogenous reinfection with Mycobacterium tuberculosis confirmed by phage typing.
Topics: Aminosalicylic Acids; Bacteriophage Typing; Drug Resistance, Microbial; Ethambutol; Ethionamide; Hum | 1973 |
[Use of 4 antibacterial preparations in the treatment of destructive tuberculosis of the lungs].
Topics: Adolescent; Adult; Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Ethionam | 1973 |
Progress of tuberculous diabetes coming under supervision during the years 1953-65 up to July 1972.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Child; Coronary Disease; Diabetes Complications; Drug | 1973 |
Drug resistant pulmonary tuberculosis treated with ethambutol and rifampicin in North East England.
Topics: Aged; Aminosalicylic Acids; Diarrhea; Drug Resistance, Microbial; England; Ethambutol; Headache; Hum | 1973 |
[Clinical value of the complex determination of the drug resistance of Mycobacterium tuberculosis].
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tuberculosis; Str | 1973 |
[Comparative evaluation of different methods in determining the virulence of Mycobacterium tuberculosis].
Topics: Animals; Bacteriological Techniques; Catalase; Culture Media; Guinea Pigs; Isoniazid; Methods; Mice; | 1973 |
Tuberculosis in a patient after renal transplantation.
Topics: Adult; Azathioprine; Bacteriuria; Ethambutol; Humans; Isoniazid; Kidney Transplantation; Male; Mycob | 1973 |
Osteomyelitis caused by concurrent infection with Mycobacterium tuberculosis and Blastomyces dermatitidis.
Topics: Amphotericin B; Blastomyces; Blastomycosis; Diagnostic Errors; Humans; Isoniazid; Male; Middle Aged; | 1974 |
Infectivity of sputum-positive tuberculous patients on chemotherapy.
Topics: Ambulatory Care; Antitubercular Agents; Ethambutol; Hospitalization; Isoniazid; Length of Stay; Myco | 1974 |
[Activity of the second-line preparations, ethambutol and rifampin, in experimental tuberculosis caused by Mycobacterium tuberculosis highly resistant to basic tuberculostatics].
Topics: Animals; Drug Resistance, Microbial; Ethambutol; Isoniazid; Mice; Mycobacterium tuberculosis; Rifamp | 1973 |
Tuberculosis in Acukland.
Topics: Adult; Age Factors; Aged; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combinati | 1973 |
[Lung cancer and pulmonary tuberculosis as a combined disease].
Topics: Adult; Age Factors; Aged; Animals; Bronchial Neoplasms; Cicatrix; Diagnosis, Differential; Female; G | 1974 |
[Bacteriological and clinical aspects of the restoration of drug sensitivity of formerly resistant Mycobacterium cultures].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Humans; Isoniazid; Mycobact | 1973 |
Tuberculosis in a family day-care home. Report of an outbreak and recommendations for prevention.
Topics: Air Microbiology; Aminosalicylic Acids; Child; Child Day Care Centers; Child, Preschool; Disease Out | 1974 |
Therapeutic efficacy of rifampin in newly detected pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Isoniazid; M | 1974 |
Ethambutol-isoniazid versus streptomycin-ethambutol-isoniazid in original treatment of cavitary tuberculosis.
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Statistics as | 1974 |
Restoration of mycolate synthetase activity in Mycobacterium tuberculosis exposed to isoniazid.
Topics: Acetates; Amino Acids; Carbon Radioisotopes; Cell Survival; Fatty Acid Synthases; Fatty Acids; Isoni | 1974 |
Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. X. September 1970 to September 1973.
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniaz | 1974 |
Primary drug resistance in children. Drug susceptibility of strains of M. tuberculosis isolated from children during the years 1969 to 1972 at the Kings County Hospital Medical Center of Brooklyn.
Topics: Antitubercular Agents; Child; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Huma | 1974 |
[Pulmonary tuberculosis resistant to streptomycin and isoniazid and treated wtih a combination of ethionamide, pyrazinamide, and cycloserine (200 cases)].
Topics: Adolescent; Adult; Age Factors; Aged; Aminosalicylic Acids; Child; Cycloserine; Drug Resistance, Mic | 1973 |
[Effect of saturation of Mycobacterium tuberculosis--a theoretical basis of the method of mazimum concentration of tuberculostatic preparations].
Topics: Animals; Antitubercular Agents; Autoradiography; Dogs; Humans; Isoniazid; Microscopy, Electron; Myco | 1974 |
[Incidence of drug sensitivity decrease in tuberculosis bacteria in untreated tuberculoses using autopsy material].
Topics: Aged; Aminosalicylic Acids; Antitubercular Agents; Autopsy; Cycloserine; Drug Resistance, Microbial; | 1974 |
Primary isoniazid-resistant tuberculosis in children. Clinical features, strain resistance, treatment, and outcome in 26 children treated at Kings County Medical Center of Brooklyn between the years 1961 and 1972.
Topics: Adolescent; Aminosalicylic Acids; Antibiotics, Antitubercular; Child; Child, Preschool; Cycloserine; | 1974 |
[Epidemiological, microbiological and clinical significance of primary drug resistance in Mycobacterium tuberculosis (collective study)].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethionamide; H | 1974 |
[Effectiveness of surgical treatment of patients with pulmonary tuberculosis with primary drug resistance].
Topics: Adolescent; Adult; Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Evaluati | 1974 |
Ambulatory management of tuberculosis.
Topics: Adult; Ambulatory Care; Aminosalicylic Acids; Antitubercular Agents; Chemical and Drug Induced Liver | 1974 |
Letter: The impact of chemotherapy on the care of patients with tuberculosis.
Topics: Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium | 1974 |
[Modern principles for the organization of drug therapy in tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Mycobacterium tuberculosis; Tub | 1974 |
[Results of examinations at admission time to the study of fibrous lesions and pulmonary tuberculosis].
Topics: Adult; Antitubercular Agents; Drug Resistance, Microbial; Humans; Isoniazid; Middle Aged; Mycobacter | 1974 |
[Effectiveness, during the 1st year, of 3 treatment durations].
Topics: Drug Evaluation; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tuberculosis; Time Fac | 1974 |
[Cooperative study of short-term antibacillary treatments in 14 French centers].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Human | 1974 |
A family outbreak of tuberculosis in Bristol in 1973 with two cases of tuberculous meningitis.
Topics: Adult; Aminosalicylic Acids; Child; Child, Preschool; Diagnostic Errors; Disease Outbreaks; Female; | 1974 |
[Clinical picture of erythema fixum generalisatum caused by PAS hypersensitivity observed in 41-year-old male with pulmonary tuberculosis after a prolonged treatment with antitubercular agents (INH and PAS)].
Topics: Adult; Aminosalicylic Acids; Drug Eruptions; Erythema; Humans; Isoniazid; Male; Tuberculosis, Pulmon | 1965 |
Isoniazid therapy in the chimpanzee.
Topics: Animals; Hominidae; Isoniazid; Tuberculin Test; Tuberculosis, Pulmonary | 1966 |
Chemotherapy of pulmonary tuberculosis with pneumoconiosis. Second report to the Medical Research Council from the Joint Investigators.
Topics: Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Dr | 1967 |
[Experience with cooperative antituberculous work of a santiary-epidemiologic station and a dispensary].
Topics: Adolescent; Adult; Ambulatory Care; BCG Vaccine; Child; Child, Preschool; Community Health Services; | 1966 |
[On the papules seen in patients on long-term INH therapy].
Topics: Adult; Drug Eruptions; Female; Humans; Isoniazid; Male; Tuberculosis, Pulmonary; Vitamin B Deficienc | 1967 |
[Severe hypersensitivity to SM, INH and PAS in a child with post-primary tuberculosis].
Topics: Aminosalicylic Acids; Child; Drug Eruptions; Drug Hypersensitivity; Female; Humans; Isoniazid; Strep | 1969 |
[Effectiveness of chemotherapy in patients with pulmonary tuberculosis in Uzbekistan].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Female; | 1969 |
[Study of blood nicotinamide during anti-tuberculous treatment].
Topics: Ethionamide; Humans; Isoniazid; Niacinamide; Pyridoxine; Tuberculosis, Pulmonary | 1970 |
[Levels of isonicotinic acid amide in patients with pulmonary tuberculosis treated with isonicotinic acid hydrazide and ethionamide].
Topics: Ethionamide; Humans; Isoniazid; Niacinamide; Pyridoxine; Time Factors; Tryptophan; Tuberculosis, Pul | 1970 |
[Neuropsychiatric incidences in antitubercular treatment consisting of isoniazid or isoniazid and ethionamide (8 cases)].
Topics: Acidosis; Adult; Alcoholism; Ammonia; Avitaminosis; Carboxy-Lyases; Chromatography, Paper; Chromatog | 1969 |
Ethambutol compared to streptomycin in original treatment of advanced pulmonary tuberculosis.
Topics: Adult; Aminosalicylic Acids; Drug Eruptions; Drug Hypersensitivity; Ethambutol; Female; Humans; Ison | 1971 |
Rifampin plus isoniazid in initial therapy of pulmonary tuberculosis and rifampin and ethambutol in retreatment cases.
Topics: Bilirubin; Drug Eruptions; Drug Hypersensitivity; Ethambutol; Humans; Isoniazid; Mycobacterium tuber | 1972 |
Reversible pellagra-like encephalopathy with ethionamide and cycloserine.
Topics: Brain Diseases; Cycloserine; Ethionamide; Female; Humans; Isoniazid; Male; Middle Aged; Niacinamide; | 1972 |
Isoniazid administration and liver injury.
Topics: Aminosalicylic Acids; Biopsy, Needle; Chemical and Drug Induced Liver Injury; Child; Drug Eruptions; | 1973 |
Isoniazid-induced acne and pellagra. Occurrence in slow inactivators of isoniazid.
Topics: Acne Vulgaris; Adult; Female; Half-Life; Humans; Isoniazid; Middle Aged; Pellagra; Skin; Time Factor | 1974 |
Early changes in pyridoxine status of patients receiving isoniazid therapy.
Topics: Adult; Alanine Transaminase; Amino Acids; Aspartate Aminotransferases; Clinical Enzyme Tests; Creati | 1974 |
[Primary drug resistance of Mycobacterium tuberculosis in Kazakhstan].
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Humans; Isoniazid; Kazakhstan; Mycobacterium tuber | 1974 |
[Pulmonary tuberculosis with resistant bacilli in untreated patients].
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Humans; In Vitro Techniques; Isoniazid; Mycobacter | 1965 |
Peripheral neuritis after long-term isoniazid.
Topics: Aged; Humans; Isoniazid; Male; Neuritis; Peripheral Nervous System Diseases; Tuberculosis, Pulmonary | 1966 |
Kanamycin: its therapeutic record in pulmonary tuberculosis in France and other European countries.
Topics: Adult; Aged; Aminosalicylic Acids; Animals; Antitubercular Agents; Ethionamide; Europe; France; Guin | 1966 |
[Therapy of pulmonary tuberculosis in its current aspects].
Topics: Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Ethionamide; Humans | 1965 |
The results of treatment in patients with cultures resistant to streptomycin, isoniazid and PAS: a five-year follow-up.
Topics: Aminosalicylic Acids; Cycloserine; Drug Resistance, Microbial; Ethionamide; Follow-Up Studies; Human | 1967 |
[Pseudo-tumoral retroperitoneal lymph node tuberculosis].
Topics: Aminosalicylic Acids; Diagnosis, Differential; Humans; Isoniazid; Lymphography; Male; Middle Aged; R | 1967 |
Treatment of pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Humans; Isoniazid; Kanamycin; Pyrazinamide; Strept | 1967 |
Denervation atrophy in isoniazid polyneuropathy. Histo-enzymatic study.
Topics: Adenosine Triphosphatases; Chronaxy; Electromyography; Extremities; Glucosyltransferases; Histocytoc | 1967 |
[Study of the effect of corticosteroid hormones, ACTH and the primary antitubercular drugs on sodium and potassium metabolism in tuberculous patients].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Aminosalicylic Acids; Antitubercular Agents; H | 1966 |
[Lupoid syndromes after absorption of isoniazid. Study of 6 cases].
Topics: Adult; Aged; Female; Humans; Isoniazid; Lupus Erythematosus, Systemic; Male; Tuberculosis, Pulmonary | 1967 |
[Rectal tuberculosis: a now rare diagnostic pitfall].
Topics: Adult; Aminosalicylic Acids; Colitis; Cycloserine; Diagnosis, Differential; Humans; Isoniazid; Male; | 1968 |
A continuing study of patients with "open negative" status at Battey State Hospital.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Child; Cycloserine; Female; Follow-Up Studies; Georgi | 1968 |
[Frequency of side-effects of tuberulostatics and its relation to the applied combination].
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Drug Synergism; Drug Tolerance | 1968 |
Ethambytol in the retreatment of pulmonary tuberculosis. United States Public Health Service cooperative trial.
Topics: Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Pyra | 1968 |
[Intravenous hormono-chemotherapy of pulmonary tuberculosis in case of drug-resistant mycobacteria].
Topics: Adenosine Triphosphate; Adolescent; Adrenocorticotropic Hormone; Adult; Antitubercular Agents; Ascor | 1969 |
[On the current early therapy methods of exsudative pulmonary tuberculosis in adults].
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Antitubercular Agents; Child; Drug Resistance, | 1969 |
[Intravenous hormono-chemotherapy of patients with chronic forms of pulmonary tuberculosis].
Topics: Adenosine Triphosphate; Adrenocorticotropic Hormone; Adult; Ascorbic Acid; Chronic Disease; Female; | 1967 |
[Actual tuberculosis therapy. An attempt to simplify and to determine a schedule of tuberculosis chemotherapy].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Synergism; Ethambutol; Ethionamide; H | 1969 |
The problem of the chronic excretor of tubercle bacilli.
Topics: Adult; Age Factors; Aged; Aminosalicylic Acids; Chronic Disease; Cycloserine; Czechoslovakia; Drug R | 1968 |
[Treatment of chronic destructive forms of pulmonary tuberculosis with drugs of the second series in different combinations].
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Cycloserine; Drug Resistance, Microbial; Ethionamide; | 1969 |
[Primary and secondary resistance in 257 cases of pulmonary tuberculosis from 1964 to 1966 at the Pneumology Service in Poitiers].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Humans; Isoniazid; Kanamyci | 1967 |
Clinical evaluation of intolerance to cycloserine.
Topics: Aminosalicylic Acids; Cycloserine; Drug Tolerance; Ethionamide; Isoniazid; Streptomycin; Tuberculosi | 1970 |
Ethambutol in the treatment of 26 patients with chronic active pulmonary tuberculosis.
Topics: Chronic Disease; Cycloserine; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Kanamycin; | 1969 |
Chemotherapy of tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Humans; Isoniazid | 1970 |
Isoniazid neuropathy in man: quantitative electron microscope study.
Topics: Adult; Aged; Biopsy; Demyelinating Diseases; Humans; Isoniazid; Microscopy, Electron; Middle Aged; N | 1970 |
Modification of the tuberculin response of rhesus monkeys by isoniazid therapy.
Topics: Animals; Disease Outbreaks; Disease Reservoirs; False Negative Reactions; Haplorhini; Isoniazid; Liv | 1971 |
[Intravenous chemotherapy of pulmonary tuberculosis].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Ethionamide; Female; Humans; Injections, Intrave | 1971 |
[Thoughts on pulmonary tuberculosis in the aged].
Topics: Age Factors; Aged; Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Female; Humans; Isoniaz | 1971 |
[Kanamycin and florimycin in the clinical course of pulmonary tuberculosis].
Topics: Adolescent; Adult; Albuminuria; Aminosalicylic Acids; Antitubercular Agents; Chronic Disease; Cyclos | 1971 |
Treatment of drug-resistant tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Cycloserine; Dr | 1971 |
Clinical and bacteriological results with Myambutol.
Topics: Adult; Chronic Disease; Cycloserine; Drug Combinations; Drug Resistance; Ethambutol; Ethionamide; Fe | 1970 |
On the epidemiology of tuberculosis in some selected countries. Highlights and prospects for control and eradication. II.
Topics: Adolescent; Aftercare; Antitubercular Agents; BCG Vaccine; Child; Comprehensive Health Care; Coopera | 1971 |
[Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
Topics: Adult; Aged; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide | 1971 |
[Immediate and remote results of intravenous chemo-hormonotherapy of initially detected pulmonary tuberculosis].
Topics: Adenosine Triphosphate; Adrenocorticotropic Hormone; Adult; Antitubercular Agents; Female; Heparin; | 1972 |
[Electroencephalographic changes and antitubercular treatments].
Topics: Adult; Age Factors; Aged; Alanine Transaminase; Aminosalicylic Acids; Antitubercular Agents; Drug In | 1972 |
[Duration of the after-control of the tuberculous patients following the termination of the treatment].
Topics: Adolescent; Adult; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide | 1972 |
[Lupus associated with ileocolitis following tuberculostatic treatment ( lupus and Crohn's disease )].
Topics: Adult; Antibodies, Antinuclear; Arthritis; Barium Sulfate; Crohn Disease; Fever; Humans; Isoniazid; | 1973 |
Isoniazid as a cause of neuropathy and sideroblastic anaemia.
Topics: Aged; Anemia, Sideroblastic; Humans; Isoniazid; Male; Peripheral Nervous System Diseases; Tuberculos | 1973 |
[Induction of Mycobacterium infection by introduction of the organisms into the lung through an intratracheal vinyl tube].
Topics: Animals; Antibiotics, Antitubercular; Disease Models, Animal; Dust; Ethambutol; Guinea Pigs; Intubat | 1972 |
Recent trends in tuberculosis care.
Topics: Aftercare; Alcoholism; Aminosalicylic Acids; Ethambutol; Hospitals, Special; Humans; Isoniazid; Occu | 1974 |
[Apropos of a case of Gayet-Wernicke's encephalopathy in a latent epileptic. Centrophenoxine and thiamine. Electro-clinical contraindications].
Topics: Acetates; Adult; Central Nervous System Stimulants; Epilepsy, Tonic-Clonic; Humans; Hydroxocobalamin | 1968 |
[Problems in the classification of certain types of segmentary allergic angitis].
Topics: Diagnosis, Differential; Drug Hypersensitivity; Endarteritis; Humans; Hypersensitivity; Isoniazid; K | 1972 |
[Effect of insulin on isoniazid and para-aminosalicylic acid metabolism in patients with pulmonary tuberculosis].
Topics: Adolescent; Adult; Aminosalicylic Acids; Drug Therapy, Combination; Humans; Insulin; Isoniazid; Midd | 1974 |
[Survey of the tuberculosis problem in the Nordic countries. Are BCG vaccination and mass screening necessary?].
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; BCG Vaccine; Ethambutol; Female; Humans; Iceland; Inf | 1974 |
Letter: Stop use of isoniazid?
Topics: Humans; Isoniazid; Tuberculosis, Pulmonary | 1974 |
Resected lung after an abbreviated rifampin regimen.
Topics: Adult; Aspergillosis; Hemoptysis; Humans; Isoniazid; Lung; Lung Diseases, Fungal; Male; Radiography; | 1974 |
Current changes in the recommendations for INH preventive treatment of tuberculous infection in Alabama.
Topics: Adult; Alabama; Chemical and Drug Induced Liver Injury; Female; Humans; Isoniazid; Liver; Male; Midd | 1974 |
[Remote results of treatment of newly identified patients with tuberculosis of the respiratory organs].
Topics: Adolescent; Adult; Aminosalicylic Acids; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle | 1974 |
[A controlled comparison of daily and intermittent triple drug regimens (SM-INH-EB) in original treatment. Report of the 16th series of Controlled Trial of Chemotherapy (author's transl)].
Topics: Adult; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Streptomycin; Tubercul | 1974 |
[Intravenous administration of antitubercular preparations in the complex treatment of patients with pulmonary tuberculosis associated with peptic ulcer].
Topics: Adult; Female; Gastrectomy; Humans; Injections, Intravenous; Intestinal Absorption; Isoniazid; Male; | 1974 |
[Hemoblastic reaction in a patient with pulmonary tuberculosis developed after the use of tubazid and PAS].
Topics: Adult; Agranulocytosis; Aminosalicylic Acids; Drug Therapy, Combination; Humans; Isoniazid; Male; Tu | 1974 |
Liver enzyme disturbances during isoniazid chemoprophylaxis in children.
Topics: Adolescent; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Child; Child, Presc | 1974 |
Infectivity of patients with pulmonary tuberculosis in inner city homes.
Topics: Ethambutol; Humans; Isoniazid; Maryland; Streptomycin; Time Factors; Tuberculin Test; Tuberculosis, | 1974 |
[Current therapy of pulmonary tuberculosis].
Topics: Anti-Bacterial Agents; Convalescence; Drug Therapy, Combination; Ethambutol; Hospitals, Special; Hum | 1974 |
On the pharmacokinetics of rifampicin I: Influence of dosage and duration of treatment with intermittent administration.
Topics: Adolescent; Adult; Aged; Chromatography, Thin Layer; Drug Therapy, Combination; Female; Half-Life; H | 1974 |
[Comparative study on an intermittent mode of pulmonary tuberculosis therapy using streptomycin and isoniazid].
Topics: Adolescent; Adult; Ambulatory Care; Aminosalicylic Acids; Drug Therapy, Combination; Humans; Isoniaz | 1974 |
Pulmonary tuberculosis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Drug Therapy, Com | 1974 |
[Effect of tubazid on catecholamine metabolism in patients with newly detected untreated pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Catecholamines; Circadian Rhythm; Epinephrine; Female; Humans; Isoniazid; M | 1974 |
[Treatment of pulmonary tuberculosis and ulcer disease by the method of rectal administration of tuberculostatic preparations].
Topics: Adult; Aminosalicylic Acids; Female; Humans; Isoniazid; Male; Middle Aged; Ointments; Peptic Ulcer; | 1974 |
[Treatment of early detected destructive pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Drug Therapy, Combination; Hum | 1974 |
[Rifampycine in the treatment of chronic pulmonary tuberculosis].
Topics: Antitubercular Agents; Drug Evaluation; Ethambutol; Humans; Isoniazid; Rifampin; Time Factors; Tuber | 1974 |
[Ratio of slow and fast isoniazide inactivators in the Czech and Slovak population (author's transl)].
Topics: Acetylation; Biotransformation; Czechoslovakia; Drug Resistance, Microbial; Female; Humans; Isoniazi | 1974 |
[Relationship between rate of inactivation of isoniazid and changes in transaminase levels during combined isoniazid-rifampicin therapy (author's transl)].
Topics: Acetylation; Drug Therapy, Combination; Female; Humans; Isoniazid; Rifampin; Time Factors; Transamin | 1974 |
[A clinical trial of short-course chemotherapy for pulmonary tuberculosis patients (author's transl)].
Topics: Adult; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomyc | 1974 |
[Change of tuberculin sensitivity during involution of experimental pulmonary tuberculosis].
Topics: Animals; BCG Vaccine; Guinea Pigs; Isoniazid; Tuberculin Test; Tuberculosis, Pulmonary | 1974 |
Isonicotinic acid hydrazide and pyridoxine deficiency.
Topics: Adult; Cystathionine; Cysteine; Female; Humans; Isoniazid; Male; Methionine; Neuritis; Tuberculosis, | 1974 |
[Delayed results of treatment of pulmonary tuberculosis with rifampicin].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Therapy, Combination; Drug Tolerance; Female; | 1974 |
[Fatal Lyell's syndrome in a tuberculous patient during treatment].
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Male; Stevens-Johnson Sy | 1974 |
[Resuscitation in acute tubazid poisoning].
Topics: Acute Disease; Adult; Antidotes; Humans; Isoniazid; Male; Respiration, Artificial; Resuscitation; Tu | 1974 |
[Characteristics of fibrous lesions].
Topics: Adult; Female; Health Surveys; Humans; Isoniazid; Male; Middle Aged; Placebos; Pulmonary Fibrosis; T | 1974 |
[Inactivation of INH and effectiveness of chemotherapy in pulmonary tuberculosis].
Topics: Acetylation; Drug Resistance, Microbial; Humans; Isoniazid; Tuberculosis, Pulmonary | 1974 |
Treatment of pulmonary tuberculosis in a patient on maintenance haemodialysis.
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Humans; Isoniazid; Kidney Failure, Chronic; Male | 1974 |
Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazed for primary treatment: the influence of various factors on the frequency of side-effects.
Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; I | 1974 |
Progressive lung disease in patients with tuberculosis and ankylosing spondylitis.
Topics: Aged; Aminosalicylic Acids; Aspergillosis; Humans; Isoniazid; Male; Middle Aged; Pulmonary Fibrosis; | 1974 |
Hyperlipidaemia as a complication of rifampicin treatment.
Topics: Alanine Transaminase; Alcoholism; Aminosalicylic Acids; Aspartate Aminotransferases; Cholesterol; Ch | 1974 |
[Proceedings: Rifampicin in initial therapy of pulmonary tuberculosis].
Topics: Drug Combinations; Ethambutol; Humans; Isoniazid; Pilot Projects; Rifampin; Streptomycin; Tuberculos | 1973 |
[Proceedings: Current status and perspectives of tuberculosis chemotherapy in Algeria].
Topics: Algeria; Ambulatory Care; Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; H | 1973 |
[Proceedings: Rifampicin adverse effects in intermittent therapy].
Topics: Adult; Aged; Aminosalicylic Acids; Drug Combinations; Drug Hypersensitivity; Female; Humans; Isoniaz | 1973 |
[Organization of chemotherapy under ambulatory conditions in the antituberculosis institutions of the Cheliabinsk district].
Topics: Ambulatory Care; Aminosalicylic Acids; Antitubercular Agents; Hospital Administration; Hospitals, Sp | 1974 |
Improving medication compliance by teaching outpatients.
Topics: Adult; Aged; Ambulatory Care; Cooperative Behavior; Female; Humans; Isoniazid; Male; Medication Erro | 1974 |
The predictability of hypersensitivity to anti-tuberculous drugs.
Topics: Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Blood Sedimentation; Drug Hypersensitivity | 1973 |
Side effects of rifampicin. A clinical study.
Topics: Acute Disease; Acute Kidney Injury; Adult; Ambulatory Care; Amylases; Chemical and Drug Induced Live | 1973 |
Side effects observed during intermittent rifampicin therapy.
Topics: Antibody Formation; Antigen-Antibody Reactions; Drug Therapy, Combination; Fever; Headache; Humans; | 1973 |
Intermittent rifampicin treatment of tuberculosis.
Topics: Drug Therapy, Combination; Ethambutol; Fever; Headache; Humans; Isoniazid; Kidney Diseases; Rifampin | 1973 |
Antinuclear factor in rapid and slow acetylator patients treated with isoniazid.
Topics: Adult; Age Factors; Aged; Aminosalicylic Acids; Antibodies, Antinuclear; Female; Humans; Isoniazid; | 1972 |
What to expect in tuberculous meningitis.
Topics: Adolescent; Adult; Age Factors; Aged; Aminosalicylic Acids; Child; Child, Preschool; Glucocorticoids | 1972 |
[INH-induced pellagra].
Topics: Adult; Child, Preschool; Female; Humans; Isoniazid; Male; Mental Disorders; Pellagra; Sex Factors; T | 1972 |
[Rheumatic diseases caused by antitubercular drugs].
Topics: Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Arthritis, Rheumatoid; Cycloserine; Dupuyt | 1972 |
[Role of isoniazid in hepatotoxicity with the INH-rifampicin combination in tuberculosis in children].
Topics: Adolescent; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug Combinations; Huma | 1972 |
Modern tuberculosis control. A six-year follow-up in an Appalacian community.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Child; Child, Preschool; Female; Follow-Up Studies; H | 1973 |
Ethambutol syrup in combination with isoniazid in the treatment of childhood tuberculosis.
Topics: Child; Child, Preschool; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Tuberculosi | 1972 |
[Changes in the factors influencing the epidemiology of tuberculosis].
Topics: Child; Humans; Hungary; Isoniazid; Mass Chest X-Ray; Tuberculosis; Tuberculosis, Pulmonary | 1973 |
Results of 20 years of tuberculosis control in Alaska.
Topics: Adolescent; Adult; Alaska; Ambulatory Care; Aminosalicylic Acids; BCG Vaccine; Child; Child, Prescho | 1973 |
Natural history of segmental lesions in primary pulmonary tuberculosis: long-term review of 383 patients.
Topics: Adolescent; Aminosalicylic Acids; Blood Sedimentation; Bronchography; Bronchoscopy; Child; Child, Pr | 1973 |
[Immunity and allergy depression during rubella in a child with primary tuberculosis and isoniazid intolerance].
Topics: Aminosalicylic Acids; Anaphylaxis; Child, Preschool; Drug Hypersensitivity; Fever; Hepatitis; Hepato | 1972 |
Late prognosis of children born into tuberculous households. The effect of isolation and simultaneous BCG-vaccination.
Topics: Adolescent; Adult; Age Factors; BCG Vaccine; Birth Weight; Child; Child Health Services; Child, Pres | 1972 |
Tuberculosis in the United States today.
Topics: Adolescent; Adult; Aged; Child; Humans; Isoniazid; Middle Aged; Tuberculosis; Tuberculosis, Pulmonar | 1973 |
Thrombocytopenia following administration of para-aminosalicylic acid.
Topics: Aminosalicylic Acids; Humans; Infant; Isoniazid; Male; Streptomycin; Thrombocytopenia; Tuberculosis, | 1973 |
Management of newborns after nursery exposure to tuberculosis.
Topics: Cross Infection; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Isoniazid; Nurseries, H | 1974 |
Medical grand rounds--from the Medical College of Virginia. Drug-induced lupus erythematosus.
Topics: Antibodies, Anti-Idiotypic; Antibodies, Antinuclear; Disease Susceptibility; DNA; DNA, Single-Strand | 1974 |
Isoniazid in the prevention and treatment of tuberculosis. A 20-year study of the effectiveness in children.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Age Factors; Child; Child, Preschool; Drug E | 1974 |
[Immediate results obtained with intermittent treatment with classical tuberculostatic drugs in tuberculosis in children].
Topics: Adolescent; Aminosalicylic Acids; Antitubercular Agents; Child; Child, Preschool; Female; Humans; In | 1974 |
Letter: Massive use of chemoprophylaxis against tuberculosis.
Topics: BCG Vaccine; Child; Humans; Isoniazid; Tuberculosis; Tuberculosis, Pulmonary | 1974 |
Incidence of tuberculosis in the schoolchildren of the Umzimkulu District.
Topics: Adolescent; Child; Health Education; Humans; Isoniazid; Rural Population; South Africa; Tuberculin T | 1974 |
Screening of isoniazid inactivators by dilution test.
Topics: Acetylation; Humans; Hydrazines; Isoniazid; Methods; Phenotype; Tuberculosis, Pulmonary | 1974 |
[Effect of E.coli-L-asparaginase alone or in combination with INH or PAS on the course of experimental tuberculosis in guinea pigs].
Topics: Aminosalicylic Acids; Animals; Asparaginase; Disease Models, Animal; Drug Synergism; Escherichia col | 1972 |
Efficacy of bacillus Calmette-Guérin and isoniazid-resistant bacillus Calmette-Guérin with and without isoniazid chemoprophylaxis from day of vaccination. I. Experimental findings in guinea pigs.
Topics: Animals; Antibody Formation; BCG Vaccine; Disease Models, Animal; Drug Resistance, Microbial; Guinea | 1973 |
Efficacy of bacillus Calmette-Guérin and isoniazid-resistant bacillus Calmette-Guérin with and without isoniazid chemoprophylaxis from day of vaccination. II. Field trial in man.
Topics: Adolescent; Adult; Aged; Bacteriological Techniques; BCG Vaccine; Cell Count; Child; Child, Preschoo | 1973 |
Curative effect of a course of monotherapy with rifampicin, isoniazid or streptomycin subsequent to combination treatment in murine tuberculosis.
Topics: Administration, Oral; Animals; Drug Therapy, Combination; Female; Germ-Free Life; Injections, Subcut | 1973 |
Comparative efficacy of daily and intermittent chemotherapy with combinations of rifampicin and isoniazid in chronic murine tuberculosis, with particular reference to the prevention of relapses.
Topics: Animals; Chronic Disease; Drug Therapy, Combination; Female; Isoniazid; Lung; Mice; Mycobacterium bo | 1973 |
Further studies on the increase in cholesterol ester content of the lungs of tuberculous mice.
Topics: Animals; Cholesterol; Chromatography, Thin Layer; Esters; Isoniazid; Lipid Metabolism; Lung; Mycobac | 1974 |
The John Barnwell lecture: Improving existing methods of control of tuberculosis: A prime challenge to the experimentalist.
Topics: Animals; Antitubercular Agents; BCG Vaccine; Biopsy; Disease Models, Animal; Drug Resistance, Microb | 1972 |
A study of 200 cases of active, recent pulmonary tuberculosis treated with rifampin-isoniazid. A follow-up history of one and one-half to three years.
Topics: Adolescent; Adult; Aged; Bilirubin; Drug Resistance, Microbial; Ethambutol; Female; Follow-Up Studie | 1972 |
Intermittent therapy with rifampin once a week in advanced pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Bilirubin; Blood Proteins; Drug Resistance, Microbial; Ethambutol; Female; | 1972 |
The antituberculosis efficacy of rifampin in 136 patients.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Drug Resistance, Microbial; Ethambutol; Female; Human | 1972 |
Rifampin-isoniazid compared with streptomycin-isoniazid in the original treatment of infectious pulmonary tuberculosis. Results of a controlled study.
Topics: Adolescent; Adult; Aged; Drug Resistance, Microbial; Female; Follow-Up Studies; Humans; Isoniazid; L | 1972 |
Intermittent chemotherapy in pulmonary tuberculosis--current aspects.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Long-Term Care; Me | 1972 |
A study in Hong Kong to evaluate the role of pretreatment susceptibility tests in the selection of regiments of chemotherapy for pulmonary tuberculosis. Hong Kong Tuberculosis Treatment Services-British Medical Research Council Investigation.
Topics: Adolescent; Adult; Aminosalicylic Acids; Antitubercular Agents; Costs and Cost Analysis; Drug Resist | 1972 |
Undiagnosed tuberculosis in a general hospital.
Topics: Adult; Age Factors; Aged; Aminosalicylic Acids; Biopsy; Body Weight; Bone Marrow; Ethambutol; Fatigu | 1972 |
[Treatment of patients with caseous tuberculosis of the lungs with individual maximally tolerated doses of Tubazid].
Topics: Adolescent; Adult; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Sputum; | 1972 |
[Intermittent 2-phase therapy using ethambutol-INH-streptomycin].
Topics: Adolescent; Adult; Antitubercular Agents; Drug Synergism; Ethambutol; Female; Humans; Isoniazid; Lon | 1972 |
Pulmonary cryptocococcis followed by pulmonary tuberculosis. A case report.
Topics: Adult; Aminosalicylic Acids; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Humans; Isonia | 1972 |
Generalized seizures following isoniazid therapy for tuberculosis in a patient with uremia.
Topics: Aged; Animals; Cerebral Cortex; Colon; Epididymis; Granuloma; Guinea Pigs; Humans; Hypertension; Iso | 1972 |
The method of vertical diffusion for the determination of drug sensitivity of Mycobacterium tuberculosis and the concentration of biologically active tubazid in the blood serum of patients with tuberculosis.
Topics: Aminosalicylic Acids; Culture Media; Humans; Isoniazid; Methods; Microbial Sensitivity Tests; Mycoba | 1972 |
Tuberculous meningitis in children. A review of 25 cases observed between the years 1965 and 1970 at the Kings County Medical Center of Brooklyn with special reference to the problem of infection with primary drug-resistant strains of M. tuberculosis.
Topics: Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; | 1973 |
[Usefulness of rifampicin for pulmonary resection of drug-resistant pulmonary tuberculosis--report of the 13th series study. C].
Topics: Adolescent; Adult; Aged; Child; Drug Resistance, Microbial; Female; Humans; Isoniazid; Kanamycin; Ma | 1973 |
Primary drug resistance. 3.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Child; Child, Preschool; Drug Resistance, Microbial; | 1972 |
[Shortening of tuberculosis treatment].
Topics: Animals; Drug Synergism; Humans; Isoniazid; Methods; Microbial Sensitivity Tests; Mycobacterium tube | 1972 |
The effect of acceptable and adequate outpatient treatment on the length of hospitalization and on readmission for relapse or reactivation of pulmonary tuberculosis.
Topics: Adolescent; Adult; Ambulatory Care; Aminosalicylic Acids; Antitubercular Agents; Child, Preschool; D | 1973 |
[Hospital chemotherapy in the presence of isoniazid-resistant and multi-resistant causative organisms].
Topics: Aged; Antitubercular Agents; Chronic Disease; Drug Combinations; Drug Resistance, Microbial; Humans; | 1973 |
[The clinical importance of the primary drug resistance of Mycobacterium tuberculosis in destructive forms of pulmonary tuberculosis].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Humans; Isoniazid; Microbial Sensitivity Tests; M | 1972 |
Rifampin in the treatment of pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1972 |
Tuberculous peritonitis. Prospective study of 32 cases in Iran.
Topics: Adolescent; Adult; Aminosalicylic Acids; Ascitic Fluid; Child; Female; Hemoglobins; Humans; Iran; Is | 1972 |
Pulmonary tuberculosis in well-treated alcoholics. Long-term prognosis regarding relapses compared with non-alcoholic patients.
Topics: Alcoholism; Aminosalicylic Acids; Follow-Up Studies; Humans; Isoniazid; Prognosis; Recurrence; Strep | 1972 |
Pulmonary tuberculosis in graphite miners.
Topics: Adult; Aged; Aminosalicylic Acids; Carbon; Humans; Isoniazid; Male; Mining; Pneumoconiosis; Sputum; | 1972 |
The Australian rifampicin trial.
Topics: Adult; Aged; Costs and Cost Analysis; Drug Resistance, Microbial; Ethambutol; Female; Follow-Up Stud | 1972 |
[Role of individual phasic analyses of ventricular systoles based on rheographic data in evaluating the effect of tubazid on the myocardium].
Topics: Heart; Humans; Isoniazid; Plethysmography, Impedance; Tuberculosis, Pulmonary; Vectorcardiography | 1972 |
[Aerosol therapy of pulmonary tuberculosis with differing degrees of resistance to GINK preparations].
Topics: Administration, Intranasal; Administration, Oral; Adult; Aerosols; Drug Resistance, Microbial; Femal | 1972 |
[Streptomycin, isoniazid and ethambutol in continuous and intermittent treatment of previously untreated pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Ethambutol; Female; Humans; Isoniazid; Male; Methods; Middle Aged; Streptom | 1972 |
Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
Topics: Ethambutol; Female; Humans; Isoniazid; Male; Rifampin; Tuberculosis, Pulmonary | 1972 |
A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
Topics: Adolescent; Adult; Aged; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Strepto | 1972 |
[Preventive treatment of tuberculosis].
Topics: Antitubercular Agents; Communicable Disease Control; Disease Reservoirs; Ethambutol; Humans; Isoniaz | 1972 |
[Problems in the administration of preventive treatment of tuberculosis].
Topics: Aminosalicylic Acids; Communicable Disease Control; Humans; Isoniazid; Recurrence; Streptomycin; Tub | 1972 |
[Ambulatory chemotherapy of tuberculosis].
Topics: Ambulatory Care; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Outpatient Clinics, Hospital; | 1972 |
Shorter treatment.
Topics: Animals; Drug Combinations; Humans; Isoniazid; Pyrazinamide; Recurrence; Rifampin; Time Factors; Tub | 1972 |
[The hazards of intravenous infusions of tubazid].
Topics: Adult; Female; Humans; Injections, Intravenous; Isoniazid; Seizures; Tuberculosis, Pulmonary | 1972 |
Experimental tuberculosis with African strains of various drug-resistance.
Topics: Africa; Animals; Catalase; Drug Resistance, Microbial; Guinea Pigs; Isoniazid; Liver; Lung; Lymph No | 1972 |
[Automatic data processing during a controlled therapeutic trial in multiple tuberculosis units (survey 6.9.12)].
Topics: Computers; Electronic Data Processing; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1972 |
[Treatment of pulmonary tuberculosis by the one-time administration of preparations depending on the degree of isonicotinic acid hydrazide inactivation].
Topics: Colorimetry; Drug Combinations; Humans; Isoniazid; Tuberculosis, Pulmonary | 1972 |
Classification of subjects as slow or rapid inactivators of isoniazid, based on the ratio of the urinary excretion of acetylisoniazid to isoniazid.
Topics: Biological Assay; Colorimetry; Humans; Isoniazid; Time Factors; Tuberculosis, Pulmonary | 1972 |
A controlled comparison of self-administered versus supervised treatment in Singapore.
Topics: Age Factors; Ambulatory Care; Aminosalicylic Acids; Body Weight; Hospitalization; Humans; Isoniazid; | 1972 |
[Regeneration processes in the wall of a tuberculous lung cavern at various stages of healing].
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Dogs; Granulation Tissue; Isoniazid; Prednisol | 1972 |
[Serum aminotransferase activity in pulmonary tuberculosis during chemotherapy with tubazid].
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Female; Humans; Isoniazid; Male; Middle Ag | 1972 |
Tuberculosis outbreak in a circus: report of a cooperative investigation.
Topics: Adolescent; Adult; Alabama; Child, Preschool; Disease Outbreaks; District of Columbia; Female; Human | 1973 |
Tuberculous bronchopleural fistula.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Bronchial Fistula; Female; Fistula; Humans; Isoniazi | 1973 |
Tuberculosis discovered while performing thoracotomy for suspected lung cancer.
Topics: Adult; Aged; Female; Humans; Isoniazid; Lung Neoplasms; Male; Middle Aged; Postoperative Care; Preop | 1973 |
Tuberculosis complicated by pregnancy.
Topics: Adolescent; Adult; Aminosalicylic Acids; Anesthesia, General; Cross Infection; Delivery, Obstetric; | 1973 |
Relapse in tuberculosis. A report from the Research Committee of the South-East Metropolitan Regional Thoracic Society.
Topics: Adolescent; Adult; Age Factors; Aged; Aminosalicylic Acids; Drug Resistance, Microbial; Female; Huma | 1973 |
Is there an anemia responsive to pantothenic acid?
Topics: Anemia, Hypochromic; Erythrocyte Count; Female; Hematocrit; Humans; Isoniazid; Middle Aged; Pantothe | 1973 |
[Lupus erythematosus following use of isoniazid].
Topics: Adult; Female; Humans; Isoniazid; Lupus Erythematosus, Systemic; Time Factors; Tuberculosis, Female | 1973 |
Control and prevention of tuberculosis.
Topics: Alabama; Female; Humans; Isoniazid; Male; Tuberculosis, Pulmonary | 1973 |
Ethambutol and isoniazid in the treatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Tuberculosis, Pulmonary | 1973 |
Intermittent chemotherapy in pulmonary tuberculosis with ethambutol and isoniazid.
Topics: Administration, Oral; Ethambutol; Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1973 |
Development of pulmonary tuberculosis several years after chemoprophylaxis.
Topics: Adult; Female; Health Education; Humans; Isoniazid; Male; Recurrence; Tuberculosis, Pulmonary | 1973 |
A second reversion of the tuberculin reaction after issoniazid prevention therapy. A case report.
Topics: Adult; Female; Humans; Isoniazid; Recurrence; Tuberculin Test; Tuberculosis, Pulmonary | 1973 |
[Chemotherapy of untreated pulmonary tuberculosis in the hospital].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Combinations; Female; Hospitals; Humans; Isonia | 1973 |
Northern highlights. 6.
Topics: Alaska; Humans; Isoniazid; Tuberculosis, Pulmonary | 1973 |
[Failure of chemotherapy in pulmonary tuberculosis in a patient with coexistent diabetes].
Topics: Aminosalicylic Acids; Diabetes Complications; Humans; Isoniazid; Male; Middle Aged; Stomach Ulcer; T | 1973 |
[Massive pulmonary embolism during bacillary tuberculous pneumonia. Remarkable effects of streptokinase].
Topics: Adult; Angiography; Electrocardiography; Ethambutol; Hematoma; Heparin; Humans; Isoniazid; Male; Phl | 1973 |
[Two cases of auricular tuberculosis with facial paralysis].
Topics: Adolescent; Adult; Ear Diseases; Facial Paralysis; Female; Humans; Isoniazid; Labyrinth Diseases; Ri | 1973 |
[Treatment of pulmonary, pleural and vertebral tuberculosis].
Topics: Dexamethasone; Drug Hypersensitivity; Ethambutol; Glomerular Filtration Rate; Humans; Isoniazid; Ple | 1973 |
[Follow-up studies up to 2 years of pulmonary tuberculosis patients submitted to the primary chemotherapy for 1 year with multiple drugs including ethambutol].
Topics: Adult; Aminosalicylic Acids; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle | 1973 |
[Comparative study of the results of 3 different regimens of antitubercular drug therapy used in rural Zaire during the last 15 years].
Topics: Adolescent; Adult; Ambulatory Care; Aminosalicylic Acids; Antitubercular Agents; Child; Democratic R | 1973 |
[Effect of chemotherapy on the function of external respiration in patients with newly detected pulmonary tuberculosis].
Topics: Adolescent; Adult; Female; Humans; Isoniazid; Male; Respiration; Spirometry; Streptomycin; Tuberculo | 1973 |
[Interrupted treatment with streptomycin and tubazid of patients with pulmonary tuberculosis].
Topics: Adolescent; Adult; Female; Humans; Isoniazid; Male; Middle Aged; Pyridoxine; Streptomycin; Time Fact | 1973 |
Transfer factor therapy in a patient with progressive primary tuberculosis.
Topics: Adult; Aminosalicylic Acids; Anemia, Aplastic; Cell Migration Inhibition; Ethambutol; Female; Humans | 1973 |
[Effectiveness of the agents of the 2d series in treating patients with chronic destructive tuberculosis of the lungs].
Topics: Adolescent; Adult; Aged; Chronic Disease; Cycloserine; Ethionamide; Female; Humans; Isoniazid; Male; | 1973 |
[Determination of active isoniazid in the blood serum after intratracheal administration in patients with coniotuberculosis].
Topics: Humans; Isoniazid; Pneumoconiosis; Trachea; Tuberculosis, Pulmonary | 1973 |
[Intermittent treatment and simplified continuous treatment of newly-detected pulmonary tuberculosis with first-line drugs and limited PAS administration. I. Methods and results].
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Drug Synergism; Female; Humans | 1973 |
[Early results of sputum-positive patients with newly-detected pulmonary tuberculosis with rifampicin combined with isoniazid and SM (preliminary report)].
Topics: Adolescent; Adult; Antitubercular Agents; Drug Synergism; Evaluation Studies as Topic; Humans; Isoni | 1973 |
Isoniazid chemoprophylaxis.
Topics: Adolescent; Adult; Aged; Child; Female; Humans; Isoniazid; Male; Middle Aged; Tuberculin Test; Tuber | 1973 |
Tuberculosis: why our concepts have changed.
Topics: Aminosalicylic Acids; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Length of Stay; Male | 1973 |
[Diphenylhydantoin poisoning induced by isoniazide. A further case].
Topics: Child; Drug Interactions; Electroencephalography; Epilepsy; Humans; Isoniazid; Male; Neurologic Mani | 1973 |
[Experience with prolonged treatment against relapses in pulmonary tuberculosis].
Topics: Adult; Aminosalicylic Acids; Female; Humans; Isoniazid; Male; Middle Aged; Recurrence; Time Factors; | 1973 |
Chest X-ray film not needed during antituberculosis chemoprophylaxis.
Topics: Adult; Aged; Child; Female; Humans; Isoniazid; Lung; Male; Middle Aged; Radiography; Tuberculin Test | 1973 |
Early hospital discharge of tuberculous patients with sputum containing acid-fast bacilli on microscopic examination.
Topics: Adult; Aged; Ambulatory Care; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Length of Stay; Male | 1973 |
[Concentration of tuberculostatic drugs introduced by different methods, in the blood of patients].
Topics: Antitubercular Agents; Cycloserine; Humans; Infusions, Parenteral; Isoniazid; Respiratory Therapy; T | 1973 |
Successive manifestations of tuberculosis in a recalcitrant patient.
Topics: Adult; Aminosalicylic Acids; Communicable Disease Control; Hospitalization; Humans; Isoniazid; Male; | 1973 |
Agranulocytosis following isoniazid. Report of a case.
Topics: Adult; Agranulocytosis; Humans; Isoniazid; Male; Tuberculosis, Pulmonary | 1973 |
Isoniazid inactivation in Indian children.
Topics: Age Factors; Body Weight; Child; Child, Preschool; Female; Humans; India; Infant; Isoniazid; Male; M | 1973 |
Reliability of outpatients taking ethambutol for tuberculosis.
Topics: Adult; Ambulatory Care; Aminosalicylic Acids; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Outp | 1973 |
Isoniazid chemoprophylaxis: a cost analysis.
Topics: Colorado; Costs and Cost Analysis; Isoniazid; Tuberculosis, Pulmonary | 1973 |
Slow and rapid inactivators of isoniazid among Greek patients.
Topics: Adult; Female; Greece; Humans; Isoniazid; Male; Middle Aged; Tuberculosis, Pulmonary | 1973 |
[Practical tuberculostatic therapy].
Topics: Administration, Oral; Antitubercular Agents; Drug Therapy, Combination; Humans; Injections, Intramus | 1973 |
Letter: Isoniazid hepatitis.
Topics: Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Tuberculosis, Pulmonary | 1973 |
Letter: Correction: figure legends in "isoniazid hepatitis".
Topics: Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Tuberculosis, Pulmonary | 1973 |
[Comparative study of 2 therapeutic schemes in pulmonary tuberculosis not previously treated].
Topics: Administration, Oral; Adolescent; Aminosalicylic Acids; Ethambutol; Evaluation Studies as Topic; Fem | 1973 |
[Necessity of an optimum stationary therapy for pulmonary tuberculosis and the dependence of its results on endogenous and exogenous factors].
Topics: Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Tuberculosis, | 1973 |
[Comparison of 2 methods for determination of the inactivation rate of isoniazid in human serum].
Topics: Humans; Isoniazid; Methods; Tuberculosis, Pulmonary | 1973 |
[Effect of INH administered prophylactically on tuberculin test in children and adolescents with exposure to superinfection].
Topics: Adolescent; Age Factors; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Isoniazid; Male | 1973 |
[Chemotherapy of chronic destructive tuberculosis of the lungs].
Topics: Aminosalicylic Acids; Antitubercular Agents; Chronic Disease; Cycloserine; Drug Therapy, Combination | 1973 |
[Excretion and concentration of tubazid, PAS and their metabolites in patients with tuberculosis and different functional conditions of kidneys].
Topics: Aminosalicylic Acids; Humans; Isoniazid; Kidney; Tuberculosis; Tuberculosis, Pulmonary; Tuberculosis | 1973 |
[Inactivation of PAS and isoniazid in children with tuberculosis].
Topics: Adolescent; Aminosalicylic Acids; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans | 1973 |
[Letter: Acute kidney failure due to rifampicin].
Topics: Acute Kidney Injury; Diarrhea; Ethionamide; Female; Humans; Isoniazid; Middle Aged; Renal Dialysis; | 1973 |
[Inactivation of the HINA preparations and certain indicators of the detoxicating function of the liver in patients with pulmonary tuberculosis].
Topics: Adult; Antitubercular Agents; Female; Humans; Isoniazid; Liver; Male; Middle Aged; Tuberculosis, Pul | 1973 |
Initial treatment of tuberculosis with rifampicin.
Topics: Adult; Aminosalicylic Acids; Drug Therapy, Combination; Eosinophils; Ethambutol; Female; Humans; Iso | 1973 |
Medical grand rounds from Touro infirmary: tuberculosis from the cradle to the grave.
Topics: Aminosalicylic Acids; Female; Humans; Isoniazid; Middle Aged; Pneumonectomy; Tuberculosis, Pulmonary | 1973 |
[Isoniazid therapy with one daily dose (author's transl)].
Topics: Administration, Oral; Drug Combinations; Humans; Isoniazid; Pyridoxine; Tuberculosis, Pulmonary | 1973 |
[Case of lowered sensitivity to hexenal after using antitubercular preparations].
Topics: Anesthesia, General; Cycloserine; Drug Antagonism; Hexobarbital; Isoniazid; Tuberculosis, Pulmonary | 1973 |
[Modern tuberculosis therapy].
Topics: Aminosalicylic Acids; BCG Vaccine; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mass Sc | 1973 |
The decline and fall of the chest clinic.
Topics: England; Ethambutol; Hospitals, General; Humans; Isoniazid; Outpatient Clinics, Hospital; Radiograph | 1973 |
[Effectiveness of the treatment of pulmonary tuberculosis with INAH preparations in different degrees of tubazid inactivation].
Topics: Drug Resistance, Microbial; Humans; Isoniazid; Tuberculosis, Pulmonary | 1973 |
[Use of rifampin and ethambutol for the treatment of pulmonary tuberculosis].
Topics: Adolescent; Adult; Drug Synergism; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; | 1973 |
[Express method of intravenous administration of tubazid].
Topics: Adolescent; Female; Humans; Injections, Intravenous; Isoniazid; Male; Methods; Tuberculosis, Pulmona | 1973 |
[Mechanism of the action of anabolic steroid preparations in experimental tuberculosis].
Topics: Anabolic Agents; Animals; Drug Interactions; Drug Therapy, Combination; Glycogen; Guinea Pigs; Isoni | 1973 |
[Ambulatory intermittent chemotherapy of patients with newly detected pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Ambulatory Care; Aminosalicylic Acids; Drug Therapy, Combination; Humans; I | 1973 |
[Organization and effectiveness of the treatment of patients with newly detected destructive pulmonary tuberculosis].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Female; Humans; Isoniazid; Male; Middle Aged; Pn | 1973 |
[Short-term chemotherapy of pulmonary tuberculosis without previous treatment (results up to July 20th, 1972)].
Topics: Drug Therapy, Combination; Ethambutol; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1973 |
[Our cases of suicide by isoniazid].
Topics: Adolescent; Adult; Female; Humans; Isoniazid; Suicide; Tuberculosis, Pulmonary; Yugoslavia | 1973 |
Cytoplasmic crystalline regions in hepatocytes of liver biopsy specimens.
Topics: Adult; Biopsy; Chemical and Drug Induced Liver Injury; Cytoplasm; Humans; Isoniazid; Liver; Liver Ci | 1974 |
The prevalence of smoking among adolescents with primary tuberculosis.
Topics: Adolescent; Adult; Black or African American; Female; Humans; Isoniazid; Male; Smoking; Tuberculosis | 1974 |
Hepatotoxicity to isoniazid. A case report.
Topics: Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Male; Middle Aged; Tuberculosis, Pulmonar | 1974 |
[INH-induced skin changes].
Topics: Alopecia; Animals; Humans; Isoniazid; Skin; Tuberculosis, Pulmonary | 1974 |
Letter: Isoniazid hepatitis.
Topics: Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Tuberculosis, Pulmonary | 1974 |
Disseminated lung opacities and cavitation associated with Strongyloides stercoralis and Schistosoma mansoni infection.
Topics: Adult; Aminosalicylic Acids; Eosinophilia; Ethiopia; Fever; Finland; Humans; Intestinal Diseases, Pa | 1974 |
Letter: Tuberculosis control--means and strategies.
Topics: BCG Vaccine; Humans; Isoniazid; South Africa; Tuberculosis, Pulmonary; Zimbabwe | 1974 |
Special problems in respiratory diseases.
Topics: Adrenal Cortex Hormones; Aged; Aging; Anti-Bacterial Agents; Anticoagulants; Asthma; Bronchodilator | 1974 |
Upper respiratory tract tuberculosis. Sixteen cases in a general hospital.
Topics: Aged; Diagnosis, Differential; Epiglottis; Esophageal Neoplasms; Hospitals, General; Humans; Ileocec | 1974 |
Congenital tuberculosis: report of a case.
Topics: Adult; Ampicillin; Ethambutol; Female; Fever; Humans; Infant; Infant, Newborn; Isoniazid; Kanamycin; | 1974 |
Editorial: Isoniazid and the liver.
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Liver; Middle Aged; Tubercul | 1974 |
Pharmacokinetic studies with an isoniazid slow-releasing matrix preparation.
Topics: Acetylation; Delayed-Action Preparations; Humans; Isoniazid; Kinetics; Tuberculosis, Pulmonary | 1974 |
High dose ethambutol; an oral alternate for intermittent chemotherapy.
Topics: Administration, Oral; Adult; Aged; Dose-Response Relationship, Drug; Drug Therapy, Combination; Etha | 1974 |
Letter: Rifampin in initial treatment of pulmonary tuberculosis: a U.S. Public Health Service tuberculosis therapy trial.
Topics: Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary; United States; Unit | 1974 |
[Liver toxicity of combined rifampicin-isoniazid-ethambutol medication (author's transl)].
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bi | 1974 |
[Effect of vitamin B6 on the blood isoniazid concentration and its role in the regulation of the functional state of central nervous system in dogs].
Topics: Central Nervous System; Drug Therapy, Combination; Humans; Injections, Intravenous; Isoniazid; Pyrid | 1974 |
[Preliminary results of initial short-term chemotherapy with INH, RMP and EMB in intermittent and biphasic administration (the 3 plus 6 experiment)].
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antitubercular Agents; Drug Therapy, Combination; Ethambut | 1974 |
Letter: Isoniazid.
Topics: Adolescent; Adult; Age Factors; Chemical and Drug Induced Liver Injury; Erythromycin; Humans; Isonia | 1974 |
Letter: Isoniazid.
Topics: Adult; Chemical and Drug Induced Liver Injury; Female; Humans; Isoniazid; Tuberculosis, Pulmonary | 1974 |
Ethambutol in pregnancy.
Topics: Abnormalities, Drug-Induced; Animals; Child; Child, Preschool; Chronic Disease; Drug Therapy, Combin | 1974 |
[Shoulder amyotrophy in vitamin B6 deficiency due to isoniazid].
Topics: Aminosalicylic Acids; Antitubercular Agents; Exercise Therapy; Humans; Isoniazid; Male; Middle Aged; | 1974 |
[Sideroblastic anemia after treatment with isoniazid (Nidrazid)].
Topics: Aged; Aminosalicylic Acids; Anemia, Sideroblastic; Humans; Isoniazid; Male; Tuberculosis, Pulmonary | 1974 |
[Diagnosis and therapy of pulmonary tuberculosis].
Topics: Diagnosis, Differential; Female; Humans; Isoniazid; Male; Tuberculosis, Pulmonary | 1974 |
[Prevention of tuberculosis in workers exposed to asbestos dust].
Topics: Adolescent; Adult; Age Factors; Asbestos; Asbestosis; BCG Vaccine; Chemical Industry; Female; Humans | 1974 |
[Treatment of primary tuberculosis].
Topics: Administration, Oral; Adult; Aminosalicylic Acids; Antibody Formation; Antitubercular Agents; BCG Va | 1974 |
Blood levels of rifampicin in liver diseases.
Topics: Ethambutol; Humans; Isoniazid; Jaundice; Liver; Liver Diseases; Rifampin; Sulfobromophthalein; Tuber | 1974 |
Letter: Massive use of chemoprophylaxis against tuberculosis.
Topics: Adult; BCG Vaccine; Child; Humans; Infant, Newborn; Isoniazid; Recurrence; South Africa; Tuberculosi | 1974 |
Tuberculosis in rural Haiti.
Topics: Adolescent; Adult; Age Factors; Aminosalicylic Acids; Attitude to Health; Child; Child, Preschool; C | 1974 |
A pilot study concerning the early immunosuppressive effects of rifampin in man.
Topics: Adult; Antibody Formation; Bacteriophages; DNA Viruses; Histoplasmin; Humans; Immunity; Immunity, Ce | 1974 |
The management of drug-resistant pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Attitude; Bacteriological Techniques; Drug Resistance, | 1968 |
[Various experimental diseases induced in guinea pigs by the historical Institut Pasteur BCG strain and by the B-1 positive catalase strain. Study of the viability of the inoculated bacteria].
Topics: Animals; Bacteriological Techniques; Catalase; Drug Resistance, Microbial; Guinea Pigs; Isoniazid; M | 1968 |
Incidence of resistant pulmonary tuberculosis in relation to initial bacterial load, Rifampicin and INH in experimental tuberculosis.
Topics: Animals; Drug Resistance, Microbial; Female; Isoniazid; Mice; Mutation; Mycobacterium bovis; Rifampi | 1970 |
Pulmonary tuberculosis due to B.C.G.
Topics: Adult; Aminosalicylic Acids; Arthritis, Juvenile; Female; Humans; Immune System Diseases; Isoniazid; | 1971 |
Conversion by isoniazid of hyperacute to chronic pulmonary tuberculosis in mice. II. Histopathology of lungs.
Topics: Acute Disease; Animals; Chronic Disease; Female; Injections, Intravenous; Isoniazid; Leukocytes; Liv | 1967 |
[Inoculation of Mycobacterium tuberculosis and INH concentration in resected lung tissue].
Topics: Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tuberculosis; Pneumonectomy; Tuberculos | 1965 |
Myotonic dystrophy, acute intermittent porphyria and neurofibromatosis in one patient.
Topics: Aminosalicylic Acids; Cataract; Cervical Vertebrae; Humans; Isoniazid; Male; Middle Aged; Myotonic D | 1966 |
The effect of isoniazid in one daily dose.
Topics: Adult; Aged; Aminosalicylic Acids; Culture Media; Female; Humans; Isoniazid; Male; Middle Aged; Myco | 1965 |
Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues.
Topics: Animals; Cortisone; Cross Infection; Drug Resistance, Microbial; Isoniazid; Mice; Mycobacterium tube | 1966 |
Microbial persistence. II. Characteristics of the sterile state of tubercle bacilli.
Topics: Animals; Drug Resistance, Microbial; Isoniazid; Mice; Mycobacterium tuberculosis; Pyrazinamide; Tube | 1966 |
Studies on the antituberculous activity of ethambutol in monkeys.
Topics: Animals; Antitubercular Agents; Blood; Ethambutol; Haplorhini; In Vitro Techniques; Isoniazid; Tuber | 1966 |
The importance of decalcification in the treatment of tuberculosis. I. The influence of decalcification in the course of healing in experimental tuberculosis in guinea pigs.
Topics: Animals; Calcinosis; Decalcification Technique; Edetic Acid; Guinea Pigs; Isoniazid; Streptomycin; T | 1966 |
Childhood tuberculosis with reference to the American Indian.
Topics: Adolescent; Adult; Aminosalicylic Acids; Child; Child, Preschool; Female; Humans; Indians, North Ame | 1967 |
[The use of Bac. subtilis for the treatment of pulmonary tuberculosis and other pneumopathies].
Topics: Aerosols; Bacillus subtilis; Biological Products; Humans; Isoniazid; Tuberculosis, Pulmonary | 1965 |
Kanamycin in the therapy of pulmonary tuberculosis in the United States.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Ethionamide; Humans; Isoniazid; Kanamycin; | 1966 |
Reversion to drug sensitivity in tubercle bacilli.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Drug Resistance, Microbial; Humans; Isoniazid; Middle | 1966 |
On certain properties and diagnostic-prognostic significance of tubercle bacilli, directly detectable but not culturable.
Topics: Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tuberculosis; Tuberculosis, Pulmonary | 1966 |
Quantitative studies of mycobacterial populations in sputum and saliva.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Drug Resistance, Microbial; Female; Humans; In Vitro | 1967 |
Cryostat tissue section culture for Mycobacterium tuberculosis.
Topics: Aminosalicylic Acids; Culture Techniques; Drug Resistance, Microbial; Humans; Isoniazid; Microtomy; | 1967 |
[Subtilis therapy in pulmonary diseases. I. Bacillus subtilis in the treatment of pulmonary tuberculosis].
Topics: Adult; Bacillus subtilis; Drug Resistance, Microbial; Humans; Infant; Isoniazid; Middle Aged; Tuberc | 1964 |
Five cases of child tuberculosis caused by strains primarily resitant to all three main anti-tuberculosis drugs.
Topics: Aminosalicylic Acids; Animals; Asthma; BCG Vaccine; Child; Child, Preschool; Drug Resistance, Microb | 1967 |
Relapse in pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Australia; Follow-Up Studies; Humans; Isoniazid; Long | 1967 |
[The open healing of cavities].
Topics: Antitubercular Agents; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Radiography; Sputum; Tub | 1966 |
Patterns of mycobacterial isolations from a tuberculosis hospital population in Kentucky.
Topics: Adolescent; Adult; Age Factors; Aged; Aminosalicylic Acids; Black or African American; Child; Child, | 1968 |
Community isoniazid prophylaxis program in an underdeveloped area of Alaska.
Topics: Adolescent; Adult; Aged; Alaska; Child; Child, Preschool; Community Health Services; Ethnicity; Heal | 1967 |
[A clinical study on the virulence of INH-resistant tubercle bacilli in the human body].
Topics: Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tuberculosis; Tuberculosis, Pulmonary; | 1967 |
[Phythyvazid-resistance of myobacterium tuberculosis and its clinical importance].
Topics: Adult; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuber | 1966 |
[On the lability of the degree of drug resistance of Mycobacterium tuberculosis strains].
Topics: Adolescent; Adult; Aged; Drug Resistance, Microbial; Humans; Isoniazid; Middle Aged; Mycobacterium t | 1967 |
The rifamycins with other drugs in the treatment of pulmonary tuberculosis: a report of nine cases.
Topics: Adult; Blood Proteins; Drug Resistance, Microbial; Humans; Injections, Intravenous; Isoniazid; Kidne | 1967 |
Primary tuberculosis in children. 2. Correlation of susceptibility patterns of M. tuberculosis isolated from children with those isolated from source cases as an index of drug-resistant infection in a community.
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Microb | 1968 |
Quantitative tests with old tuberculin in sanatorium practice.
Topics: Adolescent; Adult; Aminosalicylic Acids; Antigen-Antibody Reactions; Female; Humans; Isoniazid; Male | 1968 |
"Dysgonic" strains of mycobacterium tuberculosis on Ogawa's egg medium isolated as pathogens from patients suffering from lung tuberculosis. I. Clinical and biological findings of "dysgonic".
Topics: Adult; Albumins; Aminosalicylic Acids; Antitubercular Agents; Catalase; Culture Media; Drug Resistan | 1967 |
Spread of drug-resistant tubercle bacilli.
Topics: Adolescent; Adult; Aminosalicylic Acids; Animals; Drug Resistance, Microbial; Female; Guinea Pigs; H | 1968 |
[Virulence of inh resistant tubercle bacilli to human body. II. Comparison on the incidence of exacerbation between inh resistant and sensitive cases].
Topics: Drug Resistance, Microbial; Female; Humans; Isoniazid; Japan; Male; Mycobacterium tuberculosis; Stat | 1968 |
[Blood serum protein fractions at different stages of development of the tuberculous process].
Topics: Animals; Blood Protein Electrophoresis; Drug Resistance, Microbial; Guinea Pigs; Isoniazid; Lung; My | 1966 |
Follow-up of positive cases of pulmonary tuberculosis diagnosed in 1957.
Topics: Adolescent; Adult; Age Factors; Aged; Alcoholism; Aminosalicylic Acids; Female; Follow-Up Studies; H | 1968 |
The problem of preventive treatment with isoniazid in persons with fibrotic lesions in the lungs.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Child, Preschool; Czechoslovakia; Female; Humans; Infan | 1968 |
[Mode of action of "tuverculostatics". Consequences for the therapy].
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Ethambutol; Ethionamide; Humans; Isoniazid; Mi | 1968 |
Tuberculous meningitis due to primary drug-resistant Mycobacterium tuberculosis hominis.
Topics: Aminosalicylic Acids; Child; Drug Resistance, Microbial; Ethionamide; Humans; Isoniazid; Male; Mycob | 1968 |
[A year's results at a bacteriological tuberculosis laboratory. The importance of atypical mycobacteria].
Topics: Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Diagnosis, Differential; Drug Resistance, Mi | 1968 |
Drug-susceptibility testing by laboratories participating in cooperative studies on the chemotherapy of tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Bacteriological Techniques; Drug Resistance, Microbial; | 1969 |
Primary drug resistance to PAS, INH and streptomycin in tubercle bacilli isolated from cases of open pulmonary tuberculosis.
Topics: Adolescent; Adult; Aminosalicylic Acids; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male | 1968 |
[Some questions on chemotherapy with ethionamide].
Topics: Culture Techniques; Drug Resistance, Microbial; Ethionamide; Humans; Isoniazid; Mycobacterium tuberc | 1967 |
[Studies on the infection of drug resistant tubercle bacilli. 1. Primary drug resistance in Tokyo and Okinawa].
Topics: Aminosalicylic Acids; Asia, Eastern; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tu | 1968 |
[Studies on infection by drug-resistant tubercle bacilli. 2. Primary drug resistance in children].
Topics: Aminosalicylic Acids; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Microbial; Hu | 1968 |
[Studies on the infection of drug-resistant tubercle bacilli. 3. Experimental studies on the infection of INH highly-resistant tubercle bacilli].
Topics: Animals; Drug Resistance, Microbial; Guinea Pigs; Isoniazid; Mice; Mycobacterium tuberculosis; Predn | 1968 |
[Tuberculostatic active N,N'-diarylthioureas. 1].
Topics: Animals; Antitubercular Agents; Drug Tolerance; Guinea Pigs; Isoniazid; Mice; Mycobacterium tubercul | 1969 |
[Determination of drug sensitivity of Mycobacterium tuberculosis by means of potassium tellurite].
Topics: Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Drug Resistance, Mi | 1969 |
Evaluation of isoniazid administration on pulmonary tuberculous patients with isoniazid-resistant strain.
Topics: Animals; Antitubercular Agents; Drug Resistance, Microbial; Humans; Hydrogen Peroxide; Isoniazid; Mi | 1967 |
Resistant and sensitive strains of Mycobacterium tuberculosis found in repeated surveys among a South Indian rural population.
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Humans; India; Isoniazid; M | 1968 |
The syndrome of open cavity healing.
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Follow-Up Studies; Humans; Isoniazid; Mycobacter | 1968 |
[On the practical value of tuberculosis resistance tests].
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tuberculosis; Str | 1969 |
[Critical remarks on a clinical test of an antitubercular agent. Experiences with thiocarlide during collective work].
Topics: Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tuberculosis; Phenylthiourea; Sputum; T | 1969 |
Geographic distribution of bacteriophage types of Mycobacterium tuberculosis.
Topics: Bacteriophage Typing; Drug Resistance, Microbial; Geography; Hong Kong; India; Isoniazid; Mycobacter | 1969 |
A triple regimen of streptomycin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis.
Topics: Adolescent; Adult; Drug Synergism; Ethambutol; Female; Humans; Isoniazid; Liver Function Tests; Male | 1968 |
The ecology of drug-resistant tubercle bacilli in Eastern Glasgow.
Topics: Aminosalicylic Acids; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Female; Humans; | 1969 |
Ethambutol treatment of tuberculosis in a controlled trial.
Topics: Adult; Aged; Aminosalicylic Acids; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid | 1968 |
[Rifamicin in the studies of the Scuola Tisiologica in Naples].
Topics: Adult; Aminosalicylic Acids; Animals; Drug Resistance, Microbial; Drug Synergism; Female; Guinea Pig | 1968 |
Response to treatment with isoniazid plus PAS of tuberculous patients with primary isoniazid resistance.
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tuberculosis; Pro | 1969 |
The trend of infection with drug-resistant strains of Mycobacterium tuberculosis among untreated patients. I. Isoniazid.
Topics: Adolescent; Adult; Age Factors; Aged; Aminosalicylic Acids; Drug Resistance, Microbial; Ethnicity; H | 1969 |
Preliminary report of a recall program for persons with inactive tuberculosis.
Topics: Appointments and Schedules; California; Communicable Disease Control; Health Surveys; Humans; Isonia | 1969 |
[Drug dependance of Mycobacterium tuberculosis].
Topics: Adolescent; Adult; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Female; Humans; I | 1969 |
[Resensitization of resistant mycobacterial strains to antitubercular drugs].
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; In Vitro Techniques; Isoniazid; Mycobacterium tube | 1968 |
Isoniazid-resistant tuberculous superinfection.
Topics: Adult; Aged; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Middle Aged; Mutation; Myc | 1970 |
[Clinical significance of the degree of resistance of tubercular mycobacteria to specific chemoantibiotics (clinical note)].
Topics: Adult; Aged; Drug Resistance, Microbial; Drug Synergism; Humans; Isoniazid; Middle Aged; Mycobacteri | 1968 |
Primary drug-resistant tuberculosis in active-duty military personnel: 1959-1968.
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Humans; Isoniazid; Male; Military Medicine; Mycoba | 1970 |
Primary resistance to the major drugs in tuberculous patients, in 1961-1966.
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tuberculosis; Pol | 1969 |
Primary drug resistance in tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tuberculosis; Tu | 1970 |
[Resistance of Mycobacterium tuberculosis, the extent of isoniazid inactivation and blood bacteriostatic activity in chemotherapy of pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Isonia | 1969 |
Primary drug-resistant tuberculosis in children. A continuing study of the incidence of disease caused by primarily drug-resistant organisms in children observed between the years 1965 and 1968 at the Kings County Medical Center of Brooklyn.
Topics: Aminosalicylic Acids; Bacteriological Techniques; Child, Preschool; Drug Resistance, Microbial; Fema | 1970 |
[Dynamics of drug resistance and restoration of sensitivity of Mycobacterium tuberculosis isolated from patients].
Topics: Drug Resistance, Microbial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculos | 1970 |
The virulence of tubercle bacilli for guinea pigs and the susceptibility of guinea pigs to tubercle bacilli.
Topics: Animals; Guinea Pigs; India; Isoniazid; Microbial Sensitivity Tests; Mortality; Mycobacterium tuberc | 1970 |
Primary drug resistance (The second report).
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Female; Humans; Isoniazid; Middle Aged; Mycobacter | 1969 |
Course of cases of pulmonary tubercurosis with bacilli resistant to streptmycin, para-aminosalicylic acid and isoniazid and with multiple drug-resistance.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Child; Drug Resistance, Microbial; Female; Humans; Is | 1969 |
Rifampin in the treatment of drug-resistant mycobacterium tuberculosis infections.
Topics: Adult; Aged; Antitubercular Agents; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Mid | 1970 |
Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. VII. September 1965 to September 1969.
Topics: Aminosalicylic Acids; Antitubercular Agents; Dosage Forms; Drug Resistance, Microbial; Ethambutol; H | 1970 |
[Some aspects of tuberculosis at puberty].
Topics: Adolescent; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; | 1970 |
Primary drug-resistant tuberculosis. Report of an outbreak.
Topics: Adolescent; Adult; Aminosalicylic Acids; Child; Child, Preschool; Disease Outbreaks; Drug Resistance | 1970 |
Primary drug resistance to the major anti-tuberculosis drugs in Japan. An investigation by the Tuberculosis Research Committee (Ryoken), Japan.
Topics: Adolescent; Adult; Age Factors; Aged; Aminosalicylic Acids; Antitubercular Agents; BCG Vaccine; Chil | 1970 |
Sensitivity tests.
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Humans; Isoniazid; Methods; | 1970 |
[Restoration of drug sensitivity in Mycobacterium tuberculosis to streptomycin and isoniazid during treatment with preparations of the 1st series].
Topics: Chronic Disease; Cycloserine; Drug Resistance, Microbial; Ethionamide; Humans; Isoniazid; Mycobacter | 1970 |
Drug-resistant tuberculosis.
Topics: Child; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tuberculosis; Streptomycin; Tube | 1971 |
Primary drug resistance in tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Humans; Isoniazid; Mycobact | 1970 |
Ambulatory treatment of pulmonary tuberculosis with ethambutol-isoniazid. Cooperative study conducted in Argentina, Colombia, Ecuador and Paraguay.
Topics: Adolescent; Adult; Age Factors; Ambulatory Care; Argentina; Child; Child, Preschool; Colombia; Ecuad | 1970 |
Tuberculosis in Iran.
Topics: Ambulatory Care; Aminosalicylic Acids; Drug Resistance, Microbial; Humans; Iran; Isoniazid; Mycobact | 1970 |
[Durable character of the sterilization of experimental tuberculosis in mice by rifampicin-isoniazid association: cortisone test].
Topics: Animals; Cortisone; Drug Synergism; Isoniazid; Mice; Mycobacterium tuberculosis; Rifampin; Streptomy | 1970 |
[Bacteriologic negation and anatomic development in pulmonary specimens after rifampicin treatment of less than 10 months (10 cases)].
Topics: Adult; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Female; Humans; Isoniazid; Male; Myco | 1970 |
[Blood bacteriostatic activity in patients depending on the type of inactivation of isonicotinic acid hydrazide in the body].
Topics: Aminosalicylic Acids; Blood Bactericidal Activity; Depression, Chemical; Humans; Isoniazid; Mycobact | 1971 |
[Internal medicine treatment of pulmonary tuberculosis].
Topics: Ambulatory Care; Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Dr | 1970 |
[Repeating of sensitivity tests with tuberculosis bacteria].
Topics: Antitubercular Agents; Culture Media; Drug Resistance, Microbial; Ethionamide; Humans; Isoniazid; Mi | 1971 |
[Primary drug resistance of Mycobacterium tuberculosis isolated from untreated patients with pulmonary tuberculosis in Korea].
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Humans; Isoniazid; Korea; Mycobacterium tuberculos | 1971 |
[Comparative study of the development of rifomycin blood levels in humans by 2 different microbiologic methods].
Topics: Adult; Drug Synergism; Female; Humans; Immunodiffusion; Isoniazid; Male; Methods; Microbial Sensitiv | 1970 |
[Occurrence and clinical importance of drug resistance of Mycobacterium tuberculosis in patients with pulmonary tuberculosis].
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Humans; In Vitro Techniques; Isoniazid; Microbial | 1970 |
[Heterogeneity of drug-resistant strains of Mycobacterium tuberculosis].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethionamide; H | 1970 |
Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. IX. September 1969-September 1970.
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniaz | 1971 |
[Immunosuppressive treatment for heterologous cardiac transplantation. Its possible efficacy in a rejection crisis].
Topics: Animals; Azathioprine; Betamethasone; Dexamethasone; Glucocorticoids; Graft Rejection; Heart Transpl | 1969 |
[Bacteriological problems presented by 3 cardiac transplantations].
Topics: Escherichia coli; Heart Transplantation; Humans; Infection Control; Isoniazid; Male; Penicillin G; P | 1969 |
Factors affecting the outcome of treatment of pulmonary tuberculosis in sub-optimal conditions: an 18-month follow-up of 224 patients.
Topics: Absenteeism; Adult; Age Factors; Aged; Attitude to Health; Developing Countries; Drug Resistance, Mi | 1971 |
Rifampicin with ethambutol for drug-resistant tuberculosis.
Topics: Adult; Aged; Aminosalicylic Acids; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid | 1971 |
[Factors relating to the incidence of drug resistance for anti-tuberculosis drugs during chemotherapy. Relationship between the incidence of drug resistance and the course of original treatment].
Topics: Adolescent; Adult; Aminosalicylic Acids; Child; Child, Preschool; Drug Resistance, Microbial; Female | 1971 |
[[Comparative studies on therapeutic effects of SM.INH.PAS, SM.INH.PAS.EB twice weekly, and SM.INH.PAS.EB daily in original treatment cases of pulmonary tuberculosis].
Topics: Aminosalicylic Acids; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Radiography; Strept | 1971 |
[Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
Topics: Aminosalicylic Acids; Culture Media; Depression, Chemical; Drug Resistance, Microbial; Ethambutol; E | 1971 |
Experimental and clinical studies on the antituberculous activity of rifampicin alone or combined with other drugs.
Topics: Administration, Oral; Adolescent; Adult; Aminosalicylic Acids; Animals; Culture Media; Drug Combinat | 1970 |
[Tuberculosis by microcultivation on slides in blood medium].
Topics: Aminosalicylic Acids; Bacteriological Techniques; Blood; Culture Media; Drug Resistance, Microbial; | 1971 |
Experimental and clinical studies of rifampicin in tuberculosis.
Topics: Adult; Animals; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Mice; Middle Aged; Myco | 1970 |
[Experimental tuberculosis in mice, a model for the study of antitubercular chemotherapy].
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; | 1971 |
Rifampicin in the treatment of previously untreated pulmonary tuberculosis.
Topics: Age Factors; Drug Combinations; Ethambutol; Female; Gastric Juice; Humans; Isoniazid; Liver; Liver F | 1971 |
A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Chemical and Drug Induced Liver Injury; Cycloserine; Ethionamide; Gastrointestina | 1969 |
[The epidemiologic significance of the resistance of tuberculosis mycobacteria to isonicotinic acid hydrazide].
Topics: Adolescent; Adult; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Infa | 1971 |
Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis.
Topics: Administration, Oral; Adolescent; Adult; Animals; Drug Resistance, Microbial; Ethambutol; Female; Hu | 1971 |
Isoniazid induced life-threatening neurologic reaction in an allergic individual.
Topics: Adult; Anaphylaxis; Asthma; Bronchitis; Central Nervous System Diseases; Chemical and Drug Induced L | 1970 |
[Incidence of the bovine bacillus in human tuberculosis at Algiers in 1969].
Topics: Animals; Cattle; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium bovis; Mycobacterium t | 1970 |
Using primates in medical research. 2. Recent comparative research. Control of tuberculosis.
Topics: Animals; Animals, Laboratory; Haplorhini; Isoniazid; Macaca; Methods; Monkey Diseases; Primates; Rad | 1969 |
Conversion by isoniazid of hyperacute to chronic pulmonary tuberculosis in mice. I. Survival times of mice and course of the chronic disease; bacterial populations and responses of the host.
Topics: Acute Disease; Animals; Body Weight; Cell Differentiation; Cells, Cultured; Chronic Disease; Colony | 1967 |
Pulmonary amyloidosis simulating tuberculosis.
Topics: Amyloidosis; Biopsy; Diagnosis, Differential; Female; Humans; Isoniazid; Lung; Lung Diseases; Middle | 1972 |
Rifampin and isoniazid in previously untreated patients with pulmonary tuberculosis.
Topics: Bilirubin; Blood Pressure; Female; Humans; Isoniazid; Male; Middle Aged; Radiography, Thoracic; Rifa | 1972 |
Isoniazid and ethambutol in previously untreated patients with pulmonary tuberculosis.
Topics: Aged; Ethambutol; Humans; Isoniazid; Male; Radiography, Thoracic; Tuberculosis, Pulmonary; Visual Ac | 1972 |
Effect of rifampicin and isoniazid on liver function.
Topics: Adolescent; Adult; Aged; Aspartate Aminotransferases; Bilirubin; Child; Female; Humans; Isoniazid; L | 1972 |
[Peculiarities of PAS and tubazid metabolism in tuberculous patients treated with nerobol and ATP].
Topics: Adenosine Triphosphate; Aminosalicylic Acids; Drug Synergism; Humans; Injections, Intramuscular; Iso | 1972 |
Rifampin in treatment of advanced pulmonary tuberculosis. Report of a VA cooperative pilot study.
Topics: Adult; Agranulocytosis; Alkaline Phosphatase; Antitubercular Agents; Aspartate Aminotransferases; Bi | 1972 |
[Early and late results of massive antitubercular chemotherapy in previously untreated pulmonary tuberculosis in adults].
Topics: Adult; Age Factors; Aged; Aminosalicylic Acids; Drug Synergism; Ethionamide; Follow-Up Studies; Huma | 1972 |
[Bacteriostatic activity of blood and tubazid blood levels after administration of tuberculostatic drugs by various routes (experimental and clinical study)].
Topics: Adolescent; Adult; Antitubercular Agents; Blood Bactericidal Activity; Female; Humans; Isoniazid; Ma | 1972 |
Trial of rifampicin in the treatment of pulmonary tuberculosis. Results at 12 months.
Topics: Drug Synergism; Evaluation Studies as Topic; Humans; Isoniazid; Rifampin; Sputum; Time Factors; Tube | 1972 |
Treatment of M.M.R. detected shadows of doubtful activity with I.N.H. alone.
Topics: Adolescent; Adult; Aged; False Negative Reactions; False Positive Reactions; Female; Humans; India; | 1972 |
Some aspects of pulmonary tuberculosis in older patients.
Topics: Aged; Aging; Aminosalicylic Acids; Drug Combinations; Female; Humans; Isoniazid; Male; Radiography; | 1972 |
Use of sulphadimidine acetylation test in determining isoniazid inactivation rate in tuberculous patients.
Topics: Acylation; Depression, Chemical; Humans; Isoniazid; Sulfamethazine; Tuberculosis, Pulmonary | 1972 |
[State of the cardiovascular system after successfully completed drug therapy of pulmonary tuberculosis].
Topics: Aminosalicylic Acids; Cardiovascular Diseases; Cardiovascular System; Electrocardiography; Exercise | 1972 |
Dusting off and polishing up the control of tuberculosis.
Topics: Animals; Guinea Pigs; Humans; Isoniazid; Mice; Rabbits; Rifampin; Tuberculin Test; Tuberculosis, Pul | 1972 |
Tuberculin testing and chemoprophylaxis in tuberculosis: recommendations of the Colorado Trudeau Society.
Topics: Adolescent; Humans; Infant; Isoniazid; Methods; Tuberculin Test; Tuberculosis; Tuberculosis, Pulmona | 1972 |
Rifampin: its role in the treatment of tuberculosis.
Topics: Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary; United States; Unite | 1972 |
Changing concepts in treatment of tuberculosis.
Topics: Aminosalicylic Acids; Ethambutol; Hospitals, Special; Humans; Isoniazid; Rifampin; Tuberculosis, Pul | 1972 |
The place of rifampin.
Topics: Aminosalicylic Acids; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1972 |
Rifampin-isoniazid compared with PAS-isoniazid-streptomycin in initial treatment of pulmonary tuberculosis. A controlled cooperative trial.
Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; Aminosalicylic Acids; Aspartate Aminotransf | 1972 |
Rifampin in initial treatment of advanced pulmonary tuberculosis.
Topics: Administration, Oral; Adult; Aged; Ethambutol; Female; Humans; Injections, Intramuscular; Isoniazid; | 1972 |
Hepatotoxicity in rifampin-isoniazid treated patients related to their rate of isoniazid inactivation.
Topics: Alkaline Phosphatase; Bilirubin; Blood Proteins; Chemical and Drug Induced Liver Injury; Drug Hypers | 1972 |
Trauma in the etiology of bone and joint tuberculosis. A case report.
Topics: Adolescent; Aminosalicylic Acids; Female; Humans; Isoniazid; Radiography; Streptomycin; Tibial Fract | 1972 |
Multiple isoniazid cysts' in a child with chronic pulmonary tuberculosis. (A case report).
Topics: Child; Chronic Disease; Cysts; Humans; Isoniazid; Lung Diseases; Male; Tuberculosis, Pulmonary | 1972 |
Simplified isoniazid acetylator phenotyping.
Topics: Humans; Isoniazid; Methods; Phenotype; Tuberculosis, Pulmonary | 1972 |
[Treatment of patients with pulmonary tuberculosis--strong and weak GINK inactivators].
Topics: Evaluation Studies as Topic; Humans; Isoniazid; Tuberculosis, Pulmonary | 1972 |
The Birmingham tuberculosis drug resistance register 1956-1970.
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Emigration and Immigration; England; Humans; Isoni | 1972 |
A preliminary trial of lividomycin in patients with pulmonary tuberculosis.
Topics: Adult; Aged; Amino Sugars; Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Femal | 1972 |
The prophylactic treatment tuberculosis.
Topics: Adolescent; Adult; Aged; Child; Delaware; Female; Humans; Isoniazid; Male; Mass Screening; Middle Ag | 1972 |
Rifampin: clinical experience with a new anti-tuberculosis drug.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Humans; Isoniazid; Rifampin; Streptomycin; Tuberc | 1972 |
Acute psychotic reaction probably caused by ethionamide.
Topics: Adult; Ethionamide; Humans; Isoniazid; Male; Prednisolone; Psychoses, Substance-Induced; Pyrazinamid | 1972 |
Classification of subjects as slow or rapid inactivators of isoniazid, based on the ratio of the urinary excretion of acetylisoniazid to isoniazid.
Topics: Acylation; Humans; Injections, Intramuscular; Isoniazid; Methods; Specimen Handling; Spectrophotomet | 1972 |
[Efficiency of interrupted therapy of tuberculosis (experimental study)].
Topics: Antitubercular Agents; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Methods; Rifampin; Tim | 1972 |
[Use of a new rectal form of isoniazid in the treatment of patients with pulmonary tuberculosis].
Topics: Adult; Emulsions; Humans; Isoniazid; Male; Rectum; Tuberculosis, Pulmonary | 1972 |
[Has the intermittent therapy of pulmonary tuberculosis a future in industrialised countries?].
Topics: Animals; Antitubercular Agents; Belgium; Congo; Drug Combinations; Ethambutol; Female; Humans; Isoni | 1972 |
[The development of shifting infiltrates in adolescents in the initial period of primary tuberculosis].
Topics: Adolescent; Aminosalicylic Acids; BCG Vaccine; Female; Humans; Isoniazid; Tuberculosis, Pulmonary | 1972 |
[Blood bacteriostatic activity in pulmonary tuberculosis patients undergoing treatment with drugs of the 1st and 2d series].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Blood Bactericidal Activity; Female; Humans; Isoniaz | 1972 |
[Experimental justification of a single diurnal dosage of basic tuberculostatics].
Topics: Aminosalicylic Acids; Animals; Evaluation Studies as Topic; Isoniazid; Rabbits; Streptomycin; Time F | 1972 |
[Value of the ethambutol-isoniazid combination in the treatment of pulmonary tuberculosis].
Topics: Drug Synergism; Ethambutol; Humans; Isoniazid; Tuberculosis, Pulmonary | 1972 |
[Drug therapy of pulmonary tuberculosis].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Synergism; Ethambutol; Humans; Isoniazid; Rest; Ri | 1972 |
Tuberculosis in South Vietnam.
Topics: Adolescent; Child; Child, Preschool; Hospitals; Humans; Infant; Isoniazid; Outpatient Clinics, Hospi | 1972 |
[Criteria and methods for determination of the HINA preparations inactivation].
Topics: Biotransformation; Humans; Isoniazid; Metabolic Clearance Rate; Tuberculosis, Pulmonary | 1972 |
Bronchopulmonary sequestration and pulmonary tuberculosis.
Topics: Adult; Angiography; Bronchopulmonary Sequestration; Bronchoscopy; Ethambutol; Humans; Isoniazid; Lun | 1972 |
[Controlled intermittent treatment of newly detected patients with limited forms of tuberculosis of the lungs without destruction].
Topics: Aminosalicylic Acids; Antitubercular Agents; Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonar | 1972 |
Isoniazid and the liver.
Topics: Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Tuberculosis, Pulmonary | 1972 |
Implications of the Hong Kong Study of policies of sensitivity testing.
Topics: Aminosalicylic Acids; Costs and Cost Analysis; Drug Resistance, Microbial; Hong Kong; Humans; Isonia | 1972 |
Tuberculosis risk in persons with "fibrotic" x-ray lesions.
Topics: Adolescent; Adult; Age Factors; Aged; Czechoslovakia; Female; Germany, East; Health Surveys; Humans; | 1972 |
Madras Study of intermittent oral chemotherapy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ambulatory Care; Aminosalicylic Acids; Drug Combinati | 1972 |
Hong Kong Policy Study for sensitivity testing: the main results.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Drug Combinations; Drug Resistance, Microbial; Hong K | 1972 |
A national treatment survey in Singapore.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Child; Drug Hypersensitivity; Female; Health Surveys; Huma | 1972 |
[Maximum therapeutic efficiency of a guternary antitubercular preparation. (Streptomycin-ethambutol-rifampicin-isoniazid)].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Chronic Disease; Drug Combinations; Ethambutol; Eval | 1972 |
[Treatment of pleural and pulmonary tuberculosis by drug combinations including rifampicin. Early results].
Topics: Adult; Antitubercular Agents; Drug Combinations; Ethambutol; Evaluation Studies as Topic; Female; Hu | 1972 |
[Evaluation of alternative regimen of SM-INH-PAS and KM-TH-CS at three months interval in initial treatment of far advanced pulmonary tuberculosis. A report of the 12th series controlled trial of chemotherapy].
Topics: Adult; Aminosalicylic Acids; Cycloserine; Ethionamide; Evaluation Studies as Topic; Female; Humans; | 1972 |
Chemoprophylaxis in tuberculous infection.
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Child; Female; Gastrectomy; Humans; Immunosuppressiv | 1972 |
Isoniazid plus rifampicin in the initial treatment of pulmonary tuberculosis.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; Drug Combinations; Drug Resistance, Mi | 1972 |
Isoniazid plus ethambutol in the initial treatment of pulmonary tuberculosis.
Topics: Aged; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Male; Optic Neur | 1972 |
Superficial abscess formation: an unusual presenting feature of tuberculosis.
Topics: Abscess; Adiposis Dolorosa; Adolescent; Adult; Aminosalicylic Acids; Blood Cell Count; Blood Sedimen | 1971 |
Tuberculosis among patients with various radiologic abnormalities, followed by the chest clinic service.
Topics: British Columbia; Humans; Isoniazid; Lung Diseases; Mass Chest X-Ray; Pleurisy; Pneumoconiosis; Pulm | 1971 |
Isoniazid and liver disease.
Topics: Chemical and Drug Induced Liver Injury; Communicable Disease Control; Humans; Isoniazid; Liver Disea | 1971 |
Recent developments in the treatment of infectious diseases. V. Management of tuberculosis in the community hospital.
Topics: Aminosalicylic Acids; Cross Infection; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Sanita | 1971 |
[Primary drug resistance to standard drugs in previously untreated patients with pulmonary tuberculosis in Poznań in 1966-1969].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Humans; Isoniazid; Poland; | 1971 |
[Preliminary report on out-patient intermittent drug therapy in cases of active sputum-positive pulmonary tuberculosis].
Topics: Adult; Aged; Ambulatory Care; Female; Humans; Isoniazid; Male; Middle Aged; Sputum; Streptomycin; Ti | 1971 |
[Test-therapy to determine the activity of minor forms of pulmonary tuberculosis].
Topics: Adolescent; Adult; Aminosalicylic Acids; Antitubercular Agents; Female; Humans; Isoniazid; Male; Str | 1971 |
Reactivation of inactive tuberculosis in Northern Canada.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Canada; Child; Female; Hospitalization; Humans; Inuit | 1971 |
The effect of some antituberculous drugs upon the upper gastrointestinal tract: an experiment with para-aminosalicylic acid, isoniazid, and streptomycin.
Topics: Adult; Aminosalicylic Acids; Aspartate Aminotransferases; Eosinophils; Gastric Mucosa; Glycoside Hyd | 1971 |
[Comparative study: Streptomycin, Isoniazid (Ethambutol) vs. Rifampicin, Isoniazid (Ethambutol)].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Time Factors; Tubercul | 1971 |
[Newer therapeutic possibilities in the treatment of chronic open pulmonary tuberculosis].
Topics: Antitubercular Agents; Chronic Disease; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmo | 1971 |
[Isoniazid dosage in renal insufficiency].
Topics: Humans; Isoniazid; Kidney Failure, Chronic; Tuberculosis, Pulmonary | 1971 |
[Intravenous gluronazide administration in combination with continuous ethambutol medication per os].
Topics: Administration, Oral; Drug Synergism; Ethambutol; Glucuronates; Humans; Injections, Intravenous; Iso | 1971 |
[Rifampicin and liver].
Topics: Humans; Isoniazid; Jaundice; Liver; Rifampin; Tuberculosis, Pulmonary | 1971 |
Isoniazid and the liver.
Topics: Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Societies, Medical; Tuberculosis, Pulmona | 1971 |
[Effect of hyaluronidase on the permeability of the blood-tissue barriers in the complex therapy of patients with pulmonary tuberculosis].
Topics: Adolescent; Adult; Female; Humans; Hyaluronoglucosaminidase; Isoniazid; Male; Middle Aged; Permeabil | 1971 |
Drug resistant pulmonary tuberculosis treated with ethambutol and rifampicin in North East England.
Topics: Aminosalicylic Acids; Chronic Disease; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionam | 1971 |
Folate deficiency in pulmonary tuberculosis: relationship to treatment and to serum vitamin A and beta-carotene.
Topics: Adult; Aged; Aminosalicylic Acids; Carotenoids; Erythrocytes; Ethionamide; Female; Folic Acid; Folic | 1971 |
Transitional drug-resistance in tuberculosis.
Topics: Drug Resistance, Microbial; Humans; Isoniazid; Microbial Sensitivity Tests; Sputum; Tuberculosis, Pu | 1971 |
[Hepatic tolerance in man of rifampicin-isoniazid association].
Topics: Female; Humans; Isoniazid; Liver; Liver Function Tests; Male; Rifampin; Tuberculosis, Pulmonary | 1971 |
[Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
Topics: Adult; Aminosalicylic Acids; Ethambutol; Female; Humans; Isoniazid; Male; Rifampin; Streptomycin; Tu | 1971 |
[A case of icterus in the course of treatment with rifampicin. Histological records].
Topics: Aged; Biopsy; Chemical and Drug Induced Liver Injury; Ethionamide; Female; Humans; Isoniazid; Jaundi | 1971 |
[Hepatitis induced by combined rifomycin and isoniazid].
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Drug Synergism; Female; Humans; Isoniazid; Male | 1971 |
Pharmacological study of rifampicin after repeated high dosage during intermittent combined therapy. I. Variation of the rifampicin serum levels (947 determinations).
Topics: Analysis of Variance; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Rifampin; Sarc | 1971 |
[Initial pulmonary tuberculosis treated with the isoniazid-rifampicin combination and followed after cessation of treatment].
Topics: Adolescent; Adult; Aged; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Rifampin; | 1971 |
[Intermittent administration of streptomycin, isoniazid and ethambutol in pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyridoxine; Strep | 1971 |
[Pulmonary tuberculosis as a complication of diabetes based on clinical material between 1947 and 1970].
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Child; Diabetes Complications; Diabetes Mellitus; Hum | 1971 |
[Clinical significance of isoniazid inactivation in treating patients with pulmonary tuberculosis].
Topics: Adult; Aged; Chronic Disease; Evaluation Studies as Topic; Humans; Isoniazid; Male; Middle Aged; Rad | 1971 |
[Comparative evaluation of antimicrobial properties of actinomyces, isolated in patients with pulmonary tuberculosis treated with phthivazid and streptomycin].
Topics: Actinomyces; Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1971 |
[Comparative evaluation of antimicrobial properties of actinomyces isolated from the patients with pulmonary tuberculosis, treated with phthivazid and streptomycin].
Topics: Actinomyces; Humans; Isoniazid; Microbial Sensitivity Tests; Sputum; Streptomycin; Tuberculosis, Pul | 1971 |
Serial tuberculin testing and isoniazid therapy in general hospital employees.
Topics: Adult; Child; Female; Hospitals, General; Humans; Isoniazid; Male; Personnel, Hospital; Time Factors | 1971 |
The influence of para-aminosalicylic acid on isonicotinic acid hydrazide blood levels after oral and intravenous administration.
Topics: Aminosalicylic Acids; Humans; Isoniazid; Tuberculosis, Pulmonary | 1966 |
Isoniazid and loss of memory.
Topics: Adolescent; Adult; Ambulatory Care; Female; Follow-Up Studies; Humans; Isoniazid; Male; Memory; Meth | 1968 |
Serum transaminase levels in pulmonary tuberculosis. Effect of triple treatment with 4-4 1-di-isoamyloxythiocarbanilide or PAS in combination with streptomycin and isoniazid.
Topics: Adolescent; Adult; Alanine Transaminase; Aminosalicylic Acids; Aspartate Aminotransferases; Blood Do | 1968 |
[Chemoprophylaxis in prevention of epidemics of tuberculosis of the respiratory organs].
Topics: Humans; Isoniazid; Military Medicine; Tuberculosis, Pulmonary; Yugoslavia | 1968 |
The prognosis of pulmonary tuberculosis under modern treatment.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Disability Evaluation; Female; Follow-Up Studies; Hum | 1968 |
International co-operation in tuberculosis research.
Topics: Antitubercular Agents; BCG Vaccine; Humans; International Cooperation; Isoniazid; Mass Chest X-Ray; | 1968 |
Isoniazid and ethionamide serum levels and inactivation in Finnish subjects.
Topics: Adolescent; Adult; Age Factors; Alcoholism; Ethionamide; Female; Finland; Humans; Injections, Intrav | 1969 |
Isoniazid inactivation status and the development of chronic tuberculosis.
Topics: Adolescent; Adult; Aged; Alcoholism; Chronic Disease; Female; Humans; Isoniazid; Male; Middle Aged; | 1969 |
[Diabetes mellitus and pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Child; Child, Preschool; Deficiency Diseases; Diabete | 1970 |
[Effects of antitubercular agents on the fetus during therapy of tuberculous pregnant women].
Topics: Aminosalicylic Acids; Antitubercular Agents; Audiometry; Auditory Perception; Female; Fetus; Hearing | 1971 |
Preventing tuberculosis.
Topics: Isoniazid; Tuberculosis, Pulmonary | 1971 |
[Endocavernous treatment of caverns with atypical Mycobacteria].
Topics: Aminosalicylic Acids; Antitubercular Agents; Catheterization; Cycloserine; Depression, Chemical; Dru | 1970 |
Isoniazid prophylaxis in tuberculosis prevention: Charleston County experience.
Topics: Humans; Isoniazid; South Carolina; Tuberculosis, Pulmonary | 1965 |
[Chemoprophylaxis of tuberculosis with isoniazid. (Biological problems and clinical problems)].
Topics: Animals; BCG Vaccine; Cattle; Drug Resistance, Microbial; Humans; In Vitro Techniques; Isoniazid; Tu | 1966 |
Comparison of ethambutol-INH versus INH-PAS in original treatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Ethambutol; Female; Humans; In | 1966 |
Kanamycin: its therapeutic record in pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Hearing Disorders; Humans; Isoniazid; Japan; Kanam | 1966 |
A comparison of the toxicity of prothionamide and ethionamide: a report from the research committee of the British Tuberculosis Association.
Topics: Adult; Aged; Bilirubin; Body Weight; Drug Tolerance; Ethionamide; Feeding and Eating Disorders; Fema | 1968 |
Acute fulminant hepatic failure with bilateral tuberculous cavitation.
Topics: Aged; Aminosalicylic Acids; Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Male; Tubercu | 1968 |
Drug-resistant pulmonary tuberculosis in Norway. Preliminary report.
Topics: Aminosalicylic Acids; Humans; Isoniazid; Norway; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1969 |
Cycloserine in the treatment of pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Cycloserine; Drug Resistance, Microbial; Ethionamide; Humans; Isoniazid; Strep | 1970 |
Cycloserine in the treatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Chronic Disease; Cycloserine; Drug Resistance, Microbial; Female; Humans; I | 1970 |
Position of cycloserine in the treatment of pulmonary tuberculosis.
Topics: Cycloserine; Drug Resistance, Microbial; Ethionamide; Humans; Isoniazid; Tuberculosis, Pulmonary | 1970 |
Results of treatment of patients with pulmonary tuberculous with a combination of cycloserine and other tuberculostatics.
Topics: Chronic Disease; Cycloserine; Drug Resistance, Microbial; Ethionamide; Humans; Isoniazid; Tuberculos | 1970 |
General survey of the clinical results of treatment of pulmonary tuberculosis with cycloserine in Turkey.
Topics: Cycloserine; Ethionamide; Humans; Isoniazid; Pyrazinamide; Tuberculosis, Pulmonary | 1970 |
Limitations of the clinical activity of cycloserine therapy. Appearance of resistance to cycloserine when used alone and in combination with other drugs.
Topics: Cycloserine; Drug Resistance, Microbial; Ethionamide; Humans; Isoniazid; Prognosis; Tuberculosis, Pu | 1970 |
[Significance of chemoprophylaxis and its methods in the treatment of children with the 1st signs of positive tuberculin test].
Topics: Adolescent; Child; Child, Preschool; Humans; Infant; Isoniazid; Tuberculin Test; Tuberculosis, Pulmo | 1965 |
[Level of active isoniazid in the serum of tuberculous children].
Topics: Blood; Child; Child, Preschool; Humans; Infant; Isoniazid; Tuberculosis, Pulmonary | 1965 |
Routine tuberculin testing in infants and young children. An appraisal of its necessity and effectiveness.
Topics: Child, Preschool; Humans; Infant; Infant, Newborn; Isoniazid; Tuberculin Test; Tuberculosis, Pulmona | 1966 |
Primary tuberculosis in childhood. Indications and contraindications for corticosteroid therapy: observations on 577 treated cases.
Topics: Adolescent; Aminosalicylic Acids; Antitubercular Agents; Child; Child, Preschool; Dexamethasone; Eth | 1965 |
[The use of isonicotinylhydrazide paraaminosalicylate in treatment of the primary infection in children].
Topics: Aminosalicylic Acids; Child; Humans; Isoniazid; Tuberculosis, Pulmonary | 1965 |
Role of tebafen in primary tuberculosis.
Topics: Child; Child, Preschool; Female; Humans; India; Infant; Infant, Newborn; Isoniazid; Male; Streptomyc | 1965 |
Tuberculosis in childhood. Diagnosis and treatment.
Topics: Child; Child, Preschool; Humans; Isoniazid; Tuberculosis, Pulmonary | 1966 |
[The role of inactivation of phthivazid in the therapy of tuberculosis in children].
Topics: Child; Humans; Isoniazid; Tuberculosis, Pulmonary | 1965 |
[Chemoprophylaxis of tuberculosis in children with negative Pirquet reaction living in infected environment].
Topics: Adolescent; Child; Child, Preschool; Humans; Isoniazid; Tuberculosis, Pulmonary | 1965 |
Tuberculosis in children in the United States. Trends and current status.
Topics: Adolescent; BCG Vaccine; Child; Humans; Isoniazid; Tuberculosis, Pulmonary; United States | 1966 |
Indolent non-caseating Mycobacterial tuberculosis.
Topics: Aminosalicylic Acids; Child, Preschool; Diagnosis, Differential; Female; Humans; Isoniazid; Male; Ra | 1967 |
TB, PPD, and INH.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Humans; Isoniazid; Male; Mass Chest X-Ray; Tuber | 1967 |
[Place and task of preventive chemotherapy in the framework of tuberculosis control].
Topics: Child, Preschool; Humans; Infant; Infant, Newborn; Isoniazid; Placebos; Tuberculin Test; Tuberculosi | 1965 |
Results of the cooperative study on chemotherapy of tuberculosis in the National Sanatoria.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Follow-Up Studies; Humans; Isoniazid; Radiography | 1966 |
Prophylactic effect of isoniazid in young tuberculin reactors.
Topics: Adolescent; Black or African American; California; Child; Costs and Cost Analysis; Emigration and Im | 1967 |
[Management of tuberculosis in children].
Topics: Adolescent; Child; Child, Preschool; Humans; Infant; Isoniazid; Streptomycin; Tuberculosis, Pulmonar | 1967 |
Pulmonary surgery for tuberculosis in children.
Topics: Adolescent; Bronchial Diseases; Child; Child, Preschool; Female; Humans; Infant; Isoniazid; Male; Pn | 1967 |
[Lupus (L.E.D.) during the course of isoniazid (INH) therapy].
Topics: Adult; Antibodies, Antinuclear; Female; Humans; Isoniazid; Lupus Erythematosus, Systemic; Tuberculos | 1967 |
Bullous emphysema in childhood tuberculosis.
Topics: Aminosalicylic Acids; Child; Child, Preschool; Female; Humans; Infant; Isoniazid; Male; Prednisone; | 1967 |
[The diagnosis of pyridoxine deficiency based on the estimation of the erythrocytic aspartate aminotransferase and its stimulation in vitro with pyridoxal-5'-phosphate].
Topics: Aspartate Aminotransferases; Child, Preschool; Deficiency Diseases; Erythrocytes; Humans; In Vitro T | 1967 |
[The use of ethionamide in the treatment of primary infection in children].
Topics: Adolescent; Child; Child, Preschool; Ethionamide; Female; Humans; Isoniazid; Male; Tuberculosis, Pul | 1966 |
[Studies on the problem of hepatic involvement in tuberculosis in childhood].
Topics: Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Chromatography, Paper; Humans; Infa | 1966 |
Identification and chemoprophylaxis of tuberculous infection.
Topics: Adolescent; Child; Female; Humans; Isoniazid; Male; Tuberculin Test; Tuberculosis, Pulmonary | 1967 |
Urine testing for isoniazid in the supervision of out-patient oral chemotherapy for pulmonary tuberculosis. The failure of a routine service.
Topics: Africa, Eastern; Ambulatory Care; Humans; Isoniazid; Methods; Tuberculosis, Pulmonary | 1967 |
Comparative studies of various antituberculosis drug regimens by means of serum antimycobacterial activity tests in man.
Topics: Adolescent; Adult; Aminoisobutyric Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Micro | 1967 |
Primary tuberculosis in African children.
Topics: Adolescent; Child; Child, Preschool; Humans; Infant; Isoniazid; Streptomycin; Tuberculin Test; Tuber | 1967 |
Beware.
Topics: Attitude to Health; Child; Child, Preschool; Humans; India; Isoniazid; Puerto Rico; Tuberculin Test; | 1968 |
Erythema nodosum: occurrence in two siblings and mother.
Topics: Adult; Child; Child, Preschool; Erythema Nodosum; Female; Humans; Injections, Intramuscular; Isoniaz | 1968 |
["Directed selectively differential" chemoprophylaxis].
Topics: Adult; Child; Humans; Hypersensitivity, Delayed; Isoniazid; Radiography; Tuberculin Test; Tuberculos | 1967 |
[Current aspects of congenital tuberculosis. Review of the literature apropos of a case beginning as otitis].
Topics: Adult; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Isoniazid; Maternal-Fetal Exchang | 1968 |
Infants of tuberculous mothers: further thoughts.
Topics: BCG Vaccine; Child; Humans; Infant, Newborn; Isoniazid; Tuberculin Test; Tuberculosis; Tuberculosis, | 1968 |
Diagnosis and treatment: approaches to newborn infants of tuberculous mothers.
Topics: BCG Vaccine; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Isoniazid; Male; Pregnancy; | 1968 |
[Tuberculin sensitivity and isoniazid prophylaxis].
Topics: Adolescent; Adult; Age Factors; Child; Humans; Infant; Isoniazid; Netherlands; Time Factors; Tubercu | 1968 |
[Treatment of tuberculosis of children in the age of puberty (isoniazid and morfazinamide)].
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Female; Humans; Isoniazid; Male; Morphol | 1968 |
Chemoprophylaxis of tuberculosis.
Topics: Antitubercular Agents; Child; Child, Preschool; Humans; Isoniazid; Tuberculosis, Pulmonary | 1968 |
[Secondary manifestations of the antibacterial therapy of tuberculosis in children].
Topics: Adolescent; Age Factors; Aminosalicylic Acids; Child; Child, Preschool; Female; Humans; Infant; Ison | 1967 |
Newborn infants of tuberculous mothers, further comment.
Topics: Female; Humans; Infant; Isoniazid; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infe | 1969 |
[Results of the treatment of children and adolescents in the early period of primary tuberculous infection].
Topics: Adolescent; Aminosalicylic Acids; Antitubercular Agents; Child; Child, Preschool; Humans; Infant; Is | 1968 |
Isoniazid prophylaxis in a slum area.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Humans; Isoniazid; Male; Middle Aged; Pove | 1969 |
[Remote results of antitubercular chemoprophylaxis and its current applications].
Topics: Adolescent; BCG Vaccine; Child; Humans; Immunity, Active; Isoniazid; Italy; Tuberculosis, Pulmonary | 1967 |
The treatment of tuberculosis in children.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; BCG Vaccine; Child; Humans; Isoniazid; Streptomycin; | 1969 |
[Report on five cases of congenital tuberculosis. Possibility of achieving a sterilisatio magna by intensive and early therapy in one case of congenital tuberculosis by deglutition].
Topics: Adult; Autopsy; Deglutition; Female; Humans; Infant; Infant Mortality; Infant, Newborn; Isoniazid; M | 1969 |
[Cysts in the lung of tuberculous children].
Topics: Adolescent; Child; Child, Preschool; Cysts; Humans; Infant; Isoniazid; Lung Neoplasms; Tuberculosis, | 1968 |
[Late results and modern indications in INH chemoprophylaxis].
Topics: Humans; Isoniazid; Retrospective Studies; Tuberculosis, Pulmonary | 1968 |
[The role and significance of vitamin B6 in some pathological conditions in children. I].
Topics: Adolescent; Child; Child, Preschool; Drug Antagonism; Ethionamide; Humans; Infant; Isoniazid; Pyrido | 1969 |
[Liquefying effect on suppurations of an oral dose of calciferol].
Topics: Abscess; Adrenal Insufficiency; Adult; Calcium; Chloramphenicol; Citrates; Citric Acid Cycle; Empyem | 1969 |
Toxicity of pyrazinamide, administered once weekly in high dosage, in tuberculous patients.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; Blood Chemical Analysis; Female | 1968 |
The paradox of BCG.
Topics: Adult; BCG Vaccine; Humans; Infant; Isoniazid; Tuberculin Test; Tuberculosis; Tuberculosis, Pulmonar | 1969 |
Tuberculosis of the spine treated by chemotherapy and operative débridement. A long-term follow-up study.
Topics: Adolescent; Aminosalicylic Acids; Antitubercular Agents; Casts, Surgical; Child; Child, Preschool; D | 1969 |
Tuberculosis of the hip and knee treated by chemotherapy, synovectomy, and débridement. A follow-up study.
Topics: Adolescent; Aminosalicylic Acids; Antitubercular Agents; Arthrodesis; Cartilage, Articular; Child; C | 1969 |
[Modernized indications for chemoprophylaxis of tuberculosis in children and adolescents].
Topics: Adolescent; Aminosalicylic Acids; BCG Vaccine; Child; Child, Preschool; Drug Tolerance; Female; Huma | 1969 |
[Manifestations of a rheumatic type caused by antituberculosis chemotherapy].
Topics: Acrodynia; Aged; Antitubercular Agents; Arthritis, Rheumatoid; Cycloserine; Ethionamide; Female; Hum | 1969 |
Massive lymphadenopathy in primary pulmonary tuberculosis in children.
Topics: Child, Preschool; Female; Humans; Infant; Isoniazid; Lymphadenitis; Male; Pulmonary Atelectasis; Rad | 1969 |
[Problems related to ambulatory treatment with isoniazid and aminosalicylic acid].
Topics: Ambulatory Care; Aminosalicylic Acids; Humans; Isoniazid; Male; Tuberculosis, Pulmonary | 1967 |
[Chemotherapy and chemoprophylaxis in children's sanatorial antituberculous institutions].
Topics: Aminosalicylic Acids; Child, Preschool; Hospitals, Special; Humans; Isoniazid; Schools, Nursery; Tub | 1969 |
[Rifampicin in tuberculosis. Summary of the observations and discussion].
Topics: Drug Synergism; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1968 |
A 5-year study of patients with pulmonary tuberculosis treated at home in a controlled comparison of isoniazid plus PAS with 3 regimens of isoniazid alone.
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Follow-Up Studies; Home Car | 1969 |
[Preliminary use of ethambutol in the therapy of tuberculosis in children].
Topics: Age Factors; Antitubercular Agents; Child; Child, Preschool; Drug Synergism; Ethambutol; Female; Hum | 1968 |
[Concentration of free isoniazid in blood and its urinary excretion in various methods of administration to children with pulmonary tuberculosis].
Topics: Adolescent; Child; Humans; Injections, Intravenous; Isoniazid; Time Factors; Tuberculosis, Pulmonary | 1970 |
The treatment of tuberculosis in children.
Topics: BCG Vaccine; Child; Humans; Isoniazid; Tuberculosis, Pulmonary | 1970 |
Attack rate of tuberculosis in a 5-year period among close family contacts of tuberculous patients under domiciliary treatment with isoniazid plus PAS or isoniazid alone.
Topics: Ambulatory Care; Aminosalicylic Acids; Child; Child, Preschool; Environmental Exposure; Female; Foll | 1970 |
[Prevention of tuberculosis in infants and young children exposed to tuberculous infection].
Topics: Child, Preschool; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Tuberculosis, Pulmonary | 1969 |
Foreign body (peanut) in the left main stem bronchus.
Topics: Arachis; Bronchial Diseases; Bronchoscopy; Diagnosis, Differential; Female; Foreign Bodies; Humans; | 1970 |
Ethambutol in primary childhood tuberculosis.
Topics: Child, Preschool; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Humans; Infant; Isoniazid; | 1970 |
Ethambutol in unresponsive childhood tuberculosis.
Topics: Aminosalicylic Acids; Child; Child, Preschool; Drug Resistance, Microbial; Drug Synergism; Ethambuto | 1970 |
[Respective roles of chemoprophylaxis and BCG in the prevention of infantile tuberculosis].
Topics: Adolescent; Adult; BCG Vaccine; Child; Child, Preschool; France; Humans; Infant; Infant, Newborn; Is | 1970 |
[Chemoprophylaxis of tuberculous infection in pre-allergic state].
Topics: BCG Vaccine; Female; Humans; Infant; Infant, Newborn; Isoniazid; Tuberculosis, Pulmonary | 1970 |
[Diphasic treatment of pulmonary tuberculosis in children using rifamycin, ethambutol and isoniazid].
Topics: Child; Child, Preschool; Drug Synergism; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Rifamp | 1970 |
Interpretation of the multiple puncture tuberculin reaction.
Topics: Adult; Antibody Specificity; BCG Vaccine; Child; Cross Reactions; Humans; Isoniazid; School Health S | 1970 |
[Use of single daily doses of tuberculostatic preparations in extra-pulmonary tuberculosis in children].
Topics: Adolescent; Aminosalicylic Acids; Child; Child, Preschool; Female; Humans; Isoniazid; Male; Tubercul | 1970 |
[Current problems in primary tuberculosis of children].
Topics: Adolescent; Adult; BCG Vaccine; Child; Child, Preschool; Humans; Hypersensitivity, Delayed; Isoniazi | 1971 |
[Prevention of tuberculosis among children born into families infected with tuberculosis].
Topics: Breast Feeding; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Isoniazid; Male; Methods | 1970 |
[The clinical picture, course and treatment of focal pulmonary tuberculosis in adolescents under current conditions].
Topics: Adolescent; Adult; Aminosalicylic Acids; Female; Humans; Isoniazid; Male; Tuberculosis, Pulmonary | 1970 |
The school tuberculosis surveys.
Topics: Child; Health Surveys; Humans; Isoniazid; Mass Screening; New Jersey; School Health Services; Tuberc | 1971 |
Comments on logistics of chemoprophylaxis of tuberculosis.
Topics: Adolescent; Child; Humans; Isoniazid; New York; School Health Services; Tuberculin Test; Tuberculosi | 1971 |
Logistics of chemoprophylaxis of tuberculosis.
Topics: Adolescent; Child; Child, Preschool; Female; Humans; Isoniazid; Male; New York; School Health Servic | 1971 |
Logistics of chemoprophylaxis of tuberculosis.
Topics: Adolescent; Child; Humans; Isoniazid; New York; School Health Services; Time Factors; Tuberculosis, | 1971 |
Potentially serious side effects of high-dose twice-weekly rifampicin.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Antibodies; Child; Coombs Test; Epistaxis; Female; Fev | 1971 |
Serum immunoglobulins in pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antibodies; Antibodies, Antinuclear; Ethnicity; Female; Humans; Immunoglobu | 1971 |
[Tuberculosis in children. Experience with 132 children in the Juliana Hospital from 1960-1969].
Topics: Age Factors; Aminosalicylic Acids; Isoniazid; Netherlands; Radiography; Streptomycin; Tuberculosis, | 1971 |
[Efficacy of ethambutol, used in combination with isoniazid, in the treatment of hilar and peripheral adenopathies and tubercular adenomesenteritis in children. Changes in the clinical and radiological pictures, blood sedimentation rate, hemochromocytomet
Topics: Adolescent; Blood Protein Electrophoresis; Blood Sedimentation; Child; Child, Preschool; Ethambutol; | 1971 |
Clinical experiences in cases of primary tuberculosis with tuberculostaticum Isoxyl.
Topics: Child, Preschool; Drug Combinations; Drug Synergism; Female; Humans; Infant; Isoniazid; Lung; Male; | 1970 |
[Results of many years of chemical prevention of tuberculosis in children].
Topics: Evaluation Studies as Topic; Humans; Isoniazid; Time Factors; Tuberculin Test; Tuberculosis, Pulmona | 1971 |
[Immediate results of intravenous chemotherapy of pulmonary tuberculosis in children and adolescents].
Topics: Administration, Oral; Adolescent; Aminosalicylic Acids; Child; Female; Humans; Injections, Intraveno | 1971 |
[Effectiveness of chemotherapy in children with chronic tubercular infections].
Topics: Aminosalicylic Acids; Child; Child, Preschool; Chronic Disease; Humans; Isoniazid; Tuberculosis, Pul | 1971 |
Isoniazid acetylation rates (phenotypes) of patients being treated for tuberculosis.
Topics: Humans; Isoniazid; Phenotype; Tuberculosis; Tuberculosis, Pulmonary | 1971 |
Evaluation of cycloserine as an antituberculous drug.
Topics: Aminosalicylic Acids; Cycloserine; Drug Resistance, Microbial; Humans; Isoniazid; Microbial Sensitiv | 1970 |
Tuberculous meningitis developing during the course of chemotherapy for pulmonary tuberculosis.
Topics: Child, Preschool; Humans; Isoniazid; Male; Prednisone; Streptomycin; Tuberculosis, Meningeal; Tuberc | 1969 |
In Canada: a trial of chemoprophylaxis in inactive tuberculosis.
Topics: Aminosalicylic Acids; Canada; Drug Resistance, Microbial; Follow-Up Studies; Humans; Isoniazid; Tube | 1969 |
[Changes in ECG following intravenous administration of isonicotinic acid hydrazide].
Topics: Adult; Aged; Electrocardiography; Female; Humans; Injections, Intravenous; Isoniazid; Male; Middle A | 1969 |
Isoniazid prophylaxis in Alaskan Boarding schools. A comparison of two doses.
Topics: Adolescent; Adult; Alaska; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Indians, Nort | 1969 |
[Intravenous method of chemotherapy of pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Female; Humans; Injections, In | 1969 |
[A comparative study of tubazid inactivation in patients with pulmonary tuberculosis with fractional and single daily doses].
Topics: Adult; Female; Humans; Isoniazid; Male; Middle Aged; Tuberculosis, Pulmonary | 1969 |
Case of extreme hypersensitivity to almost all antituberculous drugs.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cortisone; Drug Hypersensitivity; Ethambutol; Fludrocor | 1969 |
Pulmonary tuberculosis in the elderly.
Topics: Aged; Aminosalicylic Acids; Hospitalization; Humans; Hypersensitivity; Isoniazid; Radiography; Strep | 1969 |
[Preventive administration of isonicotinic acid hydrazide in long-term corticosteroid therapy].
Topics: Adult; Aged; Female; Glucocorticoids; Humans; Isoniazid; Male; Middle Aged; Prednisone; Time Factors | 1969 |
Liver damage and isoniazid allergy.
Topics: Adult; Aminosalicylic Acids; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; De | 1969 |
[Effect of basic tuberculostatic preparations of the 1st and 2d order in the bioelectric activity of the brain in patients with pulmonary tuberculosis].
Topics: Action Potentials; Adolescent; Adult; Antitubercular Agents; Brain; Cerebral Cortex; Cycloserine; De | 1969 |
Drugs in the treatment of tuberculosis--1969.
Topics: Aminosalicylic Acids; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; | 1969 |
Treatment of patients with pulmonary tuberculosis classified according to the history of previous chemotherapy and without reference to pre-treatment drug sensitivity.
Topics: Aminosalicylic Acids; Brazil; Chronic Disease; Drug Resistance, Microbial; Hospitalization; Humans; | 1969 |
[Isoniazid-H3 distribution in a tubercular focus in the wall of a pulmonary cavern in rats].
Topics: Animals; Isoniazid; Lung; Rats; Tritium; Tuberculosis, Pulmonary | 1969 |
The pathogenesis and treatment of isoniazid-resistant tuberculosis in 13 patients.
Topics: Adult; Antitubercular Agents; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Middle Ag | 1969 |
[Bacteriostatic concentration of tubazid, streptomycin and PAS in the blood of tuberculous patients in separate and combined administration of the drugs].
Topics: Aminosalicylic Acids; Drug Synergism; Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1969 |
[Disorders of hemopoiesis in relation to treatment of pulmonary tuberculosis].
Topics: Anemia, Aplastic; Humans; Isoniazid; Male; Middle Aged; Thiosemicarbazones; Tuberculosis, Pulmonary | 1969 |
[Clinical results obtained by rifomycin treatment of patients with recent tuberculosis].
Topics: Drug Synergism; Humans; Isoniazid; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1969 |
[Treatment of recent pulmonary tuberculosis with combined rifomycin-isoniazid].
Topics: Adult; Drug Synergism; Female; Humans; Isoniazid; Male; Rifampin; Time Factors; Tuberculosis, Pulmon | 1969 |
[Tubazid therapy of cavernous pulmonary tuberculosis in rabbits].
Topics: Animals; Isoniazid; Lung; Rabbits; Tuberculosis, Pulmonary | 1969 |
[Immediate and remote results of chemoprophylaxis in children and adolescents in foci of tuberculosis infections].
Topics: Disease Reservoirs; Follow-Up Studies; Isoniazid; Time Factors; Tuberculosis, Pulmonary | 1969 |
[Improved therapy of tuberculosis with a well tolerated INH derivative (INHG)].
Topics: Cycloserine; Ethambutol; Ethionamide; Glucuronates; Humans; Isoniazid; Middle Aged; Pyrazinamide; St | 1969 |
Therapeutical aspects in chronic pulmonary tuberculosis.
Topics: Adolescent; Adult; Age Factors; Aminosalicylic Acids; Antitubercular Agents; Chronic Disease; Collap | 1969 |
Chronic tuberculosis in refractory patients--therapeutic aspects.
Topics: Aminosalicylic Acids; Antitubercular Agents; Chronic Disease; Cycloserine; Drug Resistance, Microbia | 1969 |
[Ethionamide and tubazid in the therapy of pulmonary tuberculosis].
Topics: Adult; Aged; Ethionamide; Humans; Isoniazid; Middle Aged; Tuberculosis, Pulmonary | 1969 |
[Changes in the blood coagulation in patients with pulmonary tuberculosis during treatment with preparations of the first order].
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Blood Coagulation; Blood Coagu | 1969 |
[Comparative evaluation of several functional tests of the liver in patients with pulmonary tuberculosis with side-reactions to tuberculostatic preparations].
Topics: Adult; Antitubercular Agents; Cycloserine; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Liver; | 1969 |
[Neuropsychiatric repercussions of antitubercular treatment with isoniazid, or isoniazid and ethionamide (apropos of 8 cases)].
Topics: Adult; Coma; Ethionamide; Female; Humans; Isoniazid; Male; Mental Disorders; Middle Aged; Neurologic | 1969 |
[Treatment of pulmonary tuberculosis by combined rifampicin-isoniazid-streptomycin, and return to work after the 45th day].
Topics: Absenteeism; Adult; Drug Synergism; Humans; Isoniazid; Male; Middle Aged; Prognosis; Rifampin; Strep | 1969 |
[Remote results of the treatment of pulmonary tuberculosis in former military personnel].
Topics: Adult; Aminosalicylic Acids; Eligibility Determination; Hospitals, Special; Humans; Isoniazid; Male; | 1969 |
[Isoxyl in the treatment of pulmonary tuberculosis].
Topics: Female; Humans; Isoniazid; Male; Phenylthiourea; Tuberculosis, Pulmonary | 1969 |
[Experience with the chemoprophylaxis of pulmonary tuberculosis in diabetes mellitus patients].
Topics: Diabetes Complications; Humans; Isoniazid; Tuberculosis, Pulmonary | 1969 |
[Effectiveness and problems of the treatment of tuberculosis under the environmental conditions of an underdeveloped country].
Topics: Ambulatory Care; Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Humans; Is | 1969 |
[Acute agranulocytosis in a pregnant woman treated for pulmonary tuberculosis].
Topics: Agranulocytosis; Female; Humans; Isoniazid; Pregnancy; Pregnancy Complications, Hematologic; Pregnan | 1969 |
Bi-weekly streptomycin and isoniazid therapy after daily treatment for 3 months. Second investigation.
Topics: Adult; Humans; Isoniazid; Male; Middle Aged; Prognosis; Streptomycin; Tuberculosis, Pulmonary | 1969 |
Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Drug Resistance, Microbial; Drug Synergism; E | 1969 |
[Results of routine treatment of pulmonary tuberculosis patients treated for the 1st time].
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Drug Synergism; Female; Humans; Isoniazid; Male; Midd | 1969 |
[Comparative study (tolerance and effectiveness) of classic antituberculous therapy (P.A.S.-streptomycin-isoniazid) and a new combination (prothionamide-streptomycin-isoniazid)].
Topics: Administration, Oral; Amides; Aminosalicylic Acids; Drug Combinations; Humans; Injections, Intraveno | 1969 |
Jaundice and death from isoniazid.
Topics: Adult; Aged; Female; Humans; Isoniazid; Jaundice; Male; Middle Aged; Tuberculosis, Pulmonary | 1970 |
Posthospital chemotherapy of the unreliable patient.
Topics: Adult; Aged; Alcoholism; Ambulatory Care; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle | 1970 |
[Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Drug Synergism; Ethambutol; | 1970 |
Isoniazid and alcohol.
Topics: Adult; Alcoholic Intoxication; Alcoholism; Drug Synergism; Ethanol; Humans; Isoniazid; Male; Tubercu | 1970 |
The infectiousness of the tuberculin-positive child.
Topics: Child; Humans; Isoniazid; Tuberculin Test; Tuberculosis, Pulmonary | 1970 |
[Mechanism of action and effectiveness of intravenous administration of tubazid, streptomycin and PAS in the therapy of pulmonary tuberculosis].
Topics: Adolescent; Adult; Aminosalicylic Acids; Child; Child, Preschool; Humans; Injections, Intravenous; I | 1970 |
[Significance of the isoniazid inactivation in the therapy of pulmonary tuberculosis].
Topics: Humans; Isoniazid; Tuberculosis, Pulmonary | 1970 |
Madras study of two once-weekly regimens: clinical aspects.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Child; Drug Resistance, Microbial; Humans; Isoniazid; | 1970 |
Madras study of two once-weekly regimens: laboratory aspects.
Topics: Drug Resistance, Microbial; Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1970 |
[Controlled study of a bi-weekly treatment with isoniazid and ethionamide].
Topics: Adult; Drug Resistance, Microbial; Ethionamide; Female; Humans; Isoniazid; Male; Tuberculosis, Pulmo | 1970 |
[Comparison of 2 intermittent therapeutic regimens: ethionamide-isoniazid and streptomycin-isoniazid].
Topics: Drug Resistance, Microbial; Ethionamide; Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1970 |
Trial of sanatorium treatment including a comparison of standard and intermittent continuation chemotherapy: Central Bohemian Tuberculosis Services-WHO-British Medical Research Council investigation.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Humans; Isoniazid; Middle Aged; Streptomycin; Time Fa | 1970 |
A five regimen study of triple-versus double-drug chemotherapy--U.S. Veterans Administration study.
Topics: Aged; Aminosalicylic Acids; Drug Resistance, Microbial; Humans; Isoniazid; Streptomycin; Tuberculosi | 1970 |
Ethambutol in primary chemotherapy.
Topics: Aminosalicylic Acids; Ethambutol; Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonary; Visual A | 1970 |
[Liver function during tuberculosis therapy with streptomycin, isoniazid and aminosalicylate].
Topics: Aminosalicylic Acids; Humans; Isoniazid; Liver; Streptomycin; Tuberculosis, Pulmonary | 1970 |
Preventive treatment for tuberculous infection. Recommendations of the National Communicable Disease Center.
Topics: Communicable Disease Control; Humans; Isoniazid; Mass Screening; Tuberculin Test; Tuberculosis, Pulm | 1970 |
[Purple weals due to rimifon].
Topics: Adrenocortical Hyperfunction; Adult; Humans; Isoniazid; Male; Skin Diseases; Tuberculosis, Pulmonary | 1970 |
[Beware of tuberculosis].
Topics: Adult; Antitubercular Agents; Female; Humans; Immunosuppressive Agents; Isoniazid; Male; Middle Aged | 1970 |
Ethambutol in the retreatment of chronic pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Chronic Disease; Cycloserine; Depression, Chemical; Drug Synergism; Ethambutol | 1970 |
Jaundice after rifampicin.
Topics: Aged; Aspartate Aminotransferases; Humans; Isoniazid; Jaundice; Liver Function Tests; Male; Rifampin | 1970 |
Tuberculous meningitis during therapy for pulmonary tuberculosis.
Topics: Adrenal Cortex Hormones; Drug Resistance, Microbial; Humans; Infant; Isoniazid; Tuberculosis, Mening | 1970 |
Tuberculous meningitis during therapy for pulmonary tuberculosis.
Topics: Drug Resistance, Microbial; Humans; Infant; Isoniazid; Tuberculosis, Meningeal; Tuberculosis, Pulmon | 1970 |
Tuberculous meningitis during therapy for pulmonary tuberculosis.
Topics: Drug Resistance, Microbial; Humans; Infant; Isoniazid; Tuberculosis, Meningeal; Tuberculosis, Pulmon | 1970 |
[Ethambutol combined with streptomycin and isoniazid for the original treatment cases of pulmonary tuberculosis].
Topics: Aminosalicylic Acids; Drug Synergism; Ethambutol; Female; Humans; Isoniazid; Male; Streptomycin; Tub | 1970 |
[Experience in local therapy of tubercular caverns and residual cavities with administrations of sealing materials].
Topics: Humans; Isoniazid; Tuberculosis, Pulmonary | 1970 |
Chemoprophylaxis to control tuberculosis.
Topics: Humans; Isoniazid; Tuberculosis, Pulmonary | 1970 |
[Four drug combination including Ethambutol and early switching to entirely new regimen in initial treatment of pulmonary tuberculosis].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Drug Synergism; Ethambutol; | 1970 |
[Some functional shifts occurring in the cardiovascular system, following a long-term antibacterial treatment].
Topics: Adolescent; Adult; Aminosalicylic Acids; Ballistocardiography; Cardiovascular System; Electrocardiog | 1970 |
[Distribution and elimination of isoniazid-H3 in pulmonary tuberculosis patients].
Topics: Adult; Female; Humans; Isoniazid; Male; Middle Aged; Tritium; Tuberculosis, Pulmonary | 1970 |
[Treatment of pulmonary tuberculosis with intermittent dosage of streptomycin and isoniazid].
Topics: Adolescent; Adult; Aged; Drug Tolerance; Female; Humans; Isoniazid; Male; Middle Aged; Streptomycin; | 1970 |
[Therapeutic results of freshly diagnosed pulmonary tuberculosis EMB in association with SM and INH administered both continuously and intermittently].
Topics: Ethambutol; Humans; Isoniazid; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1970 |
[Results of treatment of pulmonary tuberculosis in school children with modified standard chemotherapy].
Topics: Adolescent; Aminosalicylic Acids; Child; Female; Humans; Isoniazid; Male; Time Factors; Tuberculosis | 1970 |
[Classical chemotherapy: the intermittent method in freshly diagnosed pulmonary tuberculosis. Preliminary report].
Topics: Humans; Isoniazid; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1970 |
Twenty-seven months of chemoprophylaxis for prevention of tuberculosis in Mississippi.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Infant, | 1970 |
It's time for BCG vaccine.
Topics: BCG Vaccine; Humans; Isoniazid; Tuberculin Test; Tuberculosis; Tuberculosis, Pulmonary; United State | 1970 |
[Clinical experience in the single administration of daily doses of chemical preparations].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Humans; Isoniazid; Male; Streptomycin; Time Fact | 1970 |
[New drugs in the treatment of primary tuberculosis].
Topics: Aminosalicylic Acids; Child; Child, Preschool; Ethambutol; Female; France; Humans; Isoniazid; Male; | 1970 |
Adverse effects of isoniazid and their significance for chemoprophylaxis.
Topics: Biopsy; Cholestasis; Drug Hypersensitivity; Isoniazid; Liver; Transaminases; Tuberculosis, Pulmonary | 1970 |
Pulmonary tuberculosis, isoniazid and cancer.
Topics: Adult; Aged; Alcohol Drinking; Gastrointestinal Neoplasms; Humans; Isoniazid; Lung Neoplasms; Male; | 1970 |
[Comparative study of specific blood activity in patients with fibrous-cavernous pulmonary tuberculosis during administration of different combinations of antibacterial preparations].
Topics: Blood Bactericidal Activity; Cycloserine; Ethionamide; Humans; Isoniazid; Pyrazinamide; Time Factors | 1970 |
Capreomycin-induced serum electrolyte abnormalities.
Topics: Adult; Aged; Alkalosis; Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Female; Humans; Hy | 1970 |
Alcoholism and tuberculosis in Victoria.
Topics: Adolescent; Adult; Age Factors; Aged; Alcoholism; Aminobenzoates; Australia; Child; Child, Preschool | 1970 |
A two-year follow-up of 181 sputum-positive tuberculosis patients treated in Gateshead between 1961 and 1966.
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Hypersensitivity; Drug Resistance, Microbial; Engl | 1970 |
Twice-weekly streptomycin plus isoniazid for tuberculosis.
Topics: Adult; Aminosalicylic Acids; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Female; | 1970 |
[Blood concentration of basic tuberculostatic preparations with single administration of daily doses in pulmonary tuberculosis].
Topics: Aminosalicylic Acids; Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1970 |
Mental disorders caused by isonicotinic acid hydrazide (INH) in the course of treatment of pulmonary tuberculosis.
Topics: Affective Symptoms; Age Factors; Alcoholism; Central Nervous System Diseases; Delirium; Delusions; E | 1970 |
[Appearance of agranulocytic reaction associated with acute onset on tonsillitis against a background of ethoxyd, tubazid and metazid administration].
Topics: Adult; Agranulocytosis; Antitubercular Agents; Humans; Isoniazid; Male; Tonsillitis; Tuberculosis, P | 1970 |
[Severe hypoprothrombinemia in a tubercular patient treated by combined rifampicin, isoniazid, streptomycin and prothionamide].
Topics: Adult; Drug Synergism; Female; Humans; Hypoprothrombinemias; Isoniazid; Isonicotinic Acids; Rifampin | 1970 |
[Pulmonary tuberculosis in aged patients: therapeutic methods and results (121 cases)].
Topics: Age Factors; Aged; Aminosalicylic Acids; Antitubercular Agents; Drug Synergism; Female; Humans; Ison | 1970 |
[Streptomycin therapy during pregnancy and its effect on the hearing of the offspring].
Topics: Aminosalicylic Acids; Audiometry; Auditory Perception; Auditory Threshold; Child; Child, Preschool; | 1970 |
[Errors in testing the INH content in the organism].
Topics: Humans; Isoniazid; Tuberculosis, Pulmonary | 1970 |
[Results of initial treatment of pulmonary tuberculosis using ethambutol, isonicotinic acid hydrazide and rifampicin].
Topics: Adolescent; Adult; Aged; Drug Synergism; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; R | 1970 |
[Treatment of patients with pulmonary tuberculosis with the use of differentiated single doses of Tubazid].
Topics: Adult; Aged; Humans; Isoniazid; Middle Aged; Tuberculosis, Pulmonary | 1970 |
[Level of isoniazid in fluid biological media in aged patients with pulmonary tuberculosis complex antibacterial therapy].
Topics: Age Factors; Aged; Cantharidin; Cortisone; Exudates and Transudates; Humans; Insulin; Isoniazid; Mid | 1970 |
[3 cases of severe acute tubazid poisoning].
Topics: Adolescent; Adult; Humans; Isoniazid; Male; Middle Aged; Tuberculosis, Pulmonary | 1970 |
Clinical experience after more than a year's ethambutol administration.
Topics: Adult; Chronic Disease; Drug Combinations; Ethambutol; Humans; Isoniazid; Middle Aged; Sputum; Strep | 1970 |
Rifampicin in retreatment and original treatment cases of pulmonary tuberculosis.
Topics: Drug Combinations; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Time Factors; Tuberculosis | 1970 |
[Case report on the treatment of bone tuberculosis with rifampicin (Rimactan)].
Topics: Adrenal Cortex Hormones; Bronchitis; Humans; Isoniazid; Male; Middle Aged; Prognosis; Rifampin; Spon | 1970 |
A triple regimen of streptomycin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 2.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Ethambutol; Female; Humans; Isoniazid; Male; Middle A | 1970 |
The incidence of genito-urinary tuberculosisin the Western Region of Scotland.
Topics: Adolescent; Adult; Age Factors; Aged; Aminosalicylic Acids; Animals; Cattle; Child; Drug Resistance, | 1970 |
[Infectius hepatitis (Botkin's disease) in patients with pulmonary tuberculosis].
Topics: Female; Hepatitis A; Humans; Isoniazid; Male; Streptomycin; Tuberculosis, Pulmonary | 1970 |
[Chemoprevention of tuberculosis in patients with anthracosilicosis].
Topics: Adult; Anthracosilicosis; Humans; Isoniazid; Male; Middle Aged; Tuberculosis, Pulmonary | 1970 |
Clinical experiences with thiocarlide (Isoxyl) in combination therapy of freshly evaluated tuberculosis.
Topics: Aminosalicylic Acids; Drug Combinations; Drug Synergism; Ethionamide; Female; Humans; Isoniazid; Mal | 1970 |
Isoxyl: a review of the results of its use over a five-year period in the tuberculosis field service of a large urban area.
Topics: Adult; Aminosalicylic Acids; Cycloserine; Drug Combinations; Drug Resistance, Microbial; Ethionamide | 1970 |
Original course of chemotherapy in pulmonary tuberculosis with a double drug regimen: isoniazid-streptomycin versus isoniazid-thiocarlide.
Topics: Drug Combinations; Drug Resistance, Microbial; Evaluation Studies as Topic; Follow-Up Studies; Human | 1970 |
[Activity of Isoxyl on Mycobacterium kansasii; studies in vitro and in the pneumoconiotic guinea pig].
Topics: Administration, Oral; Animals; Body Weight; Drug Combinations; Ethambutol; Ethionamide; Guinea Pigs; | 1970 |
[Ethambutol in the treatment of pulmonary tuberculosis].
Topics: Administration, Oral; Animals; Cattle; Drug Combinations; Drug Resistance; Ethambutol; Eye Diseases; | 1970 |
Clinical experience with Myambutol in the treatment of polyresistant chronic tuberculosis.
Topics: Adult; Cycloserine; Drug Combinations; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin | 1970 |
The practicing physician, the tuberculin reactor and isoniazid.
Topics: Connecticut; Humans; Isoniazid; Tuberculosis, Pulmonary | 1971 |
Pulmonary alveolar proteinosis. Treatment of a case complicated by tuberculosis.
Topics: Acetylcysteine; Adult; Aminosalicylic Acids; Female; Heparin; Humans; Isoniazid; Oxygen; Oxygen Inha | 1971 |
[Changing picture of tuberculosis during a decade].
Topics: Adult; Age Factors; Aged; Aminosalicylic Acids; Drug Resistance, Microbial; Ethambutol; Female; Huma | 1971 |
The results of tuberculosis chemotherapy in chest clinic practice.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Child; Child, Preschool; Drug | 1971 |
[The hemogram and ESR in pulmonary tuberculosis during intravenous administration of the primary antitubercular drugs].
Topics: Adolescent; Adult; Aminosalicylic Acids; Blood Cell Count; Blood Sedimentation; Drug Hypersensitivit | 1971 |
[Comparative findings from various approaches of treating infiltrative and cavernous pulmonary tuberculosis in rabbits].
Topics: Administration, Oral; Aminosalicylic Acids; Animals; Injections, Intramuscular; Isoniazid; Pyridoxin | 1971 |
[Place of ethambutol associated with isoniazid or with rifampicin in the treatment of pulmonary tuberculosis].
Topics: Adolescent; Adult; Drug Synergism; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampi | 1971 |
Drug-resistant tuberculosis in Waltham forest, 1953-68. A clinical and epidemiological study.
Topics: Adult; Age Factors; Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; England | 1971 |
[Clinical problems of the syntropy of pulmonary tuberculosis and stomach resection].
Topics: Cycloserine; Digestion; Female; Humans; Isoniazid; Male; Postoperative Complications; Sex Factors; S | 1971 |
[Evaluation of initial combined chemotherapy with SM, INH and EB for pulmonary tuberculosis. 2. Comparison of SM, EB and INH regimen with that of SM, PAS and INH for experimental tuberculosis of mice].
Topics: Administration, Oral; Aminosalicylic Acids; Animals; Ethambutol; Isoniazid; Lung; Mice; Spleen; Stre | 1971 |
Acute hepatitis due to para-aminosalicylic acid.
Topics: Acute Disease; Adult; Aminosalicylic Acids; Chemical and Drug Induced Liver Injury; Female; Humans; | 1971 |
[Enzyme reactions in the lungs of rabbits with tuberculous inflammation].
Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Isoniazid; Lung; Lymphoid Tissue; Macrophages; Phag | 1971 |
Trial of rifampicin in the treatment of pulmonary tuberculosis. A preliminary report.
Topics: Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1971 |
[Chemotherapy of pulmonary tuberculosis in pregnancy].
Topics: BCG Vaccine; Female; Humans; Infant, Newborn; Isoniazid; Pregnancy; Pregnancy Complications, Infecti | 1967 |
[On acute isoniazid poisoning on the basis of 2 successfully treated cases].
Topics: Adult; Alcoholism; Blood Transfusion; Brain; Brain Edema; Gastric Lavage; Glucose; Glutamates; Human | 1967 |
Severe hypoglycaemia in the course of treatment with streptomycin, isoniazid and ethionamide.
Topics: Aged; Ethionamide; Humans; Hypoglycemia; Isoniazid; Male; Streptomycin; Tuberculosis, Pulmonary | 1967 |
Comparative study of biweekly streptomycin and isoniazid with daily P.A.S. and isoniazid regimens in the treatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Aminosalicylic Acids; Antitubercular Agents; Female; Humans; Isoniazid; Male; Mid | 1967 |
[Striae cutis atrophica following INH medication].
Topics: Adult; Atrophy; Connective Tissue; Female; Humans; Isoniazid; Skin Diseases; Tuberculosis, Pulmonary | 1967 |
[Toxicity of the primary tuberculostatics].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Humans; Isoniazid; Pyrazinamide; Streptomy | 1967 |
The rate of isoniazid inactivation in Finnish diabetic and non-diabetic patients.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Diabetes Mellitus; Diabetes Mellitus, Type 1; Female; F | 1967 |
[Current established major antibiotic therapy of pulmonary tuberculosis].
Topics: Aminosalicylic Acids; Antitubercular Agents; Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonar | 1967 |
[A case of acute poisoning with tubazid].
Topics: Adult; Humans; Isoniazid; Male; Tuberculosis, Pulmonary | 1967 |
[Initial clinical results on the use of combined isoniazid plus trypsin and chymotrypsin in pulmonary tbc].
Topics: Chymotrypsin; Drug Synergism; Humans; Isoniazid; Trypsin; Tuberculosis, Pulmonary | 1967 |
[On the therapeutic evaluation of high doses of tubazid].
Topics: Adolescent; Adult; Aged; Humans; Isoniazid; Middle Aged; Tuberculosis, Pulmonary | 1967 |
[Resorption and intensity of inactivation of isoniazid].
Topics: Diet Therapy; Gastrointestinal Diseases; Humans; Isoniazid; Tuberculosis, Pulmonary | 1967 |
[Treatment of primary bronchopulmonary infection].
Topics: Aminosalicylic Acids; Bronchial Diseases; Drug Synergism; Humans; Infections; Isoniazid; Lung Diseas | 1967 |
[Blood and urine INH levels, administered orally alone or combined with proteolytic enzymes].
Topics: Adult; Drug Synergism; Humans; Isoniazid; Male; Peptide Hydrolases; Tuberculosis, Pulmonary | 1967 |
[Utilization in the treatment of tuberculosis in children of a single daily oral dose of isoniazid and para-aminosalicylic acid].
Topics: Aminosalicylic Acids; Child; Child, Preschool; Drug Synergism; Female; Humans; Infant; Isoniazid; Ma | 1967 |
[Clinical significance of the inactivation of tubazid in the endobronchial method of treatment of destructive pulmonary tuberculosis].
Topics: Adolescent; Adult; Humans; Isoniazid; Methods; Middle Aged; Tuberculosis, Pulmonary | 1967 |
[Effectiveness of chemotherapy in patients with primary distructive tuberculosis].
Topics: Adult; Age Factors; Aminosalicylic Acids; Female; Humans; Isoniazid; Male; Middle Aged; Streptomycin | 1967 |
[Trial treatment of pulmonary tuberculosis with a combination of isoniazid and an injectable diphenylthiourea preparation].
Topics: Adolescent; Adult; Aged; BCG Vaccine; Drug Tolerance; Female; Humans; Injections, Intramuscular; Iso | 1967 |
[Capreomycin, ethambutol and isoniazid in the original treatment of pulmonary tuberculosis].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Drug Synergism; Ethambutol; Female; Humans; Isoniazid; Mal | 1967 |
[On the usefulness of vitamin B 6 during treatment with isoniazid].
Topics: Animals; Humans; Isoniazid; Mental Disorders; Polyneuropathies; Transaminases; Tuberculosis, Pulmona | 1967 |
[Experience with te new antitubercular agents isoxyl, ethambutol, morphazinamid and rifomycin].
Topics: Culture Techniques; Cycloserine; Ethambutol; Humans; Isoniazid; Monocytes; Phenylthiourea; Pyrazines | 1967 |
[Clinical experiences with INH-isoxyl therapy of primary tuberculosis].
Topics: Antitubercular Agents; Child; Child, Preschool; Drug Synergism; Humans; Infant; Isoniazid; Phenylthi | 1967 |
[Experience in the conduct of chemical measures for tuberculosis prevention among the troops].
Topics: Humans; Isoniazid; Male; Military Medicine; Tuberculosis, Pulmonary; USSR | 1967 |
[The epidemiological and clinical significance of the drug resistance of Mycobacterium tuberculosis].
Topics: Adolescent; Adult; Child; Drug Resistance, Microbial; Humans; Isoniazid; Streptomycin; Tuberculosis, | 1967 |
[On the present status of chemotherapy of lung tuberculosis, especially in ambulatory use].
Topics: Adolescent; Adult; Aged; Ambulatory Care; Child; Child, Preschool; Ethionamide; Female; Humans; Infa | 1967 |
[Contribution on the relationship between tuberculosis and alcoholism. Experimental morphological study results].
Topics: Acid Phosphatase; Alcoholism; Alkaline Phosphatase; Animals; Antitubercular Agents; Bronchi; Ethanol | 1967 |
[Experimental and scintigraphic study of aerosol therapy, particularly in pulmonary tuberculosis].
Topics: Aerosols; Animals; Chloramphenicol; Cycloserine; Guinea Pigs; Humans; Isoniazid; Neomycin; Radionucl | 1967 |
Hypersensitivity angiitis during treatment for pulmonary tuberculosis.
Topics: Adult; Aminosalicylic Acids; Drug Hypersensitivity; Humans; Isoniazid; Male; Middle Aged; Muscles; S | 1968 |
The eradication of tuberculosis infection by isoniazid chemoprophylaxis.
Topics: Adult; Child; Humans; Isoniazid; Naval Medicine; Tuberculin Test; Tuberculosis, Pulmonary; United St | 1968 |
The clinical spectrum of primary tuberculosis in adults. Confusion with reinfection in the pathogenesis of chronic tuberculosis.
Topics: Adolescent; Adult; Age Factors; BCG Vaccine; Chronic Disease; Disease Outbreaks; Female; Follow-Up S | 1968 |
Chemoprophylaxis for the prevention of tuberculosis.
Topics: Humans; Isoniazid; Pneumoconiosis; Silicosis; Tuberculosis, Pulmonary | 1968 |
Pulmonary tuberculosis in patient on intermittent haemodialysis.
Topics: Adult; Aminosalicylic Acids; Female; Humans; Isoniazid; Kidney Failure, Chronic; Renal Dialysis; Str | 1968 |
Tuberculous chemotherapy for recalcitrant outpatients administered directly twice weekly.
Topics: Adult; Aged; Ambulatory Care; Attitude to Health; Female; Humans; Isoniazid; Male; Middle Aged; Outp | 1968 |
The use of second line drugs in patients with drug resistance to standard tuberculostatics.
Topics: Ambulatory Care; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Hypersensitivity; Dr | 1968 |
Isoniazid and impairment of memory.
Topics: Adolescent; Adult; Female; Humans; Isoniazid; Male; Memory; Middle Aged; Psychological Tests; Tuberc | 1968 |
Tuberculosis control in India.
Topics: Ambulatory Care; BCG Vaccine; Costs and Cost Analysis; Humans; India; Isoniazid; Mass Chest X-Ray; R | 1968 |
Reactivation of tuberculosis: some factors involved.
Topics: Age Factors; Follow-Up Studies; Humans; Isoniazid; Racial Groups; Time Factors; Tuberculosis, Pulmon | 1968 |
Incidence of drug hypersensitivity in the chemotherapy of tuberculosis.
Topics: Adolescent; Adult; Age Factors; Aged; Aminosalicylic Acids; Blood Sedimentation; Drug Hypersensitivi | 1968 |
A follow-up study of 134 cases of pulmonary tuberculosis treated with adequate chemotherapy in 1953-1954.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Canada; Female; Follow-Up Studies; Humans; Isoniazid; | 1968 |
Domiciliary drug therapy of pulmonary tuberculosis in a rural population in India.
Topics: Adolescent; Adult; Aged; Home Care Services; Humans; India; Isoniazid; Middle Aged; Rural Health; Tu | 1968 |
The chemoprophylaxis of tuberculosis in Gurkha soldiers.
Topics: Humans; Isoniazid; Male; Military Medicine; Tuberculosis, Pulmonary | 1968 |
[Effect of INH prophylaxis on tuberculin reactions in children].
Topics: Child; Child, Preschool; Humans; Isoniazid; Tuberculin Test; Tuberculosis, Pulmonary | 1968 |
Comparison between high daily dosage of isoniazid in divided doses and low daily dosage in a single dose in triple-drug regimens.
Topics: Adult; Aminosalicylic Acids; Drug Resistance, Microbial; Female; Humans; Isoniazid; Japan; Male; Mid | 1968 |
A pilot trial of rifampicin in tuberculosis.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Tolerance; Ethionamide; Female; Humans; Ison | 1968 |
Acute hepatic necrosis associated with ethionamide.
Topics: Adolescent; Aminosalicylic Acids; Chemical and Drug Induced Liver Injury; Ethionamide; Female; Human | 1968 |
[Tubazid poisoning].
Topics: Adult; Humans; Isoniazid; Male; Tuberculosis, Pulmonary | 1968 |
[Peculiarities of the clinical course of initially detected extensive pulmonary tuberculosis].
Topics: Adult; Female; Humans; Isoniazid; Male; Middle Aged; Thiosemicarbazones; Tuberculosis, Pulmonary | 1968 |
[Treatment of patients with fibrous-cavernous pulmonary tuberculosis with thioacetazone and large doses of isoniazid].
Topics: Adult; Aged; Female; Humans; Isoniazid; Male; Middle Aged; Thiosemicarbazones; Tuberculosis, Pulmona | 1968 |
Chemoprophylaxis in tuberculosis.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Georgia; Humans; Infant; Infant, Newborn; | 1968 |
[Rifampicin in experimental tuberculosis].
Topics: Animals; Ethambutol; Ethionamide; Isoniazid; Mice; Models, Biological; Rifampin; Tuberculosis, Pulmo | 1968 |
A comparison of tuberculosis control in Alaska and the District of Columbia.
Topics: Alaska; District of Columbia; Hospitalization; Humans; Isoniazid; Mass Chest X-Ray; Preventive Healt | 1968 |
A ten-year experience with the treatment of forcibly detained male tuberculous patients in New York City.
Topics: Isoniazid; New York City; Prisons; Streptomycin; Tuberculosis, Pulmonary | 1968 |
Systemic (cerebral) chromoblastomycosis: diagnosis during life, drug sensitivities, and treatment of a single case.
Topics: Adult; Amphotericin B; Brain Diseases; Chromoblastomycosis; Diagnosis, Differential; Female; Humans; | 1968 |
Diphenylhydantoin intoxication attendant to slow inactivation of isoniazid.
Topics: Animals; Cats; Drug Tolerance; Humans; Isoniazid; Phenytoin; Tuberculosis, Pulmonary | 1968 |
Updating tuberculosis control in occupational medicine.
Topics: Isoniazid; Mass Chest X-Ray; National Institutes of Health (U.S.); Occupational Health Services; Tub | 1968 |
[Bacteriological and pathological study of the changes in the early stages of airborne infection with tubercle bacilli. 3. Influence of isoniazid treatment and BCG vaccination].
Topics: Animals; BCG Vaccine; Guinea Pigs; Isoniazid; Lung; Tuberculosis, Pulmonary | 1968 |
[Review of tuberculosis control measures. 4. Studies on high risk groups at the present in Japan and on the effects of chemoprophylaxis].
Topics: Adolescent; Adult; Aged; BCG Vaccine; Child; Female; Humans; Isoniazid; Male; Middle Aged; Tuberculi | 1968 |
[Review of tuberculosis control measures. 5. Intensity of tuberculin reaction after positive conversion and the effects of chemoprophylaxis].
Topics: Humans; Isoniazid; Tuberculin Test; Tuberculosis, Pulmonary | 1968 |
[Evaluation of new classification standards for the effects of chemotherapy].
Topics: Aminosalicylic Acids; Drug Therapy; Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1968 |
[Tubazid treatment of cavernous pulmonary tuberculosis in the dog].
Topics: Animals; Dogs; Isoniazid; Pyrogens; Tuberculosis, Pulmonary | 1968 |
[Early and late results of the first "massive" antitubercular treatment using ETA].
Topics: Ethionamide; Female; Humans; Isoniazid; Male; Retrospective Studies; Statistics as Topic; Tuberculos | 1968 |
[Level of INH in blood serum in tuberculous patients treated by means of ultrasonic inhalations].
Topics: Aerosols; Humans; Isoniazid; Tuberculosis, Pulmonary; Ultrasonics | 1968 |
[Tryptophan test in the assay of pyridoxine (vitamin B6) in patients with pulmonary tuberculosis with regard to treatment with INH and ETA].
Topics: Ethionamide; Female; Humans; Isoniazid; Male; Pyridoxine; Tryptophan; Tuberculosis, Pulmonary | 1968 |
[Side effects of ETA combined with INH and SM in the first antituberculous treatment of pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Drug Tolerance; Ethionamide; Female | 1968 |
[Certain aspects of new combinations of drugs for the treatment of drug-resistant tuberculosis].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Ethionamide; Humans; Isonia | 1968 |
[Intermittent long-term cheomotherapy in experimental tuberculosis of the mouse].
Topics: Animals; Antitubercular Agents; Drug Resistance, Microbial; Ethionamide; Isoniazid; Mice; Streptomyc | 1968 |
[Results of a study carried out in Morocco on intermittent treatment of pulmonary tuberculosis with a bi-weekly combination of isoniazid and streptomycin adminisrered intramuscularly].
Topics: Drug Resistance, Microbial; Humans; Injections, Intramuscular; Isoniazid; Morocco; Streptomycin; Tub | 1968 |
[Results of bi-weekly treatment with isoniazid and streptomycine in 135 cases of pulmonary tuberculisis, in Algiers].
Topics: Adult; Algeria; Drug Resistance, Microbial; Female; Follow-Up Studies; Humans; Isoniazid; Male; Stre | 1968 |
Intermittent ambulatory treatment of tuberculosis once a week, preceded by a 30-day intensive hospital treatment.
Topics: Ambulatory Care; Hospitalization; Humans; Isoniazid; Pyridoxine; Sputum; Streptomycin; Tuberculosis, | 1968 |
[Modification in standard chemotherapy: administration of drugs in a single daily dose (Preliminary report)].
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Humans; Isoniazid; Medication Systems, Hospital; Midd | 1968 |
[Percentage ratio of free- and acetyl-INH in the urine as a method of determination of the INH inactivation pattern].
Topics: Adult; Humans; Isoniazid; Models, Biological; Tuberculosis, Pulmonary | 1968 |
[Current possibilities of classical chemotherapy in new cases of pulmonary tuberculosis].
Topics: Acute Disease; Adult; Aminosalicylic Acids; Female; Humans; Isoniazid; Male; Retrospective Studies; | 1968 |
[Intermittent chemotherapy].
Topics: Humans; Isoniazid; Methods; Streptomycin; Tuberculosis, Pulmonary | 1968 |
[Resistance of arterial capillaries in tuberculous patients].
Topics: Capillary Resistance; Humans; Isoniazid; Pulmonary Artery; Pulmonary Circulation; Tuberculosis, Pulm | 1968 |
[Primary resistance to the major antitubercular drugs in pulmonary tuberculosis patients during 1961-1966].
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Humans; Isoniazid; Retrospective Studies; Streptom | 1968 |
[Reasons for failures in chemotherapy of tuberculosis].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Drug Synergism; Drug Tolera | 1968 |
[Problems of primary resistance].
Topics: Drug Resistance, Microbial; Hospitalization; Humans; Isoniazid; Male; Middle Aged; Tuberculosis, Pul | 1968 |
[Biweekly treatment of pulmonary tuberculosis by isoniazid and streptomycin with or without initial continuous phase. Results obtained in Algeria].
Topics: Adult; Algeria; Drug Synergism; Female; Humans; Isoniazid; Male; Periodicity; Streptomycin; Tubercul | 1968 |
[Bronchial tuberculosis due to reinfection].
Topics: Adult; Aged; Bronchial Diseases; Bronchoscopy; Female; Humans; Isoniazid; Lung Diseases; Male; Metho | 1968 |
[On antitubercular prevention with isoniazid].
Topics: Animals; Cattle; Communicable Disease Control; Guinea Pigs; Humans; Isoniazid; Tuberculosis, Bovine; | 1968 |
[Report on the scientific and didactic activity at the Clinica Tisiologica of Rome University, the research center and the Ospedale Sanatoriale Carlo Forlanini of INPS during 1967].
Topics: Hospitals, Teaching; Humans; Isoniazid; Italy; Lung Neoplasms; Nuclear Medicine; Research; Tuberculo | 1968 |
[Convulsive crises and coma revealing acute isoniazid poisoning].
Topics: Adult; Coma; Female; Humans; Isoniazid; Seizures; Tuberculosis, Pulmonary | 1968 |
[Prophylactic and preventive measures in the fight against tuberculosis].
Topics: Aminosalicylic Acids; Antitubercular Agents; BCG Vaccine; Cycloserine; Humans; Isoniazid; Streptomyc | 1968 |
[Psychiatric and neurological symptoms caused by cycloserine poisoning].
Topics: Adolescent; Adult; Cycloserine; Electroencephalography; Ethionamide; Female; Humans; Isoniazid; Kana | 1968 |
[Clinical picture and therapy of patients with a combined course of infectious hepatitis and pulmonary tuberculosis].
Topics: Hepatitis A; Humans; Isoniazid; Tuberculosis, Pulmonary | 1968 |
Modification of the serum isoniazid levels by different preparations of paraaminosalicylic acid.
Topics: Absorption; Aminosalicylic Acids; Depression, Chemical; Fluorometry; Humans; Isoniazid; Sodium; Spec | 1968 |
[Biweekly treatment of pulmonary tuberculosis with isoniazid and streptomycin, with or without initial continuous phase. Results obtained in Algiers].
Topics: Algeria; Drug Resistance, Microbial; Humans; Isoniazid; Streptomycin; Time Factors; Tuberculosis, Pu | 1968 |
Intermittent chemotherapy for tuberculosis in an urban community.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Child; Child, Preschool; Female; Humans; Isoniazid; M | 1969 |
Musculoskeletal tuberculosis.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Child; Humans; Isoniazid; Middle Aged; Streptomycin; | 1969 |
Focal pulmonary alveolar proteinosis in pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Ethionamide; Humans; Isoniazid; Pulmonary Alveolar Proteinosis; Steroids; Stre | 1969 |
Public health aspects of relapsing tuberculosis.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Child, Preschool; Denmark; Female; Humans; Isoniazid; M | 1969 |
Tuberculosis, isoniazid and corticosteroids.
Topics: Adrenal Cortex Hormones; Adult; Female; Humans; Isoniazid; Prednisone; Tuberculosis; Tuberculosis, P | 1969 |
[Management of chronic pulmonary tuberculosis using ethambutol (6 months of treatment)].
Topics: Adult; Chronic Disease; Cycloserine; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Middl | 1969 |
Incidence of drug intolerance to antituberculosis chemotherapy.
Topics: Aminosalicylic Acids; Antitubercular Agents; Colorado; Drug Hypersensitivity; Humans; Isoniazid; Str | 1969 |
Agranulocytosis following isoniazid--a case report.
Topics: Adult; Agranulocytosis; Humans; Isoniazid; Male; Tuberculosis, Pulmonary | 1969 |
Pulmoary tubercular lesions modified by chemotherapy.
Topics: Collagen; Humans; Isoniazid; Lung; Lymphocytes; Macrophages; Pneumoconiosis; Pulmonary Alveoli; Stre | 1969 |
Tuberculosis from the Far East.
Topics: Asia, Eastern; BCG Vaccine; Humans; Isoniazid; Military Medicine; Tuberculosis, Pulmonary; United St | 1969 |
Tuberculosis from the Far East.
Topics: Asia, Eastern; Humans; Isoniazid; Military Medicine; Public Health; Tuberculin Test; Tuberculosis, P | 1969 |
[Late results of modified classical therapy].
Topics: Aminosalicylic Acids; Drug Tolerance; Female; Humans; Isoniazid; Male; Retrospective Studies; Sputum | 1969 |
[Side effects of antibacterial drugs in the clinical course of pulmonary tuberculosis].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Humans; Isoniazid; Middle Aged; Str | 1969 |
[Evaluation of initial combined chemotherapy with SM, INH and EB for pulmonary tuberculosis. I. Clinical comparison of SM, INH and EB regimen with SM, INH and PAS regimen].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Radiography | 1969 |
Observations on human infection with Mycobacterium bovis.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Animals; Cattle; Drug Resistance, Microbial; Humans; | 1969 |
[Effect of corticotherapy on the residual pulmonary lesions after antitubercular chemotherapy].
Topics: Animals; Bronchiectasis; Cattle; Cortisone; Drug Synergism; Isoniazid; Lung; Pulmonary Emphysema; Ra | 1969 |
[The function of the cardiovascular system in patients with pulmonary tuberculosis treated by intravenous administration of streptomycin, tubazid and PAS].
Topics: Adolescent; Adult; Aminosalicylic Acids; Cardiovascular System; Humans; Injections, Intravenous; Iso | 1969 |
Fungal infecton of central nervous system supervening during routine chemotherapy for pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Aspergillosis; Brain Diseases; Central Nervous System Diseases; Humans; Isonia | 1965 |
[Chronic neuritis and convulsive syndrome following the administration of isoniazid].
Topics: Adolescent; Female; Humans; Isoniazid; Optic Neuritis; Seizures; Tuberculosis, Pulmonary | 1965 |
[Scientific and didactic activity of the C. Forlanini tuberculosis clinic, center for studies and sanatorium of the I.N.P.S. during the year 1964].
Topics: Academies and Institutes; Bronchitis; Isoniazid; Italy; Mycobacterium; Tuberculosis, Pulmonary | 1965 |
Retreatment of drug resistant tuberculosis at Battey State Hospital.
Topics: Adolescent; Adult; Aged; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; I | 1965 |
The prospective use of BCG and isoniazid chemoprophylaxis in prevention of tuberculosis in developed and developing countries.
Topics: Adolescent; BCG Vaccine; Humans; Isoniazid; Tuberculosis, Pulmonary | 1965 |
[Comparison of efficiency of large and small doses of isoniazid in combined treatment in pulmonary tuberculosis].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Female; Humans; Isoniazid; Male; Tuberculosis, P | 1965 |
Ethionamide 1,000 mG. and isoniazid 400 mG. in previously untreated cases of pulmonary tuberculosis.
Topics: Ethionamide; Follow-Up Studies; Humans; Isoniazid; Prognosis; Statistics as Topic; Tuberculosis, Pul | 1965 |
Ethionamide, 750 mg. daily, plus isoniazid, 450 mg. daily, in previously untreated cases of pulmonary tuberculosis.
Topics: Drug Synergism; Ethionamide; Humans; Isoniazid; Tuberculosis, Pulmonary | 1965 |
Bilateral tuberculous granulomas of the tongue.
Topics: Adult; Aminosalicylic Acids; Diagnosis, Differential; Humans; Isoniazid; Male; Pyridoxine; Tongue Di | 1965 |
[One-year results of initial therapy of cavernous pulmonary tuberculosis with isoniazid, streptomycin and ethionamide].
Topics: Ethionamide; Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1965 |
[Problems of post-sanatorial antimycobacterial treatment].
Topics: Antitubercular Agents; Cycloserine; Ethionamide; Follow-Up Studies; Humans; Isoniazid; Pyrazines; Tu | 1965 |
The long-term use of intermittent streptomycin plus isoniazid in the treatment of tuberculosis.
Topics: Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1965 |
On the separation of drugs from W/O emulsion systems (cavity fillers). 1. Influence of the water portion, preparation technic and temperature with special reference to physical-galenic reference numbers.
Topics: Animals; Chemistry, Pharmaceutical; Emulsions; Humans; In Vitro Techniques; Isoniazid; Tuberculosis, | 1965 |
[Significance of the inactivation of isonicotinic acid hydroxide preparations in the combined treatment of pulmonary tuberculosis].
Topics: Adult; Female; Humans; Isoniazid; Male; Tuberculosis, Pulmonary | 1965 |
[Inactivation of tubazid and its influence on the effectiveness of antibacterial therapy of patients with pulmonary tuberculosis].
Topics: Adolescent; Adult; Humans; Isoniazid; Middle Aged; Tuberculosis, Pulmonary | 1965 |
[Critical study of antibiotic tests systematically performed before treatment of pulmonary tuberculous patients].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Hypersensitivity; Drug Tolerance; Ethionamide; Hum | 1965 |
[On the freeing of drugs from W/O emulsion systems (cavity fillers). 2. Influence of degree of dispersion].
Topics: Chemistry, Pharmaceutical; Emulsions; Isoniazid; Tuberculosis, Pulmonary | 1965 |
Drug sensitivity in pulmonary tuberculosis. Incidence of primary and acquired drug-resistance in 1960-1963.
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Humans; Isoniazid; Statistics as Topic; Streptomyc | 1965 |
[Results of conservative treatment of specific upper lobe cavities].
Topics: Adult; Female; Humans; Isoniazid; Thiosemicarbazones; Tuberculosis, Pulmonary | 1965 |
[INH-metabolism and development of resistance].
Topics: Drug Resistance, Microbial; Humans; Isoniazid; Tuberculosis, Pulmonary | 1965 |
[Treatment of pulmonary tuberculosis with a combination of long-acting isoniazid inhalation and pyridoxine].
Topics: Drug Synergism; Humans; Isoniazid; Pyridoxine; Tuberculosis, Pulmonary | 1965 |
[Toxico-allergic reactions in the use of antibacterial preparations in patients with tuberculosis of the lungs].
Topics: Drug Hypersensitivity; Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1965 |
[Comparative data on the tolerance of phthivazid, methazid and tubazid in patients with pulmonary tuberculosis].
Topics: Female; Humans; Isoniazid; Middle Aged; Tuberculosis, Pulmonary | 1965 |
[Experimental studies on the pulmonary artery ligation. II. Pulmonary artery ligation and rabbit pulmonary tuberculosis with and without INAH treatment].
Topics: Animals; Isoniazid; Pulmonary Artery; Rabbits; Tuberculosis, Pulmonary | 1965 |
[Clinical significance of the resistance to the classical tuberculostatics].
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Humans; Isoniazid; Streptomycin; Tuberculosis, Pul | 1965 |
[Treatment of INH- and streptomycin-resistant patients].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Humans; Isoniazid; Streptomycin; Tuberculosis, Pu | 1965 |
[Clinical and bacteriological problems of ethionamide therapy].
Topics: Drug Resistance, Microbial; Ethionamide; Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1965 |
[Simultaneous determination of INH and ethionamide concentration in the lung].
Topics: Ethionamide; Humans; Isoniazid; Lung; Tuberculosis, Pulmonary | 1965 |
[Evaluation of classical chemotherapy in in-patient and out-patient treatment of freshly detected pulmonary tuberculosis].
Topics: Aminosalicylic Acids; Hospitalization; Humans; Isoniazid; Outpatient Clinics, Hospital; Poland; Stre | 1965 |
[Antibacterial therapy of pulmonary tuberculosis in the Bulgarian People's Republic and possibilities of its improvement].
Topics: Aminosalicylic Acids; Bulgaria; Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1965 |
[The significance of INH metabolism analysis for therapy. II].
Topics: Blood Chemical Analysis; Humans; Isoniazid; Tuberculosis, Pulmonary | 1965 |
[On qualitative demonstration of tuberculostatics in the control of taking of drugs].
Topics: Aminosalicylic Acids; Cycloserine; Ethionamide; Humans; Isoniazid; Pyrazinamide; Streptomycin; Tuber | 1965 |
[Effect of simultaneous administration of 5-bromosalicylhydroxamic acid (T40) and INH on the concentration of free INH in urine of tubercular patients].
Topics: Antitubercular Agents; Drug Synergism; Humans; Isoniazid; Tuberculosis, Pulmonary; Urine | 1965 |
[INH-induced pellagra in pulmonary tuberculosis].
Topics: Adult; Aminosalicylic Acids; Diagnosis, Differential; Female; Humans; Isoniazid; Male; Middle Aged; | 1965 |
[Contributions to the treatment of tuberculosis with combined Timosulfone and INH].
Topics: Adult; Female; Humans; Isoniazid; Male; Middle Aged; Radiography, Thoracic; Sulfones; Tuberculosis, | 1965 |
The effect of INH on the liver cell in patients with pulmonary tuberculosis and viral hepatitis.
Topics: Adult; Cycloserine; Humans; Isoniazid; Liver; Liver Function Tests; Middle Aged; Streptomycin; Tuber | 1966 |
Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
Topics: Adult; Aminosalicylic Acids; Ethionamide; Female; Humans; Isoniazid; Male; Sputum; Streptomycin; Tub | 1966 |
Clinicopathologic conference.
Topics: Demyelinating Diseases; Female; Humans; Isoniazid; Middle Aged; Tuberculosis, Pulmonary | 1966 |
Results of one-year chemotherapy in previously untreated patients with cavernous pulmonary tuberculosis.
Topics: Adult; Aminosalicylic Acids; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Middle Age | 1966 |
Pyridoxine-responsive anemia conditioned by isonicotinic acid hydrazide.
Topics: Adult; Aged; Anemia; Black or African American; Female; Humans; Isoniazid; Male; Pyridoxine; Tubercu | 1966 |
Reversible sideroblastic anemia caused by pyrazinoic acid (Pyrazinamide).
Topics: Adult; Aminosalicylic Acids; Anemia; Anemia, Sideroblastic; Erythropoiesis; Ethionamide; Female; Fol | 1966 |
Assay of antituberculosis drugs in tuberculous patients.
Topics: Aminosalicylic Acids; Humans; In Vitro Techniques; Isoniazid; Tuberculosis, Pulmonary | 1966 |
Serum antimycobacterial activity test and chemotherapy of the patients infected with unclassified mycobacteria.
Topics: Adult; Aminosalicylic Acids; Humans; Isoniazid; Mycobacterium; Mycobacterium Infections; Serologic T | 1966 |
Healing of Pott's disease with antimicrobial therapy.
Topics: Adult; Aminosalicylic Acids; Humans; Isoniazid; Male; Middle Aged; Tuberculosis, Pulmonary; Tubercul | 1966 |
[Reflections on a complex hyperlipemia revealed during treatment with isoniazed].
Topics: Humans; Hypercholesterolemia; Hyperlipidemias; Isoniazid; Male; Middle Aged; Tuberculosis, Pulmonary | 1966 |
Combined therapy with isoniazid and ethionamide in ulcero-caseous tuberculosis.
Topics: Adult; Animals; Ethionamide; Female; Humans; In Vitro Techniques; Isoniazid; Male; Middle Aged; Rabb | 1966 |
Ambulatory treatment of pulmonary tuberculosis. A clinical evaluation of 1684 patients.
Topics: Adult; Aminosalicylic Acids; Child; Drug Resistance, Microbial; Evaluation Studies as Topic; Female; | 1966 |
[Studies on the combined use of preparations from tubercle bacilli and antituberculous drugs for pulmonary tuberculosis].
Topics: Adolescent; Adult; Aminosalicylic Acids; Female; Humans; Injections, Intradermal; Isoniazid; Male; T | 1966 |
[Primary bacterial resistance in pulmonary tuberculosis: epidemiologic deductions].
Topics: Drug Resistance, Microbial; Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1966 |
Effects of isonicotinic acid hydrazide administered to tuberculous guinea-pigs at different doses and at different space intervals.
Topics: Animals; Guinea Pigs; Isoniazid; Tuberculosis, Pulmonary | 1966 |
[Effect of INH therapy on tuberculous lesions developing during blocking of the reticulo-histiocytic system].
Topics: Animals; Isoniazid; Mononuclear Phagocyte System; Rabbits; Trypan Blue; Tuberculosis, Pulmonary | 1966 |
[Pulmonary tuberculosis and pregnancy].
Topics: BCG Vaccine; Female; Humans; Infant, Newborn; Isoniazid; Lactation; Pregnancy; Pregnancy Complicatio | 1966 |
A two-year follow-up of patients with quiescent pulmonary tuberculosis following a year of chemotherapy with an intermittent (twice-weekly) regimen of isoniazid plus streptomycin or a daily regimen of isoniazid plus PAS.
Topics: Aminosalicylic Acids; Follow-Up Studies; Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1966 |
Kaolin agglutination test in diagnosis of tuberculosis in Kenya.
Topics: Adolescent; Adult; Aged; Agglutination Tests; Black or African American; Black People; Child; Child, | 1966 |
Glucose-6-phosphatase activity in experimental tuberculosis and following isoniazid treatment.
Topics: Animals; Glucosephosphate Dehydrogenase; Guinea Pigs; Isoniazid; Kidney; Male; Tuberculosis, Pulmona | 1966 |
[Is there still justification for using streptomycin solely as a "protective drug" in surgery?].
Topics: Aminosalicylic Acids; Humans; Isoniazid; Streptomycin; Tuberculosis, Pulmonary | 1966 |
[Pronounced Tubazid-induced polyneuritis in a patient with pulmonary tuberculosis].
Topics: Adult; Humans; Isoniazid; Male; Polyneuropathies; Tuberculosis, Pulmonary | 1966 |
[On the effects of streptomycin and isonicotinic acid hydrazide on Mantoux reactions].
Topics: Eye Diseases; Humans; Hypersensitivity, Delayed; Isoniazid; Streptomycin; Tuberculin Test; Tuberculo | 1966 |
[Hematic concentrations of free isoniazid after rectal administration].
Topics: Adolescent; Adult; Humans; Isoniazid; Middle Aged; Tuberculosis, Pulmonary | 1966 |
[Chemotherapy of asympthomatic tuberculin conversion].
Topics: Adolescent; Adult; Aged; BCG Vaccine; Child; Child, Preschool; Female; Humans; Hypersensitivity, Del | 1966 |
[The cavern plug treatment, a bronchoscopic contribution on the problem: open and closed cavern healing].
Topics: Adult; Antitubercular Agents; Bronchoscopy; Emulsions; Fats; Humans; Isoniazid; Male; Methods; Middl | 1966 |
[Necessity of the isoniazid and pyridoxine combination in phthisiology].
Topics: Humans; Isoniazid; Pyridoxine; Tuberculosis, Pulmonary | 1966 |
[Preliminary findings and considerations on primary resistance to SM, INI, and PAS in the Provincial Antitubercular Association of Naples].
Topics: Adolescent; Adult; Aminosalicylic Acids; Drug Resistance, Microbial; Humans; Isoniazid; Middle Aged; | 1966 |